Comparison of two indirect calorimetry devices at varying levels of inspired oxygen by Poulsen, Mathias Krogh et al.
   
 
Aalborg Universitet
Comparison of two indirect calorimetry devices at varying levels of inspired oxygen
Poulsen, Mathias Krogh; Thomsen, Lars Pilegaard; Kjærgaard, Søren; Rees, Stephen
Edward; Karbing, Dan Stieper
Published in:
Intensive Care Medicine Experimental
DOI (link to publication from Publisher):
10.1186/s40635-016-0099-9
Publication date:
2016
Document Version
Publisher's PDF, also known as Version of record
Link to publication from Aalborg University
Citation for published version (APA):
Poulsen, M. K., Thomsen, L. P., Kjærgaard, S., Rees, S. E., & Karbing, D. S. (2016). Comparison of two indirect
calorimetry devices at varying levels of inspired oxygen. Intensive Care Medicine Experimental, 4(Suppl. 1, Part
Two), 258-259. [A497]. DOI: 10.1186/s40635-016-0099-9
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            ? Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            ? You may not further distribute the material or use it for any profit-making activity or commercial gain
            ? You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us at vbn@aub.aau.dk providing details, and we will remove access to
the work immediately and investigate your claim.
Downloaded from vbn.aau.dk on: May 01, 2017
MEETING ABSTRACTS Open Access
ESICM LIVES 2016: part two
Milan, Italy. 1–5 October 2016
Published: 29 September 2016
NEUROMONITORING
A391
Physiologic monitoring for neurocritically-ill patients: an
international survey of intensivists
S. Sivakumar1, F.S. Taccone2, K.A. Desai1, C. Lazaridis1
1Baylor College of Medicine, Neurology/Neurocritical Care, Houston, TX,
USA; 2Erasmus Hospital, Intensive Care Medicine, Brussels, Belgium
Correspondence: C. Lazaridis - Baylor College of Medicine, Neurology/
Neurocritical Care, Houston, TX, USA
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A391
Introduction In addition to systemic hemodynamics, the management
of neurocritically ill patients is often informed by neuromonitoring. In
the absence of high-level evidence clinicians are often guided by per-
sonal and local expertise. Little is known about practices as they pertain
to the use of such monitoring in patients with acute brain injury (ABI).
Objectives To investigate practices in bedside monitoring for ABI pa-
tients. Particularly interested in differences among “neurointensivists”
(NIs; defined here as intensivists whose clinical practice is com-
prised > 1/3 by neurocritical care) and other intensivists (OIs). Also, to
explore patterns specific to traumatic brain injury (TBI) and subarach-
noid hemorrhage (SAH), as well as preferences and availability of
particular technologies/devices.
Methods Electronic survey of 22 items including two case-based sce-
narios; endorsed by SCCM (9,000 recipients) and ESICM (on-line
newsletter) in 2013. A sample size of 370 was calculated based on a
population of 10,000 physician members, a 5 % margin error, and
95 % confidence interval. We summarized results using descriptive
statistics (proportions with 95 % confidence intervals). A chi-square
test was used to compare proportions of responses between NIs and
OIs with a significance p < 0.05.
Results There were 655 responders (66 % completion rate); 422(65 %)
were classified as OIs and 226(35 %) as NIs. More NIs follow
hemodynamic protocols for neurocritically-ill patients (56 % vs. 43 %, p
0.001), in TBI (44.5 % vs. 33.3 %, p 0.007), and in SAH (38.1 % vs. 21.3 %,
p < 000.1). For delayed cerebral ischemia (DCI), more NIs target cardiac
index (CI) (35 % vs. 21 %, p 0.0001), and fluid responsiveness (62 % vs.
53 %, p 0.03), use more bedside ultrasound (BUS) (42 % vs. 29 %, p
0.005) and arterial waveform analysis (40 % vs. 29 %, p 0.02). For DCI
neuromonitoring, NIs use more angiography (57 % vs. 43 %, p 0.004),
TCD (46 % vs. 38 %, p 0.0001), and CTP (32 % vs.16 %, p 0.0001). For
CPP optimization in TBI, NIs use more arterial waveform analysis (45 %
vs. 35 %, p 0.019), and BUS (37 % vs. 27.7 %, p 0.023), while more OIs
monitor mixed venous oxygen saturation (54.1 % vs. 45 %, p 0.045). For
TBI neuromonitoring, NIs use more PbtO2 (28 % vs. 10 %, p 0.0001). In
the case scenario of raised ICP/low PbtO2, most employ analgosedation
(47 %) and osmotherapy (38 %). Fewer make use of preserved pressure
reactivity, particularly OIs (vasopressor use 23 % vs. 34 %, p 0.014).
Conclusions There is large heterogeneity in the use of monitoring pro-
tocols, variables, and technologies/devices. “Neurointensivists” not only
employ more neuromonitoring but also more hemodynamic monitor-
ing in patients with acute brain injury. ICP/CPP remain the most com-
monly followed neuro-variables in TBI patients, with low use of other
brain-physiology parameters, suggesting that clinicians make limited
efforts to individualize these goals.
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Introduction Impairment of cerebral autoregulation has been pro-
posed as a possible explanation of cognitive dysfunction in patients
with septic shock. Although transcranial Doppler has previously been
used to assess cerebral autoregulation, this technology can only evalu-
ate at single points in time. In contrast, near-infrared spectroscopy
offers continuous assessment of cerebral autoregulation.
Objectives Assess cerebral autoregulation using NIRS in patients
admitted to the intensive care unit with septic shock.
Methods We included 20 patients admitted with septic shock admit-
ted to the intensive care unit (ICU) at Vancouver General Hospital
(VGH). The ICU is a 31-bed mixed medical-surgical unit affiliated with
the University of British Columbia. We excluded patients with acute
or chronic neurological disorders, end stage liver disease, long-term
dialysis, and those admitted following a cardiac arrest. We measured
regional cerebral oximetry (rSO2) by NIRS (INVOS®, Covidien, Ireland)
for 24 hours. NIRS and mean arterial pressure (MAP) data were
collected in real time using ICM + ® brain monitoring software
(Cambridge University, UK). ICM+ calculates a moving Pearson
correlation coefficient (COx) between 30 consecutive, 10 second
average MAP and rSO2 values. Impaired cerebral autoregulation
was defined as a COx greater than 0.3. We also defined the im-
paired autoregulation index (IARindex) as the percentage of moni-
toring time spent with an impaired autoregulation. The IARindex
was calculated for each 6 hours period (H0H6; H6H12;H12H18,
H18H24), and for 24 hours.
Results We analyzed 19 patients, one patient being excluded from
analysis due to removal for arterial line [mean (Standard deviation);
median (interquartile)] age 67(12), APACHE II score 21(6) median
MAP 72 [67–75] mmHg, median rSO2 64 [57–70] %, median end tidal
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carbon dioxide 30 [27–35] mmHg and median temperature 37.1
[36.8-37.3] °C. After removal of artefacts, the mean monitoring time
was 22 h08 (8 h54). All patients had impaired cerebral autoregulation
during their monitoring time. The mean IAR index was 17 (9.5) %.
During H0H6 and H18H24, the majority of our patients; respectively 53
and 71 % had an IAR index > 10 %.
Conclusion According to our data, patients with septic shock had im-
paired cerebral autoregulation within the first 24 hours of their ad-
mission in the ICU. In our patients, we described a variability of
distribution of impaired autoregulation according to time.
References
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Introduction Patients with a traumatic brain injury (TBI) remain in
hospital for extended periods. It is likely that muscle mass in these
patients diminishes over the hospital admission, yet this has not previ-
ously been quantified. Ultrasonography may provide a useful measure
of changes in muscle size over the hospital stay.
Objectives To quantify changes in ultrasound-derived quadriceps
muscle layer thickness (QMLT) and establish the feasibility of repeated
ultrasound examinations throughout the entire hospitalisation of pa-
tients with a TBI.
Methods Adult patients with a moderate-severe TBI (Glasgow Coma
Scale 3–12) consecutively admitted to the intensive care unit (ICU) at
a single trauma referral centre over 12 months were eligible follow-
ing informed consent. Ultrasounds of QMLT at the midpoint and
two-thirds between the anterior superior iliac spine and top of the
patella were conducted weekly during admission. Data were cen-
sored at 3-months and are mean (SD) unless otherwise stated.
Results Thirty-three patients [45.4 (16.6) years; 88 % male; 55 %
severe TBI; Trauma Injury Severity Score 0.5 (0.3); median APACHE II
18 (IQR: 14–22); admission body mass index 27.2 (6.5) kg/m2] were
studied. Primary injury cause was vehicular (58 %) and 67 % of TBIs
were multi-trauma. Median length of ICU and ward-based stay was
13.4 [IQR: 6.5-17.9] and 31.8 [9.4-52.4] days, respectively. At 3-months
all patients were alive and four remained in hospital. A total of 123
ultrasounds were taken; 30 (24 %) in ICU and 93 (76 %) on the acute
ward, equal to 3.7 ultrasounds per patient. Ultrasounds were not pos-
sible at 21 % of time-points in hospital due to patient agitation and
61 % at 3-month follow-up due to inability to attend appointment in
person. Twenty-eight (85 %) patients had >1 ultrasound taken during
their admission, for which the mean baseline measure was 1.78
(0.72) cm and within patient standard deviation 0.3 cm. Nineteen pa-
tients (58 %) had >2 ultrasounds during the hospital admission with
a baseline measure of 1.78 (0.68) and proximate measure to dis-
charge of 1.53 (0.52) cm. There was a 6.2 (35.8) % decrease between
the baseline and proximate discharge measures. QMLT decreased
over the first four weeks of hospital admission [week 1 (n = 22): 2.01
(0.84), week 2 (n = 24): 1.66 (0.59), week 3 (n = 19): 1.50 (0.57), week 4
(n = 13): 1.40 (0.38)]. At 3-months the QMLT was 2.00 (0.7) cm (n =
22), with a decrease from baseline of 3.2 (26.0) %.
Conclusions This is the first study to describe longitudinal change in
muscle size over the hospital admission in patients with a moderate-
severe TBI. Whilst technically feasible, issues with compliance and
missing data and intra-individual variation between measurements
are challenges when conducting regular ultrasound measures in this
population. Muscle thickness reduced throughout hospitalisation, but
improved towards baseline by 3-months.
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Introduction Cerebral infarction due to delayed cerebral ischaemia
(DCI) remains a significant cause of morbidity and mortality following
aneurysmal subarachnoid haemorrhage (SAH). Damage to the brain in
the first 72 hours (“early brain injury”) is likely to play a key patho-
physiological role but remains difficult to quantify objectively and non-
invasively at the bedside- especially in those patients who do not
require sedation or ventilation. Current diagnostic modalities used in
routine clinical practice are either invasive, require ionising radiation or
contrast or have a high learning curve and user variability.
Objectives We sought to determine whether saccadic eye movements
are impaired following SAH and whether measurement of saccadic la-
tency (SL) in the acute period post-aneurysm rupture is associated with
the likelihood of developing DCI in patients after SAH.
Methods 24 male/female patients (mean age 53.32, range 31–70)
with World Federation of Neurosurgeons (WFNS) grade I and II
aneurysmal SAH, treated endovascularly within 72 hours of rupture
were recruited. DCI and DCI-related cerebral infarction were defined
as per consensus guidelines.1 Saccadometry data was collected at
three time points: in the first 72 hours, between days 5 and 10 and at
three months post-SAH. Data from 10 healthy age/gender matched
controls was collected on one occasion for comparison.
Results Age-adjusted median SL in patients was significantly pro-
longed in the first 72 hours post-SAH when compared to controls
(188.7, 95 % CI = (176.9, 202.2)ms v 160.7, 95 % CI = (145.6,
179.4)ms, p = 0.0054 t-test). By 3 months post-SAH, there was no
significant difference in median SL compared to controls (188.7, 95 %
CI = (176.9, 202.2)ms v 180.0, 95 % CI = (165.1, 197.8)ms, p = 0.4175
t-test). Patients diagnosed with cerebral infarction due to DCI had a
significantly higher age-adjusted median SL in the first 72 hours than
those without infarction (240.6, 95 % CI = (216.7, 270.3)ms v 204.1, 95 %
Fig. 1 (abstract 392). IAR index by 6 hours period
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CI = (190.7, 219.5)ms, p = 0.0157 t-test). This difference was more pro-
nounced during days 5–10 post-SAH - the peak incidence for DCI
(303.7, 95 % CI = (266.7 352.7)ms v 207.6, 95 % CI = (193.7, 223.6)ms, p
< 0.0001 t-test). A binary generalised linear model showed that median
SL in the first 72 hours was the only significant predictor of cerebral in-
farction after SAH.
Conclusions This is the first study to use saccadometry to measure eye
movements in patients with SAH during the acute period post-rupture.
Results show that median saccadic latency in the first 72 hours follow-
ing SAH is an independent predictor of the risk of developing cerebral
infarction due to DCI. Saccadometry may act as a potential objective
biomarker of early brain injury to guide the need for intensive care
admission and treatment.
References
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Introduction Spreading depolarisations (SD) occur spontaneously in is-
chaemic cortex and are implicated in the evolution of the ischaemic
penumbra. Subsequent enlargement of the ischaemic lesion causes
worse neurological outcomes. Monitoring for SDs is solely performed
through invasive electrocorticography (ECoG) which is located when a
patient requires emergency surgery. SDs can cause significant haemo-
dynamic changes which may be amenable to non-invasive monitoring.
Objectives This study seeks to develop such a technique using near-
infrared spectroscopy (NIRS). NIRS allows surrogate measure of cerebral
blood flow by inferring changes in the concentration of oxyhaemoglo-
bin and deoxyhaemoglobin.
Methods 5 ischaemic brain injury patients requiring emergency
neurosurgery (4 retrospective, 1 prospective) recruited to the COSBID
study at King's College Hospital (and monitored with ECoG) under-
went concomitant NIRS monitoring. The NIRS data was analysed for
significant haemodynamic response to SDs.
Results In total, three ECoG-confirmed SDs occurred during NIRS
monitoring, each in a different patient. Two acute (one minute) hypo-
perfusion responses were seen after an SD in one patient. One acute
(one minute) hyperperfusion response was seen after an SD in one pa-
tient. Three subacute (20 minute) hypoperfusion responses were seen
across two patients.
Conclusion This preliminary data is promising that NIRS can be used
to assess the haemodynamic responses secondary to SDs. More data
is required so that the responses can be characterised adequately
which could lead to a novel non-invasive monitoring technique.
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Introduction Two central physiologic targets in the management of
severe traumatic brain injury (TBI) are the intracranial pressure (ICP)
and the partial brain tissue oxygen tension (PbtO2). Intracranial pres-
sure and PbtO2 thresholds are incorporated into step-tiered clinical
protocols and guidelines however by the time treatment is provided,
it may be too late. The ability to predict the onset of these “crisis”
events would potentially provide clinicians with valuable time to
attempt aborting the episode and/or to appropriately manage it.
Combining statistical machine learning with physiologic and clinical
insight allows the construction of robust quantitative models to pre-
dict future events such as elevated ICP or low PbtO2. Such models
provide targets for evidence-based individualized treatment in real
time.
Objectives Develop computer algorithms that can recognize physio-
logic patterns in TBI patients that occur in advance of intracranial
pressure ICP and PbtO2 crises. The automated early detection of crisis
precursors can provide clinicians with time to intervene in order to
prevent or mitigate secondary brain injury.
Methods A retrospective study was conducted from prospectively
collected physiologic data. Intracranial pressure and PbtO2 crisis
events were defined as ICP ≥ 20 mmHg lasting at least 15 minutes
and PbtO2 values < 10 mmHg for at least 10 minutes, respectively.
The physiologic data preceding each crisis event were used to iden-
tify precursors associated with crisis onset. Multivariate classification
models were applied to recorded data in 30-minute epochs of time
to predict crises between 15 and 360 minutes in the future. Our
cohort consisted of 817 severe TBI subjects admitted to the neuro-
surgical intensive care unit of Ben Taub General Hospital in Houston,
Texas.
Results Our algorithm can predict the onset of an ICP crisis with
30 minutes advance warning and an AUC of 0.86 using only ICP mea-
surements and time since last crisis. An analogous algorithm can pre-
dict the start of PbtO2 crises with 30 minutes advanced warning and
an AUC of 0.91.
Conclusions We report here novel algorithms that provide accurate
and timely predictions of intracranial hypertension and tissue hyp-
oxia crises in patients with severe TBI. Almost all of the information
needed to predict the onset of these events is contained within the
signal of interest and the time since last crisis. These predictive algo-
rithms offer clinicians the opportunity to prepare and potentially pre-
vent secondary brain injury insults.
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Introduction Early identification of patients without potential for recov-
ery of brain function may prevent inappropriate treatment of comatose
patients after cardiac arrest. We recently showed that evolution of the
EEG pattern within the first 24 hours after cardiac arrest robustly con-
tributes to multimodal prediction of either poor or good outcome [1].
Objectives We aim to confirm our results and present a cost-
effectiveness analysis.
Methods 432 consecutive comatose patients after cardiac arrest were
included in a prospective cohort study on two intensive care units.
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Continuous EEG was measured during the first three days. EEGs
were visually classified as unfavorable (isoelectric, low-voltage,
burst-suppression-with-identical-bursts), intermediate, or favorable
(continuous patterns), at 12, 24, 48, and 72 hours by two reviewers,
independently. Outcome was dichotomized as good (CPC score 1
or 2) or poor (CPC score 3, 4, or 5) at six months. EEG parameters
were related to outcome using logistic regression analysis. Cost-
effectiveness in the hospital is currently estimated by decision tree
analysis.
Results Poor outcome occurred 54 % of included patients. Single
parameters unequivocally predicting poor outcome in the first 277
patients were an unfavorable EEG pattern at 24 hours, absent
pupillary light responses at 48 hours, and absent SSEPs at 72 hours.
Together, these had a specificity of 100 % and a sensitivity of 50 %.
Favorable EEG patterns at 12 hours were strongly associated with
good outcome. EEG beyond 24 hours had no additional predictive
value. For the remaining 155 patients, EEG analyses are ongoing.
Data on cost-effectiveness, based on the assumption of EEG based
treatment discontinuation, will be presented.
Conclusions EEG within 24 hours is a robust contributor to prediction
of poor or good outcome and should be included in guidelines for
treatment of comatose patients after cardiac arrest.
Reference
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Introduction Mechanisms of early brain injury (EBI) following
aneurysmal subarachnoid hemorrhage (SAH) are poorly understood.
Using brain perfusion CT (pCT) and cerebral microdialysis (CMD), we
examined the relationship of cerebral energy metabolism with brain
perfusion during the EBI phase after SAH in humans.
Methods Prospective observational cohort of poor-grade SAH pa-
tients monitored with cerebral microdialysis (CMD) who were resusci-
tated according to current guidelines. Data from brain pCT
(performed 44 ± 25 hrs from ictus) were matched to CMD epochs dis-
playing cerebral energy dysfunction, defined by a CMD lactate/pyru-
vate ratio > 40 and/or lactate > 4 mmol/L.
Results A total of 19 pCT and 127 hours of CMD samples (15 pa-
tients) were analyzed. The majority (14/19) of pCT were associated
with cerebral energy dysfunction, despite main cerebral physiologic
variables were within normal range (intracranial pressure 14.2 ±
7.2 mmHg, PbtO2 25 ± 10 mmHg). Energy dysfunction was associated
with simultaneous normal (n = 9; 28–65 mL/100 g/min) or hyperemic
cerebral blood flow (n = 5; 69–85 mL/100 g/min). Energy dysfunction
also correlated with concomitant pathological elevations of glutam-
ate and glycerol, that were more pronounced in hyperemic than nor-
mal pCT (LPR 54 ± 12 vs. 42 ± 7 and glycerol 157 ± 76 vs. 95 ±
41 μmol/L, both p < 0.01; glutamate 38 ± 52 vs. 26 ± 24 μmol/L, p =
0.18, t-test for comparisons between groups).
Conclusions EBI after SAH is associated with profound cerebral
metabolic and cellular distress, despite normal-hyperemic brain
perfusion. Our findings reveal alternative pathophysiological
mechanisms to ischemia in the EBI phase of SAH in humans and
support therapeutic strategies targeted to energy dysfunction in
this setting.
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Introduction Raised intracranial pressure is a common manifestation of
severe brain injury. Rapid diagnosis and timely intervention is required
to prevent secondary brain damage and death.An accurate, reliable,
noninvasive, point-of-care monitoring device to identify presence of
intracranial hypertension would be helpful in situations where there is
clinical suspicion for intracranial hypertension. Bedside ocular ultra-
sound is an emerging noninvasive technique to measure optic nerve
sheath diameter. Knowledge of the normal range of optic nerve sheath
diameter in a healthy population is essential to interpret this measure-
ment as a marker of raised intracranial pressure in clinical practice.
Objectives To evaluate normal optic nerve sheath diameter in
healthy volunteers in Pakistan.
Methods Hundred healthy volunteers of Pakistani origin, aged more
than 18 years were recruited in the study. The ultrasound probe was
placed on the superior and lateral aspect of the orbit against the
upper eyelid with the eye closed. For each subject, the primary inves-
tigator performed three measurements on each eye. The measure-
ments of each eye were then averaged to yield a mean optic nerve
sheath diameter (ONSD). Results are presented as mean ± standard
deviation (SD). Statistical analysis was performed with SPSS software
version 19. Mann Whitney U test was used to compare unpaired
variables between genders and Wilcoxon matched pairs signed rank
test to compare left and right eyes.
Results The median ONSD of right eye was 4.84 mm and 95 % of
individuals had mean ONSD in the range 4.84-4.97 mm while the
median ONSD of left eye was 4.86 mm and 95 % of individuals had
mean ONSD in the range 4.85-4.96 mm. There was no difference
among the 3 repeated measures of ONSD in each eye. There was no
relationship between ONSD with age, gender and measurement
taken between left and right eyes.
Conclusions 95 % of healthy Pakistani adults have an ONSD less than
4.82 mm. ONSD more than 4.82 mm in this population should be
considered abnormal and may reflect raised intracranial pressure.
Note: This abstract has been previously published and is available at
[3]. It is included here as a complete record of the abstracts from the
conference.
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Introduction Autonomic control and cerebral autoregulation (CAR) may
be disturbed after traumatic brain injury (TBI) and become severely im-
paired due to intracranial hypertension (IH). Decompressive craniectomy
(DC) after TBI is a tiered therapy for patients with IH, but the links be-
tween autonomic derangement, intracranial pressure (ICP), impaired
cerebral autoregulation and outcome remain poorly explored.
Objectives We aimed to evaluate the relationship between heart rate
variability (HRV), as a surrogate of autonomic control, ICP and CAR
before and after DC.
Methods We retrospectively studied 9 adult TBI patients, admitted to
the Neurocritical Care Unit at Hospital São João, Porto that were sub-
mitted to primary or secondary DC and had completed monitoring
records 12 h before and 24 h after surgery. Patients were monitored
with continuous ECG, ICP, cerebral perfusion pressure, cerebral auto-
regulation with pressure reactivity and pressure-volume compensa-
tory reserve index (RAP). Automatic delineation of ECG signal was
performed using a wavelet-based approach and HRV analysis in time
and frequency domain was done according to the guidelines for
both periods selected.
Results A total of 48 consecutive TBI patients submitted to DC were
screened, but we had to exclude 39 patients because of incomplete
monitoring data. The median age was 27 (IQR13), 7 were men, me-
dian GCS was 6 (IQR3), median GOS was 4 (IQR2) and hospital mor-
tality was 22 %. DC led to a significantly decrease in ICP maximum
value (p = 0.011), CPP (p = 0.038) and RAP (p = 0.008) after surgery.
There were no significant differences between values of PRx and
HRV variables both in time and frequency domain. However, we
found statistically significant correlations between HRV nonparametric
variables and multimodal brain monitoring variables (Fig. 2). Before DC
normalized low frequency (LFn), high frequency (HFn) and LF/HF ratio
are positively correlated with ICP maximum (ICPmax) value, (respect-
ively Rs = 0.5,p = 0.000; Rs = 0.3,p = 0.005;Rs = 0.4,p = 0.0001). After DC
the correlation becomes negative but non-significant. Total power (Tp)
has a positive and significant correlation with CPP before DC (Rs =
0.5,p = 0.000). RAP is negatively correlated with Tp and HF after DC
(Rs = −0.4,p = 0.000;Rs = −0.5,p = 0.000). PRx increases after DC and
we could not find any important correlation with HRV.
Conclusions Further studies are warranted to better understand the
brain changes and autonomic distress associated with high intracra-
nial pressure and decompressive craniectomy.
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Introduction: The idea of a non-invasive method of measuring intra-
cranial pressure (ICP) is captivating, as disadvantages seen in relation
to the invasive methods of ICP measuring, that is, hemorrhage, infec-
tion, and costly expenses are avoidable.
Objectives: Determine the value of ultrasonographic transcranial
Doppler (TCD) and optic nerve sheath diameter(ONSD)in assessing
increased ICP and outcome of moderate to severe traumatic brain in-
jury patients.
Fig. 3 (abstract A400). Multimodal Brain Monitoring before
and afterDC
Fig. 2 (abstract A400). Monitoring time frame analysis before and
after DC
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Methods: 40 patients with moderate to severe traumatic brain
injury(GCS ≤ 13) admitted to a university teaching hospital were en-
rolled. ONSD and TCD measurements were performed daily for
7 days. TCD was performed on both middle cerebral arteries(MCA),
recording peak systolic (sFV), end diastolic(dFV)and mean time-
averaged(mFV)blood flow velocities in cm/s. The Gosling and King's
pulsatility index(PI) was calculated:PI = sFV-dFV/mFV. Marshall and
Rotterdam head CT neuroimaging scales were recorded on admis-
sion, 48 hours and 5 to 7 days later. Glasgow Outcome Scale(GOS)-
was assessed six months after discharge for survivors.
Results: The PI significantly increased in days 2 and 3 then it
showed a non-significant decrease in day 4 and 5, all compared to
baseline value. This was followed by a significant decrease in days
6 and 7. Comparing the PI's daily reading with the previous day
was significant, increasing from day 1 to day 2, and from day 2 to
day 3 then decreasing from day 3 till day 7(p < 0.001). The PI
showed a significant direct correlation the Marshall and Rotterdam
Scales on days 3 and 7, and Rotterdam Scale on day 7. A significant
direct correlation was demonstrated between the ICU LOS and the
PI determined on days 4 to7. No significant correlation was found
between the mean ONSD and the PI measured on days 1 to 5, but
a significant direct correlation was demonstrated between the two
parameters on day 6 and day 7. The sFV, dFV and mFV were signifi-
cantly higher on days 2 to 4 in survivors than in non-survivors.
While the PI on day 2 and 3 was significantly lower in survivors
than in non-survivors. On day 2, a mFV of ≤27.31 cm/sec was
94.44 % accurate in detecting non-survivors. On day 3, a mFV of
≤6.62 cm/sec was 100 % accurate in detecting non-survivors. On
day 2, a PI of >1.26 was 89.47 % accurate in detecting non-
survivors. On day 3, a PI of >1.87 was 100 % accurate in detecting
non-survivors.
Conclusions: There was a significant day-to-day changes in the
ONSD and PI in TBI patients making serial estimation of clinically/
radiologically diagnosed raised ICP possible in the absence of
invasive ICP measurement.The correlation between PI and CT
imaging of the head together with its cost-effectiveness, safety to
the patient and permanent availability makes the sonographic
approach highly beneficial. TCD derived parameters predicted
survival in TBI patients.TCD derived PI correlated directly with ICU
length of stay.
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Introduction: Veno-arterial extracorporeal membrane oxygenation
(VA-ECMO) is increasingly used to treat severe cardio-pulmonary fail-
ure. Among the possible complications, central nervous system (CNS)
events, such as stroke or hemorrhage, are associated with long-term
neurologic morbidity and increased mortality. Additionally, peripheral
VA-ECMO can result in delivery of hypoxic blood to the brain. The
use of cerebral near-infrared spectroscopy (NIRS) can detect cerebral
hypoperfusion non-invasively.
Fig. 4 (abstract A401). ROC curve for PI to determine its ability
to predi
Fig. 5 (abstract A401). ROC curve for mFV to determine its ability
to pred
Fig. 6 (abstract A401). Correlation between ONSD and PI on day 7
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Methods: We reviewed our institutional VA-ECMO database (n = 159)
from November 2008 to December 2015 and identified those pa-
tients who were monitored with cerebral NIRS. Sensors were placed
on the patients´ foreheads using the Foresight device (CAS Medical
Systems, Inc, Branford, USA). Regional saturation (rSO2) was recorded
and analysed by calculating the time below different thresholds
(60 %, 55 % and 50 %).
Results: A total of 39 patients (age: 54 [48–72] years) had cerebral
NIRS monitoring during VA-ECMO for cardiogenic shock (n = 19),
refractory cardiac arrest (n = 14) and post heart/lung transplant-
ation (n = 6). ECMO was applied for 6 [3–10] days and NIRS
monitoring for 3 [2–4] days. Nine (23 %) patients developed an is-
chemic stroke (8/9 in the anterior circulation) and 6 (15 %) differ-
ential hypoxia -lower PaO2 in the upper body than in the lower
body, because of normal cardiac output with severe impairment of
pulmonary function- during the first 3 days of monitoring. Hospital
mortality was 22/39 (56 %). Twenty-seven (69 %) patients had a
drop of rSO2 < 60 % for at least 5 % of the NIRS monitoring period,
resulting in hemodynamic interventions, which involved increasing
pressure, oxygenation, and/or ECMO flow. In the 3/6 patients with
differential hypoxia, these interventions were unsuccessful and a
veno-arterial-venous ECMO was implemented. Patients developing
ischemic stroke had a higher differential right-left rSO2 (11[6–12]%
vs. 6 [4–7]%; p = 0.004) than others. Survivors had a shorter rSO2
time < 60 % than non-survivors (6.6[1.2-24.5]% vs. 43 [12–60]%;
p = 0.007).
Conclusions: Cerebral NIRS monitoring may be helpful in patients
undergoing VA-ECMO to detect cerebrovascular events or brain
hypoperfusion/reduced oxygen delivery. In these patients cerebral
hypoperfusion is associated with a poor outcome.
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Introduction: Although it has been demonstrated previously that
patients with aneurysmal subarachnoid hemorrhage (aSAH) may also
experience neurocardiac injury, the impact of this complication on
cerebral and peripheral tissue perfusion is not well understood.
Objectives: We aimed to determine if neurocardiac injury as defined
by increased levels of cardiac troponin I (cTnI) was associated with
changes in regional cerebral (CrSO2) and peripheral (PrSO2) tissue
oxygen saturation as measured with continuous near-infrared spec-
troscopy (NIRS) across days 1–3 after aSAH.
Methods: Longitudinal prospective analysis of 13 patients with aSAH.
Inclusion criteria: age 21–75 years, spontaneous aneurysm rupture,
Fisher grade >1 and/or Hunt and Hess grade >2, and with NIRS data.
Exclusion: traumatic SAH, and recent myocardial dysfunction. cTnI
was measured at least daily. Continuous non-invasive CrSO2 and
PrSO2 commenced immediately following study enrollment. CrSO2
was acquired utilizing two separate sensors affixed to the left and
right forehead, while PrSO2 was obtained utilizing a single sensor at-
tached to either the left or right thenar eminence. Continuous CrSO2
and PrSO2 values were recorded every 5 milliseconds and then aver-
aged on hourly intervals for statistical analyses. The daily peak values
of cTnI were used in the analysis as a time-varying variable. The
hourly averaged CrSO2 and PrSO2 values were also treated as time
varying variables. Generalized estimating equation (GEE) was used to
evaluate the association between cTnI and both right and left CrSO2,
as well as PrSO2, where cTnI was used as the independent variable
and CrSO2/PrSO2 as dependent variables, while controlling for age
and gender.
Results: The 13 patients in the analysis had a mean age of 56.6 years,
SD = 8.9, and were predominantly female (85 %). The GEE modeling
revealed that higher peak cTnI was significantly associated with
lower PrSO2 and higher left-sided CrSO2. Higher cTnI was also associ-
ated with a trend toward lower CrSO2 on the right side, but that was
not statistically significant (Fig. 7).
Conclusions: Neurocardiac injury after aSAH as defined by higher
levels of cTnI is associated with impaired peripheral perfusion, but its
impact on cerebral perfusion is variable. Further investigation in a lar-
ger sample is needed to see if site of the aneurysm, cerebral vascular
autoregulation, or vasospasm may play a role.
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Introduction: Stroke is a major health problem including both ische-
mic and hemorrhagic types. Although a long-recognized clinical
phenomenon, there remain many questions regarding the epidemi-
ology of seizures and epilepsy after ischemic stroke, their effect on
outcome, and their treatment [1].
Objectives: This pilot study assesses the incidence of seizures in
acute ischemic cerebrovascular disease.
Methods: The study was carried out on all patients presented within
the first 24 of ischemic cerebrovascular stroke admitted to the units
of Critical Care Medicine, Alexandria Main University Hospital, during
a period of 6 months. EEG was performed in the first 24 of presenta-
tion, at the end of the first and second week of admission and if the
level of consciousness deteriorated at any time during the acute
phase of cerebral infarction and not explained by CT findings or any
metabolic derangement.
Fig. 7 (abstract A403).
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Results: Among all the study group, the incidence of overall seizures
was 20 %, of them, incidence of non-convulsive seizures were 13.3 %
compared to 6.6 % of the patients showed convulsive seizures. Most
seizures occurred on the first 24 hours of ischemia (66.7 %) com-
pared to those occurring at the end of first week (25 %) and those at
the end of the second week (8.3 %).
Conclusions: Ischemic stroke is considered as a risk factor for the de-
velopment of seizures and status epilepticus both convulsive and
non-convulsive types especially during the first twenty-four hours.
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Introduction: Sepsis is associated with immune suppression, includ-
ing depressed cellular immunity. A decrease in surveillance by
immune cells could be one of the mechanisms explaining the
growing perception that patients surviving sepsis are at increased
risk of developing cancers. However, other mechanisms may be
involved in this increased rate of tumors in sepsis survivors, involv-
ing humoral factors. Sepsis is also associated with marked up- or
down-regulation of various soluble mediators affecting cell growth.
We hypothesized that some of these mediators may promote the
proliferation of tumors.
Objective: To identify and isolate this (those) plasma factor(s) enhancing
tumor cell growth.
Methods: Heparinized human blood samples were collected from
patients with septic shock and in healthy donors. Human adenocar-
cinoma epithelial cells from lung (A549), colon (SW620), breast
(Hs578T), and liver (HepG2) and human monocytic leukemia cells
(THP-1 and HL-60) were grown to 70 % confluence and incubated
with 5 - 15 % septic or healthy plasma, or control media. After
24 hours, cell proliferation was evaluated by MTT Cell Proliferation
Assay. Septic and healthy plasma fractionation was performed using
classical biochemical techniques.
Results: Septic plasma supported significantly higher epithelial cell
proliferation than plasma from healthy subjects (+48 % in A549,
+59 % in SW620, +41 % in Hs578T, and +29 % in HepG2 cells with
15 % plasma). Interestingly, this effect was not observed in tumoral
cells of monocytic origin. Adding healthy plasma to septic plasma
decreased the tumor epithelial cell proliferation effect seen with sep-
tic plasma alone in a dose-dependent manner. Initial plasma fraction-
ation studies suggest that the proliferation factor(s) in septic plasma
remains in an immunoglobulin- and albumin-free plasma fraction,
is(are) not precipitable by 50 % ammonium sulfate, and is(are) a
trypsin-sensitive protein(s) > 50 kDa.
Conclusions: The identification of such plasma protein(s) affecting
tumor cell growth could be of great interest in the fields of sepsis
and cancer biology.
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Introduction: In immunocompromised patients, acute respiratory fail-
ure (ARF) is associated with high mortality [1] and many studies have
confirmed the utility of prolonged non invasive ventilation (NIV) in
such condition. Lately High Flow Nasal Cannula (HFNC) has been
used in ARF in various patient subsets but not specifically in post
transplant patients.
Objectives: To compare HFNC vs NIV as the modality to manage ARF
in postoperative hypoxemia in post liver transplant patients.
Methods: This was a pilot study conducted in a Liver Transplant in-
tensive care unit (ICU) of a tertiary care hospital in India. We ran-
domly assigned 20 consecutive post transplant patients who
developed respiratory failure in the post-operative period to either
HFNC group (n = 10) or to NIV group (n = 10). The HFNC was initiated
at a flow rate of 60 l/min whereas NIV was set at EPAP of 5 cm and
IPAP at 10 cm. Both the device setting and oxygen titration was
done according to arterial blood gas (ABG) analysis. Apart from ABG
analysis, we assessed the COMFORT scale as well as the RASS and
CAM-ICU scale of the patient and also assessed the total nutritional
deficit at the end of 48-hr therapy duration. The need for invasive
mechanical ventilation (IMV) was also noted for both the groups.
Results: None of the patients in the HFNC group required need for
IMV whereas 2 patients in NIV group had to be intubated. Patients in
the HFNC group had better average PaO2 as compared to NIV (98.2
vs 72.6 mm Hg) respectively. The patients in the NIV group received
more sedation with dexmedetomidine as compared to HFNC group
(22 vs 10 hrs) respectively. The patients in the HFNC group were
more comfortable as compared to NIV group and two patients in the
NIV group developed delirium for which they required IMV. The aver-
age RASS score was 0 to +1 in the HFNC group whereas it ranged
from −2 to +2 in the NIV group. All patients were fed either orally or
enterally but the NIV group consumed less feeding due to the inabil-
ity to feed orally and apprehension of aspiration due to aerophagia
when fed enterally. The NIV group received 52 % less calories as
compared to HFNC group in 48-hr period.
Conclusions: HFNC is may be an excellent armamentarium for man-
aging hyperemic respiratory failure in immunocompromised patients
with reduced risk of intubation, more comfortable to the patients
and little interruption in providing adequate nutrition.
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Introduction: To study the effect of intra-abdominal hypertension
(IAH) on the frequency of ventilator associated pneumonia (VAP) in
critical care patients with risk factors for IAH.
Methods: This one-center prospective study was conducted in the ICU
of the University Hospital of Larissa, Greece. Consecutive critical care
patients were recruited if they presented risk factors for IAH. Patients
were evaluated systematically for IAH and VAP for a 28-day period.
Results: Twenty-four out of 59 (41 %) patients presented IAH and 28
(47.4 %) presented VAP; seventeen (70.83 %) patients presented VAP
following IAH. Multivariate analysis showed that VAP [1.18(1.10-1.22)
(p = 0.004)], COPD [1.28(1.09-1.86) (p = 0.001)] and the use of antacids
[9.54(2.74-33.19) (p = 0.016)] were independently associated with IAP.
Conclusion: IAH may have an adverse impact on the frequency of
VAP in critically ill patients with risk factors for IAH.
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Objectives: Macrolides, apart from its antibiotic properties, are able
to modulate the inflammatory response: inhibit production and
secretion of pro-inflammatory cytokines (IL-1, IL-6, IL-8 and TNF-α),
increase levels of anti-inflammatory cytokines (IL-10) and inhibit
secretion of nitric oxide (NO). Our working hypothesis is that the use
of azithromycin (AZM) with ceftazidime (CFZ) in a mouse model of se-
vere sepsis by P. aeruginosa, modulates the inflammatory response.
Methods: lethal sepsis model mouse with a clinical P. aeruginosa
strain (Pa4) is characterized. i) CFZ (dose 100 mg / kg / ip / 12 h), ii)
AZM (30 mg / kg / ip / 24 h): To study the inflammatory response,
the following treatment groups (n = 15) for 72 hours were performed
iii) COMB: CFZ + AZM, iv) control of infected animals and untreated
group (CON) and v) group of uninfected mice. TNF-α determinations,
IL-6, IL-10 and nitrite / nitrate (NOx) routine employed as a surrogate
marker of NO metabolism in mouse plasma by ELISA (commercially
available kits) ratio were performed.
Results: We compare the TNF-α, IL-10 and NOx plasma concentra-
tions, in each group (4 and 8 hours post-treatment) related to those
obtained in the CON group.
The COMB (AZM + CFZ) group showed lower plasma concentrations
of TNF-α (pg/ml) than AZM and CFZ groups: [CON: 1477–716; COMB:
720–567; AZM: 1911–1663; CFZ: 793–666].
Plasma concentrations of IL-10 (pg/ml) were higher in the COMB and
AZM groups than in the CFZ one: [CON: 1868–1761; COMB: 1541–
2035; AZM: 1860–2002; CFZ: 1898–1886].
NOx concentrations (M) observed were lower in the COMB group
than in AZM and CFZ ones: [CON: 76–47; COMB: 59–28; AZM: 61–51;
CFZ: 35–42].
Conclusions: These results suggest the immunomodulatory capability
of AZM as an adjunct treatment to appropriate antibiotic. Further
studies are needed to infer these findings to human setting.
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Introduction: Intravenous glutamine can have beneficial effects on
critically ill patients by preserving gut barrier and improving immune
function.
Objectives: We wanted to prove the benefit of intravenous glutam-
ine in patients admitted to medical intensive care unit (MICU) with
severe sepsis and receiving enteral nutrition.
Methods: Randomized, single center, double -blind, placebo-controlled,
pilot study on patients admitted to the MICU who met the criteria for
severe sepsis. In the intervention arm, intravenous glutamine was given
for 5 days at a dose of 0.5 g/kg body weight/day. All patients were fed
enterally as per the MICU feeding protocol. The primary outcomes were
28-day mortality and the occurrence of new infections. We also looked
at severity scores (SOFA), ICU length of stay (LOS), hospital LOS and
duration of mechanical ventilation.
Results: Thirty nine patients were randomized to receive glutamine
(n = 19) or placebo (n = 20). The glutamine group had less disease se-
verity than placebo (median SOFA score 8 versus 11, p =0.038). There
was no difference in 28-day mortality between the glutamine and
placebo groups (42 % vs 15 %, p = 0.06). When adjusted for disease
severity, the glutamine arm had 5.6 times higher death rates (95 %
CI 1.1-30.2, p = 0.044). The glutamine group had lesser incidence of
new infections (0 % vs 30 %, p = 0.02). There was no difference in
ICU LOS, hospital LOS or the duration of mechanical ventilation.
Conclusions: Intravenous glutamine increases mortality risk in ICU
patients with severe sepsis, although it reduces risk of new infections
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Objective: Sepsis is characterized by dysregulated immune response to
infection leading to organ dysfunction. Vitamin D plays a pivot role in
the immune system and low levels of vitamin D have been shown to
be associated with worse outcome in septic patients. In this study we
tested vitamin D levels sequentially and aimed to define the vitamin D
response in septic shock.
Methods: Between September 2014 and January 2016, 41patients with
septic shock were included in the study. Patients were excluded if they
had a disease affecting calcium and vitamin D metabolism such as ma-
lignancy, chronic kidney disease, parathyroid disorders, pancreatitis,
tumor lysis syndrome, rhabdomyolysis, renal tubular disorders and
pregnancy. We measured vitamin D levels in day 1 and day 5after diag-
nosis of septic shock.
Results: The median (min-max) age of 41 patients was 67 (19–88). 21of
these patients were male. The median APACHE II score was 28(11–45).
Day 1 and day 5 median vitamin D levels were 6.8 ng/ml(1–30) and 12
(2–29) ng/ml, respectively. Baseline corrected calcium and ionized cal-
cium levels were 9.04 mg/dl (4.70-11.50) and 1.09 mmol/L (0.80-1.22).
21of the 41 septic shock patients died within 28 day. The APACHE II
scores were similar between the survivor and non-survivor groups [27.5
(11–40), 30 (11–45), p = 0.13]. Baseline median corrected calcium and ion-
ized calcium levels of survivors vs. non-survivors were 9.01 mg/dl (8.3-
10.0) vs 9.16 mg/dl (4.7-11.5) and 1.07 mmol/L (0.90-1.18) vs. 1.10 mmol/
L (0.80-1.22). Day 1 median vitamin D levels of survivors and non-
survivors were 8.7 ng/ml(4.3-30.4) and5.3 ng/ml (1.0-21.7), respectively(p
= 0.047). Day 5 vitamin D levels were not statistically different between
survivors and non-survivors (n = 17; 12.3 ng/ml and n = 7; 5.7 ng/ml, p =
0.37).Vitamin D levels increased in the survivor group from 8.7 ng/ml in
day 1 to 12.4 ng/m lin day 5, however the difference was not statistically
different (p = 0.18). Vitamin D levels did not change in the non-survivor
group from day 1 to day 5 (5.3 ng/ml to 5.7 ng/ml, p = 0.89).Kaplan Meier
survival analysis revealed that patients with vitamin D levels ≥ 6.8 ng/ml
(median value) had increased 28-day survival as compared to patients
with low vitamin D levels (<6.8 ng/ml) (long rank test p = 0.012).
Conclusion: Our study showed that vitamin D response might be differ-
ent between surviving and non-surviving patients during the course of
septic shock. Surviving patients had higher day 1vitamin D levels as
compared to non-surviving patients. Increase in vitamin D level from
day 1 to 5 suggests a clinically significant albeit statistically insignificant
association of vitamin D and survival, in line with high vitamin D levels
in baseline comparisons of the groups, favoring survivors, due to the lim-
ited sample size. Further studies in larger groups are clearly warranted.
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Introduction: Central-Line-Associated Bloodstream Infections (CLABSI)
have been studied extensively in ICU patients. There are no data in the
literature regarding a potential association between obesity and
CLABSI.
Objectives: To test the hypothesis that CLABSI depends on the pres-
ence of obesity in critically ill patients.
Methods: We conducted an 18-month observational study on 576
critically ill patients, in three general ICUs in Greece. All patients had
inserted a triple-lumen catheter in a central vein (internal jugular,
femoral or subclavian). Body Mass Index (BMI) was determined by a
dietitian on ICU admission. BMI was categorized a priori as < 18.5
(underweight), 18.5-24.9 (normal weight), 25–29.9 (overweight), and
>30 (obese). CLABSI was diagnosed by examining the catheter's tip
and a blood sample. Multivariate logistic regression analysis was
used to estimate the association between BMI groups and CLABSI.
Results: From the 576 critically ill patients, (258 men, 318 women)
mean aged 62.3 ± 18.4 years, 28 (4.9 %) were underweight, 220
(38.2 %) normal weight, 234 (40.6 %) overweight and 94 (16.3 %)
obese. CLABSI was diagnosed in 156 (27.1 %) patients. Overweight
and obese patients had significant higher CLABSI rates than the
other patients (p < 0.05). Obese patients had significantly less survival
rates (p < 0.05). Patient's data according to the BMI category are
shown on Table 1. Additional adjustment for obesity-central line
catheter association for the presence of CLABSI attenuates the obes-
ity- central line catheter association: underweight CLABSI OR = 1.79
(95 % CI 1.54-2.03; p = 0.006); normal weight CLABSI OR = 1.86 (95 %
CI 1.80-1.93; p = 0.003); overweight CLABSI OR = 1.63 (95 % CI 1.54-
1.72; p = 0.001); obese- CLABSI OR = 1.64 (95 % CI 1.50-1.78, p =
0.001).
Conclusions: Obesity appears to be associated with the presence of
CLABSI in critically ill patients. This could be partially attributed to
the more efforts made by physicians to insert the catheter in the
obese patients than the other patients.
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Introduction: Sepsis induces a hyperinflammatory phase with a con-
comitant immunosuppression that predominates after initial phase
Table 1 (abstract A411). Patient's characteristics according to BMI categor
Underweight
(N=28)
Normal weight
(N=220)
Overweight
(N=234)
Obese
(N=94)
p
Apache II score 23.7±7.7 20.5±6.9 23.2±6.9 26.8±5.7 0.001
Femoral vein catheter
insertion, n (%)
10 (35.7%) 30 (13.6%) 28 (11.9%) 14 (14.9%) 0.025
Subclavian vein catheter
insertion, n (%)
10 (35.7%) 142 (64.5%) 156 (65%) 54 (61.4%) 0.025
Jugular vein catheter
insertion, n (%)
8 (28.6%) 48 (21.9%) 56 (21.1%) 20 (23.7%) 0.025
N of attempts for catheter
insertion
1.3±0.6 1.1±0.2 2.1±0.6 3.3±1.2 0.028
CLABSI, n (%) 6 (21.4%) 30 (13.6%) 86 (36.8%) 34 (36.2%) 0.001
ICU LOS 11.4±11.8 15.1±10.7 23.1±16.5 24.4±10.4 0.001
Hospital LOS 16.2±14.1 21.1±10.6 28.9±12.3 29.3±15.4 0.001
Survival, n (%) 16 (42.9%) 148 (67.3%) 94 (40.2%) 8 (8.5%) 0.001
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and exposes to a failure of controlling primary infection, or to an in-
creased risk of secondary infections. Blood monocyte (Mo) HLA-DR
expression (MHC Class II) seems to characterize well innate immuno-
depression. The LILR expression on immune cells interacting with
HLA class I induces a functional inhibition of neutrophils (PMN) as
shown by the expression of LILR B2 modified during sepsis1.
Objectives: To investigate the expression of LILR subtypes on blood
Mo CD16- (classical Mo) and Mo CD16+ (non-classical patroller) as on
PMNs and eosinophils (Eo) vs expression on Pl cells, more related to
lung tissue inflammation2, during sepsis.
Methods: In patients having severe sepsis or septic shock: 1/(flow
cytometry)LILR A2, LILR B1, LILR B2, LILR B3, LILR B4 and HLA I on Mo
CD16-, Mo CD16+, PMN (CD16+ Granulocytes (Gr)) and CD16- Gr in
Bl and Pl. 2/ (chemiluminescence3) Spontaneous and stimulated ROS
production. Measurements done at the 1st collection of PL (T1) and a
week after (T2) when possible. Statistical analysis: non parametric
tests. Ethical committee: CPP Ile De France VII, n° PP 15–010.
Results: 11 patients were enrolled, vs 7 healthy volunteers (HV, Bl only).
Compared to HV, in Bl, HLA-DR expression decreased in patients on Mo
CD16- (p < 0,05) with a higher ROS production (p < 0,05). HLA-DR
expression was higher on Mo CD16+. All LILR expressions were signifi-
cantly higher on Mo CD16-, Mo CD16+, PMNs, except for LILRB1, with a
decrease in their ligand HLA-I (p < 0,05). On Gr CD16-, LILR B1 only was
increased. Comparison between Bl and Pl showed no differences
except for LILRB3 expression being higher on PMNs with a higher HLA-
DR expression on Mo CD16-. All LILR expressions decreased between
T1 and T2 (p < 0,05) regardless the patients prognosis.
Conclusions: The increased LILR expression in Bl myeloid cells during
sepsis was similar in Pl cells, with a decrease along time without rela-
tion with prognosis. LILR expression could be used both in Mo and
PMNs in association with Bl Mo HLA-DR to characterize immunode-
pression and the potential therapy for immunomodulation.
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Introduction: Sphingosine-1-phosphate (S1P) is a G-protein coupled
signaling lipid. In particular S1P has been shown to reduce sepsis in-
duced endothelial leakage and cytokine release from immune cells
and to regulate vascular tone.
Among others these processes are responsible for the high mortality
of critically ill patients. Therefore S1P has been studied in critically ill
patients; lately low S1P concentrations have been associated with
sepsis severity by our group [1].
S1P is mainly released by haematopoietic cells such as erythrocytes (EC)
and thrombocytes (TC) [2]. EC produce and secrete S1P continuously,
whereas TC produce S1P but release S1P only upon activation [3].
Objective: We were interested if S1P concentration in blood of critic-
ally ill patients may be influenced by red blood cell (RBC) transfusion.
Methods: S1P concentration in serum and EDTA plasma of 28 critic-
ally ill patients was measured before and after transfusion of one
RBC preservation at several times (pre and 30 min, 180 min, 24 h
post). S1P was also measured in the transfused RBC preservation. Dif-
ferences between transfusion of “fresh” (RBC ≤ 15d) and “old“(RBC >
15d) RBC were analysed.
Clinical data like SOFA scores, haemoglobin (HB) and haematocrit
(Hct) values of all patients were monitored repeatedly.
Results: S1P concentration was higher in RBC preservations com-
pared to serum and plasma levels in patients (P < 0,05). Serum S1P
levels were higher compared to plasma S1P levels (p < 0,05), though
serum and plasma levels correlated positively during time. S1P con-
centration in plasma declined 30 min after transfusion (p < 0,05) and
increased to pre levels within 24 h. Serum levels did not change.
Comparing “fresh” and “old” blood preservations, S1P concentration
was significantly higher in “fresh” RBC (P < 0,05). However in patients,
blood S1P values did not differ if “fresh” or “old” RBCs have been
transfused.
Conclusions: RBC preservations contain high amounts of S1P com-
pared to patient´s endogenous S1P. S1P concentration in RBC preser-
vations correlates negatively with duration of storage. Transfusion of
RBC influences plasma S1P negatively within 30 min. S1P declines
immediately after transfusion and increases thereafter during the
next 24 h. Serum S1P levels are not changed by RBC transfusion.
However alteration of plasma S1P levels by RBC transfusion had no
influence on the clinical outcome of our patients.
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Introduction: Biomarkers influenced by tissue utilization, clearance, and
metabolic derangements have not been shown to be able to identify
complex cellular abnormalities of critical illness pathobiology.1 Currently
there are no comparative data on metabolic and innate immunity - in-
flammatory changes in adult (A) and pediatric (P) patients with early-
onset sepsis or systemic inflammatory response syndrome (SIRS).
Objectives: To determine the «at risk of mortality» profiles in A and P
intensive care unit (ICU) patients in comparison to ICU-survivors and
healthy (H) controls. To assess possible associations of heat shock
proteins (HSP) and Resistin and Adiponectin hormone changes or
oxygen consumption (VO2), dioxide production (VCO2), energy ex-
penditure (EE) and metabolic pattern alterations with mortality in the
early phase of critical illness.
Methods: Seventy-eight adults (S/22; SIRS/23; H/33) and 67 children
(S/18; SIRS/23; H/26) mechanically ventilated were included in the
study. Blood samples were obtained within 24-hours upon admission.
Mean Fluorescence Intensity (MFI) for HSP expression in monocytes
(m) or neutrophils (n) was determined by Flow Cytometry. Restistin,
Adiponectin and extracellular (e) HSP72 were measured using ELISA
and energy-expenditure (EE) by E-COVX. Genomic DNA was extracted
with PureLink Genomic DNA kit to detect HSP72 SNPs.
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Results: More patients with septic shock (p < 0.005) or patients with
lactate >2 mmol/L (p < 0.02) were recorded among non-survivors (A
12.7 % vs. P 7.4 %) compared to survivors. APACHEII, eHSP72, tropo-
nin, and lactate levels were higher and VO2, VCO2, EE, metabolic pat-
tern, and albumin lower among non-survivors compared to survivors
in both groups (p < 0.05). Also, non-survivors P had higher PELOD,
Resistin, and anion gap and lower EF (p < 0.05); non-survivors A
showed a trend for higher eHSP72, nHSP72, and Resistin levels. In
both age groups, the rs6457452 and rs1061581 HSP72 haplotypes
were not related to mortality. In a logistic regression model, high lac-
tate in A and resistin levels in P were independently associated with
mortality (p < 0.01). For predicting sepsis-3 in both groups, low VO2,
VCO2, metabolic pattern, and albumin and high lactate levels
achieved a receiver operating characteristic curve >0.7 (p < 0.05).
Conclusions: Intensive care adult and pediatric patients at risk of mor-
tality show similar inflammatory - immunity and metabolic profiles not
influenced by the rs6457452 and rs1061581 HSP72 SNPs. High lactate
levels and hypometabolism better predict mortality in both groups.
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Introduction: Despite the promise of Ig therapy, the last Surviving Sepsis
Guidelines (2012) does not suggest using intravenous Ig in adults with se-
vere sepsis or septic shock, requiring more research in this field.
Objectives: Assess the prognostic value of serum immunoglobulins
(Igs): IgG, IgA and IgM determined within 24 hours from severe sep-
sis (SS) or septic shock (SSh) onset.
Methods: A cohort study was performed in 133 critically ill adult pa-
tients admitted to the Intensive Care Unit (ICU). Demographic vari-
ables, severity score, mortality at 28 days were recorded, those
patients who had been administered the first dose of intravenous im-
munoglobulins were excluded. The Igs were determined by nephe-
lometry, Dimension Vista.® Siemens. Statistical analysis was
performed using SPSS 15.0 for Windows (SPSS Inc. Chicago, IL, USA).
Results: Of the 133 patients enrolled in the study 16.5 % met SS criteria
and 83.5 % SSh. The mean age was 62 [inter-quartile range (IR): 48.5-
70.5] years, 62.4 % were men. The main sources of infection were:
respiratory tract 36.8 % and intra-abdomen 28.6 % The mediam stay in
the ICU was 6 [3.5-11] days and mortality at 28 days was 21.8 % (n =
29). Median serum IgG Igs were 792 [607 to 976.5] mg / dl, IgA 204
[147.5 to 315] mg / dl, and IgM 76 [46.5 to 132] mg / dl. Patients who
died had significantly higher levels of clinical severity with APACHE II
29.8 vs 24.1, 8.9 vs 12.1 Sequential Organ Failure Assessment (SOFA)
and organ dysfunction number 4.6 vs 3.6 and in serum IgA: 323 vs
195 mg / dl. This difference was not statistically significant in levels of
IgG 822 vs. 774 mg / dl or IgM 86 vs. 72.5 mg / dl.
Conclusions: Serum levels of IgG, IgA and IgM were higher in pa-
tients who died, but only IgA showed a prognostic value when was
measured within 24 hours from SS or SSh onset.
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Introduction: The new sepsis definition, known as Sepsis-3, shifted
the diagnostic focus from infection with systemic inflammation to in-
fection triggered organ failure, and it does away with the systemic
inflammatory response syndrome criteria (SIRS). The role of cellular
innate immunity and inflammatory-metabolic abnormalities in S and
SIRS development has not been clarified.
Objectives: To examine early heat shock proteins (HSP) and Resistin
and Adiponectin hormone changes, along with clinical, inflammatory,
and metabolic profiles, in adult (A) and pediatric (P) intensive care
unit (ICU) patients with sepsis (S). To compare the S profiles with
those of SIRS or healthy-controls (H) in each group.
Methods: . Seventy-eight adults (S/22; SIRS/23; H/33) and 67 children
(S/18; SIRS/23; H/26) mechanically ventilated were included in the
study. Blood samples were obtained within 24-hours upon admission.
Mean Fluorescence Intensity (MFI) for HSP expression in monocytes
(m) or neutrophils (n) was determined using 4-colour Flow Cytome-
try. Restistin, Adiponectin and extracellular (e) HSP72 using ELISA. E-
COVX for energy-expenditure (EE). Genomic DNA was extracted by
using the PureLink Genomic DNA kit to detect the polymorphic
HSP72 SNPs rs1061581 and rs6457452.
Results: Similarly in A and P ICU-patients, APACHEII, SAPS3, HR, CRP,
lactate, creatinine, and resistin, were higher and EF, mHSP72, VO2,
VCO2, EE, metabolic pattern, glucose, and albumin lower in S com-
pared to SIRS and/or H (p < 0.05). Only PELOD and MAP in P and INR,
nHSP72 and glucose in A differed among groups (p < 0.05). For pre-
dicting sepsis-3 in both groups CRP, resistin, lactate, and eHSP72 in
P, achieved a receiver operating characteristic curve (AUROC) > 0.80
(p < 0.05). In a logistic regression model resistin and mHSP72 inde-
pendently discriminated S from SIRS in children only (p < 0.001). In A
and P, genotype HSP72 analysis did not disclose any group differ-
ences regarding the rs6457452 or the rs1061581 haplotypes.
Conclusions: Sepsis presents with repressed innate immunity and me-
tabolism and enhanced inflammatory response in adult and pediatric sep-
tic patients. These changes may help in depicting a common for adults
and children new sepsis-3 profile discriminated from the one of SIRS.
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Introduction: The major reported causes of death within the first
30 days after lung transplantation (LT) are graft failure and non-CMV
infections. Delay in starting effective antimicrobiological treatment in
case of infections is associated with worse outcome. It is imperative
to diagnose the presence of infectious complications after LT in a
timely fashion. Biomarkers have been proposed as a tool to improve
early diagnosis of infections in this population.
Objectives: To determine how sequential measurements of PCT and
CRP could improve the diagnosis of early infectious complications
after LT.
Methods: Multicentre prospective observational study between Sep-
tember 2014 and September 2015. The study included all 7 centres
authorized to perform lung transplantation in Spain.Biomarker mea-
surements were executed on ICU admission (day 1) and daily till 7th
postoperative day. Patients were split into two groups depending on
the presence of infectious complications.
Results: Two hundred and thirty three consecutive patients (148
men, median age 56 [range 47 to 61] years) underwent single (n =
108, 46.4 %) or bilateral (n = 125, 53.6 %) LT. In the whole population,
both biomarkers, PCT and CRP, presented similar kinetics during
study period with an initial increase in their levels, a plasma peak re-
corded in the first 48 hours and a progressive decline over the next
days. PCT plasma levels were similar for PGD grades 1 and 2 and in-
creased significantly in the group of patients with PGD grade 3. CRP
levels were similar in all groups. The median PCT levels were signifi-
cantly lower in patients without infection than in patients with 'Infec-
tion' for all days of follow up (Table 2). During the first 5
postoperative days (day 0 to day 4), PCT levels beyond median value
were statistically associated with higher risk of infection. Thus, PCT
levels beyond 0.50 ng/ml on ICU admission or 1.17 ng/ml on postop-
erative day 1 were associated with an increase in risk of infection of
two-fold and three-fold respectively. Associations remain significant
after adjusting by sex, age, need of postoperative ECMO, creatinine
levels and type of lung transplant. However, after stratifying by pri-
mary graft dysfunction presentation these associations disappeared
with respect to the group of patients with PGD 3 and increased in
the NO PGD 3 group.Therefore, in the absence of PGD 3, previously
described cut-off levels for day 0 and day 1 were significantly associ-
ated with an increase of three-fold and four-fold in the risk of infec-
tion development.
Conclusions: In absence of severe PGD, PCT peak levels are predictor
of infectious complications development during the first postopera-
tive week. PGD grade 3 produce an important increase of PCT levels
and interfere with PCT infectious diagnosis ability. PCT was superior
to CRP in infections diagnosis during this period.
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Introduction: The development of neuropsychological dysfunction in
survivors of critical care has been widely documented in the litera-
ture (1). In contrast, the impact on patient outcomes of anxiety and
depression at the time of critical care admission has been less well
documented (2).
Objectives: We conducted a pilot study to determine the feasibility
of assessing critical care patients' anxiety and depression during their
admission and the potential impact of these morbidities on patient
outcomes.
Methods: Patients were recruited following admission to a general
intensive care unit post surgical intervention. Patients had a Hospital
Anxiety and Depression Scale (HADS) assessment on day 7 and day
15 post operatively, In addition demographic (gender, age, elective
vs emergency surgery, cancer vs non-cancer surgery, prior anti-
depressant use), intervention and outcome (length of stay, infection,
additional oxygen requirement, in-dwelling catheter in situ) data was
collected.
Results: One hundred and twenty two patients were recruited to the
study and 69 (56.6 %) had a HADS assessment on day 7. Amongst
the 52 patients that did not have a HADS assessment completed, 27
(52 %) were discharged prior to day 7 and 16 (31 %) either refused
or were not appropriate for assessment.
The completed HADS assessments indicated that 29 % and 30 % of
patients had significant anxiety and depression scores respectively.
Increased day 7 median anxiety scores were associated with female
gender (6 vs 4, P = 0.04), anti-depressant use (8 vs 5, P = 0.01), oxy-
gen requirement (9 vs 5, P = 0.049), infection (7 vs 4, P = 0.05) and
urinary catheter use (8 vs 4, P = 0.04). Increased median depression
scores were associated with female gender (7 vs 5, P = 0.04) and hos-
pital stay longer than 14 days
(7 vs 5, P = 0.007).
Twenty-four patients had a further HADS assessment on day 15, with
35 patients having been discharged from hospital in the intervening
period. Based on Wilcoxon Signed Ranks tests, anxiety but not de-
pression scores appeared to decrease during the patient's hospital
stay (z = 2.03, P = 0.04 and z = 0.25, P = 0.8, respectively).
Conclusions: The assessment of anxiety and depression amongst
peri-operative critical care patients is feasible. Increased anxiety levels
appear associated with a number of interventions. Increased depres-
sion scores appear associated with increased hospital length of stay.
Anxiety but not depression levels appear to decrease over time dur-
ing patients' hospital stays.
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Table 2 (abstract A417). Median levels for PCT levels for each day
Overall NO
Infection
Infection in
trasplant
recipient
NO
Dysfunction
grade 3
Primary graft
dysfunction
grade 3
N=233 N=181 N=52 N=205 N=28
PCT
LEVELS
Median Median Median P
value
Median Median P
value
ICU
Admission
0.50 0.36 2.00 <0.001 0.47 4.57 <0.001
Day 1 1.17 1.01 3.83 <0.001 1.07 4.90 <0.001
Day 2 1.14 0.94 2.73 <0.001 1.01 2.61 0.006
Day 3 0.70 0.55 1.70 <0.001 0.69 1.32 0.402
Day 4 0.56 0.50 0.78 0.002 0.54 1.11 0.105
Day 5 0.28 0.20 0.40 0.006 0.28 0.48 0.680
Day 6 0.20 0.20 0.30 0.026 0.20 0.39 0.447
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Introduction: Postoperative pain might be ameliorated by substitut-
ing propofol for sevoflurane anesthesia. Support for this theory
comes from human pain models in which propofol reduced hyper-
algesia and allodynia in response to pinprick and electric stimula-
tion.1 Benefit may result from central and peripheral analgesic effects
of sub-hypnotic doses of propofol, as well as suppression of spinal
sensitization.2,3 Additional analgesic effects of propofol likely result
from interactions with N-methyl-d-aspartate (NMDA), non-NMDA re-
ceptors, and via activation of gamma-aminobutyric acid A (GABAA)
receptors in the dorsal root ganglion nociceptor cells.
Consistent with multiple analgesic mechanisms, some studies report that
patients anesthetized with propofol have less postoperative pain than
those anesthetized with volatile anesthestics.Other studies, though, do
not support a postoperative analgesic effect of intraoperative propofol.
Objectives: Because it remains unclear whether intraoperative propo-
fol analgesia ameliorates postoperative pain, we tested the primary
hypothesis that postoperative opioid requirements are greater in pa-
tients anesthetized with sevoflurane than propofol.
Methods: Ninety patients having open vein stripping were random-
ized to either sevoflurane or propofol anesthesia. Pain was treated
with bolus piritramid and patient-controlled morphine hydrochlor-
ide. The primary outcome was total opioid use from the end of sur-
gery until the first postoperative morning. Pain scores (11-point
Likert verbal response score) were recorded by a blinded investiga-
tor at 30-minute intervals for the initial 4 hours and on the first
postoperative morning.
Results: Sevoflurane was not superior to propofol on postoperative
opioid consumption, giving a ratio of means (95 % interim-adjusted
CI) of 0.91 (0.33, 2.4), P = 0.74. Medians [quartiles] of morphine sulfate
equivalents were 9.8 mg [4, 19] in the sevoflurane group and 10
[6, 20] mg in the propofol group. In addition, no difference on
pain score over time was found between two groups, with a
mean difference on an 11-point scale of 0.20 (95 % interim-
adjusted CI: -0.36,0.73, P = 0.31).
Conclusions: Intraoperative sevoflurane did not reduce postoperative
analgesia, which is consistent with most previous reports.
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Introduction: In the last decades, several methods have been developed
for the noninvasive assessment of the level of consciousness during gen-
eral anesthesia by processing physiological signals. The performance of
the developed indices depends on a large number of factors such as the
choice of the signal, the selected parameters, the inter-individual variabil-
ity, etc. However, it is not clear how the type of the model that is used
for the index development and calculation can affect its performances.
Objectives: The objective of the study was to compare two electroenceph-
alographic (EEG) derived depth of anesthesia indexes that were developed
with two different models: an adaptive neuro-fuzzy inference system
(qCON ANFIS) and a quadratic equation model (qCON QE). The models
have the same inputs based on the energy on four EEG frequency bands.
Methods: After IRB approval, 71 patients scheduled for elective surgery
were randomized in four groups. Anesthesia was induced using effect-
site controlled, target controlled infusion with effect size concentration
of propofol set to 8.6, 5.9, 3.6 or 2 μg/mL while the corresponding remi-
fentanil was set to 1, 2, 4 and 8 ng/mL respectively. Data were used
from 2.5 minutes before to 11 minutes after starting pumps. Patients
enrolled were adults from both genders with age 53 ± 13 years, weight
79 ± 14 kg and height 174 ± 9 cm (mean ± standard deviation).
The EEG was recorded with qCON 2000 monitor (Quantium Medical,
Barcelona, Spain) at a sampling frequency of 1024 Hz. The qCON ANFIS
and qCON QE indices were calculated on one-second EEG windows.
The agreement between the two anesthesia indexes was evaluated
with correlation (R2), prediction probability (Pk) and Bland Altman ana-
lysis by calculating the bias and the standard deviation (SD) of the dif-
ferences between the two indexes. Limits of agreement were defined
as the bias ± 1.96SD in which 95 % of the differences between the two
indexes are expected to lie. It is considered a clinically acceptable level
of agreement when two indexes would differ by less than 10 units.
Results: Fig. 9 shows the density plot of qCON QE vs. qCON ANFIS.
Table 3 shows the values of the R2 and Pk between qCON ANFIS and
qCON QE. Figure. 10 shows the results of the Bland Altman analysis
of qCON ANFIS versus qCON QE.
Conclusions: The two indexes qCON ANFIS and qCON QE that were
developed with two different models showed a strong correlation
(R2 > 0.95, Pk > 0.95) and a good agreement (Bias < 1 and limits of
agreement < 10). In conclusions, changing the model of the qCON
calculation from a fuzzy based model to a quadratic equation do not
affect the index performances in depth of anesthesia assessment,
with the advantage of working with a quadratic model structure that
has less coefficients than the fuzzy model.
Table 3 (abstract A420). Values of R2, Pk (Standard Deviation SE)
Indexes R2 Pk SE
qCON ANFIS vs. qCONQE 0.9591 0.9637 0.0003
Fig. 10 (abstract A420). Bland Altman analysis: qCON QE vs. qCON
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Introduction: Delirium occurs frequently in ICU patients and is associ-
ated with numerous adverse effects. Apart from the hyperactive,
hypoactive and mixed subtype, recently the 'rapid reversible sedation-
related delirium' was described which disappears after discontinuing of
sedatives and is thought to have different outcomes then regular
hypoactive delirium. Apart from a burden for the patient, the presence
of delirium may also increase the workload for ICU professionals. Typic-
ally, workload in the ICU is measured using the Simplified Therapeutic
Intervention Scoring System (TISS-28).
Objectives: To determine the effect of delirium status on ICU
workload.
Methods: A retrospective cohort study was performed at the ICU of
a university medical center. All ICU patients admitted between De-
cember 2011 and July 2013 were classified for their delirium sub-
type status, using the CAM-ICU. Peterson criteria were used to distin-
guish between the delirium subtypes, added with Patel's criterion for
rapid reversible sedation-related delirium. Demographics and other
relevant data relating to ICU workload were collected.
Results: A total of 3,926 ICU patients were admitted during the study
period (Table 4). The age was 62 ± 15 (mean ± SD), of which 64.6 %
were male. The APACHE II score was 17 ± 7, and hospital mortality
was 11.6 %. Patients were ventilated for median 2 [IQR 2–3] days.
The LOS-ICU was median 1 [IQR 1–3] day, and in-hospital LOS was
median 5 [IQR 5–17] days. In total 881 (22 %) patients were classified
as delirious of which the alternating subtype had the highest inci-
dence. Delirium duration was median 1 [IQR 1–2] day, the dose of
haloperidol administered was median 19 [IQR 9–42] mg. The overall
TISS-28 score was 28 ± 7. After adjusting for APACHE II score the
TISS-28 score did not differ between delirious patients and non-
delirious patients, (28.4 ± 6 versus 27.2 ± 8, respectively). In addition,
no differences in TISS-28 score were found between the delirium
subgroups. Patients with delirium stayed significantly longer on the
mechanical ventilator, in the ICU and in-hospital (all p < 0.001).
Conclusions: Severity of illness but not delirium contributes in a
higher workload in ICU patients. Furthermore, there were no differ-
ences in subgroups of delirium regarding workload. Importantly,
however, delirium does burden ICU patients in the ICU.
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Introduction: Continuous infusions of sedative analgesia prolong
the duration of mechanical ventilation and increase the risk of com-
plications. Numerous scoring systems exist that assess depth of
sedation, with current guidelines supporting the use of the RASS
(Richmond Agitation-Sedation Scale) [1]. Studies highlight that car-
ing for more awake patients is more demanding and increases
workload for healthcare staff [2,3]). A preliminary audit was under-
taken on our General Intensive Care Unt (GICU) in 2014–2015 to
identify whether patients were optimal sedated, as determined by
RASS.
Objectives: As a result of the previous audit three main areas for im-
provement were identified.
1. To achieve optimum levels of sedation as determined by RASS.
2. To achieve a gradual reduction in sedation to achieve spontaneous
breathing on the ventilator at the earliest opportunity.
3. To achieve predictable and timely sedation holds.
Methods: A ´targeted RASS´ tool was developed, which was simple,
colour coded and kept at the patient bed-side. A protocol for gather-
ing data from audited sedation days was developed.
The protocol was instigated over a 5 week period from 4/1/2016 to
5/2/2016. All sedated patients were included, except for those having
treatment withdrawn. On each patient, data was collected at the be-
ginning and end of each shift. Including baseline and target RASS,
times of RASS allocation made and sedation drug usage. Data was
collated on a spreadsheet within the ICU.
Results: Total number of admissions were 156 patients, total number
of sedated, ventilated days were 46. 38 out of the 46 patients had
targets set during ward rounds (82 %) There was no difficulty allocat-
ing patients to groups.
11 patients were allocated to RED which achieved 100 %
compliance.
13 patients were allocated to AMBER which achieved 63 % compli-
ance. Reduction in sedation drugs and RASS at the end of each shift
was, on average, reduced.
14 patients were allocated to GREEN which achieved a 32 % compli-
ance. Sedation drugs were largely stopped or reduced. On average
the RASS was lower. Successful extubation occurred in 5 patients.
Agitation leading to re-sedation occurred in 8 patients.
Conclusion: A simple, clear and effective tool for communication be-
tween medical and nursing staff can improve practice and be trans-
lated into a real reduction in sedation drug administration and lower
levels of sedation.
Table 4 (abstract A421). Outcome measures stratified to delirium status
Not
delirious
Hyperactive Hypoactive Alternating Rapid
reversible
N=3045 N=68 N=322 N=330 N=161
Mean TISS28 27±8 27±6 28±6 29±6 28±6
APACHE II score 17±6 19±6 21±7 21±7 17±5
Days ventilated 1 [1–2] 2 [1–3] 3 [2–10] 6 [2–14] 2 [1–2]
Delirium duration 0 1 [1–2] 1 [1–2] 1 [1–1] 1 [0–1]
Cumulative dose of
haloperidol (mg)
0 9 [4–16] 17 [8–30] 24 [11–54] 1 [1–1]
ICU stay in days 1 [1–2] 2 [1–5] 5 [2–11] 7 [3–17] 1 [1–3]
Hospital stay in days 7 [4–14] 9 [5–17] 16 [9–31] 22 [12–38] 7 [6–14]
Fig. 9 (abstract A420). Scatter density plot of qCOn QE vs. qCO
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Introduction: Delirium is common in Intensive Care Unit (ICU) pa-
tients and negatively affects outcome. However, recognition of delir-
ium by ICU physicians is poor [1]. To improve detection, delirium
screening tools have been developed, but these are subjective and
insensitive in routine, daily practice [2]. Previously, we showed that
patients with and without delirium could very well be distinguished
with one minute of bipolar electroencephalography (EEG) and rela-
tive delta power as an indicator of slowing of background activity
[3]. Based on these findings, a prototype EEG-based delirium monitor
was built, with real-time artefact removal and an improved detection
algorithm.
Objectives: To validate an EEG-based delirium monitor in patients at
risk of delirium.
Methods: In this ongoing multicentre study, we will include 154 frail,
surgical patients aged ≥60 years. Preoperatively (T-1) and on postop-
erative day 1 to 3 an EEG recording is performed together with a
standardized cognitive assessment that is a video-taped. Diagnosis of
delirium is based on the video by two, or in case of disagreement,
three delirium experts (psychiatrists, geriatricians or neurologists) in-
dependent of each other, and independent of the EEG recording.
EEGs are automatically analysed after artefact removal using wave-
form analyses, as well as analysis of relative delta power, and com-
pared with the classification of the delirium experts (gold standard),
to obtain sensitivity, specificity and the predictive values.
Preliminary results: Among 45 patients (75 % men, mean age
76 years, SD 7 years), 5 patients were diagnosed as delirious. The fig-
ure shows the development of delirium in an example patient and
the findings of the waveform analysis on the consecutive days after
surgery. Sensitivity and specificity of the waveform- and relative delta
power analyses were promising, and final results will be presented at
the ESICM meeting.
Conclusions: Our findings suggest that EEG-based monitoring is
promising for objective and reliable detection of delirium in routine
daily practice.
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Introduction: Delirium is a frequently occurring syndrome in patients
admitted to the Intensive Care Unit (ICU) or Medium Care Unit
(MCU), yet the pathophysiology remains poorly understood. An ex-
cess of central serotonin can lead to an altered mental status, associ-
ated with autonomic hyperactivity, and neuromuscular excitation.
(Boyer EW et al. 2005, Buckley NA et al. 2014) Drugs with serotoner-
gic properties are frequently and for prolonged periods administered
to ICU/MCU patients. Therefore central serotonergic toxicity may con-
stitute a predisposing, contributing or precipitating factor in the
emergence of delirium.
Purpose: to determine the number of patients admitted to the ICU
or MCU who are diagnosed with delirium, and who show characteris-
tics of serotonin toxicity (Sternbach 1991, Dunkley EJC et al. 2003) in
association with the administration of serotonergic drugs.
Methods: During a 10-week prospective observational cohort study
in the ICU and MCU, patients aged 18 or older, diagnosed with delir-
ium in the ICU or MCU were included. Patients were considered as
delirious in case of a positive CAM-ICU and/or at the start of haloperi-
dol prescription on suspicion of delirium. Once included, patients
were screened for recent administered serotonergic drugs and
screened for physical signs associated with serotonin toxicity by a
standardized physical examination by a specifically trained physician.
Results: A total of 61 patients diagnosed with delirium were enrolled.
In 44 out of 61 patients (72,1 %) the use of drugs potentially contrib-
uting to serotonergic toxicity was recorded. Out of 44 patients, 7
(16 %) patients showed physical signs of serotonin toxicity and in
addition met the Hunter serotonin toxicity criteria, suggesting the
presence of serotonergic toxicity. None of these patients were recog-
nized as such by the treating physicians.
CONCLUSIONS: A significant proportion of delirious patients in the
ICU might in fact be classified as suffering from central serotonin tox-
icity. The awareness of potential serotonin toxicity is low among
physicians.
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Introduction: Delirium in ICU associated with both short and long
term adverse outcomes. Cancer patients admitted to ICU have sev-
eral risk factors to develop delirium. Most published data on delirium
are about general ICU patients and there are no large studies in can-
cer patients in ICU.
Objectives: We conducted prospective study to know the
incidence and risk factors associated with delirium in cancer
patients.
Methods: Adult cancer patients in ICU were included over a period
of 6 months. Demographic data, type/stage of cancer, treatment
details including drugs administered were noted. Hemodynamic
status, mechanical ventilation, presence of sepsis, patient's sleep
and mobilization status were also noted for the assessment of risk
factors associated with delirium. Sedation was scored using the
Richmond Agitation-Sedation Scale (RASS) and delirium was
assessed using the Confusion Assessment Method (CAM-ICU) per
shift by the bedside nurses, if they were responsive to verbal com-
mands (RASS score of −3 or lighter level of sedation). If delirium
was positive even in one shift in a day, it was considered as a delir-
ium day.
Results: Patients with comorbidities showed higher incidence of
ICU delirium as compared to those without {73(63.5 %) vs
42(36.5 %)}. Tobacco consumers showed higher incidence of delir-
ium as compared to those without {85(73.1 %) vs 30(26.1 %)}.
Recent chemotherapy showed positive correlation with delirium as
compared to those who did not receive chemotherapy or received
it more than one month back {63(54.8 %) vs 51(44.3 %) vs 1(0.9 %)}.
Sleep deprived patients had higher incidence of delirium as com-
pared to patients without {90(78.3 %) vs 25(21.7 %)}. There was a
significant association of Midazolam with delirium as compared to
those who did not receive the drug{104(90.4 %) vs 11(9.6 %), p-
0.000}. Patients who had delirium had median length of stay 7 days
as compared to 3 days among without delirium. On multivariate
analysis of the risk factors comorbidity(P-0.003,OR-13.3), tobacco con-
sumption(P-0.015,OR-5.95), Midazolam(P-0.000,OR-47.50), mechanical
ventilation(P-0.022,OR-9.09) and sleep deprivation (P-0.030,OR-
7.18) showed statistically significant association with the
delirium. Delirium also showed significant association with in-
creased length of both ICU (P-0.000,OR-1.73) and hospital stay
(P-0.004,OR-1.02).
Conclusion: Incidence of ICU delirium among cancer patients was
70.6 %. Recent chemotherapy mechanical ventilation, Midazolam,
comorbidities, tobacco and sleep deprivation were the independent
predictor of ICU delirium in cancer patients. ICU delirium increase
both ICU and hospital length of stay.
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Introduction: Delirium is defined as an acute cognitive impairment,
inattention and disorganized thoughts, may be associated with the
use of benzodiazepines, opioid administration, mechanical ventilation
duration and immobilization, the management of it depends on
multidisciplinary team strategies.
Objective: The purpose of this study was to compare the results of
patients with and without Delirium that were submitted to an early
mobilization protocol in the Intensive Care Unit (ICU).
Methods: Cohort study in the general ICU of a University Hospital, South-
ern Brazil. The study was conducted between February and December
2013. Were excluded patients using mechanical ventilation for less than
24 hours, under 18 years old, patients submitted to passive exercises or
who did not have early mobilization. Only patients that received active
and active-assisted early mobilization were included. Patients were di-
vided between Delirium and no-Delirium groups. Data were reported as
mean and standard deviation. The variables were compared through of
Mann–Whitney test, t-test parametric and the statistical significance level
was 5 % (p ≤ 0.05).
Results: In the period were admitted 474 patients of which 127 were in-
cluded. The incidence of Delirium was 48 %. The main causes of admis-
sion in groups with delirium and without delirium were medical non-
neurological (34 % vs. 33 %), medical neurological (22 % vs. 9 %) and
Traumatic Brain Injury (22 % vs. 26 %). There were no significant. The
data are demonstrated in Tables 5 and 6.
Conclusion: In this cohort study, we found no differences in the outcomes
of patients with or without delirium submitted to early active mobilization.
Most of patients had good response to an early mobilization protocol.
Table 5 (abstract A426).
Delirium (61) Non Delirium (66) p-value
Male (n-%) 43 (70) 43 (65)
Age (n-%) 49±18.25 43±19.55 0.10
APACHE II 24±4.94 24 ± 6.51 0.49
SOFA 12±3.28 11 ± 3.73 0.17
Death ICU (n-%) 2 (3) 8 (13) 0.131
Table 6 (abstract A426).
Delirium (61) Non Delirium
(66)
p-
value
MV (hours) 179±124.09 175±183.61 0.26
Sedation time (hours) 100±80.52 108±122.18 0.62
Midazolam (mg) 2532±3168.53 3258±5828.26 0.68
Fentanyl (μg) 45804
±70319.75
41422±84192.46 0.25
Propofol (mg) 3289±9146.06 4570±9392.23 0.89
Haloperidol (mg) 39±38.85 54±40.33 0.15
Glasgow Coma Scale - ICU
discharge
14±1.42 13±1.92 0.57
Functional independence measure 61±31.34 68±30.03 0.40
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Introduction: The presence of delirium in the intensive care unit
(ICU) is often underestimated due to its variable clinical presentation.
The incidence and risk factors of delirium have not been studied in
critically ill cancer patients.
Objective: To evaluate the incidence and risk factors of delirium in
critically ill cancer patients.
Methods: The present study was an observational and descriptive study
that included 69 critically ill cancer patients admitted to ICU of the Insti-
tuto Nacional de Cancerología of México, between December 2015 and
March 2016. Delirium was diagnosed by daily evaluation using the Con-
fusion Assessment Method for the ICU (CAM-ICU). The clinical data was
obtained from the patient´s medical record. No interventions were done.
Results: Of the 69 critically ill cancer patients included in this study, 35
(50.7 %) were men; with a median age of 49.55 years; 2 (7.2 %) had his-
tory of delirium, and 2 (2.9 %) had delirium at ICU admission. Solid tu-
mors were the most frequent malignances 49 (71 %), and 20 (29 %)
had hematological malignancies. The principal admission diagnosis to
ICU was septic shock in 27 (39.1 %). During the first 24 hours in ICU, 20
(68.1 %) required mechanical ventilation, 25 (36.1 %) received midazo-
lam as a sedative, and 47 (68.1 %) fentanyl as an analgesic.
The incidence of delirium was 15.9 %. The hyperactive type delirium was
the most common. There was no difference between risk factors (sex,
age, comorbidities, history of delirium, use of analgesic, sedation or corti-
costeroids, and severity of critical illness) in patients who presented delir-
ium and those who did not. The most important independent risk factors
for delirium were the total number of ventilated days during ICU stay (P
= 0.009) and the length of stay in ICU (P < 0.001). The following variables
were independent predictors of delirium: the total number of ventilated
days during an ICU stay, relative risk (RR) 1.09 (95 % confidence interval
(CI); 0.98 to 1.22) and the length of stay in ICU, RR: 1.173 (95 % CI; 1.04 to
1.32). The ICU mortality was 10.1 %, no patients with delirium died.
Conclusion: The incidence of delirium in the oncologic ICU is low,
the length of stay in ICU and the total number of ventilated days
during an ICU stay were the most important risk factors for its pres-
entation; There is no relation between delirium and ICU mortality.
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Introduction: Addiction is one of the main problems in our society,
Iran,about 3 % of the whole population. Many of critically ill patients
needing intensive care units (ICU)admission suffer from underlying
disease such as ischemic heart disease, hypertension, diabetes and
so on, and are opium addicted too. Consequently, the control of pain
and agitation in the intensive care unit plays an important role in
early discharge and improving patient´s outcome.
Objectives: Comparing opium tincture and methadone on the con-
trol of pain, agitation, and ICU outcomes in opium addicted ICU ad-
mitted patients.
Methods: In this randomized pilot study, a total of 50 inhalant opium
addicted patients aged 18–84 years, enrolled into the study and they
were divided into two groups of 25, the opium tincture(T) and
methadone group(M). Patients received morphine infusion according
to needs before allowing enteral drugs (at most one day). After tha-
t(as day one of study), in the T group, patients received 10 cc opium
tincture in dark tea(total 50 cc) through nasogastric (NGT) tube and
10 cc normal saline intravenously (IV) every 8 hours. The M group re-
ceived 50 cc dark tea via NGT plus 10 mg mehadone diluting to
10 cc IV every 8 hours.Then patient´s pain and agitation were mea-
sured and compared based on (BPS) behavioral pain scale and Rich-
mond agitation sedation scale (RASS), and delirium by CAM-ICU. If
BPS scale was desirable (−0, 1), the same dose continued, but if it
was ≤ −1 or ≥ 2, the doses was decreased or increased by 2.5 (cc or
mg) respectively at next interval. Rescue medications were IV mor-
phine, midazolam and haloperidol.
Results: Current study shows that the use of opium tincture in the
pain management(by BPS) of opium addicted ICU patients had sig-
nificant desirable impact and, (p-value = 0.041) compared with
methadone especially after deleting confounding variables (mor-
phine, midazolam and haloperidol) (P-value = 0.019).But considering
agitation (RASS) there was no difference before (p-value = 0.684) and
after the deleting confounding variables (p-value = 0.630) between
the two groups. Extubation time, duration of ICU and hospital stay
was not different between the two groups.
Conclusions: In inhalational opium addicted patients admitted to ICU
enable of starting oral medications, pain is better controlled with
Opium Tincture in comparison to Methadone.
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Introduction: Patients with severe ARDS or intractable cardiogenic
shock are increasingly treated with veno-venous or arterio-venous
extracorporeal membrane oxygenation (ECMO). During ECMO, intra-
venous (IV) sedation with midazolam (MIDA) and/or propofol (PROP)
may be inadequate because these drugs become highly sequestrated
in the circuit. The volatile anaesthetic sevoflurane (SEVO) has been
shown to be a potential alternative to IV sedation in cardiac surgery
and general ICU patients.
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Objectives: We assessed the efficacy and safety of prolonged use of
SEVO in a cohort of hemodynamically unstable critically ill patients
under ECMO.
Methods: Patients initially sedated with IV MIDA and/or PROP and
then switched to SEVO, were retrospectively reviewed. The liquid
form of SEVO was infused via a modified heat-moisture exchanger
(AnaConDa®, Sedana Medical AB, Uppsala, Sweden) placed between
the Y-piece and the endotracheal tube. SEVO was given as an initial
bolus of 1.2 mL followed by a continuous infusion started at 5 mL/h.
Infusion rate was adjusted to reach a measured end-tidal SEVO (ETS)
concentration between 0.8 and 1.4 %. Sedation level aimed to obtain
a RASS score of −3 to −4. Mean blood pressure and norepinephrine
requirement were evaluated before start of SEVO and after respect-
ively 2 h and 6 h of treatment. ETS was measured after stabilization,
and at 24 h and 72 h. Wilcoxon signed rank test was used to com-
pare variables over time. Values were expressed as means ± SD.
Results: Twenty-one patients (12 males, age 53 ± 15 years; 16 ARDS
and 5 cardiogenic shock) were studied. Mean APACHE II score was
25 ± 5. MIDA and PROP dose before start of SEVO were respectively
2.1 ± 2.6 mg/min and 2.4 ± 0.9 μg/kg/min. Ten patients were cura-
rized. Initiation of SEVO allowed immediate cessation of IV sedation
and curarization. Opioid analgesia was continued unchanged. SEVO
treatment was not associated with changes in MAP (73 ± 12 vs. 72 ±
10 mmHg; p = 0.56) or norepinephrine need (0.11 ± 0.06 vs. 0.13 ±
0.19; p = 0.83). As compared with baseline (1.1 ± 0.3 %), ETS remained
unchanged after 24 h (1.2 ± 0.3 %) and 72 h (1.3 ± 0.4 %). Patients
were treated for 13 ± 9 days. Twelve patients (57 %) survived. No ad-
verse events were noted. Random 8 h-samples of ambient air in the
bedside breathing zone revealed SEVO concentrations well below
the National Institute for Occupational Safety and Health 2 ppm limit.
Conclusions: In hemodynamically unstable patients under ECMO,
prolonged SEVO sedation is an effective, well-tolerated, and safe al-
ternative for "classic" IV MIDA and PROP-based sedation.
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Introduction: Patients admitted to the intensive care unit (ICU)
usually require use of hypnotics and sedatives to ensure comfort and
proper adaptation to mechanical ventilation. An important require-
ment for an adequate sedation is frequent and proper assessment of
its depth. Inadequate sedation can lead to problems of over-
sedation, under-sedation and/or delirium in ICU, especially in elderly
patients.
Objective: To compare the total dose of sedative use and the rate of
over-sedation in patients over 65 years admitted to the ICU, adjust-
ing sedation by monitoring with BIS® versus monitoring with the ex-
clusive use of sedation scales.
Methods: A randomized, clinical trial including patients over 65 years
who were admitted to the ICU affected with medical or surgical
pathology of non neurological etiology who required sedation for
more than 24 hours to maintain adaptation to mechanical ventila-
tion. Patients were randomized into two groups: the intervention
group using BIS monitoring to adjust sedation in order to maintain
values between 50–60 and; the control group in which sedation was
adjusted with the exclusive use of Richmond Agitation-Sedation
Scale (RASS) to maintain RASS −2. The study was approved by the
institution's Research Ethics Committee. Statistical analysis: We used
the chi square test to compare categorical data and proportions, and
the T-test, Mann–Whitney test or Kruskal-Wallis, as appropriate, to
compare continuous variables. An alpha level of 0.05 was used to
determine statistical significance. All data in the present study was
analyzed using SPSS version 22.0 (SPSS Inc, Chicago, USA).
Results: Until now 56 patients have been randomized. 27 (48 %) pa-
tients in the control group and 29 (52 %) in the intervention group.
Related to the general characteristics, demographics (age, weight,
height, gender), medical history (hypertension, diabetes, cognitive
impairment, lung disease and chronic renal failure), pathology and
admission severity scores (APACHE II and SOFA) there were not sta-
tistically significant differences between groups. Besides analgesia;
midazolam, propofol or remifentanil were also used in both groups
(without significant differences). There were not statistically signifi-
cant differences in midazolam and propofol, total daily dose, days of
mechanical ventilation, ventilator associated pneumonia, delirium,
ICU mortality and ICU length of stay.
Conclusions: No statistically significant differences were observed be-
tween the groups of this pilot study using BIS to adjust the sedation.
We attribute these findings mainly to the lack of adherence to the
protocol.
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Introduction: How much sedation is given, and for how long, is im-
portant in determining patient outcome as both over sedation and
under sedation can have potentially deleterious consequences. Over
sedation can increase time on ventilator support and prolong ICU
duration of stay. Under sedation can cause hyper-catabolism, immu-
nosupporession, hypercoagulability and increase sympathetic
activity.
Objectives: The aim of this audit was to look at our use of sedation
in a large 18bed teaching unit in Glasgow. We aimed to look at pro-
pofol dosage, to particularly look if patients exceeded their maximum
hourly dose, sedation scoring tools and whether it was regularly
assessed, the addition of other sedative agents and when, and
whether sedation load was associated with increased ventilator days.
Methods: We looked at a snapshot of 40patients picked at random
admitted to the Queen Elizabeth University hospital, Glasgow over
the previous six months. The Richmond-Agitation Sedation scale was
used as the sedation scoring tool.
Results: Data was collected for 40patients. 57.5 % were male. The
median age was 57 years. Weight and height were not documented
for 21patients. 6 patients were given in excess of the recommended
dose of propofol according to weight (mg/kg/hr). These were six of
the patients in which weight was actually documented so exceeding
maximum recommended daily dosing could have been more of an
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issue than is described. All patients were sedated with propofol and
an opiate, either remifentanil or alfentanil. Half of the patients were
found to be over sedated in the time period, with RASS scores of −4
or −5. Six out of the forty patients did not have sedation scores doc-
umented daily as part of their care. When other agents were consid-
ered, they were considered relatively late in the patient stay (days 4–
5). CK and triglycerides were never checked when propofol had been
used in high doses for a significant length of time. Average length of
ventilation was 4 days (12 hours - 12 days) with unsurprisingly higher
propofol use seen in the patients ventilated for longer periods of
time. Excess sedation was more common in the younger patient with
a past history of drug or alcohol dependence.
Conclusions: Delirium and over sedation is associated with an in-
crease in morbidity and mortality. As can be seen from our snapshot
of data, we are poor at documenting daily sedation scores, with a
significant proportion of our patients being documented as over se-
dated. Propofol use is excessive, and could perhaps lead to iatro-
genic complications and morbidity. Patients who were heavily
sedated were ventilated for longer.
We are now working on a sedation protocol within our unit to im-
prove our practice.
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Introduction: There is evidence that the type of intravenous fluid used
in patients who are critically ill or who have undergone major surgery
may have an impact on the progression and recovery of Acute Kidney
Injury. Patients undergoing renal transplantation are not specifically in-
cluded in this work. Our centre changed the general peri-operative
fluid regimen from routine use of normal saline (NS) to Plasmalyte (bal-
anced solution containing physiological sodium, chloride, potassium,
magnesium with an acetate buffer), including all patients undergoing
renal transplantation. We hypothesised that this change would reduce
peri-operative hyperkalaemia and thus reduce the need for immediate
renal replacement therapy (RRT).
Methods: The peri-operative fluid management guidance was chan-
ged in March 2013. We performed a single centre retrospective ob-
servational study of consecutive renal transplant recipient's pre and
post policy change to assess its impact on transplant patients. The
local renal database, patient notes, a computer based pathology sys-
tem and clinic letters were used to collect data. We excluded pa-
tients with incomplete data of the peri-operative period, who had
not received the standard fluid regimen of the time and those with
an immediate surgical complication that rendered dialysis inevitable.
Results: There were 47 transplant recipients in the NS group and 29
in the Plasmalyte group. The percentage of patients not requiring
RRT in the first 48 hours post operatively in the Plasmalyte group
were significantly higher than in the NS group (D1 97 vs 81 % p
0.046, D2 94 vs. 72 %, p 0.025) (Fig. 12). There were no cases of
hyperkalaemia in the immediate post operative period for patients
who had received Plasmalyte (P < 0.0001) (Fig. 13).
A greater urine output in the first 24 hours after surgery was ob-
served in the plasmalyte group, 2195mls (95 % CI:1423–2966) vs.
913.8mls (95 % CI:563.3-1264, P < 0.0001) which may indicate earlier
onset of recovery from the post transplant AKI. Baseline characteris-
tics were similar between each group except there were a higher
proportion of DCD donors in the NS group compared to the Plasma-
lyte group (36 % vs. 17 %, p < 0.001).
Conclusions: Renal transplant recipients who did not have an imme-
diate surgical complication and received only Plasmalyte in the peri-
operative period, had a lower incidence of RRT in the first 48 hours
following surgery than those who received normal saline. This may
be attributed to the lower incidence of immediate hyperkalaemia in
the Plasmalyte group.
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Introduction: Pulmonary complications after major surgery are com-
mon affecting up to 30 % of patients, increasing hospital length of stay,
short and long-term mortality1. Despite this, very little specific action is
taken to prevent post-operative pulmonary complications (PPC) within
major surgery programmes. Even the Enhanced recovery after surgery
[ERAS] programme, does not specifically address this.
Objectives: Central Manchester Foundation Trust (CMFT) successfully
implemented ERAS+ aimed at reducing PPC in 2014 and we now
have results to show its sustained benefit.
Methods: Using quality improvement methodology, a multidisciplinary
team developed an innovative surgical pathway combined with ele-
ments of ERAS. Working with the Boston Medical Centre, we produced
ICOUGH UK2 consisting of - Incentive spirometry, Coughing and deep
breathing, Oral care, Understanding (patient and family education),
Getting out of bed and Head-of-bed elevation. Additional innovations
within the ERAS+ include: Prehabilitation/Reablement tools; SURGERY
SCHOOL - patient and family preparation session and ICOUGH UK
multimedia resources including ICOUGH TV. Pathway innovation oc-
curred during sponsored listening sessions with patients and relatives.
We introduced ICOUGH prescriptions attached to drug charts to pro-
mote compliance and this was audited weekly. All elective surgical pa-
tients requiring critical care admission were screened for the
development of PPC on days 1, 3, 5, 7 and 15 after surgery using stand-
ard definitions3. We prospectively measured baseline PPC between
April 2013–4 and repeated PPC audit following introduction of ERAS+
in September 2014 through to Jan 2016.
Results: ERAS+ has been successfully developed and embedded in a
large NHS university teaching hospital. More than 200 critical care
nurses have been trained in ERAS+. Surgery school has been embed-
ded, with over 350 patients attending; qualitative feedback has been
overwhelmingly positive. Since September 2014, utilising ERAS+
within critical care in greater than 500 patients has resulted in a sus-
tained reduction of 40 % in PPCs.
Conclusions: ERAS+ implementation into a large teaching hospital
has successfully reduced PPCs in major surgery patients. ERAS+ can
be rapidly adopted by European healthcare, with a significant reduc-
tion in patient morbidity and hospital length of stay. This innovation
aligns with domains 1, 3–5 of the NHS Outcome Framework4.
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Introduction: Inhaled NO is a well-known selective pulmonary vaso-
dilator in Europe since 20 years nevertheless few study really de-
scribed the daily ICU practice. The objective of this study was to
determine the gap between guidelines and real life.
Methods: This is a multicenter, prospective, observational study on
iNO administered through an integrated delivery and monitoring de-
vice (EZ-Kinox) in 12 French and 1 Belgian centers for pulmonary ar-
terial hypertension after cardiac surgery (PAH CS) and for persistent
pulmonary hypertension of the newborn (PPHN). The following pa-
rameters were observed: dose, treatment duration, ventilation
modes, monitoring procedures, weaning procedures and occurrence
of a rebound effect. Concomitant pulmonary vasodilators treatments
and safety data were also collected.
Results: 236 patients were studied among 238 patients enrolled
within one year period : 81 children and 117 adults with PAHCC and
38 neonates with PPHN. Echocardiography or pulmonary artery
catheterization were performed to diagnose PAH respectively in
86 % and 31 % of the cardiac patients. In the neonatal group 97.4 %
had an echocardiographic diagnosis. Inhaled NO was initiated before
ICU admission in adult population (57 %) but rarely in cardiac
pediatric patients (12.7 %), p < 0.01 and 38.9 % in neonates. The me-
dian initial dosage of iNO set was 20 ppm [18–20] in the cardiac
pediatric group and 10 ppm [10–15] for adults and 16.7 ppm [11.2-
20] for neonates with a median duration respectively 3.9 days [1.9-
6.1], 3.8 days [1.8-6.8] and 3.07 days [1.04-5.74]. The NO therapy clas-
sically was delivered during controlled ventilation mode including
high frequency oscillation and more and more via non invasive venti-
lation as high flow nasal cannula. The clinical effect of iNO was con-
sidered sufficient in 89 % of the cases and the dose was gradually
decreased before definitive withdrawal in 86 % of the cases. Adverse
effects (AE) occurred 75 times (80 % of the patients without AE) in-
cluding rebound effect in 1.2 % of children, 3.4 % of adults and
2.6 % of neonates, methaemoglobinemia was observed on 7.9 % of
neonates and 1.7 % of adults. The NO2 generated by contact be-
tween NO and O2 was above 0.5 ppm value in 17 % of the pediatric
cases, 1 % of the adult cases and never observed on neonates popu-
lation. All these AE related to iNO recovered without sequelae. Pul-
monary vasodilators (levosimendan, sildenafil, milrinone) were
associated in 95 % of the cases in pediatrics, 23 % in adults (p < 0.01)
and 23.7 % in neonates. ICU stay was 8 days [6–15] for children,
10 days [6–16] for adults and 3.7 days [1–5.7] for neonates.
Fig. 14 (abstract A433). Incidence of PPC in major elective
surgery patient
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Discussion. This survey confirms the good efficacy and safety of NO
therapy in the three populations. Occurrence of rebound effect is
particularly rare with a large application of a gradually withdrawal of
iNO and pulmonary vasodilators use. The usage of last generation of
NO devices subject to prior training allows good compliance with
recommendations.
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Introduction: Administration of normal saline has been associated with
the development and exacerbation of acute kidney injury, [1] and this
may be related to hyperchloraemia. Since recipients of kidney trans-
plants often require large volumes of fluid replacement, we hypothe-
sised improved post-operative biochemistry and quicker renal recovery
following a switch from saline to Plasmalyte fluid therapy during the
routine peri-operative period.
Methods: The peri-operative fluid management guidance was chan-
ged in our centre in March 2013. We performed a single centre retro-
spective observational study of consecutive renal transplant
recipients before and after the policy change to assess its impact on
transplant patients. We used the local renal and pathology databases,
paper and computerised patient notes and clinic letters to collect
data. We excluded patients with incomplete data of the peri-
operative period or who had not received the standard fluid regimen
of the time.
Results: 47 patients received normal saline and 29 received plasmalyte.
Demographics were similar between groups, except the saline group
contained more patients receiving a kidney donated after cardiac death
(36 % vs 17 %, p < 0.001). In both groups, fluid administration rates were
matched to urine output and overall fluid balance was equal between
the two groups. Electrolyte data for the two groups are shown in Fig. 15
and demonstrate significantly higher potassium and chloride and lower
bicarbonate levels in the normal saline group (P < 0.0001).
There was a higher proportion of hyperkalaemia (serum K+
>6.0 mmol/L) immediately post-op (21 % vs 0 %), over the first
24 hours (32 % vs 21 %) and over the second 24 hours post-
operatively (15 % vs 7 %) in the patients who received normal saline
(P < 0.001). The saline group had a longer length of stay (11 days vs
7 days, p < 0.0001), and lower eGFR at 3 months post-op (43 vs
51 ml/min; P = 0.016), although by 1-year post-transplant, mean renal
function was identical at 51 ml/min in both groups (Fig. 16).
Conclusions: The sole use of Plasmalyte fluid replacement in the
peri-operative period is associated with improved potassium, chloride
and acid base homeostasis after kidney transplantation when com-
pared to normal saline. The use of Plasmalyte is safe (despite the
concern that it contains potassium), and may be associated with im-
proved early renal outcomes. Whilst evidence of benefit for balanced
replacement fluids in the general population is conflicting, after
transplantation the effects may be more pronounced as the volumes
of fluid administered are greater.
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Introduction: Owing to an aging society, both the number of opera-
tions for patients aged >85 years and the average age of patients ad-
mitted to the intensive care unit (ICU) are rapidly increasing.
However, mortality is not an appropriate outcome measurement in
patients aged >85 years; a more important outcome is home return
(HR), because the quality of life is valuable to these patients.
Objectives: To identify predictors for HR of patients aged >85 years
admitted to the ICU after surgery.
Study design and settings: Retrospective analysis of medical records
at a university hospital.
Subjects: Patients aged >85 years admitted to the ICU after surgery
(n = 187).
Fig. 15 (abstract A435).
Fig. 16 (abstract A435).
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Methods: Patients were divided into a HR group (patients who
returned home after discharge) and non-HR group (deceased or
transferred to nursing facilities). Perioperative data and outcome
were assessed and compared. Multivariate logistic regression analysis
was conducted to identify independent predictors.
Results: The average age of patients was 88 years. HR occurred in
61 % of patients, and mortality was 9 %. The HR group showed
higher preoperative albumin level than the non-HR group. More pa-
tients in the non-HR group experienced hip surgery than in the HR
group (51 % vs. 12 %, P < 0.001). APACHE II score was higher (P <
0.001) in the non-HR group. In multivariate analysis, preoperative al-
bumin, hip surgery, and APACHE II score were identified as inde-
pendent predictors of HR.
Conclusion: Predictors of HR of surgical critically ill elderly patients
included preoperative albumin level, hip surgery, and APACHE II
score on ICU admission.
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Introduction: Immediate postoperative liver transplant recipients are
at risk for developing acute kidney injury (AKI) with a reported inci-
dence between 17 to 95 %. Recent findings suggest that the
chloride-rich resuscitation fluids may increase the incidence of acute
kidney injury in critically ill and surgical patients. Hyperchloremic
fluids have been shown to induce renal vasoconstriction, attenuate
renal artery flow velocity, and reduce renal cortical tissue perfusion.
Objectives: The association between postoperative serum chloride
levels and the incidence of immediate postoperative acute kidney in-
jury in the ICU in liver transplant recipients were evaluated.
Methods: Adult patients (≥18 years old) who underwent liver trans-
plantation at Seoul National University Hospital between July 2010
and December 2012. Preoperative serum chloride levels were mea-
sured within 24 hours before the operation and postoperative serum
chloride levels were routinely measured every 8 hours during the ini-
tial 72 hours after ICU admission (10 measurements). The average
serum chloride level was defined as the average of the 10 serum
chloride levels in patients who did not develop AKI or developed AKI
72 hours after liver transplantation and the average of the preopera-
tive serum chloride level and the serum chloride levels measured be-
fore the development of AKI in those who developed AKI within
72 hours. Patients were divided into 3 groups according to their
average chloride level.; normochloremia group (96–106 mEq/L),
hypochloremia group (<96 mEq/L), or hyperchloremia group
(>106 mEq/L). The primary outcome was postoperative AKI according
to the RIFLE criteria. Secondary outcomes included in-hospital mor-
tality and surgical site infection.
Results: AKI developed in 46.6 % (158/339) of the patients. The over-
all in-hospital mortality was 4.7 %. Compared to normochloremia, AKI
was more frequent in patients with hyperchloremia (adjusted OR
1.826 [95 % CI 1.133-2.944], P = 0.013) and hypochloremia (adjusted OR
8.794 [95 % CI 1.820-42.498], P = 0.007). There was no difference in pre-
operative chloride levels between patients who developed AKI and
those who did not (104.54 ± 8.41 vs 103.18 ± 6.14 mEq/L, P = 0.089).
Conclusions: Hyperchloremia and hypochloremia were both associ-
ated with an increased risk of developing AKI in the immediate post-
operative period after liver transplantation in the ICU.
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Introduction: Electrolyte abnormalities are common in critically ill
populations and are associated with mortality. Previous reports have
demonstrated a relationship between serum sodium fluctuations and
mortality in a cohort of surgical critically ill patients (1–3).
Objectives: Our primary aim was to assess the association between
serum sodium fluctuations and 28-day mortality in a cohort of adult
surgical patients requiring intensive care. Our secondary aim was to
assess the association between dysnatraemia and 28-day mortality in
surgical patients requiring intensive care.
Methods: We performed a retrospective analysis of the Multi-
Parameter Intelligent Monitoring in Intensive Care (MIMIC-II) data-
base. Subjects were categorized by severity of dysnatraemia and so-
dium fluctuations during the index ICU admission. Dysnatraemia was
defined as a sodium concentration upon ICU admission outside
physiologic range (135–145 mmol/L). Univariate and multivariable lo-
gistic regression was used to test primary and secondary aims.
Results: We identified 8600 subjects, 39 % female with a median age
of 66 years for analysis; 28-day mortality was 8 %. Fluctuations in
serum sodium were found to be associated with 28-day mortality
(adjusted odds ratio (OR) per 1 mmol/L change: 1.10 (95%CI 1.08-
1.13)) in dysnatraemia. In subjects who remained normotraemic,
there was an association between fluctuation in serum sodium and
28-day mortality (adjusted OR 1.13, 95%CI 1.10 - 1.16; p < 0.001). Sub-
jects with dysnatraemia were more likely to be dead at 28-days
(17 % vs 7 %; p < 0.001). Severity of dysnatraemia was associated
with 28-day mortality (adjusted ORs (95 % CI): severe hyponatraemia
(<130 mmol/L) 2.68 (1.72-4.17); mild hyponatraemia (130–134 mmol/
L) 1.59 (1.24-2.05); mild hypernatraemia (146–150 mmol/L) 2.46 (1.76-
3.43); severe hypernatraemia (>150 mmol/L) 4.73 (2.54-8.80)).
Conclusions: Fluctuations of serum sodium, including in patients
whose sodium remained within the normal range, were independ-
ently associated with an increase in 28-day mortality. Severity of dys-
natraemia was associated with 28-day mortality. These findings are
consistent with previous reports and suggest that minor fluctuations
in sodium may be associated with mortality.
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Introduction: Cv-aCO2/Da-vO2 has been suggested as a marker of ad-
equacy of resuscitation in shock states. A ratio >1 reflects the meta-
bolic tipping point at which CO2 production exceeds oxygen
consumption, akin to the anaerobic threshold in cardiopulmonary ex-
ercise testing, but with the advantage of measurement from paired
arterial and central venous blood gas analysis. It is of prognostic
value in critical care, and in sepsis when combined with lactate[1, 2].
We investigate the role of Cv-aCO2/Da-vO2 in liver resection surgery.
Our anaesthetic technique uses fluid restriction, diuresis and venodi-
lation to decrease CVP, which improves outcome[3]. On completion
of resection, goal-directed fluid therapy (GDFT) is initiated. This tech-
nique provides an ideal model of rapid haemodynamic changes in
which to investigate Cv-aCO2/Da-vO2.
Objectives: To establish: 1) Is there a relationship between peri-
operative Cv-aCO2/Da-vO2 and outcome? 2) If Cv-aCO2/Da-vO2, in-
verse CO2 gap or serum lactate correlate with cardiac output (CO)
Methods: This is a subset of data from the prospective observational
study MicroHepFlow, investigating microcirculation in liver resection
surgery. All patients received general and thoracic epidural anaesthe-
sia, fluid restriction, GTN, remifentanil and furosemide. Oesophageal
Doppler (OD) was used at the anaesthetists' discretion. Prospective
data was collected at pre-defined time points. The Clavien-Dindo
(CD) Classification was used for post-operative complications. Statis-
tical analysis was with linear regression and Fischers exact test.
Results: In 31 patients, 17 with CO data, a Cv-aCO2/Da-vO2 > 1 and
lactate ≥2 was common (55 % at maximal desiccation and 52 % fol-
lowing GDFT). There was no consistent relationship between this and
the incidence of complications. C-D complications ≥ Grade III were
rare (6 %). Neither Cv-aCO2/Da-vO2, inverse CO2 gap nor serum lac-
tate concentration significantly correlated with CO.
Conclusions: The expected positive association between Cv-aCO2/
Da-vO2 > 1 and lactate ≥2 with post-operative complications was not
observed, potentially due to a low incidence of serious complica-
tions. The lack of significant correlation between Cv-aCO2 / Da-vO2
and inverse CO2 gap with cardiac output is informative and suggests
that these variables are poor surrogates of cardiac output in this
setting.
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Introduction: Despite goal-directed fluid therapy, vasopressor sup-
port may be necessary in the early post-operative period to maintain
adequate systemic blood pressure. Persistent requirement for moder-
ate doses of vasopressor support (vasoplegia) has not been reported
in patients recovering from following major gynae-oncology debulk-
ing surgery (GODS). Risk factors for, and complications of, vasoplegia
have not been described.
Objectives: Describe the incidence of vasoplegia following GODS,
and the risk factors for, and complications of, vasoplegia.
Methods: Patients were identified from our ICU patient database
(WardWatcher software) and additional clinical details acquired from
electronic databases including the IntelliSpace Critical Care and
anesthesia (Philips) and a local bespoke system (The Guildford
Gynae-oncology database). Statistical analysis was performed using
binary logistic regression using log transformed data for all non-
parametric variables (SPSS).
Results: Between February 2014 and September 2015 there were
176 elective admissions to our ICU for care of patients following
GODS. The median age was 67 years (IQR range 56–76) and median
weight was 70 kg. 75 % had ovarian or endometrial cancer. The me-
dian estimated blood loss (EBL) was 900mls. 67.1 % of this group
had an epidural inserted for post-operative analgesia and the mean
rate of a standard infusion was 10mls/h. 52.3 % of patients received
a vasopressor for at least one hour during their post-operative stay
on ICU (either phenylephrine or noradrenaline). 16.5 % of the group
remained on a dose of noradrenaline ≥0.1mcg/kg/min at 08:00 on
the first post operative day - considered to reflect vasoplegia. Median
ICU length of stay (LOS) was 2.0 days (IQ range 1.1-3.0), and median
hospital LOS 5.7 days (IQR 4.3-7.1). ICU mortality was < 1 % (1/176)
and 6 month mortality 4 % (7/176). The only pre-operative variable
associated with requiring vasopressors was haemoglobin; median
was 119 g/L in those who required vs. 128 g/L in those who did not
(p = 0.02). Epidural use was associated with requiring vasopressors
(OR 3.74,CI 1.91-7.30, p < 0.005). Cumulative fluid balance was associ-
ated with vasoplegia (OR of log 26.22, CI 4.75-144.59, p < 0.005) and
a peak lactate greater than median, 3.1 mmol/L (OR of log 4.99, CI
1.63-15.33, p = 0.005). The presence of vasoplegia was association
with a prolonged hospital stay (odds ratio of 6.40, CI 2.31-17.70,
p < 0.0005).
Hospital LOS in those who didn't require any vasopressors was 4.9d
(3.9-6.1), in those who required some vasopressors was 5.8d (5.0-7.9),
and in those with had vasoplegia was 7.0d (6.0-9.8), p < 0.0001 KWT.
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Conclusions: Lower pre-operative haemoglobin concentration was
associated with requirement for vasopressors, as was epidural use
and cumulative fluid balance. Vasoplegia was uncommon, associated
with cumulative fluid balance and elevated peak lactate, and a pro-
longed duration of hospital stay. Mortality was low.
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Introduction: Patients undergoing thoracic surgery commonly
undergo a radial catheter placement to fulfill the need for continu-
ous blood pressure monitoring, other than blood gas
analyses 1.
Objectives: In this prospective observational study, we recorded
cardiac output and pressure measurements obtained by an uncali-
brated pulse contour method in a totally non invasive manner
(ClearSight system, Edwards Lifesciences) to assess hemodynamic
variations during normal and one lung ventilation (OLV) in supine
and lateral decubitus in thoracic surgery.
Methods: After Ethical Committee approval was obtained, we en-
rolled patients with age > 18 years, scheduled for thoracic surgery
and OLV with double-lumen tube in lateral decubitus. Exclusion
criteria: ASA > III, severe baseline hemodynamic impairment which
required invasive monitoring and amine infusion.
Key hemodynamic parameters, including Stroke Volume Index (SVI),
Stroke Volume Variation (SVV), Cardiac Index (CI) and Continuous
Blood Pressure (cBP) were recorded at three time points: two lung
ventilation in supine position (T1), two lung ventilation in lateral de-
cubitus (T2) and one lung ventilation in lateral decubitus (T3).
Results: 11 consecutive patients scheduled for thoracic surgery
were included. Overall, our patients showed no hemodynamic
impairment throughout the passage to lateral decubitus and OLV
(CI 3,1 ± 0,9 l/min/m2 at T1, 2.5 ± 0.6 l/min/m2 at T2, 2.5 ± 0.7 l/
min/m2 at T3; p = 0.09 T2 and T3 vs T1). Only in 3 patients a
decrease in CI was detected after the position change (−37 %,
−42 % and −43 %, respectively, T2 vs T1), which required prompt
intervention.
Conclusions: The lack of invasiveness and the simplicity of the
system allowed satisfactory monitoring and, subsequently, appro-
priate therapy, without the need of arterial catheter placement
for invasive monitoring, while an automatic, intermittent, non-
invasive blood pressure measurement would have not readily
detected the observed hemodynamic variations.
Even if most studies underline the not-interchangeability of the
finger cuff method with the currently used invasive devices2, in
our low to moderate risk thoracic surgery patients not receiving
an arterial line, ClearSight was able to track hemodynamic
changes during the different phases of the surgical procedure, in
particular those related to position changes and to the OLV.
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Goal of study: The aim of our study was to evaluate the predictive
value of CVP with regard GEDI, and correlate these parameters to
cardiac Index (CI) and extravascular lung water index (EVLWI).
Methods: Prospective study. Surgical intensive care unit, university
hospital.
Patients and interventions: 129 hemodynamic measurements using
the PiCCO (Pulsion Medical System, Germany) were performed in 28
patiens during major liver resection.
Results: Mean CVP (8,44 +/− 4,22 mmHg) was normal, whereas mean
GEDI (625,3 +/− 111,34 mL/m2) was decreased.
Forty-two CVP measurements were elevated despite simultaneous GEDI
levels indicating a normal or decreased preload. Sensitivity, specificity,
positive predictive value, and negative predictive value of CVP with re-
gard to volume depletion (GEDI < 650) were 8,25 (0–14,66. CI 95 %),
100 (99,89-100, CI 95 %), 100 (50–100, CI 95 %), 29, 4 (21,99-26,96, CI
95 %) respectively. CVP did not correlate to GEDI (r = −0,045, p = 0,42),
CI (r = 0,13, p = 0,216) and EVLWI (extravascular lung water index)
(r = −0,04, p = 0,38). GEDI significantly correlated to CI (r = −0,23,
p < 0,01) and VVS (r = −0,32, p < 0,01).
Conclusions: Volume depletion according to GEDI was found in more
than half the patiens. The predictive values of CVP with regard to
volume depletion were low GEDI and its changes significantly corre-
lated to CI and its changes, which was not observed for CVP. There-
fore, GEDI appears to be more appropiate for volume management
during mayor liver resections with the aim to avoid intraoperative
bleeding and transfusión.
Note: This abstract has been previously published and is available at
[4]. It is included here as a complete record of the abstracts from the
conference.
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Introduction: Weaning-induced pulmonary oedema (WiPO) is a well-
recognised cause of weaning failure, but its incidence and risk factors
have not been established and the effects of fluid removal have not
been systematically described.
Objectives: To describe the epidemiology of WiPO and the effects of
diuretics.
Methods: We included 81 patients who performed 283 spontaneous
breathing trials (SBT).Three experts established the diagnosis of WiPO
based on various patient characteristics. Demographic data were col-
lected. A passive leg raising (PLR) test was performed before SBT in
81 patients. We also observed the effects of diuretics when this treat-
ment was decided.
Results: SBT failed in 129 cases (46 % of all SBT). WiPO occurred in
59 % of these failing cases. Compared to patients without WiPO (n =
52), patients with at least one WiPO (n = 29) had a significantly
higher prevalence of obesity (45 % vs. 17 %, resp), COPD (38 % vs.
12 %, resp), dilated cardiopathy (48 % vs. 17 %, resp) and low left
ventricular ejection fraction (55 % vs. 21 %, resp). In 16 cases with
WiPO and a negative PLR at baseline, diuretics were administered. In
9 of these cases, the PLR remained negative before the following
SBT. A new episode of WiPO occurred in 7 of these instances while
the two other ones were extubated. In 7 other cases, the PLR be-
came positive before the following SBT. WiPO did not occur anymore
in 6 of these 7 patients who were extubated, while the remaining
one was not.
Conclusions: WiPO was responsible for 59 % of weaning failures.
Obesity, previous cardiopathy and COPD were its main risk factors.
When fluid removal had changed preload-independence to preload-
dependence, the following SBT was very likely to succeed.
A445
Heart lung interactions measured by means of phase
synchronization analysis under three ventilatory modes: pressure
control, pressure support and NAVA
T. Fossali1, R. Colombo1, D. Ottolina1, M. Rossetti1, C. Mazzucco2, A.
Marchi2, A. Porta3, E. Catena1
1Ospedale Luigi Sacco - Milano, Department of Anaesthesia and
Intensive Care, Milano, Italy; 2Politecnico di Milano, Department of
Electronics information and Bioengineering, Milano, Italy; 3Università
degli studi di Milano, Department of Biomedical Science of Health,
Milano, Italy
Correspondence: T. Fossali - Ospedale Luigi Sacco - Milano,
Department of Anaesthesia and Intensive Care, Milano, Italy
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A445
Introduction: Pulmonary and cardiac systems are deeply connected in
physiologic conditions by autonomic nervous system. In particular Re-
spiratory Sinus Arrhythmia (RSA) modifies heart rate in correspondence of
inspiration to permit a better ventilation-perfusion matching. Cardio-
respiratory phase synchronization analysis (CRPS) defined as a repetitive
occurrence of m heartbeats at the same relative phases within n consecu-
tive breathing cycles, also provides indexes relevant to nonlinear interac-
tions between cardiac and respiratory systems complementary to RSA (1).
These mechanisms are poorly studied during mechanical ventilation.
Objectives: Aim of the study was to compare cardio-ventilatory inter-
actions in different mechanical ventilation modes by means of CRPS
and RSA analysis.
Methods: The study was conducted in the Intensive Care Unit of
Luigi Sacco Hospital, Milan, Italy. The experimental protocol consisted
of three randomized sessions of 30 minutes corresponding to differ-
ent ventilation modes: Pressure Control Ventilation (PCV), Pressure
Support Ventilation (PSV) and Neurally Adjusted Ventilatory Assist
(NAVA). Electrocardiographic (ECG) and airway volume (AWV) signals
were acquired at 250 Hz sampling rate and continuously registered
(Philips IntelliVue MX800, iXtrend software). Signals were analyzed
offline: the Hilbert transform was applied to AWV signal to estimate
the respiration phase. In the synchrogram the phase values of the
AWV observed in correspondence of the R-wave peak on the ECG
was drawn as function of the cardiac beat number. The quan-
tification of cardio-respiratory coupling was assessed by the syn-
chronization index (SYNC), i.e. the percentage of beats in which it
could be observed the most frequent PLR. RSA amplitude, the differ-
ence between the longest and the shortest R-R interval on the ECG,
was estimate for each respiratory cycle.
Results: 20 mechanically ventilated patients were included. Mechan-
ical ventilation was set to guarantee constant minute ventilation (MV
10 ± 4 vs 10 ± 3 vs 10 ± 2 liters/minute for PCV, PSV and NAVA re-
spectively). CRPS analysis showed a significant variation of SYNC
index between the different modes (Fig. 3), while RSA was not able
to detect meaningful differences (23 ± 26 ms, 24 ± 24 ms and 22 ±
22 ms, p = 0.6, for PCV, PSV and NAVA respectively).
Conclusions: Analysis of CRPS is possible in ventilated patients. Our
results endorse the hypothesis that under ventilation with a fixed fre-
quency, the interactions between cardiac and respiratory fluctuations
were stronger than in the case of patient driven modes of mechan-
ical ventilation, as PSV and NAVA (2). The lack of variation of RSA
may be due to sedation and mechanical ventilation.
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Introduction: Initial cardiac rhythm (ICR) is associated with mortality
in cardiac arrest (CA) patients with return of spontaneous circulation
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(ROSC) [1]. However, knowledge regarding a possible association be-
tween substance abuse and mortality is limited.
Objectives: (1)To determine whether substance abuse is associated with
in-hospital mortality in patients with CA admitted to ICU`s (intensive care
units), and (2) to study the association between substance abuse and ICR.
Methods: CA patients with ROSC– admitted to the ICU`s at Oslo Uni-
versity Hospital Ullevål from Feb.3, 2014 to Feb.2,2015 – were in-
cluded as part of a multicenter prospective observational study of
ICU patients in Oslo (n = 900). Informed consent was given by the
next of kin, and if possible, later by the patient. Illicit drug/alcohol
abuse (acute or chronic) was assessed via standard questionnaires,
biochemical analysis (drug screen) and medical records. The patients
were divided into groups based on ICR: 1) non-shockable rhythm
(asystole/pulseless electric activity) and 2) shockable rhythm (VF/VT).
Chi-square test was used for statistical analysis, p value < 0.05 was
considered statistically significant.
Results: 145 patients (116 (80 %) males)) were included, reflecting a
participation rate of 95 %. 72(50 %) had non-shockable rhythm, and
73(50 %) had shockable rhythm (mean age 62 vs 63). There were sig-
nificantly more females in the non-shockable group (21vs.8, p < 0.01),
corresponding with earlier studies. Acute drug intoxication was con-
sidered triggering cause in 7 patients (5 %), all males (mean age 43vs
64). Main agents were: opioids (4/7), alcohol (2/7,both with blood
levels > 4.2 g/L (92 mmol/L)) and benzodiazepines (1/7). All these pa-
tients were in the non-shockable group. However, the sample size
was too small for further analysis to be pursued.
Among the 31 (21 %) classified with chronic substance abuse
(27(87 %)males, mean age 59 vs. 64) alcohol was the predominant
substance (75 %), followed by illicit substances (21 %) and prescrip-
tion drugs (5 %). The proportion of patients with chronic abuse was
significantly higher among patients with non-shockable rhythm
(32 % vs 13 % p = 0.005). In-hospital mortality was significantly
higher among patients with non-shockable rhythm (83 % vs 42 %,
p < 0.001). Chronic abuse, however, was not significantly associated
with in-hospital mortality (p = 0.43).
Conclusions: Chronic substance abuse is common among patients with
CA and is significantly associated with non-shockable ICR. As expected,
in-hospitality mortality was significantly higher in the non-shockable
group. Although chronic abuse was associated with non-shockable ini-
tial rhythm, it was not associated with in-hospital mortality.
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Introduction: Cardiac arrest (CA) is a major health problem in
western countries. Despite improvements in quality of treatment, it
still has a high rate of morbidity and mortality in patients. CA results
in a harmful inflammatory response and overwhelming amounts of
reactive oxygen species are produced, spreading out across the
body, causing leakage of vascular walls and damage to organs. The
mouse is an increasingly used preferred model in preclinical CA stud-
ies due to the knowledge concerning the mouse genome and the
general availability of genetically modified mice. Volatile anesthetics
are often used in these models as they are easy to apply and short-
acting. However, volatile anesthetics are known to protect against I/R
injury, reduce myocardial infarct size by preconditioning and may
protect vital organs by postconditioning.
Objectives: This pilot study investigates the use of i.v. or volatile
anesthetics in a mouse model for CA.
Methods: Experiments were approved by the ethical committee of VU
Medical Centre Amsterdam. Mice randomly assigned to one of the two
groups. Thereafter they were weighed, sedated with 4 % sevoflurane and
buprenorphine (0.05 mg/kg s.c.) or a mixture of fentanyl/midazolam/ace-
promazine (FMA: 0.47 mg/kg, 9.38 mg/kg, 9.38 mg/kg; respectively i.p.),
intubated and placed on a heating mat. The mice were pressure-
controlled ventilated with 21 % O2 (90–100 breaths/min, PEEP 4cmH2O,
peak 16cmH2O). Anaesthesia was maintained with 2.5-3 % sevoflurane or
with FMA (0.08 mg/kg, 1.56 mg/kg, 1.56 mg/kg i.v.). 21 mice were se-
dated and anesthetized with sevoflurane and 6 with FMA. Electrocardio-
gram (ECG) was recorded continuously. For measurement of aortic
pressure, a fluid filled polyethylene catheter was inserted in the right ca-
rotid artery, advanced into the aortic arch and connected to a pressure
transducer. Via a fluid filled polyethylene catheter, inserted in the jugular
vein, potassium chloride (KCl: 0.08 mg/kg) was administered and subse-
quently CA induced. CA was defined as a mean arterial pressure (MAP) of
less than 20 mmHg and no ECG activity and lasted for 8 min. Thereafter
the mice were resuscitated by manual chest compression (~300/min)
and a bolus 0.1 ml epinephrine (0.1 mg/ml i.v.). Resuscitation ended after
15 min or upon ROSC, defined as sinus rhythm on ECG and mean arterial
pressure >40 mmHg lasting at least 5 min.
Results: 17 out of 21 (81 %) mice in the sevoflurane group achieved
ROSC within 90 seconds after the start of resuscitation. In contrast,
none of the 6 mice sedated and anesthetized with FMA achieved
ROSC within 15 minutes after CA. No significant differences in aortic
pressure, heart rate or body temperature was observed before CA.
Conclusion: Sevoflurane is the best choice for anesthetics in a mouse
CA model with successful resuscitation. However, our data suggest a
profound postconditioning effect of sevoflurane which should be in-
vestigated in further detail.
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Introduction: Impaired renal sodium excretion may contribute to
ICU-acquired hypernatremia (IAH). Thiazides are suggested as an ef-
fective treatment by interfering in renal sodium reabsorption [1].
Objectives: Primary aim of the study was to reduce serum sodium
concentration (sNa) in patients with IAH, defined as sNa ≥ 143 mmol/
l, with hydrochlorothiazide (HCT) in comparison to placebo. Second-
ary endpoints were a difference in urine sodium concentration (uNa)
and the duration of severe IAH, defined as sNa ≥ 145 mmol/l.
Methods: A monocentric, double-blind placebo-controlled trial was
conducted in 50 patients with IAH and an impaired renal cation ex-
cretion, defined as (urine potassium + uNa) < sNa in a spot urine sam-
ple. Patients were randomized for enteral HCT 25 mg (n = 25) or
placebo (n = 25) 1qd for a maximum of 7 days. Patients on renal re-
placement therapy, on medications inducing diabetes insipidus or
with recent use of diuretics were excluded. The trial received no
funding and was registered at clinicaltrials.gov (NTC01974739).
Results: Baseline characteristics in both groups were comparable. At
baseline median sNa was 146 mmol/l in both groups ([145–148] in
the HCT-group, [144–150] in the placebo group, p = 0.4). Over time
sNa decreased significantly with 4 mmol/l in both groups, with no
significant difference between groups. At baseline uNa was 25 [10–
62]mmol/l in the HCT-group and 20 [10–66]mmol/l in the placebo
group. Over time uNa increased significantly in both groups: 46 [16–
86]mmol/l in the HCT-group and 36 [9–78]mmol/l in the placebo
group, with no difference between groups (Fig. 17, Table 7). Median
duration of sNa ≥ 145 mmol/l was 3 days in both groups (p = 0.91).
No adverse advents or side effects were registered.
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Conclusions: HCT 25 1qd did not significantly affect sNa nor uNa in
patients with IAH.
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Introduction: Most of mass methanol outbreaks are reported in
underdeveloped countries were financial resources are scarce. In The
Czech Republic, in 2012–2013 the mass methanol outbreak was re-
ported with 138 victims. Finding optimal cost-effective treatment is
cornerstone for every medical system.
Objectives: Primary objective of our study was to define total hos-
pital cost, find major parameters which influence total hospital cost
and its relation to clinical outcome. Choice of antidote (ethanol or
fomepizol) and choice of elimination technique (continuous or
intermittent hemodialysis), its impact to hospital costs and clinical
outcome were analyzed.
Methods: In cooperation with Czech Toxicology Information Centre
(TIC) and Czech medical insurance companies reimbursed medical
costs were defined. 54 survivors fulfilled follow up investigation. Hos-
pital costs and its correlation to admission parameters was provided.
Effectiveness of treatment modalities and consequent medical costs
were analyzed.
Results: The median hospital costs were 2,422 (interquartile
range, IQR: 1,364-4,748) euros. The median one-year medical
costs were 633(IQR 439–1,228) euros. Anion gap, pH, HCO3-, lac-
tate, serum creatinine, methanol level, decreased GCS strongly
correlated with total hospital costs. All non-survivors were
comatose at admission. Fomepizol treatment increase adjusted
hospital costs 2,8 times without difference in clinical outcome.
Choice of intermittent hemodialysis led to faster residual metha-
nol clearance, formic acid clearance and showed trend to
decreased hospital costs.
Conclusions: We were able to define major admission parameters
that have impact to total hospital costs. Fomepizol antidote signifi-
cantly increases costs without impact to clinical outcome. Intermit-
tent hemodialysis shortens secondary elimination time and tend to
lower costs.
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Introduction: Few studies have evaluated the prognostic importance
of linezolid-induced thrombocytopenia in intensive care unit (ICU) pa-
tients because there are many confounding conditions such as sepsis,
disseminated intravascular coagulation, and low thrombocytopenia
level when admitted to the ICU.
Objectives: We determined the prevalence and risk factors of
linezolid-induced thrombocytopenia in the ICU.
Methods: Patients treated with linezolid from January 2005 to
December 2015 in the ICU were reviewed retrospectively. To differ-
entiate other causes of thrombocytopenia, the Naranjo algorithm
was used to determine the degree of probability for every linezolid-
induced thrombocytopenia.
Results: Sixty patients were included in this study. The mean (SD)
age of the patients was 69.8 (±11.9) years. Twenty-nine patients
(48.3 %) presented linezolid-induced thrombocytopenia. Patients
with thrombocytopenia had higher incidence of any malignancy
(41.4 % vs. 9.7 % p = 0.007), elevated baseline creatinine (1.7 [0.9-2.5]
vs. 0.9 [0.6-1.3], median [IQR] mg/dL, p = 0.042) and lowered
platelet on the first day of linezolid administration (160 [128–230]
vs. 194 [118–285] *103/mm3 median [IQR], p = 0.296). Patients
who developed thrombocytopenia received more transfusions
(34.5 % vs. 6.5 %, p = 0.009) and showed increased ICU mortality
(62.1 % vs. 32.3 %, p = 0.037). By means of a logistic regression
model, higher incidence of any malignancy (odds ratio, 9.060,
95 % confidence interval, 1.942-42.271) and elevated serum cre-
atinine level after linezolid administration (odds ratio, 1.655, 95 %
confidence interval, 1.027-2.669) were significant risk factors of
linezolid-induced thrombocytopenia in the ICU.
Fig. 17 (abstract A448). Decrease sNa and increase uNa at
study end
Table 7 (abstract A448). Results at last day of study inclusion
HCT (n = 25) Placebo (n = 25) P-value
Serum [Na+], mmol/l 141 [137–147] 144 [139–146] 0.32
Urine [Na+], mmol/l 110 [70–124] 84 [52–126] 0.34
Decrease in serum [Na+], mmol 4 [1–9] 4 [2–6] 0.47
Increase in urine [Na+], mmol 46 [26–86] 36 [9–78] 0.31
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Conclusions: Patients with any malignancy or elevated baseline cre-
atinine who were treated with linezolid in the ICU are more likely to
develop thrombocytopenia.
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Introduction: Intravenous boluses of furosemide are commonly given
to critically ill patients to modulate fluid balance1–3. However, their
effect on urinary output (UO), fluid balance, electrolyte losses and
hemodynamics has not been systematically studied. Therefore, we
sought to compare UO, fluid balance, electrolyte losses, biochemical,
and hemodynamic effects in the six hours before and after the ad-
ministration of a 40 mg IV bolus of furosemide.
Methods: We conducted a prospective observational study in critically ill
patients where the attending clinician had decided to administer a
40 mg bolus of IV furosemide. We collected information on UO, fluid bal-
ance, urinary electrolyte losses, serum and urinary creatinine, serum bio-
chemistry, and hemodynamics and compared the 6-hour pre-bolus
period with the 6-hour post-bolus period. We performed linear regression
analysis to identify predictors of the extent of urinary output response.
Results: We studied 24 patients (13 females) with a median (IQR) age
of 72 (64, 81) years. The intravenous bolus induced a > 1000 ml in-
crease in urine output (UO) in 6 (25 %) patients, a 500–1000 ml in-
crease in 7 (29.2 %) patients, a < 500 ml increase in 9 (37.5 %)
patients, and no increase in 2 (8.3 %) patients. The median UO in-
creased in 23 (96 %) patients and failed to increase in 1 (4 %) patient
for a median difference in UO of 561 (250, 1046) ml. The 6-hour fluid
balance became negative in 16 (72.7 %) patients and positive in 8
(36.3 %) patients, with a median change of −520 (−1206, 98) ml.
However, we observed no difference in free water clearance. Fur-
osemide significantly increased urinary sodium, potassium and chlor-
ide losses by 67 (31, 129) mmol, 9.4 (1.8, 18) mmol and 61 (44, 138)
mmol respectively, and decreased blood chloride levels by 1.5 (0.5,
3.0) mmol/l. There were no detectable changes in hemodynamics.
On linear regression analysis, UO increased by 37 ml (95 % CI 19 to
56 ml) / 6 hour for every 1 mmHg increase in mean arterial pressure
and decreased by 35 ml (95 % CI 9 to 61 ml) / 6 hour for every 1 g/L
increase in serum albumin.
Conclusions: We defined the overall median effect of furosemide on
urine output, urinary sodium, potassium and chloride losses and fluid
balance in critically ill patients and provided information on how
such effects were modulated by mean arterial pressure and albumin
levels. Our findings are likely to assist clinicians in their therapeutic
expectations and choices.
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Introduction: In 1998, Weinberg and colleagues reported results
from a study that pointed towards reduced bupivacaine toxicity by
intravenous lipid emulsion (ILE) in rats[1]. The use of ILE as an anti-
dote has increased dramatically and associations in several countries
have launched guidelines regarding the use of ILE in local anaes-
thetic systemic toxicity (LAST). Recently, two systematic reviews from
the international expert team 'Lipid Emulsion Therapy Workgroup'
were published[2,3]. The review on ILE for LAST concluded that treat-
ment appears to be effective in some cases of LAST, but there is no
evidence showing that ILE is more effective than vasopressors. The
review on ILE for non-local anaesthetic toxicity concluded that the
quality of evidence for ILE being an effective antidote remains low to
very low.
Objectives: We present a systematic review including all published
reports regarding humans treated with lipid rescue from 1998 until
2016.
Methods: Web of science and PubMed were used for the literature
search. To limit the search we used predefined criteria. This resulted
in 195 papers, which were independently reviewed and categorized
by using a modified version of WHO-UMC causality categories[4]. This
is a 6-graded assessment scale that combines clinical and pharmaco-
logical aspects with the quality of documentation. Grade 1 implies a
certain causal connection, 2 probable, 3 possible and 4 unlikely.
Grade 5 implies none or negative effect of ILE and 6 unassessable.
Log p-values were identified for all involved toxins. Further, the
reviewing experts evaluated which main symptom reasonable had
led to the decision of giving ILE.
Results: In total, 135 case reports received grade 1–4 and 34 grade 5.
Forty of the 135 case reports that had reported a positive effect of
ILE were parenteral intoxications while 95 were oral poisonings.
Three of 135 cases were classified as a certain correlation between
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giving ILE and improvement of symptoms, 34 cases as probable cor-
relation, 71 possible and 27 unlikely. Mean classification grade in par-
enteral intoxications was 2.3. Mean classification grade among the
oral poisonings was 3.1, which was a highly significant difference.
None of the oral poisonings received the classification grade 'certain'.
The parenteral intoxications had a mean log p-value of 4.2 which
was significantly higher than that for oral poisonings which was 3.2.
Indications for ILE in parenteral intoxications were cardiac arrest and
neurological symptoms and for oral poisonings hypotension and
arrhythmia.
Conclusions: The evidence for ILE being an effective antidote is
sparse. Thirty-four out of 135 published cases indicates no or nega-
tive effect, despite the immense impact of publication bias. It seems
reasonable not to use ILE in oral poisonings.
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Introduction: Inmune Heparin-induced thrombocytopenia (HIT) is a
prothrombotic disorder caused by an immune-mediated complica-
tion that results from a platelet activating inmune response triggered
by the interaction of heparin with a specific platelet protein, platelet
factor 4 (PFA). Fondaparinux is a safety treatment of HIT, even
though is not recommended in acute renal failure (ARF) because of it
renal elimination and significant risk of accumulation.
Objectives: Report the safety profile and efficacy of fondaparinux
(thrombotic and major bleeding complications) in patients with HIT
and ARF during continuous renal replacement therapy (CRRT).
Methods: We reviewed consecutive elegible patients with HIT and
ARF in one medical university center (Clínica Universidad de Navarra)
over a 5 year period, who received fondaparinux for anticoagulation
at the time of the HIT diagnosis.
Results:
- Of the 12 patients recorded that received fondaparinux as anticoa-
gulation therapy, 5 of them shared the criteria of HIT and ARF with
CRRT. We analyzed four of the five patients, excluding one because
of loss of information.
- The mean age of the patients was 67 yo, three men and one
woman. All of them present acute renal failure with a mean basal
creatinine of 2.57, meeting the criteria of CRRT.
- All patients had cardiac surgery with heparin administration last
more than 24 hrs with a mean of 4.5 days.
- Platelets at admission were documented and in all cases they
dropped more than 50 % of the original value.
- After the administration of Fondaparinux, all the patients had a re-
covery of the platelet count until the basal value, with a mean of
28.25 days.
- None of the patients developed new, recurrent or progressive
thrombosis. No major bleeding complications were documented.
Conclusions: Fondaparinux is a safety alternative of anticoagulation
therapy in patients with HIT and ARF during continuos renal replace-
ment therapy.
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Introduction: Hyperthermia with rhabdomyolysis and Multiple Organ
Dysfunction Syndrome (MODS) is a rare, life-threatening complication of
methamphetamine derivatives (MA) and 3,4-methylenedioxymetham-
phetamine (MDMA) consumption. The association between hyerthermia
and MODS was established from case reports subject to publication bias.
Objectives: To explore the association between hyperthermia and
MODS development in patients requiring ICU admission due to MA/
MDMA intoxication.
Methods: Patients with a positive urine test for MA (Triage TOX Drug
Screen. Biosite. USA) who required admission to ICU at Can Misses Hos-
pital between the 1st of January 2004 and the 31th of December 2014
were identified. Patients admitted for major trauma, near-drowning or
acute coronary syndrome were excluded. Vital signs, clinical data, toxi-
cological results, time prior to ICU admission and mortality at discharge
from ICU were recorded. Only tympanic temperatures were considered.
SAPS-3 and daily SOFA scores were calculated. Hyperthermia was set as
a tympanic temperature above 38,9 °C. MODS was defined by the pres-
ence of a score of 3 or 4 in at least two items of the SOFA scale, exclud-
ing the neurological at 48 hour of admission or at the time of death.
Results: Forty patients were identified after excluding three accord-
ing to pre-established criteria. They were predominantly young
(26 years (19–41)) male (33 patients) with no previous medical his-
tory (33 patients). The co-use of other substances was common. The
main cause of admission was altered level of consciousness (35 pa-
tients), 25 (62.5 %) were in coma. Four cases were admitted due to
an out-of-hospital cardiac arrest. Seventeen patients (42.5 %) pre-
sented hyperthermia, of which eleven had MODS (4 died within the
first 24 hours). No patient with a maximum temperature below 39 °C
developed MODS. Six patients with hyperthermia (35.2 %) had a fa-
vorable outcome without MODS. Among them, the maximum
temperature (40.62 ± 0,7 vs 41.46 ± 0.7 °C, p 0,03), the maximum
value of CPK (3.967 ± 1.283 vs 40.387 ± 1.027 U/L, p 0.01), the SAPS-3
(45,5 ± 4 vs 80,7 ± 3, p < 0,001) and SOFA scores (6 (0–9) vs 10 (6–19),
p 0,001 at 24 hours; 2 (0–8) vs 15 (13–17), p 0,003 at 48 hours) were
significantly lower. No differences in origin (e.g. club), co-use of other
substances or temperature control measures were observed among
this group. There was a trend toward a greater delay in admission to
ICU (176 ± 77 vs 103 ± 9 min, p 0.76) that was not statistically signifi-
cant among this group. All patients admitted due to out-of-hospital
cardiac arrest presented with hyperthermia (41,8 ± 0,5 °C) and MODS
(3 died within the first 24 hours).
Conclusions: 1. Hyperthermia appears to be strongly associated with
the presence of MODS in patients with MA/MDMA intoxications.2.
There is a subset of patients with hyperthermia who do not develop
MODS. This is not fully explainable by differences in peak
temperature or in hyperthermia management.
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Introduction: The Dutch Healthcare Inspectorate and Quality Insti-
tutes mandated hospitals to perform a double-check during IV medi-
cation preparation and administering at the bedside. Double check
during IV med. preparation was already secured into the workflow.
The bedside check is an addition to the nursing workload. The ICU
nursing staff of VU University medical center (VUmc) is concerned
that the bedside check will not be as effective as expected and that
implementing this double check will generate disturbances in other
ICU processes.
Objectives: Perform a workload measurement during 4 ICU shifts.
Perform a literature study and survey other ICU's. Interview with the
dedicated ICU pharmacist.
Methods: The workload measurement was performed to clarify how
much extra time the bedside check added to the normal nursing task
performance. We measured the frequency and time of the bedside
check. The literature study was performed to find evidence of experi-
ences and potential problems with the single check versus double
check. Interviewing the pharmacist was to inquire the concerning
double checks as well as supporting advice.
Results: The workload measurement has been performed during four
8-hour shifts. There were 9 to 12 patients admitted at the ICU during
these shifts. The N/P ratio was 1:1.5 up to 2.0. The additional check
takes 1,5 min. per patient, this is added to the 2 minutes that the IV
med. preparation check already takes. The bedside check added 27
interruptions to the 15 interruptions for IV med. preparation because
the preparation check included multiple medications simultaneously
and the bedside check 1 of 2 IV meds per moment.
There are more quantitative studies then qualitative studies [1]. Most
studies conclude that more studies need to be conducted [2].
Other Dutch hospitals struggle with the same problem. Some hospi-
tals enlarged pharmacy service to prepare more medication to de-
crease nurse's workload.
Discussion: Evaluating double check workload, it was less time con-
suming then expected although the frequency of the check brings
more interruptions. Every interruption brings a disturbance to nurse's
concentration and work, this could potentially increase patient risk.
Therefore the amount of interruptions should be reduced to a mini-
mum. Meanwhile, technology makes giant leaps. This has the poten-
tial to replace the double check. BCMA is making progress and is
more efficient and foul proof than human checks. Because of the
wide spread variety in results its hard to draw further Conclusions: It
is even doubtful whether further studies make sense, given the
current advances in technology. If available, BCMA technique (com-
bined with CPOE) should be implemented as soon as possible. If not
available, than hospitals should focus on a select part of medication
checking based on specific risks and workflow [3].
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Introduction: Inadequate antimicrobial treatment of nosocomial in-
fections is an independent determinant of mortality in the critically ill
patient. Multi-drug resistant Gram-negative bacilli, mainly Acineto-
bacter species, are responsible for a significant proportion of nosoco-
mial infections. Acinetobacter has been found to be resistant to
many currently available antimicrobial agents. Recently there has
been renewed interest in colistin, which had earlier been abandoned
for serious adverse effects.
Objectives: To assess rational colistin use in a prospective study at
the ICU wards of a university affiliated hospital in Iran
Methods: Standard treatment Guideline for colistin use were pro-
vided and approved by pharmacy and therapeutics committee
and Study criteria were developed to assess the several parame-
ters involved in colistin therapy. These parameters include the
appropriateness of indication, dosing regimen, duration of ther-
apy and monitoring for toxicity. Clinical and paraclinical parame-
ters such as Glomerular Filtration Rate (GFR), microbial culture,
antibacterial sensitivity, WBC count and fever were collected and
recorded for analysis.
Results: One hundred patients were enrolled in this study, including
64 male and 36 female patients. In most of patients(97 %), the origin
of infection was hospital acquired.In this study colistin therapy was
87 % specific, in the remaining 13 %, the initial therapy with colistin
was empirical. The most frequent infection was ventilator associated
pneumonia (69 %). None of the patients received loading dose. The
maintenance dose of colistin in 76 %, dosing interval in 71 %, and
duration of treatment in 84 %, was appropriate. In this study,
68.12 % of colistin use was compatible with standard treatment
guideline.
Conclusions: Based on the results of this study,the main observed
drawbacks were inappropriate dosing regimen,especially not consid-
ering loading dose in life threatening infections, inappropriate main-
tenance dose, and continuation of colistin, which has to be revised
in order to achieve an effective treatment.
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Objectives: The aim of this study is to evaluate our treatment results
in pregnant women presented with intoxication.
Methods: The patients admitted to intensive care unit (ICU) with in-
toxication between April 2010-May 2015 were evaluated retrospect-
ively and 18 pregnant intoxication cases were achieved.
Results: Median age was 29 (22–40). Median pregnancy week was
15.5 (5–32). Eleven (61.1 %) patients were multi drug intoxication, 5
(27.8 %) patients were carbon monoxide (CO) intoxication and 2 pa-
tients were mushroom intoxication. The drugs that were taken in
order to commit suicide were mostly antidepressants, antibiotics and
analgesics. Median duration of stay in ICU was 1.5 (1–5) days. Median
Glasgow Coma Score (GCS) was 15 (14–15). Additional comorbid dis-
eases were positive in 4 (22.2 %) patients. Hyperbaric oxygen therapy
(HBOT) was applied to all patients with CO intoxication. Median ap-
plication number of HBOT was 1 (1–3). Activated carbon, proton
pump inhibitors for gastric protection and medical treatment were
given to all patients with multi drug intoxication. The 2 patients with
mushroom intoxication received only symptomatic treatment.
When we compare the pre and post treatment AST, ALT and CK values
of the patients with multi drug intoxication there were significant de-
crease. But, there were no differences between troponin values. In the
patients with CO intoxication there were no significant differences be-
tween the pre and post treatment carboxyhemoglobin (COHb) values
(Table 8).
All patients were discharged with healing. Seventeen of the patients
had no problem related with their pregnancy and they gave birth at
term (37–38 weeks). All babies were healthy at birth and they did not
have any problem associated with intoxication. One of the patients
ended her pregnancy with her own decision in her early pregnancy.
Conclusions: In conclusion, we did not observe any severe complica-
tion in clinically stable intoxication patients with normal laboratory
findings in their pregnancy.
A458
Alcohol-related major traumatic brain injury: a province-wide
retrospective analysis
N. Kureshi1,2, L. Fenerty1, G. Thibault-Halman1, M. Erdogan3, S. Walling1,
R.S. Green2,3, D.B. Clarke1
1Dalhousie University, Queen Elizabeth II Health Sciences Centre,
Division of Neurosurgery, Halifax, Canada; 2Dalhousie University, Critical
Care, Halifax, Canada; 3Trauma Nova Scotia, Halifax, Canada
Correspondence: R.S. Green - Dalhousie University, Critical Care, Halifax,
Canada
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A458
Introduction: Traumatic brain injury (TBI) is a leading cause of death
and disability. In the Canadian province of Nova Scotia, TBI occurs in
approximately 50 % of major trauma seen annually. Although alcohol
use increases the risk of experiencing TBI, it remains unclear whether
outcomes in alcohol-impaired TBI patients are different from those of
unimpaired patients.
Objectives: The objective of this study was to describe the character-
istics and patterns of major TBI seen over a 14-year period at the
provincial level in Canada. We evaluated the effect of alcohol on
length of stay (LOS) and mortality in patients with major TBI.
Methods: This was a retrospective case series. Data were obtained
from the Nova Scotia Trauma Registry for all patients presenting with
major TBI (abbreviated injury score [AIS] head ≥3) in Nova Scotia hos-
pitals between 2002 and 2015. Injury rates were calculated on the
basis of 100,000 population using population estimates from Statis-
tics Canada. Patients were compared by blood alcohol concentration
(BAC) at time of injury: negative (0–1.9 mmol/L), low (2–21 mmol/L),
and moderate/high (≥22 mmol/L). A logistic regression model was
constructed to test for outcomes and adjusted for the effects of age,
gender, location, injury severity score (ISS), maximum AIS head, and
BAC level.
Results: Overall, 4518 major TBI patients were seen in provincial hos-
pitals during the study period. The mean age of TBI patients was 51
± 25 years; 72 % were male. The majority of injuries were the result
of blunt trauma (93 %), with relatively few major TBIs resulting from
penetrating trauma (7 %). The most common mechanisms of injury
were falls (46 %) and motor vehicle crashes (27 %). Analysis of
census-based subpopulations demonstrated that injury rates varied
significantly by geography (from 25 to 65 TBIs per 100,000 popula-
tion). Testing for alcohol was performed in 43 % of cases. Patients
who were tested for alcohol tended to be male (79 %) and middle-
aged (mean age 44 ± 20 years). A positive BAC (i.e., ≥2 mmol/L) was
found in 47 % of patients who were tested. Mean acute LOS was
similar for all three BAC groups. Mortality was independently pre-
dicted by increasing age (odds ratio [OR] = 1.01; p < 0.001), male gen-
der (OR = 1.30; p = 0.049), an ISS between 16 and 75 (OR = 2.67; p <
0.001), a maximum AIS head of 5 or 6 (OR = 3.21; p < 0.001), injuries
occurring outside of the capital city of Halifax (OR = 1.70; p < 0.001),
and having a lower BAC level (OR = 0.99; p < 0.001).
Conclusions: The results of this study show significant regional vari-
ation in major TBI rates in the province of Nova Scotia. Our findings
suggest that low BAC levels are associated with increased mortality
in major TBI patients. There are ongoing needs for prevention and
intervention efforts that focus on unintentional falls and motor ve-
hicle crashes, especially in older adults. Further study is warranted to
elucidate the mechanisms underlying the effects of alcohol on out-
comes in patients with major TBI.
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Introduction: N-acetylcysteine (NAC) is an antioxidant with direct
and indirect antioxidant actions used in the clinical setting. Oxidative
stress is known to play a pivotal role in the intestinal ischemia-
reperfusion (IIR).
Objectives: Therefore we studied the effect of different pretreatment
regimens with NAC on the IIR injury in rats.
Methods: Thirty-five male Wistar rats were randomly assigned to 5
groups. In group SHAM only laparotomy was performed. Group
Table 8 (abstract A457). Comparison between pre and post treatment
Pretreatment Posttreatment p
Mean (Range) Mean (Range)
AST 14.78 (11.00–20.20) 14.45 (9.00–20.00) <0.001
Drug intoxication ALT 9.76 (5.98–20.62) 9.00 (6.00–13.00) <0.001
CK 53.80 (33.00–85.00) 52.09 (30.00–120.00) <0.001
Troponin 0.03 (0.01–0.07) 0.016 (0.00–0.03) NS
Carbon monoxide
intoxication
COHb 14.25 (0.60–27.90) 2.70 (0.60–4.60) NS
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CONTROL underwent IIR without NAC. In the other groups, NAC was
administered intraperitoneally with different regimens: 150 mg/kg
before ischemia (NAC150), 300 mg/kg before ischemia (NAC300) and
150 mg/kg before ischemia plus 150 mg/kg 5 min before reperfusion
(NAC150 + 150). Measurements in tissues and blood were conducted
at 4 hours of reperfusion following exsanguination.
Results: Histological score of the liver was significantly improved in
NAC300 compared with control (1.7 ± 0.5 vs. 2.9 ± 1.1 respectively, p
= 0.05). In addition, NAC treatment significantly reduced liver trans-
aminases in all groups of treatment, mostly in group NAC300. Plasma
malondialdehyde levels were lower with NAC treatment, although
not statistically significantly. Lung glutathione peroxidase was signifi-
cantly increased in group NAC300 (p = 0.04), while the other oxida-
tion biomarkers showed no significant differences.
Conclusions: NAC exerts a significant protective role in liver injury
following IIR, which seems to be independent of an intestinal pro-
tective effect. Additional administration of NAC before reperfusion
was of no further benefit. The most effective regimen among the
compared regimens was that of 300 mg/kg before ischemia.
Keywords: intestinal ischemia-reperfusion, n-acetylcysteine, oxidative
stress, liver injury, rat model
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Introduction: The benefits of pre-hospital emergency anaesthesia
(PHEA) are controversial. The timing of this intervention can be a difficult
decision, particularly for conscious trauma patients with significant
hypotension secondary to presumed hypovolaemia. Patients who are
hypovolaemic prior to induction of anaesthesia are at risk of severe car-
diovascular instability post induction, which may be difficult to manage.
Objectives: The aim of this study was to compare the mortality rate for
severely injured hypovolaemic trauma patients (without evidence of
major neurological injury) undergoing PHEA with a patient cohort with
the same physiology who were transported to hospital without PHEA.
Methods: A five year retrospective database review of a physician-
led pre-hospital trauma service was performed to identify trauma pa-
tients who were hypotensive (systolic blood pressure < 90 mmHg) on
scene with a GCS between 13 and 15 between 01/09/2009 and 31/
08/2014. Pre-hospital records were consulted independently by two
pre-hospital clinicians to determine the likelihood of hypovolaemia
based on clinical factors.
The primary outcome measure was mortality, defined as death before
hospital discharge. The secondary outcome measure was mortality for
patients hypotensive on scene secondary to presumed hypovolaemia.
Results: In total, 9480 patients were attended in the study period;
236 patients were included in the final analysis. Of these, 101 pa-
tients received PHEA on scene and 135 did not. Fifteen patients who
underwent PHEA on scene died (14.9 %) compared with six patients
(4.4 %) in the group of patients who were not intubated on scene,
p = 0.01. The unadjusted odds ratio for death using the exact logistic
regression model was 3.763 (1.30-12.21) p = 0.01. This increased to
5.96 (95 % CI 1.76-20.17) p = 0.004 after adjustment for age, mechan-
ism of injury and initial heart rate. Subgroup analysis identified a sta-
tistically significant increase in mortality for hypovolaemic trauma
patients who underwent PHEA. In the group of 101 patients anaes-
thetised on scene, 58 patients (57.4 %) were considered to be hypo-
volaemic prior to induction of anaesthesia, 14 died (24 %). In the
group of 43 patients (42.6 %) intubated on scene not meeting criteria
for hypovolaemia, one patient died (2 %), p = 0.003. After adjustment
for age, mechanism of injury and initial heart rate the odds ratio for
mortality was 9.99 (95 % CI 1.69-58.98) p = 0.01.
Conclusions: Our results show an association between PHEA and
mortality in awake hypotensive trauma patients, which is increased
when hypotension is confirmed to be due to hypovolaemia. This
study supports the hypothesis that where patients are hypovolaemic
and awake on scene it might, where possible, be appropriate to
delay induction of anaesthesia until after hospital arrival.
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Introduction: Early Mobilisation Therapy (EMT) may improve out-
come in the critically ill but the evidence is very limited 1. We have
conducted a multi-centre randomised controlled trial (RCT) compar-
ing two levels of EMT.
Objectives: To test the hypothesis that more intensive EMT will im-
prove longer term physical outcome in the critically ill.
Methods: A full trial protocol has been published2. We conducted a 3
centre RCT between January 2012 to July 2015. Eligible patients had re-
ceived at least 48 hours of invasive ventilation before recruitment. The
Intervention arm received up to 90 min per day of EMT Monday to Fri-
day whilst the control arm received up to 30 min per day Monday to
Friday. The primary trial outcome was the physical component of the
SF-36 quality of life measure at 6 months after recruitment.
Results: 308 patients were recruited (150 assigned to the intervention
arm and 158 to control). The groups were well matched in terms of age,
gender, pre-morbid function, illness severity, type of admission and BMI.
Between enrollment and final follow-up at 6 months 94 (30.5 %) partici-
pants died. Of the remaining 214 participants 116 completed and
returned the SF-36 at 6 months. There was no significant difference in
baseline demographics between survivors who completed the SF-36 and
those who failed to respond. Full survival data were available for all par-
ticipants via a national database. The total number of EMT session deliv-
ered to the Intervention group was higher than the standard group
(2061 v 1326) and the time delivered was correspondingly higher (456.2
v 255.8 hours in total). Physical health as measured by the SF-36 Physical
Component score improved in both groups over the 6 month follow up
period with no significant difference at 6 months (37.0 Intervention v
37.1 Control; difference in means and 95 % CI 0.3 [−6.1 to 6.7]). There
was no significant difference in any of the secondary measures or in
6 month mortality (Intervention 28.7 % standard 34.4 % Cox proportional
hazard ratio 1:00 [95 % CI 0.60-1.68]).
Conclusions: Intensive EMT did not improve the recovery or outcome at
6 months of critically ill patients ventilated for at least 48 hours compared
to standard EMT.
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Objectives: To prospectively evaluate the impact of Selective Digestive
Decontamination (SDD) application on nosocomial infections and
colonization rates after 4 years in an ICU.
Methods: This study was conducted in a 30-bed-medical-surgical
ICU. All consecutive patients admitted to the ICU from October 1,
2011 to September 30, 2015 expected to require tracheal intub-
ation > 48 hours were given SDD (SDD study group) with a 4-day
course of intravenous cefotaxime, plus enteral colistin, tobramycin,
nystatin in an oropharyngeal paste and in a digestive solution.
Oropharyngeal and rectal swabs were obtained on admission and
once weekly. We used ENVIN nosocomial infection criteria. We
compared all patients admitted to ICU who acquired nosocomial
ICU infections from October 1, 2010 to September 30, 2011 (non-
SDD group) to the SDD study group. In both groups, categorical
variables were summarized as frequencies and percentages and
the continuous ones as means and standard deviations (SD)
when the data followed the normal distribution or medians and
interquartile ranges (IQR) when they did not. The percentages
were compared using the test of chi-square test or Fisher exact
test, means with the t-test and medians with the Wilcoxon test
for independent samples. Those variables that showed statistical
significance in the univariate analysis were introduced in a
multivariate logistic regression analysis. For each one of the ac-
quired infections (catheter-related and other secondary bacter-
emias, pneumonia and urinary infections and antibiotic resistant
bacteria (ARB) infections) the incidences per 1000 days of expos-
ure in each cohort and the corresponding relative risks were ob-
tained using the Poisson regression. Statistical significance was
set at p ≤ 0.05. We analyzed colistin and tobramycin resistant
colonization and also antibiotic consumption (Defined antibiotics
Daily Doses (DDD).
Results: Results are shown in Figs. 18, 19 and 20.
There were no statistical significant differences between both
groups in type of ICU admission or demographic data. Patients
with SDD had significantly less Extended Spectrum Betalactamase
(ESBL), Gram Negative Bacteria Multirresistant (GNB MR) and Aci-
netobacter spp infections. We had also a significant reduction in
nosocomial pneumonias and other secondary bacteremias and
ARB rates in SDD group versus non SDD. There was no infection
by Clostridium difficile. The exogenous infections were 76,08 %.
Colistin resistant colonization was 14,1 % and tobramycin resist-
ant colonization was 20,7 % of samples. There was a decrease on
the DDD/100 ICU stays after SDD.
Conclusions: After 4 years applying SDD a significant reduction
of infections by ESBL, GNB MR and Acinetobacter was observed.
A significant decrease of nosocomial pneumonia, secondary
bacteremias and ARB infections rates was also shown. An anti-
biotic consumption reduction was found after SDD. Low rates of
colistin and tobramycin resistant colonization bacteria have been
observed.
Fig. 18 (abstract A462). Univariate analysis
Fig. 19 (abstract A462). Multivariate logistic regression analysis
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Introduction: Lactate supports brain energy metabolism and pro-
motes cerebral vasodilation. Hypertonic lactate (HL) solutions are
emerging as a therapeutic alternative after acute brain injury how-
ever their effect following aneurysmal subarachnoid hemorrhage
(SAH) is unknown.
Methods: We prospectively studied critically ill SAH patients (n = 7,
age 64 ± 6 years) monitored with cerebral microdialysis (CMD) and
transcranial Doppler (TCD) who were resuscitated according to
current guidelines and had no intracranial hypertension (clinicaltrial.-
gov NCT01573507). Intervention consisted of a 3-h infusion of HL
(30 μmol/kg/min, administered within 48 h from SAH, to achieve
blood arterial lactate ≈ 4–5 mmol/L). Endpoints were the effect of HL
on cerebral energy metabolism (using hourly CMD concentrations of
lactate, pyruvate and glucose) and brain perfusion (using hourly TCD
measurement of middle cerebral artery cerebral blood flow velocities,
MCBFV).
Results: Treatment with HL was associated with a significant increase
of cerebral extracellular lactate (3.6 ± 1.6 vs. 5.5 ± 1.5 mmol/L), pyru-
vate (118.5 ± 51.1 vs. 166.4 ± 47.5 μmol/L) and glucose (1.1 ± 0.2 vs.
1.6 ± 0.3 mmol/L; all p < 0.01, paired t test for comparisons between
baseline and peak values during HL). HL therapy was also associ-
ated with improved brain perfusion (MCBFV 61.8 ± 28.5 vs. 79.7 ±
35.3 cm/sec; p < 0.05), while cerebral perfusion pressure (79 ± 16 vs.
83 ± 13 mmHg) and PbtO2 (20 ± 7 vs. 20 ± 7 mmHg) did not
change significantly.
Conclusions: Our findings show that HL administered during the
early post-injury phase following SAH improves brain energy metab-
olism by exerting a beneficial cerebral glucose sparing effect. HL also
increases brain perfusion, which seems independent from cerebral
perfusion pressure and PbtO2, and appears related to cerebral extra-
cellular lactate supplementation. These preliminary data support
larger studies to examine the value of HL solutions in patients with
SAH and other forms of acute cerebrovascular diseases.
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Introduction: Intensive care unit acquired weakness (ICUAW) is a se-
vere complication of critical illness. ICUAW is associated with muscle
wasting, muscle weakness, respiratory failure as well as increased
morbidity and mortality and features massive skeletal muscle atrophy
by destruction of the contractile myosin elements. No specific treat-
ment has been established.
Objectives: Aim of the study was to investigate if protocol-based
physiotherapy (pPT) or pPT with additional evoked muscle contrac-
tion by electrical muscle stimulation (EMS) are more effective to pre-
vent skeletal muscle atrophy in critically ill patients when compared
to standard physiotherapy (sPT).
Methods: A randomized clinical trial was performed. Participants
(inclusion criterion: SOFA score ≥ 9) were randomly split into 2
groups, either treated started at the day of admission with sole pPT
or pPT with EMS daily. Data of patients treated with standard
physiotherapy (sPT) were available from an earlier trial[1]. An open
surgical muscle biopsy from the musculus vastus lateralis was ob-
tained at median day 15 of critical illness. Histological examination
of muscle biopsies and quantification of myocyte cross-sectional
area (MCSA) for type I, IIa, and IIb fibers using ImageJ software
(fiber count > 100 per patient) were performed after applying the
toluidine blue ATPase Method: Non-parametric tests were per-
formed. Ethic vote (Charité EA 2/041/10).
Results: 39 critical ill patients were enrolled in this final analysis
(19sPT, 11pPT, 9 pPT + EMS). There were no significant differences in
baseline characteristics and fiber type distribution between the
groups. The MCSA for all fiber types of patients with pPT with or
without additional EMS were larger than the MCSA of patients with
sPT. Compared to pPT alone, additional evoked muscle activation by
EMS increases MCSA for type I,IIa and IIb muscle fibers. Data are
shown as frequency-distribution histograms.
Conclusions: For the first time we show that pPT is associated with
reduced skeletal muscle atrophy when compared to sPT. EMS re-
sulted in an additional reduction of muscle atrophy. The histological
findings showed reduced muscle atrophy through preventive physio-
therapy procedures. Further studies are needed to solidify our find-
ings and to analyze if this reduction in atrophic response can be
confirmed on molecular (i.e. analysis of myosin heavy chain, protein
homeostasis) and functional levels and improves the long-term out-
come of critical ill patients.
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Objective: Central venous-to-arterial carbon dioxide difference
(PcvaCO2) has demonstrated its prognostic value in critically ill pa-
tients suffering from shock, and current expert recommendations ad-
vocate for further resuscitation interventions when PcvaCO2 is
elevated. PcvaCO2combination with arterial-venous oxygen content
difference (PcvaCO2/CavO2) seems to enhance its performance when
assessing anaerobic metabolism. However, the fact that PCO2 values
might be altered by changes in blood O2content (the Haldane ef-
fect), has been presented as a limitation of PCO2-derived variables.
The present study aimed at exploring the impact of the Haldane ef-
fect on PcvaCO2 and PcvaCO2/CavO2 during the early phase of shock.
Methods: Prospective interventional study. Ventilated patients suffer-
ing from shock within the first 24 hours of ICU admission. Patients re-
quiring FiO2 ≥ 0.5 were excluded. At inclusion, simultaneous arterial
and central venous blood samples were collected. Patients under-
went ahyperoxygenation test (5 minutes of FiO2 100 %), and arterial
and central venous blood samples were repeated. Oxygenation and
CO2 variables were calculated at both timepoints.
Results: Twenty patients were studied. The main cause of shock was
septic shock (70 %). The hyperoxygenation trial increased oxygen-
ation parameters in arterial and venous blood, whereas PCO2 only
changed at the venous site. Resulting PcvaCO2 and PcvaCO2/CavO2-
significantly increased (6.8 (4.9, 8.1) vs 7.6 (6.7, 8.5) mmHg, p 0.001;
and 1.9 (1.4, 2.2) vs 2.3 (1.8, 3), p < 0.001, respectively). Baseline
PcvaCO2, PcvaCO2/CavO2 and ScvO2 correlated with the magnitude of
PO2 augmentation at the venous site within the trial(rho −0.46,
p 0.04; rho 0.6, p < 0.01; andrho 0.7, p < 0.001, respectively). In-
creased PcvaCO2/CavO2values were associated with higher mortal-
ity in our sample (1.46 (1.21, 1.89) survivorsvs2.23 (1.86, 2.8)
non-survivors, p < 0.01).
Conclusions: PcvaCO2 and PcvaCO2/CavO2 are influenced by oxygen-
ation changes not related to flow. Elevated PcvaCO2 and PcvaCO2/
CavO2 values might not only derive from cardiac output inadequacy,
but also from venous hyperoxia. Elevated PcvaCO2/CavO2 values were
associated with higher PO2 transmission to the venous compartment,
suggesting higher shunting phenomena. Rather than a limitation, the
contribution of the Haldane effect to CO2-derived variables might
represent an additional marker of severity of shock.
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Introduction: Transpulmonary thermodilution (TPTD) has been estab-
lished to measure cardiac output CO, global end-diastolic volume
GEDV and extravascular lung water EVLW. To facilitate interpretation
of these data several ratios have been developed, including pulmon-
ary vascular permeability index (defined as EVLW/(0.25*GEDV)) and
global ejection fraction ((4*stroke volume)/GEDV). PVPI and GEF have
been associated to the aetiology of pulmonary oedema and to sys-
tolic cardiac function, respectively. However, several studies showed
that the use of femoral venous access results in a marked overesti-
mation of GEDV which also falsely reduces PVPI and GEF. One of
these studies suggested a correction formula for femoral venous ac-
cess that markedly reduces the bias for GEDV (1). Consequently, the
last PiCCO-algorithm requires information about the CVC, and correc-
tion for femoral access has been shown. However, two recent studies
demonstrated inconsistencies of this algorithm using incorrected
GEDV for PVPI (2), but corrected GEDV for GEF. Nevertheless, these
studies were based on mathematical analysis of data displayed by
the PiCCO in a total of 15 patients equipped with only a femoral, but
not with a jugular CVC.
Objectives: To compare PVPI_fem and GEF_fem derived from fem-
oral TPTD to values derived from jugular indicator injection in 25 pa-
tients with both jugular and femoral CVCs.
Methods: 54 datasets in 25 patients CVC were recorded. Each dataset
consisted of three triplicate TPTDs using the jugular venous access as
the gold standard, while the the femoral access with (PVPI_fem_cor)
and without (PVPI_fem_uncor) information about the femoral
Fig. 21 (abstract A464). [MCSA]
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injection site was used to evaluate, if correction for femoral GEDV
pertains to PVPI_fem and GEF_fem.
Results: 15 male, 10 female patients; 60 ± 15 years; 79 ± 16 kg; 173 ±
8 cm. PVPI_fem_uncor was significantly lower than PVPI_jug (1.48 ±
0.47 vs. 1.84 ± 0.53; p < 0.001). Similarly, PVPI_fem_cor was signifi-
cantly lower than PVPI_jug (1.49 ± 0.46 vs. 1.84 ± 0.53; p < 0.001). This
is explained by the finding that PVPI_fem_uncor was not different to
PVPI_fem_cor (1.48 ± 0.47 vs. 1.49 ± 0.46; n.s.). This clearly suggests
that correction for femoral CVC does not pertain to PVPI. GEF_fe-
m_uncor was significantly lower than GEF_jug (20.6 ± 5.1 % vs. 25.0
± 6.1 %; p < 0.001). By contrast, GEF_fem_cor was not different to
GEF_jug (25.6 ± 5.8 % vs. 25.0 ± 6.1 %; n.s.). Furthermore, GEF_fem_-
cor was significantly higher than GEF_fem_uncor (25.6 ± 5.8 % vs.
20.6 ± 5.1 %; p < 0.001). This emphasizes that an appropriate correc-
tion for femoral CVC is applied to GEF_fem_cor.
Conclusions: Uncorrected femoral injection for TPTD results in signifi-
cantly lower values for PVPI and GEF. While the last PiCCO algorithm
appropriately corrects for GEF, the correction is not applied to PVPI.
This results in substantial underestimation of PVPI.
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Introduction: Prediction of fluid responsiveness in hemodynamically
unstable patients with spontaneous breathing activity has been a clin-
ical challenge. It has been best assessed by passive leg raising test. Pre-
ejection period, the time from the onset of ventricular depolarization to
the beginning of left ventricular ejection, is a systolic time interval
found to decrease with greater preload1. The effect of passive leg rais-
ing test on the pre-ejection period has not been studied in this context.
Objectives: Our objective was to test whether fluid responsiveness
could be predicted by the response of pre-ejection period to passive
leg raising test. We also examined whether baseline end expiratory
inferior vena cava diameter could predict fluid responsiveness in this
category of patients.
Methods: Thirty patients with spontaneous breathing activity consid-
ered for fluid loading were included. We used transthoracic echocar-
diography to measure stroke volume, and pre-ejection period before
and during passive leg raising test as well as before and after fluid
loading (500 ml saline 0.9 % over 15 minutes). An increase in stroke
volume of 15 % or more after volume expansion defined fluid re-
sponders. We also measured baseline end expiratory inferior vena
cava diameter obtained from the subcostal window.
Results: 19 patients were responders (63.3 %). Passive leg raising test
induced-changes in stroke volume of ≥ 9.3 % predicted fluid respon-
siveness with a sensitivity of 100 % and specificity of 81.8 %, the area
under receiver operating characteristic curve (AUC) was 0.96; 95 %
confidence interval (CI) [0.91,1.0], meanwhile, passive leg raising test-
induced changes in pre-ejection period of ≤ −5.0 % predicted fluid
responsiveness with a sensitivity of 94.7 % and a specificity of
45.5 %, the AUC was 0.62; 95 % CI [0.4,0.85]. Baseline inferior vena
cava diameter (in cm) failed to identify responders vs. non-
responders (1.20 ± 0.37 vs 1.38 ± 0.51 respectively, p = 0.36).
Conclusions: In hemodynamically unstable patients with spontaneous
breathing activity, passive leg raising test-induced increase in stroke vol-
ume of ≥ 9.3 % accurately predicted fluid responsiveness, while passive
leg raising test-induced decrease in pre-ejection period of ≤−5.0 % was
sensitive, but not specific in the prediction of fluid responsiveness. Base-
line inferior vena cava diameter failed to identify fluid responders.
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Introduction: Persistent signs of skin hypoperfusion after resuscitation
in patients with shock are associated with worse outcomes, but assess-
ment is rather subjective. Skin laser Doppler (SLD) techniques allow skin
blood flow (SBF) to be measured more objectively and non-invasively.
Objective: To measure SBF at the extremities using a SLD technique
in patients with shock and to determine if they are correlated to pa-
tients outcomes.
Method: SBF was evaluated in the fingertip and toe (PU: perfusion
units) using a SLD (PeriFlux System 5000, Perimed, Sweden) at basal
skin temperature and after warming to 37 °C in 28 consecutive pa-
tients admitted with circulatory shock (need for vasoactive agents to
maintain MAP > 60 mmHg) on ICU admission and 10 healthy volun-
teers. Organ dysfunction was assessed using the sequential organ
failure assessment (SOFA) score. Statistical analysis was performed
using STATA 13.0. The area under the receiver operating curve (AUC)
was calculated to identify the predictive performance of SBF. Results
are presented as median (p25-75) values.
Result: Global ICU mortality was 32 %. Demographic data and SBF
are shown in Table 9. The AUCs for prediction of mortality at basal
temperature were 0.77 (0.58-0.97) and 0.65 (0.47-0.92) for the finger-
tip and toe respectively and 0.71 (0.51-0.93) for the SOFA score.
Conclusion: Measurements of SLD at fingertip and toe may represent
an interesting monitoring technique for shock patients. Their prog-
nostic value is similar to SOFA score.
Table 9 (abstract A468). Demograpic data
Survivors(n=19) Non
survivors
(n=9)
P All (n=28) Volunteer
(n=10)
P
SOFA score 10(8–11) 12(9–13) 0.06 11(9–12) - -
Age (years) 63 (55–57) 58 (41–68) 0.20 62 (54–72) 30(36–
31)
<0.01
Mean arterial
pressure
(mmHg)
69 (67–86) 67 (62–84) 0.40 69 (65–85) - -
Cardiac index
(L/min/m2)
2.7 (2.4–3.2) 2.4 (1.6–
4.4)
0.60 2.6 (2.1–
4.4)
- -
Noradrenaline
(mcg/Kg/min)
0.16
(0.10–0.26)
0.50
(0.09–0.80)
0.16 0.18
(0.10–0.45)
- -
Lactate
(mmol/L)
1.4 (1.1–1.7) 3.8
(1.6–4.9)
0.01 1.6
(1.2–2.8)
- -
Shock Types
•Septic, n 14 7 0.29 21 - -
•Cardiogenic,n
5 1 - 6 - -
•Haemorrhagic,n
0 1 - 1 - -
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Introduction: Investigating the use of dynamic haemodynamic
parameters, such as pulse pressure variation (PPV) and stroke
volume variation (SVV), for predicting fluid responsiveness prior
to volume expansion has led many scientific discussions lately.
Also, according to current consensus statements their use is
increasingly recommended in suitable patients [1]. Extended
hemodynamic monitoring (EHD) beyond measurement of cardiac
filling pressures (central venous pressure, pulmonary artery occlu-
sion pressure) is still rare. A recent study revealed that only a
minor part of critical ill patients are supervised with specific
monitoring to assess fluid responsiveness [2]. It remains unclear if
this is due to lacking availability of the specialised devices or the
limitations of the use of automated functional parameters of
preload.
Objectives: This analysis was designed to assess the availability of
monitoring, the clinical suitability of using PPV or SVV, and if and
how they are actually used in German, Swiss, and Austrian ICU´s.
Methods: This is a sub-analysis of the ICU-CardioMan Trial. For this
multicentre, one day cross-sectional study data regarding patients'
hemodynamic monitoring was collected from 161 participating ICUs
from Germany, Switzerland and Austria by means of a web-based
case report form. The ICUs gave detailed information on availability
of EHD in general and provided data from 1789 patients concerning
monitoring, as well as information on the patients' specific character-
istics that have impact on treatment suitability of PPV and SVV to
predict fluid responsiveness.
Results: EHD was widely available throughout the examined ICUs.
Only a minority of patients was reported to be monitored with
EHD during the study period (see Table 11). In the group of the
patients that needed catecholamines and/or vasopressors
(39.2 %) the share of patients monitored with EHD was signifi-
cantly higher. In this subgroup, 66.8 % of those patients had
sinus or pacer rhythm. Of this portion another 30.9 % were
mechanically ventilated in a controlled mode.
Conclusions: Though widely available EHD to predict fluid respon-
siveness is still not comprehensively implemented in daily clinical
routine. Over one third of patients that required catecholamines/ va-
sopressors fulfilled the criteria for assessment of PPV or SVV. The
high share of patients not fulfilling the criteria for using PPV and SVV
stresses the need for further development of functional parameters
of preload operating independently from the presence of controlled
mechanical ventilation.
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Introduction: Weaning from mechanical ventilation remains a chal-
lenge in intensive care units (ICU); respiratory muscle fatigue may be
important in difficult weaning. We evaluated whether reconnection to
mechanical ventilation for one hour after the effort of a spontaneous
breathing trial could reduce extubation failure in critically ill patients.
Objectives: reconnection to mechanical ventilation for one hour after
the effort of a spontaneous breathing trial could reduce extubation
failure in critically ill patients.
Methods: In this prospective, randomized, multicenter trial, patients
who successfully completed a spontaneous breathing trial were ran-
domized to direct extubation (Control group) or reconnection to the
ventilator for a one-hour rest before extubation (Rest group). Statis-
tical analysis included multivariable logistic regression models for
extubation failure.
Results: We randomized 243 patients to the Control group and 227
patients to the Rest group. The most common spontaneous
Table 10 (abstract A468). SBF in Patients and Volunteers
Survivors(n=19) Non
survivors
(n=9)
P All (n=28) Volunteer
(n=10)
P
Fingertip SBF
at basal
temperature
(PU)
31.4 (11.1–49.4) 9.8 (7.8–
12.3)
0.02 20.5(9.8–
38.7)
175.7(196.5–
218.0)
<0.01
Fingertip SBF
at 37°C(PU)
60.9(21.2–70.1) 17.2(13.9–
49.0)
0.09 49.7(15.8–
70.0)
274.8(201.2–
320.1)
<0.01
Toe SBF
at basal
temperature
(PU)
32.5(8.7–44.7) 15.5(6.1–
21.9)
0.20 16.3(8.2–
35.8)
49.0(44.6–
55.1)
0.02
Toe SBF at
37°C(PU)
39.2(19.5–72.9) 20.5(9.9–
36.1)
0.04 30.7(17.3–
52.7)
116.7(99.9–
122.2)
<0.01
Table 11 (abstract A469). Implemented extended monitoring
Implemented Monitoring Total Vasoactive
agents
Mechanical
ventilation
n = 1789 n = 702 n = 874
Invasive pressure monitoring 87.0% 98.6% 96.1%
Cardiac output monitoring 12.3% 24.2% 20.8%
Cardiac filling pressures
(CVP, PAOP)
55.4% 74.4% 69.5%
Dynamic parameters (SVV, PPV) 8.7% 16.5% 14.9%
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breathing trial method was T-tube, and the median time from intub-
ation to spontaneous breathing trial was similar between groups
(5.7 days in the Control group and 5.5 days in the Rest group; p =
0.2). Extubation failure within 48 hours after extubation was more
common in the Control than in the Rest group (58 (23.9 %) vs. 24
(10.6 %) patients; p < 0.001). Rescue noninvasive ventilation was ad-
ministered in 47 (57 %) patients, 16 (34 %) of whom required reintu-
bation. Reintubation was more common in the Control than in the
Rest group (35 (14 %) vs. 12 (5 %) patients; p < 0.001) mainly due to
inability to manage secretions in both groups. Hospital and ICU
length of stay and mortality did not differ between groups.
Conclusion: One-hour rest after a successful SBT reduced the rates of
extubation failure within 48 h after extubation and reintubation.
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Introduction: Driving pressure (ΔP) across the respiratory system
has been shown to strongly predict hospital mortality in ARDS
patients, with a threshold in the vicinity of 14–15 cm H2O above
which the relative risk of mortality significantly increased (1). We
wonder whether this result may be due to the wide range of
tidal volume and PEEP used across the trials included (1).
Objectives: Therefore, we investigated ΔP in two trials in which lung
protective mechanical ventilation was applied to ARDS patients. Our
working hypothesis is that ΔP is a risk factor just like compliance (Crs)
or Plateau pressure (Pplat) of the respiratory system are.
Methods: ARDS patients included in Acurasys (2) and Proseva (3) trials
were used. The first trial compared the neuromuscular blocking agent
(NMBA) cisatracurium vs. placebo and the second the prone vs. the su-
pine position. Both had near inclusion criteria (notably PaO2/FIO2 <
150 mm Hg and PEEP ≥ 5 cm H2O) and similar lung protective mechan-
ical ventilation (4) (in particular tidal volume 6 ml/kg predicted body
weight and PEEP/FIO2 table). Both found survival benefit in the experi-
mental group. SOFA, continuous NMBA infusion, prone position, com-
bined use of NMBA and prone position, lactate, pH, PaCO2, PaO2/FIO2,
lactate, breathing frequency, VT, PEEP, Pplat, Crs and ΔP were recorded
at day 1 after inclusion together with gender, age and SAPSII at the
time of admission and compared between survivors and nonsurvivors
at day 90. Cox proportional hazard models were used with covariates
significantly different between survivors and non survivors at the
threshold of 0.20 and mortality at day 90 as dependent variable. We
planned to test colinearity between ΔP, Crs and Pplat and, if it was veri-
fied, to use a specific Cox model for each of them.
Results: Both trials enrolled 805 patients of who 787 had data avail-
able at day 1 of who 533 survived and 254 did not. In the univariate
analysis, ΔP averaged 13.7 ± 3.7 and 12.8 ± 3.7 cmH2O (P = 0.002) in
nonsurvivors and survivors, respectively. Colinearity between ΔP, Crs
and Pplat was statistically significant. The Cox model for ΔP alone is
shown in Table 13. ΔP was associated with a 5 % increased risk of
mortality at each 1 cmH2O-increment.
Hazard ratios (HR) were 1.05 (1.02-1.08) (P = 0.004) and 0.985 (0.972-
0.999) (P = 0.023) for Pplat and Crs, respectively, in the specific ana-
lyses. PEEP and VT were not significant risk factors in any model.
Conclusions: When lung protective mechanical ventilation is applied
ΔP is still a significant predictor of mortality.
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INTRODUCTION: Evidence for harm from mechanical ventilation
strategies using high tidal volumes in patients without acute
respiratory distress syndrome (ARDS) at onset of ventilation is
increasing, but it is highly uncertain how these patients are cur-
rently ventilated in intensive care units (ICUs) worldwide.
OBJECTIVES: To describe ventilation practice in ICU patients with-
out ARDS at onset of mechanical ventilation, and to compare
ventilation settings and outcomes between patients at low versus
high risk for ARDS.
METHODS: This was an international multicenter prospective cohort
of patients without ARDS undergoing invasive ventilation, conducted
during one week in 119 ICUs from 16 countries across four conti-
nents. The Lung Injury Prediction Score (LIPS) was used for risk strati-
fication for ARDS (≤4 [low] vs. > 4 [high]). The primary outcome was
Table 12 (abstract A471).
Variable HR HR 95% lower
CI
HR 95% upper
CI
P
value
Age, per year 1.04 1.03 1.05 <0.001
SOFA, per unit 1.06 1.02 1.10 0.001
Continuous NMBA,
reference=yes
0.87 0.65 1.18 0.624
Prone position, reference=yes 0.69 0.50 0.94 0.021
Respiratory rate, per unit 1.01 0.99 1.01 0.376
Arterial pH, per unit 0.049 0.008 0.298 0.001
Lactate, per unit 15.84 1.22 205.18 0.034
Lactate x pH, per unit 0.69 0.48 0.98 0.039
ΔP, per cmH20 1.05 1.02 1.09 0.003
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to describe ventilation practice in ICU patients without ARDS at onset
of mechanical ventilation. Secondary outcomes included comparison
of ventilation settings and outcomes between patients at low versus
high risk for ARDS.
RESULTS: Of 3,023 patients screened in participating ICUs, 935 ful-
filled inclusion criteria (Fig. 23). Tidal volume sizes, and level of posi-
tive end-expiratory pressure (PEEP) were 7.9 [6.8-9.1] ml/kg predicted
body weight (PBW), and 5 [5–7] cmH2O, respectively. Tidal volume
sizes were not different between patients with low and high risk
for ARDS; PEEP level was higher in patients with high risk though
differences were minimal (6 [5–8] versus 5 [5–7] cm H2O; p <
0.001) (Fig. 24). Occurrence of pulmonary complications and hos-
pital mortality was higher in patients with high risk for ARDS
(35.4 % vs 23.4 %; p < 0.001 and 31.9 % vs 15.8 %; p < 0.001, re-
spectively) (Fig. 25).
CONCLUSIONS: A large proportion of patients without ARDS at
onset of mechanical ventilation received high tidal volumes.
?A3B2 show $132#?>Patients with higher risk for ARDS had
higher incidence of pulmonary complications and worse clinical
outcomes. These findings indicate the potential for improvement
in the management of patients without ARDS.
References
- Determann RM, et al. Crit Care 2010;14:R1.
- Esteban A, et al. Am J Respir Crit Care Med 2013;188:220–30
- Serpa Neto A, et al. JAMA 2012;308:1651–1659.
- Serpa Neto A, et al. Crit Care Med 2015;43:2155–63.
- Serpa Neto A, et al. Intensive Care Med 2014;40:950–7.
A473
Are changes in diaphragm thickness during mechanical ventilation
associated with clinical outcomes? A prospective multi-centre
cohort study
E.C. Goligher1, E. Fan1, M. Herridge1, S. Vorona1, M. Sklar1, M. Dres1,2, N.
Rittayamai1, A. Lanys1, C. Urrea1, G. Tomlinson3, W.D. Reid4, G.D.
Rubenfeld1, B.P. Kavanagh1, L.J. Brochard1, N.D. Ferguson1
1University of Toronto, Interdepartmental Division of Critical Care
Medicine, Toronto, Canada; 2Sorbonne Paris Cité, UPMC Univ Paris 06
INSERM, UMRS1158, Groupe Hospitalier Pitié-Salpêtrière Charles Foix
Service de Pneumologie et Réanimation Médicale, Paris, France;
3University of Toronto, Department of Medicine, Toronto, Canada;
4University of Toronto, Department of Physical Therapy, Toronto, Canada
Correspondence: E.C. Goligher - University of Toronto,
Interdepartmental Division of Critical Care Medicine, Toronto, Canada
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A473
Introduction: Changes in diaphragm thickness (Tdi) are common
during mechanical ventilation (MV) (1). However, the impact of
changes in Tdi on clinical outcomes is unknown and it is uncertain
Fig. 22 (abstract A472). Flow of Patient Screening and Enrollment
Fig. 23 (abstract A472). Ventilation parameters in patients
without ARDS
Fig. 24 (abstract A472). Outcome from patients without ARDS
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whether targeting specific levels of inspiratory effort during MV
would prevent changes in Tdi or accelerate liberation from MV.
Objectives: To determine whether changes in Tdi during the early
course of MV are associated with impaired liberation from MV and to
further establish the links between ventilator settings, patient inspira-
tory effort, changes in Tdi, and clinical outcomes.
Methods: In 3 ICUs, Tdi and diaphragm thickening fraction (TF, a
measure of inspiratory effort) were prospectively measured on a
daily basis by ultrasound. Patients were classified according to
the initial change in Tdi recorded on the first day that the
change in Tdi exceeded 10 % up to MV day 7. Patient character-
istics, ventilator settings, severity of illness scores and outcomes
in hospital were recorded. Predicted relationships were analyzed
by multivariable regression modelling and causal mediation
analysis.
Results: We enrolled 212 patients (outcomes available for 207). Initial
changes in Tdi occurred early in the course of MV (median MV day 3,
IQR 3–5). Consistent with our previous findings (1), the rate and dir-
ection of change in Tdi over time were strongly associated with TF in
this cohort (p < 0.001). Controlled MV was associated with an acceler-
ated decline in Tdi (p = 0.01) mediated by TF (proportion of effect
mediated = 0.3, p < 0.01 for mediation effect). Both decreased and in-
creased Tdi were associated with prolonged ventilator dependence
(Table 12, Fig. 22, log rank p < 0.001), even after adjusting for age, se-
verity of illness, sepsis, and comorbidities. Mean TF below 15 % or
above 30 % over the first 3 days of MV was associated with pro-
longed ventilator dependence in survivors (adjusted p = 0.02) and a
higher risk of complications of acute respiratory failure (adjusted p =
0.02). The associations between mean TF and these outcomes were
mediated by changes in Tdi (proportion mediated 0.44, p = 0.05, and
0.29, p = 0.02, respectively).
Conclusions: Early changes in diaphragm thickness following initiation
of MV are associated with marked differences in clinical outcomes. Both
insufficient and excessive inspiratory effort levels are associated with
prolonged ventilator dependence due in part to changes in Tdi. Titrat-
ing ventilatory support to maintain TF between 15-30 % might prevent
changes in Tdi and accelerate liberation from MV.
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Introduction: Breathing is a cyclic activity that is not monotonous
and is therefore variable. During mechanical ventilation (MV), breath-
ing variability is reduced. Breathing variability has been mostly quan-
tified with two indices: the coefficient of variation (CV) that is
defined as the standard deviation to the mean ratio, and the ampli-
tude ratio of the spectrum's first harmonic to its zero frequency (H1/
DC). Previous reports have suggested that low variability was associ-
ated with weaning failure and increased mortality. However, these
studies have quantified variability either on very specific time points
or on the contrary on the whole intensive care unit stay.
Objectives: The aim of our study was to quantify breathing variability
at the early phase of weaning according to those two indices. We
further evaluated the factors associated with and the prognosis im-
pact of low breathing variability.
Methods: Ancillary study of a multicentre, randomized controlled
trial comparing neurally ventilator adjusted assist to pressure support
ventilation during the early phase of weaning. Airway flow and pres-
sure were recorded during 20 minutes 12, 24, 36 and 48 hours fol-
lowing inclusion. Respiratory rate, tidal volume and mean inspiratory
flow were measured. Variability was assessed according to CV and
H1/DC. Impact of variability on clinical outcome was determined with
a Receiver Operating Characteristic.
Results: 108 patients mechanically ventilated for 5 days (3–9) were in-
cluded, 72 men (68 %), aged 66 (37–86) years, SAPS II 44 (35–59), 62 %
were mechanically ventilated for de novo hypoxemic respiratory failure.
Sensitivity and specificity were plotted as functions of the ability of
the CV of respiratory rate (RR), tidal volume (Vt) and mean inspiratory
flow (Vt/Ti) to predict day-28 mortality. The curves intersected at a
coefficient of variation of respectively 0.21 for respiratory rate, 0.16
for tidal volume and 0.14 for mean inspiratory flow (Fig. 26).
Table 13 (abstract A473). Outcomes associated with changes in Tdi
during MV
Initial change in diaphragm thickness during
mechanical ventilation
Outcome >20%
decrease
(n=31)
10–20%
decrease
(n=46)
<10%
change
(n=85)
10–20%
increase
(n=29)
>20%
increase
(n=18)
p-
value
Hospital mortality
(%)
50% 29% 33% 36% 39% 0.41
Ventilator-free days
at 60 days
(median, IQR)
32 (0–50) 49 (12–
55)
54 (0–
57)
37 (0–
53)
40 (0–
50)
0.003
Duration of
mechanical
ventilation in
survivors (median,
IQR)
9 (7–14) 8.5 (5–
18)
5 (3–8) 9 (5–22) 12 (9.5–
20)
0.0002
Complications of
acute respiratory
failure (death/
reintubation/
tracheostomy/MV
duration > 14
days) (%)
77% 57% 46% 64% 72% 0.023
Fig. 25 (abstract A473). Time to disconnection from the ventilator
varies with the initial change in Tdi
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Day-28 mortality was significantly reduced in patients with a high
CV-Vt (>16 %) (12 % vs 31 %, p = 0.02) and in patients with a low
H1/DC (≤40 %) (16 % vs 60 % p = 0.04). Low variability was not asso-
ciated with significant difference in term of hospital and intensive
care unit length of stay, ventilator free days, and duration of MV. Pul-
monary gas exchanges were greater in patients with high CV-Vt
(PaO2/FiO2 = 193 (156–241) vs 230 (183–288), p = 0.03). No significant
difference in term of gender, age, SAPS 2, Charlson score or length
of MV prior to inclusion was observed with decreased variability.
Conclusions: In MV patients at the early phase of weaning, low vari-
ability is associated with higher mortality. Low variability is associated
with worse oxygenation. Whether low variability is a causative factor of
mortality or a consequence of severity remains to be determined.
Therapies in neurointensive care: effects on
physiology and outcomes
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Introduction: Intravenous haloperidol (IVH) is frequently adminis-
tered on a scheduled basis to treat delirium in critically ill adults.
However, dosing recommendations for this indication have been de-
rived from older studies evaluating the use of IVH in psychiatric pa-
tients [trough level H: 8.4 μg/L (SD 6.7 μg/L), 3–6 mg per day]
without delirium and who are not critically ill. To establish the opti-
mal dose of IVH in critically ill adults with delirium, the relationship
between IVH serum concentrations and clinical response is required.
Objective: To establish the relationship between serum haloperidol
concentrations and clinical response in critically ill adults with delir-
ium who are managed with a scheduled IVH protocol.
Methods: This single-center, prospective study included consecutive crit-
ically ill adults with delirium without prior exposure to haloperidol, neuro-
logical or psychiatric disease, end-stage liver disease, a QTc interval≥
450 msec, requiring deep sedation, or requiring a medication known to
interact with haloperidol. Delirium was deemed to be present when the
bedside nurse and the intensivist agreed that the Intensive Care Delirium
Screening Checklist (ICDSC) was ≥ 4 and was managed with a scheduled
IVH delirium treatment protocol. IVH was initiated at 1 mg q8h (0.5 mg
q8h in patients≥ 70; 2 mg q8h if agitation present) and titrated upwards
q24h by 0.5 mg q8h to 2 mg q8h based on the ICDSC score and delirium
symptoms present. Trough haloperidol (TH) serum concentrations were
measured on days 2 and 3 of IVH and analyzed with a validated liquid
chromatography mass spectometry Method:
Results: Baseline characteristics of the 14 patients enrolled were:
male (64 %), mean age of 65 (SD 8), Body Mass Index (BMI) of 28 (SD
5) and a SOFA score of 7 (IQR 4 to 8) and were initiated on IVH dose
as follows: 0.5 mg q8h (n = 2), 1 mg q8h (n = 10) and 2 mg q8h (n =
2). IVH dosing across day 2 and 3 of haloperidol use was similar with
the day it was initiated. The mean H dose (q8h) in the 48 h up to the
TH determinations was 1.6 mg (SD 0.19). At the time of IVH initiation,
the median (IQR) ICDSC score was 5 (4 to 5.3) and was relatively un-
changed across day 2 [4 (3 to 5)] and day 3 [4 (3 to 5)], p = NS. The
mean (SD) H serum concentration was not significantly different be-
tween days 2 and 3 [2.2 (1.5) vs. 1.5 (0.9) μg/L; p = 0.15].
Conclusions: This preliminary report is the first study to evaluate the
pharmacokinetics and the pharmacodynamic response of low-dose
IVH when administered to critically ill adults to treat delirium. We ob-
served low trough levels of IVH and lasting delirium (for the first
three days after initiation of IVH). The IVH dose that should be used
to treat delirium in the ICU requires further investigation.
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Introduction: Fever is a dangerous secondary insult for the injured
brain (1). In a recent study (2) examining Paracetamol administration
for fever control in acute brain injury (ABI) patients (pts), a reduction
in intracranial pressure (ICP) was observed only in subjects with a
baseline ICP > 15 mmHg.
Objectives: 1) to analyze ICP trend after antipyretics administration,
2) to evaluate if ICP variations are influenced by ICP value before an-
tipyretics administration.
Methods: Adults pts with ABI admitted to our Intensive Care Unit
(ICU) were prospectively evaluated after antipyretics administration
[4 time points: baseline (t-0), 30 minutes (t-30), 60 minutes (t-60) and
120 minutes (t-120)]. Inclusion criteria were: 1) monitoring of intra-
arterial blood pressure, core temperature (Tc), and ICP and 2) a Tc ≥
37.5 °C. Exclusion criteria were: 1) hypovolemia, 2) administration of
drugs with hemodynamic effects during the study period, 3) adminis-
tration of antipyretics in the 6 hours before the start of the study, 4)
acute heart failure and 5) cerebral vasospasm.
Results: 62 pts [male 35; mean age 52,2 (SD ± 14,2) years; median Glas-
gow Coma Scale (GCS) 6 (IQR 3–7) at ICU admission] were enrolled.
Diagnosis at ICU admission were: 33 (53,25 %) subarachnoid
hemorrhage (SAH), 16 (25,8 %) traumatic brain injury (TBI), 10 (16,1 %)
intracerebral hemorrhage (ICH) and 3 (4,8 %) acute ischemic stroke
(AIS). Paracetamol (1 gr intravenous) was administered to 32 pts and
Diclofenac Sodium (12,5 mg intramuscular) to 30 pts. At t-0, 34 pts
(54,8 %) showed an ICP ≤ 15 and 28 (45,2 %) an ICP > 15 mmHg. No
statistically significant changes in ICP were observed in the overall
population after antipyretic administration: 14.9 ± 5.1, 14.9 ± 4.6, 14.4 ±
4.5, 15.1 ± 4.3 mmHg at t-0, t-30, t-60 and t-120 respectively (P = 0.6). A
statistically significant reduction in ICP (19.5 ± 3.2, 17.6 ± 4.6, 16.4 ± 4.9,
16.0 ± 4.4 mmHg at t-0, t-30, t-60 and t-120 respectively; P < 0.001) was
observed in the group of pts with t-0 ICP > 15 mmHg. Conversely, a sta-
tistically significant increase in ICP (11.2 ± 2.7, 12.7 ± 3.4, 12.8 ± 3.5, 14.4
± 4.1 mmHg at t-0, t-30, t-60 and t-120 respectively; P < 0.001) was ob-
served in the group of pts with a t-0 ICP≤ 15 mmHg. A statistically sig-
nificant reduction in Tc, mean arterial pressure (MAP) and cerebral
perfusion pressure (CPP) was observed in all groups of patients (overall
population and pts with ICP > or ≤ 15 mmHg) after antipyretic therapy.
Conclusions: ICP variations are influenced by ICP value before antipy-
retics administration. If these data are confirmed in future studies,
the decision to start antipyretic therapy should take into account the
baseline ICP value.
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Introduction: Intracranial hypertension (ICH) is one of the main cause
of death, and of poor neurological recovery after traumatic brain in-
jury (TBI). The use of a continuous osmotherapy has been described
in retrospective single-center studies, but its effectiveness is
discussed.
Objectives: The first objective was to describe the association be-
tween the use of a continuous osmotherapy and mortality in patients
developing a post-traumatic ICH. Secondary objectives were to inves-
tigate the impact of continuous osmotherapy on long-term neuro-
logical recovery and on tolerance.
Methods: We pooled the data from three prospective multicenter
studies: the corti-TC trial (ref 1), the BI-VILI study (NCT01885507) and
the Atlanrea cohort (NCT02426255). We included all patients with
traumatic brain-injury, hospitalized in ICU and receiving mechanical
ventilation for more than 24 hours.
ICH was defined as one or more episodes of intracranial pressure
higher than 20 mmHg and that has required a specific therapeutic
intervention.
In one participating center, continuous osmotherapy (NaCL20% (ref
2)) was initiated as the first line treatment of intracranial hyperten-
sion, and its administration was pursued up to the end of the period
at risk of ICH.
The primary endpoint was the survival rate at day 90. The secondary
endpoint was the Glasgow Outcome Scale (GOS) at day 90 (GOS = 1
death, GOS = 5 minor sequelae).
A crude comparison of patients with ICH treated or not with continu-
ous osmotherapy was first performed. To consider the biases related to
this observational study, an adjustment on potential confounders (age,
glasgow coma scale, pupil reactivity, Marshall score, hypotension and
hypoxemia) was performed by both a propensity analysis and a multi-
variate analysis.
The protocol for this study was approved by an ethics committee.
Results: Among the 1054 included patients, 545 (51.7 %) devel-
oped ICH.
Out of 143 patients with ICH and treated with a continuous
osmotherapy, 106 (74.1 %) were alive at day 90 as compared to 265
(65.9 %) patients with ICH and not treated with continuous
osmotherapy (p = 0.07). With the continuous osmotherapy, the rela-
tive risk of survival was 1.43 (95 % CI, 0998–2062, p = 0.05). Adjusted
hazard ratio for survival at day 90 was 1.43 (95 % CI, 1.02 - 1.99, p =
0.003) in propensity score-adjusted analysis and 1.67 (95%CI, 1.12-
2.50, p = 0.01) in multivariate analysis.
At day 90, GOS was higher in patients treated with continous
osmotherapy (64 (45.2 %) patients had a GOS = 4–5 vs 115 (35.8 %),
p = 0.01).
Severe hypernatremia (≥160 mmol / l) was more frequent in treated
patients (9.1 % vs 2.2 %, p < 0.001). No case of central pontine myeli-
nolysis was recorded.
Conclusions: Continuous osmotherapy for the treatment of post-
traumatic ICH was associated with improved adjusted 90-day sur-
vival. A randomized clinical trial is warranted before definitive
Conclusion:
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Introduction: Prediction of prognosis in Intracerebral hemorrhage
(ICH) is always challenging: the ICH score was developed to predict
outcomes and limit futile overtreatment1. Recent guidelines on ICH
management have significantly modified our traditional nihilistic
approach2,3.
Objectives: To compare observed and predicted 6-months mortality
in a cohort of consecutive ICH patients admitted to the Neurosurgical
ICU of San Gerardo Hospital (Monza, Italy) from 2013 to 2015.
Methods: Retrospective analysis of prospectively collected data of
ICH patients with ICU length-of-stay >24 hours. We retrieved clinical
data, CT scans, DNROs within 48 hours from admission, 30 days mor-
tality and modified Rankin Scale (mRS) along with the ICH score and
6-months survival.
Results: 100 consecutive patients (64 ± 14 years old, 57 % males, me-
dian GCS 7 at admission, median ICH volume 75 cm3) were included.
DNRO: 28 %, all died, 71 ± 11 years old, median GCS 4 at admission,
median ICH volume 110 cm3.
No DNRO: 72 %, 62 ± 15 years old, median GCS 9 at admission, me-
dian ICH volume 47 cm3 (p < 0.05 vs. DNRO). Surgery was performed
in 71 %.
Overall, ICU mortality was lower than expected accordingly to the
ICH score (see Fig. 27) (i.e. 33 %). mRS was ≤3 and >3 in 21 (30 %)
and 46 (64 %) of the discharged patients, respectively. 180-days sur-
vival globally approached 60 % (95%CI 50–70).
Considering the severity on admission:
- ICH score < 3 (33 %), median length of stay in ICU of 3 days. 17
(51 %) patients underwent to neurosurgery. Mortality was non-
significantly different between patients receiving neurosurgery and
patients receiving medical treatment.
- ICH score ≥ 3 (67 %) had a median length of stay of 5.5 days.
Neurosurgery was performed in 34 (50 %), and observed short- and
long-term mortality was significantly lower for patients that under-
went to neurosurgery than in patients receiving medical treatment
(see Figs. 28 and 29).
Conclusions: We observed mortality to be lower than predicted by
ICH score and functional outcome to be acceptable in one-third of
patients. Full treatment including neurosurgery significantly im-
proved short and long term survival for patients with ICH score ≥3.
Prognosis estimation after an ICH remains a challenging subject and
early DNROs and limitations of treatment should be carefully
evaluated.
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Introduction: Influenza infection causes severe morbidity and mortality
around the world. Pandemic influenza A(H1N1)pdm09 have been de-
scribe to increases disease severity comparing with seasonal flu viruses.
There are limited data comparing clinical differences between influenza
A (H1N1)pdm09 and influenza A(H3N2) infection in critically ill patients.
Objectives: Our aim was to analyse the demographic and clinical dif-
ferences between patients admitted to ICU due to pandemic influ-
enza A(H1N1)pdm09 and seasonal influenza A(H3N2) infection.
Methods: Prospective, observational, multicenter study conducted in
148 Spanish ICUs from 2009 to 2015. Individuals with Influenza
A(H1N1)pdm09 were compared with those infected by influenza A
(H3N2). All serotypes were confirmed using RT-PCR at ICU admission. Pa-
tients´ demographic, clinical, radiologic features, laboratory values, ICU
and hospital length of stay (LOS) and outcomes were recorded. Discrete
variables are expressed as percentage and continuous variables as me-
dians with 25th to 75th interquartile range (IQR). Differences between
groups were assessed using the x2 test and the Fisher exact test for cat-
egoric variables and Mann–Whitney U test for continuous variables.
Results: Of 2898 patients with confirmed influenza infection at ICU
admission, 110 were excluded due to influenza B (n = 56) or non-
serotype A typification (n = 54). At all, 2421 patients with influenza A
(H1N1) were compared to 367 patients with influenza A (H3N2). Pa-
tients with A(H1N1) were much younger (50 [38–61] vs 61 [50–73], P
< 0.001), presented a higher multiorgan dysfunction (61,2 % vs
55,4 %, P = 0.038), and required more invasive mechanical ventilation
(70,6 % vs 65.1 %, P = 0.046), and prone position(18.9 % vs 13.0 %, P
= 0.007). Patients with A(H3N2) had more comorbidities: COPD
(30.4 % vs 19.5 %, P < 0.001), heart failure(18,6 % vs 10.0 %, P <
0.001), chronic renal failure(14,5 % vs 7,6 %, P < 0.001), and dia-
betes(23,9 % vs 15,3 %, P < 0.001). Patients with A(H3N2) presented
more bacterial coinfection pneumonia (26,5 % vs 14,4 %, P < 0.001)
and a higher vaccination rate (23,5 % vs 5,7 %, P < 0.001). Influenza
A(H1N1) group have an increased ICU length of stay (LOS) (11[5–21]
vs 8[4–19], P < 0.001) but there is no difference in hospital LOS. No
statistically significant difference in overall mortality was observed
(21.9 % H1N1 vs 24.2 % H3N2, P = 0337).
Conclusions: Our data suggest than Infuenza A subtypes have
different clinical presentation in critically ill patients. Influenza
A(H1N1)pdm09 affect younger patients with less comorbidities suf-
fering an acute and more severe respiratory disease. Influenza A
(H3N2) is presented more frecuently with bacterial coinfection in
older patients with more chronic illness and especially CPOD. The
overall mortality was high without differences between groups.
References: Schaffer A.et al. BMC Public Health. 2012; 12:869. Mitchell
R. et al. Am J Infect Control. 2013; 41:1032–7.
Fig. 27 (abstract A478). Mortality (observed and expected) at 30
days according to ICH score.
Fig. 28 (abstract A478). Global 180-days survival (±95%CI) of patients
admitted to neuro-ICU with ICH (N= 100 patients).
Fig. 29 (abstract A478). 180-days survival of patients undergoing to
neurosurgery and receiving only medical treatment
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 248 of 607
A480
The dynamics of the pulmonary microbiome during mechanical
ventilation in the intensive care unit and the association with
occurrence of pneumonia
T. Zakharkina1, I. Martin-Loeches2, S. Matamoros1, P. Povoa3, A. Torres4, J.
Kastelijn1, J.-J. Hofstra1, M. de Jong1, M. Schultz1, P. Sterk1, A. Artigas5, L.J.
Bos1
1Academic Medical Center, University of Amsterdam, Amsterdam,
Netherlands; 2St James's University Hospital, Dublin, Ireland; 3Hospital
São Francisco Xavier, Lisbon, Portugal; 4Hospital Clinic, Barcelona,
Spain,;5Autonomous University of Barcelona, Barcelona, Spain
Correspondence: L.J. Bos - Academic Medical Center, University of
Amsterdam, Amsterdam, Netherlands
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A480
Introduction: During the past ten years the paradigm of a “healthy
lung is a sterile lung” was challenged [1–5]. The healthy lung ap-
peared to be populated by multiple resident bacterial species, that
migrate to the distal airways from the oral cavity [2]. According to
the adapted island model the respiratory microbiome represents a
dynamic community, where the equilibrium point is achieved by the
balance between immigration and elimination mechanisms [6].
Objectives: We hypothesized that mechanical ventilation and anti-
biotic administration decrease the diversity of the respiratory micro-
biome and that these changes are more profound in patients who
develop ventilator-associated pneumonia (VAP).
Methods: Intubated and mechanically ventilated ICU-patients were
included. Tracheal aspirates were obtained three times a week. 16S
RNA sequencing with the Roche 454 platform was used to measure
the composition of the respiratory microbiome. Associations were
tested with linear mixed model analysis. The relative changes were
compared between patients that did and did not develop VAP.
Results: 35 patients were included; 11 had VAP, 18 did not have VAP.
Six additional patients developed pneumonia within the first 48 hours
after intubation. Duration of mechanical ventilation was associated
with a decrease in Shannon diversity (fixed-effect regression coeffi-
cient (ß): −0.03 [95%CI: −0.05 - -0.005]), but the administration of
antibiotic therapy was not (fixed-effect ß: 0.06; 95%CI: −0.17 - 0.30).
There was a statistically significant increase in abundance of Pseudo-
monadales and a decrease in abundance of Lactobacillales, Gemel-
lales, Actinomycetales and Clostridiales between the moment of
intubation and extubation. There were no statistically significant dif-
ferences between patients that did and did not develop VAP.
Conclusions: Mechanical ventilation, but not antibiotic administra-
tion, was associated with changes in the respiratory microbiome.
Duration of mechanical ventilation was associated with increased
abundances of Pseudomonadales. The dynamics in the respiratory
microbiome were not different between patients that did and did
not develop VAP.
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Introduction: Immunocompromised (IC) patients have poor outcome
in the ICU. To our knowledge, no study to date has specifically evalu-
ated ventilator-associated (VA) lower respiratory tract infections (LRTI)
in this population.
Objectives: To determine the incidence, etiology and outcome of
VA-LRTI in IC patients, and to compare it with patients with no appar-
ent immunosuppression.
Methods: Post-hoc analysis of the large prospective multinational
TAVeM database, coming from 114 ICUs [1]. All consecutive patients
receiving mechanical ventilation for >48 h were included. The inci-
dence, etiology and outcome of VA-LRTI (ventilator-associated tra-
cheobronchitis (VAT), and ventilator-associated pneumonia (VAP) [1])
were compared between IC (neoplasia, haematological malignancy,
AIDS, allogeneic stem cell transplant, immunosuppressant drug,
organ transplant) and non-IC patients.
Results: Among the 2960 included patients, 663 (22 %) were IC. The
incidence of VA-LRTI was significantly lower in IC compared with
non-IC patients (116 (17.5 %) versus 573 (25 %), p < 0.0001, OR = 0.64
[95%CI 0.51-0.79]). Although VAT incidence was significantly lower in
IC compared with non-IC patients (7.8 % vs 11.7 %, p = 0.04), no sig-
nificant difference was found in VAP incidence between the two
groups (9.7 % vs 13.3 %, p = 0.13, respectively).
In patients with VA-LRTI, rate of prior antibiotic treatment was signifi-
cantly higher in IC compared with non-IC patients (80 % vs 66 %, p
= 0.001). The incidence of progression from VAT to VAP was similar
in IC and non-IC patients (7/52 [13 %] vs 32/268 [12 %], p = 0.76).
IC and non-IC patients received appropriate antibiotics for VA-LRTI in
the same proportions (77 % vs 79 %, p = 0.5). Same results were ob-
tained in VAT and VAP subgroups. Among IC patients with VAT, 39/
52 (75 %) received appropriate antibiotics. Percentage of IC patients
with progression from VAT to VAP was significantly lower in patients
who received appropriate compared with those who received in-
appropriate antibiotic treatment (8 % vs 31 %, p = 0.035, OR 0.19
(95 % CI 0.03-0.99)).
The incidence of multidrug resistant (MDR) bacteria was higher in IC
compared to non-IC patients with VA-LRTI (72 % vs 59 %, p = 0.01),
similar results were found in the subgroup of patients with VAP (78 %
vs 58 %, p = 0.001), but not in those with VAT (65 % vs 61 %, p = 0.52).
Among patients with VA-LRTI, MRSA (5.2 % vs 1.7 %, p = 0.025) and
Enterobacter spp. (21 % vs 10 %, p = 0.001) were significantly more
frequent in IC compared with non-IC patients.
ICU mortality rate was higher in IC compared with non-IC patients
with VA-LRTI (54 %, vs 30 %, p < 0.0001, OR 2.68 (95 % CI 1.78-4.02)).
Similar results were obtained in VAT and VAP subgroups.
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Conclusions: Incidence of VA-LRTI is significantly lower in IC com-
pared with non-IC patients. MDR bacteria and mortality rates are
significantly higher in IC compared with non-IC patients with VA-
LRTI.
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Introduction: Severe community-acquired pneumonia (CAP) remains
a significant cause of morbidity and mortality [1]. In the Netherlands
the guidelines recommends a duration of antibiotic therapy in severe
CAP for at least five till seven days.
Objectives: The purpose of this trial was to evaluate whether procal-
citonin measurements were able to reduce antibiotic usage in pa-
tients with severe CAP in Dutch intensive care units by reducing the
duration of antibiotic treatment without increasing mortality or recur-
rent infections.
Methods: From 2009 until 2013 a randomized intervention trial was
performed in three university medical centres and 12 teaching hospi-
tals in the Netherlands [2]. In this Dutch multicentre trial all patients
admitted to the intensive care unit and who received antibiotics for
presumed infection were assigned to a PCT-guided or standard-of-
care antibiotic discontinuation. In this study a sub analysis for all pa-
tients with a severe community-acquired pneumonia was performed.
Stopping advice for antibiotics was provided when PCT was ≤20 %
of its peak value or ≤0.5 ug/L. Mortality and duration of antibiotic
treatment (DOT) were the primary endpoints of this study.
Results: In 15 ICUs 440 patients with severe community acquired
pneumonia were randomized for PCT-guidance (n = 208) or
standard-of-care (n = 232). The median DOT was 5.5 (3–8) and 7 days
(4–10) respectively (P < 0 · 001). No difference in reinstitution of anti-
biotics or CRP-levels within 28 days after randomization was ob-
served. Mortality at 28 days was 43/208 (20.7 %) and 58/232 (25 ·
0 %) in the PCT and standard-of-care group respectively (P = 0.31).
One-year mortality was 63/208 (30.3 %) and 90/232 (38.8 %) in the
PCT and standard-of-care group respectively.
Conclusions: In this prospective randomized trial, the addition of
PCT-measurements to assist intensivists in duration of antibiotic ther-
apy in severe community-acquired pneumonia, resulted in a clear re-
duction of antibiotic treatment from 7 days (IQR 4–10 days) in the
control group to 5.5 days (IQR 3–8 days) in the PCT-guided patient
group, without increase of mortality or subsequent antibiotic
prescriptions.
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Introduction: Ventilator-Associated Pneumonia (VAP) is a leading
nosocomial infection in intensive care unit (ICU) patients undergoing
mechanical ventilation (MV). Giving that such patients show an in-
creasing risk of important gastrointestinal (GI) bleeding, stress-ulcer
prophylaxis (SUP) has been recommended for the prevention of
upper GI hemorrhage. SUP strategy rely on drugs that block the se-
cretion of gastric acid and increase the gastric pH (histamine-2-recep-
tor antagonists - H2RA, and proton pump inhibitor - PPI) and those
that does not alter gastric pH (sucralfate). The increase of gastric pH
leads to bacterial overgrowth and potential colonization of trachea
determining a higher risk of VAP.
Table 14 (abstract A481). Outcomes of patients with VA-LRTI
Immunocompromised n=663 Non-immunocompromised n =
2297
VAT
n=52
VAP
n=64
No VA-
LRTI
n=547
p VAT
n=268
VAP
n=305
No VA-
LRTI
n=1724
p
Mechanical
ventilation
duration, d
16
(10–
25.5)
15
(8–
27)
7 (4–
14)
<0.001 13 (8–
22)
14 (8–
26)
7 (4–
12)
<0.001
Length of ICU
stay, d
23
(16–
38)
20
(13–
30)
12 (7–
20)
<0.001 21
(14–
33)
21
(13–
34)
12 (8–
19)
<0.001
ICU mortality,
%
42 64 39.5 0.001 26.5 34 26.5 0.016
Fig. 30 (abstract A482). Kaplan-Meier plot for survival
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Objectives: In the setting of a study designated to assess VAP out-
comes, we collected data on known VAP risk factors (SUP strategy).
Our objective was to evaluate the risk of VAP accounting for expos-
ure to H2RA, PPI and sucralfate.
Methods: We recruited 772 patients in a multicenter prospective ob-
servational study, conducted in 21 Italian ICUs. Patients admitted to
the ICU for at least 48 hours, received MV from the admission, and
were followed until discharge, the day of withholding MV, the day of
transfer in other hospital ward, or death.We recorded demographic
data, admission category, and severity scores on admission. Each day
of ICU staying SUP approach (H2RA, PPI or sucralfate) was recorded.
VAP was defined as pneumonia occurring after a MV period of at
least 48 hours during the ICU stay.Independent relationships be-
tween VAP incidence and the specific SUP approach was assessed by
using a logistic regression analysis.
Results: Among 772 patients experiencing on average 11.3 days of
MV, 116 (15 %) developed VAP. Sucralfate was less frequently used
(8 %), while 28 % has been receiving H2RA and 77 % PPI. The risk of
VAP was higher for patients treated mainly with PPI (OR 4.27, 95%CI
2.57-7.09) than those who received H2RA (OR 2.30, 95%CI 1.08-5.07).
Conclusions: Our study show that the use of ranitidine is associated
with a lower risk of VAP, compared with PPI. Sucralfate was less fre-
quently used in the participating ICUs. Although some meta-analysis
indicate a lower risk of VAP associated with sucralfate, an important
study have not established a superiority of this medication compared
with ranitidine [1]. Miano et al. compared the use of pantoprazole vs
ranitidine in Cardiothoracic Surgery patients showing that pantopra-
zole was associated with a higher rate of VAP [2]. Such VAP rate asso-
ciated with PPI would seem to be linked to a greater antacid power
than ranitidine. This can lead to a more extensive gastric bacterial
colonization in patients treated with these drugs. Randomized-
Controlled Trial of Stress-ulcer prophylaxis are needed to assess
which drug show the highest risk of VAP and the relationship with
the incidence of major GI bleeding.
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Introduction: Low preoperative albumin reflects a poor nutritional
status that influences outcome in cardiac surgery (CS). However,
postoperative albumin levels are influenced by nutritional status and
inflammatory response. Thus, its value and utility as a prognostic
marker is unclear.
Objectives: To evaluate the influence of postoperative plasma levels
of albumin in the outcome of patients who underwent cardiac sur-
gery (CS).
Methods: Prospective, observational study in Surgical ICU in a referral
hospital. Albumin was measured during the first 24 h after CS, to-
gether with clinical data and outcomes including in-hospital and
long-term mortality (follow-up of 4.6 ± 2.4 years). Patients were
classified into different categories based on plasma albumin levels:
normal(≥35 g•L−1), low deficit(30–34.9 g•L−1), moderate deficit(25–
29.9 g•L−1) and severe deficit (<25 g•L−1).
Results: 2818 patients were included. Mean age was 64.5 ± 11.6 years;
63.8 % (n = 1799) were male; Body Mass Index: 28 ± 4.3Kg · m-2.
5.8 %(n = 162) had normal levels, 32.8 %(n = 924) low deficit,
44.3 %(n = 1249) moderate deficit and 17.1 %(n = 483) severe deficit.
We showed that not having low albumin levels 24 h after CS was
protector for in-hospital (HR:0.844;95 % IC:0.805-0.844;P = 0.007) and
long-term mortality (HR:0.846; 95 % IC:0.821-0.871; P < 0.001).
Subgroups of patients with low albumin levels showed worst survival
during hospital stay (98.1 % for normal subgroup, 97.3 % low deficit,
95 % moderate deficit and 85.9 % severe deficit; P < 0.001) and from
the long-term mortality scenario (5-year mortality was 94.3 % for nor-
mal subgroup, 87.4 % low deficit, 83.1 % moderate deficit and
72.4 % severe deficit; P < 0.001). Multivariable analysis showed higher
in-hospital mortality, sepsis and hemorrhage related complications
and higher ICU stay in subgroups of patients with low albumin levels
Predictors for the presence of any levels of hypoalbuminemia were
suffering from any degree of chronic kidney disease (OR:1.316;95 %
IC:1.085-1.595;P = 0.005), preoperative low hemoglobin levels
(OR:1.060;95 % IC:1.033-1.088;P < 0.001), previous CS (OR:1.229;1.067-
1.415;P = 0.004) and longer Cardiopulmonary bypass time
(OR:1.904;95 % IC:1.902-2.128;P < 0.001).
Conclusions: Physicians may be aware about the degree of hypoal-
buminemia in the postoperative of CS due to its influence in out-
comes, even in long-term survival. Relationship between factors
associated with nutritional and inflammatory status may be associ-
ated with the development of postoperative hypoalbuminemia.
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Introduction: Post-operative pulmonary complications (POPC) are
common with a reported incidence ranging from 2 %-40 %. Adverse
outcomes include death, longer hospital stays and lower long term
survival, which is independent of pre-operative risk. The most widely
recognised prediction tool for POPCs is ARISCAT. Interventions to re-
duce POPCs have been studied individually but the use of a care
bundle (CB) has not been widely investigated. Enhanced recovery
(ER) pathways are 'standard of care' for major surgery - however
some patients may benefit from additional focused interventions. An
example of a CB for POPCs is the ´I COUGH´ study, which demon-
strated a trend towards reduction in POPCs. Results may be superior
if the intervention is targeted to a high-risk group.
Objectives:
1) To perform a survey of members of the ESICM POIC section: to
choose international experts for the Delphi and to share their opin-
ions on a POPC-CB.
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2) To recruit a team of experts to participate in and complete an
email-based Delphi consensus, leading to the formulation of a CB.
Methods: A SurveyMonkey of members of the ESICM POIC section
was conducted. International experts were identified from this sur-
vey. A Delphi consensus was conducted anonymously via email over
3 rounds, to 36 independently chosen experts. Each round com-
prised of a series of statements which experts were asked to respond
to using a five-point Likert scale. There were free text spaces for
comments and the possibility for papers to be circulated. After each
round, anonymous feedback was circulated to the Delphi group and
the previous results were used to create the statements for the sub-
sequent round. At the end of the process, final feedback was sent to
the group with the consensus and suggested care bundle.
Results: Survey: 362 respondents.
·Routine screening for high-risk of POPC occurs in 50 % of centres.
·Information about current practice in relation to various pre-, intra-
and post-operative interventions was ascertained.
·Almost 80 % of respondents would be happy to assess the feasibility
of implementing a POPC-CB.
Delphi: The preferred number of components in the POPC care bun-
dle was 7.
Care bundle elements supported by the consensus process were:
·PRE-operatively: a supervised exercise programme and inspiratory
muscle training.
·INTRA-operatively: low tidal volume ventilation with individualised
PEEP, use of routine monitoring to avoid hyperoxia and efforts made
to limit neuromuscular blockade.
·POST-operatively: deep breathing exercises and mandatory elevation
of the head of the bed.
Conclusions: A POPC care bundle has been suggested for use, in
addition to enhanced recovery pathways, in major surgical patients
at high-risk of POPC. Prospective evaluation of feasibility, before an
evaluation of effectiveness, is now indicated.
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Introduction: 80 % of UK in-hospital surgical mortality occurs in
those undergoing high-risk surgical intervention such as emergency
laparotomy (EL) (1) these patients are among the largest consumers
of hospital resources (2, 3). Furthermore it was suggested that UK
outcomes are worse than comparable countries (4).
In the 2011 review of peri-operative care of high-risk patients NCE-
POD reported care was good in less than half of patients leading to
considerable health and financial costs (5).
As such there was a clear need for a change in the approach to pa-
tients having an EL. Since this study the first national emergency
laparotomy audit (NELA) has been published demonstrating a 30-day
mortality of 11 % (6).
Objectives: The aims were to create a focused, evidence-based Emer-
gency Laparotomy Pathway (ELP) delivered by a multidisciplinary (MDT)
team, utilising care bundles to improve delivery of care and assess the
impact of the pathway on hospital mortality and length of stay (LOS).
Methods
Pathway design: A Emergency Laparotomy Group (ELG) was con-
vened and designed the ELP based on principles of best basic prac-
tice and the recommendations of the RCS (2) and NCEPOD (5). The
ELP covered the entire surgical stay of the patient in 4 stages.
Study protocol: Data was collected for consecutive patients, 50 pre
and 96 post-ELP during 2011/2012. The primary outcome measure
was in hospital mortality. Secondary outcomes were ICU mortality,
ICU and hospital LOS.
Results: The in-hospital mortality fell from 21.7 % Pre-ELP to 9.6 %
Post-ELP (p = 0.048). There is a strong trend towards significance in a
survival analysis (p = 0.053). There was no significant difference in
hospital LOS between Pre and Post cohorts. (Median 15.5 days vs
15 days, p = 0.875). There was no difference in the ICU LOS (3 vs
2 days, p = 0.3339), nor in the utilisation of high level beds.
Conclusion: The introduction of an ELP reduced the in hospital mor-
tality significantly, this has since been further evidenced with a 4-
centre (including our own) study demonstrating a case-mix adjusted
decrease risk of death from 15.6 % to 9.6 %, p = 0.002 (7). ELP is a
useful tool reducing the risk of failure to deliver optimal care.
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Introduction: Dexmedetomidine was shown to improve 28-day mor-
tality compared with lorazepam in a subgroup analysis of sepsis pa-
tients in the MENDS randomized controlled trial1).
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Objectives: This study aimed to demonstrate whether a sedation
strategy using dexmedetomidine was superior to that without dex-
medetomidine in septic patients, in terms of 28-day mortality and
ventilator-free days within a 28-day period.
Methods: A multicenter randomized controlled trial was conducted
to evaluate the dexmedetomidine-based strategy in septic patients
in eight ICUs. We included adult septic patients who were expected
to require mechanical ventilation for at least 24 hours. Patients were
randomized to receive sedation strategy either with dexmedetomi-
dine (DEX group) or without dexmedetomidine (non-DEX group).
Additionally, fentanyl, propofol, and midazolam were used as re-
quired to achieve the sedation goal in both groups which was set to
Richmond Agitation Sedation Scale 0 (calm) for daytime and −2 (light
sedation) for nighttime.
Results: We included 201 patients (mean age 68.8 years), of
whom 127 (63 %) were men. Mean Acute Physiology And
Chronic Health Evaluation (APACHE) II score was 23. The baseline
characteristics were similar between groups. In the DEX group,
well-controlled sedation rate was higher (p = 0.002) and delirium
rate was lower (p = 0.03) during ventilation compared with those
in the non-DEX group. At 28 days, 19 of 100 patients (19 %) in
the DEX group and 28 of 101 patients (28 %) in the non-DEX
group had died (p = 0.14). The ventilator-free days in a 28-day
period did not differ between the groups, at 22 days (interquar-
tile range [IQR], 17–25) and 21 days (IQR, 15.5-24.5) (p = 0.49). In
a predefined subgroup analysis that included 104 patients with
APACHE II score of 23 or more, 28-day mortality in the DEX
group was significantly lower than that in the non-DEX group
(odds ratio 0.40, 95 % confidential interval 0.17-0.93).
Conclusions: A sedation strategy using dexmedetomidine compared
with a strategy without dexmedetomidine induced well-controlled
sedation in ventilated septic patients but did not significantly im-
prove 28-day mortality and the number of ventilator-free days. Al-
though more critically ill patients may benefit from a
dexmedetomidine strategy, further studies are needed to confirm
this result.
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Introduction: Using a restrictive transfusion strategy appears to
be safe in critically ill patients [1,2] but there may be subgroups
of patients benefiting from transfusion at a higher haemoglobin
level [3].
Objectives: We explored if subgroups of patients with septic shock
had worse outcome when transfused at a lower versus a higher
haemoglobin threshold.
Methods: By performing post-hoc analyses of the whole trial popula-
tion of 998 patients from the Transfusion Requirements in Septic
Shock (TRISS) trial [2], we investigated the intervention effect in pa-
tients with severe co-morbidity (chronic lung disease, haematological
malignancy or metastatic cancer), patients who had undergone sur-
gery (either elective or acute) and patients with septic shock as de-
fined by the new definition of septic shock: lactate above 2 mmol/l
and treatment with vasopressors [4].
Results: The baseline characteristics were mostly similar between the
2 intervention groups in the different subgroups. There were no dif-
ferences in the intervention effect on 90-day mortality in patients
with chronic lung disease (test of interaction P = 0.31), haemato-
logical malignancy (P = 0.47), metastatic cancer (P = 0.51), septic
shock by the new definition (P = 0.20) or in those who had under-
gone surgery (P = 0.99), see Table.
Conclusions: In exploratory analyses of a randomised trial in patients
with septic shock, we observed no mortality benefit in any subgroups
of transfusion at a haemoglobin threshold of 90 g/dl vs. 70 g/dl.
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Introduction: At discharge from the Intensive Care Unit (ICU) physi-
cians may integrate information of a patient's condition before ICU
admission (medical history, functional status, quality of life) with the
Fig. 31 (abstract A488). Results
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sequence of events during the ICU stay to estimate the prognosis of
future well-being [1,2]. In 2006, the Sabadell group developed a sim-
ple but subjective prognostic score which made this prognosis expli-
cit [1,2]. However, the Sabadell score has not been validated beyond
hospital survival or for long-term health related quality of life
(HRQoL).
Objectives: To compare ICU physicians' subjective long-term progno-
sis with the observed long-term survival and HRQoL.
Methods: The first admissions of all patients discharged alive from
the ICU of the University Medical Center Utrecht between March
2012 and December 2014 were included in the study. The Sabadell
score was determined and recorded by the treating physician at the
time of ICU discharge ('0 - Good prognosis', '1 - Poor long-term
prognosis (>6 months) with unlimited ICU readmission', '2 - Poor
short-term prognosis (<6 months); ICU readmission debatable', or
'3 - Death expected during hospitalisation, ICU readmission not
recommended'). Survival status was verified using the municipal
registry one year after ICU discharge. In one-year ICU survivors
HRQoL was measured using the EuroQoL 5D-3LTM index score, di-
chotomized at 0.4 into high or low HRQoL. The analyses included
agreement between Sabadell score and one-year outcome cat-
egories, and a description of correctly and incorrectly estimated
prognosis groups.
Results: Of the 4,874 eligible patients, 3,796 (77.9 %) had completed
follow-up and were included into the study (see Fig. 32). In-hospital
mortality was 3.1 %, 9.3 %, 39.1 % and 81.6 % for the Sabadell scores
0–3 respectively. In 2,849/3796 (75.1 %) the Sabadell score accur-
ately predicted one-year outcome (Fig. 33). Table 15 shows patient
characteristics for the study population, and the groups where prog-
nosis was over- and underestimated respectively. Compared to pa-
tients with a correct estimate of prognosis, both patient groups with
over- or underestimated prognoses were more often admitted for
non-surgical reasons, and more severely ill at admission and during
ICU stay.
Conclusions: In three out of four patients, the Sabadell score was in
accordance with one-year prognosis. Only in less than 10 % of pa-
tients surviving ICU there was major disagreement between a physi-
cian's prediction and the observed long-term outcome.
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Table 15 (abstract A489) Patient characteristics
Total
population
Prognosis
correctly
estimated
Prognosis
overestimated
Prognosis
underestimated
p-
value
N 3,796 2,849
(75.1%)a
765 (20.2%)a 182 (4.8%)a –
Sex (male) 2,405
(63.4%)
1,833 (64.3%) 459 (60.0%) 113 (62.1%) .081
Age at ICU
admission
65 (55–73) 65 (55–72) 67 (58–75) 65 (53–73) <.001
Admission
type -
<.001
Elective
surgical
2,317
(61.1%)
1,951 (68.5%) 302 (39.6%) 64 (35.4%)
Urgent
surgical
593
(15.6%)
401 (14.1%) 160 (21.0%) 32 (17.7%)
Medical 881
(23.2%)
495 (17.4%) 301 (39.4%) 85 (47.0%)
APACHE IV
score
44 (33–60) 41 (31–54) 55 (41–76) 58 (42–81) <.001
Total
maximum
SOFA scoreb
5 (3–8) 5 (3–8) 6 (4–10) 8 (4–11) <.001
SOFA score
at discharge
4 (3–6) 4 (3–6) 4 (3–6) 4 (3–6) <.001
ICU length
of stay
1 (1–2) 1 (1–2) 1 (1–4) 3 (1–8) <.001
Continuous variables are presented as median (interquartile range) and tested
for differences using a Kruskal Wallis test, categorical variables are presented
as n (percentage) and tested for differences using a Chi-square test
ICU intensive care unit, LoS length of stay, APACHE IV acute physiology and
chronic health evaluation fourth edition, SOFA sequential organ
failure assessment
apercentage reflects proportion of total sample size
bSum of highest SOFA component scores during admission
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Introduction: Early and enhanced rehabilitation of patients in critical
care is associated with improved patient outcomes (1). We have pre-
viously published the results of a quality improvement project pro-
moting early and enhanced rehabilitation for patients mechanically
ventilated for greater than 5 days, and shown an improvement in
mobility levels at ICU discharge that was associated with a significant
reduction in ICU and hospital length of stay, ventilator days and in-
hospital mortality (2). The impact of such mobility programs on lon-
ger term outcomes is unknown.
Objectives: To assess the 3 year mortality of patients mechanically
ventilated for more than 5 days and who survived to ICU discharge
pre and post a quality improvement project enhancing rehabilitation
on critical care.
Methods: The study took place within a large, tertiary referral ICU. A
supportive rehabilitation team was created within the ICU in April
2012 with a focus on promoting early and enhanced rehabilitation
for patients at high risk for prolonged ICU and hospital length of
stays. The intervention has been described in detail in a previous
publication, and was successful in improving mobility levels at ICU
discharge. For all patients who survived to ICU discharge, mortality at
3 years was assessed.
Results: The mean age of the total court was 53 years. A total of
201 patients in the pre-quality improvement (Pre QI) group and
222 patients in the post quality improvement (Post QI) were dis-
charged from ICU alive. The 3 year mortality rate was 81/201
(40.3 %) in the Pre QI group vs 60/222 (27 %) in the Post QI
group; p = 0.004.
Conclusions: The introduction of early and enhanced rehabilitation
within the ICU was associated with a significant reduction in 3 year
mortality of ICU survivors. This hypothesis generating data warrants
further evaluation in future randomized controlled trials of the
intervention.
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Introduction: Admission to the ICU deeply impacts on post-ICU mor-
tality and quality of life, but the information on the issue is still
scarce(1).
Objectives: To analyze epidemiological data and evolution of pa-
tients on mechanical ventilation (MV) in the ICU and to define inde-
pendent variables associated to long-term (1 year) mortality.
Methods: National, prospective, multicenter cohort study sponsored by
the Argentinian Society of Intensive Care Medicine, including patients
receiving MV >72 hr (3/5-8/31/2014). Epidemiological and evolution
variables were recorded, and after hospital discharge patients/their rela-
tives were interviewed face-to-face or by telephone at 2, 6 and
12 months. Comparisons were made between survivors (S) and non-
survivors (NS). Data are analyzed according to their nature; a p < .05
was considered significant. Independent predictors of post-ICU mortal-
ity were identified by logistic regression.
Results: 320 patients from 26 hospitals across Argentina were in-
cluded. The data are shown on Tables 16, 17 and 18.
Global post-ICU mortality was 22 %; respectively 15 %, 5 % and 2 %
at 2,6, and 12 months post hospital discharge. Independent predic-
tors of mortality were: age (OR 1.07[.04-1.08;]; p 0.000) and SOFA24hs
(OR 1.12[1.02-.1.23];p 0.013). Calibration and discrimination of the
model were adequate (GOF 0.407; AUROC 0.79, respectively).
Conclusions:
1. Most patients were middle-aged men, admitted to public hospitals
for medical causes, 60 % with ≥1 comorbidities and very acutely ill,
according to APACHE II and SOFA scores.
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2. Complications as ARDS, shock and infections were frequent, occur-
ring in more than a half of patients.
3. 1-year mortality was 22 %. Most patients died within two
months after hospital discharge. Yet no single ICU event was as-
sociated with post-ICU mortality; only age and organ failures
were independent predictors of this outcomes.
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Introduction: To survey the outcome of patients with dengue infec-
tion admitted to intensive care unit (ICU).
Objectives: Because the outcome of adult patients with dengue in-
fections requiring ICU admissions remains unclear, this study was
conducted to assess the clinical manifestations and the prognostic
factors of critical ill patients with severe dengue.
Methods: This study was conducted in a tertiary referral hospital of
96 adult ICU beds. In this retrospective study, all of the patients with
laboratory-confirmed severe dengue infections and admitted to ICU
were enrolled between July 31 and November 31 in 2015 during the
large outbreak period. The medical records of all the recruited pa-
tients were retrospectively reviewed and the following information
was collected: age, gender, clinical manifestations, disease severity
scores, underlying conditions, laboratory examinations, and outcome.
The primary endpoint is to find the predictors of in-hospital
mortality.
Results: During study period, there were a total of 4787 patients with
dengue infections, and 143 (2.99 %) patients with severe dengue in-
fection required ICU admission. Among 143 critically ill patients, their
mean age was 69.7 years. Hypertension (n = 90, 62.9 %) and diabetes
mellitus (n = 70, 49.0 %) were the two most common underlying dis-
eases. Eighty patients (55.9 %) had co-bacterial infections, and 33 pa-
tients had co-bacteremia. Hematologic system was the most common
failure organ, followed by chest and cardiovascular systems. Fever was
the most common presentation (n = 112, 78.3 %), followed by anorexia
(n = 47, 32.9 %), and abdominal pain (n = 46, 32.2 %). Overall, a total of
33 patients had mortality, and the rate of mortality was 23.1 %. In
multivariate analysis, we found that in-hospital mortality was signifi-
cantly associated with lower Glasgow coma scale, lower platelet count
before ICU discharge, and higher number of organ failures.
Conclusions: The outcome of severe dengue patients requiring ICU
admission remains high and the mortality was associated with lower
Glasgow coma scale, lower platelet counts and more organ failures.
Additionally, more than half of patients would have bacterial infec-
tions during severe dengue infections.
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Table 16 (abstract A491). Characteristics of Patients
All Survivors Non
Survivors
p
Age 50[29–66] 41[25–60] 66[53–74] 0.000
Male gender 184(58%) 118(57%) 59(41%) 0.79
Marital status Married/
cohabiting Single Widower
153(48%)/
133(43%)/
34(11%)
46%/
47%/ 8%
53%/
29%/ 18%
0.005
Widower vs
single
P<0.001
Diagnostic category Medical
Scheduled surgery
Emergency surgery Trauma
Trauma + Cranial trauma
51%/ 17%/
8%/ 8%/
15%
47%/
18%/ 8%/
9%/ 19%
66%/
13%/ 9%/
7%/ 6%
0.025
Occupational status
Occupied (any type of
employment/study)
51% 62% 40% 0.000
Years of study 9±4 9±4 9±4 0.45
Health Insurance 60% 57% 70% 0.05
Admission to public hospitals 65% 68% 56% 0.06
Transferred from Emergency
Ward Home Operating room
Another Hospital
49%/ 15%/
1%/ 18%/
17%
49%/
13%/ 1%/
19%/ 18%
49%/
21%/ 3%/
16%/ 11%
0.20
Table 17 (abstract A491). Severity Scores
All Survivivors Non
survivors
p
Charlson score 0 1
≥ 2
118(37%) 72(22%)/
130(41%)/
43% 21%/
36%/
21% 31%/
46%/
0.008
APACHE II 18±7 17±7 20±8 0.004
SOFA24hs 7±4 6±3 8±3 0.007
Admission
Glasgow
14[8–15] 14[9–15] 14[8–15] 0.64
Table 18 (abstract A491). Events during ICU Stay
All Survivors Non Survivors p
Shock at admission 51% 49% 59% 0.15
Shock on evolution 57% 55% 63% 0.27
Duration of shock (days) 3[2–6] 3[2–5] 3[2–4] 0.3
ARDS 45% 48% 36% 0.07
Ventilator-associated pneumonia 26% 29% 19% 0.09
Catheter-related infection 41% 40% 43% 0.71
Length of MV(days) 10[6–19] 10[6–19] 10[6–19] 0.85
ICU stay (days) 16[10–26] 15[9–24] 18[11–27] 0.07
Hospital stay (days) 29[17–52] 28[16–52] 42[21–57] 0.06
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Introduction: Eosinopenia is associated with short term adverse out-
comes in the critically ill. In survivors of critical care, it is not know if
eosinopenia is predictive of adverse outcomes following hospital
discharge.
Objectives: We hypothesized that eosinopenia at ICU admission
would be associated with increased hospital readmission rates and
higher mortality following hospital discharge.
Methods: We performed a two center observational study of patients
treated in medical and surgical intensive care units. We studied
68,648 patients, age ≥ 18 years, who received critical care between
1998 and 2012 and survived hospitalization. The exposure of interest
was absolute eosinophil count within 48 hours of ICU admission
and categorized a priori as ≤10/ul, 10-50/ul, 50-350/ul (normal
range) and >350/ul. The primary outcome was all cause mortality
in the 90 days following hospital discharge determined using the
US Social Security Administration Death Master File. 365-day
follow-up was present in all cohort patients. Adjusted odds ratios
were estimated by multivariable logistic regression models with
inclusion of covariate terms for age, race, gender, Deyo-Charlson
Index, patient type (medical versus surgical), sepsis and number
of organs with acute failure.
Results: The cohort patients were 57.8 % male, 20.3 % nonwhite and
48.8 % surgical. 10.1 % of the cohort had sepsis, and the mean age
was 61.7 years. Median [IQR] absolute eosinophil count was 90 [30–
190]. 90-day post discharge mortality was 7.7 %. 30-day readmission
rate was 14.3 %. A decreased absolute eosinophil count was a ro-
bustly associated with all-cause post discharge mortality as well as
hospital readmission and discharge to a care facility instead of home.
Patients with an absolute eosinophil count of ≤10/ul or 10-50/ul have
an adjusted OR of 90-day post-discharge mortality of 1.58 (95%CI,
1.46-1.71; P < 0.001) or 1.49 (95%CI, 1.38-1.60; P < 0.001) relative to
patients with an absolute eosinophil count of 50-350/ul. Patients with
an absolute eosinophil count of ≤10/ul or 10-50/ul have an adjusted
OR of 30-day readmission of 1.08 (95%CI, 1.01-1.15; P = 0.018) or 1.10
(95%CI, 1.04-1.17; P = 0.001) relative to patients with an absolute eo-
sinophil count of 50-350/ul. Finally, patients with an absolute eosino-
phil count of ≤10/ul or 10-50/ul have an adjusted OR of discharge to
a care facility of 1.34 (95%CI, 1.28-1.41; P < 0.001) or 1.30 (95%CI,
1.24-1.36; P < 0.001) relative to patients with an absolute eosinophil
count of 50-350/ul. An absolute eosinophil count >350/ul was not as-
sociated with study outcomes.
Conclusions: In critical illness survivors, eosinopenia at ICU admission
is a robust predictor of mortality following discharge, hospital re-
admission, and discharge to a care facility. Eosinopenia is a marker
for ICU survivors at an especially high risk for adverse outcomes.
Thus, patients with eosinopenia may benefit from closer post dis-
charge follow-up and higher intensity rehabilitation.
Nutritional aspects in the ICU
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Introduction: Critical illness is marked by hypermetabolism and in-
creased protein catabolism. While studies suggest that protein deliv-
ery may be beneficial for critical illness outcomes, to date, limited
information exists regarding the association between protein delivery
during hospitalization and outcomes in ICU survivors following hos-
pital discharge.
Objectives: We hypothesized that higher protein intake might have
a protective effect in patients with malnutrition.
Methods: We performed a single center observational study of pa-
tients treated in medical intensive care units in Boston, Massachu-
setts. We studied 801 patients age ≥ 18 years, who received critical
care following between 2004 and 2011 and survived to hospital dis-
charge. All patients underwent a Registered Dietitian formal assess-
ment within 48 hours of ICU admission. The exposure of interest, grams
of protein per kilogram body weight delivered per day, was determined
from all oral, enteral and parenteral sources for up to 28 days. Nutrition
status was categorized as non-specific malnutrition, protein-energy
malnutrition, or at risk for malnutrition via anthropometric measure-
ments, clinical signs of malnutrition, malnutrition risk factors, and meta-
bolic stress. The primary outcome was all cause 90-day post-discharge
mortality. Adjusted odds ratios were estimated by mixed- effects logis-
tic regression models to describe how 90-day post-discharge mortality
differed with changes in protein delivery.
Results: The cohort was 55 % male, 79 % white with a mean age of
62.3 years. 22 % of the cohort had sepsis, 10 % had acute kidney in-
jury and 35 % had non-cardiac acute respiratory failure. 59 % had
non-specific malnutrition or protein-energy malnutrition. The 30, 90
and 365-day post-discharge mortality was 7.1 and 13.9 and 24.4 %.
The average number of nutrition delivery days recorded was 15. In a
mixed-effect logistic regression model adjusted for age, gender, race,
Deyo-Charlson Index, acute organ failures, sepsis and percent energy
needs met, 90-day post-discharge mortality rate was 17 % (95%CI: 6–
26) lower for each 1 g/kg increase in daily protein delivery (P = 0.002)
compared with the 90-day post-discharge mortality rate in the entire
cohort [OR = 0.83 (95%CI 0.74-0.94; P = 0.002)]. In a subset of patients
with malnutrition (n = 473): 90-day post-discharge mortality rate was
30 % (95%CI: 6–26) lower for each 1 g/kg increase in daily protein
delivery (P < 0.001) compared with the 90-day post-discharge mortal-
ity rate in the entire cohort [OR = 0.70 (95%CI 0.61-0.81; P < 0.001)].
Conclusions: In adult MICU patients who survive to hospital dis-
charge, protein intake appears to be predictive of out of hospital out-
comes. Patients with improvements in protein intake during
hospitalization independent of energy intake have decreased mortal-
ity in the 3 months following hospital discharge. The achievement of
ideal protein delivery may be an important factor in ICU survivorship,
especially in malnutrition.
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Introduction: SMOFlipid 20 % is intravenous lipid emulsion (ILE) con-
taining long-chain triglycerides (LCT), medium-chain triglyceri-
des(MCT), olive oil, and fish oil as a mixed emulsion containing α-
tocopherol. The aim was to assess the efficacy of this new ILE in sur-
gery compared with MCT/LCT,and it was tested for safety, tolerance,
metabolic and clinical efficacy in surgical patients.
Objectives: To assess the efficacy of this new ILE in gastrointestinal
surgery compared with MCT/LCT.
Methods: In this prospective study, 42 patients were randomized to
SMOFlipid 20 % or MCT/LCT (Lipovenoes 20 %) group. Clinical and
biochemistry data were collected. Inflammatory markers (CRP, IL-6)
and liver function indicators (ALT,AST,TBIL)were measured.
Results: 32 patients (17 males and 15 females) with a mean age
of 51 years completed the study. The patients' baseline datas(age,
gender, APACHE II) were similar in two groups(p > 0.05). The pa-
tients' baseline datas(age, gender, APACHE II)were similar in two
groups.The increment of triglyceride on day 5 from baseline was
significantly lower in SMOFlipid group than in Lipovenoes MCT/
LCT group(P < 0.05). The concentrations of alanine transaminase
(ALT), aspartate transaminase (AST) and totalbilirubin on day 5
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were significantly lower in SMOFlipid group than in control
group(P < 0.05). Inflammatory markers (CRP, IL-6)were not differ-
ent between groups(P > 0.05).
Conclusions: SMOFlipid had a better triglyceride-lowering effectas
compared with MCT/LCT and may be associated with a better liver
tolerance in surgical critically ill.
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Introduction: Muscle atrophy is one of the most important and fre-
quent problems observed in patients in Intensive Care Units (ICU).
Several mechanisms and risk factors have been described to explain
this syndrome. Glucocorticoids, which are frequently used in ICU, in-
duce muscle atrophy, but the mechanism still remains to be eluci-
dated. Connexin based hemichannels (Cx HCs), are channels formed
by six connexin proteins and communicates the intra with extra cel-
lular space since they are permeable to ions and small molecules
(e.g., ATP). Recently, CxHCs have been associated to denervation-
induced skeletal muscle atrophy (1), and may also participate in the
pathogenesis of corticoids induced muscle atrophy.
Objectives: To evaluate the possible involvement of Cx HCs in
dexamethasone-induced muscular atrophy.
Methods: C57Bl/6 wild type (WT) mice and Cx HCs knock out
(KO) mice (Cx43fl/flCx45fl/fl and Cx43fl/flCx45fl/fl:Myo-Cre) mice
were used. KO mice were skeletal muscle deficient for connexin
43 and 45. Also, Lanthanum, a connexin blocker, was used in ex-
periments. Presence and functionality of Cx HCs was evaluated
acutely after 5 hours of dexamethasone exposure, by cellular Eth-
idium uptake, Evans blue permeability, intracellular free Ca2+,
resting membrane potential, immunohistochemistry, and western
blot. NFkb Phosphorylation and mRNA levels of TNF-alpha were
also assessed. Finally, muscle atrophy was evaluated by cross sec-
tional area (CSA) after 7 days of dexamethasone exposure. Also,
atrogin-1 and MurF-1, which are two E3 ligases from ubiquitin-
proteasome system (intracellular degradation system), levels were
evaluated.
Results: Freshly isolated myofibers from mice treated with dexa-
methasone by 5 h showed de novo expression of functional connex-
ins 39, 43, 45 and pannexins (P2X7R) which were mainly distributed
on sarcolemma. Cx HCs expression was present only in WT myofi-
bers, was blocked by La, and was absent in KO mice. Accordingly, a
significant increase in basal intracellular free Ca2+ levels, and a de-
crease of resting membrane potential of about 10 mV, was observed
in myofibers from WT mice treated with dexamethasone compared
with mice injected with saline buffer or in KO mice. Moreover, dexa-
methasone induced the phosphorylation of NFkb and increased the
mRNA levels of TNF-alpha. Finally, seven days treatment with dexa-
methasone drastically reduced the CSA of myofibers from WT mice
but not KO animals. Both, atrogin-1 and MurF-1 were elevated in WT
animals in comparison with KO mice.
Conclusions: Dexamethasone induces the expression of Ca2+ perme-
able channels such as connexins, which leads to muscle atrophy.
Connexins are upstream to the activation of the ubiquitin-
proteasome system. Connexins are a novel family of proteins which
should be studied for prevention of corticoids-induced muscle
atrophy.
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Introduction: Malnutrition increases morbidity, length of
hospitalization and mortality in ICU patients (1), stressing the import-
ance of energy expenditure (EE) assessment. Indirect calorimetry is
the most accurate method, but available calorimeters do not support
EE measurement at inspired oxygen (FiO2) >80 %, preventing meas-
urement in the most severely ill. The Beacon Caresystem (Mermaid
Care, Nørresundby, Denmark) for advising on mechanical ventilation
includes indirect calorimetry designed for use in the full FiO2 range,
but has not been compared to other calorimeters.
Objectives: To compare the Beacon Caresystem to the E-COVX
(Datex-Ohmeda, GE Health Care, Helsinki, Finland) at varying FiO2.
Methods: Twenty healthy male subjects were included. Informed
consent and ethical approval were obtained in all cases. Measure-
ments from 16 subjects (age 32 ± 12 yrs) were analysed, the remain-
der excluded due to gas leakage. Subjects were mechanically
ventilated by mask (Servo-I, Maquet, Solna, Sweden) in pressure sup-
port (PS: 3 cm H2O, PEEP: 3 cm H2O) at FiO2 of 21, 50 and 85 %, in
that order, for 15 min at each FiO2. Analysis periods were selected
where COV for average oxygen consumption (VO2) and CO2 produc-
tion (VCO2) were < 5 % in five consecutive 1 min intervals (2). VO2,
VCO2 and EE were compared between devices (Beacon - E-COVX) at
each FiO2 by Bland-Altman analysis of bias and limits of agreement
(LOA) and within devices between 21 and 85 % FiO2 by paired t-tests.
Results: VO2, VCO2 and EE bias [LOA] between devices were −27
[−73 - 19] ml/min, −5 [−28 - 18] ml/min, and −157 [−434 - 121] kcal/
day at 21 % FiO2; −5 [−50 - 50] ml/min, 6 [−22 - 34] ml/min, and −12
[−345 - 320] kcal/day at 50 % FiO2; and 26 [−87 - 139] ml/min, 50
[16–84] ml/min, and 327 [−179 - 834] kcal/day at 85 % FiO2. Analysis
was performed in 12 subjects at 85 % FiO2 as E-COVX was unable to
measure EE in 4 subjects. Mean ± SD changes in VO2, VCO2 and EE
within device from 21 to 85 % as percentage of mean were 11 ± 6 %
(p < 0.001), 3 ± 6 % (p = 0.11) and 9 ± 6 % (p < 0.001) for Beacon Care-
system, and −4 ± 14 % (p = 0.415), −16 ± 10 % (p < 0.001) and −9 ±
12 % (p = 0.017) for E-COVX.
Conclusions: Measurements of VO2, VCO2 and EE were comparable
between Beacon Caresystem and E-COVX at 21 and 50 % FiO2. Sig-
nificant differences were observed at 85 % FiO2 where E-COVX
slightly underestimated VCO2 and EE and Beacon Caresystem slightly
overestimated VO2 and EE. Only Beacon Caresystem allowed EE
measurement at 85 % FiO2 in all 16 subjects.
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Introduction: Acute respiratory distress syndrome (ARDS) is a com-
mon lung disease. Extracorporeal lung support (ECLS) can be an add-
itional lifesaving tool. Patients with severe ARDS often suffer from a
catabolic state with massive loss of weight including skeletal muscle
and fat tissue. For ICU patients in general there is evidence, that goal
directed feeding could improve outcome and indirect calorimetry
(IC) is the gold standard to measure resting energy expenditure
(REE). Due to the O2 uptake and CO2 removal by lung and ECLS, an
IC in the common way is not feasible. So far it is unclear if and which
impact ECLS has on caloric needs of patients with ARDS.
Objectives: We introduce our MEEP (Measuring Energy Expenditure
in ECMO Patients) protocol, which enables us to determine the REE
in patients with ECLS. We investigated the impact of ECLS in ARDS
patients on REE.
Methods: We perform a common IC and extend it by a calculation of
the O2 uptake and the CO2 elimination by the ECMO filter due to
blood gas analyses (BGAs) and the ECMO blood flow [1]. Sum O2 up-
take and CO2 elimination were used in the equation of Weir [2] to
calculate REE. With this protocol we performed a monocentric, con-
trolled, prospective, observational pilot study. We included 20 pa-
tients with ARDS and ECMO treatment and 20 matched ARDS
patients without ECLS as control. Informed consent was given by
legal proxy. The COSMED Quark RMR® was used to perform IC, BGAs
were done by ABL Flex 800 and filter blood flow was measured by
the ECMO device. For all patients we measured resting energy ex-
penditure and calculated the most prevalent predicting equations for
REE for comparison. Nonparametric tests were performed. Data were
shown as median [IQR]. P-values ≤ 0.05 are assumed as being signifi-
cant. Ethic vote(EA1/293/13).
Results: Patient´s baseline characteristics were without significant dif-
ferences except SOFA Score at time-point of measurement for pa-
tients with ECMO 12.5 [8.0/14.5] and without ECMO 7.5 [6.0/9.5] (p =
0.002). We report that our MEEP-protocol is safe, easy and feasible to
perform in ECMO patients. We show for the first time, that measured
REE values according to our MEEP protocol do not significantly differ
between ARDS patients with ECMO (2013 kcal/d [1786/2333]) com-
pared to ARDS patients without ECMO (1857 kcal/d [1602/2085]) (p
= 0.165). All investigated equations predicting REE do not fit the
measured REE according to the MEEP protocol neither in non-ECMO
patients (data not shown) nor in ECMO patients.
Conclusions: Due to our MEEP-protocol REE is easy measurable in
ARDS patients with ECLS. ECMO per se does not to influence REE.
Equations to estimate caloric needs do not fit the REE of critically ill
patients with ECMO. We recommend to implement sequential mea-
surements of REE in critically ill during ECMO treatment to improve
goal directed feeding.
Trauma critical care
A499
CRASH-2 from the coal face - experience from a major trauma
centre in the United Kingdom
A. Lee, R. Inglis, R. Morgan, G. Barker
John Radcliffe Hospital, Adult Intensive Care Unit, Oxford, UK
Correspondence: A. Lee - John Radcliffe Hospital, Adult Intensive Care
Unit, Oxford, UK
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A499
Introduction: The administration of tranexamic acid to trauma pa-
tients with risk of haemorrhage is one of only seven treatments
shown to improve mortality in critically ill patients in multi-centre
randomized controlled trials [1,2]. Nonetheless, four years on from
CRASH-2, the implementation of this simple, low risk intervention,
which has the potential to save 600 lives a year in the UK, remains
suboptimal [3].
Objectives: To measure the proportion of trauma patients deemed
to be at risk of haemorrhage (as evidenced by the administration of
a first dose of tranexamic acid) that correctly received the second
dose of tranexamic acid. We designed a quality improvement project
to improve compliance with this measure, and here we report pre-
liminary Results:
Methods: All patients admitted under a 'trauma call' between Janu-
ary 2015 and January 2016 at the John Radcliffe Hospital in Oxford, a
major trauma centre in the United Kingdom, were included in our
study. Tranexamic acid administration information was collected for
all patients. Interventions included disseminating tranexamic acid in-
formation to trauma doctors verbally and during departmental induc-
tion. We also added both doses of tranexamic acid into the
electronic prescribing bundle for trauma patients in our hospital. Fur-
ther interventions are ongoing.
Results: The John Radcliffe Hospital received 1373 patients as 'trauma
calls' between January 2015 and January 2016. Of the 184 patients who
received the first dose of tranexamic acid, 82 patients correctly received
the second dose (45 %). We present a run-chart of percentage of pa-
tients receiving both doses of tranexamic acid over time, out of all the
patients who received the first dose of tranexamic acid.
Conclusions: We have demonstrated that a majority of patients who
would have received two doses of tranexamic acid under the terms of
CRASH 2 are not receiving this life-saving treatment. This finding
highlighted the difficulty in translating evidence-based recommenda-
tions into everyday practice and the need for quality improvement pro-
jects in this area. Responsibility for the administration of tranexamic
acid lies across multiple specialties, and so measures to improve its ad-
ministration need to target a diverse group of healthcare staff. En-
gaging stakeholders from all relevant parties has proved challenging
Fig. 34 (abstract A498). Resting energy expenditure in
ECMO patients
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and an early focus on inter-specialty collaboration is our key recom-
mendation to centres who intend to implement similar initiatives.
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Introduction: Emergency physicians are required to assess the sever-
ity of patient's illness and predict their prognosis with restricted situ-
ation at emergency department (ED). Trauma is one of the most
severe injuries at ED and its outcome highly depends on initial ap-
propriate management. Therefore, several scoring systems have been
developed on the last decade. However, the environment on ED has
changed and physicians have been still occasionally misled.
Objectives: Vital signs are widely used in both emergency medical
service and ED. It is a role of not only the static parameter but also
the dynamic one to help emergency physicians classify trauma pa-
tients' severity. Thus, we aimed to analyze the association between
changes in vital sings (ΔVS) and in-hospital mortality among trauma
patients.
Methods: This study was multicenter observational retrospective
study from Japan Trauma Data Bank. It consisted of major emer-
gency hospitals in Japan from January 2004 to December 2013. In
this period, a total of 159,157 trauma patients were registered. Of
these, 75,833 patients (48 %) were analyzed since all vital signs (sys-
tolic blood pressure, heart rate, and respiratory rate) were available
both at site and at ED.
We developed a new scoring system to predict in-hospital mortality
for trauma patients using three ΔVS and age. The patients were
judged on these 4 items with one point added for each positive one;
when systolic blood pressure decreased more than 30 mmHg, heart
rate increased more than 20/min, respiratory rate increased 10/min,
or old (age ≧65).
Results: Mean age (±SD) was 54 (±24) years old. 29,309 (39 %) were
aged over 65 years old. 25,854 (34 %) were women. Overall, in-
hospital mortality rate was 5,834 (7.7 %). The in-hospital mortality
rate increased from 6.4 % to 18.9 % when systolic blood pressure de-
creased more than 30 mmHg. In a similar way, it increased from
7.0 % to 16.5 % when heart rates increased 20/min. Also, it increased
from 7.5 % to 10.7 % when respiratory rates increase 10/min. Old
patients (> = 65 years old) had severe outcome than young adults (it
increased from 5.1 % to 11.8 %). As using our scoring system, in-
hospital mortality rate increased: 0 point was 3.5 %; 1 point was
9.5 %; 2 points was 18.5 %; 3 points was 33.0 %; and 4 points was
48.6 %. The area under the ROC curve of this predictive model was
0.675 (95 % CI 0.668-0.683).
Conclusions: Our new trauma scoring system, ΔVS scoring system,
which focus on changing vital signs, predicts in-hospital mortality. It
is useful to improve that emergency physician's decision and identifi-
cation of patients who need critical care.
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Introduction: Systemic hypotension is a predictor of increased mor-
tality in patients with traumatic brain injuries. Post-intubation
hypotension (PIH) has been demonstrated to be common and
associated with poor patient outcomes in other critically ill patient
populations requiring emergent endotracheal intubation (ETI). The
importance of PIH remains unclear in the trauma population.
Objectives: To determine the incidence of PIH in adult trauma pa-
tients and assess the association of PIH with mortality.
Methods: This study was a retrospective case series of adult
(≥16 years) trauma patients requiring intubation after referral to a
provincial trauma team located in a level 1 center in Halifax, Nova
Scotia, Canada between 2000 and 2015. PIH was defined as (a) de-
crease in systolic blood pressure (SBP) to < 90 mmHg; (b) reduction
in SBP of 20 % from baseline; (c) decrease in mean arterial pressure
to < 60 mmHg; or (d) initiation of, or increased infusion dosage of,
any vasopressor medication (bolus or infusion) during the 15-minute
period after ETI. Data was collected from a provincial trauma registry
and the patient chart, and included demographics, co-morbidities,
trauma characteristics, intubation time, as well as all fluids, medica-
tions, adverse events, interventions, and vital signs during the 15 mi-
nutes before/after ETI. We evaluated the incidence of PIH and
created a logistic regression model to determine the likelihood of
mortality in the PIH and non-PIH groups after controlling for gender,
age, intubator, mechanism of trauma, injury severity, traumatic brain
injury and volume of fluid administered.
Results: Overall, 477 patients arrived unintubated and required ETI
by the trauma team over the study period, of which 444 patients
met eligibility criteria and were included in the analysis. The inci-
dence of PIH was 35.6 % (158/444) in our study population. In-
Fig. 35 (abstract A499). Run Chart TxA Audit Jan 2015 – Jan 2016
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hospital mortality occurred in 47 (29.7 %) in the PIH group,
compared to 45 (15.7 %) in the non-PIH group. After controlling for
possible confounding factors, the development of PIH was associated
with increased mortality (OR = 2.17; CI: {1.25, 3.77}; P = 0.006).
Conclusions: In our study, development of PIH was common (35.6 %)
and associated with increased mortality (OR 2.17). Clinicians should
attempt to minimize hemodynamic instability during ETI in patients
with traumatic injuries. Further investigation of PIH in the trauma
population is warranted.
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Introduction: Recently, the population of elderly people has been in-
creasing rapidly all over the world. Especially, Republic of Korea is
now progressing to an aging society. The social activities of the
aging population have increased, which has also increased the num-
ber of elderly patients injured.
Objectives: The aim of this study is to analyze the clinical characteris-
tics and injury pattern of geritaric patients involved in trauma.
Methods: This study was conducted retrospectively from January
2015 to March 2016 among trauma patients who visited single
trauma center in Seoul, Korea. The patients divided in two groups, a
geriatrics group and an adult group on the basis of an age of 65. Pa-
tients under 18 years of age were excluded. The variables related
with trauma were extracted and compared.
Results: Total number of the included patients was 384, and the
number of elderly patients was 74. There were no significant differ-
ences in Revised Trauma Score (RTS), intensive care unit (ICU) admis-
sion, hospital stay between the two groups. There were differences
in the mechanism and the locations of the injury, gender, injury se-
verity score (ISS), trauma and injury severity score (TRISS), mortality,
drinking at admission between the two groups. Most common injury
mechanism in the adult group was driver traffic accident (24.5 %)
and in the geriatric group was pedestrian traffic accident (45.9 %). In-
jury of extremity (44.8 % vs 59.5 %) (p = 0.028) was more common in
the geriatric group than in the adult group. And female patient was
more common in the geriatric group (26.8 % vs 40.5 %) (p = 0.020).
The average ISS of the geriatric group was higher than that of the
adult group (17.8+/−11.52 vs. 14.0+/−12.06, p = 0.015). The mortality
was higher in the geriatric group (14.9 %) than in the adult group
(4.5 %) (p = 0.003). But drinking at admission was higher in the adult
group (33.9 % vs 10.8 %) (p < 0.00).
Conclusions: The mortality rate and the average ISS were greater
within the geriatric group than the adult group despite there was no
difference in the RTS, ICU admission. Also elderly people were prone
to pedestrian traffic accident with the lower drinking rate compare
than the adult group.
Prediction models and outcome
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Introduction: Sepsis is a dynamic medical condition where patients´
clinical status can change rapidly in either direction. Different bio-
markers and scores have been studied to assess sepsis severity and
prognosis. Procalcitonin, C-reactive protein and interleukin-6 are bio-
markers referred as helpful to follow evolution and outcomes. APA-
CHE II model was developed to predict hospital outcomes, based on
data from the first 24 hours. SOFA score describes the degree of
organ dysfunction over time and evaluates morbidity, but has been
used also for predicting mortality.
Objective: Our aim was to study the ability of different biomarkers
(procalcitonin, C-reactive protein and interleukin-6) and scores (APA-
CHE II and SOFA), determined on day 1, to predict outcome in septic
patients. Besides, we studied sequential SOFA score to find out its
dynamics at early sepsis and its correlation with mortality.
Methods: We assessed 48 consecutive septic patients admitted to our
medico-surgical ICU. Procalcitonin, C-reactive protein and interleukin-6
were determined on day 1. APACHE II was calculated on day 1, and daily
SOFA score was calculated for 5 consecutive days, determining also the
maximum SOFA. Mann–Whitney U test and ROC curves were carried out
to study association of these variables with 28-day mortality.
Results: In our cohort of septic patients (mean age 69 ± 13) there were
43 survivors and 5 non-survivors. Procalcitonin, C-reactive protein and
interleukin-6 did not show correlation with 28-day mortality. APACHE II,
SOFA scores on days 1 and 2, and maximum SOFA, also showed no cor-
relation with 28-day mortality. However, when analyzing SOFA scores on
days 3, 4 and 5, we found significant lower scores in survivors compared
to non-survivors: SOFA-3 (p= 0.048), SOFA-4 (p= 0.016), and SOFA-5 (p=
0.018). The ROC curve analysis also showed association with 28-day
mortality: SOFA-3 (AUC 0.772, p = 0.048), and stronger for SOFA-4
(AUC 0.823, p = 0.019), and SOFA-5 (AUC 0.820, p = 0.021).
Conclusion: Day 1 values for procalcitonin, C-reactive protein,
interleukin-6, APACHE II and SOFA did not correlate with outcome.
But, low SOFA scores on day 3, and specially in days 4 and 5, are
good predictors of survival, meaning that after 48 hours of admis-
sion, regardless of the initial score, those patients with a low SOFA
score have higher probability to survive. While SOFA scores at admis-
sion, and maximum SOFA, had bad performance in predicting mor-
tality, sequential SOFA scores add information on the course of the
disease, and improve the ability to predict the likelihood of survival.
Larger studies are required to find out SOFA based prediction models
with improved accuracy.
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Introduction: Epidemiological sepsis research in administrative data
is widely used in the USA. Risk adjustment models [1] enable ad-
justed outcome comparisons and benchmarks between regions, hos-
pitals, or over time. For Germany we recently reported first results of
an administrative data Approach [2] but a risk model is lacking.
Objectives: To develop and asses a risk model of hospital mortality
for sepsis based on German hospital claims data.
Methods: The hospital claims data of almost all inpatients in
Germany is combined into one dataset at the Federal Statistical Of-
fice. Anonymized statistical analysis can be performed via remote
data access. In data from 2010–2013 all adult cases with pathogen-
based or clinical sepsis codes (A & R codes, ICD-10) were classified by
severity. Age, sex, type of hospital admission, coded foci of infection
and comorbidities based on categories of the Charlson and Elixhau-
ser comorbidity indices, coding of sepsis as main diagnosis and year
of treatment were assessed as possible risk factors. Predictors of hos-
pital mortality were identified by backwards binary logistic regression
in a derivation cohorts separately for each severity group. Perform-
ance of models was tested in validation cohorts. Models were then
fitted with the selected predictors for the different severities in all
cases and predicted mortality risk was calculated. Combined model
performance across all severities was assessed by discrimination
using the “area under the curve” (AUC), by calibration plotting ob-
served against predicted mortality over risk quantiles, and by ex-
plained variance.
Results: 441 207 cases with sepsis without organ dysfunction
(hospital mortality 13,5 %), 284 883 with severe sepsis (mortality
40,3 %) and 112 609 with septic shock (mortality 59,6 %) were
identified. 41–43 of 53 assessed predictors remained in the final
models. Overall discrimination (Fig. 36), explained variance (R2 =
0.25), and calibration (Fig. 37) were good. Strongest risk factors
were age and advanced liver and hemato-oncologic disease. A
urogenital focus and sepsis as main diagnosis were associated
with lower hospital mortality. Mortality decreased from 2010 to
2013 for sepsis (p < 0.0001) and severe sepsis (p < 0.0001) but not
for septic shock (p = 0.11).
Conclusions: We developed a well performing risk adjustment model
for sepsis mortality in German administrative data. This enables com-
parisons and benchmarks from administrative data in Germany. Hos-
pital characteristics will be included into the model in the next
development step.
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Introduction: Patients at risk of rapid deterioration and critical illness
often have preceding changes in their physiological parameters.
Objectives: The systematic review quantifies the prognostic accuracy
of screening instruments of the Modified Early Warning Score
(MEWS) to detect risk of in-hospital mortality.
Fig. 36 (abstract A504). ROC curve of combined model
Fig. 37 (abstract A504). Predicted and observed hospital mortality
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Methods: The review process followed guidelines consisting of 5
steps suggested for systematic reviews. Relevant studies from Janu-
ary 2000 to December 2015 were obtained from electronic data-
bases. Standards for Reporting of Diagnostic accuracy (STARD) and
Quality Assessment of Diagnostic Accuracy Studies instrument (QUA-
DAS-2) were used to assess individual study quality and bias. Med-
Calc statistic software was used to assess and combine the data and
diagnostic accuracy across studies. Pooled diagnostic odds ratio and
area under The ROC Curve (AUC) analysis was used to evaluate the
prognostic accuracy of MEWS tool.
Results: A total of 402 citations were identified yielding 16 studies
for inclusion in this systematic review. Studies were significantly het-
erogeneous in terms of age and sample size. For predicting in-
hospital death, MEWS with high risk group as cut-off ≥ 4 and ≥ 5 had
the Diagnostic odds ratio (DOR) of 14.278 (95 % Confidence Interval
[CI] 12.185 to 16.730, I2 = 56.59 %]) and 3.28 (95%CI:2.489 to 4.323, I2
= 48.64 %). On pooled AUC analysis, there was a trend for MEWS to
estimate fair at the discriminative power of test. AUC of MEWS ≥ 4
was 0.778 (95%CI:0.715 to 0.841, I2 = 89.54 %) and of MEWS ≥ 5 was
0.646 (95%CI:0.611 to 0.682, I2 = 49.69 %).
Conclusions: On Meta-analysis of sixteen of MEWS studies, this
showed a robust positive trend to predict in-hospital death. MEWS
equal 4 or greater may be the favored tool to alert the deterioration
in hospitalized patients.
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Introduction: The world population is ageing. Together with this fact
there is increase rate of elderly patient's admissions to Intensive Care
Units. Therefore, studies aimed in elderly population are important.
The prognostic scores have been widely used in intensive care medi-
cine, among them SAPS 3 and APACHE II have a significant import-
ance. The sensitivity and specificity of all the systems are vary
depending on the score systems and the different groups of
patients.
Objectives: Validate and compare SAPS 3 and APACHE II in elderly
patients admitted in ICU in Salvador-BA, Brazil.
Methods: Prospective cohort study placed in a general ICU. In the
study were included patients above age of 65 admitted to general
ICU, from March 2010 to May 2013. All the patients were assessed
using the SAPS 3 (Global Equation and Central & South American
Equation) and APACHE II scoring systems. Logistic regressions ana-
lysis was used to calculate the sensitivity, specificity and accuracy as
well as the OR probability of mortality. The ability to predict mortality
was performed with ROC curves. The differences between observed-
to-predicted mortality were analyzed with the Hosmer-Lemeshow
test.
Results: There were analyzed 1106 patients, 497 (44.9 %) males. Me-
dian age: 76 years (IQR: 71–83 years). Hospital mortality 207 (18.7 %).
Median SAPS 3 and APACHE II: 48 (IQR: 42–55), 14 (IQR: 11–18). The
sensitivity, specificity and accuracy were respectively 70 %, 68.7 %
and 71.4 % for SAPS 3 Global Equation; 70 %, 68.7 % and 71.4 % for
SAPS 3 Central & South American Equation (CSA); 67.6 %, 69.1 % and
68.81 % for APACHE II. The area under the curve (AUC) of these
models was: 0.748 for SAPS 3 Global Equation, 0.745 for SAPS 3 Cen-
tral & South American Equation (CSA) and 0.740 for APACHE II. But
the Hosmer-Lemeshow goodness-of-fit test H statistic also revealed
poor performance for SAPS 3 Central & South American Equation
(CSA) scoring system.
Conclusions: In our series, the SAPS 3 Global Equation is the model
that best predicts mortality in patients with at least 65 years admit-
ted to a Brazilian ICU. Also, SAPS 3 Central & South American Equa-
tion (CSA) revealed poor calibration for critical care elderly patients.
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Introduction: Recent guidelines on the definition of sepsis from the
Sepsis 3 working group have suggested the use of a simplified ver-
sion of the SOFA score as an initial way to screen for sepsis (1). This
score allocates a point each for new altered mentation (GCS < 15), re-
spiratory rate greater than 22 and a systolic blood pressure <
100 mmHg. It has been given the term qSOFA based on the original
SOFA (sepsis related organ failure assessment). The purpose of the
score is to identify patients early with sepsis as dealy in recognition
is associated with an increased mortality and increased length of
stay. We decided to evaluate whether the qSOFA score when applied
to ICU patients could be validated for use in our patient population.
Methods: A historical patient cohort was identified by searching the
WardWatcher CIS dataset for all patients admitted from 01/01/204 -
31/12/2014 to a five bedded teaching hospital Intensive Care Unit in
Glasgow. These patients demographic data was collected along with
the parameters from qSOFA (as above) along with outcome data.
After removal of patients with incomplete datasets, statistical analysis
was performed.
Results: There were 3357 patients included in the study, with ana-
lysis of 1353 due to incomplete qSOFA data. Baeline data for these
patients was as follows: 58.9 % male, mean age 57.4 +/− 0.9 years,
mean APACHE-II score 19.7 +/− 0.5, mean predicted mortality 37 +/−
1.5 %, mean length of stay 5.0 +/− 0. days and mortality of 33 %.
Using the available data from Wardwatcher we generated qSOFA
data as below.
Conclusions: As can be seen from above there is a good correlation
between the qSOFA and APACHE-II in terms of recognition of sever-
ity. There is a significant correlation between qSOFA and increased
length of stay and mortality. This would suggest that qSOFA is a
quick and useful tool that can be used on ICU admission to aid prog-
nostication which can assist in discussions with patients, relatives
and colleagues.
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Introduction: Hyperglycaemia occurs frequently in the critically ill
and may be secondary to either diabetes (recognised or not), or
stress induced hyperglycaemia. Stress induced hyperglycaemia oc-
curs in patients who have normal glucose tolerance following reso-
lution of their acute illness. Whether stress induced hyperglycaemia
unmasks latent insulin resistance and/or impaired β-cell function has
not been adequately explored.
Objectives: To evaluate the association between stress induced
hyperglycaemia, the development of diabetes and long-term mortal-
ity in survivors of critical illness.
Methods: This is a retrospective, multi-centre observational study. All
adult patients surviving admission to a tertiary intensive care unit
(ICU) in South Australia between 2004 and 2011 were included.
Stress induced hyperglycaemia was defined as a blood glucose ≥
11.1 mmol/l within the first 24 hours of ICU admission. Prevalent dia-
betes was identified through ICD-10 coding or prior registration with
the Australian National Diabetes Service Scheme (NDSS). Incident dia-
betes was identified as NDSS registration > 30 days after hospital dis-
charge until July 2015. The predicted risk of developing diabetes was
described as sub-hazard ratios using competing risk regression. Sur-
vival was assessed using Cox proportional hazards regression.
Results: Stress induced hyperglycaemia was identified in 2,883
(17 %) of 17,074 patients without diabetes. The overall incidence of
subsequent type 2 diabetes following critical illness was 4.8 % (821
of 17,074). The risk of diabetes in patients with stress induced hyper-
glycaemia was approximately double that of those without (HR 1.91
(95 % CI 1.62, 2.26), p < 0.001) and was sustained regardless of age or
severity of illness. Subdividing age into approximate deciles the
greatest risk was seen in the 50–59 year age group with over a
seven-fold risk (HR 7.90 (5.38, 11.60), p < 0.001). Stress induced hyper-
glycaemia was not associated with increased long-term mortality in
patients who survived their hospital admission.
Conclusions: Stress induced hyperglycaemia within 24 hours of ad-
mission to the ICU identifies patients at greater risk of subsequent
diabetes.
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Introduction: Although several clinical guidelines recommend main-
taining blood glucose between 144 and 180 mg/dL, these are insuffi-
cient evidences to assess the benefit and harm of this glycemic target.
Objectives: We conducted a network meta-analysis to assess the impact
of glycemic target 144-180 mg/dL on the incidence of hypoglycemia,
the risk of infection and mortality in compared with other glycemic tar-
get as < 110 mg/dL, 110-144 mg/dL and >180 mg/dL.
Methods: We considered all studies from three recent systematic re-
views [1–3] and searched the PubMed database for studies that com-
pared target blood glucose levels among critically ill patients.
The primary outcomes were in-hospital mortality, and the secondary
outcomes were the incidence of hypoglycemia, and risk of sepsis or
bloodstream infection.
Results: We identified 71 studies through the re-analysis of the three
systematic reviews, and 431 studies through the PubMed search. Thirty-
nine potentially eligible studies were considered for inclusion, although
12 studies were excluded after screening the full texts. Thus, the net-
work meta-analysis included 14,495 patients from 27 studies. The mean
patient age was 61.6 years, and 21.7 % of the patients had diabetes.
There was no significant difference of in-hospital mortality and risk of
sepsis or bloodstream infection among 3 glycemic bands (<110 mg/dL,
110-144 mg/dL and 144-180 mg/dL). Target blood glucose levels of
144–180 mg/dL had significantly lower in-hospital mortality and risk of
sepsis or bloodstream infection in compared with >180 mg/dL (odds
ratio [OR]:0.82, 95 % credible intervals [CI]: 0.69-0.96; OR: 0.69, 95 % CI:
0.52-0.92, respectively). Our network meta-analysis revealed that target
blood glucose levels of < 110 mg/dL and 110–144 mg/dL were associ-
ated with a 6–7 fold higher risk of hypoglycemia, compared to targets
of 144–180 mg/dL and >180 mg/dL. There were no significant differ-
ences in the risk of hypoglycemia between < 110 mg/dL and 110–
144 mg/dL (OR = 0.76 (95 % CI: 0.49-1.11). There were also no signifi-
cant differences in the risk of hypoglycemia between and between
144–180 mg/dL and >180 mg/dL (OR = 1.0 (95 % CI: 0.30-2.70). The rank
probability analysis indicated that a target blood glucose level of 144–
180 mg/dL had the highest probability of being the best target blood
glucose level for reducing hypoglycemia and hospital mortality rates
and was the second best target level, following a target level of 110–
144 mg/dL, for reducing sepsis or bloodstream infection rates.
Conclusions: The results of our network meta-analysis indicate that tar-
get blood glucose levels of 144–180 mg/dL is an optimal target for balan-
cing the risks and benefits of insulin therapy among critically ill patients.
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Table 19 (abstract A507). qSOFA
qSOFA 0 1 2 3 p-value
n 97 384 574 296
APACHE II 13.5 +/− 1.2 16.2 +/− 0.8 20.4 +/− 0.7 24.8 +/− 1.3 <0.001
ICU stay 3.6 +/− 0.8 4.4 +/− 0.5 5.1 +/− 0.5 5.7 +/− 0.8 0.006
Mortality 12.4% 21.9% 35.5% 50.3% <0.001
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Introduction: Diabetes is a risk factor for the development and sever-
ity of critical illness, and the need for Intensive Care Unit (ICU) admis-
sion. Despite this, diabetes does not confer a greater risk of death for
those with critical illness within the index hospital admission. How-
ever, long-term outcomes in patients with diabetes who survive ICU
admission remain unknown.
Objectives: Our objectives were to evaluate the effect of diabetes on
both long-term survival rates and average years of life lost for pa-
tients admitted to ICU and who survived hospitalisation.
Methods: We evaluated all adult patients in South Australia between
2004 and 2011 who survived hospitalisation requiring admission to a
Public Hospital ICU. Demographic and admission data from the
Australia and New Zealand Intensive Care Society Adult Patient Data-
base were linked to population based datasets to match (i) Inter-
national Classification of Disease (ICD-10) codes for diabetes through
the Department of Health Integrated South Australian Activity Collec-
tion dataset, (ii) diabetes diagnosis in the national register (the National
Diabetes Service Scheme), and (iii) mortality through the Australian Na-
tional Death Index. Life years lost were calculated using age and sex
specific life-tables from the Australian Bureau of Statistics.
Data are presented as frequencies and proportions for categorical
variables and mean (standard deviation) or median [interquartile
range] for continuous variables. Between group comparisons were
performed by t-test, Wilcoxon rank-sum or Chi-square tests. Longitu-
dinal survival was analysed using Cox proportional hazards regres-
sion and average life years lost by linear regression.
Results: 5451 patients with and 17022 patients without diabetes
were included. Patients with diabetes were older (64.7 (14.9) vs 57.6
(19.7) years; p < 0.0001) and had higher illness severity on admission
to ICU (APACHE III 62 [48, 80] vs 54 [38, 72]; p < 0.0001). Crude mortality
rates [95%CI] were 105.5 [101.6-109.6] and 67.6 [65.9-69.3] per 1000
person years for those with and without diabetes respectively. Patients
with diabetes were more likely to die after hospital discharge (un-
adjusted hazard ratio 1.52 [95 % CI 1.46-1.59]; p < 0.001) (Fig. 38).
Diabetes remained an independent risk factor for death when ad-
justed for age, sex, site, indigenous status, APACHE III score and ad-
mission diagnosis (hazard ratio 1.17 [95 % CI 1.12-1.22]; p < 0.01).
Patients with diabetes also suffered a greater number of average life
years lost and this was most marked in the 4th and 5th decades of life
(Fig. 39).
Conclusions: Mortality and number of life years lost for ICU survivors
with diabetes is greater than for survivors without diabetes. Strat-
egies to improve outcomes for these patients should be evaluated.
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Introduction: Glycated hemoglobin A1c (HbA1c) is used to estimate
chronic glycemic control. Recently, several studies suggested that the
optimal glycemic control in acutely ill patients might be better being
adjusted according to the premorbid chronic glycemic control (1–3).
However, the majority of patients would not have been measured
the HbA1c-level prior to the acute illness. As the HbA1c-level would
be affected by the patients' conditions, HbA1c-levels during an acute
illness may not reflect the actual premorbid glycemic status. Only
limited research has been conducted so far to assess the value of
HbA1c-levels during the state of an acute illness to estimate the pre-
morbid glycemic control (4).
Fig. 38 (abstract A510).
Fig. 39 (abstract A510).
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Objectives: Assessment of the relationship between HbA1c during
the state of an acute illness and HbA1c levels measured within
30 days before an acute illness.
Methods: These are retrospective observational studies. The Ethics
Committee of the Kobe University Hospital approved this investigation.
The committee waived the need for informed consent concerning
studies involving the use of databases. We screened patients' HbA1c
levels that were measured within 30 days prior to an emergency sur-
gery, requiring general anesthesia. Among them, we selected patients
whose HbA1c levels were also measured on the day of the surgery.
Thus we obtained HbA1c-levels measured within 30 days before the
emergency surgery (preHbA1c) and on the day of the surgery (opeH-
bA1c). Those HbA1c-levels were measured in the same laboratory. The
correlations of the two HbA1c levels were assessed, using Pearson's
correlation coefficient. Agreement between the two HbA1c-levels was
assessed using the Bland-Altman approach.
Results: We studied 100 HbA1c-levels in 50 patients. The patients
were 66.8 years old in average. 31 of them were male patients
(62 %). 38 out of 50 patients (76 %) were required emergency cardio-
vascular surgery. PreHbA1c was measured 11.4 days before the emer-
gency operation. The average preHbA1c was 6.3 % and the opeHbA1c
was 6.2 %. There is a significant correlation between preHbA1c and
opeHbA1c (r = 0.83, p < 0.001). The mean difference between preHbA1c
and opeHbA1c was −0.1 % (95 % confidential interval; −1.2 % to
0.9 %). This difference of the two HbA1c did not correlate with the time
between the two measurements (r = 0.17, p = 0.29).
Conclusions: The HbA1c-level on the day of surgery is a useful
marker of premorbid glycemic control in patients requiring emer-
gency surgery.
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Introduction: Hypoglycaemia during ICU admission is associated with
adverse outcomes after discharge. In both health and patients with dia-
betes, acute hypoglycaemia triggers counter-regulatory responses in-
creasing cardiac contractility and accelerating gastric emptying. However,
antecedent hypoglycaemia attenuates endogenous catecholamine and
vagal responses to subsequent hypoglycaemia1. Accordingly, patients
who were hypoglycaemic during ICU may be unable to mount a physio-
logical response to hypoglycaemia once discharged from ICU.
Objectives: To determine the effects of antecedent hypoglycaemia on
cardiac and gastric responses to subsequent hypoglycaemia in health.
Methods: Ten healthy men (age 22.5 (1.0) years, BMI 23.8 (0.5) kg/m2)
were studied on two occasions, lasting 30 hours, separated by ≥ 6 weeks
and randomised to either 'control' (Day 1 (C1) - three euglycaemic clamps
at a blood glucose of 6 mmol/L followed day 2 (C2) - one hypoglycaemic
clamp at 2.8 mmol/L), or 'antecedent hypoglycaemia' (Day 1 (AH1) - three
clamps at blood glucose of 2.8 mmol/L followed by day 2 (AH2) - one
clamp at 2.8 mmol/L). Cardiac contractility was measured using fractional
shortening (FS) via 2D echocardiography on days 1 and 2 of the control
(FSC1 and FSC2) and antecedent hypoglycaemia (FSAH1 and FSAH2) pe-
riods. Gastric emptying (GE) was measured on day 1 and day 2, for both
control (GEC1 and GEC2) and antecedent hypoglycaemia (GEAH1 and
GEAH2) study periods, using scintigraphy, following ingestion of a stan-
dardised meal consisting of 100 g of minced beef labelled with 20 MBq
99mtechnetium-sulphur colloid. Radioisotopic data were acquired for
180 minutes. Data are mean (SE).
Results: Fractional shortening was greater (FSC2 vs. FSC1, P < 0.01)
and gastric emptying faster (GEC2 AUC vs. GEC1 AUC, P = 0.01) during
acute, single episode hypoglycaemia compared to euglycaemia.
When testing the effect of antecedent hypoglycaemia compared to a
single episode of hypoglycaemia, fractional shortening may be atten-
uated (FSAH2 vs. FSC2, P = 0.06), whereas gastric emptying was un-
affected (GEAH2 AUC vs. GEC2 AUC, P = 0.74) (Figs. 40 and 41).
Conclusions: In health, the increase in cardiac contractility during
acute hypoglycaemia may be affected by antecedent hypoglycaemia
whereas acceleration of gastric emptying during acute hypoglycaemia
does not appear to be affected by antecedent was unaffected. These
data suggest that antecedent hypoglycaemia during ICU may have
“downstream” effects after discharge.
References
1. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses
to subsequent hypoglycemia after 1 episode of hypoglycemia in
nondiabetic humans. Diabetes. Feb 1991;40(2):223–226
Grant acknowledgement
Dr Kar is supported by a Royal Adelaide Hospital A.R. Clarkson Scholarship.
Fig. 40 (abstract A512). Cardiac fractional shortening on day 1 and
day 2 of control and antecedent hypoglycaemia study periods
Fig. 41 (abstract A512). Gastric emptying curves on day 1 and day
2 of control and antecedent hypoglycaemia study periods
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Introduction: Plasmatic acid–base equilibrium remains a confusing
area more than a century after the Henderson-Hasselbalch equation
publication. However, a consensus exists concerning arterial carbon
dioxide pressure (pCO2) that would represent respiratory part of this
equilibrium 1. Stewart described this parameter as "independent", in
contrast to "dependent" parameters, e.g. pH and HCO3
− 2.
Objectives: The primary objective of this experimental trial is to dem-
onstrate that lactic acid infusion increase pCO2. This would be incon-
sistent with Stewart approach.
Methods: After local ethical committee approval, 9 anesthetized, cura-
rized and mechanically ventilated piglets were studied. Lactic acid infu-
sion (0.33 mmol.kg−1.min−1) was administered. Each 3 minutes, an arterial
gasometry was done. Each minute, the following parameters were col-
lected: mean arterial pressure (MAP), cardiac output measured by trans-
pulmonary thermodilution (CO), pulse oxymetry (SpO2) and end-tidal
CO2 (EtCO2).
Bicarbonate (HCO3
−) was calculated like this: HCO3
− = 0.03*pCO2*10
pH-
6.1. Total CO2(tCO2) was calculated like this: tCO2 = HCO3
− + 0.03*pCO2
The primary endpoints were pCO2 increase and tCO2 stability.
To test the hypothesis of normal distribution, Shapiro Wilk test was
applied. The p values were obtained from ANOVA analyses. p < 0.05
was considered as significant.
Results: The results were: a decrease in pH (p < 0.001) (Fig. 42a), an in-
crease in pCO2 (p = 0.002) (Fig. 42b), a decrease in HCO3
− (p = 0.015)
(Fig. 42d) without significant alteration in tCO2 (p = 0.08) (Fig. 42c). We
also observed: an increase in EtCO2 (p = 0.001) (Fig. 42e) and lactatemia
(p < 0.001) (Fig. 42f). CO (p = 0.052), MAP (p = 0.506) and SpO2 (p = 0.905)
were not significantly altered.
Conclusions: This in vivo metabolic acidosis model with stable mi-
nute ventilation shows an increase in pCO2 without significant alter-
ation in tCO2. Although these results were biochemically predictable,
they question one of the basements of Stewart approach, that con-
sidered pCO2 as an independent parameter. In our study, pCO2
seems a dependent parameter. tCO2, too often neglected parameter,
seems an independent parameter.
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Introduction: Lactate, acetate and gluconate are anions used in
balanced resuscitation fluids of which lactate and acetate are
considered bicarbonate precursors. Several studies have demon-
strated that balanced fluids are commonly used for volume ex-
pansion of critically ill patients who may also have impaired liver
function (1,2). Little is known of the metabolic fate of this anions
when the primary metabolising organ is compromised. Moreover,
the role of gluconate embedded in PlasmaLyte in terms of acid–
base control is unknown.
Fig. 42 (abstract A513).
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Objectives: This study investigated the role of the liver in the
efficacy of balanced and unbalanced solutions to correct acid–
base alterations and renal haemodynamics and microvascular
oxygenation in a rat model of resuscitated hemorrhagic shock
(HS).
Methods: Ringer's Lactate (RL), Ringer's Acetate (RA), Plasma-Lyte
(PL) or normal saline (NS) were administered following HS in the
presence or absence of a 70 % partial liver resection (PLR). Renal
haemodynamics and microvascular oxygenation (by oxygen-
dependent quenching of phosphorescence) were measured as
well as levels of lactate, gluconate and acetate in plasma and
urine. Kidney wet and dry weighing was also assessed. Results:
PLR resulted in increased liver enzymes compared in control and
HS groups (p < 0.01). HS decreased systemic and renal haemo-
dynamics and reduced microvascular kidney oxygenation to 20
and 14 mmHg for cortex and medulla respectively, associated
with lactic acidosis (p < 0.01). Resuscitation with balanced fluids
did not fully restore renal oxygenation (p < 0.01). RA and PL in-
creased bicarbonate levels (15.5 ± 1.1 and 16.4 ± 1.6 vs 13.4 ± 2.0
and 11.5 ± 2.5 mmol/L) and restored pH better than RL or NS
(7.29 ± 0.09 and 7.30 ± 0.04 vs 7.22 ± 0.12 and 7.14 ± 0.09) re-
spectively in the PLR experiment (p < 0.01). PLR caused an in-
crease in plasma gluconate after PL resuscitation (10.4 ± 2.8 vs
13.8 ± 5.1 g/L p < 0.05).
Conclusions: Acetate buffered balanced fluids show superior buff-
ering effects than RL and NS. Gluconate is partially metabolized
by the liver although it does not contribute to acid–base control
because of large excretion in urine. Acetate is metabolized
regardless of liver function and may be the most efficient bicar-
bonate precursor. Lactate infusion tends to overwhelm the me-
tabolism capacities of the residual liver. NS seemed to be the
most unsuitable fluid when compared to balanced fluids, even in
cases of liver failure.
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Fig. 43 (abstract A514). Plasma and urine gluconate levels after fluid
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Introduction: Recent evidence suggests that a more liberal glycemic
control (target blood glucose level between 10 and 14 mmol/l) may
be beneficial in patients with diabetes adapted to chronic hypergly-
cemia (glycated hemoglobin A1c [HbA1c] >7 %)1. However, whether
such liberal strategies leads to relative insulin deficiency, accelerated
ketone body production and ketoacidosis is uncertain. Accordingly,
we conducted a prospective observational study to explore the inci-
dence of ketosis, ketonuria and ketoacidosis during liberal glucose
management of critically ill diabetic patients.
Methods: We studied 60 critically ill diabetic patients treated accord-
ing to a liberal glucose protocol targeting a blood glucose level
(BGL) between 10-14 mmol/l. We performed daily measurement of
bedside blood 3-beta-hydroxybutyrate (β-OHB) and semi-quantitative
urine ketones on ICU admission and on the following mornings dur-
ing the ICU stay, for a maximum of 10 consecutive days.
Results: Median (IQR) blood ketone level on admission was 0.3 (0.1,
0.8) mmol/l. Ketoacidosis was rare (3 %), but some level of ketosis (β-
OHB ≥ 0.6 mmol/l) was found in 38 patients (63 %) at some stage
during their ICU stay. However, there was no significant difference in
severity or prevalence of ketonemia and ketonuria among patients
with BGL above (permissive hyperglycemia) or below 10 mmol/l. On
multivariate linear regression there was no association between
blood ketone levels and BGL, HbA1c, lactate levels or APACHE III
score.
Conclusions: Liberal glycemic control in critically ill, predominantly
type 2, diabetic patients itself does not appear to lead to increased
ketogenesis. We found no difference in prevalence and severity of
ketonemia between patients with or without permissive hypergly-
cemia. Furthermore, severity of ketosis was unrelated to blood glu-
cose levels.
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Introduction: Reducing glucose variability (GV) is one of the aims of
blood glucose (BG) control as it is an independent predictor of ICU
and hospital mortality. Continuous glucose monitoring (CGM) might
help to decrease GV by providing frequent measurements of glucose
and information about glucose trend. However, the metrics of GV
might differ according to the frequency of measurement.
Objectives: To evaluate the correlation between GV indices derived
from intermittent glucose values and from CGM.
Methods: A correlation between GV indices derived from intermit-
tent readings (blood gas analyser [BGA]) and those derived from
CGM was searched from data recorded in the same patients over the
same period of time.
Data from patients recruited for the MANAGE (Manual vs. Automated
Monitoring Accuracy of Glucose) II trial between July 2012 and April
2014 were analysed. Inclusion criteria were age >18 years, expected
ICU length of stay of ≥ 3 days, an Acute Physiology and Chronic
Health Evaluation (APACHE) II ≥ 10, hyperglycemia >150 mg/dl at the
time of admission and need for a central venous catheter, one lumen
of which was connected to Optiscanner® (Optiscan, Hayward, CA), a
validated mid-infrared spectroscopy method of glucose measure-
ment. GV indices (standard deviation [SD], glucose variability index
[GVI], glucose lability index [GLI], mean amplitude of glycemic excur-
sions [MAGE], J-index and maximal glucose change [MGC]) were cal-
culated from blood glucose (in mg/dl) measured intermittently by
BGA and by CGM over the same period. Pearson´s correlation coeffi-
cient between intermittent and CGM values was calculated for each
metric. A Bland-Altman plot with bias (mean difference between the
device and BGA measurements) and limits of agreement (bias ± 1.96
x standard deviation of the bias) was used to analyse the agreement
between the device and the BGA results.
Results: Data from 88 patients were analysed. For each index, there
was a significant correlation (p < 0.0001) between values calculated
from intermittent readings and CGM. However, correlations were
higher for J-index (0.96), SD (0.95) and GVI (0.9) than for MGC (0.88),
GLI (0.82) and MAGE (0.77). The mean difference and limits of agree-
ment (lower limit, upper limit) observed in Bland-Altman plot were
0.01 (−0.10, 0.12) for GVI, −0.43 (−34.34, 33.47) for MGC, −0.57
(−11.90, 10.76) for SD, 0.76 (−6.23, 7.74) for MAGE, −5.59 (−110.82,
99.64) for GLI and −1034.74 (−13524.05, 11454.57) for J-index.
Conclusions: The most reliable GV indices (highest correlation and
lowest bias) are GVI and SD. These are the least influenced by the
timing of measurement.
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Introduction: Each of the three domains of dysglycemia, i.e. hyper-
glycemia, hypoglycemia and high glycemic variability is associated
with poor outcome. The glycemic control with insulin to maintain
blood glucose (BG) within a narrow range as currently recommended
involves repeated checks of BG. Near-continuous intravascular moni-
toring (CGM) can represent a useful tool to facilitate and to improve
glycemic control.
Objectives: To assess the effects of the use of CGM on the quality
and safety of glycemic control.
Methods: Adult critically ill patients expected to stay at least 3 days
in the department of intensive care of the Erasme University Hospital
in Brussels, Belgium and presenting an hyperglycemia (BG > 150 mg/
dl) up to 6 hours after admission and / or ongoing insulin therapy
with a patent access to a large peripheral vein were equipped with a
catheter connected to a enzymatic CGM sensor (GlucoClear®, Ed-
wards Lifesciences, Irvine, CA). Two of the 4 units of the department
were randomized to adjust insulin infusion rate to keep BG between
90 and 150 mg/dl (dynamic scale) using the values displayed on the
monitor (unblinded group, U). In the 2 other units (blind group (B)),
no value was displayed on the screen. The quality of glycemic con-
trol assessed by the proportion of time in range (TIR) and the safety
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assessed by the percentage of time spent below 70 mg/dl (TB70)
were calculated from the values recorded by the CGM for each day
and for the whole study period and compared between the two
groups by ANOVA.
Results: Seventy-seven eligible patients (age 61 ± 8 years, 56 males,
medical admission 74 %, APACHE II 24 ± 5, ICU mortality 23 %) con-
sented to participate and were included in the U group (n = 39) or the B
group (n = 38). 43107 BG values (22721 in the U group and 20386 in the
B group) were recorded during 1 day (n = 77), 2 days (n = 64) or 3 days
(n = 40). TIR did not differ between groups (70 ± 27 (U) vs 73 ± 23 % (B)),
nor for any of the days of recording. However, the TB70 was lower in
the U group than in the B group (0.4 ± 0.9 vs 1.6 ± 3.4 %, p < .05).
Conclusions: The use of a CGM-based strategy improved the safety
of glycemic control in a mixed population of ICU patients with stress
hyperglycemia.
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Introduction: It is well known that poor preoperative blood glucose
control is associated with poor postoperative blood glucose control
and postoperative complications. Postoperative hyperglycemia is
common in patients underwent cardiac surgery, especially in those
with a preoperative elevated HbA1c. The STG-55 (Nikkiso CO., Ltd.,
Tokyo, Japan) is a newly developed and commercialized computer
regulated continuous blood glucose management apparatus.
Objectives: To compare the usefulness and the workload of ICU
nurses of the STG-55 with the conventional sliding scale method in
diabetic patients underwent cardiac surgery.
Methods: The study was approved by the Institutional Review Board,
and written, informed consent was obtained from all participants.
This study included 28 patients underwent elective cardiac surgery
with preoperative HbA1c > 6.0 %. The management of blood glucose
was performed from immediately after admission to the ICU for two
research days. The patients were randomly assigned to control blood
glucose levels with the STG-55 group (n = 16) or sliding scale
method, SS group (n = 12). The usefulness of blood glucose manage-
ment defined the incidence of hyperglycemia (blood glucose >
180 mg/dL), hypoglycemia (<80 mg/dL), and the maximum glycemic
variability (maximum blood glucose level minus minimum blood glu-
cose level). The workload of ICU nurses defined the number of blood
samplings for the management of blood glucose and the number of
calls made to the physician.
Results: The two groups were comparable with respect to age, gen-
der, height, weight, duration of surgery, the amount of blood loss
during surgery and the preoperative HbA1c. The blood glucose levels
determined STG-55 and ABL3 acid–base laboratory analyzer were
strongly correlated (R2 = 0.936), with nearly identical values. The inci-
dence of hyperglycemia and hypoglycemia was significantly lower in
the STG-55 group (1.9 ± 1.3 vs 6.7 ± 4.9 times/day, p < 0.001; 0.2 ± 0.1
vs 5.8 ± 6.0 times/day, p < 0.001) than SS group. The maximum gly-
cemic variability was also significantly lower in the STG-55 group (46
± 32 vs 283 ± 165 mg/dL, p < 0.01). The frequency of blood samplings
(4.2 ± 3.7 vs 21.5 ± 14.1 times/day, p < 0.01), and the number of calls
made to physician (2.1 ± 2.2 vs 6.9 ± 5.4 times/day, p < 0.05) were sig-
nificantly lower in the STG-55 group than SS group.
Conclusions: Use of the STG-55 in the ICU contributed to improved
blood glucose management and reduced workload of ICU nurses
compared to using the sliding scale method.
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Introduction: Acid–base status in a body fluid is physically determined
by several “independent variables”. These are: PCO2, the “strong ion dif-
ference” (SID) and all the strong anions (among them is Cl-), and con-
centrations of nonvolatile weak acids (Atot). Normal acid–base status is
achieved when the independent variables have normal (empirically
established) values. The Simplified Fencl-Stewart´s Method can be used
at the bedside of the patient and is more accurate for the assessment
of acid–base balance. Omron, E. developed a physicochemical model
of the projected change in standard base excess (SBE) as a conse-
quence of infused crystalloid solutions of common use (isotonic saline
and balanced fluids); unfortunately this was a clinical simulation at
standard physiological state. In addition, Kaplan, L. evaluated acid–base
status after the administration of balanced fluids in trauma patients.
Nevertheless, to our knowledge, there are no other clinical trials that
evaluate de administration of other types of balanced fluids.
Objective: To assess acid–base status of critically ill patients after the
infusion of seven different types of balanced solutions
Methods: This was a retrospective, observational and descriptive
study, conducted in an intensive care unit of a tertiary care hospital.
We included all patients above 18 years old admitted to this depart-
ment from January 2014 to December 2015. We evaluated the effects
on acid–base balance after the infusion of seven different solutions:
1) Hartmann + 17.8 mEq/L sodium bicarbonate (NaHCO3) (SID 45.8),
2) Hartmann + 8.9 mEq/L NaHCO3 (SID 36.9), 3) Hartmann + 15 mEq/L
NaHCO3 (SID 43), 4) Hartmann + 25 mEq/L NaHCO3 (SID 53), 5) Hart-
mann (SID 28), 6) normal saline 0.45 % + 77 mEq/L NaHCO3 (SID 75),
and 7) dextrose solution 5 % + 154 mEq/L NaHCO3 (SID 154). Arterial
blood gases, serum electrolytes, and proteins were measured in the
same blood sample. Also SIDa, SEDe, SIG, ATOT, pCO2, change in
standard base excess (SBE), pH, [HCO3], [Na]p and SOFA were calcu-
lated. pH, SBE and PCO2 were estimated with the ABL8000 FLEX
blood gas analyzer. Data are mean ± SD or percents. We used data
analysis package SSPS.
Results: Ninety-nine patients were included. Of these, 54 % were
women and 45 % men. The most used solutions were Hartmann
(25 %), Hartmann + 8.9 mEq/L NaHCO3 (21 %), and Hartmann +
25 mEq/l NaHCO3 (18 %). Before the infusion, SIDe was under
30 mEq/L in 30 % of patients and above in 23 % of them. The effect
on the SIDe was significant before the infusion of different solutions
(p 0.01), SIDe > 30 ± 8 mEq/L. No metabolic alkalosis or greater de-
crease of SIDa/SIDe was observed.
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Conclusions: This study assesses additional varieties of fluids that
have a different SID in the clinical setting. No major acid–base distur-
bances were observed.
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Introduction: Severe acid–base balance abnormalities are frequently
observed in critically ill patients at the intensive care unit (ICU) and
can be present in different patterns. Acid–base profiles of critically ill
cirrhotic patients with acute-on-chronic liver failure (ACLF) have not
been investigated.
Objectives: To assess disturbances of acid–base status in critically ill
patients with ACLF in comparison to patients without.
Methods: Preliminary analysis of patients admitted to medical ICU at
the Medical University of Vienna. Presence of cirrhosis and ACLF, re-
spectively, was assessed, and blood for laboratory- and blood gas
analysis was drawn from an arterial line. Reference values were ob-
tained from blood samples of healthy volunteers (n = 14). Mortality
was assessed on site.
Results: A total of 615 patients were studied, 142 of these patients
had underlying liver cirrhosis. One hundred twenty-eight patients ful-
filled criteria of ACLF. Median SOFA score of the total cohort was 10
(IQR 6–13), median SAPS II score 53 (IQR 38–70) and median age 60
(IQR 49–69) years.
Patients with liver cirrhosis showed a marked metabolic acidosis
compared to critically ill patients without (Base excess (BE) -6.8 (IQR
−12.3 to 0.8) mmol/l vs. -1.5 (IQR −5.2 to 2.7) mmol/l, p < 0.001). Ana-
lysis of the BE subcomponents revealed that this acidosis was primar-
ily attributable to hyperchloremia (BECl = −4.6 (IQR −7.5 to 0.8) mmol/
l), lactate (BELactate = −2.7 (IQR −6.1 to −1.0) mmol/l), and unmeasured
anions (BEUMA = −1.6 (IQR −6.2 to 1.8) mmol/l). Interestingly, hyper-
chloremic acidosis antagonized by hypoalbuminemic alkalosis was
found in critically ill patients with and without liver disease. In pa-
tients with cirrhosis, we observed respiratory alkalosis (partial pres-
sure of arterial carbon dioxide (PaCO2) = 36.4 (IQR 28.5 - 44.5) mmHg)
counteracting metabolic acidosis.
With progression to ACLF, the compensatory mechanisms (hyperven-
tilation and hypoalbuminemia) became insufficient resulting in pro-
gression of metabolic acidosis. Accordingly, BE in patients with ACLF
grade 3 was −10.1 (IQR −17.4 to −3.6) mmol/l with a resulting pH of
7.29 (IQR 7.14 to 7.41). Lactate (BELactate = −3.6 (IQR −8.3 to −1.5)
mmol/l) and unmeasured anions (BEUMA = −3.9 (IQR −8.9 to 0.9)
mmol/l) were main contributors to metabolic acidosis in ACLF grade
3. The extent of metabolic derangement attributable to lactate and
unmeasured anions, respectively, in patients with cirrhosis was asso-
ciated with 28-day-mortality (Fig. 44).
Conclusions: Metabolic acidosis is a common feature of cirrhosis and
ACLF at the ICU and is more severe compared to patients without
cirrhosis. Acidosis in ACLF is primarily attributable to lactate and un-
measured anions. Although hyperchloremic acidosis did contribute
to metabolic acidosis in critically ill patients, we found no clinically
relevant difference in chloride-related acidosis between patients with
and without liver disease.
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Introduction: Liver transplantation is the treatment of choice in end
stage liver disease, but significant mortality rate and organ shortage
has resulted in multiple attempts to chose good donors and appropri-
ate recipients. (1) The Stewart´s approach is a new concept in critical ill
patients and can identify occult acid–base disturbances. (2,) Although
study on Stewart´s approach were increased in recent years but its
diagnostic and prognostic advantages remain contraversial. (3)
Objectives: Our primary objective was correlation between SIG
(strong ion difference) in donor and graft function. Secondary object-
ive was comparison between SIG and marginal graft criteria as a pre-
dictor for liver transplantation outcome.
Methods: In 51 donors, marginal graft criteria were determined. SIG
in all cases were calculated and we followed mortality and complica-
tions in recepiants at 72 hr,1 week, 1 month after transplantation.
Results: 54.9 % of livers were marginal. Mean MELD Score in recipi-
ents was 21.25 ± 5.95 . According to calculated SIG value, recipients
were divided into SIG > 10 and SIG < 10. This study showed that no
Fig. 44 (abstract A520). Kaplan Meier Plot: UMA means
unmeasured anions
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difference was seen in these two groups(pvalue; 0.154) .Also no dif-
ference was seen in two groups.(marginal and non-marginal)(Pvalue
= 0.245)Conclusions: In this study, SIG was not a good predictor for
liver transplantation outcome.
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Introduction: Despite recent medical advances and improved sur-
vival, patients with haematological malignancies (HM) still have a
high mortality, and end-of-life (EoL) care has become an integral part
of their treatment.1 Evidence suggests less palliative care involve-
ment and limited advanced care planning in patients with HM, prob-
ably because of the unclear transition between curative and
palliative phases of their disease.1,2 Critical Care Outreach Services
(CCOS) have been shown to participate in more than 50 % of EoL
planning as part of their everyday workload.3
Objectives: To evaluate the role and input of CCOS in EoL care of pa-
tients with HM.
Methods: We retrospectively reviewed the records of all patients
with HM from January 2014 to October 2015 who were referred to
CCOS in a London specialist hospital. Variables analysed included
age, diagnosis, ICU admission, time spent by CCOS, interventions pro-
vided and in-hospital mortality.
Results: There were 145 patients who were reviewed on 257 differ-
ent occasions. Their age ranged from 18 to 84 years (median 56) and
their diagnoses are shown in Fig. 45.
Of those, 16/145 (11 %) patients were identified as palliative; 81 % of
them received EoL care on the ward. National Early Warning Scores
at referral ranged from 2 to 10 (median 7). A total of 723 days was
spent by CCOS in reviewing patients with HM, with 146 days (20 %
of their clinical time) spent on palliative patients alone (median time
5.5d vs. 3d for non-palliative patients). Overall, in-hospital mortality
among these patients was 81 %.
The services provided by CCOS to palliative patients were mainly fa-
cilitation of symptom control (67 %) and/or support of ward teams in
making treatment limitation decisions (78 %). High Flow Nasal Can-
nula Oxygen (HFNC) was initiated in 38 % of patients for symptom
control, which was deemed successful in all but 2 patients.
Conclusions: A considerable part of the CCOS workload is spent on
supporting the management of palliative haematology patients. In-
volvement in alleviating symptoms and initiating EoL discussions fea-
tures strongly in the interventions requested by the ward teams. The
significant use of HFNC therapy for symptom control that was ob-
served in this population also warrants further investigation.
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Introduction: Professionals working in intensive care and palliative units
(ICUs/PCUs) care for patients with life-threatening diseases, make ethical
decisions, and provide end-of-life care. However, while palliative care aims
to reduce suffering, intensive care has a major focus on saving lives.
Objectives: To identify and compare the experiences of ICU and PCU
healthcare professionals related to: contact with dying and death, mak-
ing of ethical decisions and communication and delivery of bad news.
Methods: Mixed approach, combining quantitative (questionnaire on
experiences in the work context) and qualitative ones (interviews
with doctors and nurses). 10 ICU and 9 PCU participated in this
study. 392 professionals completed the survey; 28 were interviewed.
A descriptive quantitative analysis was performed; the chi-square test
was used to analyse the association between variables (significance
level of p < .05). Interviews were subject to content analysis.
Results: In the week prior to survey completion, more professionals
working in ICUs reported a patient's death; this was not statistically
significant. The experience most mentioned by the professionals of
both types of units during interviews was caring for patients nearing
death. In the week before completing the questionnaire, the most
common ethical decision was palliative/terminal sedation; this was
more, often in ICUs (27 % vs. 12 %; p = .004). In the day of question-
naire completion, the most frequent ethical decision was also pallia-
tive sedation. Though this decision was more frequent in ICU,
Fig. 45 (abstract A522).
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statistical significance was not reached (p = .440). The communication
of the diagnosis/prognosis to the patient, either in the week before
or in the day of questionnaire completion was more frequent in
PCUs (45 % vs. 29 %, p = .005; 22 % vs. 12 %, p = .026, respectively).
Communication about the diagnosis/prognosis with the family in the
week before survey completion was held with equal frequency by
professionals from both contexts (58 % of professionals). Although
not reaching statistical significance (p = .303), more professionals
from PCU proceeded to communication with family about the
diagnosis and prognosis (32 % vs. 26 %) in the survey day. From the
analysis of the interviews, it was denoted that it were mainly profes-
sionals of PCU who referred to the communication on the diagnosis/
prognosis, both with the patient as with the family.
Conclusions: The workplace experiences in ICU and PCU are, despite
some differences, guided by similarities. Caring for patients with life-
threatening situations and imminent death and the need to make
ethical decisions occur frequently in both contexts. The communica-
tion about the diagnosis/prognosis occurs more often in PCU. This
highlights the need for integrating communication strategies of pal-
liative care, in intensive care.
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Introduction: Complex elective surgery is increasingly provided to an
aging population with heightened risk for prolonged ICU stay or death.
While risks of surgical and anaesthetic procedures are routinely dis-
cussed preoperatively in the process of obtaining informed consent,
the patients' preferences in case of unfavourable ICU outcomes are
rarely discussed and most critically ill patients do not have advance di-
rectives. If patients at risk of a prolonged ICU stay or death could be
identified preoperatively, this would provide an opportunity to make
their preferences known in a timely and adequate manner.
Objectives: To identify the predictive validity of routine pre-operative risk
assessment for an unfavourable ICU course (ICU stay > 24 hours or death),
and to assess the prevalence of advance directives in these patients.
Methods: Among all 13437 elective adult surgical cases seen in a ter-
tiary university hospital´s pre-operative anaesthesiology clinic in
2014, 1832 consecutive cases were drawn. Data were extracted from
hospital and ICU databases, including patient demographics, pre-
operative American Society of Anesthesiologists (ASA) classification,
length of ICU stay, mortality and presence of advance directives. A
receiver operating characteristic analysis was conducted to test the
predictive validity of ASA for a) having an ICU stay > 24 h and b)
dying in the ICU or afterwards. Optimal cut-offs were identified by
maximum Youden's J statistic.
Results: Among 1832 patients, 937 (51 %) were male, median age
was 63 years (interquartile range 49–74), planned procedures were
mainly from General, Trauma, Cardiothoracic, Eye, Gynecological,
Urological or ENT Surgery. Pre-operatively, patients were classified
into ASA risk classes (15 %, 41 %, 40 % and 4 % into ASA 1–4, re-
spectively). Postoperatively, 504 (28 %) patients were admitted to the
ICU. Of these, 373 (74 %) had an ICU LOS > 24 hours and 68 (13 %)
died in the ICU or afterwards. Among patients with an ICU stay >
24 hours, presence of an AD was documented in 49 (15 %) and
power of attorney for a legal proxy in 71 (22 %). Pre-operative ASA
classification predicted an ICU stay >24 h with an area under the
curve (AUC) of 0.79, and death in the ICU or afterwards with an AUC
of 0.85. The optimal cut-off for both adverse outcomes was ASA ≥ 3.
For ICU stay >24 h sensitivity was 0.85, specificity was 0.67; for death
in or after ICU sensitivity was 0.93 and specificity was 0.58.
Conclusions: Preoperative ASA classification with a cut-off of ≥ 3 has
a good predictive validity to identify the risk of prolonged ICU stay
or death in patients undergoing elective surgery. Such risk stratifica-
tion could be useful to initiate advance decision-making at the time
of the pre-operative work-up of these patients and thus increase the
prevalence of adequate ADs in the ICU.
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Introduction: Studies have shown variations in practice across hospitals
regarding treatment-limitations and mortality for brain-injured patients.
Objectives: To study treatment-limitations and associated mortality
in a Norwegian trauma hospital and documentation of ethical as-
pects such as presence of advanced directives, dialogue with fam-
ilies, multi-team discussions, reasons and considerations behind
decisions, conflicts and involvement of clinical ethics committees.
Methods: A retrospective study of a 2-year cohort of severe head in-
jured patients admitted 2011–12 to Oslo university hospital, Norway.
Trauma registry data were combined with data from medical records.
For data validation a definition guide for study variables was developed.
Adults with abbreviated injury score head 4,5,6 were included (n = 579).
Results: Eighty-five % of all patients were admitted to ICU. Treatment
limitations were identified in 17 % of cases (101 patients). Decisions
were: Withholding organ support (12 cases), withholding surgery (52
cases), withdrawing intracranial pressure-targeted therapy (23 cases),
DNR-orders (44 cases), no-escalation of treatment (19 cases) or with-
drawing organ support (44 cases). For some patients initial decisions
were changed (19 cases) or revoked (3 cases) along the dynamic
treatment trajectory. Twenty-six patients with devastating brain in-
jury progressed to brain death. No patients had advanced directives.
Dialogue with family was documented in most cases (98). No major
conflict between families and treatment team was identified and there
was no involvement by CEC. Rationale behind decisions was identified
as medical only in 80 % of cases. Treatment-limitations followed situa-
tions categorized as futile (59 cases) or “potentially inappropriate treat-
ment” (42 cases) (1). The overall 30-day mortality was 16 % (35 % for
patient with GCS < 9 and 7,5 % for patients with GCS >8). Treatment-
limitations were identified in 93 % of cases of in-hospital death. In-
hospital mortality was 73 %, 30-day mortality 82 % and 2-year mortality
93 % in the treatment-limiting group (n = 101 patients, 25 patients
were transferred to other facilities with limitations). In-hospital mortality
was 1 %, 30-day mortality 2 % and 2-year mortality 8 % for patients
without limitations made at the trauma hospital (n = 478).
Conclusions: Treatment limitations are common in patients with
traumatic brain injury and were closely associated with in-hospital
death. Withholding or withdrawing life-sustaining therapy in this
early phase of hospitalization was primarily based on the medical
situation and at the discretion of the physician. Whether patients'
values and preferences were adequately addressed or had an impact
on decisions (when appropriate) remains unclear.
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Introduction: This study assessed opinion of healthcare workers
about consent and acceptable outcome in the context of decom-
pressive hemicraniectomy for 'malignant cerebral artery infarction”
Method: Seven Hundred and seventy three healthcare workers at
the two major public neurosurgical centres in Western Australia par-
ticipated in this study. Participants were asked to record their opin-
ion regarding consent and acceptable outcome based on the
Modified Rankin Score (mRS). They were then given a detailed ana-
lysis of the evidence for clinical efficacy of the procedure and an ex-
planation of the “disability paradox”. They were then asked to
reconsider their initial responses.
Results: Of the 773 participants included in the study 407 (52.7 %)
initially felt that they would provide consent for a decompressive cra-
niectomy as a life-saving procedure but only a minority of them con-
sidered mRS 4 or 5 as an acceptable outcome (for mRS ≤ 4: n = 67,
8.7 %; for mRS = 4: n = 57, 7.4 %). After introducing the concept of
the disability paradox and the evidence for the clinical efficacy of de-
compressive craniectomy, more participants were unwilling to accept
decompressive craniectomy (18.1 % vs. 37.8 %) but, at the same
time, more were willing to accept mRS ≤ 4 as an acceptable outcome
(for mRS ≤4: n = 92, 11.9 %; for mRS = 4: n = 79, 10.2 %).
Conclusion: Most participants felt that survival with dependency
to be unacceptable. However, many would appear to be willing
to provide consent for surgery in the hope that they may sur-
vive with some degree of independence.
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Objective: To analyze why patients who are assessed by an intensivist
physician for some reasons are not admitted to ICU. Also we want to
find out what happened to this patients after intensivist evaluation.
Design: Observational and prospective study during 12 consecutive
months.
Scope: Second level Hospital with 550 beds and 18 ICU boxes.
Method: We searched daily for patients who were assessed but not ad-
mitted to ICU during 12 consecutive months. We write down medical
record number, which of the hospital departments asked for that ICU
evaluation and the reason why the patient was not finally admitted to
ICU (low severity, life-sustaining treatment limitation or not ICU bed
availability). We follow up those patients until hospital discharged, find-
ing either decease, hospital discharge or later ICU admission.
Results: 1297 patients were assessed but not admitted to ICU.
The reasons for not admission were low severity in 736 patients
(56.8 %), life-sustaining treatment limitation in 459 patients
(35.5 %) and no ICU bed availability in 102 situations (7.9 %).
Main hospital departments that asked for assessment without
consequent ICU admission were Emergency (N = 899, 69 %), In-
ternal Medicine (N = 140, 10.8 %) and General Surgery (N = 62,
4.8 %). Life-sustaining treatment limitation decision was mostly
taken in Emergency Department (N = 253) and Internal Medicine
(N = 83), 166 cases survived and were discharged from hospital
(36 %). 736 patients were dismissed because of low severity, but
91 were finally admitted to ICU later (12.3 %) and 125 patients
died (16.9 %). 102 patients were not admitted because of no ICU
bed availability, majority were treated in Observation Room in
Emergency Department (N = 94, 92.2 %); 29 of them were admit-
ted to ICU later (28.4 %) and 20 died (19.6 %).
Conclusions: From these results we conclude that maybe the lack
of beds in ICU can generate a belated admission to ICU and
higher mortality rate in recoverable patients. One third of pa-
tients with a life-sustaining treatment limitation decision finally
survive the hospitalization. Also we conclude that a considerable
amount of intensivist clinical assistance during the shifts takes
place outside de ICU.
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Introduction: Addressing the quality of end of life care has become
an important focus of research and patient management in the ICU.
Although quality of care and support for patients who die in the ICU
and their families are well described, a little is known about the deci-
sion making process and the quality of care provided for patients
dying outside the ICU.
Objectives: To characterize the care for patients dying during the last
hospitalization in terms of circumstances of death, provided palliative
care, medical decision making, nurses perceptions and family experience.
Methods: A prospective observational cohort study in two ter-
tiary university centers in Prague, Czech Republic. Data from the
patient documentation and semi-structured questionnaire with
the attending physician and the nurse present at the moment
of death were collected. A semi-structured phone interview with
the family member was held 3–6 months after the death. The
study has received an IRB approval.
Results: Among 44236 patients hospitalized between February 2015 and
February 2016, 1097 has died, of them 926 patients (86,4 %) were en-
rolled in the study (42.1 % in the ICU and 57.9 % at wards). The basic pa-
tients´ characteristic is presented in the Table 20. The majority of deaths
in the hospitals were expected and hence not preceded by a cardiopul-
monary resuscitation. The mention of a poor prognosis was documented
in a majority of cases, the DNR and DNI being the most frequent type of
treatment limitation both in ICU and wards. The treatment limitation was
communicated with the family fare more often than to the patient (81 %
and 31 %, respectively). Patients did not have an advance directives
document, nor were their treatment preferences documented during the
last hospitalization (0,5 and 1,62 %, respectively). The various aspects of
treatment limitations in the ICU vs. wards are presented in Table 21.
Conclusions: This is the first large prospective study comparing the de-
cision making process and the perceptions of clinicians and family
members of patients dying in a tertiary care hospital. The study shows
an insufficient interdisciplinary and intra-team communication with dis-
crepancies between the documented and the agreed treatment limita-
tions. Furthermore, a difficult communication with patients and their
families in final phases of patients´ lives suggests a gap between the
care provided and the patients preferences regarding the end-of-life,
although these are known to be key aspects of good end-of-life care.
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Objective: To compare the different strategies of analgesia and sed-
ation applied in control cardiac death donors (DCD) versus non-
donors after limitation of life sustaining treatment (LLST) thru ter-
minal extubation (TE).
Methods: Retrospective study (January 2012 - March 2016) in a
Spanish tertiary hospital. We studied all patients that underwent
LLST thru TE. Demographic factors, general patient characteristics
(comorbidities, diagnosis upon ICU admission, APACHE II on ad-
mission and SOFA in the previous 24 h before TE), ICU length of
stay and timing from TE to cardiac arrest together with their
donor/non-donor condition were recorded. We also analyzed the
different types and doses of analgesic and sedation drugs (mor-
phine, fentanyl, remifentanyl, propofol and midazolam) and the
different strategies used (bolus administration, increase of the in-
fusion rate or both). In order to simplify dosage analysis we used
the intervals previously described by other authors1. Statistical
analysis with c2 and Mann–Whitney U test. Statistical significance
p < 0,05.
Results: During the period studied we recovered a total of 68
patients with LLST thru TE that were divided in two groups:
DCD (group A, n = 26) and non-donors (group B, n = 42).
Demographic data and general characteristic are described in
Table 22.
There were no statistical differences regarding the different types
and doses of analgesia and sedation, and the different strategies
used in group A vs group B (Table 23 and Fig. 46). Although none of
the following reached statistical significance we found that the num-
ber of patients receiving doses described as superior to standard
accounted for an important percentage in both groups, and that
there was a higher rate of bolus administration followed by an in-
crease in infusion rate un group B (53,3 %) when compared to group
A (29,4 %).
Conclusion: In our study we found no differences in dose, type and
strategy applied for analgesia and sedation after TE regardless of
whether the patient was a potential organ donor or not.
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Table 21 (abstract A528). Comparison of treatment limitations: ICU vs.
wards
ICU (N= 390) Wards (N=536) Logistic
regression, (OR,
95% CI), p
Documented poor
prognosis
90,7% 88.3% 1.3 (0.8;2.1),
p=0.3
Death expected
during current
hospitalization
(perception of the
physician)
89,3% 84.6% 1.5 (1.01;2.3),
p=0.044
Palliative care
provided (perception
of the physician)
41,9% 62.8% 0.5 (0.4;0.7),
p<0.001
Documented
treatment limitation
DNR: 88.4%; DNI:
47.6%; no RRT:
31.1%; no
catecholamines:
25,8%
DNR: 72.9%; DNI:
56,8%; No ICU
transfer 19.4%; No
antibiotics 6.5%
2.8 (1.8;4.4),
p<0.001; 0.7
(0.5;0.95),
p=0.024; NA; NA
Limitation of
treatment never
discussed among
staff
31,5% 36.6% 0.8 (0.6;1.05),
p=0.112
CPR 24h prior death 13,8% 3,7% 3.9 (2.3;6.6),
p<0.001
Nurse involved in
decision 4.5
4,5% 3.2% 1.4 (0.6;3.1),
p=0.385
Info about the
treatment limit: − to
the family - to the
nurse - to the patient
76.3%; 98.3%;
40.0%
81.4%; 96.0%;
31.1%
0.7 (0.5;1.1),
p=0.114; 2.4
(0.9;6.9), p=0.098;
1.5 (0.5;4.6),
p=0.5
Family present at the
moment of death
15,8% 10,7% 1.6 (1.06;2.3),
p=0.024
Table 20 (abstract A528). Patient characteristics
Characteristic of the patients N=926
Age (mean; ±SD) 75±13.8
Charleson comorbidity scale (mean;±SD) 6.9 ±2.7
Performance status at hospital admission on the
scale from 0 to 4
0–1.24% 1–4.8% 2–9.45% 3–
30.3% 4–54.2%
Advance directives (%) 0.5
Length of the last hospitalization (median days;
IQR)
8 (2–19)
Table 22 (abstract A529). Demographic data and general characteristics
Group A Group B
Age (mean) 53±12 years 66±15 years*
Presence of comorbidity 73% 90% (p 0,058)
Specific comorbidities:
− Cardiovascular risk factors
− Heart disease
− All other comorbidities without
differences between groups
46%
4% (1 patient)
76%
31%
Main diagnosis upon ICU admission
(without differences between groups)
1*) Cardiac arrest; 42,3% 1*) Cardiac
arrest; 38,1%
2*) Ischemic stroke and
respiratory pathology:
15,4%
2*)
Hemorrhagic
stroke; 26,2%
3*) Hemorrhagic stroke:
7,7%
3*) Ischemic
stroke: 9,5%
APACHE II on admission (mean) 24±6 points 27±8 points
SOFA 24 hours before TE (mean) 7±2 points 9±3 points*
ICU length of stay (mean) 12±11 days 5±5 days*
Timing from TE to cardiac arrest
(median)
11 (9 to 17) minutes 18 (10 to 105)
minutes*
*p<0,05
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Introduction: Quality of care is a key aspect of intensive care medi-
cine. Spanish Society of Intensive and Critical Care and Coronary
Units (SEMICYUC) published in 2011 quality indicators in critically ill
patients.
Objectives: The aim of the present study was to analyze the degree
of compliance of the six bioethics quality indicators in Spanish ICU.
Methods: Multicenter survey in Spanish ICU. During a time of 30 days
a questionnaire was sent to local investigators of ICU. Question were
related with the six bioethics quality indicators published by SEMI-
CYUC: Indicator 96: Adequacy of care at the end of the life. Indicator
97: Information to patients and their relatives in ICU. Indicator 98: ad-
vance directives in decision makings. Indicator 99: Informed written
consent forms corrected filled out . Indicator 100: Limitation life sup-
port. Indicator 101: Restraints applications. The data were analyzed
using SPSS version 15 for Windows.
Results: 68 ICU participate. 50 belongs to public health services and
14 with other financial management. 70,6 % were university hospi-
tals. Indicator 96: 44 % have end of life protocol available. Consensus
decisions with participation of nurses in 79,6 %. Indicator 97: Daily in-
formation in 97 %, 82 % have specific room for information, in 92 %
information is given by the doctor and in 61 % information is written
in the medical record. Indicator 98: Advance directives 53 %. Indica-
tor 99: percentage of informed written consent forms correctly filled
out was variable according type of procedure. Indicator 100: 48 %
have a limitation life support written form. Indicator 101: 40 % have
a restraint application protocol.
Conclusions: Best compliance was observed in the indicator related
with the information in ICU.
We must to improve variability observed about written inform
consents and to promote advance directives in clinical decision
making.
Bioethics quality of care in ICU take on great importance.
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Introduction: Despite technological advances that allow the support
of organ and prolongs life, death in intensive care units is frequent.
However, the success of care should not only be measured by sur-
vival, but should include the quality of life of each patient who sur-
vives and the comfort of the terminally ill.
Objectives: To evaluate the comprehension of nurses and physicians
concerning end-of-life decisions.
Methods: The study consisted of a cross-sectional survey with a
self-completed questionnaire applied to nurses and physicians on
a voluntary and anonymous basis. The questionnaire was con-
structed around the meaning of end-of-life decisions: withdrawal
and withhold life-sustaining treatments and do not resuscitate
decisions.
Results: A total of 174 questionnaires were delivered and 109 were
returned (response rate of 63 %). However, two of the questionnaires
were excluded by multiple responses to each question. Seventy-one
percent were nurses, 29 % were physicians and 59 % were female;
the median age was 35 years-old and the median years of practicing
was 11; 64 % had religious beliefs (53 % of the physicians and 68 %
of the nurses). The comprehension of end-of-life decisions was noted
in 86 % of the physicians and nurses: 93 % comprehended the
meaning of withdrawal and withhold life-sustaining treatments and
97 % comprehended the meaning of do not resuscitate decision.
There were no significant statistical differences in the comprehension
of end-of-life decisions between physicians and nurses. The religious
belief was a factor significantly associated with poor comprehension
of end-of-life decisions (p 0,044), namely withhold life-sustaining
treatment.
Conclusions: In this study, we found that not all physicians and
nurses of an emergency and intensive care department compre-
hend the meaning of end-of-life decisions. Religious belief was
significantly associated with poor comprehension of en-of-life de-
cisions, namely withhold life-sustaining treatment. This study
draws our attention to the need to improve training and educa-
tion about end-of-life decisions in the emergency and intensive
care units and to conduct further studies to evaluate the compre-
hension of the nurses and physicians on other departments of
the hospital.
Table 23 (abstract A529). Analgesia and sedation practices
Group A Group B
Standard dose 15,8% 16,7%*
High dose 84,2% 83,3%*
Bolus OR increase of perfusion rate 70,6% 46,7%*
Bolus AND increase of perfusion rate 29,4% 53,3%*
*p>0,05
Fig. 46 (abstract A529).
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Introduction: Withholding or withdrawal has been reported in 19-
50 % of deaths in Indian ICUs, withdrawal being limited to only 8 %
of cases1. Various reasons have been identified as barriers to end of
life care in India2. A recent physician interview based Asian multi-
national study has highlighted significant difference in such
practices3.
Objectives: This study was undertaken to look at the attitude of In-
dian families towards end of life care (EOL) issues.
Methods: A standard protocol for family discussion was developed.
Relevant end of life care issues was discussed in presence of admit-
ting physician, ICU nurse, medical administrator and members of ICU
team. The filled up EOL family discussions forms related to 44 critic-
ally ill adult patients admitted to ICU between March 2010 & March
2011 were retrospectively analyzed. The discussions held during non-
regular hours were excluded.
Results: The data included 26 male and 18 female patients, admitted
with a medical diagnosis (n = 18), surgical (n = 4), trauma (n = 6) or
cancer (n = 16). The age of patients varied from 20–40 years (22.7 %,
n = 10), 40–60 yrs. (18 %, n = 8), 60–80 yrs. (36.36 %, n = 16) and 10
patients (22.7 %) were >80 years of age. In majority of the discus-
sions more than 3 members of the family participated (n = 29), 2
members (n = 12) and 1member in 3 patients.
All families participated in end of life care discussions. They under-
stood and agreed on a situation of medical futility and irreversibility
in their loved ones and 79.54 % (n = 35) families requested for no
further escalation in treatment. 43 % (n = 19) families agreed for No
CPR orders, whereas 20.45 % (n = 9) agreed for Do not intubate and
do not ventilate orders. Only 4.54 % (n = 2) families agreed for with-
drawal of ventilator, 9 % agrees for withdrawal of vasopressors and
only 1 family (2.27 %) agreed for organ donation. Majority of the
families (90.9 %, n = 40) tried to understand the measures given to
alleviate pain and the feeling of dyspnoea related to ventilator with-
holding or withdrawal.
Conclusions: Our study shows willingness of families to participate in
end of life care discussions and accepting medical futility and irrever-
sibility of such situations. Withholding life care was more acceptable
than withdrawing.
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Introduction: Advance care planning (ACP) is the process in which the
patient makes decisions in consultation with health care givers about
future health care once they become incapable of deliberate medical
treatment decisions. ACP is increasingly recognized as area of concern
respecting quality of care in the ICU and other wards in the hospital.
However, research shows that ACP discussions (ACPd) are still rare in
hospital settings: clinicians underestimate the number of patients will-
ing to discuss ACP and the feeling being unskilled, inadequately trained
or inexperienced may hamper a meaningful patient-doctor discussion.
Objectives: To develop and evaluate an e-module preparing resi-
dents to perform effective and timely ACPd.
Methods: Development of an e-module aiming to equip residents
with knowledge, skills and appropriate attitudes for ACPd, preferably
in a simulated situation before real life practice in the workplace. The
design of this e-module is inspired by the 4C/ID-model. First, experts
explain the ethical, legal and social issues concerning ACP that con-
stitute the learning goals of the e-module. Subsequently, five cases
are presented in videos illustrating appropriate performance. Each
case is provided with comments from experts and residents and their
advice based on personal experience. Cases are presented in increas-
ing complexity sequence. Roles of patients are performed by trained
simulation patients. Residents, senior staff and nurses demonstrate
lifelike ACPd designed to illustrate preset educational goals.
Documenting ACP agreements in the electronic health record is shown
using screen shots. Finally, background information by experts and use-
ful links are offered. Learners work through the e-module at their own
pace with the option to interrupt and looking back. The e-module was
piloted in a group of residents purposefully sampled from a variety of
specialties with a web-based 5 point Likert scale survey with room for
narrative explanation to evaluate satisfaction of participants.
Results: In this pilot 18 residents participated, mean age 30.4 (+/−
SD 2.6) year, 33 % male, in training for neurology (n = 5), internal
medicine (n = 5), surgery (n = 3), anesthesiology (n = 2), cardiology (n
= 1) and undisclosed (n = 2), ranging from 1st to 6th year of training
(median 3rd). 83 % of participants (strongly) agreed with the state-
ment that the e-module is well-arranged. 89 % (n = 16) review the e-
module as giving sufficient insight in the necessity of ACPd. Ten resi-
dents (55 %) appraise the e-module offering guidance for performing
ACPd themselves in clinical practice. Overall satisfaction was 7/10
points (median, range 6–8).
Conclusions: This pilot suggests s that an e-module showing appropri-
ate behaviors based on clarified skills and attitudes by role models in
lifelike situations may help to engage residents in learning activities
and actual practice to master ACPd, thus contributing to quality of care.
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Introduction: Early mortality in ICU may be related to the reason for
admission, comorbidity, severity and initial therapy.
Objectives: To describe severity and comorbidity relationship with
early mortality in patients admitted in ICU.To analyze differences in
patients early died in ICU according limitation of life-sustaining ther-
apy (LST) decisions.
Methods: Observational study in an ICU of a community hospital.
Time of study: 12 months. Inclusion criteria were patients who died
within the first 48 hours of ICU admission. The variables analyzed
were age, sex, comorbidity Charlson index, APACHE II and lactate
levels at ICU admission. Two groups of patients were compared ac-
cording LST decisions. The data were analyzed using SPSS version 18
for Windows.
Results: 65 consecutive patients were analyzed. In 23 % limitation of
life sustaining therapy was decided. Table 24 shows the differences
between the patients who died with and without LST, lactate levels
at ICU admission were 96.1 and 43.2 mg/dl in Not LST group and LST
group respectively. There were not observed differences in reason of
admission.
Conclusions: Predominant clinical profile of patients died early in ICU
was elderly patient with high comorbidity, APACHE II and lactate
levels at admission. Limitation of life-sustaining therapy decisions
were not associated with severity parameters. Comorbidity was
higher in this group of patients.
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Majority of death occur in critical care unit (CCU) after withdrawal/
withholding of treatment. Our aim was to analyse the documentation
of the complex issues surrounding end of life care (EOL) decision in
our CCU. We collected data about our CCU practice of EOL decision
and compared with the best practice recommended by Royal college
of Anaesthetist in 2012. Our goal was to improve the quality of care
of the patients with EOL in our CCU. It's a retrospective audit. All the
patients in CCU for whom the decision of withdrawal of life prolong-
ing treatment from 01/04/2014 -31/03/2015 were included in this
study. The data was taken from ACUBASE electronic notes and CCU
monitoring charts of the relevant cases and analysed using Microsoft
EXCEL.
Out of the 217 deaths in CCU 81 (37.3 %) were due to withdrawal of
treatment. We had found the excellent documentation regarding
family discussion (93.8 %) and formal decision of withdrawal of sup-
port (83.9 %). All the patients (100 %) had valid DNACPR form. The
documentation of method of withdrawal was 59.2 %, on the other
hand the treatment limitation on admission as advanced care plan,
documentation of patient discussion about EOL, consideration of
spiritual aspect, time of withdrawal, organ donation were docu-
mented in 22 %,2 %,12 %,16 % and 30 % of cases respectively. In
the method of withdrawal we audited the organ supports and symp-
tom relief medications. Only 73 % of the patients had analgesics and
26 % had sedatives during the process of dying. This is because the
prescription was done in drug chart. Feeds/fluids were continued in
78 % of patients.
As a result of this audit we proposed the following actions To formu-
late a template in ACUBASE with essential elements of EOL which
will be filled by the relevant CCU consultant and copy of it will be
handed over to the bed side nurse for further care. The time of with-
drawal will be documented by the bed side nurse after family gath-
ering and fulfilment of spiritual aspects in the monitoring chart and
the doctor who certifies the death will document it on the ACUBASE.
MECHANICAL VENTILATION
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Introduction: Consistency of definitional criteria for terminology ap-
plied to describe various patient cohorts receiving mechanical venti-
lation within intensive care unit (ICU) and post-acute care settings is
important for understanding prevalence, risk stratification, effective-
ness of interventions, and projections for resource allocation. Al-
though a 2005 consensus conference defined prolonged mechanical
ventilation (PMV) as mechanical ventilation for ≥21 consecutive days
(1), we hypothesized that variable definitions are used when apply-
ing this terminology.
Objectives: To quantify use of the term PMV and how it is defined
within the literature.
Table 24 (abstract A534). Clinical characteristics of patients
LST (n:15) Not LST
(n:50)
Age, median 72 67.5
Sex (male%/female%) 46,7/53,3 66/34
APACHE II, median 27 26
Origin prior ICU: Emergency; Medical ward
Surgical ward Extrahospitalary
20%; 13,3%;
20%; 46,7%
34%; 20%;
8%; 38%.
Mechanical ventilation (%) 86,7 94
Vasoactive drug (%) 73,3 80
Charlson Index <3 3–5 >5 13,3% 13,3%
76,3%
16% 28%
56%
Fig. 47 (abstract A535). Number of Days in CCU before withdrawal
of treatme
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Methods: Scoping review of studies (all designs except single case
study) reporting a study population (adult and paediatric) using the
term PMV or synonym. Two authors screened electronic databases
(1980–2013) and abstracted data (country; care venue; diagnostic
categories; terms used to describe cohort, definitional criteria for
these terms, and rationale; and reported outcomes) independently
on a standardized form with accuracy verified by a 3rd author.
Results: We screened 5331 references, identified 539 references for
full text review and excluded 120. Of the 419 studies meeting inclu-
sion criteria, 363 (87 %) were conducted in a single care venue type
(most commonly ICU), 30 (7 %) in multiple care venue types, 17
(4 %) were database studies, and 9 (2 %) surveys. Studies repre-
sented cohorts from 38 countries most commonly the US (187,
44 %). Most studies (297, 71 %) reported data on a heterogeneous
patient cohorts, 66 (16 %) studies reported data on surgical patients
only (46/66, 70 % cardiac surgery). Other studies described chronic
obstructive pulmonary disease (16, 4 %), trauma (22, 5 %), neuromus-
cular (17, 4 %), and sepsis (1, 0.2 %) cohorts.
A total of 741 terms were used to refer to the 419 study cohorts.
Most commonly used terms were: PMV (253, 60 %), admission to a
specialized unit (107, 26 %), and long-term mechanical ventilation
(79, 19 %). Some authors (282, 67 %) defined their cohorts based on
duration of mechanical ventilation with 154 (55 %) using this as the
sole criterion. We identified 37 different durations of ventilation ran-
ging from 5 hours to 1 year with >21 days being the most common
(28/282, 7 %). For studies describing a surgical PMV cohort, minimum
ventilation duration required for cohort inclusion was ≥24 hours for
20/66 (30 %) studies with ≥15 days as the maximum duration. More
than half (237, 57 %) did not provide a reason/rationale for the defin-
itional criteria used, with only 28 (7 %) studies referring to a consen-
sus definition.
Conclusions: Substantial variation exists in the terminology and def-
initional criteria for cohorts of patients receiving mechanical ventila-
tion. Standardization of terminology and definitional criteria is
required for study data to be maximally informative.
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Introduction and objectives: The use of continuous waveform cap-
nography is well established within the theatre environment, and is
now considered a standard of care within intensive care by UK na-
tional bodies1 2 3.
University Hospital Birmingham is a large UK teaching hospital. His-
torically within this unit the use of capnography has not always been
routine on all invasively ventilated patients. This quality improvement
project aimed to implement national guidelines in our unit.
Methods: To assess the usage, availability and attitudes towards
using capnography, a baseline audit of the use of capnography on
ventilated patients, during airway interventions and patient transfers
was performed.
Concurrently a staff questionnaire was circulated to the multidiscip-
linary ICU team to complete, in order to assess their knowledge and
attitudes towards capnography and promote awareness of national
guidelines.
A business case was developed to purchase sufficient modules and
consumables to allow for use on every invasively ventilated patient.
Teaching of critical care staff was carried out by the trusts practice
development team in conjunction with volunteers from within the
critical care team. This covered the system set up and interpretation
of the capnography waveform.
Mandatory use of capnography was then introduced into local guide-
lines and its use was then re-audited.
Results: The audit results are shown in Table 25.
Conclusions: The routine use of capnography for invasively venti-
lated patients has risen by 62 %.
The use for airway interventions and patient transfers appears to
have remained at the same level or fallen though both these area
had much higher baseline rates of use.
This highlights an area for further improvement and the wider dis-
semination of this work will contribute to further improvement in
local practice.
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Introduction: Disturbances of external respiratory function (ERF) are
in a leading position among extracranial complications after severe
traumatic brain injury (STBI). According to the opinion of the most
specialists, disturbances of ERF belong to the complications resulted
from aspiration and damage of mucous tunic of tracheobronchial
tree. Aspiration of gastric contents usually occurs owing to con-
sciousness depression accompanied by STBI.
Objectives: To determine the development periods and to study the
development rate of acute respiratory distress syndrome (ARDS) in
isolated STBI complicated with aspiration of gastric contents and
blood.
Methods: The study was conducted in neurosurgery intensive care
unit at Republic Research Center of Emergency Medicine. 33 of 165
patients with STBI admitted between 2013 and 2014 had aspiration.
28 were male and 5 were female. Mean age was 35 ± 3. Glasgow
coma score after admission was 5–9. All patients were intubated and
mechanically ventilated. Patients were divided into 2 groups accord-
ing to the etiology of aspiration agent. First group (n = 33) - patients
Table 25 (abstract A537). Audit Results at Baseline and Post Quali
Baseline (22/01/
14)
Re Audit (05/01/
16)
Mechanically Ventilated Patients 24 18
Capnography in Use in Bed space 5/24 (21%) 15/18 (83%)
Capnography used for Airway Interventions 12/13 (92%) 7/11 (64%)
Capnography used for Ventilated Patient
Transfer
21/35 (60%) 3/5 (60%)
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with aspiration of gastric contents or blood. Second group (n = 33) -
control group, i.e. with isolated STBI without aspiration. Aspiration
was confirmed with fiberoptic bronchoscopy.
Results: We conducted analysis of extravascular fluid in the lungs. In
21 patients with aspiration of gastric contents (first group) the
amount of extravascular water in lungs (EVWL) 3–6 hours after the
trauma was 7.8 ± 3.0 mL/kg (normal value is 3–7 mL/kg), PaO2/FiO2
ratio was 275.0 ± 127.2, after 24 hours EVWL was 7.3 ± 2.9 mL/kg,
PaO2/FiO2 ratio was 291.8 ± 94.1. Fifteen patients were with ARDS
criteria and their EVWL was 9.6 ± 1.6 mL/kg, PaO2/FiO2 ratio was
218.0 ± 72.9. In 12 patients with aspiration of blood, EVWL 3–6 hours
after the trauma was 9.3 ± 2.9 mL/kg, PaO2/FiO2 ratio was 336.2 ±
20.7. Nine of them had ARDS criteria and their EVWL was 10.2 ±
2.2 mL/kg, after 24 hours it was 10.5 ± 4.9 mL/kg. In the second
group after 3–6 hours, EVWL was 6.8 ± 1.5 mL/kg, PaO2/FiO2 ratio
was 330.5 ± 183.2 and none of the patients had ARDS criteria. After
24 hours EVWL was 6.6 ± 0.8 mL/kg, PaO2/FiO2 ratio was 323.9 ±
122.4, and three of them had ARDS criteria, EVWL was 9.6 ± 1.4 mL/
kg, PaO2/FiO2 ratio was 234.0 ± 17.2.
Conclusions: Hence in patients with STBI and aspiration of gastric
contents we observed significant increase in EVWL (p = 0.05) and de-
crease in PaO2/FiO2 ratio in the first hours after trauma in compari-
son with the patients without aspiration. Accumulation of EVWL can
be considered as one of ARDS criteria, but only with other signs of
damage. ARDS is registered in the first hours after trauma roughly in
50 % of cases in patients with aspiration of both gastric contents
and blood.
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Introduction: Acute respiratory failure (ARF) can be divided in hypox-
emic or hypercapnic, depending on the leading modification in
blood gas analysis, being the first one the most common. Mechanical
Ventilatory Support is one of the treatment mainstays of patients in
the Intensive Care Units (ICU), either as management for a primary
respiratory imbalance or to protect the airway. Non-invasive mechan-
ical ventilation (NIMV) is defined as any method in which positive
pressure is delivered by a face mask or any other interphase without
the use of an endotracheal tube.
Objetives: It is well established in which pathologies NIMV can be
useful, but an inadequate patient selection may cause an increment
in morbidity and mortality as well as a delay in endotracheal intub-
ation. While the aim in most studies is to determine which patholo-
gies NIMV will have a better outcome, the main objective in our
study was to define whether the blood gas values (pH, paCO2 and
paO2) are the ones that may indicate which patients are better suited
for NIMV.
Methods: Retrospective observational study of all adult patients ad-
mitted to the ICU (mixed ICU) between March 2014 and April 2016
but data presented in this abstract is a preliminary report as we pre-
tend to add more patients in the ongoing months. Patients with
DNR order were excluded as well as patients that required endo-
tracheal intubation in the first 2 hours after the beginning of NIMV.
Patient's data was analyzed with the purpose of finding cutoff points
in blood gas values that could suggest which patients had a better
outcome. Patients divided in two groups (survivors or non-survivors)
and mean values were compared using Student's t test. A p value of
less than 0.05 was considered to be statistically significant.
Results: 52 patients were included and their data analyzed: n = 22
(42.3 %) were female and n = 30 (57.7 %) male, with a mean age of
74 ± 12 (36–94). Of all, n = 15 (29 %) required endotracheal intub-
ation; overall mortality rate was 23.1 % (n = 12). Patients who
survived had higher PaO2/FiO2 ratio than those who did not (p =
0.04) and tend towards higher PaCO2 levels although p values were
not statistically significant (p = 0.07). ARF cause with the highest mor-
tality was cardiogenic acute pulmonary edema in n = 5 patients
(41.7 %).
Conclusion: The use of NIMV can be considered as an alternative to
endotracheal intubation in hypercapnic patients while the benefit of
its use has not been proven in severe hypoxemia (PaO2/FiO2 ratio
less than 100) at least in our group of patients and it actually may
lead to a worst outcome.
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Introduction: The recent literature has demonstrated the feasibility
of ultrasound in performing PCT in coagulopathic patients with less
complications(1) but none of the studies have included patients with
coagulopathy and difficult neck anatomy by ultrasound.
Objectives: To validate the new technique of performing PCT in a
patient with unsatisfactory neck anatomy as defined by a innovative
classification under real time ultrasound.
Methods: We prospectively conducted this pilot study of 28 PCT in
coagulopathic patients. We defined the neck anatomy in three cat-
egories depending on the presence of blood vessels in the track of
needle even at the lowest visible inter-tracheal space on ultrasound.
The unsatisfactory category was defined as presence of multiple ves-
sels in the centre of the field, good category had one blood vessel in
the centre of the field, excellent category had clean procedure field
with no blood vessels. The technique that we adopted in PCT in un-
satisfactory category was liberal instillation of 2 % Xylocaine in the
skin and subcutaneous tissue between the vessels and creating a po-
tential space for the needle. We also avoided putting any predeter-
mined incision on the skin during the procedure and followed an
entire seldinger technique by dilating the skin and subcutaneous tis-
sue using the 5Fr tracheal dilator provided in Portex® ULTRAperc®.
The entire procedure was done under real time ultrasound guidance.
Blood loss was estimated by the number of gauze pieces soaked
with blood with one gauze piece soaking 5 ml.
Results: The average local anesthesia requirement was around 10 ml
for instillation. The INR ranged from 2.1 to 2.9 and the platelet count
ranged from 20,000 to 75,000. None of the patients required any
blood product transfusion. The maximum blood loss was 15 ml and
none of the patients required abandoning of the procedure.
Conclusions: This modification of the classical technique of PCT in
patients having unfavorable neck anatomy resulted in increased
safety with minimal blood loss. Ultrasound guidance is a very useful
modality to define such unfavorable neck anatomy which are non
amenable by just palpation of neck. Correction of coagulopathy may
not be mandatory if real-time ultrasound is used during this modified
technique of PCT.
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Introduction: Respiratory infections have long been recognized as
precipitators of exacerbations and a concomitant pneumonia has
been reported in 7-10 % of acute decompensated heart failure
(ADHF) patients. Detecting patients, who present with an ADHF and
signs of superimposed pneumonia, is difficult because of the non-
specific nature of physical examination or chest x-ray abnormalities
in the setting of cardiogenic pulmonary edema. Nahm et al. devel-
oped neutrophil delta neutrophil index (DNI) as a new indicator for
immature neutrophils and DNI expression is induced by bacterial
infection.
Objectives: No information is available on the clinical usefulness of
DNI with respect to the diagnosis of superimposed pneumonia in pa-
tients with ADHF. Therefore, we evaluated the presence of difference
of initial DNI according to presence of pneumonia in patients with
ADHF, the predictive value of DNI and the usefulness of DNI in com-
bination with C-reactive protein (CRP), which is the commonly used
for predicting inflammation and infection in the ED, for diagnosis of
superimposed pneumonia in patients presenting with ADHF at the
ED.
Methods: This is a retrospective and observational study of consecu-
tive patients more than 18 years of age who were diagnosed with an
ADHF in the ED over a 7 month period. Patients were categorized by
the ADHF group and the superimposed pneumonia group. Serum C-
reactive protein (CRP), DNI, and β-natriuretic peptide (BNP) were
measured upon ED arrival.
Results: The superimposed pneumonia group included 78 patients
(38.4 %). Median initial DNI and CRP were significantly higher in the
superimposed pneumonia group (0 % vs. 1.2 %, p < 0.001 and
0.52 mg/dL vs. 7.33 mg/dL, p < 0.001), respectively. In the receiver
operation characteristic (ROC) curve for initial DNI and serum CRP for
differentiating superimposed pneumonia in ADHF patients, area
under curve (AUC) of DNI [0.800 (95 % confidence interval 0.737-
0.853)] and CRP [0.834 (95 % confidence interval 0.774-0.883)] were
all good and there was no a statistical difference of AUC between
two inflammatory markers (p = 0.367). The AUC of the initial DNI and
CRP combination [0.862 (95 % CI 0.806-0.907)] was not significantly
higher than the AUC for initial CRP alone [0.834 (95 % CI 0.774-.883)]
(p = 0.099).
Conclusions: Initial DNI was significantly higher in the superimposed
pneumonia group than in the ADHF group and the prediction ability
for ADHF with superimposed pneumonia of initial DNI in the ED was
as good as those of serum CRP.
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Introduction: Gas exchange is more severely impaired in H1N1-ARDS
often necessitating rescue therapies.Those with severe ARDS if can´t
be offered ECMO have Prone ventilation as only option. Prone venti-
lation1 hasn't been studied in details as far as H1N1-ARDS is
concerned.
Objectives: We examined whether early application of prone posi-
tioning would improve survival among patients with severe H1N1
ARDS.
We also tried to assess feasibility of prolonged proning (>20 Hours)
Method: A single center observational study of 61 adult patients,
with PCR confirmed H1N1 infection, admitted between December 1,
2014 & June 31, 2015.
Patients with severe ARDS as per Berlin definition, after 6–12 hours
of mechanical ventilation were assigned to undergo prone-
positioning sessions of at least 20 hours or stay supine as per family/
treating physician´s decision.
Patients who ended receiving ECMO were excluded.
Those who had P/F ratio ≤1.0 on FiO2 ≥ 0.8 and PEEP ≥ 10 cmH2O at
end of 20 hrs were kept further proned in sets of 4 hrs till they
achieved this goal and then turned supine.
The primary outcome was 28 days all cause mortality after inclusion.
Respiratory characteristics,effect of first prone ventilation on the P:F
ratio and PEEP requirement,complications and clinical outcome were
collected.
Results: 31 patients had severe ARDS after 6–12 hours of mechanical
ventilation.
28 days mortality rate in these patients was 51.61 %(n = 16).
Mean P:F ratio was 0.73 + 0.14.
All patients had a Compliance of < 20 ml/cmH2O (Mean cpl 16.3 +
1.52 ml/cmH2O).
17 patients were turned to prone position within 48 hours of mech-
anical ventilation.
13 patients remained in supine position,1 patient with 26 week preg-
nancy received HFOV.
Mortality rates in prone & supine group were 47.05 % (n = 8) &
61.53 % (n = 8) respectively. (p = 0.431)
12 patients showed a significant increase in P:F (≥30 %) but only 8
showed a concomitant decrease in PEEP (≥2cmH2O) at the end of
first prone session.
Target end points of proning got achieved in 11 patients.
Mean duration of prone session was 21.97 + 6.17 hours.
Average number of prone sessions was 2.5 among survivors & 4.5
among non-survivors.
Fig. 48 (abstract A540). Blood loss
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7 patients received session of prolonged prone positioning (>24 hrs)
out of which 4 (57.14 %) survived.
Complications: 10 patients needed to stop enteral feeding transiently
during prone session due to increased residual gastric aspirate.
9 patients had Grade 1 pressure sores on the face.
1 patient in prolonged proning had sudden cardiac arrest during the
prone session.
Conclusions: Easy feasibility & rapid response assessment make
prone ventilation an ideal choice for the initial treatment of patients
with severe H1N1-ARDS.
For who can not be put on ECMO for various reasons, prolonged
proning is an option as rescue therapy and should be evaluated by
RCTs.
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Introduction: Use of generic drugs, which are bioequivalent to
brand-name drugs, is now a common practice. However, there is still
concern among patients and physicians that brand-name drugs are
more efficient than generic drugs (1).
Objectives: To compare efficiency and tolerance of two marketed
forms: original brand-name (NIMBEX®) and generic (CISATREX®)
cisatracurium-induced paralysis in hypoxemic ventilated patients.
Material and methods: A cross-over, randomized, double-blind
physiological trial. Was compared, neuromuscular blockade induced
respectively by the original brand-name and generic continuous cisa-
tracurium infusion during two successive periods, separated by a one
hour washout period. Neuromuscular function was monitored by vis-
ual estimation of the contractions (number and height) of the thumb
in response to a calibrated train-of-four (TOF) stimulation every 5 mi-
nutes. A continuous infusion of cisatracurium was started at 0.06 mg
−1kg−1h−1. The cisatracurium infusion rate was then increased by in-
crements of 0.03 mg−1kg−1h−1 every thirty minutes to reach and sus-
tain a TOF of 2/4. Were measured, the delay of paralysis defined by
the time needed from infusion onset to reach a TOF of 2/4 and re-
spective recovery times defined by the time needed to reach a TOF
of 4/4 after stopping cisatracurium infusion. Under optimized sed-
ation and ventilation, patients admitted for hypoxemic acute respira-
tory failure with a P/F < 200 and requiring paralysis were enrolled.
Patient's characteristics and SAPS II score were assessed at admission.
Ramsay sedation scale, respiratory and hemodynamic parameters, P/
F ratio were evaluated at baseline. Tolerance was assessed by signifi-
cant variations (>30 %) of heart rate and/or systolic blood pressure.
Number needed to demonstrate a significant difference between the
delays to reach a TOF of 2/4 in the two studied cisatracurium forms
was estimated at 22 patients.
Results: Twenty two patients were included. Median age was 56[41,
73] years. 14(61,9 %) were male. 17(77.3 %) had ARDS and 5(22.7)
had status asthmaticus. Median SAPS II at admission, 34[25, 43].
11(52,3 %) patients had a PaO2/FIO2 ratio < 100. Median paralysis
delay was respectively 70[44, 96]min in NIMBEX® and 70[43, 97]min
in CISATREX®; (p = 0.579). Figure. 49 displays respective TOF kinetics
in the two forms of cisatracurium. The median recovery time from
paralysis was respectively 60[40, 80]min in NIMBEX® and 60[42,
78]min in CISATREX® (p = 0.924). There was no significant
hemodynamic variations neither in NIMBEX® nor in CISATREX®.
Conclusion: The present study revealed no significant difference in
efficacy as in tolerance between original brand-name NIMBEX® and
generic (CISATREX®) of cisatracurium.
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Introduction: The Richmond Agitation-Sedation Score (RASS) records
the level of sedation of a patient from −5 to +4, and has been used
in the Royal Surrey County Hospital Intensive Care Unit since Novem-
ber 2012. Maintaining optimum levels of sedation (RASS −2 to 0) im-
proves clinical outcomes (1).
Objectives: The objectives of this audit were to assess the median
level of sedation in ventilated patients, record any variation in score
at different times of day or night and measure the frequency of re-
corded score. This audit was then repeated to measure any improve-
ment in practice.
Methods: All patients sedated and ventilated during July 2015 were
audited and then re-audited in November 2015. Patients were ex-
cluded if it was felt that reducing the level of sedation was
inappropriate.
Results: 300 scores were obtained during July 2015 and 672 in No-
vember 2015. The median sedation score was −2 in July and −3 in
November. 41.5 % were too heavily sedated at −3 or below in July
and 53.3 % in November.
The majority of scores were recorded frequently with 84 % of pa-
tients in July having a score recorded at least every 2 hours and
91 % in November.
Conclusions: Sedation scores are being recorded frequently, with
few long gaps for either month. Sedation protocols should be used
in order to target the lowest possible levels of sedation. There should
Fig. 49 (abstract A543).
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be discussion around whether targets should be different at night
compared with daytime.
There has been no improvement in sedation practice in November
compared with July 2015. Fewer than half (45.5 %) of patients were
sedated to optimum levels in July and this fell to 38.2 % in Novem-
ber. There may be merit in maintaining an infusion of the opioid,
whilst reducing or stopping the hypnotic, rather than stopping both
completely. Maintaining staff awareness of the benefits of optimising
sedation is prudent.
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Introduction: The management of severe Legionella pneumonia can
include extracorporeal membrane oxygenation (ECMO) to rescue
those patients which develop refractory hypoxemia or extreme re-
spiratory acidosis. However, some physicians remain skeptical about
this approach, considering that evidence is very weak and only de-
rived from case series from single ECMO centers. We believe that
reporting experience from diverse centers is important to expand the
knowledge and the predictors of benefit from ECMO support in pa-
tients with Legionella pneumonia.
Objectives: Clinical, physiological, functional and biomechanical
characterization of a population with severe Legionella pneumonia
treated with extracorporeal life support in a ELSO recognized ECMO
centre.
Methods: Protocol-driven prospective registration and analysis of
data from a population of 9 patients diagnosed with severe acute
respiratory distress syndrome (ARDS) secondary to Legionella
infection, with additional respiratory physiology evaluation and
characterization during the ECMO run treatment.
Results: From 2013 to 2015, nine patients with Legionella pneumonia
and severe ARDS have failed conventional mechanical ventilation
and were treated with extracorporeal oxygenation (Quadrox HLS or
PLS Oxygenator System from Maquet). Median age was 46.6 ± 12.3
and all patients were male. ECMO criteria admission were hypoxemia
(median pre-ECMO PaO2:FiO2 of 73.5 ± 22.9 mmHg) associated with
respiratory acidosis (median pre-ECMO PaCO2 of 69,6 ± 12,5 mmHg
and pH of 7.22 ± 0,08). Murray score was 3.17 ± 0,16 and SAPS II was
43.7 ± 9.8. Symptoms to cannulation was 4.4 ± 2.2 days, which repre-
sented a very early strategy to ECMO implementation. Initial static
compliance was 25.9 ± 7.6 ml/cmH2O, did not changed significantly
by day four (27.7 ± 13,4), and improved to 38.1 ± 13.4 by day seven.
Six patients were smokers, six had acute kidney injury AKIN 3 and
three had circulatory shock. During ECMO run, all patients were add-
itionally conventionally ventilated with a lung rest strategy (Vt
2.0 ml/kg, driving pressure below 15 cmH2O and PEEP of 10 to
14 mmHg). Seven patients were treated with azithromycin and two
patients with levofloxacin. We did not prescribed corticosteroids in
any patient. All patients survived ECMO run (median time of 9.8 ±
4.5 days) and hospital discharge.
Conclusions: We showed excellent results derived from a strategy of
extracorporeal oxygenation in patients with the most severe forms of
Legionella pneumonia. We believe that early referral and early imple-
mentation of a protocol-driven ECMO technique, with better under-
standing of its physiological and management principles, might
improve the outcomes of patients with severe Legionella pneumonia.
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Introduction: Percutaneous Tracheostomy is a procedure commonly
performed in the intensive care unit1, being considered as first choice in
patients in critical condition due to the lower rate of complications asso-
ciated with this procedure2, reports of perioperative complications ran-
ging from 2 to 6 %3 such as bleeding, death, false passage, extubating,
pneumothorax, emphysema, hypertension and inability to perform the
technique; Postoperative complications were reported from 9 to 17 %3,
including bleeding, displaced tube, pneumothorax, infection and death.
In our intensive care unit we have one year experience of performing
percutaneous tracheostomy, with very low rate of complications so far.
Objectives: To determine the incidence of complications related to per-
cutaneous tracheostomy in critical ill patients in our intensive care unit.
Methods: A retrospective study was conducted in our intensive care
unit during March of 2015 to February of 2016, counting 23 patients
who underwent percutaneous tracheostomy for any indication, and
the complications observed in each procedure were recorded in a
data collection sheet.
Results: We obtained a population of 23 patients, 11 females and 12
males, all diagnoses of these patients were divided into groups, in-
cluding 9 patients with lung disease (39.2 %), 7 patients with neuro-
logical disease (30.4 %), and 7 patients with abdominal disease
(30.4 %), with an average of 8.47 days of mechanical ventilation, and
an average of 15.4 minutes duration of the percutaneous tracheos-
tomy, in which 2 episodes of extubating without clinical repercussion
as perioperative complications were reported (8.9 %), and a tube dis-
placement which required endotracheal intubation as a postopera-
tive complication (2.3 %).
Conclusions: We observed a low incidence of perioperative compli-
cations in our patient population, as well as a very low incidence of
postoperative complications compared with that reported in the
reviewed articles, no serious complications in any patient who per-
form percutaneous tracheostomy were observed. We strongly recom-
mend percutaneous tracheostomy as a safe method to the bedside
of most patients in critical condition, regardless of their disease.
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Introduction: Acute Kidney Injury (AKI) is a frequently encountered
syndrome in the critically ill. While the role of AKI in increasing short-
term mortality is evident, results regarding its role in long-term mor-
tality are conflicting. Advanced age and pre-existing co-morbidities
are known risk factors for AKI and also the main determinants for the
long term-mortality of initial survivors of intensive care (1).
Objectives: To determine whether AKI is an independent risk factor
for increased three-year mortality among 30-day survivors of critical
care.
Methods: This prospective study enrolled 2901 patients from 17
Finnish intensive care units (ICU) in 2011–2012. In this analysis, we in-
cluded 30-day survivors of the cohort. We compared the crude
three-year mortality of AKI and non-AKI patients and adjusted for
confounders using Cox proportional hazard model. We performed
sensitivity analyses by excluding patients with 1) chronic kidney dis-
ease (CKD), 2) stage 1 AKI, or 3) CKD, stage 1 AKI only, or an esti-
mated pre-admission creatinine.
Results: The study included 2336 30-day survivors of intensive care.
Of these, 808 (34.6 %, 95 % CI 32.7 %-36.5 %) developed AKI accord-
ing to the Kidney Disease: Improving Global Outcomes -criteria. The
crude mortality at three years was 190/808 (23.5 %, 20.6 %-26.4 %) in
the AKI patients and 289/1528 (18.9 %, 17.0 %-20.9 %) in the non-AKI
patients (p = 0.010). In adjusted Cox model, AKI was not an inde-
pendent risk factor for three-year mortality (hazard ratio (HR) 1.05; CI
95 % 0.86-1.27, p = 0.644), whereas age (HR 1.03; 1.03-1.04), chronic
obstructive pulmonary disease (HR 1.63; 1.26-2.10), chronic kidney
disease (HR 1.53; 1.23-2.07), chronic liver failure (2.90; 1.89-4.44), ma-
lignancy (HR 3.18; 2.18-4.62), rheumatoid diseases (HR 1.87; 1.35-2.60)
and poor premorbid functional performance were. Pre-existing ar-
teriosclerosis, diabetes, hypertension, systolic heart failure, thrombo-
philia and characteristics of the ICU admission and treatment
(operative admission, higher SAPS II score without age and renal
points, use of vasoactives and severe sepsis) did not independently
associate with an increased hazard for three-year mortality. In the
sensitivity analyses, AKI was not associated with an increased hazard
for three-year mortality.
Conclusions: Our findings imply that increased long-term mortality
among patients with AKI who survive critical illness is not related to AKI
per se, but rather to increased age and pre-existing comorbidities.
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Introduction: After years of negligence, a kidney-brain crosstalk has
become an issue [1].The link between cognitive impairment and
chronic kidney disease is widely acknowledged. Less is known about
the influence of AKI. Recently, an increase of serum beta-2 micro-
globulin (B2M), an uremic toxin, was proved to be associated with
cognitive decline (CD) in mice [2].
Objectives: To investigate relation between acute and chronic
changes of kidney biomarkers: B2M, creatinine, cystatin C, NGAL and
cognition in patients (pts) undergoing aortic valve replacement (AVR)
Methods: Eighty over 70-year-old consecutive pts with severe aortic
stenosis undergoing surgical AVR (SAVR, n = 40) or trascatheter AVR
(TAVR, n = 40) were enrolled in prospective, observational single-
centre study. All biomarkers were tested before AVR and 6, 12, 18,
24, 36 and 48 h afterwards, at discharge and at 6-month follow-up.
Mini Mental State Examination (MMSE) was performed before AVR, at
discharge and follow-up.
Results: Higher serum B2M levels were consequently correlated with
lower MMSE score at all time-points: at baseline (0.305; p = 0.01), at
hospital discharge (0.296; p = 0.013) and at 6-month follow-up (0.496;
p < 0.001). Correlations of other biomarkers were inconsistent. There
was also correlation between B2M increase from baseline to dis-
charge and CD, (drop in MMSE) over hospital stay (309; p = 0.009).
This was not observed within other biomarkers.
The risk of in-hospital CD was significantly higher in pts with B2M in-
crease over the median change of 0.42 mg/dl (OR 2.66;95 % CI 1.02-
6.94; p = 0.043). None such relation was noted with other biomarkers.
Univariate log. regression analysis indicated trend for association be-
tween in-hospital B2M increase and CD (OR 2.02; 95 % CI 0.994-4.09;
p = 0.052). Significant risk factors were baseline MMSE (OR 1.32; 95 %
CI 1.09-1.6; p = 0.004) and max. postprocedural CRP (1.06; 95 % CI
1.0-1.13; p = 0.035). In multivariate log.regression analysis adjusted
for demographic variables, typical cardiovascular and periprocedural
risk factors in-hospital increase of B2M was third the most associated
with CD (OR 2.55; 95 % CI 0.878-7.38; p = 0.085). It followed higher
baseline MMSE (OR 0.703; 95 % CI 0.533-0.927; p = 0.013) and dia-
betes mellitus (OR 4.32; 95 % CI 0.92-20.4; p = 0.065).
We did not find relation between changes of B2M and cognition
over the follow-up. The connection could have been obscured by
multimorbidities burden in this population.
Conclusions: Our study is the first in human to report relation be-
tween acute changes of uremic toxin and cognition with B2M as a
key player. By analogy to cardio-renal syndrome, four types of neuro-
renal syndrome should become an issue.
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Introduction: Acute kidney injury (AKI) is a serious complication in
patients admitted to the Intensive Care Unit (ICU) which increases
morbidity and mortality. Controversy exist about the associated risk
factors.
Objectives: The aim of this study was to analyze the incidence of AKI
in cardiac ICU and related risk factors.
Methods: Retrospective observational study of patients admitted to
a Cardiac ICU who developed AKI between 2004 and 2014. AKI was
defined as impaired renal function with elevation to twice baseline
serum creatinine or need renal replacement therapy (RRT). Demo-
graphic data and clinical variables to determine AKI incidence were
collected. In patients undergoing cardiac surgery, risk factors for AKI
development and history of intraoperative blood products transfu-
sion were analyzed. Values expressed as mean + − SD or %.Signifi-
cant variables in the univariate analysis were entered into a
multivariate logistic regression model to calculate the Odds Ratio
(OR) with confidence interval of 95 %.
Results: We analyzed a series of 8146 patients, mostly males
(64.8 %), age 66.92 +/− 12.60 years. Patients origin: 6171 (75.8 %)
underwent cardiac surgery of valve replacement and / or coronary
bypass graft, 507 (6.2 %) of hospitalization floor, 478 (5.9 %) of Emer-
gency Department, 354 (4.3 %) of Coronary Care Unit, 307 (3.8 %)
from other Hospitals, 149 (1.8 %) other ICU, 123 (1.5 %) after cardiac
catheterization, and 57 (0.7 %) postoperative Care Unit. AKI devel-
oped in 763 patients (9.5 %).Two groups were compared. Group 0:
without AKI and group 1 with AKI development during ICU stay. Pa-
tients in group 1 were older: 66.71 +/− 12.72 vs 68.88 +/− 11.22 years;
p < 0.001; mostly males: 68.7 %; the average ICU stay was higher:
6.09 +/− 12.89 vs 16.44 +/− 21.21 days; p < 0.001. 382 patients in AKI
group died (50.2 %) and 20.3 % were treated with RRT. The subgroup
of patients undergoing cardiac surgery who developed AKI had a
higher baseline creatinine, urea and LOGISTIC EUROSCORE: 1.05 +/−
0.54 vs 1.39 +/− 0.60 p < 0.001; 49.90 +/− 22.25 vs 69.18 +/− 32.19 p
< 0.001; 6.06 +/− 4.42 vs 9.76 +/− 7.64 p < 0.001, respectively. They
also received more intraoperative red blood cells 1.62 +/− 2.32 vs
2.88 +/− 2.26 p < 0.001, plasma 1.25+/−1.80 vs 2.59+/−2.19 p < 0.001
and platelets transfusion 0.40+/−0.62 vs 0.81+/−0.74 p < 0.001. In the
multivalent analysis intraoperative red blood cells, plasma and plate-
lets transfusion proved to be independents factors for the develop-
ment of AKI in ICU: OR 1.147 CI (1.070 to 1.230) p < 0.001; 1.365 CI
(1.280 to 1.445) p < 0.001; 2.054 CI (1.644 to 2.515) p < 0.001,
respectively.
Conclusions: age > 70 years old, baseline creatinine, baseline urea,
preoperative hemoglobin were risk factors for development of AKI in
our study. Intraoperative transfusion of packed red blood cells,
plasma and platelets were independents factors of development of
AKI after cardiac surgery.
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Introduction: Acute kidney injury (AKI) is a serious complication of crit-
ical illness with attributed morbidity and mortality both at short-term
and long-term. (1, 2) The incidence of AKI in critically ill patients varies
substantially with the population evaluated and the definitions used. (1,
3, 4) We aimed to assess how the timing and the incidence of AKI varies
with AKI definitions, both with and without using urine output criteria.
Methods: We included all patients admitted to our 42 bed intensive
care unit (ICU) from 1st January 2014 until the 11th of June 2014. Inci-
dences of AKI and timing were estimated using RIFLE, AKIN and
KDIGO definitions.
Results. A total of 1376 critically ill patients were included in our cohort.
AKI incidence proportions varied from 15 to 21 % using RIFLE, AKIN and
KDIGO serum creatinine criteria. AKI incidence proportions varied from 35
to 38 % when urine output criteria were added to the RIFLE, AKIN and
KDIGO definitions. AKI was detected after a median of 24 hours (IQR 24–
48 hours) using serum creatinine criteria and AKI was detected after a
median of 13 hours (IQR 7–23 hours) using urine output criteria.
Conclusion. Incidences of AKI are influenced by which definition is used.
Addition of urine output criteria to serum creatinine criteria may result in
a doubling of AKI incidences and an eleven hours time gain in a critically
ill population.
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Introduction: BACKGROUND. The incidence of acute kidney injury (AKI)
occurring in patients admitted to intensive care units (ICUs) ranges from
30 % to 60 %. It has shown to be an important predictor of morbidity
and mortality in the critically ill and continuous renal replacement therap-
ies represent a cornerstone in its management. The Kidney Disease Im-
proving Global Outcomes Guideline (KDIGO Guideline) on renal support
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for AKI suggests initiating CRRT when life-threatening changes in fluid,
electrolyte and acid–base balance exist.
Objectives: To determine the incidence and prognosis of AKI requir-
ing CRRT in a tertiary cardiothoracic centre.
Methods: Of the 1829 patients admitted to level 3 areas in Harefield
Hospital during 2015, 229 required CRRT (12.52 %). 161 (70 %) were
male, with a median age of 59 years. 109 (47.6 %) were hypertensive
and 55 (24 %) were diabetic. The most frequent reason for admission
was cardiac surgery (36.2 %, 83 patients), followed by medical admis-
sions from the cardiology ward (10 %, 23 patients) and patients on
veno-arterial extracorporeal membrane oxygenation (VA-ECMO,
10 %, 23 patients); further breakdown is shown in Fig. 50. The most
prevalent indication for initiation of CRRT was metabolic acidosis
(58.5 %, 134 patients), followed by fluid overload (15.3 %, 24 pa-
tients) and uraemia (13.1 %, 30 patients). 69.9 % of the patients were
haemodynamically unstable when CRRT was initiated (as defined by
the need for two or more vasoactive drugs). The ITU mortality in the
CRRT group was 36.2 % (83 patients) compared with 6.01 % (110 pa-
tients) in the general group admitted to level 3 areas. The mean
length of stay in ITU was 18 days in the CRRT group vs. 3.6 days in
the general level 3 group.
Conclusions: Acute kidney injury is associated with an increased risk
of morbidity, mortality, and length of stay. In our tertiary cardiothor-
acic unit metabolic acidosis is the most frequent indication.
References: Kidney Disease: Improving Global Outcomes (KDIGO) Acute
Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute
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Introduction: New biomarkers are important for early detection of
acute kidney injury (AKI), but few studies have previously evaluated
the stability.
OBJECTIVES The aim of this study was to investigate whether timing
of centrifugation and/or storage time in a refrigerator influenced the
measured concentrations of urinary AKI biomarkers.
Methods: Ten adult intensive care unit patients (with and without
AKI) donated urine aliquoted into 8 aliquots of 2 ml. Half of the ali-
quots were centrifuged (500 RCF, 20 °C, 5 minutes) early (immedi-
ately) and the remaining late (after thawing). Aliquots were stored in
a refrigerator for 0, 1, 2 and 3 days and frozen at −70 °C before ana-
lyses. The measured biomarkers were Cystatin C and Neutrophil
Gelatinase-Associated Lipocalcin (NGAL) using the Bio-Plex Pro Hu-
man Kidney Toxicity Panel 2 assay, and Tissue inhibitor of Metallo-
proteinase 2 (TIMP-2) and Insulin-like Growth Factor-Binding Protein
7 (IGFBP-7) using the NephroCheck test. Measured concentrations
are reported as median (interquartile range), and compared using a
2-tailed paired Wilcoxon signed rank test.
Results: Biomarker concentrations were similar in aliquots with early
versus (vs.) late centrifugation not stored in a refrigerator (Cystatin C
1342 (52–3960) vs. 1173 (56–3887) ng/ml, p = 0.80, NGAL 1296 (42–
3200) vs. 1402 (39–2661) ng/ml, p = 0.26 and NephroCheck 0.22
(0.09-3.10) vs. 0.23 (0.08-2.32), p = 0.77, respectively). Biomarker levels
were comparable in early centrifuged aliquots stored in a refrigerator
for 0 vs. 3 days (Cystatin C 1342 (52–3960) vs. 1312 (61–3834) ng/ml,
p = 0.29, NGAL 1296 (42–3200) vs. 1085 (41–3090) ng/ml, p = 0.26
and NephroCheck 0.22 (0.09-3.10) vs. 0.26 (0.09-2.46), p = 0.29,
respectively).
Conclusions: The measured concentrations of urinary Cystatin C,
NGAL and the NephroCheck test were not influenced by timing of
centrifugation and/or storage in a refrigerator up to three days.
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Introduction: Diverse biomarkers are employed for diagnosis of
acute kidney injury (AKI) and in the last years, new biomarkers are
being studied for the early detection of this disease.
Objective: The aim of this work is to study if measurement of amino-
peptidasic activities in different urine fractions may be of interest in
the early diagnosis of acute kidney injury (AKI) in patients undergone
to cardiac surgery.
Methods: A prospective, single-center and observational study was
carried out in urine samples from patients undergone to cardiac sur-
gery obtained at arrival to Critical Care Unit. Urine samples were cen-
trifugated 10 minutes at 1000 g and supernatants (S1) were
centrifugated 15 minutes at 17000 g to remove cellular fragments
and other debris. Supernatants were subjected to ultracentrifugation
60 minutes at 200.000 g to obtain exosomic fraction and a final
supernatant (S2). Glutamyl aminopeptidase (GluAp) and alanyl
Fig. 50 (abstract A551). Reason for admission
Fig. 51 (abstract A551). Indication for CRRT
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aminopeptidase (AlaAp) activities in the different urine fractions were
quantified by fluorimetry in samples from patients.
Results: The study included 143 patients, 80 of them developed AKI.
GluAp activity was significatively increased in patients that devel-
oped AKI after surgery (p < 0.05 vs. no AKI) in S1 and S2 superna-
tants. AlaAp activity was increased (p < 0.05) only in S2 supernatant.
No differences were found in cellular or exosomic fractions from pa-
tients that developed AKI vs. no AKI patients. ROC-AUCs to distin-
guish AKI from no AKI patients were greater for AlaAp and GluAp in
S2 than in S1 supernatant, and they were also greater than ROC-AUC
for proteinuria, albuminuria, NAG and NGAL.
Conclusions: Aminopeptidasic enzymes can be detected in cellular,
exosomic and soluble fractions of urine. Measurement of GluAp and
AlaAp in soluble fraction improves sensitivity and specificity for early
diagnosis of AKI in patients undergone to cardiac surgery.
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Introduction: Acute kidney injury (AKI) is a common clinical problem
in critically ill patients, independently predicts poor outcome.Despite
significant improvements in therapeutics, its mortality and morbidity
remains high. A major reason for this is the lack of early markers for
AKI and hence an unacceptable delay in initiating therapy. AKI, as a
component of the crush syndrome, is the second cause of death
after direct trauma, although it can be prevented by early and vigor-
ous intravenous fluid therapy .Few studies have evaluated the epi-
demiology of AKI in trauma.
Objectives: To evaluate and compare the predictive value of serum
cystatin-c (Cys-c) with creatine phosphokinase(CPK) for AKI in adult
trauma patients admitted in ICU.
Methods: Retrospective interrogation of prospectively collected data
of 300 adult trauma patients aged≥ 18 years admitted and stayed
more than 24 hours in ICU were done . We measured serum cystatin-c
(Cys-c) and creatine phosphokinase (CPK) of previously collected and
freezed serum samples. Impression of AKI was applied according to RI-
FLE criteria in intensive care unit within first 24 hr (early AKI) then asso-
ciation of Cys-c and CPK with different stages of AKI were evaluated.
Results: The median age was 34.8 (1 8–80) years, 90 % were male.
The crude prevalence of AKI was 193 (65 %) with a maximum RIFLE
category of Risk in 1 21 (40.3 %), Injury in 67 (22.3 %), and Failure 5
(1.7 %). Younger age and male sex were independently associated
with higher risk of AKI in the first 24 hours after trauma . Mean APA-
CHE IV score between AKI and Non-AKI groups were not statistically
different. Considering serum Cys-c, the lower frequency of AKI (1
44,63.2 %) was observed among the patients with Cys-c < 0.78 and
the higher (49, 71 %) among the patients with Cys-c ≥ 0.78 (p value
= 0.001). According to serum CPK, the lowest frequency of AKI (87,
56.1 %) was observed among the patients with CPK < 2000 and the
highest (1 8, 90 %) among the patients with CPK of 5000–1 0000 (p
value = 0.003). For diagnosis of AKI, Cys-c showed to have significant
odds ratio of 5.874 (p value: 0.003 with 95 % CI; 1,79-1 9.23) in com-
parison with CPK which had no correlation (odds ratio of 1). The pre-
dictive diagnostic performance of both Cys-c and CPK were fair on
the first day (area under the curve 0.565 and 0.61 8, respectively) by
plotting ROC curve
Conclusions: In adult trauma victims admitted in ICU, serum Cys-c
but not CPK could predict development of early AKI .
References
1- Mai T. Nguyen & Prasad Devarajan .Biomarkers for the early detection of
acute kidney injury. Pediatr Nephrol 2008; 23:2151–21 57
2- Sean M. Bagshaw, Carol George, R.T. Noel Gibney, Rinaldo Bellomo . A
Multi-Center Evaluation of Early Acute Kidney Injury in Critically Ill Trauma
Patients . Renal Failure 2008; 30:581–589
Grant acknowledgement
This study was financially supported by vice chancellory of research of Shiraz
university of medical sciences.
A555
Predictive model for acute tubular necrosis complications and the
need for early renal replacement therapy
J.A. Diaz1,2, R. Silva1,2, D.J. Garcia1, E. Luis1, M.N. Gomez1, R. Soriano1, P.L.
Gonzalez1
1Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico;
2Universidad de Guanajuato, Intensive Care Unit, Leon, Mexico
Correspondence: J.A. Diaz - Universidad de Guanajuato, Intensive Care
Unit, Leon, Mexico
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A555
Introduction: Acute tubular necrosis (ATN) is an important complica-
tion in critically ill patients and it is associated with the need for early
renal replacement therapy (RRT) and poor prognosis1. It is multifactorial
being the principal causes; hemodynamic instability and systemic in-
flammatory response syndrome2. In patients with AKI, considering the
hemodynamic status with Shock index (SI) and inflammatory response
with serum C reactive protein (CRP) 3 could be predictors for the devel-
opment of ATN and prepare the sources for the potential need of RRT.
Objective: Determine the validity of the Predictive Model for ATN
Complications (PMAC) and the need for early RRT in AKI.
Methods: A prospective study conducted in critically ill adults with
AKI in the Intensive Care Unit from UMAE1 to evaluate the validity of
a predictive model (PMAC) for the development of ATN, complica-
tions and the need for early RRT. Sampling was not probabilistic with
a total of 30 patients. The inclusion criteria were all critically ill adult's
age between 18–75 years old that developed AKI based on the defin-
ition of KDIGO´S Guidelines4 in creatinine value and/or urinary out-
put. We obtained the worst SI (Cardiac rate/Systolic arterial pressure)
from the patient's vital signs registration and obtained CRP serum
level in milligrams per deciliter (mg/dl). PMAC is obtained by the
product of Shock index and CRP. We defined ATN by Sodium excre-
tion fraction (FeNa) more than 2 %, urine nitrogen excretion fraction
(FeUrea) more than 55-63 % and/or the evidence of granular casts in
urinalysis. We also registered the AKI complications and if RRT was
needed in the first 72 hrs.
Results: We evaluated the ROC curves using PMAC. A PMAC ≥ 9.8
predicts development of ATN with a sensitivity of 92 % and specifi-
city of 76 %. PMAC ≥ 14 predicts development of any complication
due to AKI with a sensitivity of 85 % and specificity of 88 %. PMAC ≥
23 predicts the need for early RRT with a sensitivity of 88 % and spe-
cificity of 95 %.
Conclusions: In critically ill patients that present AKI, PMAC is an easy
to obtain, accurately and cheap predictor. A cut off ≥ 9.8 is helpful to
foretell diagnosis of ATN, ≥ 14 predicts development of AKI compli-
cations and ≥ 23 the need for early RRT.
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Introduction: Many concerns are associated with the use of serum
creatinine as the main determination of acute renal injury. The search
for a reliable kidney injury biomarker is an area of continuous re-
search interest.
Objectives: To determine weather uNGAL and/or uIL-18 are good
predictors of acute kidney injury (AKI).
Methods: In this study, we examine urine neutrophil associated lipo-
calin (uNGAL) and urine interleukin (IL)-18 as predictors of AKI in
comparison to serum creatinine in 30 patients admitted to ICU.
Results: We did not find any clear role of both biomarkers in the
diagnosis and evaluation of patients with AKI. Urine NGAL and IL-18
did not show any statistical significance between patients who devel-
oped AKI versus those who did not. Although, our results showed
that uIL-18 is found to be elevated in patients who developed AKI at
the day of ICU admission AUC-ROC 0.805 (95 % CI: 0.514 - 1.0) and a
level of 1000 pg/ml was specific but not sensitive in diagnosing AKI.
Conclusions: Urine NGAL and IL-18 role in diagnosing AKI cannot be
clearly identified by comparing them to serum creatinine owing to
the fact of different clinical value of both biomarkers.
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Time AKI (N=13) No AKI (N=17) ^P
Creatinine Admission 0.82 ± 0.36 0.85 ± 0.27 ^0.747
uNGAL Admission 2.5 (1.3–3.3) 3.8 (1.0–4.8) #0.483
uNGAL Day 1 1.3 (1.3–4.0) 2.5 (0.8–3.8) #0.592
uNGAL Day 2 2.5 (1.3–3.8) 2.5 (1.0–4.0) #0.902
uNGAL Day 3 1.3 (1.0–3.9) 2.5 (1.0–3.9) #0.680
uIL-18 Admission 500 (300–1650) 500 (225–700) #0.432
uIL-18 Day 1 500 (130–750) 500 (200–725) #0.711
uIL-18 Day 2 300 (250–650) 400(130–575) #0.902
uIL-18 Day 3 400 (130–650) 200 (130–500) #0.385
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Introduction: ADVOS® (Hepa Wash GmbH, Munich, Germany) is a
new advanced dialysis device that is approved in the European
Union for treatment of kidney and liver failure. Apart from removing
water soluble and albumin bound substances it is able to counteract
severe acid–base-disequilibrium on an individualized basis.
Objectives: Aim of this study is to quantify the ADVOS®´ efficacy in
improving respiratory acidosis in hypercapnic patients at the inten-
sive care unit.
Methods: Retrospective analysis of patients with acute kidney failure
and respiratory acidosis that were treated with the ADVOS®-device
via a conventional dialysis catheter at an interdisciplinary intensive
care unit.
Results: 10 patients were included in the analysis, 6 (60 %) were
male, the mean age was 58 ± 16 years. All patients were mechanically
ventilated and suffered from severe multiorgan failure. Mean SAPS II
was 50 ± 12 and mean SOFA-Score was 16 ± 3. Parameters of mech-
anical ventilation did not change significantly during treatment with
the ADVOS® device (PEEPpre 11 ± 4 mbar versus PEEPpost 11 ± 4 mbar,
p = ns, FiO2pre 66 ± 21 versus FiO2post 64 ± 24, p = ns, tidal volume pre
371 ± 106 ml versus tidal volumepost 372 ± 109 ml, p = ns, respiratory
ratepre 28 ± 5 /min versus respiratory ratepost 29 ± 6 /min, p = ns).
PaO2/FiO2 prior to treatment was 143 ± 77 mmHg versus 154 ±
70 mmHg at the end of treatment(p = ns).Mean blood flow rate of
the ADVOS® device was 148 ± 68 ml/min, median flow rate of the
concentrate was 160 ml/h and mean dialysate-pH-setting was 8,4 ±
0,5. Unfractioned heparin was used as anticoagulant in 6 patients
and 4 patients had regional citrate anticoagulation. Mean duration of
each treatment session was 16 ± 8 hours.pH and HCO3− increased
significantly during treatment with ADVOS® (pHpre 7,28 ± 0,12 versus
pHpost 7,38 ± 0,1, p < 0,001, HCO3-pre 28 ± 8 mmHg versus HCO3-post
32 ± 9 mmHg, p < 0,01) and PaCO2 decreased significantly (PaCO2pre
66 ± 12 mmHg versus PaCO2post 53 ± 10 mmHg, p < 0,001). We ob-
served significant differences of the acid–base-status pre and post
the ADVOS® device: PvCO2preMem 67 ± 18 mmHg versus PvCO2postMem
24 ± 15 mmHg, p < 0,001, pHpreMem 7,26 ± 0,14 versus pHpostMem 7,74
± 0,23, p < 0,001, HCO3-preMem 27 ± 7 mmHg versus HCO3-postMem 32
± 6 mmHg, p < 0,001). We could not observe any device related side
effects during treatment. 28-survival-rate of the patients was 70 %.
Conclusions: ADVOS® is a new advanced dialysis device that is ap-
proved in the European Union. ADVOS® is able to remove CO2 with-
out an extracorporeal membrane oxygenator and to support patients
with respiratory acidosis.
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Introduction: Acute kidney injury (AKI) occurs in approximately 8-
23 %1,2 of patients on neurointensive care units (NICU) and is an in-
dependent predictor of mortality, multiplying the risk of death by
6.17 times.1 The proportion of patients with chronic diseases is
also increasing with a consequent increase in the number of pa-
tients requiring renal replacement therapy (RRT) on neurointen-
sive care units. The immediate availability of renal replacement
therapy on NICUs in the UK may therefore have an increasingly
important impact on the morbidity and mortality of brain injured
patients in the future.
Methods: A telephone survey of United Kingdom National Health
Service (NHS) adult NICUs was undertaken, with 16 questions to illicit
the logistics of delivery of RRT to NICU patients.
Results: Results were obtained from 81 % (25/31) of the adult neuro-
surgical centres in the NHS. Only 40 % (10/25) of centres have a ded-
icated NICU. Of these, only 4 had nursing staff trained to deliver RRT,
with just 3 units possessing their own RRT equipment. 40 % (4/10) of
the units with a dedicated NICU provided RRT on other intensive
care units within the same hospital versus 33 % (5/15) of neurosurgi-
cal centres with mixed critical care patients. Some centres transferred
their patients to other hospitals within the same trust for renal
replacement therapy (30 % of dedicated NICUs versus none of
the mixed intensive care units). 84 % (21/25) of units had < 30
patients a year requiring RRT. Five units used citrate regional
anticoagulation for the circuit and only 4 units had point of care
testing (ACT, TEG, ROTEM) for monitoring anticoagulation immedi-
ately available on the unit.
Conclusions: There are numerous barriers to the provision of renal
replacement therapy in neurointensive care patients. This survey has
not explored the physiological problems encountered with RRT in
these patients, but has highlighted that the maintenance of training,
competency and logistical problems sometimes affects the consist-
ent, direct availability of RRT to NICU patients. This is especially true
of units without traumatic brain injury patients, where medical staff
may become deskilled in the practice of RRT over time. It also high-
lights the logistical challenges in providing renal replacement ther-
apy in patients who are at high risk of intracranial bleeding without
point of care testing immediately available to monitor the anticoagu-
lation of the circuit.
References
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Table 27 (abstract A556). Diagnostic performance of renal biomarkers
in pred
AUC-ROC SE P 95% CI
Creatinine Admission 0.593 0.112 0.409 0.374–0.813
uNGAL Admission 0.569 0.116 0.544 0.342–0.795
uNGAL Day 1 0.525 0.116 0.827 0.298–0.751
uNGAL Day 2 0.503 0.114 0.981 0.278–0.727
uNGAL Day 3 0.547 0.115 0.680 0.322–0.772
uIL-18 Admission 0.580 0.114 0.482 0.357–0.803
uIL-18 Day 1 0.549 0.115 0.662 0.325–0.774
uIL-18 Day 2 0.560 0.115 0.593 0.334–0.787
uIL-18 Day 3 0.635 0.110 0.234 0.419–0.850
Table 28 (abstract A556). Various biomarkers predictivity to AKI at
admission
Variables AUC-ROC SE P 95% CI
Creatinine 0.506 0.146 0.959 0.220–0.793
uNGAL 0.523 0.125 0.858 0.278–0.768
uIL-18 0.805 0.115 0.017* 0.514–1.000
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Introduction: Advanced cardiac life support (ACLS) has been the rec-
ognized standard of care in cardiac arrest since 1974. Several studies
have demonstrated the importance of adherence to ACLS algorithms
during cardiac arrests in improving return of spontaneous circula-
tion1 and survival to hospital discharge2. However, many residents
feel unsure about their skills in resuscitation, and those who feel
confident may be falsely self-assured3.
Objectives: Analyse the adherence to ACLS guidelines in a standard-
ized simulated cardiac arrest scenario and identify potential obstacles
to guideline conformity.
Methods: This study used an observational design to evaluate ad-
herence to ACLS protocol in residents attending standardized car-
diac event simulations. 36 residents were exposed to the same
scenario of ventricular fibrillation and were filmed and reviewed
by two independent scorers. Their adherence to ACLS protocols
was measured using a standardized checklist based on the 2010
AHA guidelines4.
Results: Overall adherence to ACLS protocol was fair (79.1 %).
Residents consistently performed well in their assessment of the
initial presentation (88.0 % adherence) and their initiation of
chest compressions once pulselessness was detected (97.2 %).
Quality of CPR was high in terms of hand placement, compres-
sion depth, and rate (97.2 %; 88.9 %; 97.2 %); however half
(52.8 %) of the residents failed to place the backboard under the
patient.
Residents struggled to keep CPR interruptions around defibrillation
and rhythm analysis/pulse checks under 10 seconds (55.6 % and
59.7 % respectively). Only 63.9 % of the residents correctly identified
the initial rhythm. No resident delivered a shock in under 1 minute
from rhythm onset and in 36.1 % of cases it took longer than three
minutes from rhythm onset to defibrillation.
Conclusions: In our study residents demonstrated overall satisfactory
adherence to the 2010 ACLS guidelines, especially the detection of
pulselessness and initiation of CPR showed good compliance. Future
training should emphasize correct rhythm analysis and the handling
of CPR interruptions while performing defibrillation and rhythm/pulse
checks - this could lead to a better outcome in patients suffering a
cardiac arrest.
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Introduction: Septic shock is associated with a severe cardiovascular
stress response. Beta-blockade represents a novel way of addressing
this; esmolol titrated to keep heart rate < 95 bpm in critically ill pa-
tients receiving high-dose noradrenaline resulted in improved out-
comes [1]. We measured a series of biomarkers of cardiac stress and
injury in an observational study of critically ill patients with septic
shock. We then used a long-term fluid-resuscitated rat model of sep-
sis to assess the same cardiac markers.
Objectives. To measure the degree of cardiac stress in critical illness
using the biomarkers of cardiac injury, troponin T (cTnT) and of ven-
tricular dysfunction, B-natriuretic peptide (BNP).
Methods: Study 1: Observational study of 27 critically ill patients with
septic shock from faecal peritonitis or community-acquired pneumo-
nia. Daily measurements of cTnT and BNP were performed on days 0
to 3 (measured by ELISA).
Study 2: Awake, instrumented yet fully mobile male Wistar rats (350
± 50 g) received an intraperitoneal injection of faecal slurry to induce
sepsis. Fluid resuscitation (crystalloid 10 ml/kg/h) was commenced at
2 h. At 6 h, an echo-measured stroke volume rate cut-off of 0.20 ml
was used to classify animals into predicted survivors (S) or non-
survivors (NS) (n = 6 per group). Blood was sampled at 6 h and 24 h
for cTnT and BNP (ELISA). Control animals were treated identically ex-
cept for faecal slurry injection.
Results were analysed using two-way ANOVA and post-hoc testing
and considered statistically significant when p < 0.05.
Results: cTNT was significantly elevated in critically ill patients on the
day of ICU admission, and was significantly higher in NS (Fig. 55).
BNP was significantly elevated in NS patients only. Likewise, in the
experimental model of sepsis (Fig. 56), non-surviving rats had an
early elevation of the same cardiac biomarkers. (p < 0.05 for both
cTnT and BNP compared to survivors).
Conclusions: Sepsis is associated with excess cardiac stress, as dem-
onstrated in both a critically ill patient population and in a rat model
of faecal peritonitis. Whether beta-blockade can be used to amelior-
ate this cardiac stress is the subject of further studies.
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Fig. 55 (abstract A560). ICU patient levels of (a) BNP and
(b) Troponin
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Introduction: Sepsis is characterized by life threatening organ dys-
function with dysregulated immune response. Cardiac dysfunction
seen in sepsis is unique as it is reversible within 7–10 days. Parker et
al1 in 1984, showed paradoxically,lower ejection fraction in survivors
of septic shock. It was suggested that non survivors,were unable to
correct the vasoplegia(reduced systemic vascular resistance). This
view has been questioned by a recent meta-analysis2. A prognostic
model combining biomarkers like Troponin I and echocardiographic
parameters has not been well described.
Objectives: To assess sepsis induced cardiac dysfunction by 2D echo-
cardiography and Troponin I.
Methods: After obtaining institutional ethical committee approval,a
prospective observational study was done in an university medical
college from February 2016 to April 2016. Inclusion criteria were pa-
tients diagnosed with sepsis3. Pregnant patients and patients with
poor echo window were excluded. Echocardiographic assessment
was done within 48 hrs of diagnosis of sepsis by standard methods.
Primary outcome was ICU mortality and secondary outcome was ICU
length of stay. Statistical analysis was done using STATA12™.Indepen-
dent variables identified as significant in a bivariate analysis were in-
cluded as co-variates in a logistic regression model with outcome as
the dependent variable. Discrimination and calibration were assessed
by receiver operating characteristics(ROC) and Hosmer-Lemeshow
goodness of fit tests.
Results: Fifty eight patients were screened, ten were excluded due to
poor echo window. Baseline characteristics and Troponin I were simi-
lar in survivors and non survivors, except APACHE II, SOFA and age.
Echocardiographic parameters, MAPSE, a`and E/e` were found to be
statistically significant. In the logistic predictive model only APACHE
II and MAPSE were found to be significant co-variates.(APACHEII co-
ef 0.4869 p = 0.02, MAPSE −9.3672 p = 0.04, constant 0.7109). The dis-
crimination of this model was good ROC(0.95) and calibration was
satisfactory(chi2(df8),1.98, p = 0.98).
Conclusions: Sepsis induced cardiac dysfunction assessed by echo-
cardiography showed measurement of MAPSE when combined with
APACHE II was a good predictor of mortality. Results of this study
need further validation from larger study.
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Introduction: The therapeutic use of hyperoxic ventilation in critically
ill patients is controversial. A major concern is the induction of arteri-
olar vasoconstriction with subsequent microvascular hypoperfusion.
Recently, severe sublingual microcirculatory alterations were reported
with high oxygen inspired fraction in healthy volunteers.
Objective: To show the effects of short-term hyperoxic ventilation on
sublingual microcirculation and peripheral perfusion in patients with
septic shock.
Methods: The sublingual microcirculation was assessed by SDF-
videomicroscopy in 11 patients with septic shock during normoxic
ventilation and after 5 minutes of ventilation with FiO2 = 1.0. We also
evaluated the capillary refill time (CRT). To rule out a delayed effect
of hyperoxia, we studied 8 healthy volunteers in normoxia, and after
5´and 30´ of 100 % oxygen through a nasal mask.
Results: In patients with septic shock, hyperoxic ventilation increased
arterial PO2 from 75 [67–82] to 312 [278–415] mm Hg. Sublingual
microcirculation (Fig. 57) and CRT (6.0 [4.0-9.4] vs. 8.3 [3.4-10.6])
remained unchanged. In normal subjects, arterial PO2 reached 388
Fig. 56 (abstract A560). Rat sepsis levels of (a) BNP and
(b) Troponin
Table 29 (abstract A561). Patient characteristics
Variable Survivors n=29 Non Survivors n=18 P value
Age 54.89(12.61) 65.94(11.51) 0.003
APACHE II 16.34(4.91) 25.84(6.44) <0.001
SOFA 4.86(2.58) 10.57(3.70) <0.001
a` 10.45(2.79) 7.99(3.31) 0.012
E/e` 6.32(1.75) 8.03(2.79) 0.025
MAPSE 0.026(Mann-Whitney U test
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[359–421] mm Hg after 5´of high FiO2. After 5´and 30´ of hyperoxia,
there was no change in either sublingual perfusion or CRT.
Conclusions: In patients with septic shock and in healthy volunteers,
short-term hyperoxic ventilation neither modified sublilgual microcir-
culation nor peripheral perfusion.
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Introduction: Many drugs are recommended as first-line vasopressor
agents in the treatment of shock. There is a continuing controversy
about whether one agent is superior to the other.
Objectives: To synthesise the evidence from trials using a multiple
treatment comparison methods thereby permitting a broader com-
parison across multiple therapies.
Methods: Randomised controlled trials in patients with shock of
vasopressor drugs were identified from MEDLINE, Embase, and
Cochrane Central Register of Controlled Trials through July 2015. We
performed a random-effects model within a Bayesian framework
using Markov Chain Monte Carlo simulation to calculate pooled Odds
Ratio and 95 % credibility intervals. The main outcome measure was
death from any cause in-intensive care unit, in-hospital or 28 days.
Results: We identified 23 studies with 4,406 patients allocated to 10
treatments: dopamine, epinephrine, terlipressin, phenilephrine, and
norepinephrine alone or combined with dobutamine, dopexamine,
terlipressin and dobutamine or vasopressin. First, pair-wise meta-
analyses with a random-effects model were carried out. Second, a
random-effects model multitreatment meta-analysis within a Bayes-
ian framework (using Markov Chain Monte Carlo simulation) was
performed.
We performed 2 sensitivity analyses:
1) using only septic shock subgroups and
2) double blinded trials with intention to treat analysis.
We performed 45 comparisons. There was no significant between-
group difference in the rate of death. In sensitivity analyses, the re-
sults were qualitatively similar to the results obtained with 23
studies.
Conclusions: There were no significant differences in the rate of
death between patients with shock who were treated with any vaso-
pressor agent.
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Introduction: Hyperglycemia is a feature of septic patient and has
been associated with poor outcome and higher mortality. In contrast
insulin has been shown to decrease mortality and to prevent the in-
cidence of multi-organ failure but is often associated with deleterious
hypoglycemia. Protein Tyrosine Phosphatase 1B (PTP1B) is a negative
regulator of insulin signaling and NO production. We found that
PTP1B inhibition or gene deletion improved mesenteric endothelial
function, reduced cardiac and vascular inflammatory markers, leading
to reduced cardiac dysfunction.
Objectives: The purpose of the present study was to assess the poten-
tial therapeutic effect of total PTP1B invalidation on glucose metabolism
and cardiovascular insulin resistance using experimental model of sepsis.
Methods: Thus, in order to address this question, we developed a
Cecal Ligation and Puncture (CLP) model of sepsis. CLP is followed
by subcutaneous fluid resuscitation. To evaluate the potential thera-
peutic effect of PTP1B invalidation, we used PTP1B−/− mice.
Results: Indirect calorimetry study showed that CLP induced a signifi-
cative diminution of VO2 inspired, VCO2 expired, physical activity
with food and water consumption. This study characterizes a severity
of our CLP model without difference between WT vs PTP1B−/−.
Although this severe model, PTP1B−/− mice showed improved GTT
and ITT. Moreover, the limited increase of insulinemia in CLP PTP1B
−/− mice emphasizes the improvement of glucose metabolism.
Moreover, the heart expression of cytokines showed a significative
increase of inflammation and oxidative stress in WT CLP mice com-
pared with PTP1B−/− mice. Plasmatic dosage of insulin before and
15 minutes after glucose injection showed an elevation of insulin
concentration in WT CLP mice showing a functional pancreas.
Insulin- and flow-mediated dilatation assessed in isolated-perfused
mesenteric arteries was abolished in WT CLP mice and was improved
in PTP1B−/− mice.
Isolated perfused heart study showed that CLP induced a significa-
tive reduction of left ventricular developed pressure and cardiac effi-
ciency in WT and PTP1B−/− mice. However, efficiency cardiac study
showed a different utilization of substrate between WT CLP and
PTP1B−/− CLP, WT sham and PTP1B−/− sham.
Moreover, we showed that PI3k/Akt molecular pathway is functional in
CLP mice suggesting a GLUT4 expression or translocation alteration. In
fact, GLUT4 expression study showed that in plasma membrane fraction
and endosome fraction, GLUT4 expression is abolished in WT CLP mice.
We also found that PTP1B−/− mice subjected to CLP had a higher sur-
vival rate compared to WT.
Fig. 57 (abstract A562).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 292 of 607
Conclusions: CLP-induced sepsis changes the carbohydrate mechan-
istic by abolishing GLUT4 expression and PTP1B inhibition restores
GLUT4 expression and improves metabolic function, cardiovascular
function and survival. This suggests that, PTP1B inhibition may be an
attractive target for the treatment of sepsis.
Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.
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Introduction: Septic shock is a condition of extreme physiological stress
associated with significant haemodynamic, immune and hormonal ab-
normalities. Beta-blocker therapy is associated with improved organ dys-
function and survival in patients with severe, prolonged septic shock [1].
Precise mechanisms of putative benefit however remain uncertain.
Objective: To investigate the impact of esmolol on the inflammatory
and catecholamine stress response during sepsis.
Methods: We used an awake, fluid-resuscitated rat model of faecal
peritonitis in which 72 h mortality can be accurately predicted at 6 h
post-insult by stroke volume (<0.20 ml) [2] and interleukin(IL)-6 [3].
After the 6 h echocardiogram, rats were randomised to receive either
esmolol (75 mcg/kg/min, preceded by a loading dose of 500 mcg/kg
for one minute) or equivalent volume of placebo for the next
18 hours. Rats (n = 12) then underwent repeat echocardiography,
followed by terminal blood and tissue sampling. This included plasma
levels of IL-6 (pro-inflammatory cytokine) and IL-10 (anti-inflammatory
cytokine) (ELISA, BD Biosciences) and catecholamine levels (ELISA,
Cusabio). Comparison was made against non-septic control rats (n = 6).
Results were analysed using two-way ANOVA with post-hoc testing,
and considered statistically significant when p < 0.05.
Results: Septic animals had increased levels of IL-6 and IL-10 at 24 h
that were greater in predicted non-survivors (Table 30). Esmolol sig-
nificantly decreased IL-6 levels in both predicted survivors and non-
survivors compared to placebo-treated rats, whereas IL-10 levels
were increased by esmolol. However, no change was seen in cat-
echolamine levels.
Conclusions: Treatment with esmolol altered plasma cytokine bal-
ance towards a more anti-inflammatory profile in both predicted sur-
vivors and non-survivors in this model of faecal peritonitis. However,
circulating catecholamines were unaffected.
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Introduction: Hospitalized patients often receive oxygen supplemen-
tation, which may lead to a supraphysiological oxygen tension
(hyperoxia). Hyperoxia has hemodynamic effects, including an in-
crease in systemic vascular resistance suggesting arteriolar vasocon-
striction. Despite several in-vivo, ex-vivo and in-vitro studies
involving humans and various types of animals, the mechanism be-
hind hyperoxia-induced vasoconstriction remains unclear. To en-
hance our understanding of this phenomenon, we set out to
develop an experimental model of hyperoxia-induced vasoconstric-
tion in murine vessels.
Objectives: To develop an ex-vivo mouse model to study the under-
lying mechanisms of hyperoxic vasoconstriction.
Methods: Femoral arteries (conduit vessel) and gracilis- and mesen-
teric arterioles (resistance vessels) were isolated from 10–12 week old
C57BL/6 mice. Vessels were pre-constricted with noradrenaline to ap-
proximately 50 % of their maximal diameter for vasodilation studies.
Mesenteric arteries developed spontaneous myogenic tone. Agonist
induced endothelium-dependent (acetylcholine, arachidonic acid)
and -independent (nitroprusside, noradrenaline) dilation and con-
striction were examined under normoxic (PO2 ~ 80 mmHg) and sev-
eral hyperoxic conditions (PO2 ~ 220, ~350 and ~660 mmHg) using
no-flow pressure myography.
Results: Oxygen tension did not influence the endothelium-
dependent dilation of femoral arteries (Fig. 58, left) or gracilis arteri-
oles (Fig. 58, right). Endothelium independent dilation was not af-
fected either. Comparably, oxygen tensions also did not influence
the degree of spontaneous myogenic tone of mesenteric arteries or
the response to arachidonic acid or noradrenaline.
Conclusions: In this study, the isolated femoral artery and gracilis
and mesenteric resistance arterioles from mice did not show altered
vascular tone responses under hyperoxic conditions. We therefore
discourage researchers to use these vessels for mechanistic research
of hyperoxic vasoconstriction.
Table 30 (abstract A565). Data shown as median (IQR); ^p<0.05 versus
placebo
Control (n=6) Predicted survival
(n=7)
Predicted non-
survival (n=5)
IL-6 (ng/mL) Placebo 0.1 (0.0–0.1) 2.1 (2.0–3.5) 12.9 (8.2–18.4)
Esmolol - 1.4 (1.0–1.7) ^ 3.0 (2.2–4.5) ^
IL-10 (ng/mL) Placebo 0.0 (0.0–0.1) 0.4 (0.2–0.6) 0.7 (0.4–1.0)
Esmolol - 1.4 (1.3–3.2) ^ 1.2 (0.7–3.2)
Adrenaline (ng/mL) Placebo 5.5 (4.7–6.3) 7.1 (5.3–15.4) 6.2 (5.5–12.8)
Esmolol - 6.4 (5.2–12.3) 8.9 (7.0–9.3)
Noradrenaline
(ng/mL)
Placebo 0.5 (0.2–0.7) 3.2 (2.9–4.8) 3.2 (1.2–5.1)
Esmolol - 2.6 (2.0–3.5) 3.0 (1.4–5.0)
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Introduction: The mechanisms of persistent hyperlactemia during
endotoxic shock are probably multifactorial. Both hypoperfusionre-
lated anaerobic production and adrenergicdriven aerobic generation
have been implicated. More recently an early and severe impairment
in exogenous lactate clearance has also been described [1]. Theoret-
ically, an excessive adrenergic response could influence all these
mechanisms and thus aggravate the problem. Some small experi-
mental and clinical studies have shown favorable effects on heart
rate and hemodynamic or perfusion parameters, and also in inflam-
matory and metabolic parameters with beta-blockers. Esmolol (ESM)
a short-acting selective beta-blocker has demonstrated to improve
cardiac contractibility and vascular reactivity probably in relation to
an anti-inflammatory effect. In a randomized-controlled study in
stable septic shock patients, esmolol reduced heart rate (HR), de-
creased fluid requirements and lactate levels, and surprisingly
showed a significant effect on mortality.
Objectives: To assess the effects of ESM on lactate production and
exogenous lactate clearance in an endotoxic shock model.
Methods: Twelve anesthetized sheep were subjected to a multi-
modal hemodynamic/perfusion assessment including hepatic and
portal vein catheterizations, total hepatic blood flow, sublingual
microcirculation, and muscle microdialysis. After the monitoring
phase, all received a 5 mcg/kg LPS bolus (E coli O127:B8®) and then
4 mcg•kg1•hr1 for the rest of the experiment. After 1 hr they were
volume resuscitated, and then randomized to LPS-control or LPS-
ESM. Sampling and exogenous lactate clearances at different time-
points (Fig. 59).
ESM was started at 15 mg/h and titrated every 5 minutes to achieve
a reduction of 20-30 % in relation to HR at point B.
Results: ESM was hemodynamically well tolerated. Despite progres-
sive hypotension in both groups, ESM was associated with lower ar-
terial and portal vein lactate levels. Exogenous lactate clearance was
significantly higher in ESM treated animals Table 31.
Conclusions: Esmolol was associated with lower arterial and portal
lactate levels, and less impairment of exogenous lactate clearance in
a model of septic shock. The use of ESM appears to be associated
with beneficial effects on gut lactate generation and lactate clear-
ance and exhibits no negative impact on systemic hemodynamics.
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Introduction: Evaluation of cardiomechanics (end-systolic and arterial
elastances), ventricular arterial coupling (VAC) and dynamic elastance
(dynEl) in the critical care patient treated for septic shock has been
recently addressed [1,2].
Objectives: To measured the effects of conventional treatment on
cardiomechanics, VAC and dynEl in acute septic shock patients.
Methods: In 22 intensive care septic shock patients of different aeti-
ologies we measured routine hemodynamic parameters such as
mean arterial pressure (MAP), cardiac index (CI), pulse pressure and
stroke volume variation (PPV, SVV) via pulse contour method, as well
as VAC by the non invasively method of Chen et al.[3]. We calculated
dynEl as SVV/PPV. We performed measurements prior to (T0) and
after 20 ml/kg fluid challenges (T1). In a subgroup of 6 patients vaso-
pressor support was also given between T0 and T1.
Results: In a multivariate analysis VAC was found to improve signifi-
cantly in the fluid responder group (p = 0.005) after fluid resuscita-
tion. Arterial elastance, which is a determinant of VAC was
significantly reduced in those patients (p = 0.01) and dynEl, although
not significantly, decreased. Not surprisingly we found a high correl-
ation between dynEl and Ea.In those also receiving vasopressor ther-
apy similar changes occurred.
Fig. 58 (abstract A566). Endothelium dependent vasodilation
Fig. 59 (abstract A567).
Table 31 (abstract A567).
Variable Group A B C D p
Arterial lactate
(mmol/L)
Control
ESM
2.0 ± 0.5
1.6 ± 0.4
5.1 ± 1.8
3.7 ± 0.9
8.1 ± 1.7
3.6 ± 1.0b
9.2 ± 1.8
4.5 ± 1.1b
a
a
Muscle lactate
(mmol/L)
Control
ESM
3.8 ±2.0
3.3 ± 1.7
4.6 ± 1.3
3.6 ± 3.2
5.1 ± 1.3
5.0 ± 3.8
6.9 ± 3.5
5.4 ± 2.6
a
Lactate
clearance
(ml/kg/min)
Control
ESM
2.43 ±1.14
7.32 ± 2.20b
Portal vein lactate
(mmol/L)
Control
ESM
2.0± 0.5
1.1 ± 0.4b
4.2± 1.4
2.4 ± 0.7b
6.4±1.0 2.9
± 0.9b
8.1± 1.1
4.0 ± 1.1b
a
a
aSignificant changes over time within groups (comparison made with
Friedman test and post-hoc Bonferroni correction)
bSignificant difference between control group and ESM group, respectively at
the same time point (Comparison made with Mann-Whitney U test
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Conclusions: Advanced bedside hemodynamic assessment is pos-
sible and underscore the potential value of defining the pathophysio-
logic mechanisms involved in septic shock. Although preliminary, we
speculate that patients with low Ea, (higher VAC and lower dynEL)
and low MAP would be fluid responders, whereas those with normal
or high MAP and low Ea (high VAC and lower dynEl) fluid non-
responders.
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Introduction: Persistent hyperlactatemia after initial septic shock re-
suscitation is associated with bad prognosis. However, at least three
mechanisms are involved: anaerobic glycolysis in hypoperfused tis-
sues, adrenergic-driven aerobic glycolysis and impaired lactate clear-
ance. Only the first mechanism is sensitive to further resuscitation.
Thus pursuing lactate normalization with additional fluids while con-
fronted to non-hypoxic causes could lead to the toxicity of over-
resuscitation with no clinical benefit. To develop clinical algorithms
aimed at differentiating hypoxic vs non-hypoxic profiles could have
relevant clinical consequences.
We hypothetized that a multimodal perfusion monitoring will aid in
this purpose, since the presence of low ScvO2, or increased central
venous-arterial pCO2 gradient, or an impaired peripheral perfusion
together with hyperlactatemia might identify a hypoxic-related
phenotype. This phenotype could be associated with worse out-
comes as compared with a non-hypoxic profile.
Objectives: To address this subject we perfomed a proof-of-concept
retrospective study to assess if this approach can effectively differen-
tiate two clinical phenotypes among hyperlactatemic septic shock
patients.
Methods: Retrospective analysis of a prospective database of pa-
tients with septic shock admitted to our ICU during the calendar year
of 2014. Patients with persistent hyperlactatemia committed to full
resuscitation and with complete multimodal perfusion monitoring
and follow up after initial resuscitation were included. Statistical ana-
lysis included t-test and chi-square.
Results: 44 patients (age 64 ± 16y, APACHE II 21 ± 7, SOFA 9.9 ± 3.5,
abdominal and pulmonary main sepsis sources, hospital mortality
13.6 %) were included. No difference in basal severity, hospital mor-
tality, first 24 h fluids, cardiac index or NE requirements between pa-
tients with an hypoxic (36) compared to anon-hypoxic (8) lactate
profile was observed. Other results are shown in Table 32.
Conclusions: Patients with a hypoxic-lactate profile required more
days in the ICU, and tended to receive more MV. They also received
more rescue therapies and inodilators. A multimodal perfusion
monitoring might be useful to recognize a hypoxic profile among
septic shock patients with persistent hyperlactatemia that appears to
be associated with worse outcomes and a more complex manage-
ment. Our findings should be validated in prospective studies.
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Introduction: As a potent vasoconstrictor, vasopressors play a critical
role in the management of fluid resistant hypotension in septic shock
for maintain the mean arterial pressure more than 65 mm Hg. Be-
cause of the wide variability in individual vasopressor requirement,
the absolute maximum dose of vasopressor is difficult to determine.
In general, when starting vasopressors, their doses should be titrated
to the desired effect by closely monitoring the adverse effects such
as hypoperfusion (particularly affecting the extremities, mesentery or
kidneys), dysrhythmias, myocardial ischemia, local effects, and
hyperglycemia.
Objectives: We conducted the present study to assess the risk factors
of inadequate perfusion of extremities during the vasopressors treat-
ment in patients with severe septic shock.
Methods: In this cross-sectional study, we evaluated the medical re-
cords of 73 patients who received vasopressors such as norepineph-
rine (NE), epinephrine, dopamine, vasopressin and dobutamine more
than 48 hours in patients with severe septic shock in the medical in-
tensive care unit at a tertiary university-affiliated hospital, from April
2014 to December 2015. The patients were stratified into ischemia or
non-ischemia (control) groups according to whether peripheral ische-
mia developed or not.
Results: A total 73 patients with septic shock were introduced vaso-
pressors more than 48 hours. Basically, NE introduced in all patients
but more than 2 vasopressors were 28, and 3 more than vasopres-
sors were 14. Peripheral ischemic insults including color changes oc-
curred in 43 patients (60 %). The median onset time for peripheral
Table 32 (abstract A568).
All patients
(44)
Hypoxic (36) Non Hypoxic (8) P
value
Arterial lactate
(mmol/l)
4.8 ± 3.2 4.9 ± 3.4 (0 h) 3.4
±2.9 (6 h) 2.5
±1.7 (24 h
3.8 ± 1.4 (0 h) 4.0
±1.9 (6 h) 2.7
±2.1 (24 h)
ns
Venous O2
saturation (%)
73 ± 8 72± 9 78 ± 5 0.02
Venous-arterial
pCO2 gradient
(mmHg)
7.2 ± 0.5 8.4 ± 2.2 3.4 ± 1.5 <0.001
Capillary refill
time (s)
4 ± 2 5 ± 2 3 ± 1 <0.001
ICU length of stay 13 ± 11 14 ± 12 9 ± 4 0.03
Mechanical ventilation
(MV) days
8 ± 8 9± 9 6 ± 2 0.11
Hospital length of
stay
25 (1–96) 27 ± 22 19 ± 12 0.13
Rescue therapy with
high-volume
hemofiltration (pts)
5 5 (14%)
Inodilators use (pts) 7 7 (19%)
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ischemia was 3.7 ± 4.2 days. Past medical conditions such as dia-
betes, hypertension, dyslipidemia, and cerebrovascular accidents,
and clinical severities such as APACHE (Acute Physiology and Chronic
Health Evaluation) II score, SAPS (severity of disease classification sys-
tem), and SOFA (Sepsis-related Organ Failure Assessment) scores
were not significant changes between the ischemic and non-
ischemic groups. Lower body mass index (BMI) (20.0 % ± 5.4 % vs.
22.4 ± 2.9, respectively p < 0.05), need for additional inotropics, dobu-
tamine (23 % vs. 3.3 %, respectively p < 0.05), and need for renal re-
placement therapy (76.7 % vs. 36.7 %, respectively p < 0.01) were
significant differences between the ischemic and non-ischemic
groups. While the patients who had ischemic insults were signifi-
cantly higher mortality, combined vasopressors more than 2 drugs
were not significant.
Conclusions: The use of vasopressors and its combined use more
than 2 drugs may not influence on the development of peripheral is-
chemia in patients with severe septic shock. In the future, prospect-
ive studies are needed to suggest opinions for avoiding serious
peripheral ischemia in vasopressor introduce.
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Introduction and objectives: Postoperative cognitive dysfunction
(POCD) after cardiac surgery is a common complication with an un-
clear pathophysiology leading to significant morbidity. Goal of study
was to examine the causes of cognitive impairment after cardiopul-
monary bypass.
Methods: 84 consecutive, unselected patients undergoing CABG
and/or valve procedures using CPB entered the study. Exclusion cri-
teria included:recent stroke, high -grade carotid stenosis, chronic
renal failure, hepatic insufficiency,aortic arch procedures, psychiatric
desease.All pts were administered a validated neurocognitive battery
(Mini Mental State Examination, Visual Memory Test) preoperatively,
postoperatively prior to discharge (5–7 postoprtative day), and
3 months after operation. C-reactive protein (CRP) is also quantified
from serum preoperatively, 6 h after operation and on discharge. Im-
pact of hemodynamicaly stability, hypo- and normothermia, postop-
erative drainage, antifibrinolytics, age, time of CPB on POCD was
assessed. T-test, Scheffe's test and ANOVA were used to demonstrate
statistical significance.
Results: The incidence of early POCD was 17.9 % (15/84). Mini Mental
State Examination on discharge was significantly impaired in this group
compared with preoperative level (P = 0.023) especially in subtests such
as orientation to time,attention, short-term memory, registration,
exspressive speech. Visual memory test failed to detect this cognitive
impairment.But, 21.3%pts (18/84) showed cognitive improvement on
discharge compared with preoperative level(p = 0.034).All pts with POCD
were hemodinamicaly stable, without excessive postoperative drainage,
without prolonged mechanical ventilation and infection. Baseline patient
characteristics and key perioperative data were similar between patients
who developed early POCD compared with those who did not develop
POCD (P = 0.372) . Pts with POCD had significantly elevated CRP at 6 h
time point and on discharge compared with preoperative level (50.44 ±
7.3 vs.4.75 ± 1.18; p < 0,01 and 148.47 ± 5.32 vs. 4.75 ± 2.18;p < 0.001).
Conclusion: Inflammatory stress is associated with POCD post CPB.
Why some pts develop higher stress level leading to POCD is currently
unknown. We dont know whether POCD is transient phenomenon,
because data of psichometric tests after 3 months are lacking (research
continues, we will have complete data for 3–6 months).
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Introduction: Traumatic brain injury (TBI) is a major cause of death
and disability, particularly in the young(1). Traditionally, primary
therapeutic hypothermia (PTH) was seen to be beneficial, and there
has been reported evidence of modest hypothermia as a neuropro-
tectant that improved outcomes(2). However, most recent evidence
revealed, when high quality trials were analysed, that the benefits of
PTH on mortality and neurological outcome were lost(3). In addition,
many studies have shown PTH to cause adverse effects(4).
Objectives: Our aim was to assess how the use of PTH for TBI has
evolved in the United Kingdom in light of recent evidence.
Methods: We conducted a survey of 20 neuro-critical care units across
the UK in 2010 and 2015. An electronic questionnaire examined local
protocols for PTH, triggers for commencing and discontinuation, target
temperature ranges, use of muscle relaxants, cooling equipment, moni-
toring and complications. A follow-up survey was conducted to assess
for a change in local guidelines in view of recent evidence.
Results: In 2010, 90 % of the 20 neuro-critical care units had guide-
lines for the management of TBI, 89 % of which included PTH as part
of their management: 37 % targeted a temperature of 33-34 °C, 42 %
targeted 34-35 °C, 16 % targeted 35-36 °C, while 5 % normothermia.
Practice showed wide variation between units with regards to trig-
gers for starting PTH (for ICP control: 85 % and all severe TBI: 15 %),
stopping PTH (ICP target: 82 %, a set time limit: 18 %), cooling equip-
ment (intravascular 38 %, convection methods 62 %), temperature
monitoring (rectal, oesophageal and intravascular) use of muscle re-
laxants (always with PTH 35 %, only with shivering 65 %), neuro-
monitors (ICP and transcranial doppler are most common) and most
encountered complications (immunoparesis and infection, cold diur-
esis, dysrhythmias and electrolyte imbalance). The 2015 follow-up
survey, in contrast, showed that all surveyed hospitals now have
guidelines for the management of TBI,and that PTH is no longer part
of these guidelines, with 100 % of responding hospitals now target-
ing normothermia.
Conclusions: The follow-up survey suggests that the use of PTH has
fallen dramatically out of favour in UK neuro-critical care units since
2010. Recent evidence casts doubt on the benefits and suggest the
possibility of harm.This has likely contributed to the trend of main-
taining normal body temperature.
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Introduction: Organ transplantation has become an important treat-
ment option for patients with end-stage organ failure with the ad-
vances in the technology and related medical sciences. It is very
important to improve the health care professionals' knowledge and
awareness on organ donation and transplantation along with the
safety and quality of donor organs.
Objectives: The main goal of the TNA Study was to identify weak
points or 'gaps' in the professional's knowledge in organ donation
and transplantation procedures in Turkey.
Methods: This cross sectional study was conducted via both quali-
tative and quantitative research methods during April 2013-May
2014. The questionnaire was related to obstacles, strengths, weak-
nesses and opportunities in the Turkish donor programme. The
main purpose of the interview was to obtain in-depth insight into
the training needs of Turkish transplant experts. A World Health
Organization licensed Hennessy-Hicks training needs analysis
questions (Hennessy, Hicks 2013) were incorporated in the assess-
ment were used.
Results: The questionnaire was disseminated randomly among 134
health personnel (50 doctors and 84 nurses) involved in Turkish
donor programme. The analysis of the questionnaires revealed that
the knowledge about brain death (BD) diagnostics was not good
enough in the study population. Furthermore, the group of all re-
spondents was not experienced in the brain death determination:
22 % of them have not determined BD yet, 30 % of respondents 1–3
times, and only 20 % of respondents among doctors have deter-
mined BD more that 10 times. In doctors group, only 69,6 % of re-
spondents perceive it as biological death - the percentage should be
higher indicating no doubts in the concept of BD. A big part (32 %)
of respondents estimated their acquaintance with donation proce-
dures and organization of the national donation programme as little;
26 % are somewhat acquainted and 13 % not at all. Regrettably,
20 % of all respondents (%12 of doctors) do not absolutely support
organ donation. And 4 % would not accept an organ from a
deceased donor if needed. Furthermore, the results of self-evaluation
of communication knowledge, skills and experiences for the perform-
ance of family interviews were too low: only 2 % of all respondents
feel to have very much of knowledge, skills and experiences and
20 % feel they have not at all enough knowledge or skills for per-
forming the discussions.
Conclusions: The results of the interviews revealed that lack of know-
ledge, awareness, responsibility and positive attitude towards about
BD diagnosis and organ donation process of medical staff and
nurses. Finally, lack of knowledge, skills and experiences related to
the communication with the family.
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Introduction: There are currently over 120,000 people awaiting for a
lifesaving organ transplant in the US with 22 patients per day dying
on the waiting list.1 An organ shortage is also the case for most Euro-
pean countries. Furthermore, the demand is rising due to increasing
burden of certain types of organ failure, and widening eligibility cri-
teria for transplants. In regards to procurement policies the debate is
often exhausted between opt-in and opt-out, and not enough atten-
tion has been devoted to a “non-opt” policy. Such a policy, in the lit-
erature, is better known as organ conscription.2, 3 Conscription
entails the routine procurement of organs from the dead, making
consent and family veto irrelevant. The policy tends to be uncritically
rejected as being an extreme utilitarian position that violates core
deontological side-constraints such as autonomy and personal
sovereignty.
Objectives: To examine the permissibility of conscription via norma-
tive ethics and formal justice analyses.
Methods: Systematic review of the literature on the arguments
for and against conscription to describe the current state of the
debate. Subsequently and from a moral theory standpoint the
policy is examined under the light of major normative theories
such as consequentialism, deontology, and “mixed” views such
as Parfit's triple theory. From a formal justice perspective, I em-
ploy Rawls's liberal principle of legitimacy and Sen's capabilities
approach.
Results: There are three strands of arguments for and against
conscription. These are based on normative ethics, justice and
metaphysics. Contrary to main-stream views, conscription is not
only defensible in consequentialist terms but obtains an even
stronger force when examined under a deontological and mixed-
theory lights, as well as formal justice theory. Potential conscrip-
tion from patients who have been declared dead by neurologic
criteria has been estimated to increase organ supply by many
thousands per year.
Conclusions: We ought to reconsider our procurement policy in
order to face organ shortage in ways that are ethical, just and max-
imally efficient. Organ conscription is such a policy.
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Introduction: Pain and anxiety are distressing for patients in inten-
sive care units (ICUs) and effective pain and anxiety assessment and
management are problematic in ICU settings. Existing research iden-
tifying the level and trajectory of pain and anxiety patterns in ICU pa-
tients during the first days of ICU treatment is limited, as is
information on patients' needs regarding analgosedation.
Objectives: To examine pain and anxiety patterns in ICU patients
during the first three ICU days, and to identify patient preferences
for analgosedation.
Methods: A prospective study was performed in the University Hos-
pital Interdisciplinary (medical-surgical) ICU. Pain was assessed every
four hours during the first three ICU days. Pain intensity was mea-
sured with a numeric rating scale (NRS), verbal rating scale (VRS), and
behavioral assessment scale. Anxiety was assessed every 8 hours with
either the NRS or VRS. Depth of sedation was measured using the
Richmond Agitation-Sedation Scale (RASS). Patient preferences re-
garding analgosedation were assessed one week following ICU dis-
charge using semi-structured interviews. Descriptive analyses were
performed to identify pain and anxiety patterns and patient
preferences.
Results: The sample consisted of 141 ICU patients (mean age: 68.77).
The majority (55 %) were treated for heart disease. Patients were
treated in the ICU on average for 4.6 days. Pain medications adminis-
tered in the first three days included fentanyl for 94 % of the pa-
tients, propofol for 88 % of the patients, and midazolam for 44 % of
the patients. Pain levels were relatively stable and consistent at a low
intensity. Mean pain scores were highest on day 1 and slowly de-
creased to reach the lowest levels on day 3. NRS scores: Day 1: 3.96
(SD 3.58); Day 2: 3.84 (SD 2.79); Day 3: 2.37 (SD 1.74). Anxiety scores
followed a similar pattern. Most of the patients were sleepy to lightly
sedated (RASS: −1 to −2). The deepest sedation was found on the
first ICU day. In general, 35 patients (25 %) experienced light sed-
ation as helpful because it allowed them to comprehend what was
happening. 17 patients (12 %) preferred moderate sedation and 89
patients (63 %) would rather have been deeply sedated so that they
would be protected from awareness of stressful or difficult situations.
Rapid changes in levels of sedation was experienced as stressful, anx-
iety provoking and disorienting.
Conclusions: This study demonstrated that patients in an ICU do not
experience high levels of pain or anxiety when they are only lightly
sedated. Patients need continuous updates in information pertaining
to their treatment to help cope with the uncertainties arising from
changes in levels of sedation.
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Introduction: Early mobility is defined as any activity capable of pro-
viding benefits to the patient from adequate positioning and passive
movement to exercises and functional postures as orthostatism and
ambulation. For early mobility success it is necessary a multiprofes-
sional team working.
Objective: To collect multiprofessional team perspective in order to
verify their involvement in early mobility process.
Methods: During a three days period we performed small groups dy-
namics with clinical examples to elucidate early mobility process. At
the end, we evaluated the teams' perspective asking them to re-
spond to one of each questions: 1) What do you consider important
to the patient/family? 2) How can we contribute due to this
experience?
Results: 474 professionals were approached (cleaning assistant, nurs-
ing assistant, nurses, speech therapists, physiotherapists, and clini-
cians). 155 professionals (33 %) chose to answer the first question.
The most frequent responses were: learn to listen (11 %), put yourself
in the others point of view (10 %), team work (6 %), care with respect
and love as if your own family member (6 %). The other 319 profes-
sional (67 %) chose to answer the second question. We separated
the answers in regards to attitude, consequence and feeling of this
experience. Attitude: motivation (13 %), willpower (105), commitment
(7 %), focus (7 %), attention (6 %). Consequence: dedication (17 %),
safeness (14 %), humanization (14 %), communication (105). Feelings:
empathy (12 %), affection (11 %), love (10 %), fulfillment (9 %), pa-
tience (8 %), understanding (7 %).
Conclusion: There is an emotional involvement of health care profes-
sional due to patients' assistance performance incentive.
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Introduction: Therapeutic hypothermia is indicated for refractory
intracranial hypertension [1] and post cardiac arrest [2]. It may have
effects on controlling secondary brain injury, which may occur after
traumatic brain injury or brain ischemia.
Objectives: To describe clinical and epidemiological profile of pa-
tients submitted to therapeutic hypothermia in a private ICU in
Brazil.
Methods: Design. Cross sectional. Period and setting: January 2012
to January 2015 in a 41-bed ICU from a tertiary private hospital in
Sao Paulo, Brazil. We included all ICU adult patients (age >18 years)
submitted to therapeutic hypothermia for any reason during the
period of study. Trained personnel retrospectively collected data re-
garding demographic data, such as age, hospital admission diagno-
sis, comorbidities, mechanical ventilation, vasopressors, laboratory
parameters, therapeutic hypothermia indication, method of cooling,
hypothermia duration and maintenance, target temperature, and
complications. Therapeutic hypothermia indication and management
was in accordance with international society guidelines.
Results: A total of 39 patients were submitted to therapeutic
hypothermia during the study period. Most of the patients were male
(23/39). About 1/3 of the patients were between 62–72 years. Hyper-
tension (20/39), diabetes (12/39) and hypothyroidism (7/39) were the
most prevalent comorbid conditions. Post cardiac arrest was the
major indication for therapeutic hypothermia (16/39) followed by
traumatic brain injury with refractory intracranial hypertension (6/39).
All patients were induced with cooling blanket and 97,4 % (38/39)
with ice in inguinal and axillary regions. Gavage was used in 48,7 %
(19/39) and 4 °C saline infused in 41 % (16/39). Mean target cooling
temperature was achieved in 2.2 (±1.6) hours and mean rewarming
time was 20.7 (±8.2) hours. The two most frequent hypothermia
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complications were ventricular arrhythmias (10.3 %) and bleeding
(thoracic, intra-abdominal or thoracic) (7.7 %). For those patients
whose indication was hypothermia after post cardiac arrest (n = 25),
the distribution of cardiac arrest rhythms was PEA (11/25), VT (10/25),
and asystole (4/25). Intra-hospital arrest was slightly more prevalent
(13/25) than extra-hospital. The mean CPR time was 20.9 (24.4) mi-
nutes. For this cohort of patients, intra-hospital mortality was
10.26 % (4/39).
Conclusions: In our cohort of patients, therapeutic hypothermia was
mostly indicated for post cardiac arrest patients with appropriate
management and low mortality and complication rates.
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Introduction: Bed rest, sedation and immobilization are unavoidable
during the first days of treatment with Extra-Corporeal Membrane
Oxygenation (ECMO), especially when cannulas are inserted through
the femoral vessels. The effects of immobilization of the hip on later
joint mobility on the side of a femoral cannula are unknown.
Objectives: To compare the range of motion (ROM) of immobilized
joints to that of the other joints, which were passively mobilized.
Methods: All patients requiring veno-venous or veno-arterial ECMO
with one femoral cannula in situ were included. Joints not affected
by ECMO were mobilized every day and evaluated by goniometry
every 3 days until ECMO withdrawal. After ECMO withdrawal, all
joints were mobilized daily and evaluated every 3 days until ICU dis-
charge. ROM was compared before and after mobilization (Student's
t test) and in immobilized and mobilized joints (ANOVA).
Results: Ten patients (age 49 ± 15 years, 8 male, ICU mortality 40 %)
with veno-venous (n = 5) or veno-arterial (n = 5) ECMO were included.
Passive mobilization was well tolerated by all patients. The duration
of sedation and ECMO was 6 ± 3 days. ROM was assessed until day
21 ± 13.Hip and knee ROM increased over time from the day of
ECMO withdrawal to the day of ICU discharge (by 24 % for hips [p <
0.01] and by 17 % for knees [p < 0.01]) on both sides.
Conclusions: The results of this pilot study suggest that
immobilization of a joint because of the presence of an ECMO can-
nula does not result in functional impairment.
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Introduction: Although the Spanish transplant network is regarded
as one of the best in the world due to its high rate of donors (ap-
proximately 40 per million), nowadays the number of organs needed
exceeds the demands.
Objectives: To describe the end of the life care practices in patients
suffering from severe non-reversible brain injury in order to evaluate
their suitability as potential organ donors and to introduce a path-
way for their identification and transformation into real donors.
Methods: Multicentre, observational and prospective study (ACCORD
project) in Spanish hospitals.
Two period study:
- First period (data collection): review of all the deceased patients in
our hospital due to severe non- reversible brain injury and identifica-
tion of potential organ donors.
- Second (intervention period): creation of a pathway to overcome
obstacles for the identification of potentials donors and convert
them into real donors.
Results: During the data collection phase we identified 24 patients
with severe non-reversible brain injury. Thirteen of them (52.4 %)
were males and 6 (25 %) were between 60 and 69 years old. The
principal cause of death was stroke (haemorrhagic or ischemic). Fif-
teen patients (62.5 %) were admitted to the Intensive Care Unit (ICU)
and the other nine (37,5 %) were not considerer by their primary
care team as subsidiary of ICU care or as potential donors.
Of the 13 patients admitted to the ICU, six died in brain dead and
nine after circulatory dead. Four of the deceased patients in brain
dead were real donors and five in the circulatory death group
[37,5 % (n = 9) absolute donation rate].
Of the nine patients not admitted, only one had medical contraindi-
cations for donation (33,3 % of potential donors).
In order to prepare for the intervention period, the data were ana-
lysed and shared with the different medical teams involved in the
care of these patients and an algorithm was elaborated in order to
identify the potential donors. Recollection of data for this second
period is now underway.
Conclusions: Hospitalized patients with severe non-reversible brain
injury could contribute to the increase in the number of real donors.
Programs aimed to spread the knowledge regarding the role of these
patients as potential donors, and the creations of pathways and pro-
tocols to activate the transplant coordination team could be funda-
mental to increase the number of available organs.
Table 33 (abstract A579). ROM
Mean ROM (°)
side of cannula
D0
Mean ROM (°)
side of cannula
Ddis
Mean ROM (°)
side without
cannula D0
Mean ROM (°) side
without cannula
Ddis
Hip 87+13 108+11* 85+13 105+10*
Knee 105+10 129+18* 112+12 126+21*
* p< 0,01 D0 vs Ddis D0: at ECMO withdrawal Ddis: at ICU discharge
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The participation of the intensivist in this kind of projects is essential
as conditional ICU admission plays an important role.
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Introduction: In recent years there have been major advances in
renal transplantation, including postoperative management, reflected
in decreased in-hospital mortality. However, it remains a complex
procedure in a group of patients with high comorbidity. Acute graft
failure is one of the most common complications, increased in recent
years due to non-heart beating donors (NHBD). Bedside ultrasound
and radioisotope imaging tests are routinely used during postopera-
tive management in ICU.
Objectives: To analyze the concordance of renal doppler ultrasound
(RDU) performed at bedside and radioisotopes tests after renal trans-
plantation. Evaluate delayment in renal function in NHBD.
Methods: Retrospective, observational study from 2013 to 2014. In-
clusion criteria: patients admitted in the ICU in the postoperative of
renal transplantation. Variables: Demographic information, type of
donation, analytical values, diuresis and bleeding during the ICU stay,
results of the imaging tests (ultrasound resistance index less than 0.7
and good perfusion in scintigraphy), transfusion, creatinine levels at
discharge, days of hospitalization in the ICU and mortality. Descrip-
tive statistical analysis using U of Mann–Whitney test for differences
between groups and Kappa test for the agreement between flow
tests.
Results: 172 patients were included in our study. 62 % were male.
The median age was 52 (RI 41–61) years old. Characteristics of the
patients are shown in Table 34. The median time of ICU stay was
1 day (RI 1–2). No deaths were registered. Agreement between im-
aging tests reached a Kappa Index of 0.5 (p < 0.001) (Table 35).
Conclusions: Kidney transplantation postoperative has a short length
of stay at the ICU.
Renal grafts from un-controlled NHBD showed a delay in the im-
provement of kidney function compared with other types of donors.
A medium agreement between RDU and scintigraphy was observed.
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Introduction: Survival following critical illness is improving and the
focus is moving towards optimisation of recovery. However, rehabilita-
tion is poorly understood and national guidance recommends the need
for information to be delivered to patients and their carers in an appro-
priate way (NICE CG83, 2009). In order to demonstrate adherence to na-
tional guidance and improve the patients' and their carers' awareness
about rehabilitation in the acute phase of recovery following critical ill-
ness, this project aimed to develop, implement and evaluate an infor-
mation booklet on rehabilitation after critical illness.
Objectives: To evaluate the impact of introducing an information
booklet on compliance with CG83 standards.
Methods: A three stage approach was used. Firstly, current evidence
was critiqued to identify the important and required informational
needs. This information was then used to design and develop the in-
formation booklet by the author. This was then introduced and eval-
uated for a period of 8 weeks. Compliance with NICE CG83 was
analysed using the guideline specific audit tool. A locally produced
service evaluation questionnaire and a booklet feedback form were
used to generate qualitative and quantitative outcomes.
Results: Over the evaluation period the booklet was issued on n = 29
occasions, with n = 13 completing analysis. Following the implementa-
tion of the booklet, compliance with NICE guidance (see Table 36) im-
proved from 0 % to 100 %. Improvements were made in all but two
areas of the service evaluation questionnaire. Out of 53 feedback com-
ments received, 45 were positive.
Conclusions: Production of the critical illness information booklet
was an effective method in meeting national guidelines for
Table 34 (abstract A581).
Type of donor Brain
death
NHBD
type II
NHBD
type III
Living
donor
N (%) 129 (75) 12 (7) 10 (5,8) 21 (12,2)
Lactate at ICU admission,
median (IR)
1,6 (1,1–
2,1)
1,4 (1–3,8) 1,3 (1,05–
1,75)
1,3 (0,85–
2,25)
Creatinine at ICU admission,
median (IR)
6,01
(4,58–
7,31)
6,65 (5,53–
10,20)
6,47
(4,515–
7,06)
5,31
(3,95–
6,11)
Creatinine at Hospital discharge,
median (IR)a
1,83
(1,35–
2,84)
4,75 (3,24–
6,24)
2,92 (1,86–
4,35)
1,47
(1,05–
1,66)
Diuresis during first 24 hours of
ICU admission(%)
Polyuria Oliguria Anuria 57,5 30,7
11,8
25 50 25 30 30 40 19 1 0
Bleeding during ICU stay (%) 5,8 9,1 0 3
Transfusion during
hospitalization (%)
51,2 54,5 80 33,3
aStatistically significant differences
Table 35 (abstract A581). Agreement tests
MAG3, n(%)
Normal test Yes No Total
RDU, n(%) Yes 136 (89,5) 16 (10,5) 152
No 3 (20) 12 (80) 15
139 28 167
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information provision to critical care patients and their carers. Patient
feedback for the booklets was positive but on-going evaluation and
adaptation of the current booklet is vital to ensure sustainability of
its use. More rigorously designed research trials could give more reli-
able and generalisable findings.
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Introduction: 11,000 inter-hospital transfers of critically ill patients
are carried out each year (1). These transfers carry a significant risk;
technical complications occur in up to 36 % of inter-hospital transfers
(2). Recommended guidelines are available from the
Association of Anaesthetists of Great Britain and Ireland (AAGBI) and
the Intensive Care Society (ICS).
Objectives: The department's existing system and equipment for
transfers were perceived to be inadequate. This project was to assess
the current system and implement any necessary change.
Methods: The contents of three existing bags were audited to assess
uniformity. Users' perception and experience of the bags were
audited. The results were poor. Following this, a standardised kit list
and Standard Operating Procedure (SOP), compliant with ICS guide-
lines (3), were agreed by all members of the anaesthetic, theatre and
ICU departments. New bags and protocols were introduced. Users'
perception of the bags was then re-audited.
Results: The audit of the old bags showed that only 27 % of items
were present in all 3 bags, that there was no standardised kit list,
and that some items were out of date.
Overall rating of the bags increased from 3.5 to 8.4 following the
introduction of these changes.
Conclusions: Introduction of a standardised kit list and a robust sys-
tem for checking the bags has improved consistency, safety and user
satisfaction. Following further use, the kit list will be reviewed and
revised as necessary. Consideration should be given to the Surrey
Critical Care Network adopting these bags and procedures.
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Criterion 5 % of patients or carers who received the following information
during their critical care stay : • critical illness, interventions and
treatments. • equipment. • possible short-term and/or long-
term physical and non-physical problems which may require
rehabilitation.
Pre Booklet: 0%
Post Booklet: 100%
Criterion 8 % of patients who received the following information before or
as soon as possible after their discharge from critical care: •
rehabilitation pathway • differences between critical care and
ward-based care. • transfer of clinical responsibility to a different
medical team.
Pre Booklet: 0%
Post Booklet: 100%
Criterion 9 % of patients identified as at risk who were given the contact
details of the healthcare professional(s) coordinating their
rehabilitation care pathway, on discharge from critical care.
Pre Booklet: N/A (due to 0% compliance criterion 1 - named healthcare
professional co-ordinating care pathway)
Post Booklet 100%
Fig. 61 (abstract A583). Picture of transfer bag
Fig. 62 (abstract A583). Table of questions
Fig. 63 (abstract A583). Table of questions 2
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Introduction: Delirium and Intensive Care Unit Acquired Weakness
are two of the most common sequelae in patients recovered in In-
tensive Care Unit (ICU) [1,2]. The ABCDE bundle (Awakening and
Breathing trials, Choice of sedative and analgesics, Delirium monitor-
ing and Early mobility) is a multicomponent approach effective in
preventing these complications [4]. Despite a large amount of litera-
ture about the ABCDE bundle is available, a previous attempt of im-
plementation in an Italian environment has never been reported.
Objectives: The aim of this study was to implement the ABCDE bun-
dle in a general ICU of a large university hospital in northern Italy.
Methods: A multidisciplinary team, consisting of critical care physi-
cians and nurses, reviewed the literature and developed a protocol
tailored on the Italian environment. Before the ABCDE bundle was
part of the routine practice, education of nurses and physicians has
been provided through meetings, reminders and poster that summa-
rized the key steps of the protocol was posted by the patients´ bed-
side. After the ABCDE bundle was part of the routine practice a
quality improvement (QI) program to strengthen the bundle know-
ledge has been realized: every nurse and physician attended a train-
ing course while data about facilitators and obstacles to the bundle
implementation was collected. Data about adherence to the protocol
has been collected to evaluate the effect of QI program.
Results: The ABCDE bundle has been implemented in November
2014. The Early mobility protocol became standard care from March
2015. During the QI program, some hindering factors to the imple-
mentation were identified, such as communication issues between
team members, lack of resources and low confidence with the proto-
col. In the first quarter post-implementation 27 % of total patients
were mobilized, in the second quarter post-implementation 67 % of
total patients were mobilized dangling or out-of-bed. Adverse events
related to the bundle were not observed. A year after the initial im-
plementation, the “F” phase has begun to be incorporated into
everyday practice, with a wider opening hours to relatives and a pro-
ject of live musicians.
Conclusions: Although there is no available data about a previous
implementation of the ABCDE bundle in an Italian setting, our experi-
ence demonstrate that it is feasible and safe. Further efforts are
needed to spread the knowledge of the ABCDE bundle and improve
adherence to protocol.
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Introduction: Myocardial injury, as reflected by elevated plasma car-
diac troponin levels, has repeatedly been reported in patients with
community-acquired pneumonia (CAP), but its temporal dynamics
have not been systematically studied. Furthermore, although tropo-
nin release has been associated with increased mortality, its etiology
still remains unknown.
Objectives: Our aim was to determine the incidence of troponin re-
lease in CAP patients and provide a detailed description of the clin-
ical and pathophysiological setting during which it occurs.
Methods: We enrolled consecutive patients admitted with CAP to
the intensive care units (ICU) of two tertiary care centers in the
Netherlands between January 2011 and May 2015. Patients trans-
ferred from another hospital, patients after cardiac arrest, and pa-
tients not meeting criteria for organ failure were excluded. High-
sensitivity cardiac troponin I (hs-cTnI, Abbott ARCHITECT STAT High
Sensitive Troponin-I) was measured daily during the first week. ICU
days were categorized into days with troponin release (days followed
by a 40 % increase in hs-cTnI on the next day and an absolute rise
>26 ng/L), days without troponin release (days followed by a >40 %
and >26 ng/L decrease in hs-cTnI, or a value beneath the upper ref-
erence limit (URL) of 26 ng/L), and days with possible troponin re-
lease (if fulfilling none of these conditions).
Results: Among 200 patients with CAP we analyzed 179 subjects, yield-
ing 709 classifiable ICU days. Median age was 63 (IQR 50–73) years, 113
(63 %) were males, and the median APACHE IV score was 83 (IQR 68–
106). Troponin release above the URL occurred in 145 (81 %) individ-
uals and peaked at a median of 136 ng/L (IQR 32–771). Patients with
troponin release had more comorbidities (Charlson score 6.4 vs. 2.5 me-
dian, p-value 0.06), longer ICU stays (8.3 vs. 5.4 days, p-value 0.02), and
higher hospital mortality (30 % vs. 15 %, p-value 0.06) than those with-
out. Of the 709 observation days, 72 were classified as definite, 208 as
possible, and 429 as no troponin release. Troponin release most fre-
quently occurred on day 1 (32 %) with the majority (65 %) occurring
before day 3. Inflammation and coagulation factors (fever, reduced
platelet count, increased prothrombin time), as well as supply–demand
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mismatch factors (hypotension, high shock index, noradrenalin use,
and respiratory failure) were increasingly prevalent on days with tropo-
nin release (Table 37). Furthermore, several extrinsic factors (e.g., acute
kidney injury and cardiotoxic medication use) were also associated with
troponin release.
Conclusions: Troponin release occurs in a majority of CAP patients.
Increased myocardial workload (resulting in supply–demand mis-
match) and an activated coagulation system could be potential
causes of this injury.
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Introduction: Thrombocytopenia in patients with septic shock is
common, occurring in 20-58 % of patients. While previous investiga-
tions have correlated platelet nadir to adverse outcomes, the time
course describing both the evolution and recovery of
thrombocytopenia in septic shock have not been well defined.
Objectives:
(1) To characterize the evolution of thrombocytopenia in patients di-
agnosed with septic shock, and
(2) to investigate the independent association of thrombocytopenia
and clinically relevant patient outcomes.
Methods: Retrospective propensity-matched cohort study of adults
patients with septic shock who were admitted to an intensive care
unit (ICU) in one of two tertiary care hospitals in Winnipeg, Canada
between 2007 and 2012. Data for this study was obtained from the
Co-operative Antimicrobial Therapy of Septic Shock (CATSS) database
which was further linked to the Winnipeg Regional Health Authority
Critical care database and the Laboratory Information System. The
time course of incident (new) thrombocytopenia was described rela-
tive to vasopressor requirements. Clinical outcomes of thrombocyto-
penic patients were compared to non-thrombocytopenic propensity-
matched patients.
Results: Of 980 patients, 165 (16.8 %) had thrombocytopenia at
ICU admission; 271 (27.7 %) developed thrombocytopenia in the
ICU. The median time from admission to thrombocytopenia was
2 days (interquartile range [IQR] 1–3). Among survivors, the me-
dian time from incident thrombocytopenia to platelet recovery
was 6 days (IQR 4–8). The average platelet nadir was 62 (SD
24.6) in survivors, versus 52 (SD 26.3) in non-survivors (p = 0.003).
Platelet recovery lagged behind clinical recovery. The median
time from vasopressor independence to platelet recovery was
2 days (IQR 0–4). Thrombocytopenia was not significantly associ-
ated with hospital mortality (OR 1.17; 95 % CI 0.81-1.69), but was
associated with ICU length of stay (9 vs. 6 days; p < 0.01), dur-
ation of ventilation (7 versus 4 days; p < 0.01), duration of vaso-
pressor use (4 versus 3; p < 0.01), major bleeding events (41.2 %
vs. 17.6 %; OR 3.28), red blood cell transfusions (2 vs. 0; p < 0.01),
and renal replacement therapy (69 % vs 40 %; OR 2.00).
Conclusion: Thrombocytopenia occurs early in the development
of sepsis. In septic shock, platelet recovery lags behind clinical re-
covery. Thrombocytopenia is independently associated with a lon-
ger duration of vasopressor and ventilator support and increased
major bleeding events, but may not be associated with increased
mortality.
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Introduction: Autonomic dysfunction is associated with increased
mortality in septic shock (SS) [1] but little is known about the mecha-
nisms behind this relation.
Objective: To analyze the association between changes in cardiovas-
cular indices extracted from arterial blood pressure (ABP) and heart
rate (HR) waveforms and progression of organ failure in SS.
Methods: This is a preliminary analysis of patients recruited in Gen-
eva University Hospitals for the prospective observational study
Shockomics, from 10.2014 to 12.2015. Twenty SS patients followed
during the first 3 ICU days were stratified according to change in
SOFA score from day 3 vs. day 1 into “Recovery (R)” (ΔSOFA < −1, n
= 13) and “Non-recovery (NR)” (ΔSOFA ≥ 0, n = 7) groups. Time series
of systolic (SAP) and diastolic (DAP) AP and heart period (HP) were
Table 37 (abstract A585). ICU day characteristics
Variables No
troponin
release
Possible
troponin
release
Definite
troponin
release
p-
value
Inflammation/coagulation factors
C-reactive protein (mg/L) 149 (72–255) 172 (74–
256)
206 (60–
303)
0.54
Fever (temperature > 38.5°C) 51 (13%) 20 (10%) 19 (27%) 0.03
Platelet count (10/L) 182 (105–
252)
147 (74–
224)
135 (70–
214)
<0.001
Prothrombin time (seconds) 15 (13–16) 15 (14–17) 16 (14–19) <0.001
Supply-demand mismatch factors
Tachycardia (hours HR>120
beats/min)
0 (0–1) 0 (0–0) 0 (0–3) 0.16
Hypotension (hours MAP<60
mm Hg)
0 (0–0) 0 (0–1) 0 (0–1) 0.002
Shock index (hours HR/SBP > 1) 0 (0–6.0) 0 (0–5.0) 2 (0–11) 0.03
Noradrenalin dose (ng/kg/min) 89 (48–163) 98 (63–195) 138 (63–
358)
<0.001
Respiratory failure (PaO2/
FiO2<200)
273 (65%) 141 (69%) 56 (78%) 0.03
Severe anemia (Hb<5.0mmol/L
female, <5.5mmol/L males)
61 (14%) 51 (25%) 16 (22%) 0.005
Extrinsic factors
Acute kidney injury score* 125 (29%) 84 (40%) 33 (46%) <0.001
Acute stroke, 8 (2%) 4 (2%) 3 (4%) 0.32
Use of cardiotoxic medication 18 (4%) 16 (8%) 8 (11%) 0.01
Acute heart failure 60 (14%) 26 (13%) 10 (14%) 0.79
Acute peri/myocarditis 3 (1%) 2 (1%) 1 (1%) 0.53
Acute myocardial infarction 0 (0%) 1 (0%) 2 (3%) 0.003
Table shows median (quartile 1–quartile 3) or n (%). *RIFLE stage at least ‘risk’
ICU intensive care unit, HR heart rate, MAP mean arterial pressure, SBP systolic
blood pressure, PaO2 partial pressure of oxygen in arterial blood, FiO2 fraction
of inspired oxygen, Hb haemoglobin, RIFLE risk injury failure loss end stage
classification, ng nanogram, kg kilogram, min minute
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extracted. Spectral indices were computed via autoregressive model
as very low (VLF: 0–0.04Hz), low (LF: 0.04-0.15 Hz) and high frequency
power (HF: 0.15-0.4 Hz). Baroreflex sensitivity (BRS) was computed by
the spectral analysis and transfer function methods. Wilcoxon Rank-
sum and Friedman tests were used to assess differences between
groups in each day and differences within the same group over the
3 days, respectively. Significance is for p < 0.05.
Results: There were no significant differences between groups in
demographic characteristics or comorbidities. For the HP series, there
was a significant increasing trend in total power from day 1 to 3 in
the R group (p = 0.0249); LF% also increased in the R group only (p =
0.0125). Mean DAP values increased significantly in the R group from
day 1 to 3 (p < 0.01). LF power (mmHg2), LF% and LF/HF in the DAP
series increased significantly in the R group (p = 0.0183, p < 0.01 and
p = 0,0498 respectively). In the 2nd and 3rd ICU days LF power
(mmHg2), and LF% were higher in R compared NR patients (p =
0.0394 and p = 0.0476 respectively). There were no significant differ-
ences in the SAP series. Baroreflex indices showed an increasing
trend in both groups without statistically significant results.
Conclusions: Variability of HR significantly increased in SS patients pre-
senting organ function improvement over the first 3 ICU days. This may
be driven by increased sympathetic autonomic activity. The mean value
of DAP, considered to reflect vascular resistance driven by sympathetic
vasomotor tone, raised only in the Recovery group. The ability to in-
crease DAP could be a sign of responsiveness to vasoconstrictors. Inter-
estingly SAP was not different between the 2 groups; this could be due
to the fact that it is used as target for therapy. Further investigations
are required to find specific associations with drug dosage, namely
symphatotonic drugs, and clinically relevant outcomes.
References
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Introduction: Mortality in severe sepsis and septic shock is predicted
independently by a variety of factors, such as, hyperbilirubinemia,
since there is evidence that it can induce inflammation, and apop-
tosis.1–3 However, animal data suggested that bilirubin has antioxi-
dant properties that might be cytoprotective.1,3 To date, evidence of
the discriminative power of bilirubin on survival due to its alleged
antioxidant effects are lacking.
Objectives: We hypothesized that milder elevations of bilirubin
might be protective and associated to better outcomes. Our second-
ary outcome is to identify a level of bilirubin with discriminative
power either for survival or mortality.
Materials and methods: We conducted a retrospective study using
our unit database, collecting data from 2008 to 2015, including pa-
tients >18 years-old, meeting the criteria for severe sepsis and septic
shock according to the American College of Chest Physicians/Society
of Critical Care Medicine Consensus Conference.4 We identified the
highest serum bilirubin levels within 72 hours of ICU admission and
then stratified into 4 cohorts based on hepatic SOFA cut-off values.
SOFA and APACHE II scores were recorded.
Results: We analyzed 642 patients. The highest bilirubin level was
25,1 mg/dL. Stratifying in the four cohorts, we found a significant de-
crease in survival from a bilirubin ≥1,2 (OR from 2 to 7,2 (p < 0,001))
with the highest impact from moderate increases (Wald score of 26)
(graphic 1). Patients with >11,9 mg/dL had a mean survival of 3 days.
There was also a significant difference in severity scores, renal func-
tion, liver enzymes and lactate values between the groups, which
was analyzed in a Logistic regression. There was no significant differ-
ence for UCI-days and length of mechanical ventilation.
Discussion: We found hyperbilirubinemia to be independently asso-
ciated with increased risk of death but no difference in other out-
comes, in this population. Despite a lower mortality rate, moderate
elevations were not protective but were found to have a higher pre-
dictive weight to ICU mortality. We ponder if the protective role of
mild elevations, might be true only for patients with hyperbilirubine-
mia over a much longer time frame that critical patients, which
should be studied in future prospective studies.
Conclusion: Elevated bilirubin levels in patients with severe sepsis
and septic shock were significantly associated with an increased risk
of ICU mortality, but not longer ICU stay and length of mechanical
ventilation. The protective role of the stress-induced rise of bilirubin
in septic shock, was not proven.
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Introduction: While the prevalence of euthyroid sick syndrome is
known, which is present in approximately 60 % to 70 % of septic pa-
tients in an ICU unit, there is little information on their correlation
with other clinical severity variables.
Objectives: To estimate the prevalence of euthyroid sick syndrome
and correlate the findings of thyroid hormone profile with clinical se-
verity variables.
Methods: During the period of March 2014 to February 2016, in an
ICU unit ABC Medical Center in Mexico, were documented clinical
and paraclinical findings including a thyroid hormone profile in sep-
tic patients of any etiology and severity criteria collected based on
the scale of SOFA (sequential organ failure assessment).
Results: 51 patients were included with a mean age of 68 ±
15.6 years, 47 % females and 52.9 % males. BMI of 24.1 ± 4.3 kg/m2.
The median ICU stay was 7 days (IQR 4–13) and post ICU stay of 1
(IQR 0–5). Invasive and non-invasive mechanical ventilation in 23.5
and 29.4 %, respectively. The overall mortality rate was 31.4 %. The
SOFA average was 8.5 ± 3.8. PCR median 20.57 (IQR 12.9-28.17). PCT
5.24 (IQR 1.6- 42). The proportion of patients with a history of dia-
betes, cardiovascular and thyroid disease was 29.4, 64.7 and 21.6 %,
respectively. The overall prevalence of euthyroid sick syndrome was
80.4 % (95 % CI 0.69 to 0.91 %). The correlations between thyroid
hormone profile and clinical severity variables were: for T4T with
Glasgow Coma Scale r = 0.33, (p = 0.017); for FT3 with days of hos-
pital stay r = 0.8, (p = 0.028), T4T with SOFA r = −0.28, (p = 0.047); TSH
with SOFA r = −0.3, (p = 0.031); FT4 with creatinine r = 0.4, (p = 0.018).
Total protein with FT3 and T4T with r = 0.3, (p = 0.034) and r = 0.308,
(p = 0.029), respectively. PCR with FT3 r = 0.84, (p = 0.017). The group
of patients with euthyroid sick syndrome spent more days in the ICU
8 (IQR 4–16) vs 5 (IQR 3–7), without reaching statistical significance
(p = 0.06).
Conclusions: We analyzed abnormalities in thyroid function tests and
severity scales in septic patients in an intensive care unit, where
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prevalence of euthyroid sick syndrome was 80.4 %. A lower value of
TSH and T4T correlated with the severity of patients. A lower Glas-
gow Coma Scale correlated with lower value of T4T. Euthyroid sick
syndrome has a tendency to stay longer in the intensive care unit.
Key words: Critical illness, Euthyroid sick syndrome.
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Introduction: Sepsis is a leading cause of death in critically ill pa-
tients despite the use of modern antibiotics and resuscitation thera-
pies,Biomarkers & Cardiovascular changes have an important place in
this process, myocardial depression occur in 40 % of septic patients.
Objectives: Assessment of myocardial dysfunction in sepsis & septic
shock by echocardiography parameters & biomarkers.
Methods: 20 patients (group I) with sepsis or septic shock were in-
cluded &10 patients (group II) were served as non-septic group.
Group I, Morbidity & mortality at the day 28 in ICU were targeted as
end point. laboratory investigations, APACHEIV, SAPS II, SOFA scores
were calculated. Biomarkers IL-1α, IL-1β, IL-6, IL-10, TNFα, CRP, NT-
proBNP & Troponin level were estimated on admission & day 7 in
peripheral vein (PV) &coronary sinus (CS).Trans-Thoracic Echocardiog-
raphy (TTE) & Tissue Doppler Imaging (TDI) were done on admission
& on day 7.
Results: Comparing group I Vs group II,Mortality rate was 45 %,there
was a statistically significant difference for temperature (p = 0.001),
HR (p = 0.001) & WBC count (p = 0.01) on admission. then upon com-
paring survivors Vs non-survivors in group I there was a statistical dif-
ference in HR on day 7 (p = 0.02), successful Vasopressors withdrawal
(p = 0.02). P/F ratio (p = 0.02) & ScVO2 on day 7 (p = 0.03) .Regarding
IL-1α, IL-1β, TNF-α & Troponin I there was no statistical significant dif-
ference between group I & II but IL-6, IL-10 & CRP showed statistically
significant difference on admission PV & CS. Pro-BNP shows statisti-
cally significant difference in all CS samples either between septic &
non-septic groups. Regarding ECHO upon comparing the survivors
Vs non-survivors E`d/t on day 0 shows a statistically significant differ-
ence between both groups, SAPS II & 7th day SOFA are good predict-
ive scores to mortality in sepsis.
Conclusions: Diastolic dysfunction was seen in 90 % of patients.
fever, HR, WBC counts still good early indicators for diagnosis of sep-
sis.Vasopressors withdrawal on 7th day was good predictor for sur-
vival. Admission serums IL-6, IL-10 & CRP from PV were better
indicators for Sepsis than IL-1, Pro-BNP & Troponin I.admission TNF-α
& 7th day IL-6 levels were highly prognostic to mortality.CS samples
proved that NT Pro-BNP is a good indicator for sepsis diagnosis & a
good predictor for survival,TNF-α from CS samples was also a good
predictor for mortality. SAPS II .A slower E`d/t on admission was good
predictor to mortality.
Note: This abstract has been previously published and is available at
[2]. It is included here as a complete record of the abstracts from the
conference.
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Introduction: Sepsis-associated encephalopathy (SAE) is associated
with increased morbidity and mortality in septic patients. The patho-
physiology of SAE is incompletely elucidated. It has been hypothe-
sized that impairment of cerebral autoregulation (CAR) would result
in brain hypoperfusion and neuronal damage (1), but previous stud-
ies showed conflicting results (2,3).
Objectives: The aim of the study is to evaluate CAR in septic shock
patients and test the hypothesis that its alteration is associated with
clinical encephalopathy or brain perfusion.
Methods: Adult patients diagnosed with septic shock and admitted
to the ICU stay were included (July 2015 - March 2016). Exclusion cri-
teria were: intracranial disease; arrythmias; extra-corporeal membrane
oxygenation; intra/extra-cranial arteriopathy. Transcranial Doppler
(DWL, Germany) was performed insonating left middle cerebral artery
(LMCA) with a 2-MHz probe. LMCA blood flow velocity (FV) and arter-
ial blood pressure (BP) signals were simultaneously recorded; Pear-
son´s correlation coefficient between BP and FV (Mxa) was calculated
using MATLAB (MathWorks, USA). Impaired CAR was defined as
Mxa > 0.3 (4).
Results: 24 patients were included; median norepinephrine dose
was 0.3 [0.13-0.66] mcg/kg/min. Site of infection was mainly pul-
monary (4/24,17 %) and hematogenous (4,17 %). Arterial PCO2
was 35 [32–43] mmHg, pH was 7.37 [7.35-7.43], central venous
oxygen saturation was 71 [62–73]% at time of TCD assessment.
Eight patients (33 %) received sedation during examination.
Median Mxa was 0.26 [−0.06-0.6] and CAR was impaired in 11 pa-
tients (46 %). No difference in Mxa was observed between se-
dated and non-sedated patients (p = 0.3), PaCO2 level < vs ≥
40 mmHg (p = 0.9) and presence of encephalopathy (e.g. GCS <
15 on admission) (p = 0.5). Also, no association between Mxa and
mean BP or dose of vasopressors was noted.
Conclusions: CAR was altered in almost half of the patients with sep-
tic shock. No association between autoregulation and clinical en-
cephalopathy or determinants of brain perfusion was found
(Table 38).
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Table 38 (abstract A591). Population characteristics (number (%),
median [IQR])
Male 21 (87%)
Age (years) 59 [50-67]
Coronary artery disease 4 (17%)
Apache II score 18 [13-25]
ICU LOS (days) 8 [5-16]
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Introduction: Septic shock is a life threatening condition associated
with high mortality. Poor outcome is mainly related to the inad-
equacy between oxygen delivery and cellular demand leading to the
onset of multiorgan dysfunction. Whether this multiorgan failure
affect the pancreas is not fully investigated [1].
Objective: To assess the prognostic value of increased pancreatic en-
zymes in patients with septic shock.
Methods: We conducted a prospective study in a 12-bed medical
surgical intensive care unit. All patients admitted with septic shock
were included. Demographic, clinical and biological data were re-
corded on admission. Serum amylase and lipase levels were checked
on day 1 and day 2. All the patients with increased amylase and/or
lipase serum level underwent imaging investigations. Quantitative
variables were expressed as median [quartiles] and qualitative vari-
ables were expressed as percentages. Quantitative variables were
compared by Mann–Whitney test and qualitative variables were com-
pared by Chi2 or Fisher exact test as appropriate.
Results: Thirty patients were included in our study. Median [quartile]
age was 68 [58–81] years. Sex-ratio (M/F) was 1.7. Median [quartile]
APACHE II score was 26.5 [19.8-32]. The cause of septic shock was
pneumonia in 14 patients (46.7 %), urinary tract infection in 4 pa-
tients (13.3 %), necrotizing fasciitis in 7 patients (23.3 %) and intra-
abdominal sepsis in 5 patients (16.7 %). Median [quartile] serum
amylase was 44.3 [25.6-76.4] UI/L on day 1 and 49 [25.4-177] on day
2. Median [quartile] serum lipase was 132 [74–258.5] UI/L on day 1
and 142 [73–261] UI/L on day 2. Twelve patients (40 %) had in-
creased amylase level and seven patients (23.3 %) had increased lip-
ase level. All these patients underwent imaging tests: Three patients
(10 %) had abdominal computed tomography and 9 patients (30)
had abdominal ultrasonography. Only one patient (3.3 %) had radio-
logical evidence of acute pancreatitis. Median [quartile] length of in-
tensive care unit stay was 6 [3–11] Days. 28-day mortality was
36.7 %. There was no significant difference between survivors and
deaths regarding the highest serum lipase and amylase levels re-
corded during the first 48 hours (respectively 90 [22–153] versus 46
[31–201]; p = 0.914 and 117 [65–255] versus 176 [116–295]; p =
0.197). Non-survivors at 28-day had higher APACHE II score (28 [27–
32] versus 21[19–29]; p = 0.024) and required mechanical ventilation
more frequently (100 % versus 42.1 %; p = 0.002).
Conclusion: The increase of pancreatic enzyme is common in pa-
tients with septic shock. However, pancreatic injury does not affect
the prognosis of these patients.
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Introduction: The survival rate of patients with sepsis is im-
proving(1, 2).
In our center, although promoting the standardization and
individualization of sepsis treatment, some patients die. We exam-
ined some factors of the patients with sepsis.
Objectives: We searched the worse factor of the prognosis of septic
patients.
Methods: This study was a retrospective observational study in a sin-
gle center.
We studied the patients with sepsis who admitted from the emer-
gency department to the ICU in our hospital. We defined sepsis as
patients with SOFA score 2 points worse than sepsis onset before
(Sepsis-3 Definition) (3).
The study period was from Jan. 2014 to Jun. 2015.
Gender, age, APACHE2, SOFA, and KDIGO classification of AKI were
checked.
Results: The number of patients was 60: non-survivor 18(30 %), and
survivor 42(70 %).
Table 39 showed the characteristics of each group. Table 40 showed
the correlation between KDIGO classification and the prognosis.
As APACHE2, SOFA, and KDIGO classification of AKI were bad, life
prognosis was bad.
Among SOFA score, renal function and respiratory function were well
correlated with patients mortality.
Conclusions: The acute kidney injury and acute respiratory failure
were especially worse prognostic factor among septic patients.
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Introduction: Coagulopathy in septic shock(SS) is characterized by an
imbalance between pro and anticoagulants.The coagulation cascade
Table 39 (abstract A593). Patients characteristics
Non-survive 18 cases Survive 42 cases
Gender Male : Female 10 : 8 19 : 23
Age 70.9 ± 11.0 73.1 ± 13.7 p = 0.543
APACHE2 29.2 ± 8.5 17.8 ± 7.2 p < 0.01
SOFA score 12.4 ± 2.9 6.9 ± 3.5 p < 0.01
Table 40 (abstract A593). KDIGO classsification and the prognosis
KDIGO classification of AKI Non-survive Survive Mortality (%)
non-AKI 2 22 8.3
1 7 13 35
2 4 4 50
3 3 2 60
on HD 2 1 66.7
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is over-activated,causing a consumption of clotting factors until
DIC.This extreme condition is associated to a higher mortality.RO-
TEM®, a point-of-care assay based on viscoelastic measurements of
coagulation changes in whole blood,could be useful to study the co-
agulative profiles in patients at risk of DIC[1]. However, the use of
ROTEM®for the management of SS has not been validated,yet.
Objectives: The aim of this study was to evaluate the possible role of
ROTEM®as a diagnostic and prognostic tool in SS.In particular,we
assessed its ability to identify critically ill-patients at high risk of DIC.
Methods: 21patients(43%M,57%F)admitted to our ICU with a diag-
nosis of SS[2] were enrolled.Exclusion criteria were:end-stage heart
failure and liver disease,severe cancer, age < 18y, pre-existent
hematological disorders,ongoing anticoagulation and antiplatelet
therapy. 21 healthy volunteers, age and sex matched, were recruited
to establish references values for ROTEM®parameters.ROTEM®assays
were performed at the time of ICU admission(baseline) and 24 h
later(day1). ROTEM®(Tem International GmbH, München, Germany)
was performed according to manufacturers'recommendations. The
DIC-score, calculated according to the International Society for
Thrombosis and Haemostasis, was determined over the first 24 h and
28-day mortality was recorded. Data were expressed as medians, IQR
or percentages. T-test was used for comparison between groups.
ROC curves and the correspondent AUC were used to assess visco-
elastic parameters as diagnostic biomarkers of SS and DIC.
Results: In SS EXTEM-clotting time(CT) was significantly longer both at
baseline and day 1[81.79 s(IQR64-88) and 73s(IQR66-77), respectively],
compared to controls[60s(IQR45-64),p < 0.01)]. Furthermore, EXTEM-CT
showed a great ability to identify septic patients(CT:AUC > 0.83,p < 0.01).
No differences were noticed between survivors and non-survivors. ISTH-
score for DIC was ≥ 5 in 24 % of patients, and their MCF in INTEM,
EXTEM and FIBTEM was strongly reduced[DIC vs no-DIC:48 mm (IQR47-
52) vs 68 mm (IQR65-73), 49 mm (IQR49-49) vs 69 mm (IQR66-74) and 7
mm (IQR4-11) vs 30 mm (IQR20-38) respectively, p < 0.05). The relative
ROC-curves showed that MCF could be a valid biomarker for diagnosis
of DIC(AUC > 0.95,p < 0.01 in INTEM, EXTEM, FIBTEM).
Conclusion: Our preliminary findings suggest that ROTEM®could be a
valid tool for diagnosis of coagulopathy in SS.EXTEM-CT measurement
underlined a severe impairment in the extrinsic coagulation
pathway.MCF in INTEM,EXTEM and FIBTEM seemed to be useful bio-
markers for the diagnosis of DIC.In conclusion,ROTEM®might have an
additional value to identify coagulopathy in SS.
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Hepatic dysfunction represents a common manifestation during the
sepsis process, involving portal inflammation, centrilobular necrosis,
lobular inflammation, hepatocellular apoptosis, steatosis and cholan-
gitis. The splanchnic hypoperfusion and the subsequent microcircula-
tion injuries are causative factors among other multiple factors
leading to the hepatic dysfunction in sepsis. However, how much of
the liver dysfunction is recovered after discharge from hospital is still
little known. Herein we evaluated the impact of sepsis on liver struc-
tures in sepsis survivals.
Methods: Adult Wistar rats (200 g) (n = 12) were submitted to sepsis
[iv. 2 mL E. coli 109 CFU/ mL (S9), DL80 in 26 hours]. After 2 h, 6 h,
24 h and 30 days, (T2h, T6h, T24h and T30d), the animals were sacri-
ficed, and samples of liver were collected and stained with H&E, PAS
and Sudan-Black. The T30d animals were considered survivors since
the mortality of sepsis S9 is 80 % from 26 hours after induction
Results: The histological results show that S-9 sepsis model deter-
mines a rapid and progressive liver damage. In the period of T2h, al-
though predominant hepatic aspect of normality was observed,
there was the onset of a sinusoidal congestion of focal occurrence,
presence of polymorphonuclear cells in the lumen of the vein hep-
atic centrilobular and by PAS staining was observed the glycogen ac-
cumulation in cytoplasm of hepatocytes, except around centrilobular
vein. At T6H, there was a generalized sinusoidal congestion, signifi-
cant polymorphonuclear cells infiltration in the portal area and pres-
ence of leukocytes adhering to the endothelium of the centrilobular
vein. Besides, was also observed some hepatocytes with shrunken
nucleus suggesting apoptotic cell death in progress. PAS showed a
overall decrease of glycogen in hepatocytes, suggesting a high con-
sumption of energy due to the exacerbated inflammatory process of
sepsis. Twenty four hours post sepsis, the liver was congested, mainly
in centrilobular veins, suggestive of increased vascular resistance in
the liver. The infiltration of polymorphonuclear cells, predominantly
in centrilobular and periportal areas suggested the leucocyte inva-
sion into the liver parenchyma and subsequent proinflammatory re-
action. PAS staining showed the presence of multiple small vesicles
inside the hepatocytes, suggestive of initial degenerative process in
progress and this proved to be fat vesicles by Sudan Black staining.
In 30 days after sepsis recovery, the sinusoidal spaces were com-
pressed and some congestions were located in the centrilobular vein,
moreover, there were liver cell degeneration with pycnosis and hya-
line degeneration, suggesting a chronic phase of liver dysfunction.
The overall findings demonstrated a multiple liver parenchymal ab-
normalities in post-sepsis period, suggesting the fragility of the liver
physiology to fight against a new infectious challenge.
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Introduction: The splanchnic reticulo-endothelial system is funda-
mentally involved in bacterial clearance both via innate and adaptive
immune responses. It has e.g. been reported that hyposplenism is
Fig. 64 (abstract A595). Kinetics of hepatic lesions of the acute
phase (T2h-T24h) and post-sepsis recovery (T30d)
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associated with an unfavorable outcome in sepsis. We hypothesized
that systemic inflammatory response (SIR) induced immunosuppres-
sion leads to decreased trans-splanchnic microbial clearance.
Objectives: To investigate if pre-existing systemic inflammation af-
fects the splanchnic bacterial clearance.
Methods: Fifteen anesthetized pigs were subjected to an infusion of
E. coli in a cervical vein for 3 hours. To induce a systemic inflamma-
tory response, group “EtxPreExp” (n = 6) received a continuous intra-
venous endotoxin infusion starting 24 h prior to the E. coli infusion.
Group “UnExp” (n = 6) received the bacterial infusion without prior
endotoxin exposure. To understand the effects of 24 h anesthesia
alone, three animals received saline instead of endotoxin for 24 h prior
to the bacterial infusion (“Controls”). According to the predefined statis-
tical plan, “Controls” were not included in the primary analysis. Bacterial
counts in arterial and portal venous blood were analyzed hourly during
the E. coli infusion, and were corrected for the bacterial dose adminis-
tered per body weight. Blood samples were analyzed and physiologic
parameters were recorded throughout the experiment.
Results: All animals receiving endotoxin developed SIR prior to the E.
coli infusion. The amounts of administered bacteria were comparable
between the groups. There were no differences between EtxPreExp
and UnExp groups in log arterial (2.47 (±0.49) vs. 2.38 (±0.57) CFU x
mL−1corr; mean ± SD) or portal (2.40 (±0.36) vs. 2.11 (±0.77)) bacterial
counts at 3 h, just before the end of the bacterial infusion. Further-
more, there was no difference in the ratio of portal vein to arterial
bacterial counts between the EtxPreExp and UnExp groups (Fig. 65).
White blood cell counts (p < 0.001), mean arterial pressure (p < 0.01),
base excess (p < 0.05) and pH (p < 0.001) were lower, while arterial lac-
tate levels (p < 0.001) were higher in UnExp vs. EtxPreExp group during
and after the E. coli infusion.
Conclusions: Our preliminary results show that despite diminished
immunologic and physiologic response, induced by pre-existing in-
flammatory response, the splanchnic bacterial clearance is not af-
fected in E. coli septic shock.
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Objective: To investigate the effect of biliary tract external drainage
(BTED) on liver of severe acute pancreatitis (SAP) rats and the rela-
tionship with heme oxygenase-1 (HO-1) pathway.
Methods: SD rats weighing 250–300 g were randomly assigned into
five groups (n = 6): sham surgery (SS) group, SAP group, SAP + BTED
group, SAP+ zinc protoporphyrin IX (ZnPP) group, SAP + BTED + ZnPP
group. The SAP model was induced via retrograde injection of 4 %
sodium taurocholate (1 mL/kg) into biliopancreatic duct through
duodenalwall. BTED was performed by inserting a cannula into the
bile duct of SAP rats. Tissue and blood samples were collected
24 hours after surgery. Pathological changes in organs were scored.
The level of amylase, alanine transaminase(ALT), aspartate amino-
transferase (AST) in serum were measured. The expression of
hemeoxygenase-1 (HO-1), tumor necrosis factor-α (TNF-α), and
interleukin-6 (IL-6) in tissues were analyzed by real-time PCR and
western-blot.
Results: Liver damage in SAP rats was significantly alleviated by BTED
(p < 0.05). Compared to the SAP group, the serum level of amylase,
ALT, AST, were significantly lower in the BTED group (p < 0.05). The
BETD treatment led to a significant reduction of TNF-α, IL-6 level and
a significant increase of HO-1 level in tissues than in SAP rat (p <
0.05). ZnPP significantly inhibited all mentioned effects.
Conclusions: BTED protected liver against SAP related injuries via the
HO-1 pathway.
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Introduction: Ventilator Associated Pneumonia (VAP) is one of the
most frequently seen infections in ICU setting and may have an im-
pact not only to the length of ICU stay, but o ICU outcome as well.
Objectives: The aim of our observation retrospective study was to
test the hypothesis that a correlation exists between percentage of
ventilated patients developed VAP (% VP) and the main nursing, se-
verity and outcome indexes in our both medical and surgical ICU
served in community hospital.
Methods: From January 2006 to June 2014 admitted to our ICU 620
patients, mean age 64.8 years, mean length of ICU stay (LOS)
14.2 days, mean mechanical ventilation duration per ventilated pa-
tient (V. Days) 12.23 days, mean APACHE II score on addition 21.2,
predicted mortality 38.9 %, actual mortality 31.45 %, Standardized
Mortality Ratio (SMR) 0.80. From our database we looked for between
percentage of ventilated patients developed VAP (% PV VAP) as well
as the above nursing and severity indexes per year from 2006 to
2013 and per six months period for the latest year 2014. Using linear
correlation method, we looked for linear slope, correlation coefficient
(r), and coefficient of determination (r2), and by linear regression
method using ANOVA test we looked for p value, according % PV
VAP and nursing (LOS, VD), severity (age, APACHE, Predicted mortal-
ity) and outcome (Actual mortality, SMR) indexes.
Results
Conclusions: According to our data, there was no statistically sig-
nificant correlation detected between percentage of ventilated
patients developed VAP and Age, LOS, APACHE II score, Predicted
Mortality, Actual Mortality and Standardized Mortality Ratio. On
the other hand, we detected statistical significant positive, mod-
erate correlation between percentage of ventilated patients de-
veloped VAP and Ventilation Days. Our data suggest that the
more the ventilation days, the more the percentage of ventilated
patients developed VAP increases.
Fig. 65 (abstract A596). Trans-splanchnic ratio of bacterial counts
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Introduction: Metered dose bronchodilator inhalation through venti-
lator circuit has long been used in intubated patients of chronic ob-
structive pulmonary disease (COPD). However, fixed drug dosage
now commonly used has not been endorsed by manufacturers nor
proved clinically effective [1]. Evidences suggest drug delivered this
way has suboptimal lung deposition [2]. Also, great individual varia-
tions among patients make them imprecise and unreliable[3].
Objectives: We proposed an experimental bronchodilator dosing
schedule based on each individual's airway resistance (Raw)
monitored periodically. This study tests its efficacy in Raw
reduction.
Methods: Fifty-one just-admitted, invasively ventilated COPD patients
were randomly assigned to receive either personalized or fixed bron-
chodilator dosing. Personal target Raw was defined by measuring
each one's Raw after maximally broncho-dilated by consecutive 4, 8
and 16 puffs of fenoterol metered dose inhaler (100 mcg). Thereafter,
Raw was measured every 8 hours until the 28th day. Patients of the
fixed dose group received only predetermined dose. Additional
doses of bronchodilator were given to patients of the personalized
dosing group when measured Raw exceeded patient's target Raw.
Both groups received rescue short-acting bronchodilator when dys-
pnea exacerbated.
Results: The relative deviation of Raw from its personal target was
expressed as (measured Raw - target Raw)/target Raw. Experimental
group has a smaller relative Raw deviation than control group (0.09 ±
0.10 vs 0.44 ± 0.11, P = 0.022). In a multivariate linear regression
model analysis, Raw of experimental group tended to become closer
to its personal target over time (−0.031 point of relative deviation
every day). Whereas that tendency was deviation away from its tar-
get over time in control group (0.004 point of relative deviation
every day) (Fig). The two groups did not differ significantly in
ventilator-free days from day 1 to 28, percentage of breathing with-
out assistance by day 28, episode of nosocomial pneumonia, total
puffs of rescue bronchodilator, number of drug-related adverse effect
or mortality rate at day 180.
Conclusions: Personalized dosing of bronchodilator inhalation to in-
vasively ventilated COPD patients produce a better Raw reduction
profile than fixed dosing. The conclusions of this pilot study need
consolidation by further investigations.
References
1. Dhand, R., Respir Care, 2005. 50(10): p. 1331–4.
2. Fuller, H.D., et al., Am Rev Respir Dis, 1990. 141(2): p. 440–4.
3. Malliotakis, P., et al., Crit Care, 2008. 12(6): p. R140.
Grant acknowledgement
The study was supported by grant number 102-CCH-IRP-017 (Changhua
Christian Hospital, Taiwan, R.O.C).
A600
Retrospective analysis of respiratory mechanics in ARDS: driving
pressure and outcome
Z.E. Aray, C.F. Gómez, A.P. Tejero, D.D. Monge, V.M. Losada, C.M.
Tarancón, S.D. Cortés, A.M. Gutiérrez, T.P. Álvarez
Hospital Virgen de la Concha, Medicina Intensiva, Zamora, Spain
Correspondence: Z.E. Aray - Hospital Virgen de la Concha, Medicina
Intensiva, Zamora, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A600
Introduction: In severe Acute Respiratory Distress Syndrome, there
are important structural pulmonary changes, deterioration of the oxy-
gen permeability, residual pulmonary capacity, pulmonary compli-
ance, airway resistance and recruitability. The use of lower plateau
pressures, lower tidal volumes and higher PEEPs can improve
survival.
Objective: Review our experience in the management and evolution
of patients with Severe ARDS during 3 years in a second level hos-
pital. In our analysis we took into account the treatment approach,
mode of ventilation, PEEPs, the resistance and compliance values re-
ported by the ventilator and recorded automatically.
Methods: A retrospective study of ICU patients requiring mechan-
ical ventilation between 2013–2015 at Hospital Virgen de la Con-
cha(Zamora, Spain) due to severe ARDS. 23 patients admitted
during this period have a deterioration of PaO2/FiO2 to levels
lower than or equal to 100 during a 24 hours period and requir-
ing at least 5 days of ICU admission. Epidemiological data, pre-
sumed cause of ARDS, management (steroids, neuromuscular
blocking agents, inhaled beta-agonists), mechanical ventilation
parameters (maximum PEEP,resistance,compliance,driving pres-
sure) were analysed. We divided arbitrarily between HOR (high
concentration of oxygen required, greater than or equal to 60 %)
and LOR period (low oxygen concentration required, less than
60 %).
Results: The overall severe ARDS mortality was of 56.52 %. The pro-
nation strategy was carried out in 39.13 % of the patients. The me-
dian ICU stay, mechanical ventilation and high oxygen requirement
(HOR) duration was of 24.47; 16.6 and 8.43 days. The maximum PEEP
used in this group of patients was 17 cmH20; with a median value of
13.2 cmH20. The pulmonary resistance, compliance and driving pres-
sure (DP) in the non-surviving group were (19.21 cmH20/l/sec;
45.39 ml/cmH20; 14.20 cmH20), in the surviving group were (15.38
cmH20/l/sec; 47.82 ml/cmH20; 12.10 cmH20). The mortality in the
group with DP higher than 15 during HOR was 100 %, being 33.3 %
in the group with lower DP values (p < 0.05).
Conclusions: We found that non-surviving patients have higher
resistance and lower compliance values in their respiratory sys-
tem and the improvement of its values were associated with bet-
ter clinical outcome.The driving pressure was the variable that
best stratified the surviving and non-surviving patients.
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Table 41 (abstract A598). Correlation between percentages of
ventilated pati
Slope St Error r r2 L. CI U. CI p value
Age −0.0990 0.519 −0.064 0.004 −1.161 1.161 0.8685
LOS 0.020 0.191 0.051 0.002 −0.427 0.480 0.8953
V. Days 0.354 0.130 0.716 0.513 0.045 0.663 0.0300
APACHE 0.329 0.575 0.315 0.099 −0.557 1.217 0.4084
Pr Mortality 0.969 1.112 0.313 0.097 −1.661 3.601 0.4126
Act. Mortality 1.931 1.001 0.589 0.347 −0.437 4.300 0.0951
SMR 0.029 0.018 0.523 0.274 −0.013 0.072 0.1479
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Introduction: In 2013, the Centers for Disease Control and Prevention
(CDC) published a new surveillance paradigm for complications of
mechanical ventilation (MV), in response to difficult surveillance of
ventilator-associated pneumonia (VAP) in critically ill patients (1). No
study has investigated the newly defined ventilator-associated condi-
tions (VAC) and infection-related ventilator-associated complications
(IVAC) among COPD population.
Objectives: Our study aims to determine the impact of COPD on the
incidence and outcome of VAC and IVAC, and their relationship with
VAP.
Methods: Retrospective analyse of prospectively collected data from
patients requiring MV for more than 48 hours[SN1] . VAP episodes
were assessed by prospective surveillance of nosocomial infections
according to ATS/IDSA guidelines (2). VAC and IVAC were identified
retrospectively according to current CDC definitions (1). We assessed
VAC, IVAC, and VAP rates, and their impact on outcome, according to
the presence or the absence of underlying COPD. The relationship
between VAC, IVAC and VAP episodes was also assessed in COPD
and non COPD patients. Qualitative and quantitative variables were
compared using chi-square test and Mann–Whitney U test,
respectively.
Results: Data from 472 patients (132 with COPD and 340 without
COPD) were analyzed. Similar rates of VAC (43.2 vs 36.8 %, p =
0.199), IVAC (22.0 vs 16.8 %, p = 0.189) and VAP (28.8 vs 28.5 %,
p = 0.956) were found in COPD and non COPD patients, respect-
ively. Agreement between VAC or IVAC and VAP episodes was
21.1 % and 15.8 % respectively among COPD patients, 21.6 %
and 33.3 % among patients without COPD. No significant differ-
ence was found in outcome of patients with VAC and IVAC be-
tween COPD and non COPD patients, unlike patients who
developed VAP (Table 42).
Conclusions: Incidence and outcome of VAC and IVAC were similar
in COPD and non COPD patients. Agreement between VAC or IVAC
and VAP episodes was poor in the two groups.
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Introduction: Mechanical ventilation is associated with ventilation in-
duced lung injuries (VILI) due to lung stress and lung strain. VILI can be
prevented by limiting driving pressure (ΔP) (1), plateau pressure (PPLAT),
and tidal volume (VT). INTELLiVENT-ASV is a full closed loop ventilation so-
lution that combines a ventilation and an oxygenation controller (2). The
ventilation controller adjust minute volume to reach a target end tidal
CO2 set by the user. Adaptive Support Ventilation (ASV) algorithm deter-
mines for a given minute volume the respiratory rate (RR) - VT combin-
ation associated with the minimal work of breathing (3). Recently, ASV
algorithm has been modified in order to limit driving pressure (ΔP) (4).
Objectives: In order to determine if INTELLiVENT-ASV selects a lung
protective ventilation, this prospective observational study reports on
the applied ventilation parameters and blood gas results in passive ICU
patients ventilated with INTELLiVENT-ASV in different lung conditions.
Methods: Passive patients intubated and mechanically ventilated be-
tween June 2015 and March 2016 were included. Excluded were pa-
tients with bronchopleural fistula and brain dead patients. All patients
were ventilated using a Hamilton Medical S1 ventilator in INTELLiVENT-
ASV mode. Measurements were collected once for each patient during
the first day of mechanical ventilation at the time of blood gas analysis.
Airway pressure and flow were measured by the proximal flow sensor
of the ventilator. PPLAT and total PEEP (PEEPTOT) were measured by a
5 seconds end-inspiratory and end-expiratory occlusion, respectively.
ΔP was calculated as the difference between PPLAT and PEEPTOT.
At inclusion patients were classified into one of the three predefined
lung conditions (normal lung, acute respiratory distress syndrome
(ARDS), or chronic obstructive pulmonary disease (COPD)). Data are pre-
sented as median (25th - 75th quartiles). An analysis of variance
(ANOVA) on ranks was used to compare values between each lung
conditions. Statistical significance was assumed for P value below 0.05.
Results: 120 patients were included (80 males, age: 67 (56–75) years;
ideal body weight (IBW): 65 (55–70) Kg; SAPS II: 60 (49–68)).
Conclusions: INTELLiVENT-ASV is able to select a lung protective ven-
tilation with limited driving pressure in passive ICU patients with dif-
ferent lung conditions.
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Table 42 (abstract A601). Outcome of patients with VAP, VAC and
IVAC, in COP
VAP (n=135) VAC (n=182) IVAC (n=86)
COPD(n=38) No COPD
(n=97)
COPD
(n=57)
No COPD
(n=125)
COPD
(n=29)
No COPD
(n=57)
MV
duration
(days)
38[21–53] 25[14–
37]*
25[15–
42]
23[12–35] 29[18–
44]
29[12–41]
ICU LOS
(days)
40[22–65] 29[18–
42]*
31[20–
46]
25[15–41] 37[20–
50]
31[17–43]
ICU
Mortality
22(58) 47(49) 26(46) 67(54) 12(41) 28(49)
Data are presented as number (%) or median (interquartile range)
Abbreviations: MV mechanical ventilation, LOS length of stay
*p<0.05, COPD versus non COPD patients
Table 43 (abstract A602). Ventilation selected and blood gas results
Normal
lung
Mild
ARDS
Moderate
ARDS
Severe
ARDS
COPD p
(ANOVA)
n 49 17 32 13 9
ΔP (cmH20) 9 (8–10) 10 (9–
11)
10 (8–13) 10 (8–11) 11 (6–12) 0.127
VT/IBW
(mL/Kg)
7.5 (6.6–
8.1)
6.8 (6.3–
7.5)
6.6 (6.1–7.0) 6.6 (5.7–
7.3)
9.3 (6.9–
11.1)
0.001
PPLAT
(cmH20)
16 (14–
18)
21 (17–
24)
22 (20–24) 24 (23–
26)
20 (18–
22)
<0.001
PEEP
(cmH20)
6 (5–7) 10 (8–
12)
10 (8–15) 12 (10–
18)
7 (6–10) <0.001
PaCO2 (mm
Hg)
38 (36–
42)
41 (38–
49)
41 (38–46) 46 (42–
52)
49 (45–
56)
<0.001
PaO2 (mm
Hg)
88 (79–
94)
81 (75–
120)
81 (73–96) 74 (68–
95)
76 (64–
89)
0.159
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Introduction: Electrical impedance tomography (EIT) can detect dele-
terious side effects of mechanical ventilation like alveolar cycling and
overdistension 1, 2 that may lead to the development of ventilator-
induced lung injury (VILI). The early recognition of these effects at
the bedside may accelerate the necessary modification of the ventila-
tor settings. We developed an EIT-based algorithm for personalized
adjustment of positive end-expiratory pressure (PEEP) and tidal vol-
ume (VT) with the aim of reducing alveolar cycling and overdisten-
sion and inducing lung recruitment.
Objectives: To apply the EIT-based algorithm in patients with acute
respiratory distress syndrome (ARDS) and to assess its feasibility for
personalized adjustment of ventilator settings.
Methods: We conduct a pilot clinical study in n = 20 patients requiring
mechanical ventilation for early ARDS. EIT measurements are performed
using the PulmoVista 500 device (Dräger, Lübeck, Germany). Patients
are initially ventilated according to the ARDS network algorithm 3 using
a low PEEP strategy and VT of 6 ml/kg predicted body weight (phase
ARDSNet). The patients are then ventilated according to the EIT-based
algorithm during a four-hour period (phase EIT). During the phase EIT,
ventilation maneuvers for overdistension and alveolar cycling detection
are performed every 30 minutes and PEEP and VT are adjusted accord-
ing to the EIT results. After the four-hour period, the resulting VT, PEEP,
ratio of arterial partial pressure of O2 and fraction of inspired O2 (PaO2/
FiO2), respiratory system compliance (Crs), driving pressure (ΔP
4), stand-
ard deviation of regional ventilation delay (SDRVD40) 2 and other pa-
rameters are compared to the values measured at the end of the phase
ARDSNet. All results are presented as mean values ± standard deviation
with p-values calculated by two-sided paired t-test.
Results: To date, 8/20 patients (4 men, 4 women, age 62 ± 17 years,
height 171 ± 7 cm) were included. Comparing the phases ARDSNet and
EIT, the interim analysis revealed that VT and PEEP changed from 398 ±
54 to 388 ± 117 ml (p = 0.81) and from 8.6 ± 1.1 to 14.3 ± 2.6 mbar (p <
0.01), respectively. PaO2/FiO2 improved from 159 ± 31 to 233 ± 56 mmHg
(p = 0.01). We found no significant changes in Crs (from 37 ± 7 to 40 ±
13 ml/mbar, p = 0.48), ΔP (from 10.8 ± 1.6 to 9.8 ± 1.5 mbar, p =
0.14) and SDRVD40 (from 11.2 ± 4.1 to 8.6 ± 2.5 %, p = 0.07).
Conclusions: Our preliminary results indicate that adjustment of
mechanical ventilation according to the EIT-based algorithm is feas-
ible and leads to ventilator settings that are associated with im-
proved oxygenation.
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Introduction: PEEP is a key element of protective mechanical ventila-
tion. Nevertheless, the identification of feasible bedside methods for
"optimal" PEEP selection is still controversial.
EIT allows real time monitoring of changes in End Expiratory Lung Im-
pedance (ΔEELI), which corresponds to end-expiratory volume. We rea-
soned that ΔEELI decrease after a Recruitment Maneuver (RM) might
indicate alveolar de-recruitment and inadequate PEEP. Thus, we aimed
at identifying PEEP level able to minimize decrease of ΔEELI.
Methods: We enrolled 15 intubated sedated paralyzed hypoxemic
patients undergoing controlled ventilation. The study consisted of 3
steps during which protective tidal volume and FiO2 were kept con-
stant and ΔEELI was continuously monitored:
- Step 1: PEEP was selected according to the ARDSnet protocol1 .
- Step 2: a) a RM was performed, applying pressure of 40 cmH2O for
40 seconds; b) ΔEELI was measured within 30 seconds (ΔEELI30sec) and
after 10 minutes (ΔEELI10min); c) if we observed that (ΔEELI30sec-ΔEELI10min)
≥10 % of ΔEELI30sec, a new RM was performed followed by PEEP increase
by 2 cmH2O. Steps b) and c) were repeated until PEEP level associated
with (ΔEELI30sec - ΔEELI10min) < 10 % of ΔEELI30sec (EIT-PEEP) (Fig. 66).
- Step 3: a new RM was performed, and PEEP was increased by 2
cmH2O (EIT-PEEP + 2).
Results: PEEP selection according to EIT was feasible in 13/15 pa-
tients. EIT-PEEP was significantly higher than ARDSnet PEEP (13 ± 2
cmH2O vs. 9 ± 2, p < 0.001); PaO2/FiO2 improved, both at EIT-PEEP
and EIT-PEEP + 2 (190 ± 85 and 205 ± 93 vs. 161 ± 67, p < 0.05) but re-
spiratory system compliance didn't change (p = 0.114). However, EIT
waveforms showed that at higher PEEP regional compliance of the
ventral lung was reduced (6 ± 5 ml/cmH2O and 5 ± 5 ml/cmH2O vs. 8
± 5 ml/cmH2O, p < 0.01), likely indicating relative hyperdistension,
and improved in dorsal lung region (22 ± 8 ml/cmH2O and 23 ±
10 ml/cmH2O vs. 12 ± 5 ml/cmH2O, p < 0.001), possibly indicating
recruitment; a consensual and significant increase of Cumulated
Hypedistension2 was observed in non-dependent lung zones at EIT-
PEEP + 2 (+18 ± 25 % vs. ARDSnet PEEP, p < 0.001).
Conclusions: PEEP setting by EIT appears feasible in a large fraction
of patients, allowing a bedside disclosure of recruitment and
hyperdistension.
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Fig. 66 (abstract A604). EIT PEEP setting
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Background: Standard ventilation strategies in patients undergoing
lung transplantation have not been established. The use of lung pro-
tective ventilatory strategies during and immediately after lung trans-
plantation could minimize the potential additional mechanical injury
induced by increased pulmonary stress and strain. Targeting tidal
volumes based on recipient size may lead to ventilator induced-lung
injury (VILI) to the donor lungs, especially if the allograft is relatively
undersized, contributing to the occurrence of primary graft dysfunc-
tion (PGD).
Objective: To evaluate the association between mechanical ventila-
tion settings during the first 24 hours post bilateral lung transplant-
ation with the diagnosis of ISHLT PGD grade 3 at 72 hours post
reperfusion (PGD3-72 h) and the potential role of donor/recipient
lung size mismatch.
Methods: Retrospective study of 381 consecutive patients who
underwent bilateral lung transplantation between January 2010 and
December 2014 at the Toronto General Hospital. The association of
the post transplant ICU mechanical ventilation settings and out-
comes was performed using logistic regression.
Results: 33 (8.7 %) out of 381 patients had PGD3-72 h. In the univari-
ate analysis the following settings of mechanical ventilation at ICU
admission were significantly associated with PGD3-72 h: positive
end-expiratory pressure (OR 1.55, 95 % CI 1.31-1.84), driving pressure
(OR 1.11, 95 % CI 1.01-1.24) and tidal volume according to donor pre-
dicted body weight (donor PBW) (OR 1.35, 95 % CI 1.01-1.81). Inter-
estingly, PGD3-72 h was not significantly associated with tidal
volume according to recipient predicted body weight (recipient
PBW) (OR 1.19, 95 % CI 0.80-1.77). Donor/recipient lung size mis-
match was calculated according to the ratio between donor and re-
cipient predicted total lung capacity (pTLC ratio). Tidal volume set
according to recipient PBW was 6.6 mL/kg ± 0.7 in undersized grafts
(pTLC ratio < 1) compared to 6.7 ml/kg ± 0.7 in non-undersized grafts
(pTLC ratio ≥ 1). When tidal volume was computed according to
donor PBW, it was significantly higher in patients with undersized
grafts (pTLC ratio < 1) compared to non-undersized grafts (pTLC ra-
tio ≥ 1) (7.2 ml/kg ± 0.9 vs 5.9 ± 0.7, p < 0.001). The incidence of
PGD3-72 h was higher in undersized compared to non-undersized
grafts (12 % vs 6 %, p = 0.052), but not statistically significant.
Conclusions: Following double lung transplantation, setting of tidal
volume according to recipient, instead of donor, PBW may underesti-
mate the effect of mechanical ventilation on the development of
PGD3-72 h. Future studies are required to confirm the potential con-
tribution of VILI to the occurrence of PGD.
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Purpose: Concerns have been expressed regarding a possible associ-
ation between arterial hyperoxia and adverse outcomes in critically ill
patients, including those with cardiac ischemia, stroke or post-
resuscitation. Oxygen status is commonly monitored noninvasively by
peripheral saturation monitoring (SpO2). However, the risk of hyperoxia
above specific SpO2 in critically ill patients levels is unknown. The
purpose of this study was to determine a threshold value of SpO2
above which the prevalence of arterial hyperoxia distinctly increases.
Design: A prospective observational study in mechanically ventilated
intensive care patients in a tertiary referral center.
Materials and methods: In 100 patients, we collected 200 arterial
blood gases (ABG) and simultaneously registered SpO2 levels, as well
as hemodynamic and ventilation parameters, vasoactive medication
and clinically assessed peripheral perfusion. Patients under thera-
peutic hypothermia were excluded.
Results: The risk of arterial hyperoxia, defined as PaO2 > 100 mmHg
or >125 mmHg, was negligible when SpO2 was ≤95 % or ≤96 %, re-
spectively. The majority (89 % and 54 %, respectively for PaO2 >
100 mmHg and 125 mmHg) of ICU patients with SpO2 of 100 % had
arterial hyperoxia. The relation between SpO2 and PaO2 was not
clealry affected by hemodynamic or other clinical variables (pH,
pCO2, body temperature, recent blood transfusion).
Conclusions: In critically ill patients, the risk of arterial hyperoxia in-
creases when SpO2 is >95 %. Above this saturation level, supplemen-
tal oxygen should be administered with caution in patients
potentially susceptible to adverse effects of hyperoxia.
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Introduction: The “Express” strategy is a method for PEEP titration,
where PEEP is set to reach an airway plateau pressure (Pplat) of 28
to 30 cmH2O in ARDS patients
1.
Objectives: To compare the changes between the baseline ventilator
settings and the “Express” strategy in terms of respiratory system me-
chanics and gas exchange.
Methods: Patients with early (<48 hours) moderate ARDS were in-
cluded (Berlin definition).
Baseline settings were adjusted according to our routine clinical prac-
tice and thereafter PEEP level was titrated to reach a Plat 28–30 cmH2O
(“Express” strategy). FiO2, respiratory rate (RR) and tidal volume (Vt)
were kept unchanged. Measurements of respiratory system mechanics
and gas exchange were done at baseline and after 2 hours of “Express”
settings. Patients were classified as responders or non responders accord-
ing to their change in PaO2/FiO2 (>25 mmHg) as described
2.
Results: We prospectively analysed 12 consecutive patients (9 males,
aged 56 ± 19 years). A comparison of respiratory system mechanics
and gas exchange between baseline and “Express” is detailed in
Table 44 As expected, the overall comparisons showed significant
changes in PEEP and Pplat and a significant improvement in oxygen-
ation. The main differences between PEEP responders (n = 6) and PEEP
non responders (n = 6) are shown in Table 45.
Conclusions: Overall, patients with moderate ARDS significantly im-
proved oxygenation when the PEEP “Express” strategy was imple-
mented. However, half of our patients did not improve oxygenation
and parameters of respiratory mechanics also worsened.
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Introduction: Best dynamic compliance (Cdyn) has been proposed to
titrate PEEP(1). Since electrical impedance tomography (EIT) gives re-
gional information on ventilation distribution it may be superior for
optimizing PEEP. To support the decision making of PEEP setting,
guided by EIT, the global inhomogeneity index (GI) was developed.
The GI is a global value which quantifies the homogeneity of tidal
volume distribution. The smaller the GI, the more homogeneous tidal
volume is distributed within the ventilated area. It has been argued
whether best PEEP is established when the air is most homoge-
neously distributed in the lungs(2).
Objectives: We hypothesize that the GI is not suitable to determine best
PEEP and EIT guided PEEP is not identical to PEEP set at the best Cdyn.
Methods: In our institution best PEEP guided by EIT is determined as
the best compromise between alveolar overdistension and alveolar
collapse during an incremental and decremental PEEP trial. Data
were analysed with offline software (EITdiag; Dräger Medical) that
calculates overdistension and collapse. In a retrospective analysis of
71 patients with respiratory failure due to different reasons we com-
pared the best PEEP according to EIT with Cdyn and according to
the GI with Cdyn. A PEEP difference greater than or equal to 4
cmH2O is defined as a clinical relevant difference. All patients were
ventilated with Evita Dräger ventilators in a BIPAP mode.
Results: In 82 % (58/71) of the cases GI PEEP differs 4 cmH2O or
more compared to Cdyn and in 18 % (13/71) of the cases
between EIT and Cdyn. The individual differences are shown in
Figs. 67 and 68.
Conclusions: The GI is not useful to determine best PEEP in the
above mentioned manner. Best global Cdyn may be influenced
by the effects of overdistension as well as atelectasis(3). EIT can
visualize this, enhancing the decision on the best compromise
between alveolar overdistension and collapse. Whether EIT
guided PEEP is better than Cdyn guided PEEP remains to be
determined.
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Table 44 (abstract A607). Mechanical and gasometrical variables
Variable (n=12) Baseline “Express” p=
Vt (ml/kg PBW) 6.0 ± 0.3 6.0 ± 0.2 0.81
Vt (ml) 382 ± 56 385 ± 63 0.54
RR (b.p.m.) 23 ± 4 22 ± 4 0.39
PEEP (cmH2O) 9 ± 3 15 ± 1 <0.001
Pplat (cmH2O) 20 ± 3 27 ± 1 <0.001
Respiratory system compliance (ml/cmH2O) 37 ± 11 35 ± 12 0.35
Driving Pressure (cmH2O) 11 ± 2 11 ± 2 0.31
PaO2/FiO2 (mmHg) 150 ± 31 198 ± 58 0.03
PaCO2 (mmHg) 46 ± 5 52 ± 11 0.06
Table 45 (abstract A607). Analysis between responders and not
responders
Variable PEEP responders
(n=6)
PEEP non responders
(n=6)
p=
PEEP baseline (cmH2O) 8 ± 3 10 ± 1 0.21
PEEP "Express" (cmH2O) 15 ± 1* 15 ± 2* 0.27
DP baseline (cmH2O) 11 ± 2 11 ± 3 0.13
DP "Express" (cmH2O) 10 ± 2 13 ± 1 0.04
CRS baseline (ml/cmH2O) 39 ± 12 35 ± 11 0.58
CRS "Express" (ml/cmH2O) 40 ± 15 30 ± 6* 0.15
PaO2/FiO2 baseline (mmHg) 141 ± 38 159 ± 22 0.34
PaO2/FiO2 "Express" (mmHg) 243 ± 44* 154 ± 25 0.003
DP driving pressure, CRS respiratory system compliance
*p<0.05 vs. baseline
Fig. 67 (abstract A608).
Fig. 68 (abstract A608). Bland Altman plot of differences in PEEP
between EIT and Cdyn
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Introduction: In order to avoid Ventilator Induced Lung Injury (VILI) it
is important to improve ventilation homogeneity. Homogeneous
ventilation reduces lung stress and strain diminishing lung damage.
To open up atelectatic tissue recruitment maneuvers can be per-
formed. However, it is remains unclear whether fast or slow PEEP
steps should be applied.
Objectives: Ventilation homogeneity, as measured by Electrical Im-
pedance Tomography (EIT), during fast and slow PEEP trials in
healthy and ARDS lungs.
Methods: In eight pigs EIT measurements were performed before
and after induction of ARDS with oleic acid. A fast PEEP trial was per-
formed from 0–26 cmH2O in steps of 2 cmH2O. The slow PEEP trial
was performed with PEEP levels from 0–25 cmH2O in steps of 5
cmH2O. During the fast PEEP trial each PEEP step was applied for
1 minute, whereas during the long PEEP trial each PEEP level was ap-
plied for 5 minutes. From the EIT data the intratidal gas distribution
(ITV) was calculated. The ITV divides the impedance curve of the in-
spiration in eight equal-volume sections, from which the contribution
of the dependent and non-dependent region during a breath can be
calculated.
Results: For the fast PEEP trial homogeneous ventilation was found
at 6 and 14 PEEP in non-ARDS and ARDS lungs respectively. For the
slow PEEP trial this was 5 and 15 cmH2O.
Conclusions: ARDS lungs need significantly higher PEEP levels for
homogeneous ventilation as compared to healthy lungs. However,
no difference in optimal PEEP could be found between fast and slow
PEEP steps. Therefore, we advice to apply fast PEEP steps in order to
avoid high forces acting on lung tissue for a longer period.
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Introduction: Adaptive support ventilation (ASV) is a novel electronic
ventilator protocol that incorporates the recent and sophisticated
measurement tools and algorithms.
The target tidal volume and respiratory rate are continually adapted
to patient's respiratory physics and varying medical conditions. In in-
jured lung, the ASV should actively adjust ventilatory parameters
achieving minimal work of breathing to meet the lung protective
strategies.
Objectives: We applicated ASV to patients with lung injury to verify
its efficacy in Korean population.
Methods: We observed initial mechanical ventilation parameters in 114
patients receiving ASV due to various causes (48 lung injuries including
27 community acquired pneumonia, 9 hospital acquired pneumonia, 5
interstitial lung diseases, 4 pulmonary tuberculosis and 3 idiopathic
cases; 66 without lung injury which comprise 33 trauma cases, 18
strokes, 9 suicidal attempts and 6 other cases). The mean age of stud-
ied population was 57.5 years (male: female = 42:15). The data were col-
lected within the first 12 hours of mechanical ventilation.
Results: Mean age of lung injury group was 63 years (53.3 for normal
lung group; p < 0.05), PaO2 per inspired fraction of O2 (PF ratio) was
207.7 ± 61.2 (388 ± 103 for normal lung group, p < 0.05), minute
volume was 7.6 ± 2.21 l (7.1 ± 1.83 l for normal lung group, p > 0.05),
inspiratory flow was 43.0 ± 8.2 l/min (39.2 ± 10.3 l/min for normal
lung group, p > 0.05), expiratory flow was 41.8 ± 11.4 L/min (39.2 ±
12.2 l/min for normal lung group, p > 0.05), peak pressure and plat-
eau pressure were 26.8 ± 10.2 cmH2O and 23.8 ± 6.0 cmH2O (20.3 ±
4.8 cmH2O, 16.2 ± 3.9 cmH2O for normal lung group, p > 0.05), in-
spiratory resistance was 13.5 ± 5.6 cmH2O/s/l (12.4 ± 5.3 cmH2O/s/l
for normal lung group, p > 0.05). Static compliance was measured at
26.7 ± 7.9 ml/cmH2O in lung injury group (60.7 ± 12.2 ml/cmH2O in
normal lungs; p < 0.05), and inspiratory to expiratory time ratio in
lung injuries was 0.5 (0.55 in normal lungs, p > 0.05). Expiratory time
constant (RCexp) in lung injuries was 0.54 ± 1.7 s (0.79 ± 2.2 s in nor-
mal lungs). In lung injury patients, the tidal volume was smaller (8.35
± 2.38 ml/Kg vs 6.20 ± 1.89 ml/Kg in normal lung group, p < 0.05) and
respiratory rate was higher (19.8 breaths/min vs 15.2 breaths/min for
normal lung group, p < 0.05).
Conclusions: As expected, adaptive support ventilation delivered
smaller tidal volume and higher respiratory rates for injured lungs.
ASV efficiently operated in Korean ALI patients without any serious
drawbacks and favorably adjusted the tidal volume and respiratory
rates combination in relation with RCexp to meet lung protective
strategies.
Note: This abstract has been previously published and is available at
[1]. It is included here as a complete record of the abstracts from the
conference.
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Introduction: LPV is the gold standard for mechanically ventilated
patients with features of, or at risk of ARDS1. Uptake of ARDSnet
guidelines into clinical practice has been variable3; this service im-
provement project identifies some of the barriers to changing prac-
tice and demonstrates that improvement is possible.
Objectives: We identified the variation in practice in mechanical ven-
tilation across an 78 bedded mixed Intensive Care Unit (ICU) in a ter-
tiary referral centre and implemented a strategy to promote LPV. We
aimed to identify and address the barriers to the use of LPV through
an ongoing education program.
Methods: Audits have been performed comparing unit practice to
the guidelines for LPV issued by ARDSnet. All staff on the unit were
invited to respond to an electronic survey regarding the use of LPV
in our unit, Unit guidelines have been written to guide all staff in the
use of LPV and bedside laminates supporting LPV decision making
have been attached to all the ventilators in our unit.
Results: There has been an improvement in the percentage of pa-
tients compliant with lung protective ventilation from 14.9 % to
29.0 %, a decrease in peak airway pressures greater than 30 cmH20
and an increase in those ventilated with tidal volumes less than
6 ml/kg (26 % to 64 %). There is an ongoing downward trend in tidal
volumes with 64 % of the final cohort ventilated at < 6 ml/kg com-
pared with a majority of 6–8 mls/kg in the previous two cohorts. Key
barriers to the use of LPV were identified.
Conclusions: We have demonstrated that with guideline implemen-
tation, education, promotion and decision support tools LPV per-
formance can be improved. Whilst the tide is changing, there is still
a significant performance gap; the implementation of change into
healthcare practice faces challenges of information dissemination,
unit culture, perceived role understanding, authority hierarchy and
variation between multiple autonomous practitioners.
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Introduction: Inappropriate mechanical ventilation can lead to dy-
namic hyperinflation and autoPEEP. In the absence of an esophageal
catheter, dynamic hyperinflation is typically evaluated from the ex-
piratory flow profile with the absence of zero flow at end expiration
illustrating incomplete expiration. In patients with spontaneous
breathing, expiratory profiles can vary breath to breath, making inter-
pretation of flow profiles difficult. Additional information may be
present in the capnography signal. As incomplete expirations will
result in early termination of the expiratory CO2 signal and low end-
tidal CO2 (ETCO2), a combination of complete and incomplete expi-
rations will result in variability in ETCO2.
Objectives: This study investigates whether systematic patterns of
expiratory flow and ETCO2 exist in mechanically ventilated patients
with spontaneous breathing.
Methods: Respiratory flow and capnography signals were analysed in
eleven patients on pressure support ventilation, each ventilated at 3–
5 pressure support levels. Part of these data have been published
previously (1). Flow signals were analysed to calculate the average
number of incomplete expirations over a 20 breath window. CO2
signals were analysed to calculate the variability (2*SD) in ETCO2
over the same window. Data including 2350 sets of 20 breaths were
categorized according to the analysis of flow into 3 groups, few in-
complete expirations (<2 in 20), some incomplete expirations (2–18
in 20) and many incomplete expirations (>18 in 20); and the variabil-
ity of ETCO2 was calculated for each of these groups. A Wilcoxon
rank sum test was used to compare median ETCO2 variability be-
tween groups.
Results: Significant differences were found for median ETCO2 vari-
ability between the three groups. For few (<2) and many (>18) in-
complete expirations, ETCO2 variability was low (0.13 kPa and 0.19
kPa, respectively) indicating consistently complete or incomplete ex-
pirations. For the group of some incomplete expirations (2–18)
ETCO2 variability was significantly higher (p < 0.05), at 0.44 kPa, with
great variability observed in both expiratory flow and CO2 signals.
Conclusions: These results indicate that systematic patterns can be
seen in expiratory flow and capnography signals. Combining these
signals may provide a useful source of information for easier evalu-
ation of dynamic hyperinflation.
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Introduction: Cancer survival rates are improving over time. Co-
existence of cardiac disease requiring cardiac surgery and a history
of malignancy is not unusual. Whether malignancy history impairs
short-term outcomes after cardiac surgery has not been well studied.
Objectives: Aim of this study is to describe the characteristics and
outcomes of patients with a history of solid tumor or hematological
malignancy who underwent cardiac surgery procedure under the use
of cardiopulmonary bypass.
Methods: A total of 1618 consecutive patients underwent cardiac
surgery from May 2012 to March 2016. Our clinic's electronic
database was searched for patients with a history of solid tumor
or hematological malignancies (Group A) The following factors
were compared between group A and group B (control): Age,
Euroscore II, total red blood transfusions > 3units, post-op low car-
diac output syndrome (LCOS), prolonged mechanical ventilation
(>24 hours), post-op non-invasive ventilation(NIV) because of re-
spiratory failure, acute kidney injury(AKI-RIFLE criteria), post-op
atrial fibrillation and mortality. Statistical analysis was based on x
square test.
Results: History of malignancy was found in 47 (9 females) patients
(2,9 %, group A): 9 prostate, 8 breast, 5 colon/rectum,5 lung,4 stom-
ach,3 laryngeal,2 bladder, 1 kidney,1 skin,1 salivary gland cancer,
7 lymphomas (2 Hodgin) and 1 sarcoma. In all patients, cancer
was in remission. Performed procedures were (6 emergency):41
CABG ± valve, 5 thoracic aorta surgery and 1 resection of heart
sarcoma. Cancer patients were older- mean age 68,6 ± 7,6 vs 65,1
± 10,6- and had slightly higher Euroscore II :2,4 ± 2,4 vs 2,1 ± 3,3.
Median ICU days were 2 for both groups. Median mechanical
ventilation time was 8 hours for group A vs 7 hours for group B.
No re-intubations, no strokes, no sternal wound infections were
recorded for group A while mortality was 0 %. Comparing the 2
groups for transfusions with > 3RBCs (9/47, p = 0,43), post-op atrial
fibrillation (19/47, p = 0,39), AKI(7/47, p = 0,85), NIV(5/47, p = 0,94),
prolonged ventilation (3/47, p = 0,8) and LCOS (1/47, p = 0,58) no
statistical difference was found.
Conclusions: History of cancer has no impact on postoperative mor-
tality and morbidity in patients after cardiac surgery under the use of
cardiopulmonary bypass.
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Introduction: The outcomes of HIV-infected patients, hematologic
transplant recipients and cancer patients have gradually improved
over the last 30 years outside the ICU. But research on the outcomes
of these and other groups of critically ill immunocompromised pa-
tients is scarce. It is unclear if these patients show a comparable im-
provement in outcome and, if so, whether this is due to a change in
patients' characteristics such as severity of illness.
Objectives: Determine the outcomes and characteristics of critically
ill immunocompromised patients over the last decade.
Methods: Retrospective cohort study in a Dutch Intensive Care Unit
(ICU) between 2005 and 2015. All adult patients fulfilling the defin-
ition of the APACHE II comorbidity immunologic insufficiency were
eligible for the analysis. The outcomes were analyzed in two cohorts:
2005–2010 (I) and 2011–2015 (II).
Results: A total of 861 immunocompromised patients were admitted
to the ICU between 2005 and 2015 (cohort I: n = 457 and cohort II:
n = 404). After correction with the APACHE IV pm, there was no sig-
nificant difference in ICU mortality (I:16 % vs. II:21 %) and hospital
mortality (I:24 % vs. II:30 %) between the cohorts (adjusted odds ra-
tio (“adj. OR”): 1.5, 95%CI [0.92- 2.36] and adj. OR: 1.3, 95%CI [0.89-
1.93], respectively). Patients in cohort II had 11 % more medical ad-
missions (p = 0.001), used 6 % more oral anti-diabetic medication
(p = 0.002) and suffered 5 % more from chronic kidney insufficiency
(p = 0.012) compared to cohort I. The standardized mortality ratio
(SMR) of cohort I was 0.71 95%CI [0.61-0.79] vs. 0.82 95%CI 0.74-
0.87] in cohort II. See Fig. 69.
The largest immunocompromised group consisted of patients
using corticosteroids (n = 206 cohort I, n = 140 cohort II). The ICU
mortality in this group showed an increase of 9 % in cohort II
(15 % vs. 24 %, p = 0.047) and the hospital mortality showed an
increase of 8 % (23 % vs. 31 %, p = 0.158). The mortality rates
corrected for the APACHE IV pm did not significantly differ be-
tween the cohorts (adj. OR: 1.35 95%CI [0.74-2.45] and adj. OR:
2.1 95%CI [0.995-4.51]). Patients in cohort II had 13 % more med-
ical admissions (p = 0.02), used 10 % more oral anti-diabetic
medication (p = 0.01) and suffered 6 % more from chronic kidney
insufficiency (p = 0.03) compared to cohort I.
Conclusions: Survival of immunocompromised critically ill patients,
including of the largest subgroup, did not change over the last
decade, however, patient characteristics did. Patients admitted
during the last five years have more co-morbidities and had
more medical admissions. These results suggest that recently ad-
mitted critically ill immonocompromised patients are more ser-
iously ill than in the past.
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Introduction: 25 % of UK HIV patients remain undiagnosed.A large
proportion present with a late diagnosis1.Late diagnosis is linked
with HIV related sequelae,often culminating in critical care admissio-
n.Early diagnosis in critically ill patients has a marked impact on out-
comes and costs.Testing based on traditional HIV risk factors lacks
sensitivity.The UK National Guideline (UKNG) suggests using certain
HIV indicator illnesses to prompt testing2.This may provide a frame-
work for HIV testing in critical care.No formal critical care specific
guideline exists in the UK. Less than 10 % of UK critical care units fol-
low a local HIV testing policy and the minority using UKNG report
poor compliance3.
Objectives: We aimed to audit all patients admitted to our critical
care unit against UKNG for HIV testing and to assess HIV prevalen-
ce.UKNG recommends where HIV prevalence exceeds 2/1000 of the
population,all medical admissions should be tested.Public Health
England data places our prevalence at 1.8/1000 of the population.Lo-
cal expert opinion suggests the prevalence is over 2/1000 when ac-
counting for local catchment area.We aimed to evaluate our critical
care unit's HIV prevalence and proportion of patients presenting with
late diagnosis.
Methods: A retrospective audit of all admissions to Bolton NHS
Trust's critical care unit from 1/1/15 to 31/12/15 was undertaken
using the critical care database.During this period no HIV testing
protocol was in place.Critical care consultants requested HIV tests
based on personal knowledge or after consultation with an HIV
specialist.An HIV indicator illness had a defined aetiology other
than HIV.The virology lab database was assessed for all HIV tests
sent within the Trust and cross-referenced to the critical care
database.
Results: 388 records were identified(382 patients, 6 re-
admissions).68 % were medical patients and 32 % were acute or
elective surgical.No patients were known to be HIV positive be-
fore admission.28 patients (7 %) were tested for HIV. 71 % of
these had an acute respiratory illness as the HIV indicator ill-
ness.96 patients met UKNG criteria for HIV testing. 80 % of these
had an acute respiratory illness.6/28 patients tested positive for
HIV equating to a prevalence 15/1000 population.4/6 HIV positive
patients presented with late diagnosis.
Conclusions: Based on national guidelines,25 % of patients admit-
ted to our critical care unit,had indicators to test for HIV.Ad hoc
testing only lead to 7 % of admissions being tested.The positive
rate was high,leading us to assume missed diagnosis in the inter-
ested population. Based on this data,we are changing our policy
to routine testing for all admissions with an opt-out for some pa-
tient groups.Other UK critical care units have adopted a similar
strategy3.
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Introduction: Intensive care unit (ICU) patients with haematological
malignancy have an increased risk of bleeding and thrombotic com-
plications1, adding to complications such as sepsis, respiratory failure
and renal failure and thereby increasing the mortality2–5.
Traditionally conventional methods (such as platelet count, APTT, INR
and fibrinogen) remain the standard approach, but more recently
global haemostatic methods such as thromboelastography (TEG)
have gained impact6.
Objective: The aim of this study was to observe whether TEG could
predict bleeding and thrombosis in haematological ICU patients.
Methods: Post-hoc analysis of haematological patients included in a
single ICU centre in the 6S trial (ClinicalTrials.gov NCT00962156)7.
Clinical characteristics, TEG measurements within 24-hours of ran-
domisation and bleeding complications according to WHO criteria8
were retrieved from the 6S trial database. The patient's electronic
files were reviewed for thrombotic events. We used receiver operat-
ing characteristic (ROC) curves to analyse the ability of TEG to predict
bleeding events.
Results: 202 patients with severe sepsis were admitted to the ICU of
Rigshospitalet, Copenhagen, and included in the 6S trial within 6
(IQR 1–16) hours of admission. Of these, 41 had haematological ma-
lignancy and were analyzed in the present study. Median age, SAPS
II and SOFA score were 66 (IQR 61–69), 64 (IQR 52–74 and 10 (IQR 9–
11), respectively (Table 46). During the ICU stay 19 patients (46 %)
had a bleeding episode. Nine (22 %) of these patients bled within
the first five ICU-days. Two (5 %) patients had a thrombosis during
the first five ICU-days. None of the 41 patients had a “normal” TEG
with all parameters within the reference ranges (Table 47). There was
no obvious relationship between TEG values and the risk of
thrombosis. All baseline TEG variables were poor predictors of both
bleeding within 5 days of inclusion and during the ICU admission
(Table 48).
Conclusion Baseline TEG did not predict bleeding in our heteroge-
neous cohort of haematological ICU patients with severe sepsis.
Thrombotic events were few.
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Introduction: Undiagnosed HIV infection poses a significant public
health burden in the UK; a fifth of infected individuals remain un-
aware.1 Our ICU is situated in Milton Keynes, a city with an unexpect-
edly high HIV prevalence and one of the highest late diagnosis rates
in the UK.2 This is relevant to critical care as HIV infection may influ-
ence a patient's outcome and since ICU admission provides a unique
opportunity to offer testing.
UK Guidelines for HIV testing3 do not specifically address ICU patients.
However, consideration of universal testing is recommended for med-
ical inpatients when local prevalence exceeds 2 per 1000, as in Milton
Keynes. Our previous practice of HIV testing was based on informal as-
sessment of risk, with correspondingly low testing rates. Evidence
shows that testing rates increase when opt-out policies are adopted in
other settings3 and we elected to implement this in our ICU. In patients
with capacity, we sought consent prior to testing. In those lacking cap-
acity, testing was performed in their best interests. There is limited UK
data on the cost-effectiveness of expanded HIV testing but US data
suggests it is cost-effective if 1 new diagnosis is made per 1,000 tests.4
We report our experiences following a year of opt-out testing.
Table 46 (abstract A616). Patient characteristics
Haematological disease:
- Acute myeloid leukaemia 15
- Non-hodgkin's lymphoma 9
- Multiple myeloma 5
- Chronic lymphatic leukemia 5
- Hodgkin's disease 3
- Myelodysplastic syndrome 2
- Acute lymphoblastic leukaemia 2
Shock - no.(%) 38/41 (93%)
Mortality within 90 days - no. (%) 24/41 (59%)
Table 47 (abstract A616). Thromboelastography at ICU-admission
No. R-time
Median
(IQR)
Angle
Median
(IQR)
MA
Median
(IQR)
FF-MA
Median
(IQR)
Minor/
mild
blood
loss
(WHO
grade
1–2)
No.
Severe/
Debilitating
blood loss
(WHO
grade
3–4) No.
All patients 41 10
(8–11)
54 (41–
66)
54 (46–
69)
24
(16–32)
16 11
Bleeding
within
5 days
9 11
(8–11)
61 (44–
67)
59 (47–
67)
24
(17–31)
6 2
Bleeding
during
ICU-stay
19 10
(8–12)
54 (47–
61)
53 (46–
66)
24
(18–31)
10 9
Non-bleeding patients 22 9 (8–11) 51 (37–
68)
55 (45–
71)
23
(15–32)
0 0
Thrombosis (Patient no1
and 2)
2 18 and
9
19 and
82
69 and
52
43 and
18
0 0
Table 48 (abstract A616). Area under the ROC curve
Bleeding within 5 days Any bleeding in the ICU
R-time, AUC (95%-CI) 0.53 (0.28–0.77) 0.50 (0.31–0.68)
Angle, AUC (95%-CI) 0.56 (0.34–0.78) 0.49 (0.30–0.68)
MA, AUC (95%-CI) 0.54 (0.34–0.74) 0.58 (0.40–0.76)
FF-MA, AUC (95%-CI) 0.50 (0.29–0.71) 0.54 (0.36–0.72)
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Objectives: To compare HIV testing rates before and after the imple-
mentation of an opt-out policy.
Methods: All unplanned admissions to our ICU were included and
pathology records interrogated to determine if HIV testing was per-
formed during ICU admission or in the 3-month preceding period.
We compared testing rates prior to (August 2014-January 2015;
6 months) and after (April 2015-March 2016; 12 months) the intro-
duction of opt-out testing.
Results: Our initial 6-month analysis (n = 196) showed that the major-
ity of patients (89.8 %, n = 176) were not tested during the study
period. Of the 10.2 % (n = 20) tested, 4.6 % (n = 9) were tested on
ICU. We admitted 391 patients in the first year of opt-out testing.
The percentage of untested patients halved from 89.8 % to 45.5 %
[Fig. 70] due to a 10-fold increase in ICU testing rate with 50.6 % of
patients (n = 198) receiving testing on ICU. The number of patients
tested prior to ICU admission remained low. Of the 207 tests per-
formed on ICU, one new diagnosis was made and the patient inte-
grated into local specialist services. Of the patients able to consent,
none declined testing.
Conclusions: Implementation of an opt-out testing policy improved
our rates of HIV testing and yielded one new diagnosis. We have
found this new policy to be feasible and cost-effective.
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Introduction: Over the last decade, survival rates in critically ill can-
cer patients have improved dramatically. [1] Earlier admission to the
intensive care unit (ICU) has resulted in better survival rates for critic-
ally ill cancer patients. [2] Selecting patients likely to benefit from
ICU admission is based on complex criteria, and some ICU specific
therapies such as mechanical ventilation; have been associated with
an increase in mortality. [3]
Objectives: To identify clinical characteristics of oncological patients
admitted to our ICU and to identify risk factors associated with
14 day mortality in this specific population.
Methods: Five - year retrospective observational analysis was per-
formed including all patients with a personal history of active onco-
logical malignancies admitted to the ICU of a tertiary care University
Hospital in Spain. Patients´ demographic, clinical features and out-
come were recorded. Data were expressed as frequency (percentage)
and median (interquartile range IQR). Multivariate logistic regression
with significant covariables at 0,05 was performed to identify specific
risk factors for 14 day mortality.
Results: One hundred and thirty six patients were registered in
this period. Age (median 60,IQR 2575: 5270), ICU Length of stay
(LOS) (median 5 (IQR 2575:28) Principal reason to admission to
ICU was respiratory failure (41,9 %), followed by septic shock
(33,8 %) and low conscious level (8,1 %). Top three solid malig-
nancies were lung (27.2 %), followed by breast (12.5 %) and
Bowel (11.8 %). No differences in co morbidities between Survi-
vors and nonsurvivors at 14 day were assessed. APACHE II score
was higher in non survivors median 25 (IQR 2575:18,731,5; p =
0,002) versus survivors and this group had more frequently mech-
anical ventilation and vasopressors. Multivariate logistic regression
for 14 day mortality assessed mechanical ventilation OR:3.59
(CI95%:1.438.97, p = 0,006) and APACHE II increases in 1score OR
1.06 (CI95%:1.011.23, p = 0,021) as independent risk factors for
14 day mortality in ICU.
Conclusions: Oncological critically ill patients remain as a high mor-
tality population. Mechanical ventilation and increases in one point
in APACHE II score at admission to ICU are independent risk factor
for 14 day mortality.
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Background: Patients diagnosed with hematological diseases may
require admission to the hospital Intensive Care Unit (ICU) be-
cause of severe complications from the disease or treatment
received.
Objective: To evaluate hospital mortality of haematological patients
requiring mechanical ventilation over a period of nine years in a
medical-surgical ICU.
Methods: A prospective, descriptive and single-center study with
haematological patients admitted to the ICU in the period
2006–2015. Baseline demographic data were: age, sex, APACHE
II score, haematological diagnosis, time of admission and dis-
charge from ICU and hospital, duration of invasive mechanical
ventilation and non invasive, history of surgery and mortality
(ICU, hospital, one year post-discharge). Statistical analysis: de-
scriptive, bivariate (chi 2 and t-Student) and multivariate logistic
regression analysis.
Fig. 70 (abstract A617). HIV testing rates before and after
opt-out testing
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Results: We included 121 patients. The percentage of male was
64.5 %, and average age of 54 ± 16 years. History of surgery 9.9 %.
APACHE II score was 27.1 ± 8 points. The percentage of different
hematological diseases were: 21.8 % Acute Myeloblastic Leukaemia,
27.7 % of Non Hodgkin Lymphoma, Hodgkin Lymphoma 10.1 %,
Acute Lymphoblastic Leukaemia: 5.8 %; 21.5 %, Chronic Myeloid
Leukaemia 5.9 %, and Chronic Lymphoid Leukaemia: 5.9 %, Multiple
Myeloma: 9.2 %, Aplastic anaemia: 3.4 %, etc. ICU mortality was
68.6 %, the hospital mortality 76.9 % and the mortality one year
post-discharge was 86.7 %.The average length of stay in the ICU
was 13.6 ± 16 days, compared to the average hospital stay: 22.9 ±
27 days.
The average number of days of mechanical ventilation was 9.4 ± 8.7,
and noninvasive mechanical ventilation: 2.36 ± 3.2.Hospital mortality
of acute Myeloblastic Leukaemia and non-Hodgkin lymphoma were
69 and 76 % respectively.
Conclusion Mortality in ICU of haematological patients is very high,
being higher in patients diagnosed with acute myelogenous
leukemia and non-Hodgkin lymphoma.
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Introduction: Although hematopoietic stem cell transplantation re-
cipients (HSCTR) admitted to an ICU have a high mortality (52 %-
83 %1), limited data exists regarding six-month mortality rates. The
aim of our study was to investigate the outcomes and explore non-
respiratory predictors of ICU and six-month mortality, and to com-
pare our result with a previous publication2 done in our center, in
order to learn if outcome has improved.
Methods: Retrospective study. We analyzed all HSCTR who were
admitted to our ICU from January 2009 to March 2015. We
recovered demographic data, reason for ICU admission and all
the possible variables related with mortality. Statistical analysis
was done using the Chi-square test for categorical variables and
the Mann–Whitney test for continuous non-parametric variables.
Results: During the study period a total of 25 HSCTR required ICU
care, and this accounted for 33 admissions (7 of them were readmit-
ted). General patient characteristics are shown in Table 49.
The most frequent cause for ICU admission was acute respiratory fail-
ure (56 %) followed by non-respiratory sepsis (7 patients; 28 %) and
by acute coronary syndrome, brain stroke, hemophagocytic syn-
drome and veno-occlusive disease (one case each; 4 %). Twenty pa-
tients had 2 or more organ failures: respiratory (64 %), hemodynamic
(64 %) and renal (72 %; use of renal replacement techniques in
32 %). All patients received antibiotic treatment, and 9 of them
(36 %) had positive microbiological results. Mean ICU stay was 9 days
(2–35).
In our study, ICU mortality was 48 % (12 of 25 patients), in-
hospital mortality 60 % (15/25) and six-month mortality was
72 % (18 of 25 patients). Compared to mortalities reported
30 years ago for our center the rates that we found were lower
(ICU-mortality 48 vs 76 %; in-hospital mortality 60 vs 88 %)2.
Factors related to ICU and six-month mortality are listed in
Table 50. Non-respiratory laboratory parameters (lactic,
hemoglobin, INR, aPTT, fibrinogen) and isolated respiratory (p =
0,053) and hemodynamic (p = 0,386) failures together with the
use of vasoactive drugs (p = 0,819) renal replacement therapies
(p = 0,236) or positive cultures (p = 0,656) did not reach statis-
tical significance.
Conclusions: Pre-ICU hospital days, 24 h SOFA, number of organ fail-
ures and isolated renal failure are factors associated with ICU mortal-
ity. The presence of lower counts in the first 24 h of platelets,
leukocytes and neutrophils together with pre-ICU hospital days were
related with six-month mortality. Although mortality rates in HSCTR
admitted to ICU have decreased, ICU, in-hospital and six-month sur-
vival rates are still low.
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Table 49 (abstract A620). General patient characteristics
Overall ICU mortality 6 month mortality
Survivors Exitus p Survivors Exitus p
Sex (% of women) 28% 30,77% 25% 0,748 28,57% 27,78% 0,968
Age (years) 44,72
±16,32
49,85
±15,42
39,17
±16,32
0.0969 49,43
±18,27
42,89
±16,32
0,2498
Underlying disorder
Lymphoblastic
leukemia
20% 1 4 0,181 1 4 0,353
Non-Hodgkin
lymphoma
4% 1 0 0 1
Multiple myeloma 20% 4 1 3 2
Marrow aplasia 20% 1 4 0 5
Lymphoblastic
lymphoma
4% 1 0 1 0
AML 16% 2 2 1 3
Chronic Lymphocytic
Leukemia
4% 1 0 0 1
Myelodysplastic
syndrome
8% 2 0 1 1
Panmyelosis 4% 0 1 0 1
Type of HSTC
Allogeneic 79,17% 7
(36,84%)
12
(63,16%)
0,043* 3
(15,79%)
16
(84,21%)
0,0401*
Autologous 16,67% 4 (100%) 0 3 (75%) 1 (25%)
Microtransplant 4,17% 1 (100%) 0 0 1 (100%)
GHCD 40,00% 38,46% 41,67% 0,87 42,86% 38,89% 0,856
CMV 35% 20% 50% 0,16 0,00% 46,67% 0,058
APACHE II 20,75
±5,64
19,62
±5,08
22,09
±5,64
0,257 18,71
±3,73
21,59
±5,64
0,2514
SOFA 8,38
±3,98
6,54
±3,89
10,55
±3,98
0,0061* 6,86
±1,95
9±3,98 0,0787
Continuous variables are shown as mean ± sd
P<0,005
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Introduction: Outcomes for haematology patients admitted to in-
tensive care have improved in the last decade and this has
thought to be due to a collection of factors rather than single
treatment. In 2015, the British Committee of Standards in
Haematology published an evidence based guideline outlining
the major considerations in managing critically ill patients with
haeamtological disease, for haematologists and intensivists.
Objectives: To evaluate the impact of the guideline on mortality and
use of ICU resources, for adult haematology patients at our institution.
Methods: We performed a retrospective analysis of 71 patients with
a haematological disease, admitted to our 19 bed ICU between
2013–2016. Information was collated from the Intensive care National
Audit and research database and from patient records. Data was
then organised into 2 groups (pre and post guideline) and analysed
using SPSS.
Results: Patients in the study were separated into 2 groups, 40
in the pre-guideline group vs 30 in the post guideline group. A
statistically significant improvement in mortality was found in
the group after the guideline had been implemented (43 % vs.
68 % p < 0.05) however there was no difference between the
groups in duration of intensive care stay or number of organs
supported. Admission APACHE-II scores were significantly better
after the guideline had been introduced (22.3 ± 7.11 vs. 25.5 ±
6.3) as were measures of functional status and premorbid state.
Of the patients who had respiratory failure there was no signifi-
cant difference between the groups regarding use of NIV or
early intubation that could account for our mortality results.
Conclusions: The implementation of the new guideline has re-
sulted in reduced mortality for patients admitted to ICU with a
haematological disease. While aspects of the guideline have
made no difference to outcome, our results demonstrate that
early referrals by haematologists prior to developing multiorgan
failure in individuals who have good-moderate functional cap-
acity, have a positive effect on mortality. In our institution this
was achieved with increased reliance on early warning scoring
systems, critical care outreach teams and consultant to consultant
referrals.
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Introduction: Receptors of a hematopoietic stem cell transplantation
(HSCT) are a population with a high risk of developing severe compli-
cations that require admission to intensive care units (ICU), which is
related to a high mortality. So, efforts are needed in order to improve
their prognostic.
Objectives: Our aim was to describe the cohort of receptors of an
HSCT admitted to a tertiary hospital ICU and analyze factors that are
likely to affect their survival.
Methods: Retrospective study including adult (+18 years) patients
who received an HSCT and required admission to ICU between 01
January 2010 and 29 February 2016. Quantitative variables are pre-
sented as median (IQR) and categorical as N (%).
Results: Fifty patients were included, 30 (65 %) men, with a me-
dian age of 52 (34–60) years. The underlying leading conditions
were leukemia, with 23 (46 %) patients, and lymphoma, with 17
(34 %). Reduced intensity chemotherapy was employed in 24
(47 %). Allogenic transplantation was done in 42 (84 %) cases.
Twenty-two (44 %) suffered GVHD, that was acute in 18 (36 %)
and chronic in 7 (14 %). The patients presented on ICU admis-
sion a median of 3 (2–4) organ failures, distributed as follow:
respiratory 32 (64 %), hemodynamic 25 (50 %), renal 29 (58 %),
liver 13 (26 %), hematological 37 (74 %), metabolic 22 (44 %).
Initial mechanical ventilation (MV) was required in 15 (30 %), 21
(42 %) high flow nasal cannula (HFNC), only one (2 %) non in-
vasive mechanical ventilation and 11 (27 %) low flow systems.
Finally, 27 patients (54 %) received MV. Thirty five (70 %) pa-
tients needed vasoactive drugs and 14 (28 %) renal replacement
therapy (RRT). The time from the transplantation to ICU admis-
sion was 33 (12–122) days. APACHE score was 22 (15–27). Neu-
tropenia on admission was present in 20 (43 %). The HCT-CI
was 3 (2–4).Twenty-two (46.8 %) patients were discharged to
the hematology ward and 14 (29.8 %) were discharged home.
Factors related to mortality: number of organ failures (3.5 vs
2.2; p = 0.016), need of MV (OR = 4.4, IC95%:1.2-16.9, p = 0.024)
and renal failure (OR = 10.6, IC95%:2.4-47.6, p = 0.002). Patients
who initially were treated with HFNC and needed MV had a
similar mortality than patients initially on MV. None of the 14
patients on RRT survived. We did not find differences in mortal-
ity related to APACHE score, type of HSCT, GVHD, neutropenia
and need of vasoactive drugs. In the multivariate analysis only
renal failure maintained statistical significance (OR: 9.1, IC95%:
1.9-42.4, p = 0.005).
Conclusions: Receptors of a HSCT admitted to an ICU have a great
hospital mortality (70.2 %). Patients who need MV or suffer renal fail-
ure have the worse prognostic. Patients initially on HFNC who re-
quired MV did not have a different outcome compared to patients
initially on MV.
Table 50 (abstract A620). Factors related to sixmonth or ICU morta
Overall ICU mortality 6 month mortality
Survivors Exitus
p
p Survivors Exitus p
Pre-ICU
hospital days
17,2
±20,46
7±10,12 28,25
±20,46
0,0058* 3±5,1 22,72
±20,46
0,0068*
SOFA 8,38
±3,98
6,54
±3,89
10,55
±3,98
0,0061* 6,86
±1,95
9±3,98 0,0787
Number of
organ
failures
2,84
±1,34
2,31
±1,18
3,42
±1,34
0,0475* 2,43
±1,27
3±1,34 0,3846
Renal failurea 72% 71% 72% 0,968 54% 92% 0,035
Platelets
count
90960
±97849
133615
±120817
44750
±97849
0,1737 174571
±132024
58444
±97849
0,0341*
Leucocytes
count
7205
±10144
9863
±12978
4326
±10144
0,1573 15191
±15888
4100
±10144
0,0065*
Nutrophils
count
5204
±5730
6949
±6831
3313
±5730
0,1572 10389
±7479
3187
±5730
0,0092*
P<0.005
aRenal failure is the only qualitative variable. Show as frequency
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Introduction: From March 1981 to June 1987, 25 patients (40 %)
with a previous Hematopoietic Stem Cell Transplant (HSCT)
needed ICU support in our tertiary care hospital. The main cause
of admission was acute respiratory failure (ARF)(18 patients). Six-
teen (64 %) required mechanical ventilation (MV). Mortality
amongst this group was 94 % and more than 7 days of MV was
a strong factor associated with it1.
Objectives: To study the evolution of HSCT patients with ARF that
require ICU care, the factors associated with mortality, and to
compare them to the previous data recorded in our center. Stat-
istical analysis was done using the Chi-square and the Mann–
Whitney tests.
Methods: Retrospective study from January 2009 to March 2015.
All patients admitted to the ICU with a previous history of HSCT
were included. We collected demographic data, reason for admis-
sion, respiratory support applied and factors associated with
mortality.
Results: During the period studied, 235 patients received a HSCT and
25 (10.63 %) needed ICU care. There were 33 admissions in total.
Median time between the HSCT and admission was 86 days (54–
1685). Main reason for admission was ARF (14 patients; 56 %),
followed by non-respiratory sepsis (7 patients; 28 %) and by acute
coronary syndrome, brain stroke, hemophagocytic syndrome and
veno-occlusive disease (one case each; 4 %). Median number of or-
gans that had failed upon admission was 3 (2–4): respiratory (64 %),
hemodynamic (64 %) and renal (72 %).
In the ARF group we accounted for 11 pneumonias, 2 alveolar hem-
orrhages and 1 pulmonary graft-versus-host disease. Seven patients
met Acute Respiratory Distress Syndrome (ARDS) criteria. The most
common radiographic finding was an interstitial infiltrate (14).
Twenty-three patients required respiratory support: 4 high-flow nasal
cannula (16 %), 8 non-invasive MV (32 %) and 11 MV (44 %; 5 after
unsuccessful non-invasive MV). Median duration of MV was10 days
(5–16). Only one patient needed prone position. Three patients
underwent a tracheostomy.
Overall ICU mortality was 48 % (12) and 6-month survival
dropped to 28 % (7). The variables associated with mortality
were: failure of 3 or more organs (p = 0.047), the presence of
ARDS (85.71 % vs. 38.46 %; p = 0.043), MV (72.73 % vs. 25 %; p =
0.022), pO2/FiO2 ratio < 120 in the first 24 hours (p = 0.011) and
ICU readmission (6 out of 7 patients: 85,7 %).
Conclusions: Although nowadays fewer patients required ICU care
after a HSCT, the main reason for admission hasn´t changed and
the mortality amongst these patients is still high.The presence of
MV, ARDS, low pO2/FiO2 ratio, three or more organ failures and
ICU readmission is associated with mortality. The need for MV in
our study was lower that in the previous one probably due to an
improvement in other ways of respiratory support.
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Introduction: Delayed admission in the ICU (defined as time from
hospital to ICU > 24 hours) has been associated with poorer outcome
Fig. 71 (abstract A623). Demographic characteristics
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in critically ill patients with haematological malignancies (1), however
no data exists concerning the subgroup of patients receiving chemo-
therapy (CT) in the ICU. Moreover, only a few small studies have
assessed outcome in this subgroup.(2)
Objectives: The aim was to assess whether CT was associated with
outcome, overall and within the subgroups of patients admitted to
the ICU ≤ 24 hours vs. > 24 hours after hospitalisation. Furthermore,
we wanted to identify prognostic indicators for hospital mortality
within the CT subgroup.
Methods: Retrospective analysis of prospectively collected data on
1011 patients included between January 1st 2010 and May 1st 2011
in 17 French and Belgian centres.(1) Clinically important variables
and variables associated with CT and mortality in univariate analysis
(P < 0.2) were included in the multivariate logistic regression analysis.
Results: Of the 1011 patients, 928 (91 %) had complete data, and
231 of them received CT in the ICU. Overall 51.9 % of the pa-
tients were newly diagnosed and 50.6 % suffered from AML.
Sixty-nine percent needed organ support (NIV, MV, vasopressors
or dialysis). Hospital mortality was similar between CT and non-
CT patients (38.5 %, vs 39.9 %, P = 0.715). However, CT patients
were younger (median 58y vs 61y, P = 0.003), had better perform-
ance status (86.1 % vs 79.5 % with ECOG 0 to 2, P = 0.025) and a
lower SOFA score (5 vs 6, P = 0.002) at admission. After adjust-
ment for all potential confounders, CT was associated with in-
creased hospital mortality (OR 1.52, P = 0.036) as compared to
non CT patients, however only when admitted in the ICU > 24 hrs
after hospital admission (OR 2.99, P < 0.001). This was not the
case for CT patients admitted ≤ 24 hrs after hospital admission
(OR 1.32, P = 0.396). Within the CT subgroup SOFA score (OR 1.19,
P < 0.001), number of previous lines of CT (OR 1.33, P = 0.039)
and comorbidity (CCI) (OR 1.15, P = 0.071) were associated with
increased mortality in multivariate analysis, while admission ≤
24 hrs (OR 0.44, P = 0.012) was protective.
Conclusions: Outcome of patients receiving chemotherapy in the
ICU was similar to the general population with haematological malig-
nancies, however only when admitted within 24 hrs after hospital ad-
mission. Earlier referral to the ICU may be a key factor to reduce
mortality in high risk patients requiring chemotherapy.
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Introduction: Sepsis is a common complication in cancer patients
and it is associated with high mortality rates. Clinical approach in crit-
ically ill cancer patients should take into account the disease course
and cancer-related determinants.
Objectives: To characterise cancer patients admitted to an onco-
logical intensive care unit with sepsis/septic shock and to determine
baseline predictors of in-hospital mortality.
Methods: This is a retrospective cohort study of all the adult cancer
patients admitted to a 6-bed Oncological Intensive Care Unit (ICU)
with the diagnosis of severe sepsis or septic shock, between 1 Janu-
ary 2012 and 31 December 2015. Solid and haematological condi-
tions were analysed separately. The analysis was performed with
multivariate logistic regression models, using a stepwise backward
elimination with complete case analysis. All the analysis was per-
formed with the software Stata 12.1®. P-value was considered signifi-
cant at < 0.05.
Results: We identified 210 patients: the mean age was 60.8 (CI 58.8-
62.8) and 65 % were male (n = 136). About 19 % (n = 40) were post-
operative and the remaining 81 % (n = 170) were medical septic
complications; 61 % were admitted with septic shock (n = 129). The
majority of cancer conditions were solid tumours - 71 %(n = 149) -
and among the haematological cancers - 29 %(n = 61) - 16 % (n = 10)
were admitted after bone marrow transplantation. The median ECOG
performance status score was 2. Only 6 % (n = 12) were in complete
response and 65 % (n = 137) were at an initial phase of the treat-
ment. Data regarding comorbidities, tumour staging, site of infection,
culture-positive sepsis and organ support at admission were included
in the multivariate analysis. ICU mortality and in-hospital mortality
were 34 % (n = 71) and 50 % (n = 104), respectively. Among solid
tumour patients, higher scores of Simplified Acute Physiology Score
II (SAPS II) and Eastern Cooperative Oncology Group (ECOG) Perform-
ance Status showed a statistically significant association with in-
hospital mortality, as expected; postoperative admission, septic shock
at admission tend to be associated with worst prognosis. Regarding
haematological conditions, only Acute Physiology and Chronic Health
Evaluation (APACHE) II score was a statistically significant predictor of
in-hospital mortality.
Conclusions: This study highlights ECOG as a predictor of in-hospital
sepsis-related mortality in patients with solid tumours and raises the
awareness around the search of oncological baseline characteristics
that may be determinants of sepsis-related mortality. This Onco-
logical ICU mortality and respective in-hospital mortality rates are
similar to mortality rates of sepsis/septic shock in general population.
These results suggest SAPS II and APACHE II as a good predictor of
in-hospital sepsis-related mortality in patients with solid tumours and
haematological patients, respectively. Larger retrospective cohorts or
prospective studies might strengthen these conclusions.
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Introduction: Sepsis and SS are one of the most serious complica-
tions in neutropenic pts. MSCs reprogram of monocytes and macro-
phages by releasing prostaglandin E2, IL-10 and decrease the
production of TNF-α and IL-6. Injection of MSCs to septic animals re-
duced mortality and improved organ function [2]. No study has in-
vestigated the efficacy of MSC therapy in pts with SS, especially
neutropenic pts.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 322 of 607
Objectives: The aim of the study was to investigate the efficacy of
MSC administration on survival and organ dysfunction in neutropenic
pts with SS.
Methods: In prospective single center randomized Russian clinical
trial of MMSCs in severe neutropenic pts with SS (RUMCESS) (NCT
01849237) 30 neutropenic pts (WBC < 0.5x109/l) were enrolled. The
pts were randomly assigned to receive either conventional therapy
(CT) of SS (CT group) (15 pts) or CT plus donor MMSCs within the first
10 hours of SS (CT +MMSCs group) (15 pts). The SOFA score was cal-
culated at onset of SS and in 2, 3, 7, 14, 21 and 28 days. Fisher´s
exact test, Kaplan-Meier method with the log-rank test & Cox propor-
tional hazard regression model were used.
Results: There were no significant differences between groups in
demographic parameters. Positive blood cultures were documented
in 8/15 patients in CT group and in 11/15 patients in CT +MSCs
group. Baseline APACHE II scores (30.6 [95 % CI 27.0-40.1] and 30.9
[95 % CI 26.1-36.7] in the CT and MSC groups, respectively) and SOFA
scores (15.9 [95 % CI 13.9-20.2] and 16.1 [95 % CI 12.1-19.0], respect-
ively) were similar in both groups. During the study period, total
SOFA score did not differ between the groups. However, since sec-
ond day cardiovascular SOFA score and respiratory SOFA score were
lower (p < 0.05) in MSCs-CT group, than in CT-group. 28-days survival
rates were 20 % (3 out of 15 pts) in CT group and 60 % (9 out of 15
pts) in CT +MSCs group (P < 0.05).
Despite higher 28-days survival rates in MSCs + CT group only 4 of 9
pts survived 28 days remained alive in 3 months, 5 pts died due to
sepsis related organ dysfunctions. In 3 months there were no differ-
ences in survival between the groups.
Conclusions: Administration of MSCs in first hours of SS improves
organ dysfunction and short-term survival in neutropenic pts, but
doesn´t prevent death from sepsis related organ dysfunctions in
long term period. Perhaps, it is required repeated administration
of MSCs.
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Introduction: Patients with acute respiratory failure on ventilators con-
stitute the majorities of patients in intensive care units (ICU). Early extu-
bation has always been one goal that medical teams want to achieve.
Objectives: Rehabilitation invention has already been administered
in ICUs in other countries and has successfully helped achieve the
goal of early extubation. It is therefore hoped that physical therapy
as intervention can help create a safe environment that facilitates
early extubation for patients.
Methods: The participating patients with acute respiratory failure
were all in the conditions of stable hemodynamics, normal nutritional
status and no infectious complications and first underwent joint as-
sessment by the medical teams based on their progresses in recov-
ery after treatment for their diseases before receiving rehabilitation
consultation, which directed them to cardiopulmonary rehabilitation
that included T-tube training. Upon the confirmation of their ventila-
tor weaning indications, their endotracheal tubes were removed.
They were then engaged in early ambulation activities ranging from
Level II to Level IV according to their abilities. During this period, the
medical teams conducted 3 sessions of education training led by
physical therapists, followed by exercises and group testing.
Results: Days of ventilator use were reduced from 6.3 (days) previ-
ously to 4.1 (days) after improvement. The secondary goal, i.e. days
in ICUs, were reduced from 10 (days) to 6.1 (days). Hospitalization
costs were also reduced from NT$329,000 before improvement to
NT$241,000 during improvement and NT$186,000 after improve-
ment. During the improvement, no tube slippage or patient falls oc-
curred. This shows that this innovative proposal has achieved its
purpose and also ensured patient safety.
Conclusions: It is suggested that medical teams for ventilation in se-
vere cases can develop weaning protocols that have shared goals
and integrate multiple technologies and find weaning solutions for
ventilator dependent patients by exploring literature and relevance
of content in protocols. This provides possible indicators for asses-
sing healthcare for ventilator dependent patients and serves as a ref-
erence for healthcare facilities in developing patient care plans.
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Introduction: Retrospective Evalution of the Intensive Care Unit Pa-
tients Who Were Affected by Syrian Civil War.
Objective: The aim of this study is to examine the clinical status of
the patients who were requiring intensive care as the victims of the
Syrian civil war.
Methods: Clinical characteristics, health state at admission into Gen-
eral Intensive Care Unit (GICU), treatments in GICU, expected, and ac-
tual mortality rates estimated based on APACHE II scores, number of
patients rejected because of full bed occupancy were evaluated
retrospectively among Syrian civil war victims who applied to the
GCI between 01.01.2013 - 12.31.2013.
Fig. 72 (abstract A626). 28-day overall survival
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Results: 159 (21.4 %) of 740 patients who were monitored in GICU
belonged to a Syrian nationality who were the victims of the Syrian
civil war. A total of 795 patients were requested for hospitalization in
GICU, while GICU stay of 55 (6.9 %) patients were rejected because
of full bed occupancy. Mean age (34.3 ± 12.4 years), gender distribu-
tion (women, n = 36; 22.6 %), and men, n = 123; 77.4 %), and the
mean APACHE II score (24.2 ± 13.7) of the patients were recorded as
indicated. The most common indications for hospitalization were
multisitel shrapnel injuries (42.7 %), subarachnoidal bleeding (SAK)
(42.1 %) caused by firearm injuries, and chest gunshot wounds
(5.6 %). Total number of days of GICU hospitalization were 4300 days,
while patients with Syrian nationality stayed in the GICU a total of
1558 (36.2 %) days. Mean duration of hospitalization was 9.7 days.
Average mortality rate among all GICU patients in 2013 (26 %) was
lower than that of Syrian citizens (n = 49 deaths, mortality rate
30.8 %; n = 12 women; 24.4 %). The standardized mortality ratio [ob-
served mortality (49/159), according to the APACHE II score of ex-
pected mortality rate (48 /159) ratio] was 1.02
Conclusions: Because of higher APACHE II score, increased incidence
of gunshot hwounds, and transportation of the patients from a dis-
tance of over 100 kilometer under unfavourable conditions increased
mortality rates were observed.
References
1. Aras M, Ataş M, Yılmaz A, et al. Being a neigbor to Syria: a retropective
analysis of patients brought to our clinic for cranial gunshot wounds in
the Syrian civil war. Clin Neurol Neurosurg 2014;125:222–8.
2. Thanapaisal C1, Saksaen P. A comparison of the Acute Physiology and
Chronic Health Evaluation (APACHE) II score and the Trauma-Injury Sever-
ity Score (TRISS) 34 for outcome assessment in Srinagarind Intensive Care
Unit trauma patients. J Med Assoc Thai 2012;95 Suppl 11:S25-33.
A629
Different levels and variances of melatonin (MT) production
observed in septic and non-septic ICU patients
K. Kiss1, B. Köves2, V. Csernus3, Z. Molnár1
1University of Szeged, Szeged, Hungary; 2Jahn Ferenc Teaching Hospital,
Budapest, Hungary; 3University of Pécs, Department of Anatomy, Pécs,
Hungary
Correspondence: K. Kiss - University of Szeged, Szeged, Hungary
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A629
Introduction: The massively increasing knowledge of recent years
about the importance of circadian rhythms is orientating the re-
searchers from laboratories towards the bedside (1).
Objectives: The daily pattern of MT production is the main regulator
of circadian rhythms, with the strongest known signal of its release
being the daily change of light and darkness. The aim of this pro-
spective study was to determine the MT production in septic and
non-septic groups of ICU patients suffering from severe night light
pollution.
Methods: Mechanically ventilated patients over 18 years, without
CNS damage were enrolled in the study. Illuminance levels (IL) were
measured by a lux meter. Serum MT levels were determined from ar-
terial blood samples. Sampling and IL measurements were performed
after admission at 01:00, 07:00, 13:00 and 19:00 constitutively for
96 hours. Blood samples were kept in total darkness before being
centrifuged, then serum samples were placed into −80 °C until MT
measurement was performed. Repeated correlation analysis was per-
formed to investigate the correlation between illuminance and MT
levels. The equality of MT variances was tested by fitting two nested
models and comparing their likelihoods.
Results: Out of the 28 enrolled patients 15 were able to take over
the study. 8 patients proved to be septic and 7 non-septic, which
was sufficient to form subgroups. Out of the 16 measurements/pa-
tient, 240 MT samples were analysed. Although IL were the lowest at
01:00 [19(3–101) lux], estimated MT peaks were missing, the median
(IQR) was 30(24–51) pg/ml at this time point. Although repeated cor-
relation analysis between MT and IL showed a non-significant
between-subject correlation (r = 0.438, P = 0.103), the MT variances of
septic subgroup were 70 % of the non-septic variances. In spite of
the low sample size the fixed effect of subgroup was statistically
highly significant (P < 0.0001), in general higher MT levels were ob-
served in the septic subgroup.
Conclusions: Our results indicate that circadian rhythm is desynchro-
nized in ICU patients, as indicated by the missing MT peaks during
the night, the absence of the normal 24 h rhythm of MT release and
by the poor correlation between illumination and MT levels. This first
observation suggests that absence of darkness at night and the miss-
ing contrast of day and night light levels can rapidly destruct the
rhythm of MT release. The cause(s) of our second observation,
namely that patients in septic subgroup showed lower MT variances
and higher MT levels in general needs to be elucidated by studies fo-
cusing on this phenomenon, conducted in larger patient population.
Based on these observations, future trials on light/dark conditions
and patient outcomes could lead to redesigned healthcare environ-
ments, which may help restore circadian rhythmicity and reach
health benefits.
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Introduction: Healthcare workers in the Intensive Care Unit (ICU) en-
vironment present very commonly with burnout worldwide1.
Objectives: Aim of this study was to assess burnout in ICU physicians
and nurses in a national level and to identify possible contributing
factors.
Methods: A cross-sectional, multicenter study in 18 Greek ICUs
was conducted between June and December 2015. Scores of Ex-
haustion, Depersonalization and Personal Accomplishment from
the Maslash Burnout Inventory Questionnaire2 were recorded in
the 469 study participants. Univariate and multivariate logistic re-
gression analysis was performed in order to identify predicting
factors for burnout.
Results: A high participation rate was recorded (65.7 %). Baseline par-
ticipant characteristics, scores of burnout, as well as statistical com-
parisons between the medical and nursing staff are shown in
(Table 51 and 52).
ICU nurses compared to doctor participants were mainly females (80.8 %
vs. 55.6 %, chi-square test, p < 0.001), almost a decade younger (p <
0.001), had less working experience (p < 0.001), and declared lower job
satisfaction (p = 0.001). Exhaustion scores were relatively low but statisti-
cally different between doctors and nurses (22.8 % and 37.5 % respect-
ively, Mann–Whitney U test, p < 0.001), while differences in scores of
depersonalization and personal accomplishment did not reach statistical
significant levels. Multivariate logistic regression analysis (Table 53) identi-
fied two independent predicting factors for high exhaustion: to be a
nurse (Odds ratio 1.6, 95 % CI 1.1-2.7, p = 0.05) and to have low job satis-
faction (Odds Ratio 0.2, 95 % CI 0.1-0.4, p < 0.001). Other factors like gen-
der, age, working experience, working in university hospitals or having
personal experience of losing a close family member were found not to
be associated with burnout.
Conclusions: Our results demonstrate low burnout levels in Greek
ICU personnel. Nurses are more exhausted compared to doctors. The
major contributing factor for burnout is job satisfaction.
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Introduction: Despite their importance in informing care interventions,
significant barriers exist in Critical Care in regards to the measurement
of height and weight. Common interventions based on weight include
lung-protective ventilation in ARDS management[1], renal replacement
therapy, and antibiotic dosing. Studies have investigated the use of a
calibrated ulnar length (UL) tape in tidal volume (VT) measurements [2],
whilst our institution uses a formula converting actual height (AH) to
ideal body weight. We have demonstrated in previous audits poor
compliance with measurement of actual height and wished to investi-
gate the performance of UL to improve compliance.
Objectives: We performed a three-way comparison comprising
height derived from UL versus AH, and clinician estimation (CE) ver-
sus AH. We sought to simulate the clinical effects of applying mea-
sured and derived values into the common clinical parameter of
6 ml/kg VT lung-protective ventilation.
Methods: We sampled 16 Critical Care patients and 4 healthy volunteers.
Participants were measured supine, semi-recumbent or sitting. UL was
measured between olecranon process and ulnar styloid. AH was mea-
sured in the position the participant was approached in, using a summa-
tion of heel to knee, knee to greater trochanter (GT), and GT to vertex
lengths. CE was estimated by a Consultant Intensivist, blinded to actual
measurements. Results were analysed using Excel, with correlation of re-
sults performed using Bland-Altman plots and regression analysis.
Results: A significant correlation between performance of UL and AH
was obtained (P < 0.01). There was no significant correlation between
CE and either UL or AH. Similarly, when converted to 6 ml/kg VT, a
statistically significant correlation was obtained between UL and AH
and (P < 0.01) but not CE.
Estimates of height ranged between -16 cm and +5 cm, most com-
monly underestimating height. VT extrapolated from CE gave a range
between −41.4 ml and +68.4 ml.
Conclusions: Significant barriers to measuring height in Critical Care
exist, including lack of pre-morbid measurement, immobility, and lack
of suitable equipment. Anecdotally there may have been a tendency
for clinicians to rely on estimation of height and weight which can erro-
neously form the basis for regimes in a range of interventions. Our
study confirms UL validity as a proxy of formal height measurement,
and the poor performance of estimation compared to AH and UL. We
propose UL measurement as an acceptable standard of care.
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Introduction: Critically ill patients have altered antibiotic pharmacoki-
netic (PK) characteristics, which are further affected by continuous
venovenous haemodiafiltration (CVVHDF) (1). Regional citrate antic-
oagulation (RCA) use is increasing and effects of RCA-CVVHDF set-
tings on antibiotic PK parameters need quantification for dose
individualisation.
Table 51 (abstract A630). Baseline participant characteristics
Physicians n=149 Nurses n=320 p values
Male gender 63 (44.4%) 58 (19.2%) <0.001
Age > 40 years 101 (67.8%) 119 (37.4%) <0.001
Working experience >10years 66 (44.3%) 129 (40.9%) <0.001
University hospital 82 (55.0%) 142 (44.4%) 0.031
Personal loss 90 (60.4%) 172 (55.1%) NS
Job satisfaction: 0.001
Low 3 (2.1%) 22 (6.9%)
Moderate 25 (17.1%) 95 (29.7%)
High 118 (80.8%) 203 (63.4%)
Table 52 (abstract A630). Participant scores of burnout
Physicians n=149 Nurses n=320 p values
Exhaustion (total score) 17 (13–26) 23 (17–30) <0.001
Exhaustion: <0.001
Low 67 (45.0%) 77 (24.1%)
Moderate 48 (32.2%) 123 (38.4%)
High 34 (22.8%) 120 (37.5%)
Depersonalization 8 (4–12) 7 (3–13) NS
Personal accomplishment 33 (29–37) 32 (28–37) NS
Table 53 (abstract A630). Univariate and multivariate logistic regression
Univariate analysis Multivariate analysis
Variables Odds
Ratio
95% CI p
values
Odds
Ratio
95% CI p
values
Females 1.474 0.930–
2.336
NS
Age < 40y 1.194 0.810–
1.759
NS
Nurses 2.029 1.301–
3.165
0.002 1.611 1.061–
2.699
0.050
Working >10y 1.089 0.736–
1.611
NS
University
hospital
1.443 0.980–
2.124
NS
Personal loss 0.874 0.591–
1.292
NS
Job satisfaction 0.193 0.126–
0.295
<0.001 0.222 0.139–
0.355
<0.001
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Electronic prescribing and recording systems have potential to im-
prove data availability and accuracy for PK analyses. Data extraction
and amalgamation from multiple sources requires a systematic ap-
proach, considering data quality assurance and research objectives.
Objectives: The aim was to develop a reliable methodology to ex-
tract and amalgamate retrospective data from dialysis machines (Pris-
maflex), the clinical information system (ICIP) in the intensive care
unit, and electronic laboratory systems, for use in future PK studies.
Using this methodology, we compared vancomycin doses and levels
in patients receiving heparin anticoagulation or RCA on CVVHDF.
Methods: All patients on vancomycin and CVVHDF in 2014 were in-
cluded. Vancomycin data were extracted from the laboratory infor-
mation system; timing of dialysis and anticoagulation mode from
ICIP (Philips); and dialysis flow data from the Prismaflex (Gambro)
machines. Extracted data reliability was categorised as high or low
risk in terms of time-sensitivity and patient-specificity for internal val-
idation of data extraction and amalgamation. High risk data had a
two part validation system to match variables across databases. Risk
assessment was undertaken by a multidisciplinary team. Open source
technologies were utilised including Perl (perl.org), REDCap (projec-
tredcap.org) and MySQL (mysql.com); and SPSS V17 (IBM Corp.) was
used for data analysis. Ethical approval was obtained.
Results: A fully coded-anonymised database for retrospective analysis
was created.
58 patients were included, representing 323 patient days with an
average of 5.57 (SD 2.14) days per patient. This resulted in 255, 56, 8
and 4 dialysis days on heparin, citrate, both and no anticoagulation,
respectively. The average vancomycin dose was 1162.22 mg
(+/−437 mg) and 1306.12 mg (+/−343 mg) on heparin and RCA re-
spectively (p = 0.032). Trough vancomycin levels were within range in
37.9 % of levels in heparinised patients and 29.72 % of levels in pa-
tients on RCA. There was no significant association between anticoa-
gulation and vancomycin trough levels in target range, χ2(1) = 1.563,
p = .668.
Conclusions: This methodology represents a promising approach for
retrospective data analysis. Our initial results indicate that anticoagu-
lation modality used is associated with vancomycin dose, but not the
proportion of trough levels in target range. Work is ongoing to fur-
ther validate data amalgamation processes and explore vancomycin
PK in these patients.
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Introduction: The impact of clinical pharmacist on preventing drug re-
lated problems in critically ill patient has been well reported in several
randomized control trials. The critical care pharmacist impact is greatly
essential in therapeutic drug monitoring, renal dosing, drug-drug inter-
action, and de-escalation of antibiotic therapy and others in this setting.
Objective: The aim of this study was to evaluate the types of inter-
ventions, clinical significance and cost saving involved with each
intervention.
Methods: A prospective observational study was conducted in a 13
bed critical care unit at tertiary care teaching hospital in AL-Khobar,
Saudi Arabia. All Patient greater or equal to 18 yrs of age, who were
admitted to our intensive care units were included in the study.
Pharmacist interventions were recorded electronically on daily bases.
The electronic documentation system collected the following infor-
mation, patient demographics and (age, gender, and weight, past
medical history, home medication, allergies, type of intervention, and
outcome.
Results: The study group consisted of 181 patients. Three hundred
and three interventions were recorded during a period of 12 months.
Therapeutic drug monitoring accounted for 66 (36 %) of total
pharmacist interventions, while 65 (35 %) was related to review &
reconciling of medication history. Furthermore (17 %) of these inter-
ventions were related to unnecessary medications mostly antibiotics.
Interventions related to renal dosing adjustment accounted for 50
(28 %) of interventions.
Conclusions: The overall interventions identified in this study well
demonstrate the impact of critical care pharmacist in improving pa-
tient outcome and preventing drug related problems.
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Introduction: Daily blood tests are a long running feature of ICU
care, and are regarded as an essential diagnostic tool by medical
staff, however they aren't without their drawbacks. The risk of iatro-
genic anaemia is a very real one and there are significant costs in-
volved in both equipment and staff time.1 With this in mind
guidelines were drawn up to limit excessive blood tests in otherwise
stable patients.
Objectives: We audited adherence to these guidelines in 2015
finding 292 unnecessary vials of blood taken in a 20 bed unit.
Guidelines were clarified and advertised on posters and then we
re-audited.
Methods: In order to establish trends and to exclude stable post sur-
gical patients we limited eligible patients to those who were on the
unit for 3 days or more. A simple proforma was designed to record
which common blood tests had been performed, daily haematocrit
and haemoglobin (if tested), and any major change in overall condi-
tion or events such as transfusions or surgery. On six randomly
assigned days over a 2 month period, all eligible patients on the unit
had a proforma filled retrospectively for all days up until their admis-
sion to the unit, or up to seven days previously, whichever sooner.
We also recorded if the patient had arterial or central access, as these
facilitate obtaining samples for testing.
Results: 70 patient days were audited across 10 individuals, with 339
tests ordered, 41 % of which were unnecessary, down from 46 % be-
fore our intervention.
Conclusions: While the bedspace posters had a modest effect, we
are now enforcing the guidelines through the weekly medical and
nursing teaching sessions, and also ensuring all requests for clinical
reasons are agreed with the registrar or nurse in charge.
We are also recommending removal or alteration of the “Critical
Care” test set that is currently available from our electronic request-
ing system in the hope that it will encourage more critical thinking
about which tests are appropriate for the patient they are caring for.
We aim to re-audit our practice within the next 6 months to ascertain
the impact of these changes.
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Introduction: Hospital Antimicrobial Stewardship (AMS) programs
have achieved savings and more rational use of antimicrobial treat-
ments. However, intervention over antimicrobial treatment of critical
patients with hematologic disease is highly complicated
Objectives: To evaluate a two years experience of an AMS program
intervention in patients with hematologic disease admitted in an in-
tensive care unit (ICU).
Methods: We designed a quasi-experimental study. AMS strategies
were put into practice during three years (January 2014-January
2016) in collaboration with the ICU nosocomial infection control
team. Antimicrobial treatment was revised twice a week. If any anti-
microbial treatment modification was recommended in the AMS
meeting, a face-to-face interview was held between AMS team and
the attending physician. ICU length of stay and ICU mortality rate
were compared with the same time period previous to AMS imple-
mentation. Continuous and categorical variables were compared
using T-student and Fischer exact test (Stata v.13.0).
Results: 190 antimicrobials of 64 patients were evaluated in 69 AS
team meetings [Age: Mean = 51.0 (SD = 13.8) years; APACHE II: Me-
dian (RIQ) = 22 (19–26)]. After ASM revision, there was 71 changes in
antimicrobial prescriptions. Recommended amendments by the AMS
team were: stop antimicrobial treatment (32; 45.1 %), change in dose
(17; 23.9 %), change to a narrower spectrum antimicrobial (10;
14.1 %), monitoring drug concentrations (10; 14.1 %), and start a
new antimicrobial (2; 3.0 %). Most of these recommendations
(84.5 %) were accepted by the prescribing physician.
No significant changes in ICU length of stay [Pre-intervention: 6.42
(IC95%: 4.39-8.45) vs AMS intervention: 6.48 (5.23-7.96); p = 0.887),
mortality (39.0 % vs 40,6 %; p = 0.827) or percentage of ICU readmis-
sion (16.0 % vs 6.6 %; p = 0.051) were observed.
Conclusions: AMS program focus in critical haematological patients
has great potential to optimize and reduce antimicrobial consump-
tion in the ICU.
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Introduction: Mechanically ventilated (MV) patients often experience
difficulties with communication. It is well-studied that being non-
vocal is experienced as distressing by most critically ill patients and
could result in severe emotional reactions (1). However, the opinions
of health care professionals on this subject remain unknown. More-
over, communication with ICU patients is becoming increasingly
important since ICU guidelines aim to reduce the use of sedatives,
thus it is expected that more patients will be awake and able to
communicate (2).
Objectives: To investigate communication issues with MV patients as
experienced by ICU health care professionals. The primary aim was
to quantify the extent of the problem and to determine its effect on
patient care and job satisfaction. The secondary aim was to identify
patient and health care factors associated with communication diffi-
culties and to evaluate the preference and effectiveness of currently
available communication methods.
Methods: A multicentre survey study was conducted from December
2015 till January 2016. An online questionnaire consisting of 37 ques-
tions was sent to nurses, residents and intensivists of seven ICUs in
the Netherlands.
Results: Out of 961 caregivers, 297 participated (30.9 % response
rate), of which 267 responses were included. Communication difficul-
ties are experienced in 50.0 % of the interactions with MV patients,
resulting in 42.5 % of the professionals to lose valuable time on daily
basis. More than 55 % of the participants indicated to lose between
30–60 minutes during an average shift. Consequently, 44.0 % indi-
cated that their job satisfaction is negatively affected, primarily with
feelings of unfulfillment (76.3 %) and frustration (70.8 %). To facilitate
communication, 32.6 % reported to regularly use augmentative and
alternative communication methods, but the most effective and pre-
ferred method remains the use of basic gestures. In addition, almost
50 % indicated to be dissatisfied with their personal communication
skills with MV patients. Over 80 % of the caregivers have not been
trained in communication with MV patients, while 72.0 % would like
to receive training in the future.
Conclusions: In half of the interactions with MV patients, health care
professionals experience communication difficulties. These difficulties
frequently lead to negative effects on patient care and job satisfac-
tion of ICU professionals. This further emphasizes the need for im-
provements such as the development of communication protocols,
skills training and continued research into new communication
methods.
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Introduction: ICU is a high demand area in the hospital, with a large
demand supply gap especially in limited resource countries. In
addition, it requires a higher staffing ratio than rest of the hospital.
Objectives: To explore the impact of multiple factors for increasing
bed turnover during expanding newly developed ICU.
Methods: Observation study during gradual opening of 18 beds
medical/surgical ICU from June 2014 till March 2016. It is a part of
Alexandria University (primary and tertiary) hospitals covering 2 gov-
ernorates receiving a lot of emergency patients. In September 2015,
outreach critical care services were provided for early discharge of
ICU patients but was inactive since April 2015 due to financial prob-
lem. In September 2015 post-operative ICU was opened but the nurs-
ing staff was recruited from general ICU. In January 2016, proactive
ICU project was implemented which included reducing the time of
delay of investigation for ICU patients, daily care plan for rapid
stabilization, implementing end of life care decisions, and avoiding
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inappropriate antibiotic or medication use. In Feburary 2016, admin-
istration increased ICU capacity with same number of nursing staff.
Results: 347 patients were admitted to Smouha University ICU, from
which 147 patients died (42.4 %). The mean mortality rate was
43.9 % (28–84.6 %), with mean APACHE II score of 23 (16–30), and
mean expected mortality 46.5 % (23.5-70.3). The relative mortality
(actual/expected) ranged from 0.35 to 1.25 with mean 0.88 %. Mean
Bed occupancy ranged from 4 till 13 beds. After failure of outreach
service, bed turnover was similar (2.29 to 2.3). Before and after open-
ing of post-operative ICU, The mortality rate of post-operative cases
was higher in post-operative ICU than in general ICU (9.5 vs 2 %, p =
0.019), with lower occupancy rate (4.5 vs 10 patients per month, p =
0.277), and higher mean ICU stay (3.5 vs 1.2 days, p = 0.02). Before
and after implementation of proactive ICU, the number of admissions
significantly increased from 18 to 33 (p = 0.003), insignificantly higher
occupancy rate from 1.8 to 2.8 (p = 0.345), and significantly de-
creased waiting time for ICU admission from 38 to 6 hours (p <
0.001). However ICU complication increased; unexpected cardiac ar-
rest from 7.5 to 18.5/1000 patient days (p = 0.002), unplanned extu-
bation from 21 to 35/1000 ventilator days (p = 0.305), deep vein
thrombosis from 0 to 4.7 % (p = 0.259) and pneumothorax from 3 to
2 % together with increased mortality and relative mortality insignifi-
cantly (45.7 to 59 % and 0.89 to 1.13 respectively)
Conclusions: From multiple efforts to increase ICU turnover, end of
life care decisions and proactive ICU seems most effective, however
the expense of increasing nursing and doctor load must be weighted
to avoid iatrogenic complications. Also diverting post-operative pa-
tients to specialized ICU needed more nurses without better patients
outcome.
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Introduction: Knowledge of the critically ill patient's Actual Body
Weight (ABW) and Ideal Body Weight (IBW) guide safe treatment
in Critical Care (1, 2). When it is not safe or practical to measure
these at admission it is necessary to estimate. Our dietician ser-
vice attends within working hours and uses a systematic method
to estimate values if these are unknown. We suspected that ABW
and height was inconsistently estimated and documented by vari-
ous teams.
Objectives: We present data from the first project chosen by the
NUHCC Better Collaboration, a multi-disciplinary team (MDT) set up
to measure and improve the care we offer (3). We aim to define,
standardise and improve documentation of safe, accurate and con-
sistent values of ABW and IBW.
METHOD.
 Phase 1: Survey current documentation of ABW, IBW and
height.
 Phase 2: Survey our MDT for opinion and feedback on a
proposed standardised approach to better systematic
documentation and estimation of ABW and IBW.
 Phase 3: Reflect on this feedback to present a definition for
optimal standard practice in sourcing and documenting safe
values.
 Phase 4: Survey performance against the approved standards
regularly with planned interventions to improve performance.
Results: The initial notes review showed that 32 % of heights and
24 % weights were documented. The majority of respondents to our
internal survey agreed that using accurate values was important, that
we should define and standardise how we do this and that there
was a definite need to improve performance (4). A small MDT group
collaborated to define best practice and it was agreed that a stand-
ard protocol for measurement and documentation of ABW and IBW
would be implemented.
Conclusion There is an evident problem with consistency of docu-
mentation for safe values of ABW and IBW within NUHCC. We have
defined our standard and are excited about implementing and em-
bedding excellent practice as a collaborative effort. We look forward
to sharing the data from the first steps of our journey to the ESICM
conference.
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Introduction: Despite initial recovery, many critically ill patients
discharged from the intensive care unit (ICU) may experience deteri-
oration1. Early identification of patients at risk might facilitate im-
provements in quality of care.
Objective: To determine risk factors associated with short-term hos-
pital outcome (unplanned ICU readmission and unexpected death on
the ward).
Methods: Prospective cohort study from August 2014 to May 2015
performed at Hospital Sírio Libanês (São Paulo, Brazil). During this
period, we analyzed 527 patients who were admitted in our ICU and
discharged alive. We used univariate and multivariate analysis to
identify risk factors associated with latter ICU readmission or unex-
pected ward death in the same hospitalization period.
Results: Forty seven patients (8.9 %) were readmitted after ICU dis-
charge and further forty seven died in the ward. Patients who had
unexpected outcomes were older compared to those with successful
outcomes (age 72 ± 17 vs 66 ± 18 respectively, p = 0.003), were sicker
(SAPS 3 of 53 [IQR 43–60] vs 38 [29–49] respectively, p < 0.001), male
sex (62.8 % vs 47.1 % respectively, p = 0.006), had a non-surgical rea-
son for hospitalization (75.5 % vs 45 % respectively, p < 0.001), more
frequently came from the ward (21.3 % vs 7.6 % respectively, p <
0.001), were less frequently independent for daily activities (54.3 %
vs 76.7 % respectively, p < 0.001), had sepsis (39.4 % vs 11.8 % re-
spectively, p < 0.001), required mechanical ventilation (44.7 % vs
14.1 % respectively, p < 0.001), vasoactive drugs (54.3 % vs 24.2 %
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respectively, p < 0.001) and dialysis (16 % vs 1.2 % respectively, p <
0.001), had higher SOFA score both at ICU admission (4 [2–7] vs 1
[0–3] respectively, p < 0.001) and discharge (2 [1–4] vs 1 [0–2] re-
spectively, p < 0.001), had higher C-reactive protein values at admis-
sion (5.8 mg/dL [1.9 - 15.6] vs 3.6 [0.8 - 8.6] respectively, p < 0.001)
and lactate values (1.9 mmoll/L [1.2 - 3.7] vs 1.7 [1.1 - 2.5] respect-
ively, p = 0.03), and higher Sabadell score at discharge (1 [1–2] vs 0
[0–1] respectively, p < 0.001). On multivariate analysis, only sepsis
and Sabadell score were independent risk factors for worse out-
comes (AUC 0.73; p < 0.001).
Conclusions: Sabadell score at ICU discharge might be a promising
subjective tool for hospital outcomes.
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Introduction: Survivors of ICU admission can develop several compli-
cations, such as physical impairment, weight loss, psychological and
social disorders, with potential impact on quality of life. Little has
been described on this evaluation in low-income countries.
Objectives: To describe the results of six years from a follow-up out-
patient Clinic evaluating adult patients that survived to admission to
ICU, three months after discharge.
Methods: Prospective cohort study evaluating adult patients that sur-
vived after admission to a general ICU of a University Hospital in South-
ern Brazil. It was included patients that stayed > 24 h in ICU and >
18 years old. All survivors were contacted by Clinic, and only were ex-
cluded that patients that did not attend to the Clinic. Socio-
demographic and medical data were collected by searching the med-
ical record. For the psychological evaluation it was used the Hospital
Anxiety and Depression Scale - (HADS) and the Impact of Event Scale-
Revised - (IES-R). It was analyzed weight and height on hospital admis-
sion and discharge, as well as at the office visit. Muscle strength was
measured by Medical Research Council (MRC) scale. Spirometry was per-
formed by using One-flow device, with standard procedures.
Results: During the period of the study (jul-2008 to dec-2014), 2615
patients were admitted to adult ICU, and 1845 were discharged alive
from hospital. Of them, 696 were evaluated at the outpatient multi-
professional Post-ICU Clinic three months after discharge. 62.9 % of
the patients were male, mean age 43.1 years, mean APACHE 20.4.
The ICU admission was due to trauma (42.1 %), medical conditions
(26.2 %) and postoperative (31.7 %). Mean ICU length of stay was
10.3 days. The most of the patients (83.3 %) required mechanical
ventilation. In outpatient evaluation, 94.6 % were on oral feeding,
mean weight loss of 11.7 % during hospital length of stay, and a
mean weight gain of 9.1 % after discharge. 31.8 % had reduced
muscle strength, with 4.9 % hemiparesis/hemiplegia and 5.7 % mod-
erate/severe tetraparesia or tetraplegia. Spirometry was abnormal in
49 %, being more common obstructive disorders (37.8 %). At psycho-
logical evaluation, 45.2 % showed emotional disorders: anxiety
(30.6 %); depression (21.4 %) and PTSD (19.5 %). 47,7 % had a family
income lesser than US$550.00/month. It was found significant social
and economical consequences for the most of the survivors and their
families.
Conclusions: A large proportion of patients had physical, social and
psychological complications three months after ICU discharge. Thus,
early identification and appropriate treatment of these complications
may be beneficial. The social and economical impact of ICU stay is to
be determined in low-income populations.
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Introduction: A recent survey on the long-term complications re-
ported by the General Practitioners of 1-year ICU survivors
showed that chronic fatigue was among the complications most
often reported [1]. One of the instruments proposed to assess fa-
tigue is the Functional Assessment Chronic Illness Therapy-
Fatigue (FACIT-F), a 13-item scale that has been validated in a
sample of the general USA population [2]. Al-shair et al. [3] who
used FACIT-F (13-FACIT-F) questionnaire in 2107 COPD patients,
recently proposed a modified 9-item FACIT-F (9-FACIT-F) for these
patients.
Objectives: The aim of this study was to compare reliability and val-
idity of 13-FACIT-F and 9-FACIT-F in a group of ICU survivors assessed
one year after hospital discharge.
Methods: The study was performed in 56 consecutive adult ICU pa-
tients staying in ICU for at least 72 hours, and able to co-operate at
the time of ICU discharge. We excluded patients with pre-existing
cognitive deficits, or resident more than 30 km from the hospital.
One year after hospital discharge, the patients who consented came
to the hospital. An investigator administered by direct interview the
following instruments to the patients who consented: 13-FACIT-F,
modified Medical Research Council (mMRC) Dyspnea scale and the
Medical Outcomes Survey Short Form-36 (SF-36). An additional ques-
tion asked whether the patient's fatigue was the same, improved, or
worsened in comparison with the pre-ICU time. Statistical analysis
was performed using Cronbach alpha for reliability, Spearman correl-
ation between FACIT-F scales and both mMRC and Vitality of SF-36
for validity, and Mann–Whitney test in patients with same/improved,
or worsened fatigue for discriminative ability of both 13-FACIT-F and
9-FACIT-F scales.
Results: 13-FACIT-F had higher internal consistency (α = 0.813) com-
pared to 9-FACIT-F (α = 0.654). The correlation between the original
and the modified scales was excellent (Table 54). The correlations be-
tween both scales and mMRC, and Vitality of SF-36 were all statisti-
cally significant (p < 0.001) (Table 54). Both 13-FACIT-F and 9-FACIT-F
values were statistically significantly different in patients with im-
proved/not changed and worsened fatigue in comparison with one
year before (Table 55).
Conclusions: Both 13-item and 9-item FACIT-F scales demonstrate
convergence with other conceptually relevant patient-reported out-
comes, namely mMRC and Vitality of SF-36. The present study dem-
onstrates that 13-FACIT-F and 9-FACIT-F have a similar ability in
discriminating between ICU survivors with improved/not changed
and worsened fatigue at one year. However, the original 13-item
FACIT-F scale may have the advantage to allow comparison with the
general population.
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Introduction: Follow up outpatient clinic after intensive care (ICU) for
has been pointed as a quality indicator of ICU care.
Objectives: The objective of this study is to describe the outcomes
of the ICU outpatient clinic in terms of clinical management.
Methods: Prospective, cohort study, over 4 years (2011–2014), at a
12-bed mixed ICU, form a tertiary care, university affiliated hospital.
Results: During the study period 1482 patients were admitted into
the ICU and 566 were observed at the outpatient clinic.
555 patients were able to answer to the screening questionnaires
and are analyzed. Of these 50 % (277) reported new complains and
30 % (168) had to be oriented for specific interventions and 6 % (33)
to more than one. Of these 168 patients: 29 % (n = 48) were oriented
to Psychiatry; 15 % (n = 26) to Internal Medicine; 10 % (n = 16) to the
Primary Care Physician; 8 % (n = 14) to General Surgery; 8 % (n = 13)
to Cardiology; 7 % (n = 12) to Physiotherapy, and 23 % (39) others.
When observed at the outpatient clinic only 230 (44 %) had resumed
previous normal activity (34 did not answer the question). Of the 291
that did not, 197 (71 %) assumed to be related to the ICU. No signifi-
cant differences were observed concerning the timing of the out-
patient clinic observation (<2 months, 2–6 months and > 6 months
after hospital discharge, p = 0.147) and resuming previous activity.
Of those that were still not able to return to previous activity (n =
291), 194 (67 %) reported new complain and 85 (44 %) needed refer-
ral for specific therapeutic approaches.
Conclusions: The importance of the ICU follow up clinic is reinforced
by the significant proportion of patients in whom new problems are
identified requiring specific referral for treatment. The impact of the
outpatient clinic in the subsequent quality of life of those patients re-
mains to be determined. We propose for those in whom new clinical
problems are addressed a second observation to evaluate its efficacy
and impact.
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Introduction: Patients who survive an episode of post admission to
intensive care for sepsis syndromes have been found to have poor
quality of life, physical and psychological problems and a high rate
of recurring illness or mortality in the first year. Follow-up clinics
have been instituted for general intensive care patients but the evi-
dence as to efficacy is sparse at present and there has been no clinic
specifically for survivors of sepsis.
Objectives: The aim of this trial is to investigate if targeted screening
and appropriate intervention to these subjects post hospital dis-
charge can result in an improved quality of life, decreased mortality,
decreased readmission to hospital and/or decreased use of health
resources.
Methods: Patients post sepsis syndrome in intensive care and receiv-
ing respiratory support for greater than 48 hours will be randomized
to one of two groups. The intervention group will attend an out-
patient clinic two monthly for six months and receive screening and
targeted intervention. Screening will include physical measures
(strength, balance) psychosocial measures (depression, anxiety,
PTSD), cognitive measures, pain, nutrition or sleep problems. The
usual care group will remain under the care of their physician. The
primary outcome will be short form (36) health survey (SF36v2Ô), re-
admission to hospital, mortality in the first 12 months, and use of
health resources in the first year. A sub group in a rural setting will
be assessed by telemedicine.
Results: Twenty patients (9 intervention, 11 usual care) have been
randomized. Patients randomised to the intervention group report a
Table 54 (abstract A642).
Cronbach alpha Present study Al-shair et al. [3]
13-FACIT-F 0.813 0.92
9-FACIT-F 0.654 0.91
Spearman CC Present study Al-shair et al. [3]
13-FACIT-F vs 9-FACIT-F 0.990 0.99
13-FACIT-F vs mMRC −0.595 −0.48
9-FACIT-F vs mMRC −0.606 −0.47
13-FACIT-F vs VT 0.531
9-FACIT-F vs VT 0.525
Table 55 (abstract A642).
Fatigue comparison
at 1-y
Improved/not changed Worsened p Mann-
Whitney
13-FACIT-F 47.50 [38.50–50.00] 38.00 [29.75–45.75] 0.001
9-FACIT-F 32.50 [27.00–34.00] 25.00 [19.75–31.00] 0.001
Fig. 73 (abstract A643). Flowchart of included patients
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number of issues including altered and unpleasant memories from
intensive care and confusion about scars. Patients were referred to
agencies including physical rehabilitation (3), a chronic pain clinic (1),
sleep study (1) and a psychologist (3). All patients have given
expressed satisfaction with the content and explanations of the clinic
visit. Six subjects have reached the 6 month mark and we have had
100 % attendance in the intervention group and 100 % completion
for SF36.
Conclusions: We have shown that this clinic is feasible and there is a
need for this service.
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Introduction: Surviving the ICU is only the beginning of getting life
back. The majority of ICU survivors experience immediate and fre-
quently persistent physical, mental and cognitive impairments that
compose post-intensive care syndrome (PICS) [1–3].
The exact prevalence of PICS is unrevealed, but it is estimated that
more than half of critical care survivors develop at least one symp-
tom throughout their recovery. Understanding who are the patients
more likely to develop PICS is a key issue.
Objectives: This study intends to determine the prevalence of PICS
in one Portuguese ICU, to characterise this population and identify
risk factors to the development of this syndrome.
Methods: We performed a prospective cohort study from January
2013 to February 2015. All ICU survivors that were admitted to
our unit during two or more days were included. In the first
24 hours of admission patients were screened for the risk to de-
velop physical and non-physical components of PICS. The pres-
ence of PICS was assessed at four time points: at ICU discharge,
one week after, at hospital discharge and three months after ICU
discharge. Additionally, we recorded clinical data on: patients'
demographics, type of admission, simplified acute physiology
score (SAPS II), length of ICU and total hospital stay, length of
sedation and mechanical ventilation.
Results: We enrolled 355 patients with a median age of 63 years and
a predominance of males (62 %). At ICU admission 87.6 % of the pa-
tients had some risk factor for PICS. Throughout time PICS was iden-
tified in 186 (54 %) patients at ICU discharge, 148 (58 %) one week
after discharge, 78 (55 %) at hospital discharge and on 106 (43 %)
patients three months after ICU. At ICU discharge, physical compo-
nents of PICS were more frequent, and at three month follow up
non-physical components were more common. Patients with higher
SAPS score, longer length of ICU and hospital stay and more ventila-
tion and sedation days were more prone to have PICS at ICU dis-
charge. These variables were independent risk actors to the
development of PICS. At three months follow-up, these same vari-
ables, except SAPS II score, were still risk factors of PICS.
Conclusions: PICS is a major concern in nowadays intensive care
units (ICU), reflecting a drift from the original focus on organ support
to patient support. Interventions in reducing the absolute number of
ventilation and sedation days might contribute to reduce the burden
of PICS.
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Introduction: Depression has been associated to ICU stay in a fair pro-
portion of patients. But most studies rely solely on the outpatient clinic
screening after ICU discharge, without considering previous psycho-
pathology of the patients or specific risk factors, like ICU memories.
Objectives: To determine the prevalence of depression after ICU dis-
charge in patients with and without a previous diagnosis of psycho-
pathology and its association with memories from the ICU admission.
Methods: Prospective cohort study of all patients seen at the out-
patient clinic, discharged between January 2011 and December 2014,
from a 12-bed, mixed ICU, at a tertiary care university affiliated hospital.
The ICU memory questionnaire and Beck Depression Inventory (BDI)
were the tools used, depression was assumed if the BDI score was
higher than 16. With depression has the dependent variable: age, sex,
previous psychopathy, acute psychiatric event, previous neurologic dis-
order, acute neurologic event and the presence of memories were
studied as risk factors, through logistic regression.
Results: During the study period 1482 patients were discharged from
the ICU, 635(43 %) died before the outpatient clinic appointment and
566(67 %) attended the clinic, of these 555 filled the BDI and 530 the
ICU memory questionnaire. These patients (n = 555) had a mean ± SD
age of 58 ± 17 years; 341(61 %) were male; 157(28 %) had a previous
diagnose of a psychopathology disorder : 79(14 %) alcoholism,
55(35 %) depression, 16(10 %) psychosis and 7(4 %) drug abuse were
the more frequent, 13(8 %) had more than one; 32(6 %) were admitted
to ICU due to an acute psychiatric event, only 2 patients without a pre-
vious diagnose were admitted with an acute psychiatric event. The
prevalence of depression in the group with a previous history of psy-
chopathology was significantly higher than in the group without:
26 %(n = 40) vs 16 %(n = 63), p = 0.008. In the univariate analysis vari-
ables significantly associated with depression after ICU were: previous
psychopathology (OR1.82), acute psychiatric event (OR3.79) and pres-
ence of memories from ICU admission (OR0.66). In the final model
those retained has independent risk factors were: acute psychiatric
event [adjusted OR(95 % CI) = 4.30(2.01-9.21)] and presence of memor-
ies from the ICU admission [adjusted OR(95 % CI) = 0.63(0.40-0.98)].
Conclusions: Depression after ICU is more prevalent among patients
that have previous psychopathology, recalling that the ICU stay is as-
sociated with a reduced risk for after ICU depression. We suggest
that when patients are admitted to ICU the relatives fill in a question-
naire about the previous cognitive, psychologic and functional status
of the patient in order to allow clinicians to determine the true im-
pact of ICU care. The elaboration of a diary to decrease post-
traumatic stress disorder following ICU has already been study, but it
would be interesting to see if that would have a positive impact in
the prevalence of depression after ICU care.
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Introduction: Many intensive care unit (ICU) patients experience
symptoms of depression, anxiety, and posttraumatic stress along
with cognitive impairment and physical debility. This combination
of symptoms has been classified as post-intensive care syndrome
(PICS). Over half of ICU survivors are reported to have significant
psychiatric symptoms which appear to diminish little over time.
Post-ICU intervention efforts may fail due to delayed initiation,
i.e., following hospital discharge after patients' perceptions of
their ICU experience has potentially solidified. Currently work is
being done to prevent physical aspects of PICS via early physical
rehabilitation while still in the ICU. However, there are no evi-
dence based practical interventions to prevent or treat the psy-
chological and cognitive consequences of the ICU stay. It is also
not known if there may be categories of patients who are more
susceptible to PICS, and would therefore benefit most from tai-
lored treatments.
Objectives: The aim of this study was to assess the prevalence of
psychocognitive morbidity among patients across six adult ICUs.
Methods: Within 96 hours of dismissal from the ICU, eligible pa-
tients completed the Hospital Anxiety and Depression Scale
(HADS; scores ≥ 8 indicating significant symptoms of anxiety or
depression), Impact of Events Scale-Revised (IES-R; scores ≥ 1.6 in-
dicating significant posttraumatic stress disorder (PTSD) symp-
toms), and Montreal Cognitive Assessment-Blind (MoCA-blind;
scores < 18 indicating cognitive impairment). Inclusion: >18 years
old; ICU stay of >48 hours; GCS > 13, CAM-ICU negative, ≤ 2 er-
rors on the 6-item Cognitive Screener. Exclusion: admitted to the
ICU for suicide attempt; known prior cognitive impairment/de-
mentia; prior diagnosis of PTSD; non-English speaking.
Results: 107 patients completed the assessment. Table 56 illustrates
prevalence of psychocognitive symptoms by the ICU type.
Conclusions: There was a high prevalence of symptoms of de-
pression (range 17-69 %), anxiety (range 18-58 %) and PTSD
(range 18-58 %). In terms of predictors of distress, patients in
the heme-onc/transplant ICU had a much lower prevalence of
symptoms of depression, anxiety and PTSD compared to pa-
tients in the other ICU units. Whether these patients experience
the ICU differently by virtue of the chronicity of their diseases
and the contextual circumstances of their ICU admissions invites
further study. There was also a high level of cognitive impair-
ment across the ICUs (range 45-83 %). Clearly more needs to be
learned about patient and unit factors that are related to psy-
chological difficulties, and tailored interventions will need to be
appropriate for individuals with cognitive impairments.
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Introduction: Prolonged ICU admission is associated with high
mortality. Provent score at day 21 has been proven effective as a
prognostic index of mortality one year after prolonged admission
in ICU in patients requiring prolonged mechanical ventilation
(over 20 days).
Objective: Assesment of Provent Score as prognostic score in ICU
mortality in patients with prolonged ICU stay (over 20 days).
Methods: Prospective descriptive study. During two years, we in-
cluded all patients with more than 20 days of stay in a medical-
surgical ICU. Previous informed consent, we collected demographics
data, diagnosis, severity index (APACHE II and SOFA scores), Provent
score variables at day 21 of ICU admission (age, platelets < 150.000/
mm3,, need of vasoactive support and renal replacement therapy),
PaO2/FiO2 at day 21, mortality and ICU stay.
Data is expressed as number and percentage; statistical analysis was
performed with Chi-square test.
Results: A total of 58 patients with prolonged ICU admission were
included. We did not find differences in age, sex, comorbidity or
severity of illness at admission between survivors and deceased
in ICU. At day 21, 33 % of the patients needed vasoactive sup-
port (72 % of deceased and 15 % of the survivors, p < 0.001),
22 % had thrombocytopenia (50 % of deceased and 10 % survi-
vors, p = 0.002), 22 % needed renal replacement therapy (33 % of
deceased and 17 % survivors, p = 0.195) and 29.3 % presented
PaO 2 / FiO 2 less or equal to 200 mmHg (55.6 % of deceased
and 16.7 % survivors, p = 0.003). ICU mortality was 31 %.
Conclusions: High Provent Score (4–5) or PaO 2 / FiO 2 below
200 mmHg.
at day 21 of admission is associated with increased intra-ICU mortal-
ity in patients with prolonged admission .
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Table 56 (abstract A647). Psychocognitive data by ICU
ICU type N
patients
HADS-
D≥8 (%)
HADS-
A≥8 (%)
IES-R≥1.6
(%)
MOCA-
blind<18 (%)
Heme-onc/
transplant MICU
11 18 18 18 45
Cardiac MICU 21 38 57 19 75
Cardiothoracic SICU 19 33 58 53 74
MICU 31 33 42 39 68
Trauma SICU 12 17 58 58 83
Cardiovascular SICU 13 69 54 46 51
Table 57 (abstract A648). ICU mortality and Provent
Survivors Deceased p
ICU mortality 36 18
Provent
0 5 (13.5%) 1(5.6%) 0.651
1 5 (13.5%) 1(5.6%) 0.651
2 16 (44.4%) 3 (16.7%) 0.044
3 9 (25%) 6(33.3%) 0.519
4-5 1 (2.8%) 7 (38.9%) 0.001
PaO2/FiO2 < 200 6 (18.8%) 10 (55.6%) 0.007
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Introduction: Patients surviving the acute phases of critical illness,
complications as polyneuropathy and prolonged mechanical ventila-
tion can appear. A high level of uncertainty exists regarding to prog-
nostication of outcomes in these patients. Chronical critical illness is
usually considered when invasive mechanical ventilation is pro-
longed for at least 21 days after acute illness.
Objectives: To study the ability of Acute Physiology and Chronic
Health Evaluation (APACHE) II and Simplified Acute Physiology
Score (SAPS) II to predict outcome in our chronically critically ill
patients.
Methods: We performed a retrospective analysis of patients ad-
mitted to our medical-surgical ICU in the last 5 years. Differ-
ences in basal characteristics and outcomes and data regarding
APACHE II and SAPS II predictive value were studied in two co-
hort of patients according to the need for more than 21 days
of mechanical. For univariate analysis Chi-square test, t-Student
and U-Mann–Whitney test was used. Receiver Operating Charac-
teristic (COR) curves was used to study predictive ability of
scores.
Results: A total of 2671 patients were admitted. Of them, 85 required
more than 21 days of mechanical ventilation (chronic).
Chronic patients were younger (65 (51.5-73) vs 68 (54–77); p
0.036), had higher APACHE II (21 (15.25-25) vs 16 (12–22); p <
0.001) and SAPS II (48.5 (37–56) vs 40 (30–53); p < 0.001), same
Glasgow scale at admission and longer ICU stay (38.5 (30–52.5)
vs 4 (2–6); p < 0.001) and hospital stay (56.5 (37.25-80.5) vs 10
(5–18); p < 0.001) Mortality was higher in prolonged mechanical
ventilation patients (33.3 vs 18.7; p 0.002). Chronic patients had
higher incidence of inmunodepression, COPD, neoplasia and mal-
nutrition at admission (statiscally significant). Required urgent sur-
gery in higher proportion (22.4 vs 11.6 %; p 0.004), more renal
support (30.6 vs 5.7 %; p < 0.001) and more parenteral nutrition
(34.1 vs 7.3 %; p < 0.001) Admission from ward was more fre-
quent in chronic patients (56.5 vs 41.1 %; p < 0.001). Table 58
shows ROC curves data. AUC differences resulted slightly lower in
medical patients [AUC 0.724 (0.588-0.860; p 0–006) vs 0.816
(0.793-0.838; p < 0.001)] and were more pronounced in surgical
patients [AUC 0.641 (0.415-0.867; p 0.270) in chronic vs 0.833
(0.789-0.876; p < 0.001)].
Conclusions: APACHE II and SAPS II showed worse predictive ac-
curacy for hospital mortality in patients requiring prolonged
mechanical ventilation after the acute phase, especially in surgical
admissions.
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Introduction: Liver transplantation patients generally are followed up
in intensive care unit (ICU) for postoperative period. Prognosis of
those patients can be predicted with some scoring systems.
Objectives: The aim of the study was to evaluate the prognostic effi-
cacy of physiological scoring systems obtained at first postoperative
day after liver transplantation on ICU stay, mortality and mechanical
ventilation(MV) duration.
Methods: Postoperative first day acute physiology and chronic health
evaluation II (APACHE II), Sequential Organ Failure Assessment
(SOFA), Model of End Stage Liver Disease (MELD) scores, ICU stay
and early (28 days) of the liver transplant patients admitted between
the years 2010–2016 to Akdeniz University ICU were evaluated, retro-
spectively. Ethic consent was obtained from local ethic committee.
Results: Record files of 119 liver transplant patients admitted to ICU
during study period were evaluated. Postoperative early ICU mortal-
ity was 15.1 %. Mean MV duration, APACHE II score, SOFA score,
MELD score were found 5 hours (1–168), 9(3–29), 6(2–16) and 18(5–
31), respectively. APACHE and SOFA scores of the patients whose ICU
stay were longer than 35 hours were significantly higher (p < 0.05).
APACHE and SOFA scores were inversely correlated with early ICU
mortality (p < 0.001). MELD score did not have significant prognostic
value on ICU stay and early ICU mortality. Independent risk factors ef-
fective on mortality were evaluated by logistic regression test indicat-
ing APACHE and blood urea nitrogen(BUN) value as independent risk
factors in terms of mortality.
Conclusions: There are conflicting results in terms of availability of
generally used physiological scoring systems for predicting the prog-
nosis after liver transplantation(3). Significant number of studies has
results confirming the prognostic value of SOFA, APACHE II and
MELD scores in ICU stay, MV duration and mortality. In our study,
early mortality and ICU stay were higher in the liver transplant pa-
tients who have higher APACHE and SOFA scores obtained at first
day of ICU admission, postoperatively(2,3). APACHE II and SOFA scor-
ing systems were found to have prognostic efficacy on ICU stay and
early mortality after liver transplantation(3). However, we found no
correlation between MELD score and mortality(1). The discrepancy
may result from the quality of liver graft as 70 % of the donation was
performed from live organ donors in our study.
References
1- Oberkofler CE, Dutkowski P, et al. Model of end stage liver disease
(MELD) score greater than 23 predicts length of stay in the ICU but not
mortality in liver transplant recipients. Crit Care 2010;14:117
2- Santoyo J, Suarez MA, et al. True impact of the indication of cirrhosis and
the MELD on the results of liver transplantation. Transplant Proc
2006;38:2462–4.
3- Pan H-C, Jenq C-C, et al. Scoring Systems for Predicting Mortality after
Liver Transplantation. PLoS One 2014; 9: e107138
A651
Comparison of apache IV with other scoring systems in the ICU in
predicting in-hospital mortality after liver transplantation
E.-J. Jung1, S.-Y. Oh2, H. Lee1
1Seoul National University Hospital, Anesthesiology and Critical Care,
Seoul, Republic of Korea; 2Seoul National University Hospital, Surgery,
Seoul, Republic of Korea
Correspondence: E.-J. Jung - Seoul National University Hospital,
Anesthesiology and Critical Care, Seoul, Republic of Korea
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A651
Table 58 (abstract A649). ROC curves for APACHE II and SAPS II
AUC CI 95% p
APACHE II Chronicl 0.702 0.586–0.817 0.003
Non-chronic 0.820 0.800–0.839 <0.001
SAPS II Chronic 0.641 0.415–0.867 0.348
Non-Chronic 0.828 0.782–0.875 <0.001
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Introduction: Several prognostic systems have been tested to predict
early in-hospital mortality after liver transplantation, showing moder-
ate performance. The recently developed Acute Physiology and
Chronic Health Evaluation (APACHE) IV score and Simplified Acute
Physiology Score (SAPS) 3 now include liver transplantation as a
diagnostic category.
Objectives: The aim of this study was to compare the performance
of APACHE IV, SAPS 3, APACHEII, MELD, MELD-Na, and CTP scores in
predicting early in-hospital mortality in liver transplant patients.
Methods: We studied 590 adult (age ≥ 18 years) patients who had
undergone living donor or deceased donor liver transplantation be-
tween October 2010 and September 2014. APACHE II, APACHE IV
and SAPS 3 were recorded on ICU admission after liver transplant-
ation. MELD, MELD-Na, and CTP scores were calculated using values
before liver transplantation.
Results: The overall in-hospital mortality rate was 2.9 %. Hosmer-
Lemeshow statistics showed good calibration for all 6 prognostic
models. The AUC was 0.83 for APACHE IV, 0.78 for SAPS 3, 0.81 for APA-
CHE II, 0.72 for MELD-Na, 0.76 for MELD, and 0.68 for CTP score.
Conclusions: The APACHE IV score and SAPS 3 in predicting in-
hospital mortality after liver transplantation showed revealed gener-
ally good discrimination and calibration. The overall discrimination
and calibration of APACHE IV were similar to those of all other
models except CTP score for predicting hospital mortality.
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Introduction: The scores have been widely used in the Intensive Care
and Cardiac Units. The SOFA initially used for the daily assessment of
organ dysfunction in septic patients, was subsequently validated for
serious patients in general, as a way of assessing daily dysfunction.
The prognosis system SAPS3 (Simplified Acute Physiology Score 3)
aims to establish a predictive mortality rate for patients admitted to
Intensive Care Units (ICU).
Objectives: To evaluate the accuracy of the SAPS 3 and SOFA scores
in the prognosis of cardiac patients admitted to the ICU of a general
hospital in northeast region of Brazil.
Methods: Prospective cohort study placed in a general ICU. In the
study were included 54 patients with cardiac disease of 314 patients
admitted patients to general ICU, from August 2015 and March 2016.
All the patients were assessed using the SAPS 3 (Global Equation and
Central & South American Equation) and SOFA scoring systems. Lo-
gistic regressions analysis was used to calculate the sensitivity, speci-
ficity and accuracy as well as the OR probability of mortality. The
ability to predict mortality was performed with ROC curves. The dif-
ferences between observed-to-predicted mortality were analyzed
with the Hosmer-Lemeshow test.
Results: The study population had the following general characteris-
tics: age 67 ± 15.3 years, men 51.9 %, with a median time of 6 days
of hospitalization (IQR = 2.5-10.5). The admission reason was clinical
in 85.2 % of patients (15.4 % NSTEMI, STEMI 3.9 %, 7.7 % UA, 23.1 %
Heart Failure, Acute lung edema 11.5 %). The median (in points) in
SAPS 3 score was 43 (CI = 38.0-49.8) and SOFA was 0 (IQR = 0–3.0)
and the area under the ROC curve was 0.93 (CI 95 % = 0.85-1.00) and
0.95 (CI 95 % = 0.89-1.00), respectively. Calibration was confirmed by
the Hosmer-Lemeshow test for SAPS 3-X2 = 0.1565 df: 8 (p = 0.99).
Sensitivity to the SAPS 3 score and SOFA was 81.82 % and 100 %,
and the specificity of the scores was 94.12 % and 79.41 % respect-
ively. The corresponding negative predictive value to scores SAPS 3
and SOFA was 94.12 % (CI 95 % = 76.81-99.28) and 100 % (CI 95 % =
86.03-100.00). The corresponding positive predictive value to scores
SAPS 3 was 84.12 % (CI 95 % = 53.45-97.72).
Conclusions: The results showed that the scores can be effective in
the prognostic assessment of cardiac patients admitted to a general
ICU, with good calibration and adequate discrimination value.
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Introduction: Saps 3 is widely used in intensive care units (ICU). How-
ever their use among the acute coronary patiens remains controversial.
Objectives: To compare, in mortality calibration terms, a general ICU se-
verity index (Saps 3) with a specific one (Grace) designed for coronary pa-
tients in a population of acute coronary syndromes (ACS) admitted in our
ICU. In addition to build a correlation equation between both scores.
Methods: During the period 1/1/2015 to 30/9/2015 a total of 287 pa-
tients with ACS were admitted in our ICU. Predicted Saps 3 mortality is
systematically recorded in our electronic clinical record. Grace score
was obtained by retrospective carefully revision of medical records ac-
cording to their authors recommendations. Saps 3 death risk was de-
rived by Mediterranean country index equation while Grace death risk
was obtained from original score variables by using Granger's regres-
sion coefficients. We compared in-hospital observed mortality with the-
oretical predicted mortality for both scores. We have used a goodness
of fit test. We used Pearson's R analysis for correlation purposes.
Results: Mean age was 63.2 years (SD 13.6) and 24 % were women.
Mean Saps 3 score was 44.1 (SD 7.8) while mean Grace index was
152.8 (DE 37.6) Estimated mortality by Saps 3 and Grace were 12.0 %
and 5.1 % respectively. Observed in-ICU mortality was 3.1 % (95 % CI
1.7-5.9) and in-hospital 5.2 % (95 % CI 3.2-8.4) Regarding correlation
analysis Grace and Saps 3 scores are linked by the following equa-
tion: Grace = 27.01 + 2.86 x Saps 3 (R2 = 0,34; p < 0.001).
Conclusions: Mortality of ACS patients in our ICU is clearly overesti-
mated by Saps 3 score. It seems more appropriate to use the Grace
specific index in this subgroup of our case-mix. It ist feasible the use
of a correlation equation between both scores.
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Introduction: The use of temporary tracheostomies to avoid complica-
tions of prolonged intubation and facilitate respiratory weaning is a
well recognised cornerstone of critical care medicine, but their insertion
and subsequent management is not without risk. Tracheostomy dis-
placement is one of the most serious and frequent of all airway events
in critical care and is associated with 50 % of airway related deaths in
this setting1,2. As such a timely emergency action plan is a necessity for
critical care areas1,2,3.
Objectives: We aimed to carry out a service improvement project to
improve timely escalation of patients with dislodged tracheostomies
to senior airway trained doctors. The project was carried out at two
sites: Queen´s Medical Centre (QMC) and Nottingham City Hospital
(NCH) of Nottingham University Hospitals NHS Trust, UK.
Methods: A rapid cycle audit was undertaken by the authors whereby
staff awareness of the local emergency airway protocol was audited on
a shift-by-shift basis. All non-airway trained clinical staff were asked
how best to get an airway expert to urgently attend a patient with a
dislodged tracheostomy. Answers were recorded and at the same time
staff were reminded of the local protocol. Other education measures
undertaken concurrently included departmental emails, posters and re-
minders during resuscitation training. A Statistical Process Control chart
of percentage correct answers per shift was plotted.
Results: Over both sites an improvement in compliance was observed
over a 4 month period. Mean compliance for the first 3 audit cycles at
QMC and NCH was 38.47 % and 24.2 % respectively versus mean compli-
ance for the final 3 audit cycles of 97.23 % and 50.53 % respectively. At
QMC, use of posters after 3 months saw a marked improvement in com-
pliance with all 8 audit cycles undertaken after distribution of the posters
exceeding the upper control limit of the preceding 3 months' worth of
data and 4 of those 8 cycles seeing greater than 90 % compliance.
Conclusions: Improved awareness of the escalation protocol over the
4 month audit period was reflected in its increased utilisation. Use of
various educational tools achieved varying results, the most effective
being distribution of posters. There is ongoing scope for staff educa-
tion in order to consistently achieve greater than 90 % compliance at
both sites and we would recommend re-audit within 6 months.
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Introduction: The length of oral ETT in males and females has been
recommended as 23 cm and 21 cm respectively from corner of
mouth to above carina, standards described for Western population.
Caucasian population tends to be taller than Asian population. We,
thus retrospectively analysed whether it is true in Asian population
of smaller stature and whether there is any correlation between
height of the patient to the ideal length of oral ETT.
Objectives: To validate the ideal length of oral ETT in Asian Popula-
tion compared to Western standards.
Methods: Retrospective analysis of the data for patient episodes,
who had oral ETT inserted in the Intensive care unit of Jurong
Healthcare, Singapore (Alexandra Hospital) from April 2011 till June
2015. The variables analysed were demographics, height and ideal
body weight of the patient, length of oral ETT and chest X rays (for
confirmation of position of ETT).
Results: There were 923 incidences of oral cuffed ETT insertion above
the age of 18 years in 750 patients and their intubation records were
analysed.
The median length of oral ETT was 22.2 cm in 600 males(SD 1.26)and
mean length in 323 females was 21 cm (SD = 1.46).The mean length
in all three ethnic groups of Chinese, Malay and Indians was 22 cm.
The median ETT depth for ICU male patients with acceptable dis-
tance from carina (2–5 cm) was 22 cm, (p < 0.0001) different from
23–24 cm but was similar in females at 21 cm (p < 0.66).
Conclusions: The local population in Singapore is representative of 3
major ethnic groups (Malay, Chinese and Indians) which covers al-
most 2/3 population of Asia. They are generally of shorter stature in
comparison to western population especially Caucasians. It has been
well documented that the ETT moves downwards towards carina by
at least 2 cm in flexion of neck and upwards by 2 cm in extension.
This plays an important role while securing ETTs especially in Inten-
sive care patients, as they tend to be intubated for an average of 3–5
days and require lot of movements during day to day care. Either se-
curing the tube too low or too high can cause either right sided
endo-bronchial intubation or high risk of accidental extubation re-
spectively. These inadvertent impediments predispose already critic-
ally ill patients to significant risks and complications. We suggest that
females and males in Asian population especially in South East Asia
should have their endo-tracheal tubes secured at corner of mouth by
at least one cm less in comparison to western population.
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Table 59 (abstract A655). Demographics 1
VARIABLES MALE (N = 491) FEMALE (N = 281)
Mean Age in Years (SD) 62.9 (16.4) 67.4 (15.6)
Mean Height in cm (SD) 166.9 (8.7) 154.5 (7.6)
Table 60 (abstract A655). Demographics 2
Ethnicity Male (N = 491) Female (N = 281)
Chinese 340 (69%) 178 (63%)
Indian 45 (9%) 31 (11%)
Malay 60 (12%) 45 (16%)
Others 46 (9%) 27 (10%)
Table 61 (abstract A655). Depth of ETT versus indication of intubation
Distance of Tip of
ETT from Carina
Respiratory failure
(N = 313)
Collapse
(N = 105)
Post operative
(N = 285)
Others
(N = 195)
Less than 2 CM 37 (12%) 15 (14%) 33 (12%) 27 (14%)
2-5 CM (acceptable
range)
192 (61%) 64 (61%) 164 (58%) 112
(57%)
More than 5 CM 76 (24%) 23 (22%) 83 (29%) 52 (27%)
Right or left main
bronchus
8 (3%) 3 (3%) 5 (2%) 4 (2%)
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Introduction: The patient with a tracheostomy tube may experience
dysphagia. The physiologic factors that may contribute to the dys-
phagia include reduced laryngeal elevation, reduced pharyngeal sen-
sation, reduced cough response, and disuse atrophy o laryngeal
musculature. A tracheostomy tube with a cuff may be placed to pre-
vent aspiration of secretions, food, and gastric contents. However, a
patient may still aspirate some food with a fully inflated cuff due to
severe dysphagia or a tracheostomy site placed too high. The identi-
fication and management of aspiration in the patient with a trache-
ostomy is important and often implies difficulties and challenging
clinical decisions.
Objetive: Comparation of the Extended Evan's Blue Dye (EEBD) test
in predicting artifical airway dysphagia versus Fiberoptic Endoscopic
Evaluation of Swallowing (FEES) as the gold standard.
Methods: We prospectively registered 26 tracheotomized patients
due to difficulty in weaning. First we used the EEBD test (2 ml blue
Evans administered with a spoon in middle third of the tongue), then
we observed wheather aspiration signs appear (early/late cough,
symptoms of asphyxia, or more than 3 percentage points basal
pulse oximetry desaturations), and the posible blue stained secre-
tions suctioned through the tracheostomy tube. Simultaneously
the FEES was performed, watching directely all the posibilities of
penetration and or blue Evans aspiration (Fig. 77). The validity
and performance enhancement were calculated, and the ROC
curve was made with 95 % CI. The study was approved by the
hospital ethics committee.
Results: 26 patients underwent FEES + EEBD: 7 had FEES without as-
piration and a negative EEBD. 19 had FEES with aspiration, 16 were
positive and 3 negative EEBD. The validity and performance enhance-
ment indexes are described in Fig. 78, with an area under curve of
0.92 ± 0.54 (95%CI: 0.82-1.00) and p = 0.006 (Fig. 79).
Conclusions
1- The EEBD is a significant and simple diagnostic screening tool in
dysphagia secondarily to artificial airway.
2- In our opinion if the EEBD is negative and there is high clinic sus-
picion, FEES should be considered to confirm, or not, dysphagia.
Fig. 74 (abstract A655) Median depth of ETT
Fig. 75 (abstract A655). ETT depth relation with Ethnic group
Fig. 76 (abstract A655). Boxplot carina distance to ETT depth Fig. 77 (abstract A656).
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Introduction: Endotracheal intubation(ETI)is a commonly performed
procedure in the intensive care unit (ICU). Many life-threatening com-
plications occur during endotracheal intubation and are associated
with poor patient outcomes.
Objectives: To analyze the indications, complications and outcomes
of patients who underwent Endotracheal intubation in ICU.
Methods: Prospective observational study, done in a university hos-
pital ICU over a period of 6 months. Adult patients admitted to ICU
requiring endotracheal intubation during ICU stay for more than
24 hours were included. Data collection included demographic pro-
file, vital parameters, APACHE II and SOFA scores, oxygenation and
ventilation status and indications for endotracheal intubation. Out-
come data was collected on complications of Endotracheal intub-
ation, mortality, ICU LOS, hospital LOS and ventilator free days.
Results: 171 patients fit into inclusion criteria. Mean age was
55.48(±15.86) years, majority of patients were males(n = 112[65.4 %]).
The mean APACHE II and SOFA scores were 19.82(±4.547) and
5.64(±2.619)respectively. Respiratory failure (51.46 %) was the most
common reason for intubation followed by neurological deterioration
(21.63 %).
Majority of Endotracheal intubations were elective (81.28 %) and
were performed by residents (43.85 %) with ICU experience of more
than 3 years. 15.7 % of patients required muscle relaxant for facilita-
tion of ETI. Most common complications were hypotension (39.18 %)
and hypoxia (27.48 %) at the time of intubation.
5 (2.9 %) patients had cardiac arrest at the time of intubation, 18
(10.52 %) patients required vasopressor support post intubation. Mor-
tality rate was 67.25 %(n = 115) with an ICU ALOS 8.27(±6.32) days
and hospital LOS 12.54(±9.1) days. Average ventilator days were
7.27(±5.06)days. 7 % of patients developed VAP and 17 % of patients
required tracheostomy. Risk factors for mortality included higher age,
high APACHE and SOFA scores, hypoxia and hypotension at the time
of intubation, requirement of vasopressor support at the time of
intubation.
Conclusions: Endotracheal intubation was associated with high com-
plications and poor outcomes.
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Fig. 79 (abstract A656).
Fig. 78 (abstract A656).
Table 62 (abstract A657). Indications for ETI
Indications for intubation n-171(%)
Respiratory failure 88(51.4)
Neurological deterioration 37(21.6)
Hemodynamic instability 22(12.8)
Extubation failure 9(5.2)
Others 16(9.3)
Fig. 80 (abstract A657). Complications during ETI
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Introduction: Supraglottic airway devices are used with increasing
frequency following routine anesthesia and for emergency airway
management. Unfortunately, not all devices allow a possibility to per-
form a secondary endotracheal intubation (ETI) through the device. A
new promising device, the Spritztube (ST), has been developed com-
bining the ability to perform both supraglottic ventilation and orotra-
cheal fibreoptic intubation using the same device. Particularly, it is
able to perform a supraglottic ventilation during positioning as tra-
cheal cannula during fibroscopy.
Objectives: To compare the ease, the time of insertion, and the suc-
cess rates of use between the intubating laryngeal mask (Fastrach™)
and the novel tracheal tube (Spritztube ®).
Methods: We evaluated the novel Spritztube and compared it to the
Fastrach using a manikin-based study. Each partecipant received a ver-
bal instruction and practical demonstration of technique of insertion
for both devices on patient simulation manikins. Each participants used
both devices in a randomised order. Time of placement (T1), time of in-
flation (T2), the elapsed procedural time (T3), ease of insertion, time of
exchange maneouver for intubation (T4), success rates and number of
attempts were recorded for each supraglottic device. After a maximum
of 3 attempts airway-management was defined as a failure.
Results: A total of 47 participants were enrolled: 36 % without
previous experience with Fibroscopy and 17 % without previous
experiences with ETI. There was no difference in number of at-
tempts for insertion between both devices(p = 0.68).Fastrach was
applied 11 s faster than the Spritztube (median T3 Fas-
trach:13 s.,Spritztube:24 s., p = 0.000). The exchange manoevrue
for ETI was 11 s faster for Fastrach than the Spritztube (median
T3 Fastrach:13 s.,Spritztube:24 s., p = 0.000). Number of attempts
for exchange to ETI were significantly more for Fastrach (p =
0.000). Participants judged Spritztube as easier insertion than Fas-
trach (p = 0.000). Spritztube had a significant higher success rate
than Fastrach (p = 0.000). However the success rate did not de-
pend on previous experience in ETI or in fibroscopy.
Conclusions: The Spritztube performed similarly to the Fastrach in in-
sertion and intubation times in a manikin setting.
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Introduction: Available data shows that dysphagia and swallowing
disorder rate secondary to artificial airway and prolonged mechanical
ventilation in critical tracheostomized patients is high (50-83 %),
nevertheless it real incidence is not yet well established. Dysphagia is
directly related to bronchial aspirations and respiratory infections.
The rate of respiratory infections on tracheostomized patients is also
very high (Some series next 100 %). The re-establishment of airway
using speaking valves allow the rehabilitation and post-recovery of
those disorders, as well as deglutition and phonatory system
rehabilitation.
The aim of EDISVAL Study is to determine the usefulness of speaking
valve in preventing respiratory nosocomial infections in critical tra-
cheostomized patients diagnosed of dysphagia secondary to artificial
airway, for what it was done a screening test of dysphagia to the crit-
ical tracheostomized patients.
Objectives: To describe the incidence of swallowing disorder in crit-
ical patients who require tracheostomy secondary to artificial airway
and prolonged mechanical ventilation.
Methods: From September 2014 until December 2015, in all patients
over 18 years, during mechanical ventilation weaning-decannulation
phase, without neurological or surgical disease which could contrib-
ute to the appearance of dysphagia, there was realized the Modified
Evans Blue Dye Test (MBDT) as dysphagia screening test. This study
was carried out of simultaneous form in 7 intensive care units includ-
ing first, second and third level centers.
Results: Mean age average of the patients was 67,6 years, the ini-
tial APACHE´S average was 23,6 points. Mean time of mechanical
ventilation was 27,6 days. During the study period we studied 37
patients by MEBDT, 34 patients were diagnosed of dysphagia,
and included to the EDISVAL study; we did not carry out other
specifics test of dysphagia to discriminate a possible MEBDT false
negative.
In the patients with negative MEBDT, not diagnosed of dysphagia, re-
spiratory infections were not registered.
In the patients diagnosed of dysfagia included at EDISVAL study, in
spite of strict measures for it prevention, including absolute oral diet,
15 respiratory infections were registered (40.54 %), 5 catalogued as
tracheobronchitis and 10 as pneumonia. 3 of the patients who suf-
fered respiratory serious infections died during hospital stay.
Conclusions: The dysphagia secondary to artificial airway incidence
in our series was 91,9 % according to the Modified Evans Blue Dye
Test. Respiratory infections were a frequent complication in the pa-
tients diagnosed of dysphagia, with a probable repercussion in the
mortality of the patients.
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Table 63 (abstract A657). Comparison of survivors and non survivors
Parameters Survivors(N=56) Non
survivors(N=115)
P value
Age (mean±SD) 50.14(±17.5) 58.08(±14.33) 0.002
Admission APACHE II (mean±SD) 16.48(±4.41) 21.45(±3.64) 0.000
Admission SOFA (mean±SD) 3.95(±1.28) 6.46(±1.25) 0.000
Requirement of vasopressor
during ETI (%)
1.75 8.77 0.000
Hypoxia during ETI (%) 4.67 34.5 0.002
Hypotension during ETI (%) 4.09 23.39 0.001
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Introduction: Available data shows that dysphagia rate, secondary to
artificial airway and prolonged mechanical ventilation, in critical tra-
cheostomized patients is high (50-83 %). Dysphagia is directly related
to bronchial aspirations and respiratory infections. The rate of respira-
tory infections on tracheostomized patients is also very high (Some
series next 100 %). The re-establishment of airway using speaking
valves allow the rehabilitation and post-recovery of those disorders,
as well as deglutition and phonatory system rehabilitation.
Objectives: Determine the usefulness of speaking valve in preventing
respiratory nosocomial infections in critical tracheostomized patients
diagnosed of dysphagia secondary to artificial ariway.
Methods: Randomized multicenter controlled clinical trial. From De-
cember 2014 until February 2016, the use of speaking valve was ran-
domized during mechanical ventilation weaning-decannulation
phase in critical patients over 18 years, tracheostomized at ICU, diag-
nosed of dysphagia secondary to artificial airway. Neurological pa-
tients were excluded. In all cases it was contraindicated oral diet
intake. This study was carried out of simultaneous form in 5 units of
intensive care including centers of the first, second and third level.
Results: 32 patients were included, 72,7 % were men, mean age of
63,21 ± 15,13 years, mean APACHE-II 22,45 ± 8,75 points. Mean time
of mechanical ventilation was 28,82 ± 14,23 days. The most common
reason for ICU admission was respiratory 39.1 % of patients, followed
by surgery and shock.
After ramdomisation 19 patients were treated with speaking valve
(SVgroup), and 13 by identical protocol without speaking valve
(decannulation protocol, DPgroup). The incident of infections in the
SVgroup was 26,3 % (5/19), 2 pneumonia and 3 cases of tracheo-
bronquitis; and 61,5 % (8/13) in the DPgroup, 5 pneumonía and 3
tracheobronquitis. Some cases of this group were more than one re-
spiratory infection process. The mortality was 0 in the SVgroup and 3
in DPgroup.
Both groups had a mean mechanical ventilation time and reasos of
ICU admission similar, APACHE-II was higher in PDgroup (19.00 vs
26.6 points) and age (61.71 vs 66.71 years). SVgroup had a higher
ICU stay than the DPgroup (51.00 vs 39.10 days) and greater hospital
stay (69.44 vs 60.75 days). Patients who died were not those with
higher APACHEII or older in DPgroup.
Conclusions: The incidence of infectious complications and mortality
was lower in SVgroup. In the following months will continue this
research in order to know if these differences are attributable to
SV use
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Introduction: High endotracheal tube(ETT) cuff pressure could dam-
age tracheal mucosa and result in significant airway complications.
We hypothesized that high cuff pressure on intensive care unit (ICU)
admission is very common. So we designed this study as a quality
measurement audit to gauge ETT cuff pressure on ICU arrival.
Methods: In this prospective observational study we included all
intubated who were admitted from different clinical area to ICU. We
measured ETT cuff pressure on ICU admission using an aneroid cuff
pressure gauge during a 6 month period.
Results: We measured ETT cuff pressure in 159 patients on their ar-
rival to ICU. The Mean cuff pressure on ICU admission was 63.94 (SD
31.52) cm H2O. There was no statistically significant difference in ETT
cuff pressure between the patients admitted from different clinical
areas. Duration between tracheal intubation and patient handover to
ICU was 9.5 (SD 8.0) hours.
Conclusion High ETT cuff pressure is very common on ICU admission
and this can set the stage for airway complications. Using cuff pres-
sure gauge is a simple and effective way to measure and readjust
ETT cuff pressure immediately after intubation.
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Introduction: In most cases, endotracheal intubation in patients with
the neck phlegmon may not be feasible due to inflammatory lockjaw
and mouth opening limitation[1,3]. Conductive anaesthesia of nervus
mandibularis can improve condition for intubations in patients with
inflammatory lockjaw [2].
The goal of work: to study the efficacy of conductive anaesthesia ner-
vus mandibularis with videolaryngoscopy “Tepro” and to provide op-
timal conditions for intubation in patients with inflammatory lockjaw.
Materials and methods: We analysed medical cases of 47 pts. with
the surgical treatment of the neck phlegmon and inflammatory lock-
jaw. The control group (n = 23) tracheal intubation was proved by
conventional laryngoscope Macintosh. In the main group (n = 24) pa-
tients have limitation of mouth opening. In those patients conduc-
tion anesthesia of nervus mandibularis was performed and trachea
intubation by videolaryngoscope “Tepro”; (Table 64).
Results: In control group, rate of difficult laryngoscopy and failed tracheal
intubation was 91.3 % due to limitation of mouth opening by lockjaw.
In main group we performed conduction anesthesia of nervus man-
dibulus and videolaryngoscopy, that significantly reduced the rate of
difficult and failed intubation to 3.3 % in comparison with patients in
the control group (χ2 = 32.36; p = 0.0000).
Conclusions. Conduction anaesthesia of nervus mandibulus with
videolaryngoscopy “Tepro” increased the amplitude of mouth open-
ing, reduced the rate of difficult laryngoscopy and failed intubation,
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improved the larynx visualization, therefore provided the best condi-
tions for intubation in patients with inflammatory lockjaw.
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Introduction: Endotracheal tubes (ETTs) that allow subglottic secre-
tions aspiration (SSA) reduce ventilator-associated pneumonia (1). An
innovative device has been recently developed to insert an aspir-
ation catheter into the subglottic region, post intubation with stand-
ard ETTs.
Objectives: In animals on mechanical ventilation up to 76 hours, we
evaluated safety and efficacy of the novel SSA strategy, in compari-
son with standard ETTs comprising SSA.
Methods: Thirteen pigs (31.7 ± 2.6 Kg) on mechanical ventilation
(MV) for 76 hours. Pigs were randomized to be intubated with a
standard SSA ETT (Control). Upon aspiration, the patency of the suc-
tion lumen was tested; then, secretions were aspirated and the vol-
ume quantified. Whereas, in the treatment group, a novel delivery
device was employed to advance a 12-Fr suction catheter into the
subglottic space and perform SSA as reported above (Fig. 81).
A: 1, Subglottic secretions aspiration catheter; 2, Delivery device to
place the aspiration catheter into the subglottic region. B: 3, ETT.
Upon insertion, the delivery device was placed along the concave
surface of the endotracheal tube and advanced up to the larynx. 4,
Then, the catheter was inserted into the internal channel of the
delivery device and advanced up to the subglottic region.
Upon autopsy, lesions of the 1) epiglottis, 2) corniculate cartilages, 3)
true vocal cords, and 5) subglottic region were grossly scored: 0: no
injury; 1: mucosal erythema and/or edema; 2: mucosal erosion; 3: ex-
posed cartilage.
Results: Six animals (4 controls and 2 treatment) were kept in the
lateral-Trendelenburg position and aspiration was performed every
4 hours. Whereas, 7 animals (2 controls and 5 treatments) were kept
in semi-recumbent position and SSA was performed every 8 hours.
Among animals in lateral-Trendelenburg position, SSA was performed
18.2 ± 0.9 and 18.5 ± 0.7 times in the control and treatment groups,
respectively (p = 0.972). Overall, the mean volume of aspiration was
0.05 ± 0.07 (range 0–0.25 mL) and 0.03 ± 0.07 mL (0–0.25 mL) of se-
cretions/hour in the control and treatment group, respectively (p =
1.000). The median [IR] level of injury was 1[0] and 1[0] in the control
and treatment group, respectively (p = 0.258). Whereas, among
animals in semi-recumbent position, SSA was performed 5.5 ± 0.7
and 7.6 ± 2.7 times in the control and treatment groups, respectively
(p = 0.378). Overall, the median [IR] volume of aspiration was 0.14 ±
0.12 (range 0–0.41 mL) and 0.17 ± 0.30 mL (0–1.33 mL) of secretions/
hour in the control and treatment group, respectively (p = 0.324). The
median [IR] level of injury was 1[0] and 1[0] in the control and treat-
ment group, respectively (p = 0.734).
Conclusions: In preliminary in-vivo evaluations, the novel SSA strat-
egy is safe and not inferior to standard ETTs comprising SSA.
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Introduction: Successful airway management is crucial in emergency
care especially when endotracheal intubation is difficult. The air-Q is
a new supraglottic airway device used as a conduit for endotracheal
intubation. This study compared the performance of air-Q with i-gel
regarding airway seal pressures and ease of intubation for better
function.
Objectives: We hypothesized that the air-Q would have better airway
sealing than the i-gel due to its larger cuff design and flexibility and
compared it between patients undergoing positive pressure ventila-
tion for general anesthesia.
Methods: 50 patients classified as ASA 1 or 2 undergoing general
anesthesia were randomly allocated into two groups, group A (Air-Q)
or group I (i-gel). Anesthesia was induced with propofol 2 mg/kg and
rocuronium 0.5/kg. We compared the ease of intubation, vital signs,
airway sealing pressures, and adverse events upon and during inser-
tion. Acceptable peak inspiratory pressures were limited to 40
cmH2O, in which cases exceeded, endotracheal intubation was
performed.
Results: Airway leak pressures were lower in group A than group I.
Hemodynamic and respiratory conditions were statistically insignifi-
cant between the two groups. Adverse events occurred in 1 patient
from group A and 4 patients from group I in the post-anesthetic care
unit.
Conclusions: The Air-Q provides an adequate airway seal and can be
efficiently used in patients undergoing positive pressure ventilation.
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Table 64 (abstract A662). Comparative characteristics of different
methods o
The groups of pts. Trachea intubation, tot (%)
Difficult Easy χ2 P
Control (n=23) 21(91,3) 2 (8,3)
Main (n=24) 2 (8,7) 22(91,7) 32,36 0,0000*
Total (n=47) 23(100) 24 (100)
Fig. 81 (abstract A663). Novel device to place SSA catheter
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Introduction: Endotracheal intubation is a common procedure in the
treatment of respiratory failure in the Intesive Care Unit (ICU). Some-
times generates local complications that might difficult or even make
it imposible to remove the artificial airway (AA). If this complications
are not detected before the AA removal, stridor, laryngeal dyspnea
or spasms might apear requiring emergency reintubation/recannula-
tion in rather difficult circumstances with severe increase in morbi-
mortality. Therefore is essential to follow a clinical guideline in the
removal of the AA once overcome weaning and espontaneous
breathing test.
Objetive: To describe the incidence of treatable causes for negative
cuff-leak test in our critical care unit.
Methods: We prospectively registered all patients admitted in our
ICU (18 beds) who underwent artificial airway procedure (endo-
tracheal tube or tracheotomy) during 24 months (from January
2014 to December 2015). In every patient who overcome the
weaning guideline process (including spontaneous breathing test),
we implemented also an aritificial airway removal guideline, con-
taining the cuff-leak test, in Volume Controlled Ventilation (CMV)
and with the cuff deflated. If leak rate was greater than 20 % of
tidal volumen, “positive test”, we could safely remove the artificial
airway. If leak rate was less than 20 %, “negative test”, an upper
airway revision by direct laryngoscopy was performed to evaluate
treatable causes.
Results: We registered 407 patients in ICU with artificial airway pro-
cedures (endotracheal tuve, tracheotomy) during the study period.
Mean age was 62 years (48–76 CI 95 %), 67,8 % were male and the
mean APACHE was 23 (33–13 CI 95 %). Before extubation/decanula-
tion, cuff-leak test was performed. 374 (91.9 %) had “positive test”
and 33 (8.1 %) “negative test”. In these negative test a direct
laryngoscopy was performed and the following treatable causes
were found: 23 laryngeal edema, 2 dental bridge impacted in the
pharynx, 1 supraostial laryngeal edema plus granuloma, 1 edema
plus decubitus, 1 laryngeal granuloma, 1 distal tube obstruction,
1 laryngeal granuloma in intercricotiroidea tracheotomy, 1 with a
bloodclot in the larynx and finally 1 with a tumor in vocal cordv
(Fig. 82).
Conclusions
 The inclusion of an upper airway direct laryngoscopy exam
after negative cuff-leak test, ensures specific diagnosis and
manage of the treatable causes.
 In all our patients, the artificial airway was safely removed after
treating the cause, avoiding the increase of morbimortality due
to reintubation/recanulation.
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Introduction: Airway management is a commonly performed proced-
ure in the ED and in the ICU. The management of the airway is cru-
cial in that setting, being tracheal intubation (TI) the gold standard.
Several studies identify higher rates of complications in these
settings.
Objectives: Assess the practice of airway approach in the ED and ICU
in a university hospital, and identify risk factors for difficult intubation
and its main complications.
Methods: Prospective observational study. Data collection regarding
the operator, the patient, the technique and the outcome were com-
pleted at the time of intubation. Attempted laryngeal visualization to
facilitate TI was used as the definition of an attempted intubation
(ATI).
Results: 182 records filled, 257 ATI during this period. The leading
cause was acute respiratory failure (26 %). 122 patients were intu-
bated at the first attempt and 60 needed 2 or more attempts (min1,
max4). The success rate of TI at the first attempt was 67 %. Intub-
ation success rate at first ATI was similar during day or night (p =
0.53). Regarding the operator: 18 % of the missed TI at first ATI were
Fig. 82 (abstract A665).
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performed by anesthetists, while that number rose to 75 % in non-
anesthetists (p = 0.013). 88 % of missed TI at first ATI were performed
by residents, while senior doctors just missed 12 % (p < 0.033). Con-
sidering the operator reported own experience: 65 % with few airway
experience didn´t intubate at first attempt, doctors with good and
excellent airway expertise just missed first ATI in 20 % and 3 % of
the times respectively (p < 0.001). Predictive signs of difficult airway
were identified in 95 patients. Being obese and neck deformity the
most reported ones (Respectively 25 % and 21 %). 70 % of patients
who have not been intubated at the first ATI had predictive signs of
difficult airway (p < 0.001). Complications were reported in 30 % of
the ATI, namely: failed intubation 18 %, esophageal intubation 9 %,
aspiration of gastric contents 2 %, and cardiac arrest 1 %. Main con-
tributory factors reported for failure to IT at first ATI: operator's inex-
perience 13 % and patient-related 11 % (both attained statistical
significance p < 0.001). Lack of equipment and lack of strategy delin-
eation were only reported in 2 % each. No surgical or rescue airway
supraglottic devices were required.
Conclusions: Failed TI and its complication are largely due to the
operator's inexperience. As our hospital is a teaching one, TI in our
ED and ICU is performed mostly at first by trainee doctors. Patient-
related factors also play a role. Risk factors assessment for difficult in-
tubation should be a routine in ICU patients Training in recognition
and planning the approach of the difficult airway and expertise im-
mediately available are crucial in the airway management in these
settings.
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Introduction: Spondylitis ankylosans (Bechterew's disease) is a com-
mon disease with an incidence of about 0.5 % in Europe. Percutan-
eous dilatational tracheostomy is a common procedure in Intensive
Care Units. . Intubation and tracheostomy can be complicated by de-
formities of the cervical spine and the temporomandibular joints and
cervical spine. A combination of cervical kyphosis and osteoporosis
also leads to complexities in patient positioning.
Objectives: These fact could suggest that patients suffering spondyl-
itis ankylosans are not suitable for percutaneous dilatational trache-
ostomy but no study or case report ever reported about feasibility of
this procedure in Bechterew`s disease.
Methods: Retrospective analysis at one Level 1 trauma center of pa-
tient records from 2002–2016, identifying all patients with Spondylitis
ankylosans (SA) and percutaneous dilatational tracheostomy (PDT).
Results: 31 patients underwent PDT. All PDTs were performed using
the Ciaglia single step dilation technique. No cardiopulmonary or
surgical complication occurred during the procedure, especially no
airway loss, no desaturation, no hemodynamic abnormalty or bleed-
ing. One patient received airway switch from a small nasal tube to a
laryngeal mask before starting the PDT procedure.
Conclusions: A percutaneous dilatational tracheostomy in a patient
with Bechterew' s disease is a safe procedure in an experienced
centre.
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Introduction: Acute Lung Injury (ALI) and Acute Respiratory Distress
Syndrome (ARDS) are characterized by a promptly release of proin-
flammatory mediators that downregulate natural anticoagulant
mechanisms, initiate the coagulation system, impair fibrinolysis and
produce the rupture of the endothelial and epithelial monolayer (1).
Proinflammatory activated Alveolar Macrophages (AM) initiate and
regulate ALI/ARDS inflammation and contribute to the propagation
of the coagulant response. Currently there is no effective treatment
for this disease. Previous studies have presented the beneficial effect
of anticoagulants for their anticoagulation and anti-inflammatory ac-
tion (2–3).
Objectives: Evaluate the effect of local heparin administration in AM
in ALI model.
Methods: Sprague–Dawley rats (~300 g) underwent intratracheal
administration of Lipopolysaccharide (LPS 10 μg/g body weight)
or Saline (0.9 %) in control animals. Saline or heparin (1000 IU/kg
body weight) was nebulized through Aeroneb system (Philips
Healthcare) at constant oxygen flow (2 L/min) before and after
LPS administration. Animals were sacrificed 24 h after injury and
AM from all groups were isolated with a bronchoalveolar lavage.
The pro and anti-inflammatory pathways involved in AM activity
were evaluated by qRT-PCR. Neutrophil and monocytic chemo-
attractant activity of AM was evaluated by CXCL1 and CCL2, re-
spectively. Data expressed as media ± SEM, relative to GAPDH and
fold over saline group (n = 8 for all the study groups). Statistics:
One-Way-ANOVA and Newman Keuls post-hoc test (Statistical sig-
nificance: p ≤ 0.05).
Results: In ALI model there was a significant increase in TNFα,
Arginase-1, Smad/TGFβ effectors and CCL2. Heparin reduced signifi-
cantly TNFα, Arginase-1 and Smad 3. Further, changes were observed
in iNOS, IL10, and Smad 2. Although no changes were detected on
neutrophil chemoattractant activity of AM, monocytic chemotattrac-
tant activity was diminished by heparin (Fig. 83).
Conclusions: Altogether indicate that AM have a major role in the
ALI development and resolution. During ALI, AM present more
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activity and the treatment with heparin is able to attenuate this re-
sponse diminishing the lung injury.
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Introduction: Classically, with increasing CO2 there is a linear in-
crease in minute ventilation and diaphragm electromyogram (EMG)
(1). Several lines of evidence suggest that the Costal and Crural por-
tions of the diaphragm are two distinct muscles (2,3). Although both
muscles would be expected to increase in parallel with minute venti-
lation during CO2 stimulation, there is no a priori reason that Costal
and Crural would have identical neuro-mechanical recruitment.
Objectives: To determine if the two portions of the diaphragm, Cos-
tal (COS) and Crural CRU) diaphragm, are recruited identically during
CO2 stimulated ventilation.
Methods: Sonomicrometry transducers and EMG wire electrodes were
implanted in the left COS and CRU of 21 mongrel dogs. After full recov-
ery from diaphragm segmental shortening, the animals were studied
awake, breathing through a mask. Airflow, EtCO2, heart rate, muscle
length and moving averaged EMG (mavgEMG) were recorded during
room air and CO2 stimulated breathing (3). Output included breath-by-
breath breathing pattern, muscle Shortening (% of change in Length
from baseline), Peak EMG (ΔPeakEMG, % of baseline-to-peak difference
in mavgEMG), EtCO2 and heart rate.
Results: For N = 21 (mean wgt 31.1 kg) studied after 16 days post-
implantation (range 10–23 days) of Sonomicrometry transducers and
EMG electrodes, minute ventilation (Vi) and tidal volume increased sig-
nificantly from room air with CO2 stimulated breathing [8.8 and 0.3,
10.2 and 0.4, 14.6 and 0.6, and 18.2 and 0.7 and 22.9 and 0.8 at room
air, low (47), medium-low(53), medium-high (58) and high (63 Torr)
CO2, respectively]. Respiratory rate did not significantly change (range
25–29). As CO2 increased, ΔPeakEMG of COS and CRU increased con-
jointly in a linear fashion tracking changes in Vi,. however, there was a
significantly (p < 0.05) greater increasing in ShortCOS compared to
ShortCRU at medium-low, medium-high and high levels of CO2.
Conclusions: With CO2 stimulation, neural drive of COS and CRU
increased together in lock-step with ventilation. However, there
was distinctive differential action of the diaphragm segments.
Relative mechanical action of COS was significantly higher than
CRU at equivalent increasing of CO2. This results suggest a
predominant contribution of the Costal portion of the diaphragm
in order to generate the tidal volume during hypercapnic
stimulation.
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Sepsis is frequently complicated by organ dysfunction and the lungs
seem to be particularly vulnerable to the inflammatory response. The
disabling fatigue and the higher susceptibility to developing a viral
respiratory infection that many survivors experience in post-sepsis
syndrome cannot yet be explained. Herein, we sought to evaluate
the impact of sepsis on lung structures of the post-sepsis survivors.
Methods: Adult Wistar rats (200 g) were submitted to sepsis [iv. 2 mL E.
coli 108 (S8) or 109 CFU/ mL (S9), DL60 and DL80, respectively, in 26 hour-
s].Under general anesthesia, the lung architecture was monitored by
histology at 6 hours after sepsis (T6h, n = 3/group) and 30th day survivals
(T30d, n = 3/group). The lungtissue wasexaminedafter staining with H.E.
Results: The S8-6 h group showed a vascular congestion of the al-
veolar wall, alveolar wall thickening and neutrophils infiltration.It was
also observed an increase in cellularity in the bronchial lumen and
BALT hyperplasia (Fig. 86). After 30 days was observed a reduction of
the alveolar wall thickening, complete reduction of alveoli vascular
congestion in the entire lung, however, there was a persistence of
the hyperplasia of BALT. In animals submitted to more severe sepsis
(S9-30d), the alveolar wall thickening remained more intense, there
was decreased of inflammatory cells infiltrates, but persisted the al-
veoli wall congestion and BALT hyperplasia and hypertrophy (Fig. 2).
These findings showed that depending on the severity of sepsis, the
parenchyma and pulmonary microcirculation injuries may have sig-
nificant recovery (S8) or minimal (S9), even 30 days after the clinical
recovery from sepsis. In addition, presence of histological signs sug-
gestive of persistence of a state of the activated BALT, even in less
aggressive sepsis (S8-30d), shows that still exist a continuous stimu-
lating inflammatory factor even in the absence of clinical signs of in-
fection. Thus, the overall data demonstrate that clinical recovery is
not synonymous of a normal physiological state, on the contrary, hist-
ology showed an ongoing severe lung disease process at post-sepsis
period. How long last these eventsis unknown, but the data suggest
that post-sepsis physiological state is far from the standard health.
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Introduction: Eph-Ephrin signaling mediates various cellular processes,
including vascular permeability, inflammation, angiogenesis, cell migra-
tion, axon guidance, fluid homeostasis, and repair after injury. The de-
tailed mechanisms of EphA2 signaling in lung injury are unknown.
Objectives: To evaluate the role of EphA2 signaling, as well as related sig-
naling pathways, in the lipopolysaccharide (LPS)-induced lung injury model.
Methods: Three experimental mouse groups were formed: PBS + IgG
(IgG instillation after PBS exposure), LPS + IgG (IgG instillation after
LPS exposure), and LPS+ EphA2 mAb (EphA2 monoclonal antibody
instillation posttreatment after LPS exposure). Cell numbers and
protein concentration in the bronchoalveolar lavage fluid (BALF),
changes in histopathology and the expression of several signaling
pathway proteins—including PI3K-Akt-NF-kB, Src, Erk, E-cadherin and
mTOR—were compared among the three groups.
Results: Acute LPS exposure significantly upregulated EphA2 and
EphrinA1 expression. Inhibition of the EphA2 receptor by intranasal
EphA2 mAb administration attenuated lung injury and reduced BALF
cell counts and protein concentration (all, P < 0.05). EphA2 mAb post-
treatment downregulated the expression of PI3K 110γ, phospho-Akt,
phospho-NF-kB, Erk1/Erk2, phospho-Src, and phospho-S6K. In
addition, inhibiting the EphA2 receptor augmented the expression of
E- cadherin, which is involved in cell-cell adhesion.
Conclusions: The present data suggest that the EphA2 receptor may be
an unrecognized modulator of several signaling pathways—including
PI3K-Akt-NF-kB, Src-NF-kB, E-cadherin, and mTOR—in LPS-induced lung
injury. Further studies are needed to verify the potential of EphA2 recep-
tor inhibitors as novel therapeutic agents for LPS-induced lung injury.
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Introduction: One of the therapeutic ventilation goals of the ARDS Net-
work protocol is to control blood pH in a certain range (7.30-7.45) [1]. Only
a strict and frequent schedule of arterial blood gas analysis can result in a
good performance for such control, which mainly relies on personal efforts.
Objective: This preliminary work was to analyze the possibility to
control blood pH via the average carbon dioxide elimination (VCO2)
that can be noninvasively measured from the exhaled air during the
closed-loop ventilation therapy [2].
METHOD. Approved by the local animal ethical committee, a male
pig (45.4 kg) was anesthetized, intubated and ventilated in supine
position for 1 h. After induction of ARDS by repetitive lung lavages,
automatic ventilation therapy was continued for 3 h. All vital parame-
ters including the CO2 data from a capnography (CO2SMO+) were
continuously recorded by a medical panel PC. Based on the ARDSNet
protocol, higher PEEP/lower FiO2 settings [1] were automatically ap-
plied to the pig. After the onset of the automatic ventilation, the
average VCO2 was computed for every 30 min.
Results: All goals of the ARDSNet protocol were satisfied in terms of
oxygenation, pH value and plateau pressure. The figure shows the
experimental results of the pH value compared to the computed
average VCO2 during the ventilation therapy. It should also be noted
that a new setting of PEEP value influences the dynamics of VCO2.
Conclusions: The carbon dioxide elimination is a possible intermedi-
ate parameter for the use of noninvasive indirect control of blood pH
that could fulfil a fully closed-loop ventilation therapy based on the
ARDSNet protocol.
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Sepsis is a leading cause of acute respiratory distress syndrome
(ARDS), characterized by diffuse injury of the alveoli-capillary
wall, increased pulmonary vascular permeability, and alveolar
and interstitial edema. The aggressive fluid therapy is a contro-
versial procedure by the possibility of increment the lung
edema. Besides, due to the difficulties to study the lung, the
consequences in the tissue injuries in sepsis patients in the
post-sepsis phases are little known. The present study investi-
gated the effects of aggressive-fluid therapy in lung tissues of
the sepsis survivors.
Methods: Adult Wistar rats (200 g) were submitted to sepsis (S8)
(iv. 2 mL E. coli 108 CFU/mL−1, DL60 in 26 hours), or sepsis and
Ringer Lactate (S8HH) (iv. 30 mL/kg/20 min), 30 minutes after
sepsis challenge. The tissue samples were evaluated by histology
(T6h,T30d), using HE dyes.The S8-6 h group showed a vascular
congestion on the alveoli walls, withintense thickening and infil-
tration of neutrophils, and increased cellular invasioninto the
bronchus lumen. BALT showed intense hyperplasia. InS8-30d ani-
mals,there was a reduction in thickening of the alveoli wall, the
absence of thecapillary congestion throughout the lung, but with
cellular debris in the bronchial lumenand a persistent BALT
hyperplasia (Fig. 88). The aggressive fluid therapy in S8HH-6 h
group resulted in lesser vascular congestion in the peripheral al-
veolar walls. More pronounced lesions were seenin the central
part of the organ (hilo); with venous congestion and thickening
of the alveoli-wall, infiltration of mononuclearcells and neutrophils
in intra epithelia's spaces of the bronchi; BALT hyperplasia was
highly evident. The aggressive fluid didnot recovered the injuries
of the S8HH-30d group. the vascular congestion and thickened
parenchyma were observed in whole lung, although without in-
flammatory infiltrate. BALT showed less hypertrophy and hyper-
plasia. In summary, although there was a worsening of the
alveoli injuries, the signs of non-activated BALT suggested low
immune activation under aggressive-fluid therapy but with high
pulmonary edema due to their high permeability characteristics.
The overall data suggested that lung not have adequate physi-
ology and anatomy to support a fluid aggressive therapy de-
manding a more careful maneuver in terms of volume and
perfusion velocity. These results reinforce the doubts that inad-
equate management of sepsis may cause consequences in the
future.
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Introduction: During weaning from invasive mechanical ventilation
(IMV), pulmonary oedema may develop due to cardiac failure, and it
is a cause of failure in weaning from IMV. Cardiogenic pulmonary
oedema produces hemoconcentration and haematocrit (Ht) is a good
marker of hemoconcentration. It is not determined if the increase of
Ht during weaning protocol may predict failure in weaning from IMV.
Objective: To determine if the increase of Ht during spontaneous
breathing trial (SBT) is a predictor of failure in weaning from IMV.
Methods: We prospectively included patients with IMV >72 hours. A
SBT was performed with a T-piece for two hours. Ht value at the start
and at the end (or failure) of the SBT was measured and the delta
was calculated. Logistic regression analysis was performed to deter-
mine the association between the increase of Ht and failure in wean-
ing from IMV. Its performance as a predictor of failure was assessed
by its discriminative capacity and calibration. A p value < 0.05 was
considered statistically significant.
Results: Fifty-five patients were analysed, 58.2 % female, mean age
49.9 years. Thirty-two (58.2 %) patients had elevation of the Ht at the
end of the SBT and 41.8 % failed in weaning from IMV. The increase
of Ht had OR of 1.22 (95%CI 1.05-1.42, p = 0.011) and behaved as a
good predictor of failure in weaning from IMV, with area under the
receiver operative characteristics (ROC) curve of 0.719 (p = 0.006) and
Hosmer-Lemeshow Chi2 of 41 (p = 0.142).
Conclusions: Patients who failed in weaning from IMV has signifi-
cantly increased the value of Ht at the end of the SBT. The increase
of Ht is a risk factor and has adequate discriminative capacity and
calibration to predict failure in weaning from IMV.
Key words: Failure of weaning from mechanical ventilation, spontan-
eous breathing trial, haematocrit.
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Introduction: With a high prevalence in Intensive Care Units (ICU),
the Ventilator-Associated pneumonia (VAP) has been responsible for
increased mortality and morbidity rates, hospital stay, duration of
mechanical ventilation (MV), costs and a set of other complications.
Usually, VAP develops 48 h after the beginning of mechanical venti-
lation (MV) and can be classified as of early- or late-onset.
Objectives: This study aims to evaluate the incidence, length of hos-
pital stay, number of days of MV, and treatment and prevention
methods (bundles) of VAP during the year of 2015, in the ICU of
CHA-Faro, as well as to compare these results with those from 2014.
Methods: Patients were evaluated according to their age, sex, type
of VAP (early-/late-onset), identified microorganism, antibiotic treat-
ment, admission type and severity scores (APACHE II and SAPS II), as
well as the assessment of the likelihood of lung infection (CPIS).
Results: Of the 473 patients admitted to the ICU, 24 developed VAP.
The incidence rate was 5.07 %, and the incidence density rate was
9.74 per 1000 ventilation days. The mean value of CPIS was 1.35 ±
7.5. Five cases were classified as early-onset (20.83 %) and 19 as late-
onset (79.17 %). The mean values of both, hospital stay (7.12 ± 9.97
and 29.83 ± 21.35) and MV (5.21 ± 9.26 and 26.17 ± 23.05), were sig-
nificantly different (p < 0.01) between patients without and with VAP,
respectively. The most common isolated microorganism was P. aeru-
ginosa (57.9 %) in late-onset VAP, with no microorganisms isolated
(60 %) in the early-onset VAP. The adherence to VAP prevention bun-
dles from January to October 2015 was 14,91 %.
Conclusions: Our data indicate that the incidence of VAP was re-
duced from 2014 to 2015. The increase on adherence to VAP bundles
might explain this signigficant reduction. Decrease on VAP incidence
was significantly asociated with reduction on days of mechanical
ventilation and length of hospital stay.
Fig. 88 (abstract A673).
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Introduction: Patients who are on mechanical ventilation have an in-
creased risk of developing Ventilator associated event (VAE) which is
tiered into three definitions; Ventilator-Associated Condition (VAC),
Infection-related Ventilator-Associated Complication (IVAC) and Venti-
lator- associated pneumonia (VAP). VAP is a rare yet serious compli-
cation that carries a high risk of morbidity and mortality. Current
guidelines, published in 2005 by the American Thoracic Society in as-
sociation with the Infectious Diseases Society of America, recom-
mend the use of empiric antibiotics therapy.
Objective: This is an ongoing research with the aim of examining the
trends in the management of VAC and minimizing the use of vanco-
mycin in patients on mechanical ventilation due to the higher risk of
developing multi-drug resistant organisms and as a consequence, de-
teriorating to IVAC and VAP as compared to other antibiotics.
Methods: A retrospective analysis of data collected from 858 patients
admitted to the intensive care unit at the University of Toledo Med-
ical Center and received empiric antibiotic therapy. Among the sam-
ple of patients, 152 met CDC-defined criteria for a ventilator-
associated event. Additionally, those that met VAE criteria were strati-
fied by VAE type, which yielded 82 VACs, 38 IVACs, and 32 PVAPS.
Results: Vancomycin was used frequently in patients on mechanical
ventilation. Among 706 patients who did not develop VAE, it was used
in 62.5 %. Furthermore, it was used in 80.5 %, 94.7 % and 81.3 % in pa-
tients who developed VAC, IVAC and VAP, respectively and 84.2 % col-
lectively. Overall, the primary use of three antibiotic groups (Penicillin,
cephalosporin and vancomycin) is consistent through each stage of
VAE and likewise in the non-VAE group; cephalosporin was used in
63.2 % in the VAE group and 51.6 % in non-VAE while penicillin was
used in 59.2 % in the VAE group and 43.3 % in the non-VAE group. In
addition, the use of Vancomycin either alone or in combination with
other antibiotics is associated with VAEs (OR = 3.2).
Conclusion By CDC definition, those that have met IVAC or PVAP
criteria would have been on a minimum of 4 days of antimicro-
bial therapy. The extensive use of Vancomycin in critically-ill pa-
tients compared to other antibiotics can be a contributing factor
in the development of resistant organisms leading to subsequent
complications.
Table 65 (abstract A676). Antibiotics usage
Antibiotic VAC
(n=82)
IVAC
(n=38)
PVAP
(n=32)
VAE
(n=152)
Non-VAE
(n=706)
PCN 44 (53.7%) 22 (57.9%) 24 (75.0%) 90 (59.2%) 306 (43.3%)
Cephalosporin 52 (63.4%) 21 (55.3%) 23 (71.9%) 96 (63.2%) 364 (51.6%)
Vancomycin 66 (80.5%) 36 (94.7%) 26 (81.3%) 128 (84.2%) 441 (62.5%)
Macrolides 19 (23.2%) 6 (15.8%) 4 (12.5%) 29 (19.1%) 83 (11.8%)
Quinolones 31 (37.8%) 16 (42.1%) 17 (53.1%) 64 (42.1%) 172 (24.4%)
Carbapenems 40 (48.8%) 17 (44.7%) 16 (50.0%) 73 (48%) 99 (14.0%)
Metronidazole 37 (45.1%) 19 (50.0%) 17 (53.1%) 73 (48%) 147 (20.8%)
Fig. 89 (abstract A676). Antibiotics usage among patients with VAC
Fig. 90 (abstract A676). Antibiotics usage among patients
with IVAC
Fig. 91 (abstract A676). Antibiotics usage among patients with VAP
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Introduction: Driving airway pressure, the difference between plateau
(end of an inspiratory pause) and end-expiratory airway pressure, can be
an independent predictor of ventilator-induced lung injury (VILI) [1]. How-
ever, during ongoing mechanical ventilation, (dynamic) end-inspiratory
airway pressure exceeds (static) plateau airway pressure, especially when
inspiratory flows are very high [2]. Thus, for the same static driving airway
pressure, different dynamic driving airway pressures can be reached.
Objectives: To compare the role of static and dynamic driving airway
pressures in the development of VILI.
Methods: Sixteen healthy piglets were anesthetized, paralyzed and
mechanically ventilated for 54 hours with no positive end-expiratory
pressure. Animals were divided into two groups that were matched for
static driving airway pressure (ΔPAW,stat), defined as above, but not for
dynamic driving airway pressure (ΔPAW,dyn), defined as the difference
between airway pressure recorded when flow zeroed immediately after
an end-inspiratory occlusion (P1) and end-expiratory airway pressure.
Lower and higher dynamic driving airway pressures were obtained by
using lower or higher inspiratory flows. Respiratory rate was always 15
breath-per-minute. VILI was diagnosed if final lung weight (measured
with a balance) exceeded initial lung weight (measured with computed
tomography), as for edema. Data were compared between the two
groups with Student's t and Fisher's Exact tests.
Results: The two groups of animals were ventilated with similar static
but different dynamic driving airway pressures (Table 66). Incidence
of VILI was 25 % among animals ventilated with lower and 75 %
among those ventilated with higher dynamic driving airway pressure
(p = 0.13). On average, lung weight decreased over time (−56 ± 60 g)
in the former group whereas it increased (98 ± 166 g) in the latter
group (p = 0.04). Mortality at 54 hours was 13 % among animals ven-
tilated with lower and 63 % among those ventilated with higher dy-
namic driving airway pressure (p = 0.12).
Conclusions: For the same static driving airway pressure, higher dy-
namic driving airway pressures may increase the incidence of (fatal)
ventilator-induced lung injury.
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Introduction: The sequence of events that at alveolar level deter-
mine lung inflation are only partially known. Methods that can
provide simultaneously high-resolution, in-vivo conditions and in-
formation about the core region of the lungs are lacking. Ventila-
tory strategies to support lung function rely upon the idea that
lung alveoli are isotropic balloons that accommodate gas pro-
gressively and that pressure/volume curves derive by the inter-
play of opening pressures and position of alveoli inside the lung.
This simplistic idea has been challenged by subpleural micros-
copy1, magnetic resonance imaging2 and computed tomography
(CT) studies3,4. Images of in-vivo lungs can be obtained from Syn-
chrotron Radiation Computed Tomography (SRCT) at resolutions
higher than conventional CT.
Objective: To evaluate kinetics of airspaces in healthy (HC) and Acute
Respiratory Distress Syndrome (ARDS) conditions.
Methods: The study was conducted in seven anesthetized New
Zealand rabbits. They underwent SRCT scans (resolution of
47.6 μm)of the lung at decreasing PEEP levels of 12, 9, 6, 3 and
0 cmH2O during end-expiratory holds. Pulmonary imaging was
executed during HC and after induction of ARDS by repeated
lung lavages and injurious ventilation (inspiratory pressure of 35
and PEEP = 0 cmH2O). Three concentric regions-of-interest (ROI)
were studied: subpleural (SP), peripheral (PE) and core (CO). Im-
ages were enhanced by phase contrast algorithms. Airspaces
Number (AN), covered area (AA) and dimensions (AD) were
computed by using the Image Processing Toolbox for MatLab
(Mathworks, Natick, USA). Student's T-test was used to assess
any statistically significant difference produced by PEEP or ROI
position.
Results: AN and AA decreased with decreasing PEEP, however in
ARDS at PEEP lower than 6 cmH2O they remained stable. The
three ROIs had similar courses but with different magnitudes. AD
during HC showed a tendency to reduce progressively after 9
cmH2O; during ARDS this tendency was observed sharply after 6
cmH2O.
Conclusions: Alveolar kinetics is different between healthy and ARDS
conditions. In HC and ARDS de-recruitment and isotropic deflation
are both present, however their entity and proportion depend on
the applied pressure. In HC, alveolar dimensions in the studied range
support the idea of a continuous derecruitment simultaneous with
isotropic deflation. In ARDS, passage from PEEP 12 to 6 cmH2O is
characterized by a sharp derecruitment (alveoli do not change appre-
ciably dimensions but can be either open or closed). In ARDS lungs
this may be consequence of their high critical closing pressures and
elastance.
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Table 66 (abstract A677).
Low ΔPAW,dyn
(n=8)
High ΔPAW,dyn
(n=8)
p
Tidal Volume, ml 633 ± 143 553 ± 158 0.31
Inspiratory flow, ml/sec 569 ± 161 1365 ± 268 <0.01
Static driving airway pressure,
cmH2O
22.4 ± 2.7 22.6 ± 2.8 0.50
Dynamic driving airway pressure,
cmH2O
25.6 ± 3.3 27.9 ± 5.1 0.03
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Introduction: We have previously found that during spontaneous
breathing (SB) the diaphragm exerts an expiratory breaking effect,
maintaining lung volume. In this experimental study in a porcine
mild acute respiratory distress (ARDS) model we compared the effect
on lung aeration between full mechanical ventilation (MV) and SB
and our hypothesis was that SB, due to the breaking activity by the
diaphragm, would improve intraparenchymal distribution of gas dur-
ing expiration and reduce atelectasis formation.
Methods: A mild acute respiratory distress syndrome was induced in
five anesthetized, tracheostomized pigs by repeated lung lavages,
targeting a PaO2/FiO2 of 250 mmHg. After stabilization, the animals
were allowed to breathe spontaneously and underwent a decremen-
tal continuous positive end-expiratory pressure (CPAP/PEEP) trial at
15, 12, 9, 6, 3 and 0 cmH2O. Then the same sequence was repeated
during MV after muscle relaxation. Para-diaphragmatic expiratory dy-
namic CT-scans were collected four (L1) and one (L2) cm cranial to
the diaphragm. The amount of gas (Vgas, [mL]) for each CT-image at
half and end expiration was calculated in all the compartments from
+100 to −1000 Hounsfield Units (HU). The amount of atelectasis (be-
tween −100 and +100 HU) for each selected CT-image was also mea-
sured. Paired samples Student t-test was applied to assess any
statistically significant difference between study conditions.
Results: At CPAP/PEEP levels equal or lower than 6 cmH2O, Vgas was
higher during SB than during MV at all distances from the diaphrag-
matic dome and, in addition, at both half and end-expiration. The in-
crease in atelectasis with decreasing CPAP/PEEP was in all animals
larger during MV than SB. Only during SB, and not during MV condi-
tions, the lung near the diaphragmatic dome (L2) was less atelectatic
than the lung further away from it (L1). More atelectasis during MV
than SB was observed already at half-expiration.
Conclusions: SB maintains the amount of lung aeration significantly
better than MV in a collapse-prone mild ARDS model. Furthermore,
SB protected against atelectasis formation: this effect was visible
already at half expiration.
Therefore we deduce that the improved redistribution of gas and the
decreased atelectasis formation depend on the preserved diaphrag-
matic contraction. These findings have potential implications for the
design of new ventilatory strategies.
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Introduction: Sepsis is a common cause for admission to the ICU and
more than a quarter who suffer from septic shock dies (1). Severe sepsis
and septic shock leads to failure of one or more organs. The brain can
get affected by septic induced organ failure, a condition known as
sepsis-associated encephalopathy (SAE).
Protective ventilation (PV), with tidal volumes (TV) of 6 ml/kg, have showed
a decrease in mortality in patients with sepsis and acute respiratory distress
syndrome, in comparison to routine ventilation (RV), TV of 10 ml/kg, and is
the recommended approach for intensivists worldwide (2). However, it's
not yet shown whether PV can affect hemodynamic adverse effects and
impaired usage of oxygen in the brain of a septic patient.
Objectives: The purpose of this study is to examine brain oxygen-
ation and hemodynamic changes in a sepsis porcine model and to
investigate whether PV may affect cerebral usage and availability of
oxygen, in comparison to RV.
Methods: Data was collected in an ongoing project concerning neu-
roinflammation in septic pigs, at the Hedenstierna Laboratory in Upp-
sala, Sweden.
Fourteen healthy pigs were randomized to two groups and anaesthe-
tized. The groups were given an infusion of lipopolysaccharide to induce
a septic like condition and was ventilated with RV (n = 6) respectively PV
(n = 8). The animals received vascular catheters in order to draw arterial
and venous blood gases before and after the blood has passed through
the brain (sagittal sinus), and to monitor hemodynamic changes. A flow
meter was applied to the left internal carotid artery. Hemodynamic data
and blood samples were collected every hour for 6 hours.
Results: No difference in mean arterial pressure or arterial oxygen
content was seen between the two groups. Protective ventilation en-
hanced oxygen delivery index to the brain (44.5 ± 14.1 to 30,3 ± 5.9
mlO2/min/m2, p = 0.018). Increased blood flow to the brain due to
reduced brain vascular resistance was seen in the PV-group in com-
parison to the RV-group (19046.2 ± 7270.4 to 26637.3 ± 5678.5 dyn ·
s · cm − 5, p = 0.018).
Conclusions: Protective ventilation induces hemodynamic changes in
cerebral blood vessels in the septic pig which reduces brain vascular re-
sistance. These changes leads to improved oxygen delivery to the
brain. Further studies will take place in order to clarify the cause behind
these changes, with an emphasis on the role of inflammatory bio-
markers and neuronal nitric oxide synthase.
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Introduction: In supine patients with ARDS, the lung usually parti-
tions into dorsal atelectasis and ventral aeration. Conventional
positive-pressure ventilation directs tidal volume (VT) preferentially to
ventral aerated areas. Attempts to 'recruit' atelectasis with positive
pressure often overinflate aerated regions. This occurs due to a large
vertical gradient of pleural pressure (Ppl) in ARDS. Prone positioning
is the only effective means to lessen this Ppl gradient.
Objectives: To test 2 hypotheses - That Continuous Negative Abdom-
inal Pressure (CNAP), by selectively recruiting basal atelectasis, would:
(1) improve lung function in a stable lung injury model;
(2) attenuate ventilator-induced lung injury in a model of progressive
lung injury.
Methods: An established model of ventilator-induced lung injury
(VILI) was used (anesthetized pig) and all animals were monitored
using esophageal manometry (Pes, pleural pressure), Electrical Imped-
ance Tomography (EIT, regional ventilation) and pulmonary artery
catheter. 2 series of experiments were performed.
Series 1 - Stable Lung Injury. 7 pigs were subject to maximal lung re-
cruitment using PEEP (20 cmH2O) followed with progressive derecruit-
ment by lowering PEEP in serial increments of 2 cmH2O; full
physiologic assessment was performed at each decrement of PEEP. This
series of assessments was performed twice in each animal: once with
CNAP (−5 cmH2O) and once with no CNAP (the order was randomized).
Series 2 - Progressive Lung Injury. Animals were randomized to
'CNAP' or 'no CNAP' (5 per group) and both groups were exposed to
standardized injurious ventilation: VT 20 mL/kg, low PEEP, and the
same expiratory transpulmonary pressure (PL, −3 cmH2O) for 4 h.
Results: Series 1 - Stable Lung Injury. CNAP considerably reduced the
vertical gradient of Ppl (measured by direct instrumentation): at PEEP
= 4: 11.3 ± 3.5 vs. 6.6 ± 2.5 cmH2O, PEEP vs. PEEP + CNAP (P < 0.01).
Application of CNAP consistently resulted in better oxygenation, re-
spiratory system compliance, and more homogeneous ventilation at
descending PEEP values from 12 to 4 cmH2O. At PEEP = 4, the P/F ra-
tio (mmHg) was 67 ± 5 (no CNAP) vs. 263 ± 36 (with CNAP, P < 0.01).
At most levels of PEEP, oxygenation with added CNAP was greater
despite a lower global PL (Fig. 92).
. Dynamic CT demonstrated that addition of CNAP (−5 cmH2O) to a
PEEP level of 10 cmH2O yielded the same amount of aeration as a
PEEP of 18 cmH2O.
Series 2 - Progressive Lung Injury. Ventilation with no CNAP resulted
in progressive lung injury; use of CNAP reduced the progression of
lung injury resulting in greater oxygenation, respiratory system com-
pliance, and homogeneity of ventilation (Figs. 93 and 94)
Conclusion CNAP selectively recruited basal atelectasis and ho-
mogenized ventilation by increasing regional PL in dependent
lung. CNAP is not only 'equal but opposite' to positive pressure;
instead, at comparable PL it improves lung function and lessens
lung injury.
BPK, TY & DE - CNAP device patent applied
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Introduction: Hepatorenal syndrome (HRS) is a frequent complica-
tion of liver cirrhosis with poor prognosis. Pathophysiology of
HRS comprises excessive splanchnic vasodilation, reduction of ef-
fective arterial volume and reduced renal perfusion. Several thera-
peutic approaches have been shown to improve prognosis of
HRS, including volume expansion with albumin, terlipressin and
transjugular porto-systemic shunt (TIPSS). While the specific
Fig. 92 (abstract A681).
Fig. 93 (abstract A681).
Fig. 94 (abstract A681).
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haemodynamics of HRS and these therapeutic approaches have
been thoroughly investigated using advanced haemodynamic
monitoring, this technology is not yet recommended in recent
guidelines.
Objectives: Therefore, it was the aim of our randomized controlled
trial to compare the outcome of patients with HRS treated according
to a pre-defined algorithm based on transpulmonary thermodilution
(TPTD) to standard treatment.
Methods: 25 patients were randomized with a ratio of 1:2 to
standard care or to the RACEHORSE-protocol (Early goal-directed
volume resuscitation in hepato-renal syndrome). This protocol
was based on three sequential algorithms including global end-
diastolic volume index GEDVI, extravascular lung water index
EVLWI, cell count in the ascites and pO2/FiO2. In summary these
algorithms aimed at GEDVI-guided volume expansion within the first
48 h, followed by a TPTD-guided strategy for fluid support using the
PiCCO-2-device (Pulsion Medical Systems SE, Feldkirchen, Germany).
Primary endpoint: Combination of complete reversal of HRS according
to the Ascites-Club-criteria (2007) within 14d AND survival without renal
replacement therapy (RRT) AND without liver transplantation for ≥28d.
Statistics: SPSS 23.
Results: 9 female, 16 male patients with alcoholic (22), viral (2)
or autoimmune (1) aetiology of cirrhosis. Patients of treatment
group (n = 16) and controls (n = 9) were comparable regarding
baseline serum creatinine (3.6 ± 1.5 vs. 3.1 ± 1.3 mg/dL), BUN
(66 ± 27vs. 54 ± 22 mg/dL), cystatin C (2.5 ± 0.8 vs. 2.5 ± 0.4 ng/
dL), indocyanine green plasma disappearance rate (4.4 ± 1.2 vs.
5.5 ± 2.3 %/min), sodium, ADH, aldosterone, adrenalin and nor-
adrenalin pevels (all p-values >0.05). The primary endpoint was
met in 0/9 (0 %) of the controls and 6/15 (40 %; p = 0.028) of
the treatment group. Several other endpoints gave hints for a
better outcome in the treatment group compared to controls,
although statistical significance was failed: Complete response
within 14d without RRT (9/16 (56 % vs. 2/9 (22 %); p = 0.072),
changes in serum creatinine after 7d (−1.0 ± 1.9 vs. -0.3 ±
1.7 mg/dl; n.s.), requirement of RRT (6/15 (40 %) vs. 5/9 (56 %);
n.s.)and days without RRT within 28d (19 ± 11 vs. 15 ± 11; n.s.).
Conclusions: Goal-directed therapy based on TPTD-guided
substitution of albumin and crystalloids improves short term
outcome of patients with HRS. Due to the limited statistical
power of this mono-centric study larger multi-centric trials also
including targets for vasopressor therapy are required to con-
firm these data.
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Introduction: A non-invasive liver function monitoring system, the
LIMON®, has been developed to measure indocyanine green (ICG)
elimination by pulse spectrophotometry. The aim is to assess the re-
lationship between pre and post-operative ICG plasma disappearance
rate (ICG PDR %/min) values and the onset of post-hepatectomy liver
dysfunction. Postoperative liver failure after hepatectomy has been
identified by the association of prothrombin time < 50 % and serum
bilirubin >50 umol/L (the “50-50” criteria).
Methods: We collected 30 patients scheduled for major liver resec-
tions. Nine had chronic liver disease. Prothrombin time and serum
bilirubin was determined on day 3 and day 5 in critical care unit after
hepatectomy. IGC PDR was measured preoperatively and 24 hours
postoperative.
Results: We submit the values obtained for the variables of the ICG
PDR pre and postoperative to an analysis of ROC curves, we found a
very good predictive capacity for postoperative PDR showing an area
under the curve of 0.96 but not well for preoperative PDR AUC= 0,667
for determined early diagnosis of postoperative liver failure. Bilirrubin
and prothrombin time show an area under the curve of 0,922 and 1.
Significant correlation was found between ICG PDRpost measure-
ment taken on postoperative day 1 and bilirubin level on day 5 (p <
0,001) and prothrombin time on day 5 (p,001).
The most sensible and specific value calculated for PDR post was 7.8.
Discussion: LiMON ICG PDR measured by pulse spectrophotometry is
a non-invasive and reliable liver function test for patients undergoing
liver resection that aids in the prediction and early detection of post-
operative liver failure.
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Introduction: Post-operative liver failure (PLF) is a major complication
after extended liver resection with a high mortality rate. Early identifi-
cation of patients at risk for PLF could improve prognosis.
Objectives: To determine the time course of lactate, lactate clearance
and the relationship of lactate with other markers of liver function
and mortality.
Methods: All consecutive patients (2008–2014) who were postopera-
tively admitted to the intensive care unit (ICU) after liver resection
were included. Patients were classified as “minor” or “major” liver re-
section based on a functional liver remnant (FLR) of ≥70 % and <
70 % respectively. Lactate clearance (%) was defined as: (lactate at
ICU admission - lactate at 6 h) / lactate at ICU admission *100. The
50–50 criteria, a validated predictor of liver failure and death after
liver resection, was defined as PT >21'' and serum bilirubin >50
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umol/L on postoperative day 3 [1]. Numbers are expressed as median
(interquartile range).
Results: A total of 382 patients admitted to the ICU after liver resec-
tions were included (80 % major resection). The main indication was
colorectal liver metastasis (63 %). At ICU admission lactate was 2.4
(1.7-3.4) mmol/L. Maximum lactate level was 2.7 (2–4) mmol/L and
occurred at 1.2 (0.3-7.9) hours after ICU admission. There was a sig-
nificant difference between the lactate clearance at 6 h between the
minor and major resections (25 % versus 14 %, P = 0.005). Highest PT
was observed 30 hours after ICU admission. Only 3 patients met the
“50-50 criteria” at day 3 and mortality at 30-days was 3.1 %. After
multivariate analysis, lactate at ICU admission and perioperative
blood loss, but not FLR, lactate clearance at 6 h or the “50-50 cri-
teria”, were independent predictors of 30-day mortality.
Conclusions: Lactate levels at ICU admission, but not lactate clear-
ance during the first 6 hours, is a strong independent predictor for
30-day mortality. In addition, lactate at ICU admission is of more
prognostic value than the often used “50-50 criteria” (day 3) and also
available much earlier.
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Introduction: Sudden cardiac arrest (CA) is one of the leading causes
of death in adults in many parts of the world. Every year estimated
350.000 to 700.000 people in Europe are suffering CA and receive
cardiopulmonary resuscitation (CPR). Hypoxic hepatitis (HH) can be
found in up to 10 % of critically ill patients. To date, data on inci-
dence and outcome of HH after out-of-hospital CA and CPR is scarce.
Objectives: Aim of the study was to determine incidence and out-
come of HH in patients after out-of-hospital CA.
Methods: Assessment of incidence of HH in a cohort of 798 consecu-
tive patients with out-of-hospital CA and successful CPR that were
treated at the Medical University Vienna, 168 (21 %) patients with HH
could be identified. Patient characteristics, admission diagnosis, se-
verity of disease, course of the disease and 28d mortality were
assessed.
Results: Overall, 168 patients representing 21 % of the total cohort
(128 male, age 56 (47–66) years) developed HH after CA with suc-
cessful CPR were assessed. CA was witnessed in 136 (81 %) cases. Ini-
tial rhythm was shockable (VT/VF) in 90 (54 %), non-shockable (PEA/
Asystole) in 75 (44 %) and unknown in 3 (2 %) patients. Time to
ROSC was 27 (13,25 - 46,50) minutes. Cardiac events leading to CA
were observed in 108 (64 %) of patients. SOFA-Score on admission
was 11 (9–12), SAPS II was 80 (75–86).149 (89 %) patients needed
mechanical ventilation on admission and 123 (73 %) needed vaso-
pressor support. Mild therapeutic hypothermia was applied in 125
(74 %) patients. 28d-survival was 45 % in patients with HH and 60 %
in the total cohort (p < 0,05). 107 (64 %) patients with HH were dead
or had bad neurological outcome (CPC III/IV) after 28d.
Conclusions: New onset of HH is a frequent finding in patients fol-
lowing successful CPR out-of-hospital and is associated with worse
outcome.
A686
Effect of acetaminophen on hepatocellular procalcitonin
biosynthesis in a human hepatoma cell line (HepaRG©)
M. Kott1, K. Zitta1, B. Brandt2, C. Schildhauer1, G. Elke1, L. Hummitzsch1, I.
Frerichs1, N. Weiler1, M. Albrecht1
1UKSH, Campus Kiel, Department of Anaesthesiology and Intensive Care
Medicine, Kiel, Germany; 2UKSH, Campus Kiel, Institute for Clinical
Chemistry, Kiel, Germany
Correspondence: M. Kott - UKSH, Campus Kiel, Department of
Anaesthesiology and Intensive Care Medicine, Kiel, Germany
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A686
Introduction: Acetaminophen (APAP) overdose is the most frequent
cause of acute liver failure in many countries. Following cell necrosis,
the release of intracellular damage-associated molecular patterns, like
high-mobility group-box protein-1 or DNA fragments, induces a ster-
ile inflammation mediated through interleukin- (IL) 1, IL-6 and tumor
necrosis factor-α (TNF-α), amongst others1. Procalcitonin (PCT) that is
frequently used to monitor the course of systemic infections and in-
flammation is also up-regulated through these pro-inflammatory me-
diators2. Therefore, PCT could be a potential biomarker to monitor
the course of APAP overdose patients.
Objectives: This pilot study sought to assess whether APAP administra-
tion induced PCT synthesis in an in vitro model of human hepatoma
cells (HepaRG©) and to explore possible dose-dependent relationships.
Methods: Human hepatoma cells (HepaRG©, Biopredic International,
Rennes, France) were cultured according to the instructions of the manu-
facturer. Cells were exposed to increasing concentrations of APAP (20 μg/
ml; 200 μg/ml, 500 μg/ml). Cell supernatants were collected after 24 hr
(time/concentration: 24/20, 24/200, 24/500) and after 48 hr (48/20, 48/
200, 48/500). To assess if HepaRG cells are capable of producing PCT,
lipopolysaccharide stimulated cells were used as positive controls (24/LPS
and 48/LPS). PCT was measured using the BRAHMS PCT LIA-Test (Thermo
Fisher Scientific, Waltham, USA). Lactate dehydrogenase (LDH), gamma-
lactate dehydrogenase (GLDH), aspartate aminotransferase (AST), and ala-
nine aminotransferase (ALT) were measured as markers of hepatocellular
injury. All analyses were carried out in duplicate.
Results: At both time points, no increase in PCT (median: 0.088 ng/
ml, 25 %/75 % percentile: 0.0815 ng/ml / 0.097 ng/ml, P = > 0.05)
was found when compared to control (0.082 ng/ml). LDH concentra-
tions (with control as 100 %) were 24/20: 106 %, 24/200: 98 %, 24/
500: 51 %, and 48/20: 98 %, 48/200: 98 %, 48/500: 51 %. GLDH was
24/20: 98 %, 24/200: 119 %, 24/500: 143 %, and 48/20: 98 %, 48/200:
98 %, 48/500: 51 %. AST was 24/20: 100 %, 24/200: 152 %, 24/500:
193 %, and 48/20: 104 %, 48/200: 144 %, 48/500: 185 %. ALT was 24/
20: 95 %, 24/200: 111 %, 24/500: 157 %, and 48/20: 90 %, 48/200:
131 %, 48/500: 95 %. LPS administration did not result in a statisti-
cally significant increase either in PCT or the assessed liver markers
when compared to control.
Conclusions: APAP and LPS administration did not result in a signifi-
cant increase in PCT in this in vitro model of APAP toxicity. APAP
concentrations might have been too low to induce enough cell ne-
crosis and consecutive inflammation, although our experiments were
based on APAP concentrations that are clinically relevant and found
in APAP overdose patients.
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Introduction: Recently, it has been proposed "LiFe" score as a quick,
easy and useful tool for evaluating patients with severe liver disease
admitted at ICU area.
Objectives: To assess the validity and usefulness of the score "LiFe"
in patients with liver disease requiring admission in Intensive Care
Medicine of our environment.
Methods: Retrospective analysis of patients with liver disease admit-
ted from May 2013 to October 2015. The following variables were
analyzed: origin of liver disease, cause of decompensation, SOFA,
APACHE II, SAPS II, MELD, lactate, bilirubin, INR (calculating "LiFe"
score), mortality and mortality at 30 days.
Results: 113 patients, 73.5 % men and 26.5 % women, mean age
57.42 ± 10.21 (34–85) were included. The severity scores: APACHE II
21.18 ± 9.38 (5–50), SAPS 51.55 ± 19.7 (10–116), 10.28 ± 6.8 SOFA (1–
24), MELD at admision18.82 ± 9.63 (6–47). The mean values of lactic
acid, bilirubin and INR: lactate 3.88, bilirubin 4,90, INR 1.82. The score
"LiFe" of the sample is 2.75 ± 2.62 (0–10), stratifying at: 20.4 % low
risk, 45.1 % intermediate risk, 24.8 % high risk and 3.5 % very high
risk . The mortality of patients in ICU: alive (71.7 %), dead (28.3 %); at
30 days: alive (56.6 %), dead (43.4 %).
Applying a Chi square test the score "LiFe" is significant in order to
assess the mortality of patients both in ICU and at 30 days (p < 0.002
and p < 0.003 respectively).
The Pearson correlation coefficient between the different scores
and the score "LiFe" is: APACHE II 0.51, SAPS II 0.41, SOFA 0.52
and MELD 0.74.
Conclusions: The score "LiFe" is a quick and useful tool in our envir-
onment for assessing the prognosis of patients with liver disease ad-
mitted to ICU. The score "LiFe" is correlated with MELD values.
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Introduction: Hypoxic hepatitis (HH) is a frequent found condition in
critically ill patients and is associated with a high morbidity and mortal-
ity. Up to 10 % of critically ill patients suffer from HH during their stay
at the ICU. Literature of HH after cardiac arrest is scarce and only avail-
able in out-of-hospital cardiac arrest (CA). To date no study evaluated
the incidence and outcome of HH in patients after in-hospital CA.
Objectives: Aim of the study was to determine incidence and out-
come of HH in patients after in-hospital CA.
Methods: Assessment of incidence of HH in a cohort of 270 consecu-
tive patients with in-hospital CA and successful CPR that were
treated at the Medical University Vienna. Patient characteristics, ad-
mission diagnosis, severity of disease, course of the disease and 28d
mortality were assessed.
Results: Overall, 51 patients representing 19 % of the total cohort
(33 male, age 67 (54,5 - 76,5) years) developed HH after CA with suc-
cessful CPR. CA was witnessed in 48 (94 %) cases. Initial rhythm was
shockable (VT/VF) in 16 (31 %), non-shockable (PEA/Asystole) in 35
(69 %). Time to ROSC was 8,5 (2–18,5) minutes. Cardiac events lead-
ing to CA were observed in 34 (67 %) of patients. SOFA-Score on ad-
mission was 11 (8–13,5), SAPS II was 88 (78,5 - 97). Mild therapeutic
hypothermia was applied in 24 (47 %) patients. In 6 (12 %) of pa-
tients with HH was a cardiac re-arrest observed. 28d-survival was
37 % in patients who developed HH compared to 63 % in patients
without HH (p < 0,05). 19 patients, who developed HH, survived
longer than one month, of these 16 (84 %) had good neurological
outcome (CPC I/II).
Conclusions: New onset of HH is a frequent finding in patients fol-
lowing successful CPR in-hospital and is associated with worse
outcome.
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Introduction: Accumulation of serum bile acids (BAs) plays a central
role in hepatic damage and disturbed BA signalling in liver disease.
However, there is lack of data regarding the impact of serum BAs on
clinical complications, acute decompensation (AD) and acute-on-
chronic liver failure (ACLF).
Objectives: Aim of this study was to evaluate the impact of circulat-
ing serum BAs on clinical complications in patients with liver
cirrhosis.
Methods: 143 patients with liver cirrhosis were included in this pro-
spective observational study. Total serum BAs and individual BA com-
position were assessed in all patients on admission. BAs were
analyzed via high performance liquid chromatography. Clinical com-
plications such as AD, ACLF and transplant-free survival were
recorded.
Results: Circulating total and individual BAs were significantly higher
in patients with bacterial infection, AD and ACLF (p < 0.001). BAs fur-
thermore correlated significantly with model of endstage liver dis-
ease (MELD) and hepatic venous pressure gradient (p < 0.001). Total
serum BAs were identified as independent predictor of decompensa-
tion on admission (independently of sex, age and severity of liver dis-
ease assessed via MELD score) (OR 1.017, 95%CI: 1.01-1.025, p <
0.001) and furthermore predicted new onset of decompensation/
ACLF during follow-up (OR1.025, 95%CI:1.012-1.038, p < 0.001).
Best cut-off predicting new onset of AD/ACLF and survival during
course of time was total BAs ≥36.9 μmol/l.
Conclusions: Circulating total and individual BAs are associated with
AD and ACLF in patients with liver cirrhosis. Measurement of serum
BAs could represent an additional marker for risk stratification in
cirrhotic patients with respect to new onset of decompensation
and ACLF.
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Introduction: Since 2011 there is the option of kidney-after-liver
transplantation (KALT) for patients with renal insufficiency via receiv-
ing extra points in the kidney allocation system during a period of 90
to 360 days after liver-only transplantation (LT).
Methods: In this retrospective analysis we included patients listed for
LT with KALT bonus at the University Medical Centre Hamburg-
Eppendorf, during a period of 05/2011 - 05/2015.
Results: 78 patients (female: 38 %, age: median 59 yrs, IQR 51–65)
were included in the study. Median length of stay at intensive care
unit was 16 days (IQR 7–37).
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28 patients (36 %) needed renal replacement therapy (RRT) pre-LT.
Median serum creatinin of those without need for RRT was 2,5 mg/dl
(IQR 1,3-3,8 mg/dl). Post-LT 46 patients (59 %) required RRT. Only 7
patients (9 %) remained with terminal dialysis-dependent kidney in-
sufficiency - 4 due to hepatorenal syndrome, 3 due to preexisting
chronic renal insufficiency of other causes.
2 patients (3 %) received a kidney transplant (KT) during the prede-
termined period of KALT bonus of 360 days. Another 5 patients
remained with need for RRT after expiry of the KALT option. One of
them underwent RT in the Eurotransplant-senior-program. 4 (57 %)
of these 7 patients had already been on RRT pre-LT.
Overall mortality rate of those without necessity of RRT pre-LT was
36 %, and 39 % in those with requirement of RRT pre-LT.
In total 29 (37 %) of 78 patients died during follow-up. 38 % of these
patients required RRT pre-LT, whereas 80 % needed RRT post-LT.
Conclusions: 9 % (7/78) of patients undergoing LT with an option for
KALT remained long-lasting with need for RRT. Only 3 % (2/78) received
a kidney graft during the predetermined period of KALT option,
whereas 5 (6 %) patients remained with necessity for RRT and subse-
quent need for KT. In these 6 % of LT-patients KALT allocation system
was not effective with respect to prioritize patients for early KT.
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Introduction: A new sorbent (Cytosorb, Cytosorbents), able to adsorb
hydrophobic molecules, could be a valid artificial support in many
conditions of organ failure through the reduction of cytokines and
other toxic molecules directly from blood. At present, extracorporeal
systems for this purpose are based instead on plasma-adsorption.
Objectives: We designed an in vitro and in vivo study. The in vitro
study evaluated the system's adsorption capacity of bilirubin and the
ability to remove protein-bound solutes, while the in vivo study veri-
fied the congruence between in vitro and in vivo results and clinical
outcomes.
Methods: The in vitro study included 3 tests. Two tests were carried
out with equimolar solution of Albumin(Alb)-Bilirubin(Bil), containing
unconjugated Bil, strongly Alb-bound[1], to verify removal of protein-
bound solutes.Test 3, 24 h long, was performed with higher concen-
tration of Bil and lower of Alb, to study the kinetics of adsorption.
The in vivo study is currently enrolling patients with severe hep-
atic dysfunction with hyperbilirubinemia. Primary outcome is to
evaluate in vivo Bil removal, whereas secondary outcomes are
the hemodynamic stabilization, the reduction of inotropes, ithe
mprovement of hepatic function and inflammatory status.
Results: The in vitro experiments showed the adsorption capacity of
the system concerning Bil, also Alb-bound (Table 67), with a minimal
Alb loss. We could not demonstrate any release of the adsorbed Bil.
For the in vivo study, we enrolled until today, 3 patients (Table 68).
Bil Mass Balance (MB) in vivo was higher than in vitro and showed
the system's capacity of Bil removal, whereas removal rate (RR) is not
significant for that purpose, being affected by many factors, first at
all Bil production. In patient 3, Cytosorb was continuously used for
4 days and it would seemed to favour reduction of inflammation,
help the recovery of hepatic function, and the hemodynamic
stabilization, with inotropic support interrupted already after 2nd
treatment.
Conclusions: The in vitro study shows the effectiveness in removing
Bil, also Alb-bound, for 24 h, without significant Alb loss. In vivo,
Cytosorb is able to remove Bil in combination with cytokine removal,
as reported in literature. Clinical effects suggest to be linked to the
precocity of treatment and the adequate dose. Its use might help in
restoring organs function. Cytosorb might represent a simple aid in
organ dysfunctions, that may work alone or in combination with
CRRT. Other experiences are ongoing to confirm these data.
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Introduction: Due to the severity of cirrhotic patient, ICU admission
remains a problem in terms of results.
Objectives: To analyze the clinical characteristics, complications and
hospital and a year evolution of patients admitted with a diagnosis
of cirrhosis in an Intensive Care Unit.
Methods: Retrospective observational study on a prospective database
of 10 years duration. All patients admitted consecutively with primary
or secondary diagnosis of cirrhosis. Sociodemographic, clinical and de-
velopmental variables are analyzed. The variables are expressed as
means ± standard deviation, and absolute and relative frequencies.
Comparisons between variables using the Student t test and Pearson
Chi2. Multivariate analysis using logistic regression. Analysis of survival
by Kaplan Meier curves and compared with the log rank test.
Results: 229 patients were analyzed, mean age 58.6 ± 13.1 years, and
78.6 % males. The most common etiologies were alcoholic in 149 pa-
tients (65.1 %) and hepatitis C virus in 36 patients (15.7 %). The most
common reason for admission was upper gastrointestinal bleeding in
33.6 % followed by acute respiratory failure in 22.3 %. The most com-
mon cause of respiratory infection was 51 cases (22.3 %) and the most
common cause of bleeding was esophageal varices in 65 cases
(28.4 %). Do not intubation order was established in 33 cases (14.4 %).
The SAPS II 49 ± 21 at admission, and the MELD index 21 ± 37.1 % pre-
sented 9. Child-Pugh C. The SOFA rate and maximum income was 7 ± 4
and 11 ± 4, respectively. Hospital and year mortality was 47.6 % and
60.7 % respectively. 137 patients required mechanical ventilation
(59.8 %). By multivariate analysis, predictors of hospital mortality were
SAPS II (OR = 1.065; 95 % CI = 1.039 to 1.091; p < 0.001), MELD (OR =
1.083; 95 % CI = 1.032 to 1.137; p = 0.001) and maximum SOFA (OR =
1.287; 95 % CI = 1.143 to 1.448; p < 0.001). After one year of admission,
the Child-Pugh classification was clearly related to survival (p < 0.001).
Table 67 (abstract A691). In vitro data
1st 2nd 3rd
Bil. (mM) 0,4 0,8 0,8
Alb. (mM) 0,4 0,8 0,4
MB Bil. (g) 0,94 1,02 2,49
Table 68 (abstract A691). In vivo data
Tot. h
treatment
Bil. Conc t0
(mg/dl)
MB Bil.
(g)
RR
%
Other
1/Cirrhosis post-
transplantation
28 45,1 2,25 36 Gram -
Sepsis
2/Cirrhosis post-
transplantation
24 36,7 6,00 0 Gram -
Sepsis
3/Hyperbilirubinemia
post-transplantation
96 53,06 20,88 64.1 Gram -
Sepsis
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Conclusions: Cirrhotic patient admitted to ICU has a high mortal-
ity. The severity of the patient´s disease and the development
of multiple organ failure are the main determinants of hospital
evolution.
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Introduction: Evaluation of grafty function after liver trasplant (OLT) is a
dificult task because diferent parameters must be taken into acount. De-
termination of clearance of indocyanine green (ICG) has been proposed
as a good method to measure liver function in diferent scenarios.
Objective: To evaluate the capability of ICG elimination as a
marker of development of graft dysfunction, kidney dysfunction
or mortality.
Material: Protective observational study. Series of cases. In our pa-
tients we measured PDR and R-15 after a dose of 0,5 mgr/Kg IV
of ICG by means of the Limon monitor (Pulsion®) the first day
after OLT.
We looked the relationship with AKIN-III, graft dysfunction
(modified Toronto criteria) and in-hospital mortality. Analysis was
performed by chi-square, Student t-test and area under curve
(AuC).
Results: 39 patients, age 55.7 ± 11.3 years, 66,7%men. Mean hospital
stay was 18.8 ± 16 days. APACHE II at admission 13.8 ± 3.6, SOFA 7.1 ±
3.4, lactate 1.8 ± 1.2 mm/L and PDR 19.5 ± 14.5 %.
In 15.4%patients a mild dysfunction was detected, without associ-
ated mortality and 20.5 % developed severe dysfunction with a
mortality of 37.55. In 15,4 % patients AKIN-3 was detected with a
mortality of 7.7 %.
None of the variables analyzed showed a good relationship with se-
vere liver dysfunction [SOFA AuC 0.69(IC 0.52-0.86, ns) and ICG
0.58(0.40-0.76, ns)]. For AKIN-3, SOFA predicted its development with
an AuC 0.92(0.83-1, p 0,001) vs PDR 0.65(0.48-0.82, ns). Regarding
mortality, SOFA AuC was 0.92(0.79-1, p 0.01), lactate 0.85(0.70-0.88,
p0.048) but ICG only 0.64(0.39-0.88, ns).
Conclusions: In our series, SOFA at admission and lactate levels
seem the best predictors for outcome, clearly surpassing ICG
clearance.
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Introduction: Plasmatic ionised calcium is vital for organic function
and homeostasis of the human body.
Plasmatic ionised calcium concentration (PICC) is afected by multiple
clinical conditions such as endocrinopathies, organ disfunction, pH
and albumin concentration.
In the critically ill patient adequate PICC is even more important in
the presence of neuro-muscular or cardio-vascular disfunction, coag-
ulopathy, bleeding and massive transfusion.
In adult critically ill patients calcium supplementation has been re-
ported to improve 28-day survival [1]. Conversely, it has been shown
that in septic patients calcium administration increases inflamatory
signaling, multiorgan dysfunction and mortality [2].
The critical post liver transplant patient admitted in ICU can present
with these conditions leading to altered PICC.
Objectives: We analysed PICC of liver transplant patients and its as-
sociation with ICU outcomes.
Methods: Retrospective single-center study in liver transplant pa-
tients admitted in ICU at a reference liver transplant center.
PICC was analysed at admission and its trend in percentual diference
from baseline (deltaPICC) reflected the initial 12 hours evolution
period. Univariable analysis was performed to explore association
with ICU lenght of stay (ILOS) and UCI vital outcome.
Results: 140 cases were included in this study.
In the ICU survivor group (n = 166) the mean PICC was 1.11 mmol/L
(SD 0.12) and deltaPICC −3.04 % (SD 15.2 %). While in non-survivor
the mean PICC (n = 9) was 1.17 mmol/L (SD 0.09) and deltaPICC (n =
7) was −16.1 % (SD 10.1 %). The diference between survivor and
non-survivor was non significative for PICC (p = 0.15; IC95% 0.021-
0.14) and significative for deltaPICC (p = 0.03; IC95% -24.5; −1.49).
In the 3 or less days ILOS group (n = 60) the mean PICC was
1.10 mmol/L (SD 0.09); in the 4 or more days ILOS group (n = 67) the
PICC was 1.15 mmol/L (SD 0.15). There was a significant PICC differ-
ence between ILOS groups (p = 0.03; IC95% 0.003-0.09). Differences
between deltaPICC between 3 or less days ILOS group (mean −1.15 %,
SD 14.4 %) and 4 or more days ILOS (mean −1.16 %, SD 10.0 %) were
not significative (p = 0.99; 0.-4.31; 4.33).
Conclusions: Univariable analysis in liver transplant post-surgical pa-
tients revealed longer ILOS significantly associated with higher PICC
at ICU admission and a negative deltaPICC significantly associated
with higher ICU mortality.
Multivariate analysis will assess the independent value of calcemia as
a risk factor in this ICU population.
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Introduction: Liver transplant (OLT) is the only definitive therapy for
patients with cirrhosis and also for those patients on acute liver fail-
ure that do not regain liver function. It is a highly demanding pro-
cedure that carries a high number of complications, but outcome is
regarded nowadays as excellent. We analyzed prospectively ten years
ago the complications in our patients and wanted to evaluate if man-
agement and results have changes in this ten years.
Objective: To define the profile of early complications after OLT and
its related variables and to compare them with our population from
ten years ago.
Material y methods: Observational prospective cohorts recruiting
all patients admitted to our unit after OLT during 2013–2015
(13–15) and retrospective comparison to a prospective cohort re-
cruited from 2003–2005 (03–05). The transplantation team has
not changed but a revision of the protocol had done during this
interval (restriction in transfusion and volume infusion, immuno-
suppression based on CysA and TAC and use of basiliximab for
patients with high risk for AKI). Definition of complications was
the same but for AKI that was recalculated in the group 03–05
according to AKIN criteria. Fir the analysis we performed chi-
square y Student t-test.
Results: Group 13–15, 180 patients; group 03–05, 131 patients. Equal
gender, age and SOFA at admission but higher Child-C (28.9 % vs
13 %, p 0.004), higher percentage of arterial hypertension (32 vs 9.2,
P 0,001) and previous renal disease (14.4 vs 6.1, p 0.032) for 13–15.
Transfusion during surgery was significantly lower for 13–15 as well
as volume infused (11.34 L vs 5.9 L for the first three postoperative
days, p 0.054).
We detected less reperfusion syndrome (19.4 vs 8.9 %, p 0.01) and
coagulopathy (23.4 vs 9.4 %, p 0.001) during surgery for 13–15, an
also a lower percentage of hypothermia (61.8 vs 17.2, p 0.0001), pul-
monary edema (4.6 vs 0.6, p 0.04) or ARDS (8.4 vs 2.2, p 0.015) during
the early postoperative course. Contrariwise, hyperglycemia was de-
tected more frequently (78.5 vs 91.1 %, p 0.03).
No changes were detected in AKI, need for RRT, encephalopathy,
hemorrhages, infections or primary graph dysfunction. Mortality was
11.5 % for 03–05 vs 6 % for 13–15 (p ns).
Conclusion Patients that opt for an OLT are sicker than before but
this fact does not suppose a higher morbidity and we even detect a
trend toward lower mortality. Changes in their management has sup-
posed a lessening of intraoperative and respiratory complications.
Sepsis biomarkers
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Introduction: The glucocorticoid receptor (GR) is ubiquitously
expressed on nearly all cell types, but tissue-specific deletion of this
receptor can produce dramatic whole organism phenotypes. Recent
data provide evidence that GR expression is progressively decreased
in experimental sepsis and that dexamethasone has a decreased abil-
ity to translocate into the cell nucleus1.
Objectives: To evaluate the protein expression of the GR in periph-
eral blood monocytes (m) and neutrophils (n) and the GR isoform a
(GRa) mRNA in whole blood in Intensive Care Unit (ICU) patients with
early-onset severe sepsis (SS) or systemic inflammatory response syn-
drome (SIRS) compared to healthy control subjects (H). To relate their
expression with serum levels of prolactin, cortisol and interleukins,
plasma levels of ACTH, and to the expression of intracellular heat
shock proteins 72 (HSP72) and HSP90α.
Methods: Consecutively admitted patients with early (first 48 hours)
SS (n = 48) or SIRS (n = 40) were admitted to a University Hospital ICU
and enrolled in the study. 35 H were included. Total RNA was iso-
lated from peripheral blood samples and cDNA was prepared. RT-
PCR was performed using Light Cycler 480 Probes Master kit,
employing primers and Taqman probes specifically designed for
NR3C1 (GRα) and RPLP0 (used as control gene), on Light Cycler 480
System (Roche). Monocytes and neutrophils protein expression was
evaluated by flow cytometry. Mean Fluorescence Intensity (MFI)
values for HSPs and GR were measured after staining surface anti-
gens CD33 and CD45 with CD33-PE/Cy5 and CD45-PE/Cy7 followed
by intracellular staining with HSP72-FITC, HSP90a-PE or GR-FITC using
4-colour flow cytometry. Prolactin and cortisol were measured using
the ADVIA centaur system, ACTH using Immulite 2000. ELISA was
used to evaluate interleukins.
Results: GR MFI was significantly higher in SS compared to SIRS and
H (p < 0.01) and was related to mHSP90α (p < 0.0001), nHSP90α (p <
0.0001), mHSP72 (p < 0.02), cortisol (p < 0.03), and IL-6 (p < 0.005).
ACTH, cortisol, prolactin, INFγ, IL-6, and IL-10 were also increased in
SS compared to SIRS and/or H. ACTH and expression levels of NR3C1
(GRα) were significantly higher in non-survivors compared to survivors
(p < 0.02) and were related to ACTH (p < 0.0001), INFγ (p < 0.002), and
IL-10 (p < 0.04).
Conclusions: Sepsis and mortality are associated with early-onset in-
creased GRa expression, which, apart from cortisol and ACTH, is also
related to HSP90α, HSP72 expression, as well as to cytokines.
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Introduction: Microparticles (MPs) are cell membrane-derived parti-
cles promoting coagulation, inflammation and cell-to-cell communi-
cation. MPs have been assessed as possible biomarkers of septic
vascular dysfunction and sepsis-induced AKI [1]. However, the role of
MPs in the crosstalk between coagulopathy and inflammation in sep-
tic patients is still unclear.
Objectives: The aim of this case–control study was to clarify the
possible role of MPs as biomarkers in Septic Shock (SS) measur-
ing Annexin V+ and endothelial-derived MPs in consecutive
patients.
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Methods: 21 patients (43 % M, 57 % F, 66 y) admitted to our ICU
with a diagnosis of SS were enrolled. Exclusion criteria were: end-
stage heart failure and liver disease, severe active cancer, age <
18 years, pre-existent hematological disorders, ongoing anticoagula-
tion and antiplatelet therapy.
21 healthy volunteers, age and sex matched, were recruited to estab-
lish references values for MPs.
Circulating MPs levels were measured at baseline (day 0) and
24 hours later (day 1) by size and Annexin V- FITC labelling, using
flow-cytometer. Endothelial MP were identified using CD62E-PE
monoclonal antibody [2]. The SOFA-score was determined over the
first 24 hours and 28-day mortality was recorded. Data were
expressed as medians, IQR or percentages. Correlations were
assessed using Spearmann ρ. T-test was used for comparison be-
tween groups.
Results: In critically ill patients V+ Annexin and E selectin+ MPs were
significantly higher than controls [4367 (IQR 2546–7419) vs 1728 (IQR
782.5-2122) MPs/ul at day 0; 367 (IQR 271–450) vs 97 (IQR 81–127.5)
MPs/ul at day 1, p < 0.01]. Spearmann's correlation between SOFA-
scores (11, IQR 8–14) and MPs revealed a moderate coefficient only
with E selectin+ MPs (r = 0.43, p < 0.038). No differences were noticed
based on outcome. Furthermore, 11 patients had a diagnosis of
sepsis-induced-AKI [18 % with stage 1–2 and 82 % with stage 2–
3,[1]) and once again their E selectin+ MPs were higher than non-AKI
septic patinets [442 (IQR 409–604) vs 275 (IQR 274–352) MPs/ul, p <
0.03] at day 0.
Conclusion Our preliminary data showed that endothelial MPs and V
Annexin+ MPs could be useful biomarkers of vascular damage. E
selectin+ MPs were strongly correlated to disease severity and renal
failure. Sepsis-induced AKI probably occurs in the setting of a more
severe microvascular dysfuction. Our results confirmed an important
endothelial alteration, probably due to an abnormal release of E
selectin+ MPs, during sepsis-induced AKI. In conclusion, MPs may be
important therapeutic targets to prevent or treat SS.
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Introduction: Sepsis is “a life-threatening organ dysfunction caused
by a dysregulated host response to infection.” Septic shock is “a sub-
set of sepsis in which underlying circulatory and cellular/metabolic
abnormalities are profound enough to substantially increase mortal-
ity.” (1) Lactate is a marker of organ hypoperfusion, thus organ dys-
function, and has been shown to be predictive of mortality (2, 3) and
is a part of the new Sepsis-3 definition of septic shock.
Objectives: To examine the role of initial lactate level in the manage-
ment of sepsis in the emergency department (ED).
Methods
Study design: A multi-centre retrospective cohort study
Patient population: All inpatients with sepsis, severe sepsis, or septic
shock with initial lactate level drawn in the ED from July 2011 to July
2015.
Study centres: ED of three community acute care centres in the Ni-
agara Region, Ontario, Canada.
Data collection: A dedicated Regional Sepsis Coordinator collected
data on demographics, comorbidities, clinical symptoms, investiga-
tions and managements. Institutional research ethics board approval
was obtained.
Results: A total of 2082 patients were included in the study. The me-
dian age was 72 years (interquartile range, 60–81), and the mean ini-
tial lactate level was 3.48 ± 2.63 mmol/L. Door-to-antibiotics time
decreased from 194 ± 156 min in the normal lactate group to 138 ±
135 min in the high lactate group (p < 0.05). Total fluid administra-
tion in first 6 hours increased from 1.9 ± 1.3 L in the normal lactate
group to 3.2 ± 1.9 L in the high lactate group (p < 0.05). Central line
insertion rates increased from 8.8 % in normal lactate group to
47.8 % in the high lactate group (p < 0.05). Intensive Care Unit (ICU)
admission rate increased from 25.4 % in normal lactate group to
54.5 % in high lactate group (p < 0.05). Unadjusted in-hospital mor-
tality for normal, low, intermediate and high lactate group was
13.9 %, 21.7 %, 32.9 % and 57.2 %, respectively.
Conclusions: Higher initial lactate level correlates with more inten-
sive ED management of sepsis including earlier antibiotics adminis-
tration, more fluid resuscitation, increase chance of central line
insertion and ICU admission. It also correlates with higher unadjusted
in-hospital mortality rate.
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Table 69 (abstract A698). Summary of results
Lactate (mmol/L) Normal
(0–2.49)
Low
(2.5-
3.99)
Intermediate
(4–5.99)
High
(≥6)
Number of patients (total
N=2082)
960
(46.1%)
508
(24.4%)
322 (15.5%) 292
(14.0%)
Time to antibiotics administration,
mean in min ± SD
192 ±
157
158 ±
129
144 ± 124 138 ±
137
Amount of fluids given in first 6
hrs, mean in mL ± SD
1934 ±
1264
2304 ±
1306
2786 ± 1547 3209 ±
1939
Number of subsequent lactates
drawn, mean ± SD
1.13 ±
2.38
2.45 ±
3.34
3.39 ± 3.84 3.98 ±
4.83
Mean time to repeat lactate,
mean in min ± SD
586 ±
1482
844 ±
2555
605 ± 951 560 ±
1464
Central line insertion rates 8.8% 16.3% 25.8% 47.8%
ICU admission rates 25.4% 35.2% 47.2% 54.5%
Unadjusted in-hospital mortality 13.9% 21.7% 32.9% 57.2%
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Introduction: Sepsis is a usual condition handled in the emergency de-
partment (ED) and, despite advances in antibiotic therapy and cardio-
vascular and respiratory support, represent a major cause of morbidity
and mortality. Presepsin is an emergent early biomarker for sepsis.
Objective: To evaluate its diagnostic accuracy, compared to other
traditional biomarkers, such as procalcitonin and C-reactive protein,
in a population presenting to emergency department (ED) with sus-
pected sepsis.
Methods: Study population: 223 patients (median age: 69 years
[(Interquartile range (IQR: 31)]; 131 (58.7 %) male) with suspicion of
sepsis, according to 2001 SCCM/ESICM/ACCP/ATS/SIS International
Sepsis Definitions Conference criteria presenting at the ED were re-
cruited. Definitive diagnosis was made according to the Third Inter-
national Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
Laboratory methods: Blood samples were collected at first medical
evaluation and analyzed for sepsis biomarkers. Presepsin concentra-
tions were measured by a chemiluminescent enzyme immunoassay
on an automated immunoassay analyser (PATHFAST).
Statistical analysis: Receiver operating characteristic (ROC) curves and
areas under the curves (AUCs) were calculated to evaluate the diag-
nostic performance of each biomarker and optimal cutoff values
were derived from ROC curves. Values p < 0.05 were considered sta-
tistically significant. Statistical analysis was done using SPSS v. 20.0
and and MedCalc statistical software v.14.8.1.
Results: Sepsis was diagnosed in 70 (31.4 %) patients. According to
the sepsis severity, septic patients were classified as sepsis [n = 57]
and septic shock [n = 13]. C-reactive protein, procalcitonin and pre-
sepsin levels were higher in septic patients than in patients without
sepsis [17.0 (21.3) mg/dL vs. 13.0 (14.1) mg/dL, p = 0.005; 4.05 (16.42)
ng/mL vs. 0.29 (0.85) ng/mL, p < 0.001; 1115 (1723) pg/mL vs. 542
(374) pg/mL, p < 0.001, respectively]. The AUC ROC curves of procalci-
tonin (0.84 [CI95%: 0.78-0.89]) and presepsin (0.79 [CI95%: 0.73-0.84])
were similar and significantly greater than that of C-reactive protein
(0.830 [95 % CI 0.55-0.68]). The corresponding procalcitonin and pre-
sepsin thresholds were 1.56 ng/mL (sensitivity 67 % and specificity
86 %) and 849 pg/mL (sensitivity 67 % and specificity 83 %).
Conclusion Presepsin was a valuable biomarker for diagnosis of sep-
sis in an ED, with a similar diagnostic accuracy than procalcitonin.
Further research is needed to clarify the role of biomarkers after than
sepsis definition has been updated.
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Introduction: Ventilator-associated tracheobronchitis (VAT) has been
suggested as an intermediate process between tracheobronchial
colonization and ventilator-associated pneumonia (VAP) in patients
receiving mechanical ventilation.
Objectives: The aim of this study was to evaluate the ability of C-
reactive protein (CRP) and procalcitonin (PCT) to differentiate be-
tween VAT and VAP on the day of infection diagnosis.
Methods: Post-hoc analysis of the large prospective multinational
TAVeM database, coming from 114 ICUs in Europe and Latin America
(1). All consecutive patients receiving mechanical ventilation for
>48 h were included in the TAVeM database. We compared VAT and
VAP at the day of infection diagnosis. Only first episodes of VAT and
VAP were taken into account.
Results: Four hundred and four patients (mean age 60 years, 238
men, ICU mortality 35 %) were studied, 207 with VAT and 197 with
VAP. On the day of infection diagnosis, the median CRP was elevated
in both groups but significantly higher in VAP (14 mg/dl and 18 mg/
dl, p = .001). PCT was also significantly higher in VAP (0.64 ng/dl and
2.1 ng/dl, p < .001). However, roughly 25 % VAT patients and 16 % of
VAP patients had PCT values < 0.25 ng/dl, while 14 % VAT patients
and 7 % of VAP patients had CRP values < 4.0 mg/dl. Dividing the pa-
tients in sepsis, severe sepsis and septic shock, the levels of PCT were
significantly different between the three groups (p = 0.008) and that
was not the case for CRP (p = 0.097).
Conclusions: Both CRP and PCT in patients with suspected ventilator
associated lower respiratory tract infection were higher in VAP than
VAT. PCT presented a higher false negative rate. The level of PCT
showed a good correlation with clinical severity.
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Introduction: Hyperlactatemia is known to predict mortality in pa-
tients with sepsis and septic shock. Elevated blood lactate concentra-
tions are conventionally viewed as a surrogate of hypoperfusion and
tissue hypoxia. Despite its limitations hyperlactatemia is an inde-
pendent predictor of mortality and thus it was included in the most
recent septic shock definition. However, both the evolution and the
time to normalization of lactate in representative cohorts of septic
patients receiving vasopressors are largely unknown.
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Objectives: Our aim was to investigate the evolution of blood lactate
level over time and its relationship to 90-day mortality in critically ill
septic patients with hypotension and in patients with septic shock
according to the recently revised definition.
Methods: We performed a post-hoc analysis from the prospective,
observational, multicenter FINNAKI study. We analyzed 513 septic pa-
tients with hypotension, lactate recordings within 4 hours of ICU ad-
mission and repeat recordings of lactate during the ICU. 265 patients
fulfilled the new definition for septic shock. The primary outcome
was the association of time-weighted mean lactate during ICU stay
with 90-day mortality.
Results: The 90-day mortality for all patients was 33.3 %. In patients
with admission lactate of > 2 mmol/L the 90-day mortality was higher
than in those with an admission lactate of ≤ 2 mmol/L (43.4 % vs
22.5 %, respectively p < 0.001). Patients with persistent lactatemia
(>2 mmol/L) at 72 hours had higher 90-day mortality compared
those with a lactate value of ≤ 2.0 mmol/L (52.0 % vs. 24.3 %, respect-
ively, p < 0.001). Time-weighted mean lactate values were signifi-
cantly higher in 90-day non-survivors than in survivors, 2.05 (1.38-
4.22) mmol/L vs. 1.29 (0.98-1.77) mmol/L, p < 0.001. The median time
to normalization of lactate was similar for 90-day survivors and non-
survivors (15.0 (5.0-35.0) vs 17.0 (3.5-43.5) hours, p = 0.67). In separate
backwards logistic regression analyses time-weighted mean lactate,
the lactate value at 72 hours, and a lactate value over 2 mmol/L at
72 hours (dichotomous variable) were independently associated with
90-day mortality, but admission lactate or time to normalization of
lactate were not.
Conclusions: In septic patients with hypotension, and in those who
additionally had hyperlactatemia, time-weighted mean lactate, lac-
tate values at 72 hours, and persisting hyperlactatemia at 72 hours
were independently associated with 90-day mortality, but time to
normalization of lactatemia and admission lactate were not.
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Introduction: Adrenomedullin and endothelin-1 are hormones with
opposing effects on the cardiovascular system. Adrenomedullin acts
as a vasodilator and seems to be important for the initiation and
continuation of the hyperdynamic circulatory response in sepsis.
Endothelin-1 is a vasoconstrictor and has been linked to decreased
cardiac performance. Few studies have studied the relationship be-
tween adrenomedullin and endothelin-1 and morbidity and mortality
in septic shock patients. High-sensitivity troponin T (hsTNT) is nor-
mally used to diagnose acute cardiac injury but is also prognostic for
outcome in intensive care.
Objectives: We investigated the relationship between mid-regional
pro-adrenomedullin (MR-proADM), c-terminal pro-endothelin-1
(CT-proET-1) and myocardial injury, measured using transthoracic
echocardiography and hsTNT in septic shock patients. We were
also interested in the development of different biomarkers
throughout the ICU stay, and how early measurements were re-
lated to mortality. Further, we assessed if a positive biomarker
panel, consisting of MR-proADM, CT-proET-1 and hsTNT changed
the odds for mortality.
Methods: A cohort of 53 consecutive patients with septic shock had
their levels of MR-proADM, CT-proET-1, hsTNT and left ventricular sys-
tolic functions prospectively measured over 7 days. The relationship
between day 1 levels of MR-proADM/CT-proET-1 and myocardial in-
jury was studied. We also investigated the relationship between bio-
markers and early (7 day) as well as later (28 day) mortality.
Likelihood ratios, pre-and posttest odds for mortality were calculated.
Results: Levels of MR-proADM and CT-proET-1 were significantly
higher among patients with myocardial injury and were correlated
with left ventricular systolic dysfunction. MR-proADM and hsTNT
were significantly higher among 7 and 28 day non-survivors. CT-
proET-1 was also significantly higher among 28 but not 7 day non-
survivors. A positive biomarker panel consisting of the three bio-
markers increased the odds for mortality 13-20-fold.
Conclusions: MR-proADM and CT-proET-1 are associated with myo-
cardial injury. A biomarker panel combining MR-proADM, CT-proET-1
and hsTNT increases the odds ratio for death, and may improve cur-
rently available scoring systems in critical care.
Grant acknowledgement
Region Halland County Council
A703
Circulating levels of advanced glycation end products (AGES) are
associated with 28-day mortality in septic patients
E. Rodriguez-Ruiz1, R. Hernández Vaquero1, A. Lopez Lago1, J.L. Garcia
Allut1, A. Estany Gestal2, M.A. Garcia Gonzalez3
1Hospital Clínico Universitario, Intensive Care Unit, Santiago de
Compostela, Spain; 2Fundación Ramón Dominguez, Unidad de
Epidemiología e Investigación Clínica, Santiago de Compostela, Spain;
3Instituto de Investigaciones Sanitarias, Grupo de genética y Biología del
Desarrollo de las Enfermedades Renales, Santiago de Compostela, Spain
Correspondence: E. Rodriguez-Ruiz _ Hospital Clínico Universitario,
Intensive Care Unit, Santiago de Compostela, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A703
Introduction: Multiple biomarkers have been studied to assess sepsis
severity and prognosis. The pathological role of the advanced glyca-
tion end products (AGEs) has become increasingly evident in numer-
ous types of diseases. A large number of papers have shown that
circulating levels of AGEs are elevated under inflammatory and/or
diabetic conditions, and associated with cardiovascular disease. Also,
accumulation of AGEs in various tissues, progresses at a physiological
normal aging, and at an extremely accelerated rate under hyperglice-
mic, inflammatory, and/or oxidative stress conditions.
Objectives: Our aim was to study the dynamics of the plasma circu-
lating levels of AGEs, and of the accumulated AGEs in the skin in sep-
tic patients during the first 5 days of the septic process, and their
association with (i) APACHE II, (ii) SOFA on days 1 to 5, and (iii) mor-
tality at day 28.
Methods: We assessed 48 consecutive patients admitted to our ICU
with the diagnosis of sepsis. We determined for 5 consecutive days
plasma circulating AGEs and skin AGEs. Plasma AGEs were measured
by quantitative fluorescence spectroscopy analysis of plasma accord-
ing to the method of Munch et al. (1) in a multi-mode microplate
reader (Synergy 2, Biotek, Winooski, VT, USA), and results were
expressed as arbitrary units (AU). Skin autofluorescence was mea-
sured with the AGE Reader mu (DiagnOptics, Groningen, The
Netherlands) (2). We correlated these results with the APACHE II,
daily SOFA, and mortality at day 28.
Results: There were 43 survivors and 5 non-survivors. We did not find
association between plasma AGEs on days 1 to 5, and APACHE II or
SOFA on days 1 to 5; neither between skin autofluorescence on days
1 to 5, and APACHE II or SOFA on days 1 to 5.
When analyzing mortality at day 28, we found that on day 1, plasma
AGEs in non-survivors were significantly higher (37,4 ± 19,1) than in
survivors (24,3 ± 11,2) (p = 0.027); the receiver operating characteristic
analysis (AUC = 0.742, p = 0.079), determined a trend but not power
enough to predict 28-day mortality. On days 2 to 5, we did not find
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differences in plasma AGEs between non-survivors and survivors.
Skin autofluorescence on days 1 to 5, did not show association with
28-day mortality.
Conclusion: In our cohort of septic patients, increased plasma levels
of AGEs on day 1, are associated with 28-day mortality. Circulating
AGEs become an early biomarker in septic patients, and its prognos-
tic efficacy needs to be determined in a larger study.
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Introduction: The usefulness of lactate levels and ScvO2 is well
known in treating patients with sepsis. We have encountered dis-
crepancies between lactate levels and ScvO2, but the reason for this
discrepancy is unknown.
Objectives: Our hospital joined the transpulmonary thermodilution
(TPTD) study, which is a multicenter, prospective, randomized con-
trolled trial. Inclusion criteria were ICU patients with sepsis undergo-
ing mechanical ventilation. Various data were collected using TPTD
and compared with CVP for transfusion. Primary outcome was
ventilator-free days and secondary outcomes were ICU length of stay,
28-day mortality, and length of hospital stay. We used these study
data to determine factors associated with the discrepancy between
lactate clearance and ScvO2.
Methods: Based on TPTD study data, we subdivided patients into the
following four groups: ScvO2 ≥ 70 % and lactate level ≥ 4 mmol/L
(HH group), ScvO2 ≥ 70 % and lactate level < 4 mmol/L (HL group),
ScvO2 < 70 % and lactate level ≥ 4 mmol/L (LH group), and ScvO2 <
70 % and lactate level < 4 mmol/L (LL group). Evaluations included
the SOFA score, SAPS II score, lactate level, ScvO2, BNP, etc. We also
analyzed mortality at 28 days, duration of mechanical ventilation, use
of renal replacement therapy, duration of catecholamine use, and
ICU length of stay.
Results: In total, 57 patients were included: HH group (n = 11), HL
group (n = 24), LH group (n = 6), and LL group (n = 16). There were
no differences in patients' characteristics or change in lactate levels,
CVP, and ScvO2 from 24 h to 72 h. Mortality at 28 days was 3/6
(50 %) in the LH group, 3/11 (27.3 %) in the HH group, 3/16 (18.8 %)
in the LL group, and 3/24 (12.5 %) in the HL group (p < 0.001). On
multivariate analysis, the odds of 28-day mortality were 8.16 (95 %
CI: 0.2-275) in the LH group, 1.46 (95 % CI: 0.05-26.8) in the HH
group, and 1.34 (95 % CI: 0.17-11.1) in the LL group.
Conclusions: Mortality at 28 days was highest in the LH group and
lowest in the HL group. These data are not conflicted our experience
and past studies. Because 28-day mortality was higher in the HH
group than in the LL group, it is possible that lactate levels are more
predictive of mortality.
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Introduction: Sepsis is a leading cause of death in critically ill pa-
tients despite improvements in antimicrobial therapy and supportive
care. Early identification of patients at high risk of dying after inten-
sive care unit (ICU) admission may help determine therapeutic
interventions.
Objective: The aim of this study was to evaluate the predictive value
of N-terminal pro- brain natriuretic peptide (NT-proBNP) for in-
hospital mortality in a cohort of patients admitted to ICU with sepsis
ands and septic shock.
Methods: Patients: 47 patients [mean age: 64.3 years (SD:17.2); male:
25 (53.2 %)] with diagnosis of sepsis and septic shock, according to
the Third International Consensus Definitions for Sepsis and Septic
Shock (Sepsis-3), admitted to ICU between October 2013 and March
2014 were enrolled.
Measurements: Blood tests for C-reactive protein (CRP), procalcitonin
(PCT) and NT-proBNP analyses were drawn on the day of admission and
48 hours later. Patients' demographic data and severity scores (APACHE
II, SAPS and SOFA) were collected. In-hospital mortality was defined as
outcome. For measurement of NT-proBNP, a chemiluminescent inmu-
noassay (NT-proBNP Dimension Vista Siemens Heathcare) and an ECLIA
assay (NT-proBNP Cobas 8000 Roche Diagnostic) were used.
Statistical analysis: Receiver operating characteristic (ROC) curves and
areas under the curves (AUCs) were calculated to evaluate the prog-
nostic value for in-hospital mortality of NT-proBNP of each biomarker
and optimal cutoff value was derived from ROC curves. Value p <
0.05 was considered statistically significant. Statistical analysis was
done using SPSS v. 20.0 and and MedCalc statistical software
v.14.8.1.
Results: In-hospital mortality rate was 34 % (16 of 47). NT-proBNP
levels at admission were significantly higher in non-survivors (me-
dian: 22546 pg/mL [IQR: 29958]) compared with survivors (median:
2310 pg/mL [IQR: 9219]; p < 0.001), and the difference remained after
48 hrs (p = 0.001). The ROC of admission and 48-hours NT-proBNP
levels for in-hospital mortality resulted in AUC values of 0.88 (95 %
confidence interval (CI): 0.77-0.99; p < 0.001) and 0.82 (95 % CI: 0.66-
0.99; p < 0.001), respectively, with a similar performance than that of
SOFA (0.84 (95%CI: 0.7-0.95; p < 0.001), APACHE II (0.86 (95%CI: 0.76-
0.97; p < 0.001) and SAPS II (0.88; 95%CI:0.78-0.98; p < 0.001). There
were not differences among survivors and non-survivors for PCT and
CRP on admission and 48-hours PCT and CRP.
Conclusions: NT-proBNP values are frequently increased in sepsis
and septic shock. Values are significantly higher in non-survivors than
survivors. Although NT-proBNP on admission and at 48 hours
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showed a good performance for prognosis of in-hospital mortality,
with AUC ROC > 0.8 for both, they did not improve the value of se-
verity scores usually used in ICUs.
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Introduction: We previously investigated efficacy of a new ventila-
tory strategy - aimed at promoting mucus clearance and preventing
pulmonary aspiration - or the Trendelenburg position for the preven-
tion of ventilator-associated pneumonia (VAP) (1).
Objectives: We now appraise patterns of systemic inflammation to
identify blood inflammatory biomarkers that could detect VAP or
ventilator-associated tracheobronquitis (VAT). Also, we evaluated the
effects of the Trendelenburg position on systemic inflammation.
Methods: Twenty-one pigs were intubated and on mechanical venti-
lation (MV) for 72 hours. Following surgical preparation, pigs were
randomized to be positioned: 1) in semirecumbent/prone position,
ventilated with a duty cycle (TITTOT) of 0.33 and without PEEP (con-
trol); 2) as in the control group, PEEP of 5 cm H2O, and TITTOT to
achieve a mean expiratory-inspiratory flow bias of 10 L/min (treat-
ment); 3) in Trendelenburg/prone position and ventilated as in the
control group (Trendelenburg). Following randomization, P. aerugi-
nosa was instilled into the oropharynx. Prior to bacterial challenge,
and every 24 hours thereafter, blood was drawn for quantification of
serum interferon (INF)-Gamma; interleukin (IL)-1α; IL-1β; IL-1 receptor
antagonist (RA); IL-2; IL-4; IL-6; IL-8; IL-10; IL-12; IL-18, tumor necrosis
factor (TNF)-α, tissue factor; angiotensin-2; adrenomedullin and pro-
tein C reactive. VAP and VAT were clinically suspected and confirmed
by histological/microbiological studies.
Results: Overall, ten animals developed VAP (4 controls, 6 treatments
and 0 Trendelenburg), four animals VAT (1 control, 0 treatments, 3
Trendelenburg) and 6 did not develop any pulmonary infection (1
control, 1 treatment and 4 Trendelenburg). Median [IR] tracheal aspir-
ate quantitative culture of P.aeruginosa was 6 [1.2], 6.1 [6.3] and 6.5
[0.4] log10 cfu/mL (p = 0.018) and P.aeruginosa pulmonary burden
was 0 [1.6], 0 [0.9] and 2.2 [4.3] in animals without infection or that
developed VAT and VAP, respectively (p < 0.001). Study treatments
significantly changed INF-γ, IL-1Ra, IL-4, IL-8 and IL-18 concentrations
(p < 0.05 for all comparisons). Multivariate analyses showed that cyto-
kines did not predict VAT; yet, IL-1Ra was strongly associated with
VAP (odds ratio 64.941 (CI 1.638 - ≻ 999), area under the ROC curve
0.85 (0.64-1.00). A value of 1.21 log pg/mL appeared to diagnose
VAP most accurately (sensitivity 90 %, specificity 80 %).
Conclusions: In a reliable animal model of MV and acquired pulmonary
infections, IL-1Ra predicts P.aeruginosa VAP with good diagnostic accur-
acy. Consistently with previous findings, the Trendelenburg position re-
duced incidence of VAP, and decreased inflammation during MV. Further
clinical studies are warranted to confirm these preliminary findings.
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Introduction: Sepsis is a leading cause of mortality in children. The
mortality remains unchanged, despite advances in treatment and the
clinical judgement is still insufficient to an early recognition of out-
comes in children with sepsis.
Objective: To evaluate the patterns of C-Reactive Protein (CRP) ratio
response to antibiotic therapy during the first 7 days in the Paediatric
Intensive Care Unit (PICU) in children admitted with sepsis.
Methods: This is a multicenter, prospective and descriptive cohort
study of children (1 month to 18 years old) admitted at PICUs of 3 ter-
tiary hospitals in Rio de Janeiro, Brazil, with sepsis diagnosis (less than
72 hours). CRP was sampled every other day during the first week of
antibiotic therapy (from D0 to D6). CRP-ratio was calculated in relation
to D0 CRP value. Patients were classified according to an individual pat-
tern of CRP-ratio response with the following criteria: fast response -
when D4 CRP was≤ 0.4 of D0 CRP concentration; slow response - when
D4 CRP was > 0.4 and D6≤ 0.8 of D0 CRP concentration (continuous
and slow response); nonresponse - when D6 CRP was > 0.8 of D0 CRP
concentration; biphasic response - characterized by an initial CRP de-
crease to levels < 0.8 of the D0 CRP followed by a secondary rise > 0.8.
We performed comparison between PICU survivors and non-survivors.
Results: This cohort included 99 patients (age median: 1.8; 52.5 %
male); the most frequent sites of infection were lung (58.6 %), central
nervous system (13.1 %), abdominal (7.1 %) and urinary (5.1 %). Out
of the 99 patients, 88 could be classified according to a predefined
pattern: 26.1 % fast response, 54.6 % slow response, 10.2 % nonre-
sponse and 9.1 % biphasic response. The ICU mortality rate was sig-
nificantly different (p < 0.001) according to the patterns of CRP-ratio
response: fast response 4.3 %, slow response 2.1 %, nonresponse
44.4 % and biphasic response 37.5 %. Besides, the time dependent
analysis of CRP-ratio and CRP course of the different patterns was
significantly different (p < 0.001).
Conclusions: In paediatric sepsis, sequential evaluation of CRP-ratio
was useful in the early identification of patients with poor outcome.
The identification of CRP-ratio pattern of response to antibiotics dur-
ing the first week of antibiotic therapy could be useful in the recog-
nition of the individual clinical evolution, influencing clinical
decision-making process at bedside.
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Objectives: The aim of this study is to analyse the relationship
between tissue hypoxia, levels of hypoxia-inducible factor 1α
(HIF-1α, a factor that activates gene expression in response to in-
flammatory and hypoxaemic conditions) and the innate immune
response in patients with septic shock, and its relationship with
mortality.
Method: Prospective observational study in patients with septic
shock and healthy volunteers (controls) to analyse normal values of
non-standard determinations (pyruvate, HIF-1α, and HLA-DR on circu-
lating monocytes). Individuals signed an informed consent and the
study was approved by the Ethics Committee. Tissue hypoxia was
monitored by non-invasive transcutaneous spectroscopy (NIRS). At in-
clusion, 3rd and 7th day, venous blood samples were obtained for
determinations above were obtained. Lactate was determined at
baseline, every 6 hours the first day and daily until day 3. Quantita-
tive variables expressed as median [IQR]. Statistical analysis: Mann–
Whitney test ranges with Wilcoxon test and Spearman rho; it was
considered significant a value of p < 0.05.
Results: Eleven patients with septic shock were included, 72.7 %
males (8 cases), median age 67 years [58–73] and 10 healthy con-
trols. The clinical severity APACHE II at ICU admission was 21 [17–25].
ICU mortality was 19 % (2 cases).
At inclusion all patients had respiratory failure (SOFA respiratory ≥2,
SaO2 76.3 % [71.2-81]), venous lactate >4 mmol/l, peripheral tissue
hypoxia data (NIRS median 58 % [49–70]), and SOFA 9 [7.5-11.5]. All
patients had elevated levels of leukocytes, CRP, serum lactate and
pyruvate. Pyruvate levels were higher in patients than in controls.
HIF-1α was higher in patients, reaching peak levels on day 3rd (2.06
times the inclusion day). In patients: a) levels of HLA-DR on mono-
cytes circulating inclusion day were 2.86 times lower than in controls;
b) IL-6 and IL-10 levels in patients were higher than in controls on
the day of inclusion, with marked reduction at day 3rd (26.25 and
6.98 times respectively), IL6 was 1088.49 pg/ml and 0.17 pg/ml, re-
spectively. IL10 values were 121.66 pg/ml in patients being undetect-
able in controls; c) there were no differences in HIF-1α, IL-6, IL-10
and tissue hypoxia between dead and survivors. In the follow up, an
inverse relationship between pyruvate and HIF-1α levels was
observed.
Conclusions: Patients with septic shock show peripheral tissue hyp-
oxia. HIF-1α appears high and rising until the third day of monitoring,
which despite a decrease in the levels of IL-6 and IL-10 in those days
was observed.
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Introduction: The high inter- and intra-patient variability and con-
founding factors during early sepsis has made it difficult to diagnose
and characterize. Despite this variability, serum cytokine levels such
as interleukin-6 (IL-6) during sepsis appear to follow consistent and
distinctive trajectories across patients.
Objectives: To classify septic patients into groups defining endotypes
of sepsis using longitudinal IL-6 trajectories and to estimate time of
sepsis onset.
Methods: The multicenter, randomized Protocol-Based Care for Early
Septic Shock (ProCESS) trial enrolled 1341 patients with septic shock
and showed a 16.3 % 14-day mortality. Patients with IL-6 measured
at 0, 6, 24, and 72 hours after enrollment were selected for this ana-
lysis. Those with IL-6 values below the lower limit of detection or
with missing measurements were excluded, leaving 164 patients for
analysis.
Each IL-6 trajectory was modeled as a differential equation evolving
in response to inflammation. 3 classes of differential equations were
used to enforce classification into specific dynamic behaviors: over-
damped response, under-damped response, and overshoot-type re-
sponse. Patient classification was performed based on best data fit to
one of the 3 possible responses.
Within each class of response, a Gaussian Mixture model on differen-
tial equation parameters was used to further classify each patient.
The centers of each cluster generated a characteristic IL-6 response
to sepsis (a master curve) for that sub-population. Aligning each pa-
tient along with their category master curve provided an estimate
for disease time-zero with respect to onset of sepsis.
Results: Subgroup analysis revealed a total of 5 distinct IL-6 re-
sponses: 1-high response and fast decline; 2- slow and protracted re-
sponse; 3- fast response and protracted decline; 4- small response
and fast decline; 5- sustained response. Statistical testing of clinical
biomarkers between clusters revealed significant differences across
12 hour bins following disease onset. There were notable differences
in vital signs, bilirubin, lactate, and urine output, establishing a cor-
respondence between trajectory endotypes and physiological vari-
ables. This suggests that endotypes can be informed from easy and
minimally-invasive measurements. Finally, endotypes were associated
with distinct low and high mortality outcome. Endotype 5 exhibited
particularly high mortality.
Conclusions: A novel data-driven approach is proposed to generate
sepsis endotypes and disease time-zero. The clusters provided
physiological characterization of phenotypes. The knowledge of dis-
ease time as well as endotype risk can be used to guide treatments
in order to shift sepsis patients towards better outcomes.
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Introduction: Acute cardiac events are common after subarachnoid
hemorrhage (SAH) and are associated with an increased risk of poor
outcome (1–3). However, the impact of cardiac events on long term
mortality after SAH are barely studied (4).
Objectives: The aim was to evaluate the impact on acute cardiac
events on long-term mortality after SAH. Our hypothesis was that
these events are associated with an increased long-term mortality.
Methods: This is a retrospective study. Medical records from all pa-
tients admitted to our NICU from 2010 to 2015 with the diagnosis
SAH were analysed. Admission variables obtained were age, medical
history, WFNS score, modified fischer grade. Cardiac varibales ob-
tained were troponin and NTproBNP levels, ECG, echocardiograpic
evaluation. Kaplan-Meier curves and Cox-regression were used in the
statistical analyses.
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Results: A total of 708 patients were admitted with suspected/
verified SAH during the study period. 118 patients did not fulfill
SAH-diagnosis, 33 patients were not included due to long time
to admission (>4 days). Cardiac variables were found in the fol-
lowing number of patients; troponin levels n = 428, NTproBNP
levels n = 342, ECG n = 454, echocardiography n = 235. In 28 pa-
tients no ECG/echo/cardiac biomarkers were found. Of the 529
patients analysed, 109 patients had died at the time mortalily
data was obtained (April 2016). In a univariate cox-regression
analysis, WFNS grade 4–5, Fisher grade, age, history of hyperten-
sion, cardiovascular disease (CVD) or renal disease, levels of
troponin and NTproBNP and ST-elevations or negative T-waves
had a significant higher risk (hazard ratio) for death. Stress-
cardiomyopathy was not significantly associated with an inreased
risk of death. Fig. 96 shows a Kaplan Meier curve of cumulative
survival in patients with troponin release, divided in upper or
lower quartiles. In a multivariable cox-regression analysis, both
troponin levels (Table 70) and NTproBNP levels were significantly
associated with an increased risk for death when adjusting for
the most important admission variables; WNFS grade 4–5, age
and history of CVD or renal disease. However, these differences
were only significant the first year after the hemorrhage.
Conclusions: Acute realease of the cardiac biomarkers troponin and
NTproBNP after SAH is an omnious clinical sign which is associated
with an increased risk of death, especially the first year after the
hemorrhage. Further research is needed to address whether mea-
sures to optimize cardiac treatment after SAH might improve
survival.
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Introduction: The concept of brain-heart interaction (1) has been de-
scribed in several brain injuries. Traumatic brain injury (TBI) may also
lead to cardiac dysfunction but evidences are mainly based upon ex-
perimental (2) and clinical retrospective studies (3).
Objectives: The present study aimed at evaluating myocardial func-
tion at the early phase of TBI using conventional 2D echocardiog-
raphy and complementary STE analysis. We hypothesized that
patients with TBI had altered cardiac function compared to the con-
trol group.
Methods: We conducted a prospective case–control study in a
level I trauma center. Twenty consecutive adult patients with
severe TBI were matched according to age and gender with
twenty control patients. Control group included adult patients
undergoing general anesthesia for peripheral trauma surgery.
Conventional and Speckle Tracking Echocardiography (STE) was
performed within the first 24 post-traumatic hours in the TBI
group and PRE/PER-operative in the control group. Primary end-
point was left ventricle ejection fraction (LVEF) measured by the
Simpson's method. Secondary endpoints included diastolic func-
tion and STE analysis.
Results: We found similar LVEF between the TBI group and the
PER-operative control group (61 % [56–76]) vs. 62 % [52–70]). LV
morphological parameters and systolic function were also similar
between the two groups. Regarding diastolic function, isovolumic
relaxation time was significantly higher in the TBI cohort (125 s
[84–178] versus 107 s [83–141], p = 0.04), suggesting subclinical
diastolic dysfunction. Using STE parameters, we observed a trend
toward higher strains in the TBI group but only apical circumfer-
ential strain and basal rotation reached statistical significance.
STE-derived parameters of diastolic function tended to be lower
in TBI patients.
Conclusions: No systematic myocardial depression was found in a
cohort of severe TBI patients. STE rather revealed correct adapta-
tion of left systolic function, while diastolic function slightly
impaired.
Fig. 96 (abstract A710).
Table 70 (abstract A710). Multivariable Cox-regression analysis
Hazard
ratio
Lower 95%
CI
Upper 95%
CI
p-
value
WFNS 4-5 3.69 2.34 5.82 <0.001
Age (per year) 1.05 1.03 1.07 <0.001
History of CVD or renal
disease
2.06 1.21 3.48 0.007
Troponin, per 100ng/l 1.09 1.02 1.16 0.010
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Introduction: In patients with subarachnoid hemorrhage (SAH), mon-
itoring brain metabolism through microdialysis catheters has re-
vealed a decrease in brain glucose concentrations during intensive
insulin therapy to control hyperglycemia. However, the use of such
catheters is not routinely applied. No data are available on glucose
concentrations into the cerebro-spinal fluid (CSF) of these patients
during insulin therapy (IT).
Methods: We reviewed data in all patients admitted after a non-
traumatic SAH over a 4-year period (2011–2014) in 5 ICUs. Inclusion
criteria were: a) age > 18 years; b) presence of an external ventricular
drain (EVD) for intracranial pressure monitoring; c) daily analysis of
CSF including glucose concentrations for at least 4 consecutive days; d)
concomitant analysis of glucose concentrations on the arterial blood
gas analysis. Demographics and clinical characteristics were recorded
on admission as well as the need for continuous IT (target glucose
levels: 110–150 mg/dL) and 3-month neurological outcome (favourable
outcome was defined as a Glasgow Outcome Scale of 4–5).
Results: Of a total of 724 patients admitted with SAH, 335 needed an
EVD and 144 met the inclusion criteria for the final analysis (median
age: 58 [49–66] years; male gender: 77/144). Median time from ad-
mission to EVD placement was 1 [0–3] days; EVD was maintained for
a period of 7 [4–12] days. Of the 115 identified aneurysms, 83 were
treated with endovascular therapy. Median Glasgow Coma Scale
(GCS) on admission was 10 [7–13] and CT-scan Fisher scale was 4 [3–
4]. A total of 46 (32 %) died during the ICU stay and 63 (44 %) had a
favourable neurological outcome. Patients receiving IT on the first
day of EVD monitoring (n = 72) had more frequently diabetes (27/72
vs. 4/72; p < 0.001) but similar GCS and Fisher scales than those with-
out IT. Together with a higher CSF red blood cells count (65210
[11900–94192] vs. 24650 [6020–64188]/mm3; p = 0.006) and similar
white blood cells and proteins levels, patients receiving IT had higher
blood glucose (180 [151–222] vs. 140 [118–155] mg/dL; p < 0.001)
and similar CSF glucose concentrations (89 [66–108] vs. 81 [72–92]
mg/dL; p = 0.13) than those without IT. Thus, the ratio between CSF
and blood glucose levels was significantly lower in patients receiving
IT than others (0.51 [0.36-0.61] vs. 0.60 [0.49-0.70]; p = 0.006).
Conclusions: Insulin therapy resulted in lower proportion of glucose
available in the CSF in patients with SAH. The impact of such findings
on cerebral recovery and outcome needs to be further evaluated.
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Introduction: The immediate events associated with aneurysmal sub-
arachnoid haemorrhage (SAH) result in early brain injury (EBI). De-
layed cerebral ischemia (DCI) may also develop between 1–2 weeks
after bleeding caused by vasospasm and other mechanisms. Charac-
terizing both type of brain injury and standardising the diagnostic
modalities is key to predicting and potentially modifying the out-
come of SAH.
Objectives: Use serial MR imaging to determine the characteristics of
early and late brain injury and investigate their role in determining
outcome after SAH.
Methods: Patients' demographic and clinical data were collected. 6-
months outcome was evaluated using the extended GOS (GOS-E).
Serial MRI scans were performed on days 0–5 (early), and 7–14 (late)
following the acute bleeding. The MRI protocol included 3D-T1, T2,
T2*-weighted sequences, 3D-FLAIR, diffusion-weighted imaging (DWI)
and apparent diffusion coefficient maps (ADC) were calculated.
FLAIR, DWI/ ADC and T2 sequences were co-registered and volumes
measured using the SPM and Analyze software. Early cerebral ische-
mia (ECI) and DCI were identified as hyper/hypointense lesions on
the correspondent DWI/ADC maps. DWI were classified on the basis
of the whole lesion volume: none (N), spotty (SP), ≤10 ml (S = small),
and > 10 ml (L = large). Early cerebral haematomas (ECH) were identi-
fied on FLAIR and T2 and similarly classified as none (N), small (S)
and large (L). All early lesions (excluding SP lesions) were named as
EBI (ECI + ECH). Chi square test and logistic regression were used for
univariable and multivariable analysis.
Results: 82 SAH patients (53 F and 29 M) were enrolled, with a me-
dian age of 57 (IQR 48–66). 54 subjects (66 %) had good grade
(WFNSS 1–3) and 28 (34 %) poor grade SAH (WFNS 4–5) on admis-
sion. 67 patients (82 %) were coiled while 14 were surgically treated
(17 %) and one was not treated. Vasospasm (defined as “late” clinical
deterioration associated to instrumental finding of arterial narrowing)
occurred in 22 patients (27 %). MRI abnormalities compatible with
ECI were found in 34 subjects (42 %), 22 classified as S lesions (65 %)
and 12 as L (35 %). 40 patients (49 %) had ECH (25 S and 15 L le-
sions), including 4 small subdural haematomas (SDH) and 2 with
both SDH and ECH. DCI was observed in 38 % of the cases (N = 31),
27 classified as S lesions and 4 as L. The Table 71 shows the results
of the univariable analysis for factors related to outcome.
Multivariable logistic regression analysis shows an association be-
tween worse outcome and poor WFNSS on admission (OR 6.3, 95 %
CI, 2–20), the presence of DCI (OR 4.2, 95 % CI 1.4-13) and EBI (OR
1.3, 95 % CI 1.3-15).
Fig. 97 (abstract A711). Primary outcome LVEF (%)
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Conclusions: These findings show that early and delayed brain injury
are both independent predictors of worse outcome after SAH, and
suggest that standard MRI protocols are useful diagnostic tools. Sig-
nificant variance in outcome still remains, indicating that additional
methods may be necessary to quantify brain damage after SAH.
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Introduction: Spontaneous intracerebral hemorrhage (ICH) is respon-
sible for 9-27 % of cerebrovascular diseases worldwide, with 37–52 %
of mortality at 30 days and 54 % a year. Brain injury biomarkers (BIB)
and inflammatory markers (IM) have been studied to predict progno-
sis in this disease.
Objectives: To associated BIB and IM with mortality and functional
outcome in patients with spontaneous ICH.
Methods: We performed a prospective observational study, with pa-
tients admitted in ICU with spontaneous ICH. BIB were determined
(Enolase, S-100B, Dimer D (DD), BNP, CRP) at admission, 1,2, 3 and
7th day, and IM (transferrin, albumin, prealbumin, Quick index (QI),
leukocytes) at admission and 7th day. APACHE II, SOFA, GCS, GRAEB
were determined at admission and the modified Rankin Scale (mRS:
poor outcome >2) and Glasgow Outcome Scale (GOS: poor outcome
< 4) at ICU discharge. Variables were summarized using %, mean (SD)
and median (minimal/ maximum). We used T-Student and χ2 (p <
0.05) for univariable analysis. We conducted a multivariable analysis
for mortality with binary logistic regression (95 % CI, OR) p < 0,05. We
obtained a ROC curve for those variables that were independent fac-
tors for mortality.
Results: We enrolled 120 patients, 68 % were men, mean age
62 years(±12.6). Global mortality was 34.2 %. 83.3 % were supraten-
torial and 16.7 % infratentorial. Mean APACHE II 14 (±6, 5) and GCS
10.4 (±4,1) and median SOFA 4 (0–14) and hematoma volume
21,35 cc3 (1–252). In the univariable analysis a worse outcome (with
mRS and GOS) was significantly associated with APACHE II, SOFA,
GCS at admission (p 0,000 each one), length of stay (LOS)-ICU and
days of mechanical ventilation (p 0,000). The BIB and IM related with
a worse mRS were DD at 1, 2 3rd day (p 0,016, 0,002, 0,000 respect-
ively), S-100B 1st and 2nd day (p 0,013 and 0,003) and CRP 1, 2 and
3rd day (p 0,039, 0,001, 0,002); and with a worse GOS were DD 2 and
3rd day (p 0,015 and 0,002), S-100B and CRP at 2nd day (p 0,04 and
0,009). Otherwise, mortality was associated with BNP at admission, 1,
2, 3 and 7th day (p 0.005, 0.006, 0.022, 0.032 and 0.010), DD 1, 2, 3
and 7th day (p 0.037, 0.001, 0.000 and 0.001), CRP 2nd day (p 0.004),
QI at admission (p 0.004), albumin at admission and 7th day (p 0.013
and 0.037), prealbumin at admission and 7th day (p 0.007 and 0.014).
After the multivariable analysis obtained the QI at admission as an in-
dependent factor with mortality OR 0.978 (95 % CI 0.962 to 0.994; p
0.009). We performed a ROC curve for QI with AUC 0.668 (p 0.003) an
a cutoff point 80.50 %.
Conclusions: BIB as S-100B and DD (1, 2 and 3rd day) and CRP (first
72 hours) in an early stage were related to worse outcome at ICU dis-
charge. QI at admission with cutoff point 80.50 % was associated
with lower risk of mortality.
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Introduction: Acute stroke is the second leading cause of death and
disability in western world1. An early risk assessment with estimate
of the severity of disease and prognosis is pivotal for optimized care
and allocation of healthcare resources. Novel biomarkers have
emerged to assist clinicians with decision making. Copeptin is a
novel neuroendocrine peptide that is a strong and independent
prognostic marker for functional outcome and death in patients with
acute stroke3.
Objectives: To validate the usage of a single Copeptin value on
admission as a short-term prognostic marker in patients with
acute stroke.
Methods:Forty patients admitted to the Critical Care Department
with acute ischemic or hemorrhagic stroke according to the AHA/
ASA criteria2 were included in the study during the period from Sep-
tember 2013 to September 2014 together with ten volunteers who
served as controls. Plasma Copeptin level was measured within
72 hours from onset of symptoms by ELISA technique. Copeptin level
was correlated with APACHE II score, GCS, Hemphill score, ASPECTS
score and Modifiesd Rankin scale.
Results: Copeptin level was statistically higher in studied group
than in controls (140.98 ± 101.7 vs. 8.29 ± 2.1 with a p-value <
0.001). There was a statistically significant difference of Copeptin
level between patients with recurrent stroke and those with no
previous history of strokes (168.2 ± 21.83 vs. 84.53 ± 20.33; with a
p- value of 0.035). Copeptin level was numerically higher in
hemorrhagic stroke (150.4 ± 98.3) than in ischemic stroke (131.6 ±
50.7) although it didn't reach any statistical significant difference
(p-value 0.73). Copeptin level was higher in convulsive patients
than in non-convulsive patients (151.13 ± 78.3 vs. 69.96 ± 14.7;
with a p value of 0.007). It was found that Copeptin level possess
a positive linear correlation with APACHE II score, Hemphill score
and Modified Rankin scale with a p-value of 0.011, 0.000 and <
0.001 respectively while it was negatively correlated with AS-
PECTS score and GCS with a p-value 0.001 and 0.005 respectively.
Copeptin level was higher in survivors than in non-survivors
(102.89 ± 30.8 vs. 255.24 ± 117.8 pmol/L with a p value 0.011. The
optimal cut off value for copeptin as a prognostic marker was
54.5 pmol/l with a sensitivity of 100 % and a specificity of 97 %.
Conclusions: Copeptin could be a novel biomarker that correlates
with poor outcome, dependence, disability and death in patients
with cerebrovascular stroke.
Table 71 (abstract A713). Results of the univariable analysis
Variable Favorable
outcome
Unfavorable
outcome
p-
value
WFNSS (1–3) (4–5) (41) (10) (13) (18) 0,0004
Median age ( IQR) 57 (46–65) 61 (55–72) 0,0756
Clinical Vasospasm (Yes) (No) (9) (42) (13) (15) 0,0063
ECI (Yes) (No) (17) (32) (17) (14) 0,0758
ECH (Yes) (No) (18) (31) (22) (9) 0,0029
DCI (Yes) (No) (13) (38) (18) (13) 0,0032
EBI (ECI + ECH) (Yes) (No) (7) (42) (14) (17) 0,0022
ECI volume > 10 mL (Yes)
(No)
(3) (46) (9) (22) 0,0006
ECH volume > 10 mL (Yes)
(No)
(6) (43) (9) (22) 0,0609
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 365 of 607
References
1. Donnan GA, Fisher M, Macleod M; et al. (2008): Seminar: Stroke. The
Lancet. 371:1612–23.
2. An Updated Definition of Stroke for the 21st Century: A Statement for
Healthcare Professionals From the American Heart Association/American
Stroke Association: Stroke. 2013;44:2064–2089;
3. Katan M, Fluri F, Morgenthaler NG; et al. (2009): Copeptin: a novel
independent prognostic marker in patients with ischemic stroke. Ann
Neurol 66:799–808.
A716
Blood biomarkers for acute stroke prognostics
F.N. Backes1, M.M. Bianchin2, S.R.R. Vieira3, A. de Souza4, A.N. Backes4, C. Klein4
1Hospital de Clínicas de Porto Alegre, Intensive Care Medicine,
Neurology, Porto Alegre, Brazil; 2Hospital de Clínicas de Porto Alegre,
Neurology, Porto Alegre, Brazil; 3Hospital de Clínicas de Porto Alegre,
Intensive Care Medicine, Porto Alegre, Brazil; 4Hospital de Clínicas de
Porto Alegre, Porto Alegre, Brazil
Correspondence: F.N. Backes - Hospital de Clínicas de Porto Alegre,
Intensive Care Medicine, Neurology, Porto Alegre, Brazil
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A716
Background and purpose: Stroke is an important cause of death
worldwide, and the majority of stroke survivors suffer from some form
of residual disability. This study aimed to investigate the association of
blood biomarkers with stroke scales and their predictive value after
acute stroke at the time of admission until hospital discharge.
Design and methods: We investigated 60 patients with acute stroke
who were admitted within 24 h of event onset at the intensive care unit
or neurovascular emergency unit of Clínicas Hospital. All patients pro-
vided venous blood samples for the measurement of neuron-specific
enolase (NSE), S100ß protein (S100ß), interleukin-6 (IL-6), C-reactive pro-
tein (CRP) and brain-derived neurotrophic factor (BDNF) within 24 h of
the acute event, on the third day and on the fifth day after the stroke.
Neurological stroke severity and global disability were determined with
the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin
Scale (mRS) at the same three times of blood collection and at the time
of hospital discharge.
Results: The serum levels of the S100ß protein, IL-6 and CRP seem to
constitute the best panel of biomarkers after acute stroke in this
study. When patients were subdivided into two groups according to
the NIHSS (NIHSS ≤ 6 and NIHSS > 6) and mRS (mRS ≤ 3 and mRS > 3)
scores, which were used as neurological outcome measures, both
neurologic scores for good outcome (NIHSS ≤ 6 and mRS ≤ 3) at hos-
pital discharge were significantly related to the S100ß protein and IL-
6 levels at all of the measured time points. Among the analyzed
blood markers, S100ß, IL-6 and PCR levels significanttly correlated
with the stroke scales and prognostic value.
Conclusion: Blood biomarkers may be useful in acute stroke either by
suggesting stroke severity or providing a prognostic value. The addition
of the S100ß protein, IL-6 and CRP to previously validated stroke scales
slightly improves the ability of these scales to predict outcome.
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Introduction: PRES is a clinicoradiological syndrome characterised by
transient neurological symptoms with vasogenic edema involving
the posterior cerebral region.
Objectives: To study the Clinical features and outcomes of patients
with PRES admitted to our ICU.
Methods: This was a prospective observational study done over
period of two years (2014–15). We included all adult patients admit-
ted to our ICU with the following criteria (1) acute onset neurologic
symptoms including headache, encephalopathy, seizure, visual dis-
turbance, or focal deficit; (2) focal vasogenic edema on brain imaging
and (3) clinical proof of reversibility. Data was collected on demog-
raphy, co-existing illness, and admission severity of illness, neuro-
logical symptoms, systolic and diastolic blood pressure, treatments
initiated and MRI findings. Outcome data collected included, mortal-
ity, ICU ALOS, no of ventilator days and neurological disability
assessed by modified Rankin scale (MRS).
Results: 14 patients were admitted with PRES. 13 patients were fe-
males, their mean age was 31.5(±8.3) years.
Etiology of PRES include eclampsia (n = 9[64.2 %]), lupus nephritis (n =
3[21.4 %]), chronic kidney disease (n = 1[7.1 %]) and hypertension (n =
1[7.1 %]). Most common presenting symptom was seizure (92.8 %),
followed by visual disturbance (42.8 %), headache (42.8 %), encephal-
opathy (14.2 %) and status epilepticus (14.2 %).
Mean APACHE II & SOFA scores were 8.5(±6.9)&2(±1.7) respectively
and GCS on admission was 12.3(±2.9). High blood pressure was seen
in 12 patients (85.7 %), their mean systolic and diastolic pressures
were 173(±9.1) /110(±5.5) mmhg respectively. MRI showed parieto-
occipital region was most commonly involved (92.8 %), followed by
frontal lobe (42.8 %).
Blood pressure was controlled with IV antihypertensive agents and
magnesium sulphate was given for eclamptic patients. Time taken for
control of blood pressure 31.25(±12) hours and time taken for awaken-
ing was 1(median) hour (range1-60). 7(50 %) patients required ventila-
tor support of which 3 patients were postoperative caesarean section
for eclampsia and 4 patients had neurological deterioration and
3(21.4 %) patients required hemodialysis. ICU ALOS was 4.35(±2.4) days
and mean ventilator days was 1.7 ± (2.0) days. One patient [1/14(7.4 %)]
died of multiorgan failure and 13 patients were discharged with no re-
sidual neurological deficit (Modified Rankin Scale-0).
Conclusions: PRES is a potentially reversible disorder with prompt
recognition and control of blood pressure.
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Table 72 (abstract A717). Patient characteristics
Demography n=14
Age mean (±SD) 31.5(10)
Female 13(92.8)
Male 1(7.14)
Etiology of PRES n=14(%)
Eclampsia 9(64.2)
Lupus nephritis 3(21.4)
Chronic kidney disease 1(7.1)
Hypertension 1(7.1)
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Introduction: In patients with traumatic brain injury (TBI), monitor-
ing of brain metabolism using micro dialysis revealed that a de-
crease in brain glucose concentrations and an increase in lactate
levels were markers of cellular alterations. However, such cathe-
ters are not used routinely. Few data are available on glucose
and lactate concentrations in the cerebrospinal fluid (CSF) of
these patients.
Objectives: Determine the relationship between glucose and lactate
concentrations in CSF and arterial blood and the CSF glucose/lactate
ratio and its correlation with outcome in severe TBI.
Methods: We reviewed data from all patients admitted to a 35-
bed medico-surgical ICU following TBI over a 4-year period
Fig. 98 (abstract A717). Clinical presentation of PRES
Table 73 (abstract A717). MRI findings in PRES(site of lesion)
Site of lesion n(%)
Parieto-occipital lobes 13(92.8)
Frontal lobe 6(42.8)
Cerebellum 3(21.4)
Brainstem 3(21.4)
Deep white matter.(internal/external capsule) 3(21.4)
Temporal lobe 2(14.2)
Cortical 2(14.2)
Basal ganglia 2(14.2)
Focal hyperacute sub-arachnoid /intraparenchymal hemorrhage 2(14.2)
Fig. 99 (abstract A717). MRI - sites of lesion in PRES
Fig. 100 (abstract A717). MRI- PRES with
intraparenchymal hemorrhage
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(2011–2014). Inclusion criteria were: a) age >18 years; b) presence
of an external ventricular drain (EVD) for intracranial pressure
monitoring; c) daily analysis of CSF including glucose concentra-
tions for at least 4 consecutive days; d) concomitant measure-
ments of blood glucose/lactate concentrations. Demographics and
clinical characteristics were recorded on admission as was the
need for continuous insulin therapy (IT; target glucose levels:
110–150 mg/dL) and 3-month neurological outcome (unfavour-
able outcome was defined as an extended Glasgow Outcome
Scale of 1–4).
Results: Of 151 patients TBI patients who needed an EVD, 56 met
the inclusion criteria (median age: 37 [26–59] years; male: 40).
Most EVDs were placed on the day of ICU admission and they
were maintained for 10 [6–14] days. Median Glasgow Coma Scale
(GCS) on admission was 7 [3–10] and most initial CT-scans were
classified as V or VI in the Marshall score (54/57). Twenty (36 %)
patients died during the ICU stay and 23 (41 %) had a favourable
neurological outcome. Patients who received IT (n = 47) on the
first day of EVD monitoring had similar blood and CSF glucose
concentrations than those who did not (n = 9). CSF and blood
glucose levels were similar in survivors and non-survivors, but
non-survivors had higher CSF lactate levels (4.2 [2.9-6.0] vs. 2.4
[2.0-3.7] mmol/L; p = 0.003) and blood lactate levels (1.8 [1.1-2.8]
vs. 1.1 [0.8-1.5] mmol/L; p = 0.03) on the first CSF analysis. The
CSF glucose/lactate ratio was lower in the non-survivors than in
the survivors (1.0 [0.8-1.7] vs. 1.9 [1.4-2.4]; p =0.008). Similar re-
sults were found when patients with an unfavourable neuro-
logical outcome were compared with the other patients.
Conclusions: Non-surviving patients after TBI have initially higher
CSF lactate levels and a lower CSF glucose/lactate ratio than survi-
vors. These observations suggest a more profound metabolic brain
distress in the non-survivors, who may benefit from an alternative
energetic substrate to glucose.
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Introduction: To prevent delayed cerebal ischaemia (DCI), patients
with spontaneous SAH (s-SAH) are frequently given supra-normal
blood pressure targets.1 If patients with DCI do not improve with
hypertensive therapy (achieved using fluids and vasopressor
drugs, e.g. noradrenaline), a trial of inotropic therapy (e.g. dobu-
tamine) may be considered.2 Consequently, vasopressor and/or
inotropic therapy is frequently required in s-SAH patients. Central
venous catheters (CVCs) are required for the safe administration
of many vasopressors and inotropes,3,4 but carry potentially ser-
ious morbidity and mortality risks,5,6 particularly as the femoral
insertion site is frequently chosen to avoid the theoretical risk of
impaired venous drainage from the head in association with in-
ternal jugular vein CVC placement.7 The authors observed that
there was a difference in practice between consultants within the
Department of Anaesthesia regarding the routine placement of
CVCs in patients with s-SAH, prompting the study.
Objectives: The purpose of the study was to investgate what propor-
tion of patients admitted to ICU with s-SAH required vasopressor
and/or inotropic support, what proportion required CVCs, and to es-
tablish guidelines as to which s-SAH patients should have CVCs
inserted routinely.
Methods: All consecutive patients admitted to Charing Cross Hospital
ICU with s-SAH for a 1-year period were included retrospectively (n = 70).
Results: Forty patients (57.1 %) had vasopressors and/or inotropes
administered. Duration of therapy was >24 hours in 38/40 (95 %);
median duration was 5.5 days (IQR 6.25 [range 1–22]). Of 44 patients
admitted to ICU with GCS ≥13 (NB World Federation of Neurological
Surgeons (WFNS) grade 3 SAH = GCS 13–14, with motor deficit), 17
(38.6 %) had vasopressors/inotropes administered, and 10 (22.7 %)
had a CVC inserted. Of 26 patients admitted to ICU with GCS ≤12
(NB WFNS grade 4 SAH = GCS 7–12, with or without motor deficit),
23 (88.5 %) had vasopressors/inotropes administered, and 23
(88.5 %) had a CVC inserted.
Conclusions: Central venous catheterization carries significant
morbidity and mortality risks, and cannot be recommended rou-
tinely in all patients admitted to ICU with s-SAH. However,
pateints with WFNS grade 4 or 5 SAH (equivalent to GCS ≤12) al-
most invariably (in 88.5 % of cases) require vasopressors/ino-
tropes and central venous catheterization. CVC insertion should,
therefore, form part of the routine anaesthetic care of patients
with s-SAH who have GCS ≤12.
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Introduction: Red cell distribution width (RDW) is a quantitative
measure of variability in the size of erythrocytes and it is used
for the differential diagnosis of anaemia. High RDW has been
associated with increased hospital mortality in some patients,
but this has not been studied in subarachnoid haemorrhage
(SAH).
Objectives: To investigate whether RDW is associated with outcome
after SAH.
Methods: We reviewed our institutional database of all adult pa-
tients with non-traumatic SAH (2013–2015). We collected demo-
graphics, SAH-related data and results of routine daily blood
analyses. The RDW (normal values: 10.9-13.4 %), was obtained
from the day of admission to day 3. We recorded ICU mortality
and long-term neurological outcome; a Glasgow Outcome scale
of 4–5 at 3-months was used to define a good neurological out-
come (GNO).
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Results: A total of 174 patients (age 55 [45–66] years; male 76/
174) were studied with a median Glasgow Coma Score of 14 [5–
15] and a Fisher scale of 4 [3–4]. Sixty-three patients (36 %) de-
veloped delayed cerebral ischemia (DCI); overall ICU mortality
was 56/174 (32 %) and GNO and 101 patients (58 %) had a GNO.
The median RDW on admission was 13.9 [13.3-14.7]% and the
highest value during the study period was 14.3 [13.6-15.1]%. A
total of 115 patients (66 %) had a high RDW on admission. The
RDW was significantly higher on admission in patients who devel-
oped DCI than in the other patients (14.0 [14.5-14.9]% vs. 13.6
[13.1-14.3]%, p < 0.001), in non-survivors than in survivors (14.4
[13.9-14.9]% vs. 13.7 [13.1-14.5]%, p < 0.001) and in patients with
poor neurological outcome than in those with GNO (14.5 [13.9-
14.9]% vs. 13.6 [13.1-14.2]%, p < 0.001).
Conclusions: RDW is higher in patients with a poor outcome after SAH.
It could be used to better stratify the severity of these patients on
admission.
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Introduction: Secondary insults such as hypoxia-hypotension (HH)
provide secondary brain damages and worsen neurologic outcome
in patients with severe traumatic brain injury (TBI). Early identification
of secondary insults with biomarkers could improve the characterization
of TBI severity to better individualize treatment. Several biomarkers have
been investigated in severe TBI; However, they have been poorly studied
after secondary brain insults. Two of them appear to be particularly of
interest1: Glial fibrillary acidic protein (GFAP) and Ubiquitin carboxy-
terminal hydrolase L1 (UCH-L1).
Objective: Our objective was to describe the effects of a stan-
dardized secondary insult including hypoxia and hypotension on
GFAP and UCH-L1 expression in rat brain in a model of severe
diffuse TBI.
Methods: Rats were randomly allocated to the following 4 groups:
Control (C), in which the entire procedure was performed except TBI
and HH; TBI, in which TBI was performed alone; HH, in which HH
phase was performed alone; TBI + HH, in which TBI was followed by
HH. The TBI model was realized according to the adapted model of
Marmarou and Foda reproducing diffuse TBI with acceleration-
deceleration damage. Hypoxia was performed by mechanical ventila-
tion with O2/N2 mixture of 10 %/90 % (decrease in arterial PaO2 to
about 40 mmHg). Hypotension was obtained with a controlled
hemorrhagic shock (mean arterial pressure (MAP) at 40 mmHg) dur-
ing 15 minutes. Brains were collected after 4 hours of mechanical
ventilation for immunohistochemistry of GFAP and UCH-L1 in 6 re-
gions known as particular sensitive to hypoxic insults2 (neocortex,
striatum, thalamus, hippocampus (CA-1 and dentate gyrus) and cor-
pus callosum). Non-parametric data were compared using Kruskall-
Wallis test (p < 0.05).
Results: Twenty-four rats were included (C, n = 9; TBI, n = 9; HH, n
= 3; TBI + HH, n = 3). For GFAP, immunostaining revealed a de-
crease of strong staining (p < 0.001) in the neocortex for TBI + HH
group compared to TBI group (Fig. 101). A similar trend was ob-
served in the hippocampus without reaching statistical signifi-
cance. In all regions, strong staining trended to decrease in TBI
group compared to control group. For UCH-L1, strong staining
tended to decrease for TBI + HH group compared to TBI group in
the neocortex (NS). Moreover, a trend of strong staining decrease
in all regions for TBI group compared to control group.
Conclusion: These preliminary results suggest that GFAP and
UCH-L1 could be early markers of secondary insults reflecting
glial and neuronal damages after severe TBI. Measurement of
GFAP and UCH-L1 in plasma and cerebrospinal fluid are in
progress.
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Fig. 101 (abstract A721). GFAP and UCH-L1 immunostaining
in brain tissue according to cerebral regions. A: strong stained
pixel/total pixel ratio for GFAP. B: strong stained pixel/ total
pixel ratio for UCH-L1. ns: non significant, **: p<0,001. C:
control group, TBI: traumatic brain injury group, HH: hypoxia/
hypotension group, TBI+HH: traumatic brain injury and
hypoxia/hypotension group
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Introduction: Intracranial pressure (ICP) monitoring (MNT) is widely
used in intensive care, due to its therapeutic and prognostic implica-
tions. PbtO2 MNT is not that frequent, despite studies supporting its
use. Given the link between hypoxia and a bad outcome, we accept
that correcting brain hypoxia may improve the final result.
Objectives: To identify to what extent survival and level of depend-
ence (analysed by GOS at 6 months, GOS-6) of neurocritical patients
(NCP) are affected by the time under certain levels of PbtO2, with
simultaneous normal ICP value.
Methods: Retrospective study. NCP admitted to our ICU (2011–15)
underwent ICP + PbtO2 MNT . Registered data, among others, were:
PbtO2, ICP (hourly), PaO2/8 h, GCS, GOS-6. NCP were divided into 3
groups (gr), depending on GOS-6: gr 0 (GOS-6 = 1: death); gr 1 (GOS-
6: 2 & 3, highly dependent); gr 2 (GOS-6: 4 & 5; moderately/not
dependent). 21 variables (VAR) were analysed, 5 of which reached
statistical relevance. We focused on the following items: T1: Time (h)
with ICP > 20; T2: Time (h) with PbtO2 < 5; and combined VAR: T10:
Time (h) with ICP < 20 + PbtO2 < 10; T15: Time (h) with ICP < 20 +
PbtO2 < 15; T20: Time (h) with ICP < 20 + PbtO2 < 20.
STATISTYCAL ANALYSIS. We conducted the study in two phases.
FIRST: we compared NCP who survived with those who did not, fo-
cusing on critical values of PbtO2 and ICP. SECOND: we analysed dif-
ferences between gr 1 and 2 for variables T10, T15 and T20. After
obtaining data descriptive, for each one of them, we applied para-
metric statistic tests. The arithmetic mean was the starting point. To
compare means we used t Student and Welch robust test. Then we
conducted a logistic regression analysis to evaluate to what extent
each VAR affects outcome or dependence. For gr 2 and 3 we per-
formed Kaplan-Meier analysis, to compare the relationship between
outcome and the time that each type of patient required to reach a
specified goal of PbtO2 (10, 15 and 20).
Results: 49 NCP were included (63.3 % men); mean age: 50
(s.d.14,92). The main results of the 1st phase are shown in Table 74.
The risk of death vs no death increases 5.8 % with every h with high
ICP. The risk of death vs no death increases 24 % with every h with
PbtO2 < 5 and normal ICP. The results of T10, T15 and T20 VAR are
shown in Table 75.
The probability of being highly vs low dependent increases 5.4 %
every h with PbtO2 < 15, given normal ICP. For variable T10, differ-
ences are nearly but not definitely statistically significant. Finally, for
VAR T10 and T15, Kaplan Meier estimator was applied, (results shown
in Figs. 102 and 103.
Conclusions: Maintained high ICP and low PbtO2 are mortality determi-
nants. Time with low PbtO2 increases the risk of death to a higher extent
than time with high ICP. Low PbtO2 is in itself an independent prognostic
factor. Even with moderate brain hypoxia, patients may reach an accept-
able functional outcome. Not only are PbtO2 values crucial for outcome,
but also time spent to achieve an acceptable value.
Table 74 (abstract A722). Survivors vs non survivors
Group 0 (N=15) Group 1+2 (N=34) Welch Logistic Regression p
Media Media p Odds Ratio (CI:95%)
T1 51,4667 14,9706 0,007 1,058 (1,020–1,097 0,003
T2 7,0000 1,4706 0,039 1,239 (1,064–1,443) 0,006
Table 75 (abstract A722). Severe vs low disability
Group 1 (N=8) Group 2 (N=26) Welch (p) Logistic
regression
p
Mean s.d. Mean s.d. Odds ratio
(CI 95%)
T10 14,6250 21,32696 2,0000 3,76298 0,139 1,134
(0,982–1,309)
0,086
T15 32,0000 31,45972 10,1154 12,31041 0,092 1,054
(1,006–1,105)
0,027
T20 62,6250 51,80165 41,0000 45,49989 0,312 (n.s.)
Fig. 102 (abstract A722).
Fig. 103 (abstract A722).
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Introduction: The study hypothesis was hypoglycaemia is an independ-
ent outcome prognosticator in severe traumatic brain injured cases.
Objectives: The study aimed to see the role of glucose monitoring in
the brain parenchyma region as independent outcome prognosticator
and its association with plasma glucose . The aim of the study was to
analyse the relationship of intracerebral glucose measured by intrapar-
enchymal cerebral microdialysis and it's relationship to blood glucose.
We also evaluated the relationship of these values to the outcome.
Methods: Prospective nonrandomised study conducted at a tertiary
care trauma centre in India.Twenty-five patients with severe TBI who
underwent decompressive craniectomy were prospectively moni-
tored with intracerebral microdialysis catheters (MD).
Results: Fifteen patients (60 %) had a good outcome in terms of GOS
at 3 months while the rest (10 patients) had poor GOS at 3 months.
There was significant difference in the incidence of hyperglycemia
(RBS > 10 mmol/L) between the two groups (p < 0.0001). The differ-
ence between the two groups while comparing episodes of
hypoglycemia was significant (p = 0.0026). Good outcome group had
fewer episodes of brain hypoglycemia during systemic hypoglycemia
(p = 0.0026). Neither mean blood glucose values nor mean cerebral
glucose values predicted outcome at 3 months.
Conclusions: After decompressive craniectomy in severe TBI, there
was a poor correlation between plasma and MD glucose concentra-
tion. A high degree of variation was seen in the correlations for pa-
tients individually. Neither mean blood glucose values nor mean
cerebral glucose values predicted outcome at 3 months. Good out-
come group had fewer episodes of both hyperglycemia and
hypoglycemia.
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Introduction: Simulation is increasingly recognised as a useful mo-
dality in post-graduate education in Intensive Care Medicine (ICM)
but is often perceived as expensive and difficult to deliver. It is used
for recruitment to ICM training posts and also forms part of assess-
ment for the Faculty of Intensive Care Medicine exam, however its
use in ICM education training lags behind anaesthesia.
Objectives: We aimed to establish and evaluate a programme of
regular, integrated, curriculum-mapped point-of-care simulation
training in a United Kingdom University Hospital Intensive Care Unit.
Methods: A 6 month pilot project was undertaken delivering dedi-
cated, weekly inter-professional simulation sessions as part of the
existing trainee education programme. This consists of weekly, 2-
hour curriculum-mapped small group sessions attended by stage 1, 2
and 3 ICM trainees. During the pilot programme, 1 hour of each ses-
sion was transferred to a simulation-based session, with scenario ob-
jectives designed to complement the teaching topic. At least 1
member of nursing staff was released from clinical duties to partici-
pate in the session. Other allied professionals were encouraged to at-
tend. Each session required 1 confederate, 1 debriefer and 1 person
to run the manikin. Scenarios were designed to explore both tech-
nical and non-technical aspects of the topic and were delivered in an
ICU side-room that is permanently set up with a manikin. Debriefing
was provided using the ´good judgement´ model. Quantitative and
qualitative feedback was sought after each session1. After 6 sessions,
interim feedback was analysed and changes were implemented for
the remaining pilot sessions.
Results: Several common themes emerged from the initial feedback.
Whilst broadly positive, participants and faculty all stated that the
room was very crowded, with many feeling that it detracted from
the learning experience. In an attempt to address this, we employed
the low-cost iOS application Airbeam®. This allows live audio and
video to be streamed over a secure wireless network between iOS
devices (iPhones and a MacBook). This allowed observers to view the
scenario from an adjacent room.
Final feedback was almost universally positive. Participants reported
greater willingness to speak up in future and highlighted specific is-
sues such as the accessibility of emergency guidelines. Quantitative
feedback demonstrated statistically significantly higher scores in all
areas for simulation versus didactic teaching.
Conclusions: We were able to provide a curriculum-mapped, in situ
simulation-based training programme within our ICU that was highly
rated by participants using low-cost, medium fidelity technology. We
present our experiences as potential template for other programmes.
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Introduction: A recent article written by The Faculty of Intensive Care
Medicine Workforce Advisory Group (FICM WAG) highlighted the
looming staffing crisis for ICM within the UK due to the increasing
need for critical care related to the increasing age of the population.
The Intensive Care National Audit and Research Centre (ICNARC)
Table 76 (abstract A724). Comparison of scores awarded for didactic
and simu
Met
objectives
mean score
(IQR)
Relevance
mean score
(IQR)
Effectiveness of
teaching method
mean score (IQR)
Standard of
teaching
mean (IQR)
Tutorial 8.632 (8–9.25) 8.97 (8–10) 8.8 (8–10) 8.995 (8–10)
Simulation 9.161 (9–10) 9.352 (9–10) 9.397 (9–10) 9.353 (9–10)
p value <0.001 0.004 <0.001 0.004
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have advised FICM WAG to expect a 4 % rise per year in the demand
for intensive care beds and the Centre for Workforce Intelligence
(CfWI) is predicting a required increase in the number of WTE in an-
aesthesia and ICM from 6,100 to 11,800 by 2033.1,2 This, in conjunc-
tion with contract reforms and a change in workforce demographic,
means that we need a multifaceted approach to increasing the num-
ber of intensivists over the coming years.
Objectives: Less than full time (LTFT) trainees are still very few in
number within ICM and we wanted to assess how the experiences
LTFT anaesthetic trainees had within the ICU setting affected their fu-
ture career choices and whether this group could be a source of in-
creasing the number of applicants to ICM dual training.
Methods: We used an anonymous web based survey distributed na-
tionwide to LTFT anaesthetic trainees.
Results: We received 115 responses. The vast majority were LTFT due
to childcare responsibilities (96.4 %). 7.2 % had been asked to
complete their ICM training full time despite approval for LTFT train-
ing from their parent specialty. 40 % had considered dual training
with ICM but ultimately decided against it. Only 3.5 % were planning
to apply in the future. 78.3 % had encountered difficulties with ICM
training related to their LTFT status. The most common issues were
engaging in extra-curricular activities, negative attitudes to LTFT
training and working patterns. 45.2 % felt they were perceived more
negatively than their FT peers. 53.1 % felt they would consider apply-
ing for dual training if there was a more structured pathway for LTFT
trainees. LTFT trainees expressed a wish to connect with others in
order to allow peer support and mentorship.
Conclusions: Very low numbers of LTFT anaesthetic trainees are pur-
suing a career within ICM due to difficulties encountered with their
training. Some of the highlighted issues may be due to the nature of
ICM but the negative attitudes experienced by LTFTs can and should
be addressed and more structured guidance for navigating LTFT
training within ICM could be developed. Innovative approaches to
allow equity of access to training opportunities would be welcomed.
We propose that although ICM and LTFT training have not been the
most natural bedfellows, there is a pressing need for this relationship
to improve. LTFT trainees may be a relatively untapped resource
which could contribute towards the necessitated expansion of the
ICM workforce.
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Introduction: Oral part of EDIC diploma examinations has changed
in 2013 into objective-structured clinical examination (OSCE) type
exam [1]. All candidates face identical questions with pre-defined
correct answers simultaneously in 7 high-throughput exam centres.
Objectives: To identify factors associated with success in part 2 EDIC
exam.
Methods: We prospectively collected self-reported data from all can-
didates sitting EDIC Part 2 in 2015, namely demographics, profes-
sional background and attendance to an EDIC part 2 or generic OSCE
exam preparatory courses. After testing association with success
(with cut-off at p < 0.10) and co-linearity of these factors as inde-
pendent variables, we performed a multivariate logistical analysis,
with binary exam outcome (pass/fail) as the dependent variable.
Structural equation modelling was used to gain further insight into
relations among determinants of success in oral part of EDIC.
Results: Out of 427 candidates sitting the exam we completed data
from 341 (80 %). Following candidates' factors were associated with
increased chance of success: English as native language (Odds ratio
4.3 [95%CI 1.7; 10.7]), use of Patient-Centered Acute care Training e-
learning program module (OR 2.0 [1.2; 3.3]) and working in EU coun-
try (OR 2.5 [1.5; 4.3]) and better results in written part of EDIC (for
each additional SD of 6.1 points OR 1.9 [1.4; 2.4]). On the contrary,
chance of success in EDIC 2 decreased with candidates´age (for each
additional SD of 5.5 years OR 0.67 [0.51; 0.87]). Factors eliminated
from the model because of lack of association with success or be-
cause of co-linearity included attendance in EDIC Part 2 prep courses
(OR 0.95 [0.52-1.70]), English as study language, baseline medical
specialty, the use of CoBaTriCE and actual working status (working or
not). Exam centres could be grouped into 3 groups with similar suc-
cess rates, and there were significant differences in exam outcomes
among these groups even after adjustment to known candidates´
factors (G1 vs G2 OR 2.4 [1.4; 4.1]; G1 vs G3 OR 9.7 [4.0; 23.1]; and G2
vs G3 OR 3.9 [1.7; 9.2]). Short data collection period (only one year)
and 20 % of missing candidates' data are the main limitations of this
study. The ESICM examination committee and Executive Committee
have taken a series of measures in order to optimise fairness and re-
producibility of the exam, which will be meticulously monitored in
upcoming series of exams.
Conclusions: Younger age, English as native language, working at a
European country and the use of PACT for preparation were factors
associated with success in oral part of EDIC exam. Despite the limita-
tions of this study, the signal of differences in outcomes among the
7 exam centres will need further investigation.
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Introduction: Burnout appears to be common among Critical Care pro-
viders. It is characterized by three components: emotional exhaustion or
loss of passion for one's work; depersonalization or treating patients as
objects and the sense that your work is no longer meaningful. Moral dis-
tress is the inability of a moral agent to act according to his or her core
values and perceived obligations due to internal and external constraints.
Objectives: To assess both burnout syndrome and moral distress
among all ICU and the Step Down Unit (SDU) providers (Physicians,
Nurses, Nurse Technicians, and Respiratory Therapists) and to esti-
mate the correlation between moral distress and burnout.
Methods: For data collection, a self-administered questionnaire for each
critical care provider was used including basic demographic data, the
Maslach Burnout Inventory (MBI) and the Moral Distress Scale (MDS).
Results: A total of 283 of the 389 (72.7 %) Critical Care providers
(Nurses, Nurses Technicians and Respiratory Therapists), agreed to par-
ticipate and the survey occurred from August and September 2015.
Out of this total, 134 were from ICU and 116 from SDU. Regarding Phy-
sicians, the same team of intensivists attended both ICU and SDU and
they were treated as an individual group and 67.3 % of them partici-
pated. Severe Burnout was identified in 18.2 % of Physicians. Consider-
ing all others Critical care providers (ICU + SDU) we identified that
22.5 % (95 % CI: 17.7-27.8 %) presented severe Burnout. There was not
statistical difference between the units: 22.1 % of ICU respondents had
severe Burnout and 23.7 % from SDU,p = 0.774. A total of 68 question-
naires of Moral Distress were incomplete and were excluded from ana-
lysis. All respondents (n = 215) reported a high level of moral distress
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overall. The mean MDS rate for all ICU respondents including both do-
mains (frequency and intensity) was 111.5 and for all SDU respondents
was 104.5, p = 0.446. We observed that those respondents with high
MDS score (>100 points) were more likely to suffer from Burnout
(28.9 % x 14.4 %, p = 0.010). Moreover, many questions from the MDS
questionnaire were significantly associated with severe burnout.
Conclusions: Our data show that moral distress, resulting from thera-
peutic obstinacy and the provision of futile care was the great prob-
lem of the critical care providers' team and significantly associated
with severe burnout.
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As the United Kingdom intensive care training curriculum develops and
the role of the intensive care physician becomes more defined so pro-
cedural skills associated with this role will become refined. Some skills
such as intubation and central access are well recognised. However, oc-
casionally less common skills may be required and these deserve a
place in the curriculum. One such skill is that of Sengstaken-Blakemore
tube (SBT) insertion. Currently the curriculum contains domain 5.18:
'Describes Sengstaken tube (or equivalent) placement'.
A trainee survey was undertaken to quantify the degree of familiarity
with this clinical tool in the Severn deanery in the South West of the UK.
A mixed cohort of 24 trainees responded (17 intensive care, 7 anaesthetic
trainees). Of those surveyed 3 had inserted SBT, 21 had not. 61 % had
some previous experience with SBT ('seen one inserted by someone' or
'looked after a patient with an SBT in situ'). Little formal teaching existed
on the topic with 57 % having received no training. 75 % felt they would
benefit from a formal teaching session.
This survey demonstrated a gap in confidence and exposure to SBT
use. As a result, a short teaching intervention was performed during a
regional training day. This focused on the common cause of GI bleeds
and situations where SBT may be of benefit, as well as practical aspects
of insertion, along a low fidelity model demonstration.
After this session a repeat questionnaire was sent out. This demon-
strated that confidence was improved (Fig. 104), with 61 % feeling
that annual training would be of benefit.
Summary: As the Intensive Care curriculum continues to develops,
trainees feel they would benefit from regular training sessions in less
common skills such as the management of Sengstaken-Blakemore
tubes. More broadly, involving trainees in the development of the
curriculum will ensure it meets the learning needs of the future work
force and guarantee high quality patient care.
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Introduction: National guidelines state that critically ill women
should receive the same standard of care for their pregnancy-
related and critical care needs. With changes to midwife training
focusing on normal labour and delivery, nursing competences are
reduced. A recent national audit identified that 43 % staff in ma-
ternity high dependency unit (HDU) areas had no specific critical
care training (1).
Objectives:
- To identify the need to cerate a HDU on the labour ward to meet
these national standards through local audit.
- Development of a training course for midwives.
Methods: A retrospective audit including all cases admitted to HDU over
a one-year period was conducted. Information regarding demographics,
diagnosis, maternal and neonatal morbidity and mortality and length of
critical care stay was collected. Secondly, a prospective audit over a 2-
week period surveyed all obstetric in-patients including demographics,
physiology scoring, level of care required and staff providing this care.
Results: The retrospective phase identified 18 patients transferred to
HDU, all post-partum. 6 of these patients could have been accommo-
dated on a HDU on labour ward, had one existed.
The prospective phase identified 17 women required HDU according to
physiology scoring. 88 % of these women were cared for by Band 6/7
midwives, and the remainder by band 5 midwives. None of the midwives
had recent critical care training. Only 26 % of patients were reviewed by
an anaesthetist and 37 % by a consultant obstetrician. 42 % did not re-
ceive the correct review prompted by their MMEOWS score.
MECU development: A 2-day course was created using a mixed-
methods teaching program including theoretical, practical and simula-
tion based sessions. The curriculum is designed to improve midwives´
confidence and skills in detecting, treating and stabilizing emerging or
established critical illness.
Fig. 104 (abstract A728). Pre versus post intervention confidence
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The midwives who participated in the MMEC course highlighted that
the practical elements, demonstrations and simulation-based teaching
facilitated their learning were particularly effective. Feedback identified
increased confidence in clinical management, increased awareness of
when to escalate and recognition of their own limitations.
Conclusions: The MECU course, as part of a larger quality im-
provement project to create a labour ward HDU environment
was created in response to local audit. This identified that such a
unit could reduce admissions to HDU provide appropriate care
for in-patients in need of a higher level of care. The course cre-
ated has a curriculum designed to increase confidence and
awareness of the issues surrounding the sick parturient and has
received excellent feedback. Future plans include development of
a regional training network.
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The aim of this audit was to demonstrate any significant improve-
ment in our inter-hospital transfer practice following the introduction
of a new simulated all day training provided to junior doctors in the
view of auditing our transfer data from 2014–2015.
A single centre retrospective audit in 21 bed mixed ICU of a non-
tertiary university hospital. During the audit period (2014–15) 29 crit-
ical care transfers were made. We audited data of referring team, lo-
cation, receiving team, transfer reason, decision-departure time,
intubation details, arterial blood gases (ABG), comments of the
teams, time of transfer, documentation and transferring doctor
grade. Our primary aim was to analyse any effect of our newly intro-
duced complex transfer training program.
In 2014, transfers were by SHO level doctors 38.5 % of cases, staff
grade and registrar level doctors were 46.1 % each, 15.3 % were not
documented.
In 2015, transfers were by SHO level doctors 6.25 % of cases, staff
grade and registrar level doctors were 93.7 % each. All transfers
were documented.
Non-clinical reasons in 2014 were 24 % opposite zero non clinical
transfers in 2015. In 2014 (53.8 %) of transfers occurred outside nor-
mal working hours (8 am to 17:00) versus 56.25 % in 2015, unlike the
past where most of transfers usually happened outside the normal
working hours.
Transfer- decision to departure time varied, with an average time of
minutes In 2014 the average time in minutes was 229 minutes which
was nearly double its peer value in 2015 (133 minutes).
Records of the doctor performing the transfer were well kept but
those of the receiving team were generally absent but thanks to the
new transfer form 24 out of 29 comments from the receiving team
were documented (82.7 %) and were consistent with the expecta-
tions with one comment saying (Excellent handover).
The transfer of the critically ill patients remains a big challenge to ju-
niors of all grades. A complex and holistic approach needed with a
broad spectrum of knowledge regarding the possible complications.
Our all day transfer course introduced in 2015 gave the opportunity
to learn and hands on simulate with a live ambulance what is it like
to be on a hot transfer.
Our data shows significant improvement in the documentation,
organization and quality of transfer without adverse events affecting
patient´s safety with lack of incident reports.
The positive feed backs from trainees and the overall improvement
of our transfer service proves that simulated training of this difficult
and grey area is fruitful and worth carry on.
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Introduction: Delirium is one of the most common complications
resulting in ICU morbidity and mortality. Despite its well-known con-
dition, delirium is frequently unrecognized by critical care teams.
Additionally, assessment of delirium in critically ill patients is not rou-
tinely performed in our country. The Confusion Assessment Method
for the ICU (CAM-ICU)1,2 is a well-validated tool for delirium evalu-
ation, however, it is the new tool for our team.
Objectives: We aimed to assess nurse competence in using the
CAM-ICU for delirium evaluation.
Methods: Our hospital had implemented the CAM-ICU for delirium
evaluation in 2 medical ICUs for a 4-month period and we subse-
quently assessed nurse competence in using the CAM-ICU by a
paper-based examination. All medical ICU nurses were enrolled to
perform the test which was composed of 5 case-scenarios. The
nurses were allowed to use CAM-ICU sheets for Richmind Agitation
Sedation Scale (RASS) scoring3 and delirium evaluation.
Results: Sixty-nine medical ICU nurses did the paper-based test. Ap-
proximately, 31 % of the examinees scored RASS inaccurately. Inter-
estingly, 60 % of them did not understand how to interpret the
mental status domain of the CAM-ICU, especially the fluctuating
course of consciousness. In addition, only 29 % of them detected
hypoactive delirium correctly. Furthermore, 80 % of the examinees
got confused to make a diagnosis of delirium in partially sedated
patients.
Conclusions: The study demonstrated the limited skill and know-
ledge of our intensive care nurses in detecting delirium by the
CAM-ICU. According to these results, a structural training program
would be provided to increase the nurse competence in delirium
assessment.
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Introduction: In 2007, Martin Bromiley established the first clinical
human factors group, which has both clinical and NTS specialists in-
volved in safety in intensive care and anaesthesia.
Human factors and NTS contribute up to 40 % of the critical inci-
dents as per the NAP 4 anaesthesia audit which was a UK based na-
tional level audit on the adverse incidents in airway management
during anaesthesia. The causes for critical incidents included lack of
situation awareness, judgement and poor decision making with poor
communication and teamwork. A mortality rate of 5.6 per million
general anaesthetics (1:180 000) in a period of over a year in anaes-
thesia, ICU and the emergency department, was reported. The pro-
ject findings suggest avoidable deaths due to airway complications
occur in ICU and the emergency department.
Objectives: To analyse the rationale of a full-scale simulator called
the Comprehensive Anesthesia Simulation Environment (CASE) to
specifically study decision-making processes of anaesthetists during
that were a take off from aviation Crew Resource Management
(CRM)in difficult Airway & Resuscitation situation.
Critical analysis of simulation as a valid and reliable tool to assess the
competency based training (CBT).
Methods: This study conducts a systematic literature search and an
analytical review from the Cochrane database of reviews and other
online sites such as Medline, Embase and Pubmed.
Results-Simulator enables faculty to provide structured simulation lab
experiences instead of trying to find appropriate and/or rare patient
care opportunities in a health care settingAny kind of environment
can be created to train multi professional teams in primary and sec-
ondary care. Currently simulators are used much more for educa-
tional purposes (undergraduate: 77 %, postgraduate: 85 %) than for
evaluation purposes (undergraduate: 14 %, postgraduate: 7 %
(Girard, Ely 2008) and that proportion needs to change with the
current needs of using simulation for evaluation of competency.
Conclusions: Human factor training develops leadership, coordination
and shared understanding of roles leading to improved performance in
anaesthesia, trauma and intensive care. Simulation is vital to validate
CBT and it can be accepted as a comprehensive way to assess proced-
ural skill. Behaviour and personality testing should be considered in the
selection process to identify the prospective trainees in the subject
along with the just use of NTS training to achieve that end. Simulation
centres require important financial and human resources and hence
the need for communication and collaboration among centres using
simulation technology to improve quality of training.
References
1. COOK, T.M. et .al NAP 4 British journal of anaesthesia, 106(5), pp. 617–631
2. CRABTREE, N.A et.alFibreoptic airway training: correlation of simulator
performance and clinical skill. Canadian journal of anaesthesia = Journal
canadien d´anesthesie, 55(2), pp. 100–104
No Grants
Fig. 107 (abstract A730). Location of the patient
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 375 of 607
A733
Living in ICU - watch out for burnout
E. Lourenço1, L. Melão1, C. Duro1, G. Baptista1, A. Alves1, B. Arminda1, M.
Rodrigues1, A. Marreiros2, C. Granja1,3,4
1Centro Hospitalar do Algarve, Hospital de Faro, Emergency and
Intensive Care Department, Faro, Portugal; 2Biomedical Sciences and
Medical Department, Algarve University, Faro, Portugal; 3University of
Medicine of Porto, CIDES/CINTESIS, Porto, Portugal; 4University of
Medicine of Faro, Faro, Portugal
Correspondence: E. Lourenço - Centro Hospitalar do Algarve, Hospital
de Faro, Emergency and Intensive Care Department, Faro, Portugal
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A733
Introduction: The professional activity in the ICU departments has in-
herent a particularly high level of stress, which is a risk factor for de-
velopment of burnout.
Studies carried out in this area have revealed high levels of burnout
and how these were related with labor absents with its conse-
quences for the functioning of units.
Objectives: To identify the possible existence of burnout and its risk
and protective factors in health professionals of the ICU Department
of Algarve Hospital Center - Faro.
Methods: Quantitative, cross-sectional, descriptive study in which we
applied a self-fulfilled questionnaire containing three items: sociode-
mographic characterization of the study population, experiences
lived in the workplace based on Embriaco questionnaire and Maslash
Burnout Inventory (MBI).
Results: Out of 77 professionals, 75 agreed to answer to the question-
naire (response rate 97.4 %). 60 returned the complete questionnaire, 8
physicians and 52 nurses. 43.3 % of the professionals had less than
10 years of work experience and 29.3 % said that if they could they
would change profession. We considered burn out if the professional pre-
sented high level on Emotional Exhaustion and Depersonalization and
low level of Personal Accomplishment; high risk of developing burnout if
high level was presented in Emotional Exhaustion or Depersonalization
and low level in Personal Accomplishment; and moderate risk if Emo-
tional Exhaustion or Depersonalization presented high level or Personal
Accomplishment presented low level. Of the 60 professionals, 48.3 %
presented moderate or high risk of developing burnout or were in
burnout. Burn out levels were higher in women (26.7 %) versus men
(13.3 %) and in physicians (25 %) versus nurses (23.1 %).
Conclusions: Burn out or high risk of developing burnout was pre-
sented in a high rate of health professionals of our unit. Being
woman and physician is associated with a higher risk of developing
burnout. Strategies aiming to reduce burnout should include coping
strategies and specific training in this field.
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Introduction: It is known that significant anxiety and depression is
suffered by relatives during a patients ICU admission with up to
33 % going on to experience post-traumatic stress disorder (PTSD)1,
2. A better understanding of these symptoms and risk factors for
developing them may help determine interventions to avoid these
adverse psychological states.
Objectives: The aim of the study was twofold. The first aim was to
quantify the number of relatives with clinically detectable anxiety
and depression using a verified scoring system. The second aim was
to see how access to information correlated with anxiety and depres-
sion scores.
Methods: A questionnaire of patients' relatives on the ICU over
a six month period (February - August 2015) was carried out.
Local ethical approval was granted. Relatives were selected at
random to be part of the study and elective admissions and ad-
missions of less than 48 hrs were excluded from the study. The
questionnaire collated data on the 'hospital anxiety and depres-
sion score' (HADS), the perceived quality of communication de-
livered and the external support outside the ICU that was
sought.
Results: The questionnaire was completed by 50 relatives. Clinically
significant anxiety was found in 38 (76 %) relatives and 20 (40 %)
had clinically significant depression. There was no correlation be-
tween length of stay and HADS. There was a correlation between
high HADS and perceived high quality of communication on the ICU.
This possibly indicates that these relatives sought or required more
information to help allay anxieties.
External information sources relating to the ICU and patients medical
conditions was actively sought in 20 (40 %) of relatives, with the
internet and friends being the most popular sources. Many individ-
uals said they felt isolated when they were at home and relied on
friends for support.
Conclusions: The results demonstrate that a large proportion of
our patients relatives suffer significant acute psychological symp-
toms. Relatives with higher HADS sought more information from
ICU staff and 40 % of relatives also sought external support and
information. Following the results of this we have developed a
website specific for our ICU with general information, useful links
and a contact email address for the ICU consultants. We plan to
re audit relatives HADS 6 months after the introduction of the
website.
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Introduction: The most common sources of clinical errors are not
from failure of clinical knowledge or skill, but rather failure of team
performance with deficiencies in communication, coordination and
teamwork. Growing evidence suggests that team training based on
crew resource management (CRM) principles may improve team-
work, patient safety, and optimization of patient care.
Objectives: We evaluated the impact of simulation based team train-
ing on acute ICU admissions and determined this improved the con-
fidence of the ICU staff and the quality of teamwork.
Methods: The project comprised 2 parts. In the first part, all partici-
pants received a 2-hour theoretical video training covering the basics
of CRM prior the beginning of the study. Subsequently, during a
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period of 3 months, the admitting physician and coordinating nurse
were asked to fill in a survey covering the 4 domains of teamwork
(Leadership, communication, stress and situational awareness) on all
acute admissions in the ICU. Items were scored on a scale of 0 (not
important or worst level) to 10 (very important or highest level).
The second part of the study consisted of structural trainings of all
physician- and nursing staff in the ICU divided in groups of 3 nurses
and 1 physician, using high fidelity MTW/CRM based simulation with
a prefixed scenario. The groups had each to fill in surveys before and
after training, and were debriefed by an experienced instructor using
video analysis. Scenario trainings were scheduled to be repeated
after 6 months.
Results: During 133 acute ICU admissions physicians and nurses had
the perception that handing over information and communication
was above average, however summaries were used poorly (median
scores 4 and 6 for physicians and nurses).
After 2 structural trainings, physician and nurses felt they were more
competent leaders (P = 0.001). Especially nurses became more
confident in a leadership role (P = 0.001). Feedback loops, briefings
and summaries were used more systematically (p = < 0.001) and
everyone was more accustomed to standard terminology. Further-
more, nurses dared to speak up more (P < 0.001). Overall, stress levels
were reduced (P = 0.015).
Conclusions: The entire team in the ICU has the perception that
structural training in CRM improves confidence and performance. Fu-
ture research is warranted to compare these results with behavioural
observations of the entire team in the ICU.
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Introduction: The number of intensive care unit (ICU) beds in the UK
per capita is proportionally one of the lowest in Europe1; the Royal
Berkshire Hospital (RBH) has one of the lowest proportions compared
to the rest of UK. Access to this resource is therefore limited and in-
creasingly intensivists are being asked to bring intensive care to the
wards2.
Objectives: To describe the work carried out by intensive care doc-
tors outside the 17 bed ICU in the 745 bed Royal Berkshire Hospital
serving a population of 600,000 people and identify any impact this
has on patient outcome.
Methods: Contemporaneously recorded requests for intensivists to
review patients on inpatient wards and in the emergency depart-
ment during 1st August 2014 - 31st July 2015 were retrieved from the
electronic ICU database. Hospital admission and discharge data were
analysed for comparison of outcomes.
Results: 1108 patients were referred; paediatric patients (n = 108)
and referrals with incomplete details (n = 105) were excluded from
analysis. 895 patients were included in analysis, median age 66 years
(interquartile range = 48-77 years). 26.6 % were admitted to ICU (n =
238), of which 76.1 % survived to discharge from RBH. 45.6 % re-
ferred patients were suitable for but not requiring an ICU admission
at the time of referral (96.1 % survived), 17.6 % were at their ceiling
of care (ward based care maximum; 19 % survived). 60.7 % of all re-
ferred patients not admitted to ICU survived to hospital discharge.
Conclusions: Intensivists spend considerable clinical time reviewing
patients on general wards, however only a proportion (26.6 %) re-
quire admission to an intensive care unit. The outcome for patients
in whom escalation in care was felt inappropriate was widely poor.
Whereas those reviewed by intensivists and considered eligible for
but not requiring of admission to ICU experienced good outcomes
(survival rate 96.1 %). Any potential effect of an increased bed cap-
acity on admission and survival is unknown.
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Introduction: Since the advent of Focussed Assessment with Sonog-
raphy for Trauma (FAST), focussed sonography has become integral
to clinical assessment in the early phase of critical illness with wide
adoption in Emergency Departments and Critical Care.
Bedside ultrasound (US) guided assessment has been demonstrated
to be superior to clinical assessment alone in examination of the
chest, abdomen, renal and musculoskeletal systems as well as a fun-
damental patient safety tool for invasive procedures [1].
While focussed US can be considered an extension of basic clinical
skills, most undergraduate programs globally are yet to address this
deficit with some uptake in Europe and the United States and none
in the UK at present.
This descriptive paper outlines our institutional experience integrat-
ing focussed ultrasound training into a 3-month Resuscitation Medi-
cine module.
Objective: Explore feasibility, engagement, self perceived and object-
ively assessed competence following integration of US into under-
graduate clinical education.
Methods: An elective program on Resuscitation medicine was de-
signed covering undergraduate learning outcomes spanning early
identification of critical illness to the concepts of organ support. Na-
tionally adopted ultrasound competencies designed for senior
trainees in Emergency Medicine and Critical Care were edited and
aligned to each component of the undergraduate module.
Students received an average of 2 hours of formal US training weekly
for an 8 week period and were each allocated a handheld device (GE
VScan) and this was integrated into their routine clinical assessment.
The following themes were prioritised:
 Enhanced Focussed Assessment with Sonography for Trauma
(eFAST)
 Echocardiography [RV/LV ratio, gross LV dysfunction,
pericardial effusion, major valvular dysfunction]
 Inferior Vena-Caval collapsibility assessment
 Thoracic assessment [pleural effusions and consolidation]
Results: Each candidate recorded an average of 35 satisfactory stud-
ies. Undergraduate candidates within this pilot were able to achieve
an OSCE assessed competence level comparable to that of post
graduate trainees approaching Royal Colleges´ defined Level-1 as-
sessment. A high degree of satisfaction was observed in formal feed-
back. Follow up for skill retention remains ongoing and will be
assessed again at 6 months and 12 months in OSCE format. No ad-
verse impact observed on acquisition of set learning outcomes.
Conclusions: Integration of US training into undergraduate clinical
education proved feasible with a high degree of satisfaction and
measured competence. While wider integration would carry cost im-
plications, this is an area that warrants careful review if the modern
undergraduate curriculums are to remain fit for 21st century practice.
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Introduction: Ventilator associated pneumonia (VAP) is associated
with a significant clinical and financial burden on intensive care units
(ICU). Length of stay (LOS), duration of mechanical ventilation (MV)
and mortality are all increased1. National Healthcare Safety Network's
(NHSN) data shows VAP rates in trauma patients are up to 3 fold
higher compared to the general ICU population. Centralisation of UK
trauma services has created larger cohorts of trauma patients in ded-
icated tertiary units1.
Objective: We aimed to identify risk factors within the trauma popu-
lation that put certain subgroups at higher risk of developing VAP.
Method: A retrospective review of all patients admitted to the ter-
tiary adult ICU of the Major Trauma Centre (MTC) at The Royal
London Hospital over a 1-year period (February 2014–2015). The
diagnosis of VAP was based on the Clinical Pulmonary Infection
Score (CPIS). Demographic, clinical and microbiological data were
collected. Mortality, LOS and duration of MV differences were studied
between VAP and non-VAP groups.
Results: Of the 1269 patients admitted to ICU, 925 required invasive
ventilation for > 48 hours. Overall incidence of VAP was 11 % (104/
925), with rates higher amongst the trauma population 19 % (61/
315) compared to the general ICU population 7 % (43/610); p <
0.0001. Patients who developed VAP had increased length of ICU
stay (19.5+/− 13.6 vs. 9.71 +/− 11.9 days; p < 0.0001) and duration of
MV (15.2 +/− 11.3 vs. 6.9 +/− 9.5 days; p < 0.0001). There was no dif-
ference in APACHE II scores and mortality between VAP and non-VAP
groups (p = 0.27 and p = 0.16 respectively). Predominant pathogens
were H.Influenza, S.Aureus, enterobacter and klebsiella. Trauma pa-
tients had increased infection with H.Influenza (28 % vs. 12 %) and
S.Aureus (36 % vs. 19 %). Trauma patients who developed VAP had
higher mean injury severity scores (ISS) (34 vs. 27; p = 0.0004) and
lower mean pre hospital Glasgow Coma Scores (GCS) (7 vs. 9; p =
0.03) compared to trauma patients without VAP. Trauma patients
with VAP had a higher incidence of significant head injury com-
pared to those trauma patients who did not get VAP (41/61
(67 %) vs. 134/254 (52 %); p = 0.04). Chest trauma rates were
similar between patients who developed VAP and those who did
not (18 % v. 14 %; p = 0.43).
Conclusion: The trauma population are at high risk for developing
VAP. Traumatic brain injury (TBI) patients are the highest risk in this
group. The ISS is a better predictor for developing VAP than trad-
itional ICU scoring systems (APACHE II). Amongst the TBI population,
ones with lower pre-hospital GCS are at higher risk, and this may re-
flect loss of protective airway reflexes and higher risk of aspiration.
VAP is associated with longer LOS and MV, but crude mortality is un-
affected. Further research should ascertain other risk factors for VAP
with focussed preventative strategies for high-risk subgroups.
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Introduction: Augmented renal clearance (ARC) has emerged re-
cently as a new concept and is being increasingly described in critic-
ally care setting. The true prevalence of ARC in these heterogeneous
populations of critical ill patients is not well known; nevertheless, it
must not be neglected: recent reports describe prevalence between
28 to 65 % within the critically ill population, varying accordingly to
methodology and case-mix.
Objectives: We aimed to determine the prevalence of ARC and to
identify the risk factors (RF) associated with ARC condition, in a large
heterogeneous population of critically ill patients.
Methods: This was an observational retrospective single-center study,
performed in a 20-bed tertiary level, university affiliated, adult inten-
sive care unit (ICU), within the period of one year. Daily routine 8 h-
creatinine clearance (8-CLCR) was measured to all admitted patients
(23 pm to 07 am), excluding measurements where serum creatinine
≥1.2 mg/dL. ARC was defined as an 8-CLCR ≥130 ml/min/1.73 m
2. De-
scriptive demographic and epidemiological characterization of the
studied population was performed. Statistical tests used in the ana-
lysis were all two-sided, and a p-value of < 0.05 was considered statis-
tically significant. A multivariable binary logistic regression model
adjusted for possible confounders (age, gender and cause of ICU ad-
mission) was carried out to define RF for ARC condition.
Results: For-hundred and seventy-seven patients (477) contributed
data, corresponding to 4271 CLCR evaluations (clearance-days). “Med-
ical” was the leading cause of ICU admission (43.3 %), followed by
“post-surgery” (31.9 %) and “trauma” (24.7 %). The average SAPS II
was 42.3 (12.6). Male gender predominated (65 %) and 98 % of the
patients were submitted to invasive mechanical ventilation. Overall,
33 % of the measurements showed ARC (n = 1409), 47 % showed
values between 60 and 130 mL/min/1.73 m2 (n = 2006) and 20 %
had values lower than 60 mL/min/1.73 m2 (n = 856). The average
8 h volume of urine was higher in patients showing ARC - 875
versus 780 mL; p < 0.001. Serum creatinine and BUN were lower
in ARC clearance-days (0.59/0.67 mg/dL, 17/23 mg/dL, respect-
ively; p < 0.01). Adjusted Odds Ratio for ARC was 2.9 (95 % IC:
2.4-3.4; p < 0.01) for gender, 1.7 (95 % IC: 1.4-1.9; p < 0.01) for
trauma admission and 1.067 (95 % IC: 1.061-1.073; p < 0.01) for
age (per year).
Conclusions: ARC was a frequent condition in this large population
of critically ill patients with normal plasma creatinine concentrations,
with an overall prevalence of 33 % of the days. Decreased renal func-
tion (lower than 60 mL/min/1.73 m2) was present in 20 % of the
days. Male gender, trauma ICU admission and young age were sig-
nificant risk factors for ARC.
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Introduction: Bedside microdialysis monitoring has shown better
results compared to CPP-targeted therapy in the treatment of
comatose patients sustaining brain injury after severe traumatic
brain injury.
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Objectives: The study aimed to see the role of glycerol and LP ratio
monitoring in the brain parenchyma region and its association with
cerebral perfusion pressure for outcome prediction.
Methods: The study was conducted on 41 patients above 18 years
of age with severe traumatic brain injury (GCS < =8) who pre-
sented to the emergency with a surgically treatable lesion. Pa-
tients who were pregnant, GCS =3 with fixed dilated pupils or
hemodynamically unstable were not enrolled in this prospective
non-randomised study. As part of routine protocol, patient under-
went a non contrast computed tomography (NCCT) head at ad-
mission along with assessment of other systemic injuries.
Informed consent and Institute ethics review board permission
was obtained prior to inclusion in this study. The outcome was
assessed using the Glasgow outcome scale (GOS).
Results: A total of 3,697 corresponding cerebral perfusion pres-
sure and brain microdialysis readings were obtained. In our
study, the mean CPP for the whole cohort was 74.27 mm Hg
(SD 14.05).
Glycerol: When compared during the first two days of monitoring,
the glycerol levels were higher in the unfavourable outcome group
(Mean 220.86; SD 25.85) as compared to the favourable outcome
group (Mean 191.76; SD 31.89)[NS].
LP ratio: In the poor outcome group, 1354 values were available for
LP ratio with a mean of 80.16 (SD 320.26). In the good outcome
group, 2047 values were obtained with a mean LP ratio of 45.77 (SD
169.82). The difference between the two groups was statistically sig-
nificant (p = 0.000).
Cerebral perfusion pressure was seen to have an inverse correlation
to LP ratio for the whole cohort as would be expected with increased
perfusion (p = 0.029).
Conclusions: CPP monitoring is important after traumatic brain injury
since cerebral blood flow is highly dependent on CPP below the
lower limit of cerebral autoregulation (CPP < 50 mmHg). Higher CPP
by its effect on metabolic parameters, such as LP ratio could be asso-
ciated with a better outcome.
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Background: It is known that psychiatric disorders after traumatic
brain injury are frequent. However, the relationship between mild
traumatic brain injury and psychiatric diseases has never been estab-
lished. We conducted a study of patients with mild traumatic brain
injury to evaluate if they had a higher risk of psychiatric diseases
compared with the general population.
Methods: We utilized a sampled National Health Insurance claims
database containing one million beneficiaries. We followed all benefi-
ciaries from January 1, 2005 to December 31, 2013 to determine if
they were diagnosed with psychiatric diseases. The definitions of psy-
chiatric diseases in our study are schizophrenia, bipolar disorders and
major depression. We further identified patients with mild traumatic
brain injury and compared their risk of psychiatric diseases with the
general population.
Results: We identified 76,991 patients with mild traumatic brain in-
jury and 881,511 patients without mild traumatic brain injury. After
controlling for age, gender, urbanization level, socioeconomic status,
liver cirrhosis, chronic obstructive pulmonary disease, diabetes,
hypertension, coronary artery disease, hyperlipidemia, history of alco-
hol intoxication, malignancies, smoking, obesity, chronic renal insuffi-
ciency and Charlson Comorbidity Index score, the adjusted hazard
ratio for psychiatric diseases was 1.46 (95 % confidence interval,
1.29—1.64).
Conclusion: Mild traumatic brain injury may be associated with diag-
noses of psychiatric diseases.
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Introduction: Thoracic injuries account for 4 % to 6 % of children
hospitalized for trauma and 25 % of pediatric trauma deaths. Almost
a third of patients with chest trauma are found to have pulmonary
contusions (PC). There is paucity of data about prevalence of ARDS in
children with PC.
Objective: To evaluate the incidence and prevalence of PC in chil-
dren with chest trauma and the association between PC and ARDS.
Methods: This is a retrospective single center cohort study. Our insti-
tutional Trauma registry was queried for patients 0–18 years of age
who were admitted between 5/2008 and 10/2015 with a diagnosis of
PC. PC at our center was defined using radiological and clinical cri-
teria. We included patients with trauma with a chest Abbreviated In-
jury Score (AIS) of 2 or greater. Patient demographic, clinical data
including age-adjusted hypotension, initial Glasgow Coma Scale
score (GCS) and injury of severity score (ISS) was collected. ARDS was
defined using the Berlin Criteria (1) and Pediatric ARDS PALICC cri-
teria (2). We excluded patients who were discharged home from the
emergency department or were dead on arrival. Continuous Data is
expressed as median with interquartile (IQR) ranges and compared
with Mann–Whitney U test, Fisher's Exact test, and Chi-Square test.
Results: Fifty out of 1916 (2.6 %) patients less than 18 yrs. of age
with trauma had PC. Of these, 58 % patients were males, and 70 %
were of non-Hispanic origin (Black 42 %, White 8 % and other 50 %).
Median age was 10.7 yrs (IQR 6.8, 14.3). Median hospital length of
stay (HLOS) was 8.5 (4,18) days. Ninety-six percent (48/50) needed
admission to the pediatric ICU. Median scores for GCS, AIS chest and
ISS were 15 (8, 15), 3 (3, 3) and 22 (18, 29) respectively. Forty two
percent (21/50) of the patients with PC needed invasive mechanical
ventilation (IMV) with the median duration of ventilatory support be-
ing 3 (2, 6) days. Fifty-two percent (11/21) of patients who needed
ventilatory support had ARDS with a median p/f ratio of 264 (106,
426). Patients with PC who needed invasive ventilatory support had
significantly longer length of ICU stay (7.5 (4, 14) vs. 3.25 (2, 5) days,
p = 0.003), lower GCS score (8 (3, 11) vs. 15 (15, 15), p = 0.0001),
higher ISS score (29 (22, 34) vs. 19 (14, 22), p = 0.02), and lower S/F
ratios (99 (95, 178) Vs. 461 (353, 471) compared to those who did not
require ventilatory support. All patients with mortality (4/50) were in
the IMV group.
Conclusions: Our experience demonstrated that over a quarter of pa-
tients with PC will require ventilatory support and more than half of
patients with PC requiring ventilatory support will develop ARDS. The
need for IMV, higher ISS score and lower GCS are risk factors signifi-
cantly associated with morbidity and thus help to identify high risk
patients.
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Introduction: Extracellular microvesicles (MVs) are subcellular plasma
membrane-enclosed particles released from activated and apoptotic
cells, emerging as key indicators and mediators of disease patho-
physiology. Acute increases in levels of circulating MVs have been re-
ported in mechanical trauma and sepsis patients (1), but the
relationship with clinical severity is unclear, due potentially to the
complex dynamics of acute inflammation. Burn injury is a unique
form of trauma with very well defined aetiology, onset of insults and
early clinical course, producing acute sterile SIRS in virtually all pa-
tients with a moderate to severe degree of injury. Severe burns may
therefore represent an optimal study population to evaluate acute
MV release and its relationship to the development of SIRS. In this
pilot investigation, we measured circulating MV levels following se-
vere burns, with severe sepsis patients as a comparator group.
Objectives: To determine the relationship between circulating MVs
and early onset SIRS following severe burns injury.
Methods: Patients with acute thermal injury admitted to the burns
Intensive Care Unit (ICU) were prospectively studied. Baseline demo-
graphic data collected included age, sex, Abbreviated Burn Score
Index (ABSI) and Belgian Outcome in Burn Injury (BOBI). Blood was
sampled within 24 hours of admission and centrifuged to remove cells.
MVs derived from leukocytes (CD45+), granulocytes (CD11b+/CD66b+),
monocytes (CD45+/CD14+), and endothelial cells (CD105+) were quan-
tified in plasma by flow cytometry. MV levels were compared to sam-
ples taken from healthy volunteers and patients with severe sepsis
recruited from the general ICU. Sepsis and burns patients that died
while on the ICU were classified as non-survivors.
Results: All circulating MV subpopulations were elevated in burns pa-
tients on day of admission (day 0) compared to healthy volunteers
(leukocyte-MVs: 3.5-fold, p = 0.005; granulocyte-MVs: 12.8-fold, p <
0.0001; monocyte-MVs: 20.4-fold, p < 0.0001; endothelial-MVs: 9.6-fold,
p = 0.01), but decreased significantly by day 2. MV levels were increased
with severe sepsis, but less consistently between patients. Leukocyte-
and granulocyte-derived MVs on day 0 correlated with clinical assess-
ment scores and were significantly higher in burns ICU non-survivors
compared to survivors (leukocyte MVs 4.6 fold, p = 0.002; granulocyte
MVs 4.8 fold, p = 0.003). Mortality prediction analysis of area under re-
ceiver operating characteristic curve was 0.92 (p = 0.01) for total
leukocyte MVs and 0.85 (p = 0.04) for granulocyte MVs.
Conclusions: These findings demonstrate, for the first time, acute
increases in circulating MVs following major burns injury and
point to their potential role in propagation of sterile SIRS-related
pathophysiology.
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Introduction: Trauma remains the leading cause of death and dis-
ability in patients under 40 years of age [1–4]. It is now widely ac-
cepted that patients with higher injury severity benefit from Major
Trauma Centre (MTC) care. This has resulted in increasing emphasis
on pre-hospital triage decision tools currently based on a combin-
ation of physiological data, diagnosis and mechanism of injury.
Hyperglycaemia was previously observed to be a predictor of neuro-
logical outcome in Traumatic Brain Injury [1] as well as associated with
elevated morbidity and mortality in patients with major trauma [2–3].
On-scene (Pre-Hospital) blood testing reflects the hyper-acute phase of
trauma and no previous studies have looked at correlation between
pre-hospital capillary glucose levels and subsequent Injury Severity
Score (ISS). If such a correlation exists, it may suggest a role for integrat-
ing glucose measurements into pre-hospital triage models.
Objective: Investigate correlation between pre-hospital hypergly-
caemia and subsequent confirmed ISS and 28 day mortality.
Method: Records of patients attended by our Helicopter Emer-
gency Medical Service over a 9-month period were retrospect-
ively examined. Clinical assessment and interventions on-scene
were contemporaneously recorded electronically by the Physician-
Paramedic team including capillary glucose measurements. In
addition, physiological, injury and outcome data was prospect-
ively recorded at all MTCs by dedicated staff on a standardised
national database - Trauma Audit and Research Network [4]. Pa-
tients who did not undergo an on-scene glucose measurement
were not included in the study.
Results: 166 patients were included in the study. Mean ISS score
was 16.5 (0–66) and overall mortality was 7.8 %. The majority
[>90 %] of cases were blunt trauma patients. Linear regression
analysis suggested a strong correlation between hyperglycaemia >
6.5 mml/L and ISS (P = 0.038) with a larger effect on ISS at a
hyperglycaemia cut-off > 7.8 (P = 0.021). There was no signification
correlation between pre-hospital hyperglycaemia and 28-day mor-
tality or Critical Care admission within our sample.
Conclusions: Our findings suggest that hyperacute elevation in
blood glucose may provide an early indication of underlying se-
vere injury and merits further investigation within a larger study.
If our findings are replicated, glucose measurement may provide
a new parameter in pre-hospital triage algorithms.
References
1. Rovlias A, Kotsou S, The influence of hyperglycemia on neurological
outcome in patients with severe head injury. Neurosurgery. 2000
Feb;46(2):335–42; discussion 342–3.
2. Yendamuri S, Fulda GJ, Tinkoff GH, Admission hyperglycemia as a
prognostic indicator in trauma. J Trauma. 2003 Jul;55(1):33–8.
3. Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC, Relationship of
early hyperglycemia to mortality in trauma patients. J Trauma. 2004
May;56(5):1058–62.
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 380 of 607
4. Trauma Audit and Research Network (TARN), United Kingdom, https://
www.tarn.ac.uk/Home.aspx
A745
Trauma admissions to the intensive care unit at Bahrain Defence
Force Hospital
M.L. Hariz1, E. Azmi1, J. Alkhan2
1BDF Hospital, Anaesthesia ICU, Manama, Bahrain; 2BDF Hospital,
Manama, Bahrain
Correspondence: M.L. Hariz - BDF Hospital, Anaesthesia ICU, Manama,
Bahrain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A745
Introduction: Major trauma has been reported to be a major
cause of hospitalization and intensive care utilization worldwide
and consumes a significant amount of the health care budget.
Objectives: The aim of this study was to describe the characteristics
and treatment outcome of major trauma patients admitted into our
ICU and to identify predictors of outcome.
Methods: Between January 2009 and October 2014, a descriptive
retrospective study of all trauma admissions to a multidisciplinary in-
tensive care unit (ICU) of the Bahrain Defence Force Hospital in the
Kingdom of Bahrain.
Results: A total of 385 cases of major trauma were admitted in
the ICU. Males outnumbered females by a ratio of 5.8:1. Their
median age was 25 years. Trauma admissions came mainly from
the Accident and Emergency (84.7 %). Motor Vehicle Collision
(MVC) was the most common cause of injuries affecting 67.4 %
of patients. The overall ICU length of stay (LOS) for all trauma
patients ranged from 1 to 103 days (mean = 6.4 ± 10.29 days).
Mortality rate was 10.4 %. According to multivariate logistic
regression analysis, the surgical specialty, revised trauma score
< 9, injury severity core >15, the need for ventilatory support
and the use of vasopressors significantly influenced mortality (P
< 0.05).
Conclusions: The impact of trauma on our icu has not been previously
documented. This study assesses the pattern, profile, frequency, and
outcome of trauma cases admitted to the multidisciplinary ten-bed
ICU. The characteristics and evolution of trauma admission of this series
of patients are similar to those described abroad. Mortality was in
agreement with ISS and RTS scores.
References
1. Hofman K, Primack A, Keusch G, Hrynkow S. Addressing the growing
burden of trauma and injury in low- and middle-income countries.
Am J Public Health 2005, 95:13–7.
2. Park K. Accidents. In In Textbook of Social and Preventive Medicine..
17edition. Edited by: Park K. Jabalpur: Banarsidas Co; 2000:304–5.
3. Museru LM, Leshabari MT. Road traffic Accidents in Tanzania: A 10-year
epidemiological Appraisal. East Central Afr J Surg 2002, 7:23–26.
A746
The use of outcome prediction models in severe traumatic brain
injury
S. Honeybul
Sir Charles Gairdner Hospital, Neurosurgery, Perth, Australia
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A746
Introduction: Predicting long-term neurological outcomes after se-
vere traumatic brain (TBI) is important, but which prognostic model
in the context of decompressive craniectomy has the best perform-
ance remains uncertain.
Methods: This prospective observational cohort study included all
patients who had severe TBI requiring decompressive craniectomy
between 2004 and 2014, in the two neurosurgical centres in Perth,
Western Australia. Severe disability, vegetative state, or death were
defined as unfavourable neurological outcomes. Area under the
receiver-operating-characteristic curve (AUROC) and slope and
intercept of the calibration curve were used to assess discrimination
and calibration of the CRASH (Corticosteroid-Randomization-After-
Significant-Head injury) and IMPACT (International-Mission-For-Prog-
nosis-And-Clinical-Trial) models, respectively.
Results: Of the 319 patients included in the study, 118 (37 %) had
unfavourable neurological outcomes at 18-month after decom-
pressive craniectomy for severe TBI. Both CRASH (AUROC 0.86, 95 %
confidence interval 0.81-0.90) and IMPACT full-model (AUROC 0.85,
95%CI 0.80-0.89) were similar in discriminating between favourable
and unfavourable neurological outcome at 18-month after surgery
(p = 0.690 for the difference in AUROC derived from the two models).
Although both models tended to over-predict the risks of long-term
unfavourable outcome, the IMPACT model had a slightly better cali-
bration than the CRASH model (intercept of the calibration curve =
−4.1 vs. -5.7, respectively), especially when the predicted risks of un-
favourable outcome were < 80 %.
Conclusions: Both CRASH and IMPACT prognostic models were good
in discriminating between favourable and unfavourable long-term
neurological outcome for patients with severe TBI requiring decom-
pressive craniectomy, but the calibration of the IMPACT full-model
was better than the CRASH model.
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Introduction: Early rehabilitation is one of the most important ther-
apy issue in the Intensive care unit (ICU). One of the most essential
part of early rehabilitation is passive verticalization provided by med-
ical tilt table. However there is no information provided about verti-
catization in polyvalent intensive care unit.
Objective: To investigate was the passive verticalization (PV) possibil-
ity and safety in the polyvalent ICU.
Material and methods: We analyzed 38 episodes of PV in 14 patients
of polyvalent ICU: polytrauma (n = 8), isolated, traumatic brain injury
(TBI) (n = 8). Verticatization was provided by the medical tilt table. In
24 (63, 2 %) cases we verticalizated patients on artificial lung ventila-
tion (ALV), in 14 (36,8 %) cases on spontaneous breathing. Verticati-
zation was provided up to 20° during first session, up to 40° during
the second and up to 50°-60° during the third session. Verticatization
session was cared out gradually with the step of 10° in 5 minutes. As
the angle of inclination was reached, patient was fixed in a final pos-
ition during 15 minutes. If any signs of orthostatic failure occurred
the patient was still fixed on the reached point till compensation, but
not more than for 15 minutes. The session was continued only after
orthostatic failure absolute regress. If no regress happed during
15 minutes the sessions was stopped.
Results: Patients on ALV successfully reached the target value during
22 (91, 7 %) sessions. Most of the sessions (19(86, 4 %)) were per-
formed without complications; in 3 cases (13, 6 %) were noted some
insignificant complications. Two of the sessions (8, 3 %) had to be
stopped because of the orthostatic failure. Patients on spontaneous
breathing reached a target angle in 12 (85.7 %) session with no com-
plications. Two of the sessions (14, 3 %) were interrupted because of
the complications. The most frequent of the verticalization are tachy-
cardia (n = 4 (10, 5 %)), arterial hypotension (n = 5 (13, 2 %)), tachyp-
nea (n = 6 (15, 8 %)).
Conclusions: In the polyvalent intensive care unit verticalization can
be used safety in patients on ALV and on spontaneous breathing.
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Introduction: Hemorrhagic shock is characterised by a mismatch of
O2 demand and supply resulting in tissue hypoxia, inflammation and
subsequent multi-organ failure (MOF)1. Hyperoxia reduced inflamma-
tion and attenuated kidney dysfunction in hemorrhagic shock in
healthy swine2. However, pre-existing cardiac disease increases mor-
tality after trauma and hemorrhage3.
Objectives: To investigate the effect of hyperoxia on kidney function
during porcine hemorrhage and resuscitation with pre-existing cor-
onary artery disease (CAD).
Methods: Hemorrhagic shock was induced by removal of 30 % of the
calculated blood volume (mean arterial pressure (MAP) 43 (40–45)
mmHg) and maintained for 3 h in anesthetized and instrumented LDL-
receptor−/− pigs with high fat diet-induced hypercholesterolemia and
CAD4. Post-shock resuscitation comprised re-transfusion of shed blood,
crystalloids and infusion of noradrenaline (NA) titrated to maintain MAP
at pre-shock values for 48 h. So far, n = 7 animals were subjected to
hyperoxia (FiO2 1.0) during the initial 24 h of resuscitation, n = 8 pigs re-
ceived standard treatment (FiO2 0.3, SaO2 ≥ 90 %). Before, at the end of,
and every 12 hours after hemorrhage, we assessed systemic and renal
hemodynamics (renal artery ultrasound flow probe), kidney function (cre-
atinine clearance, urinary output, renal venous blood gas analysis) as well
as mitochondrial activity (high resolution respirometry) of kidney speci-
mens collected at the end of the experiment. Data are median (range).
Results: Survival time, NA requirements as well as systemic and renal
hemodynamics were comparable in both groups. However, plasma
creatinine levels were significantly lower after 36 (p < 0.01) and 48 h
(p < 0.02) and creatinine clearance was significantly higher at day 2
of resuscitation (115 (100–132) ml/min vs. 64 (33–97) ml/min; p <
0.02) in the hyperoxic group. Moreover, maximal oxidative phosphor-
ylation (OxPhos) (hyperoxia: 241 (227–286), control: 189 (164–231)
pmol*mg−1*s−1; p < 0.03) and O2 flux related to ATP production (178
(171–201) vs. 128 (95–147) pmol*mg−1*s−1; p < 0.03) of renal mito-
chondria were significantly higher in the hyperoxic animals.
Conclusion: In our model of porcine, resuscitated hemorrhagic shock
with pre-existing CAD, hyperoxia significantly improved kidney func-
tion due to increased mitochondrial respiratory capacity which is in
good agreement with previous results from healthy swine2.
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Introduction: Hemorrhagic shock (HS) accounts for about 40 % of
trauma-related deaths [1]. The severity of trauma can be further
deteriorated by an additional blunt chest trauma (TxT), which in-
dependently contributes to mortality upon the development of
acute lung injury (ALI) [2]. The development of ALI following a
severe trauma is encouraged by both active and passive cigarette
smoke (CS) exposure [3]. We previously showed that CS exposure
prior to TxT enhanced post-traumatic inflammation thereby ag-
gravating lung injury [4].
Objectives: We investigated the impact of pre-traumatic CS exposure
in mice following HS alone or in combination with TxT.
Methods: After 3–4 weeks of CS-exposure, anesthetized and spon-
taneously breathing (C57BL/6) mice underwent TxT or sham sur-
gery. After initiation of lung-protective mechanical ventilation via
tracheostomy and instrumentation for vascular access, mice
underwent 1 h of hemorrhage (mean arterial pressure (MAP) =
35 mmHg) followed by resuscitation comprising re-transfusion of
shed blood, fluid administration and noradrenaline (NA) titrated
to maintain MAP > 50 mmHg. Lung mechanics, gas exchange,
hemodynamics, metabolism, and acid–base status were measured
together with lung and plasma cytokine and chemokine levels.
After 4 h, lung and kidney were harvested for immunohistochem-
istry and western blotting.
Results: Pulmonary compliance was increased in chronic obstruct-
ive lung disease (COPD) mice which had only received HS. Lung
tissue levels of the inducible nitric oxide synthase (iNOS) were
slightly elevated in nonCOPD mice which, due to more NO avail-
ability, is in line with increased NA requirements to maintain
hemodynamic targets. Also, systemic and pulmonary cytokine and
chemokine levels as well as lung tissue expression of heme
oxygenase-1 (HO-1) were increased in COPD mice. Their mortality
rates were similar, whereas in the combined trauma model COPD
mice showed an increase in mortality and elevated NA require-
ments compared to nonCOPD mice. Lung tissue HO-1 expression
was reduced in the combined trauma model.
Conclusion: CS exposure aggravated post-traumatic inflamma-
tion. CS exposure prior to TxT and subsequent HS was associ-
ated with increased mortality rates. As HO-1 has been reported
to act protective in ALI [5], we presume its reduction strongly
highlights the severity of trauma due to an exhausted ALI-
associated anti-inflammatory defence system.
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Introduction: Multi-organ failure after hemorrhagic shock is triggered
by tissue hypoxia and inflammation resulting from the mismatch be-
tween O2 demand and supply
1. In healthy swine, hyperoxia (increased
FiO2) reduced inflammation and organ dysfunction
2 after hemorrhagic
shock and did not adversely affect myocardial function upon critical he-
modilution3. Pre-existing coronary artery disease (CAD) might increase
the risk of cardiac injury during low flow states. However, the use of in-
creased FiO2 is restricted in acute coronary syndrome due to vasocon-
striction and subsequent myocardial damage4.
Objectives: To investigate the influence of hyperoxia on left ventricu-
lar (LV) function during hemorrhage and resuscitation in swine with
pre-existing CAD.
Methods: Hemorrhagic shock was induced by removal of 30 % of the
calculated blood volume (target mean arterial pressure (MAP) 40 mmHg)
and maintained for 3 h in anesthetized LDL-receptor−/− pigs with high fat
diet-induced hypercholesterolemia and CAD5. Post-shock resuscitation
comprised re-transfusion of shed blood, crystalloids and noradrenaline
(NA) to maintain MAP at pre-shock values for 48 h. Amiodarone was used
if needed to treat arrhythmia. So far, n = 7 pigs were subjected to hyper-
oxia (FiO2 1.0) for the initial 24 h of resuscitation, n = 8 pigs received
standard treatment (FiO2 0.3, SaO2≥ 90 %). Before, at the end of, and
every 12 hours after hemorrhage, we assessed hemodynamics and LV
function (pressure-conductance catheter) and cardiac mitochondrial ac-
tivity at the end of the experiment. Data are median (IQR).
Results: Survival time, hemodynamics and total doses of NA and ami-
odarone did not significantly differ between groups. Dp/dtmax transi-
ently increased after resuscitation and decreased again in both
groups, whereas dp/dtmin and the isovolumic relaxation constant tau
remained largely unaffected throughout the experiment despite high
doses of NA and tachycardia. Together with the mostly unchanged
ejection fraction, the fall in stroke volume and the rise in filling pres-
sure (pulmonary artery occlusion pressure) after re-transfusion indi-
cate increased LV stiffness and dysfunction in both groups.
However, all cardiac parameters and mitochondrial respiratory cap-
acity of the heart did not show any significant differences between
hyperoxic and control animals.
Conclusion: In our porcine model of resuscitated hemorrhagic
shock with pre-existing CAD, hyperoxia did not exert detrimental
effects with respect to LV function. Therefore, hyperoxic treat-
ment appears to be a safe approach for the treatment of O2 defi-
ciency in hemorrhagic shock even under conditions with pre-
existing cardiac comorbidity.
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Introduction: Differential expression of specific genes has been asso-
ciated with postoperative brain injury and individual variation in the
severity of the host response following cardiac surgery 1,2. We inves-
tigated the role of DNA sequence variation in modulating the ob-
served changes in gene expression.
Objectives: Our aim was to reveal the most relevant regulatory
genetic variants of the host response to elective cardiac surgery and
the clinical relevance of the variants detected. To identify these
regulatory variants we performed an Expression Quantitative Analysis
(e-QTL).
Methods: The Ambion LeukoLOCK Total RNA Isolation System was
used to purify leukocytes from whole blood isolated before in-
duction of anaesthesia and 24 hours after surgery. Gene expres-
sion was quantified using Illumina HumanHT-12 v4 expression
beadchip . The output of this analysis was filtered by fold expres-
sion and P-values were corrected to false discovery rate < 0.05.
Genotyping was performed on OmniExpressed-12v1chip. e-QTLS
analysis was peformed using Matrix e-QTL software. Pathways
analysis was performed using Ingenuity Pathways Analysis (web
based software).
Results: 46 patients scheduled for elective cardiac surgery involving
cardiopulmonary bypass (CBP) were recruited. Postoperative recovery
was uneventful with only minor complications.
Of the genes differentially regulated 24 hours after cardiac surgery
80 were up-regulated and 15 were down -regulated. The group of
up-regulated genes are primarily related to the innate immune re-
sponse and cell signalling. Of the 15 downregulated the majority are
implicated in T lymphocyte activation.
We identified 659 single nucleotide polymorphisms (10.E-06) that are
significantly associated with the cis regulation of 218 genes, 24 hours
after cardiac surgery. Analysis of the 10 top enriched pathways
showed three groups 1-Granulocyte-macrophage colony stimulating
factor (GM-CSF) group. 2- Interferon and growth factors group 3-
Leptin Pathway group .
Table 77 (abstract A750). Cardiac parameters
Pre-shock 12h 24h 36h 48h
dp/dt
max
(mmHg/
s)
normoxia
hyperoxia
2618
(2502;3291)
2770
(2696;3047)
3883
(2754;5639)
3774
(2418;6591)
4218
(3347;5078)
4762
(2734;5196)
3001
(2274;5841)
2986
(2818;4596)
2870
(2641;3098)
2806
(2209;3310)
dp/dt
min
(mmHg/
s)
normoxia
hyperoxia
−2032
(−2474;-
1830) -1971
(−2219;-
1805)
−2484
(−2727;-
2240) -2925
(−3442;-
1939)
−2496
(−4294;-
1683) -2662
(−3098;-
2245)
−3006
(−4348;-
1458) -2646
(−2926;-
2454)
−3113
(−3270;-
2956) -2615
(−2798;-
2428)
Tau (ms) normoxia
hyperoxia
30 ( 22 ; 34 )
26 ( 23 ; 31 )
18 ( 14 ; 28 )
23 ( 12 ; 33 )
14 ( 11 ; 17 )
15 ( 15 ; 20 )
18 ( 12 ; 20 )
17 ( 15 ; 20 )
18 ( 18 ; 18 )
21 ( 19 ; 23 )
Stroke
volume
(ml)
normoxia
hyperoxia
72 ( 50 ; 85 )
61 ( 59 ; 89 )
37 ( 24 ; 60 )
33 ( 30 ; 72 )
37 ( 30 ; 74 )
40 ( 34 ; 43 )
38 ( 28 ; 62 )
51 ( 29 ; 61 )
47 ( 32 ; 60 )
40 ( 28 ; 59 )
PAOP
(mmHg)
normoxia
hyperoxia
11 ( 09 ; 12 )
11 ( 10 ; 14 )
17 ( 16 ; 20 )
19 ( 16 ; 21 )
17 ( 16 ; 18 )
20 ( 17 ; 21 )
20 ( 18 ; 22 )
19 ( 16 ; 23 )
18 ( 17 ; 21 )
19 ( 17 ; 23 )
EF (%) normoxia
hyperoxia
48 ( 44 ; 78 )
46 ( 39 ; 65 )
46 ( 31 ; 52 )
39 ( 21 ; 46 )
55 ( 50 ; 60 )
64 ( 45 ; 67 )
60 ( 18 ; 67 )
28 ( 20 ; 39 )
35 ( 30 ; 39 )
43 ( 31 ; 63 )
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Conclusions: The pathways associated most strongly with the
post-operative response to surgery, are related to innate immune
response. Interestingly, we detected genes/pathways not conven-
tionally associated with the host response to cardiac surgery such
as cell proliferation, cell differentiation and cell signalling. Pro-
inflammatory and anti-inflammatory genes operate simultaneously
rather than sequentially after cardiac surgery and CPB.
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Introduction: Saline-based and hydroxyethyl starch solutions are
commonly used for volume resuscitation, but have been linked to an
increased risk of renal dysfunction.
Objective: To assess whether balanced solutions and a limited vol-
ume of hydroxyethyl starch (renal-protective fluid management
[RPF] strategy) during perioperative period could decrease the in-
cidence of postoperative renal dysfunction and improve clinical
outcomes.
Method: This retrospective study investigated 2613 patients
undergoing cardiovascular surgery. A group of patients undergo-
ing cardiovascular surgery from January 1, 2010 to July 4, 2012
were included in the control group and were given intravenous
fluids with saline-based solutions and hydroxyethyl starch perio-
peratively. The other group of patients undergoing cardiovascular
surgery from July 23, 2012 to December 31, 2013 formed the RPF
group and were given balanced solution and a limited volume of
hydroxyethyl starch solution. The primary outcome was the inci-
dence of postoperative acute kidney injury (AKI) using serum cre-
atinine. Secondary outcomes included the incidence of severe
AKI, requirement for renal replacement therapy, renal outcome at
the time of discharge. Propensity score and multivariable regres-
sion analyses were performed to assess the association of fluid
management strategy with renal outcomes.
Result: In the entire cohorts, postoperative AKI, severe AKI, in-
hospital renal replacement therapy, and persistent AKI at dis-
charge occurred in 213 (21.2 %), 54 (5.4 %), 29 (2.9 %), and 52
(5.2 %) patients of RPF group compared to 696 (43.2 %), 254
(15.8 %), 79 (4.9 %), and 194 (12.1 %) patients of control group,
respectively. In the propensity score matched cohort, the inci-
dence of AKI, severe AKI, in-hospital RRT, and persistent AKI at
discharge were also lower in the RPF group than in the control
group. After adjusting by the multivariable analyses, the RPF
group was independently associated with a lower risk of postop-
erative AKI, severe AKI, use of renal replacement therapy, shorter
postoperative extubation time and intensive care unit and hos-
pital stay.
Conclusion: The RPF strategy was associated with improved acute
renal and clinical outcomes after cardiovascular surgery. These
findings support the need for definitive clinical studies on RPF
strategy.
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Introduction: Intravenous infusion of short-acting insulin remains the
gold standard treatment of stress hyperglycemia after coronary ar-
tery graft bypass (CABG) surgery despite the risk of insulin-related
hypoglycemia. Exenatide is an agonist of the glucagon-like peptide-1
receptor that stimulates pancreatic insulin secretion and inhibits
pancreatic glucagon production. The risk of exenatide-related
hypoglycemia is theoretically null as the effect of exenatide depends
on the blood glucose level.
Objectives: The aim of the ExSTRESS study was to assess the efficacy
and the safety of intravenous exenatide in the management of stress
hyperglycemia after CABG surgery.
Methods: The ExSTRESS study (NCT01969149) was a one-center
randomized phase II trial. Patients scheduled for CABG surgery
between January and December, 2015 were eligible. Non-
inclusion criteria were: insulin-requiring diabetes mellitus, creatin-
ine clearance < 60 ml/min, and a medical history of pancreatec-
tomy, acute or chronic pancreatitis. Intravenous exenatide (EXE
group) or intravenous insulin (INS group) was randomly allocated
to achieve a blood glucose target between 5.5 and 7.7 mmol/l. A
validated insulin therapy protocol was used in the INS group [1].
The primary outcome was the percentage of patients achieving
the blood glucose target during at least half of the first 48 post-
operative hours. The secondary outcomes were: incidence of
moderate (<3.3 mmol/l) and severe (<2.2 mmol/l) hypoglycemia
during the first 48 postoperative hours, and the incidence of ad-
verse events at Day 30. According to the study protocol (O'Brien
and Fleming plan for analysis), no statistical test was used for in-
tergroup comparison. Data are presented as mean (standard devi-
ation) or number of patients (percentage).
Results: 54 and 52 patients were included respectively in the EXE
and in the INS groups (age : 70 (9) vs 68 (11) years; male : 49 (91) vs
42 (81); diabetes mellitus : 12 (27) vs 11 (26); HbA1c : 6.1 (0.7) vs 5.8
(0.6) %; Euroscore : 6.4 (2.3) vs 6.1 (2.7) %; respectively in the EXE
and in the INS groups). 39 (72) and 39 (75) achieved the blood glu-
cose target during at least half of the first 48 postoperative hours re-
spectively in the EXE and in the INS groups. The mean blood glucose
value was 6.9 (0.5) mmol/l vs 6.9 (0.4) mmol/l respectively in the EXE
and in the INS groups. 0 (0) and 0 (0) patient has presented at least
one episode of severe hypoglycemia and 2 (4) vs 1 (2) patients suf-
fered from at least one moderate hypoglycemia respectively in the
EXE and in the INS groups. 6 (11) vs 3 (6) patients did not require
intravenous insulin respectively in the EXE and in the INS groups. No
exenatide-related adverse event has been reported at Day 30.
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Conclusions: Intravenous exenatide allows a safe management of
stress hyperglycemia after CABG surgery but requires intravenous in-
sulin rescue therapy in most patients.
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Introduction: Cardiopulmonary Bypass Surgery (CPB) is associated
with organ dysfunction as a consequence of a generalized inflamma-
tory response due to blood contacting the synthetic surfaces of the
bypass equipment.
Objectives: To evaluate the safety and feasibility of increased adsorp-
tion membranes during cardiopulmonary bypass surgery.
Methods: This is a pilot study that included 20 cardiac surgery pa-
tients. Ten patients were assigned to receive CPB + OXIRIS® during
cardiac surgery and 10 patients were assigned to receive standard
CPB. Blood samples were collected and clinical variables were re-
corded (just before connection to CPB (T0), just before ending CPB
(T1), at intensive care unit (ICU) admission (T2), and 24 hours after
ICU admission (T3)). Clinical variables were registered from CPB and
up to 24 hours from ICU admission, including any adverse effect ob-
served during the use of OXIRIS® membrane.
Results: Twelve patients underwent coronary artery bypass graft
(CABG) surgery, 3 patients uderwent valve replacement surgery, and
5 patients underwent mixed surgery (CABG plus valve replacement).
No safety events were registered in both groups. Mean age was
65.9 ± 9 years and 85 % of patients were male. Mean baseline
serum creatinine was 89 ± 15 μmol/L, and mean CPB time was
113 ± 38 minutes. At T1, mean concentration of cytokines was
not statistically different between groups. In CPB-OXIRIS® group,
IL-1 and IL-6 levels were lower as compared with standard CBP.
Interleukin-4 and IL-10 were increased in the CPB-OXIRIS® group,
whereas tumor necrosis factor-α levels were not different be-
tween groups. At T2, mean serum levels of IL-1 and IL-6 were in-
creased in both groups. Furthermore, no adverse effects were
observed in CBP-OXIRIS® group during follow up.
Conclusions: No adverse effects were observed with the use of OXI-
RIS®, neither during CPB nor after 24 hours of surgery. Therefore, the
use of an increased adsorption membrane connected to CPB is safe
and feasible.
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Introduction: Diaphragmatic dysfunction is a known complication of
cardiac surgery associated with delayed weaning from mechanical
ventilation. Its incidence and evolution has not been established in
detail. Echographic evaluation of diaphragmatic excursion is a simple,
non-invasive technique that can be used at the bedside to monitor
diaphragmatic function.
Objectives: To evaluate the incidence and evolution of diaphrag-
matic dysfunction in patients undergoing cardiac surgery.
Methods: This prospective observational study was conducted from
16/10 to 23/12/2015 at a tertiary cardiac surgical center in France.
Consecutive elective adult patients operated via a median sternot-
omy with cardiopulmonary bypass were enrolled. Demographic data
was collected. Echographic measurements of right and left hemi-
diaphragm excursions were obtained using anatomical M-Mode and
averaged over 3 respiratory cycles before surgery (E1), within 48 h
following extubation (E2) and between 96 and 144 h after extubation
(E3). Values were compared using Friedman's analysis for repeated
measures and Wilcoxon test for paired samples. Diaphragmatic
dysfunction was defined as an excursion < 1 cm, as previously re-
ported1,2. An inter-observer reproducibility evaluation was per-
formed using Bland-Altman analysis.
Results: 143 patients were submitted to cardiac surgery during the
study period, of which 106 fulfilled inclusion criteria. 26 patients were
not included: 8 did not consent, machine or operator were unavail-
able in 19 patients at E1. 80 patients were included and 79 were ana-
lysed (1 patient withdrew consent). The evolution of right and left
hemi-diaphragmatic excursion is shown in graph 1. After establishing
pre-op baseline values (E1), we observed a shorter excursion after
surgery (E2) with partial recovery at E3 (Table 78). Patients that did
not develop dysfunction followed a similar pattern. At E2, unilateral
dysfunction was observed in 25 patients (37 %) and bilateral dysfunc-
tion in 4 (5 %). At E3, unilateral dysfunction remained in 9 patients
(13 %).
Conclusions: Diaphragmatic excursion was reduced after surgery but
returned mostly to normal by day 5. 30 % of patients developed a
diaphragmatic dysfunction but this was not associated with clinically
relevant complications in this small cohort.
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Introduction: Low cardiac output syndrome (LCOS) is a potential
complication in patients undergoing cardiac surgery. This clinical
situation can be associated with increased morbidity (including acute
deterioration of renal function) and mortality.
Objetive: Descriptive analysis of patients undergoing cardiac surgery
and has a low cardiac output syndrome (LCOS), its relationship with
renal failure and association with mortality.
Methods: Observational, prospective, multicenter study of patients
admitted to the ICU during the post-surgical period and develops a
LCOS (2012 Consensus definition). Preoperative data (type of inter-
vention, cardiac function, risk scores), intraoperative variables (type
of surgery, CEC, use of inotropic) and postoperative data to hospital
discharge (including complications / postoperative mortality) are re-
corded. Descriptive statistics, ANOVA and Chi2 analysis, from June
2014 to June 2015. Data analyzed using SPSS-windows.
Results: 14 centers have provided 138 patients with LCOS (age 68.3
± 9.3 years; 65 % male) operated mostly scheduled basis (59.4 %,
33.3 % urgency and 6.5 % emergency) with an Euroscore of 9.99 ±
13. Isolated myocardial revascularization (16.8 %) or accompanied by
valve surgery (24.8 %) and aortic valve replacement (11.7 %) were
the most frequent procedures. Most relevant antecedents: AMI
(31.9 %; 22 cases in the pre-intervention 90 days), severe pulmonary
hypertension (21.7 %), critical preoperative state (18.8 %), previous
cardiac surgery (18.1 %), PTCA / stent (16.7 %), LVEF < 35 % (33.6 %),
and NYHA III-IV (52.9 %). Prior to surgery, 21 patients (15.4 %) requir-
ing vasoactive drugs. 70.1 % needed two (or more) vasoactive drugs
for exit of the CPB (mean 147.4 ± 60 min). Postoperatively, 46.7 % of
patients with LCOS (n = 63) develops acute deterioration of renal
function (39 % AKI1, 23 % AKI2 and 37.7 % AKI3). The time to worst
creatinine value was 41 ± 46 hours. 20 % required renal replacement
technique; there is significant difference in the cardiogenic shock
(CS) group (11.4 % LCOS, 14.6 % clinical group and 36.6 % CS, p =
0.007). Analyzing by subgroup of AKI (worst recorded value in the
evolution), the AKI3 stage was associated with multiorgan failure
(MOF) (17.4 % AKI1, 28.6 % AKI2, 68.2 % AKI3, p = 0.001), total days
income (p = 0.03) and ICU mortality (16.7 % AKI1, 28.6 % AKI2 and
69.6 % AKI3, p = 0.001).
Conclusions: LCOS patients have a high incidence of acute deterior-
ation of renal function and need for renal replacement technique.
The AKI stadium is associated with increased development of MOF
and mortality.
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Introduction: The degree of severe inflammatory response syndrome
(SIRS) after CS is related with the development of complications in
cardiac surgery (CS). The Inmature Platelets Fraction (IPF) has been
recently associated with inflammatory response after sepsis. How-
ever, its role related with the injury during CS is unknown.
Objectives: To evaluate the role and clinical usefulness of IPF blood
levels as a tool to detect patients suffering clinically significant SIRS
after CS.
Methods: Prospective, observational study in our Surgical ICU in a
tertiary-level university hospital. IPF was measured on admission and
24 h after CS, together with clinical data and outcomes including in-
hospital mortality. Clinically significant SIRS was defined as need of
vasoconstrictors >24 h in the ICU for maintaining appropriate MAP
and diuresis.
Results: 37 patients were included (62 % male; mean age:69.1 [59.3-
78.6] years; BMI:28.1 ± 4.3Kg · m-2). 57 % were active smokers, 69 %
suffer from Hypertension, 34 % were diabetic and 60 % dyslipidemia.
74.3 % was elective surgery. 37.8 % (n = 14) suffered SIRS. Univariate
analysis showed that the variables associated with SIRS were: age
(HR: 1.12;95 % IC: 1.01-1.24; P = 0.034), Cardiopulmonary bypass time
(min) (HR:1.03; 95 % IC: 1.002-1.05; P = 0.029), ICU transfusion needs
(Red Blood Cells units) (HR: 1.93; 95 % IC: 1.09-3.42; P = 0.024), max-
imum Urea (First 24 h after CS) (HR: 1.47; 95 % IC: 1.09-1.97; P =
0.011), Difference between IPF 0-24 h (ΔIPF) (HR:3.10; 95 % IC: 1.30-
7.39; P = 0.010). Multivariable analysis showed that ΔIPF (HR: 3.78;
95 % IC: 1.099-13.002; P = 0.035) and age (HR: 1.23; 95 % IC: 1.001-
1.508; P = 0.048) were factors associated with the presence of SIRS.
Table 78 (abstract A755). Diaphragmatic excursion
Variable Patient N p value (Friedman analysis
or Wilcoxon test)
Right Excursion - E1, E2 and E3 67 <0,001
Left Excursion - E1, E2 and E3 62 0,032
Right Excursion - E1 vs E2 72 <0,001
Right Excursion - E1 vs E3 72 0,020
Right Excursion - E2 vs E3 67 <0,001
Left Excursion - E1 vs E2 67 0,003
Left Excursion - E1 vs E3 71 0,323
Left Excursion - E2 vs E3 62 0,017
Fig. 108 (abstract A755). Diaphragmatic excursion – BoxPlot
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Receiver operating characteristic curve showed that ΔIPF had an area
under the curve of 0.8224 to predict presence of SIRS. Patients who
did not develop SIRS had a negative ΔIPF whereas it was positive in
those who developed SIRS (P = 0.0005).
Conclusions: Patients who have a positive ΔIPF are prone to develop
clinically significant SIRS in our pilot study. Despite our results seem
promising, more research is still needed in order to know the role of
IPF in SIRS after CS.
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Introduction: Every year, 200 million patients undergo noncar-
diac surgery worldwide. More than one million of them die
within 30 days as a result of perioperative complications. Over
the years, venous thromboembolism (VTE) due to deep vein
thrombosis (DVT) was considered as the most important and
most dangerous complication after surgery, but recently
phenomenon of myocardial injury after noncardiac surgery
(MINS) definied as elevation in cardiac troponins level caught
the attention of researchers.
Objectives: The aim of this study was to compare the frequencies of
venous (DVT) and arterial (MINS) complications in vascular surgery
patients, and to evaluate their impact on the short (30-days) and
long-term (1-year) prognosis after surgery.
Methods: 167 patients operated due to peripheral arterial disease
of lower limbs (PAD) or abdominal aortic aneurysm (AAA) in the
Vascular Surgery Unit of a tertiary care hospital in Krakow were
enrolled in the study. Every patient had high-sensitivity cardiac
troponin T serum level measured before surgery and four times
after procedure. In every patient lower extremities venous ultra-
sound with B-mode compression test was performed three times
(before surgery and in the 4th and 7th day after surgery) by ex-
perienced physician. All patients were monitored for cardiovascu-
lar complications during hospital stay, 30 days and one year
follow-up after surgery.
Results: DVT was diagnosed in 4 patients after surgery (2.4 %).
MINS defined as an increase in TnT after surgery by at least
30 % compared with baseline level and a level of > 0.03 ug/L
(normal range 0–0,014 ug/L) was observed in 25 patients (15 %).
Annual mortality in patients with MINS was clearly higher than in
the group without MINS (6 (24 %) vs 12 (8.5 %); p = 0.02). Among pa-
tients with DVT we did not observed deaths in the year of follow-up.
Conclusions: Perioperative myocardial injury is more common com-
plication than venous thromboembolism after noncardiac surgery
and has a more significant impact on the patient's prognosis during
annual observation.
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Introduction: Red blood cell (RBC) transfusion has been associated
with increased mortality in patients undergoing cardiac surgery ac-
cording to various studies.
Objectives: The aim of this study is to analyze the impact of RBC
transfusion in survival of the intensive care unit (ICU) after cardiac
surgery.
Methods: Retrospective observational study of a series patients
undergoing cardiac surgery between January 2006 and June 2014. A
number of demographic and clinical variables taken from the Hos-
pital database are analyzed. A univariate and multivariate logistic re-
gression model was used to study the observed effect and was
adjusted for potential confounders / mediators. The odds ratio (OR)
with their respective confidence interval of 95 % was reported. P-
values less than 0.05 were considered statistically significant.
Results: A total of 3449 patients were included in the study. Age:
66.88 +/− 11.9 years old; 65.2 % male.229 patients died during the
ICU stay. In the univariate analysis, patients who survive: were more
often male, younger: 66.81 +/− 12.64 vs 67.84 +/− 12.43 years (p <
0.05); They had lower ICU stay 6.63 +/− 14.24 vs 10.60 +/− 13.99 days
(p < 0.01); less postoperative bleeding in the first 24 hours of ICU ad-
mission: 0.55 +/− 1.27 vs 1.1 +/− 1.29 liters (p < 0.01); higher pre-
operative hemoglobin: 13.64 +/− 5.8 vs 12.31 +/− 2.02 g / dl (p <
0.01); shorter time of cardiopulmonary bypass: 101.66 +/− 23.6 vs
139.17 +/− 66.09 minutes (p < 0.05); less Logistic EUROSCORE : 6.10
+/− 4.33 vs 10.27 +/− 8.58 (p < 0.01) and received fewer RBC transfu-
sion: 1.59 +/− 2.25 vs 3.62 +/− 2.63 packed red blood cells (p < 0.01).
In multivariate analysis, RBC transfusion is an independent factor that
worse survival in the ICU: OR 1.39 CI (1.31-1.47) p < 0.01, adjusted for
age, sex, length of ICU stay, postoperative bleeding, preoperative
hemoglobin, CPB duration and EUROSCORE.
Conclusions: Transfusion of RBC decreases survival after cardiac sur-
gery in patients admitted to the ICU.
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Introduction: Knowledge of predictive factors for ICU readmission
may lead in earlier identification of deterioration signs in cardiac sur-
gery patients.
Objectives: To identify perioperative factors and describe indications
and outcome indices associated with ICU readmission after cardiac
surgery performed under the use of cardiopulmonary bypass.
Methods: A total of 1334 consecutive patients who underwent cardiac
surgery during a 3 years period were retrospectively analyzed. Patients
who readmitted in ICU consisted group A and were compared with
group B, the rest of the cohort. The following factors were compared
between 2 groups: gender, severe obesity (BMI > 35), smoking habit,
diabetes mellitus, COPD, pre-op pulmonary hypertension (SPAP >
30 mmHg), pre-op ejection fraction < 50 %, cardiopulmonary bypass
time (CPB) > 120 min,prolonged mechanical ventilation- defined as >
24 hours (during initial ICU stay),transfusion with >3red blood cell (RBC)
units, re-intubation, acute kidney injury(AKI- RIFLE criteria), need of
renal replacement therapy, post-op atrial fibrillation and mortality. Stat-
istical analysis was based on x square test.
Results: A total of 29 (2.17 %) patients readmitted in ICU. Group A
patients were older (68,6 ± 9.8 vs 65,3 ± 10) with higher Euroscore II
(4.05 ± 6 vs1.99 ± 2.1).Indications for readmission were : Low cardiac
output syndrome (LCOS)(11), respiratory failure(8),cardiac arrest(4),
stroke(3), pulmonary edema(2) and tamponade(1). Statistical signifi-
cant factors for readmission were: severe obesity(10/29, p = < 0.01),
COPD(11/29, p = < 0.01), red blood transfusion with > 3 units(15/29,
p < 0.01) and prolonged initial mechanical ventilation(4/29, p =
0.018). Statistical significant outcome indices were: re-intubation(12/
29, p = < 0.01), AKI(18/29, p = < 0.01), need of renal replacement ther-
apy(8/29, p < 0.01) and post-op atrial fibrillation(19/29, p < 0.01). Mor-
tality was 10.3 % (3/29) vs 2.84 % of group B.
Conclusions: COPD, severe obesity, prolonged ventilation and blood
transfusions appear to be major factors for ICU readmission. LCOS is
the most common indication. Incidence of re-intubation, AKI, need
for renal replacement therapy, atrial fibrillation and mortality are
higher in this group of patients
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Introduction: The management of tissue perfusion in cardiac surgery
with fluid therapy is a challenging task as the parameters used to as-
sess it do not reflect microcirculatory dysfunction. Heterogeneity in
blood flow perfusion and abnormalities in capillary density characterize
microcirculation dysfunction and can be assessed with incident dark-
field illumination (IDF) imaging of the sublingual tissue. The restoration
of abnormalities for capillaries can become a target parameter for the
administering of fluids in the future in addition to the restoration of the
macro circulatory parameters solely used nowadays.
Objectives: Visualizing the sublingual microcirculation to assess sys-
temic tissue perfusion and fluid overload in post-operative cardiac
surgery patients, to propose a more accurate method to help assess
tissue perfusion in patients who undergo surgical procedures.
Methods: In this prospective observational study videos of the sub-
lingual microcirculation on post cardiac surgery patients were re-
corded with the use of the CytoCam (Braedius Medical, Amsterdam,
The Netherlands). Data was obtained in day one after the patients
left the intensive care unit (ICU). The data was recorded straight after
surgery at T0 followed by a two day T1 and T2 measurement. Three
videos were recorded at each time point. AVA software v. 3.2 (Micro-
Vision Medical, Amsterdam, The Netherlands) was used to obtain the
following microcirculatory parameters: total vessel density (TVD),
microcirculatory flow index (MFI), proportion of perfused vessel
(PPV), perfused vessel density (PVD). Macro circulatory parameters
were also collected in those time points. The weight is measured be-
fore the operation (T0), second (T1)and third day(T2) in the post-
operative cardiac surgery ward.
Results: 10 post-operative cardiac patients are included comprised of
3 females and 7 males. Varied group in cardiac surgery compromis-
ing of 5 patients which have undergone coronary bypass graft sur-
gery and 5 aortic valve surgery. The patients came directly from the
intensive care to the post-operative cardiac ward with a fluid over-
load which is currently expressed in a weight gain. All these patients
have received daily furosemide and spironolactone to account for
the fluid overload. Pre-operative weight T0(76 ± 12.6), T1(78 ± 12) T2
(77 ± 11.7) in 8 patients. There was a significant increase in the
weight at T1 compared to baseline (P: 0.0065), and a significant de-
crease in the weight at T2 compared to T1(P: 0.0193).There was a sig-
nificant increase in the TVD when comparing the T1 to T0 (24 ± 3.2,
20 ± 3.3 p = 0.0410), and T2 to T0 (26 ± 3.3 20 ± 2.7 P = 0.0005).
Conclusions: The TVD increased during the three days whilst the
weight decreased possible due to the diuretics. The cytocam is a po-
tential tool to monitor the microcirculation and can indicate and
asses fluid overload.
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Fig. 109 (abstract A761). Trends of total vessel density and weight
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Introduction: Despite being widely studied, origins of impaired
neurologic status after cardiac surgery are not fully understood. One
of the commonly reported predisposing factor is the perioperative
change in sodium concentration.
Objectives: The aim of this study is to determine whether periopera-
tive change of sodium is linked to impaired postoperative neuro-
logical status.
Methods: The observational study was conducted in a tertiary refer-
ence university hospital. Data of cardiac surgery patients were gath-
ered and analyzed. The sodium concentrations were measured
before the surgery, upon admission to the ICU and 24 hours later.
The mean values and the changes of sodium during these periods
were evaluated. The neurological status of the patients was evalu-
ated for one day after the surgery. Impaired postoperative neuro-
logical status (INS) was defined as delirium, seizures or impaired
consciousness after withdrawal of sedation and extubation of the pa-
tient in the first 24 postoperative hours. The perioperative sedation
and analgesia was executed according to the routine protocol of the
hospital. To determine the most potent predictor of INS a regression
analysis of sodium measures was performed. The most potent so-
dium measurement was further analyzed in a multivariate regression
analysis of INS risk factors adjusted for demographic variables, pre-
operative comorbidities, operative characteristics and early postoper-
ative complications.
Results: The data of 262 patients were gathered. Most of the patients
were men 65.6 % (N = 172), had a CABG procedure 62.6 % (N = 164)
with a low operative risk of median Euroscore II value of 1.62 [0.97-
2.35]. The rate of INS in the group was 9.9 % (N = 26). The mean
value of preoperative sodium was 139.57 ± 3.00 mmol/L, upon admis-
sion to ICU 135.76 ± 3.40 mmol/L and 24 h later 137.76 ± 2.65 mmol/
L, resulting in an operative change of 2.1 [0.0-4.4] mmol/L, and 24 h
postoperative change of (−) 1.85 [(−) 4.5-0.90] mmol/L. The most po-
tent predictor of INS was the 24 h postoperative change of sodium
(OR = 0.818 CI95%: 0.733 - 0.911 p < 0.001). The multivariate regres-
sion analysis of INS risk factors revealed the 24 h postoperative
change of sodium (OR = 0.80 CI 95 %: 0.71-0.90 p < 0.001) and pres-
ence of rethoracotomy as risk factors (OR = 5.28 CI95%: 1.40-19.09 p
= 0.014) of INS. The results are presented in the chart below.
Conclusions: The INS after cardiac surgery is present in a substantial
part of the patients. The most potent predictor of an INS is the 24 h
postoperative change of sodium concentration, resulting in a seven-
fold risk increase per every drop of 5 mmol/L of sodium.
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Introduction: Gelatin is a synthetic colloid resuscitation fluid for
treatment of hypovolemia. Gelatin efficacy and safety are poorly eval-
uated. Despite lack of evidence, gelatin use is widespread and in-
creasing in parts of the world. We wanted to systematically review
efficacy and adverse outcomes. Given the paucity of data from RCTs,
we also included data from non-randomised trials.
Methods: Systematic review and meta-analysis of randomised and
non-randomised studies comparing gelatin with crystalloid or albumin
for treatment of hypovolemia. Adverse outcomes were defined as mor-
tality, allogeneic blood transfusion, acute kidney injury, anaphylaxis and
extravascular uptake. Multiple databases were searched systematically
without language restrictions until August 2015 (Cochrane Central,
Medline, Embase, Indmed, MedCarib, AJO, AIM, IMEMR, WHOLIS, LI-
LACS, WPRIM, IMSEAR, Google Scholar, Grey Literature, German Na-
tional Library, German Pharmacovigilance Database and Clinical Trials
Registries). Risk of bias was assessed using the Cochrane tool for RCTs
and the Ottawa Newcastle scale for observational studies. Certainty of
evidence was assessed using the GRADE methodology.
Results: 60 studies were included, consisting of 30 RCTs with 3629 pa-
tients, 8 non-randomised studies with 10827 patients and 22 animal
studies. For those receiving gelatin, the relative risks (RR) were as fol-
lows: for mortality (RR 1.18, 95 % CI 0.98-1.41, 16 RCTs, 2525 patients;
low certainty in evidence), requiring allogeneic blood transfusion (RR
1.25, 95 % CI 0.95-1.64, 8 RCTs, 744 patients; low certainty in evidence),
acute kidney injury (RR 1.32, 95 % CI [0.61, 2.87], 3 RCTs, 212 patients,
very low certainty in evidence), anaphylactic adverse effects (RR 2.18,
95 % CI 0.87-5.44, 3 RCTs 872 patients, very low certainty of evidence).
Mean crystalloid-to-colloid ratio was 1.44 (±0.31, 6 RCTs). Four observa-
tional controlled studies (9403 patients, low risk of bias) all found an in-
creased risk for acute kidney injury (AKI) or need for renal replacement
therapy (RRT). Between 17 to 31 % of administered gelatin was taken
up extravascularly. The mean crystalloid-to-colloid ratio was 1.4.
Conclusions: Despite the poor quality of published evidence, this
systematic review shows that Gelatin solutions increase the risk of
anaphylaxis and may be harmful by increasing mortality, renal failure
Fig. 110 (abstract A761). Single spot microcirculation after diuretics
Fig. 111 (abstract A762). Decrease of sodium in 24
postoperative hours
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and bleeding, possibly due to extravascular uptake and coagulation
impairment. Plasma expansion with gelatin is not associated with a
relevant fluid-sparing benefit. Until well-designed RCTs show gelatin
is safe we caution against the use of gelatins since cheaper and safer
fluid alternatives are available.
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Introduction: Red blood cell (RBC) transfusion has been associated
with increased in-hospital morbidity and mortality after cardiac
surgery. However, the impact on quality of life has not been fully
clarified.
Objectives: The aim of this study is to analyze whether transfusion of
RBC has an impact on health-related quality of life (HRQOL).
Methods: Prospective observational study of 205 patients undergo-
ing cardiac surgery (valve replacement and / or coronary revasculari-
zation) between January and April of 2015 at a University Hospital.
Clinical data relating to patient comorbidities, surgery and postopera-
tive course were collected, including hemoglobin pre and post-
surgery and the number of blood products transfused periopera-
tively. At 6 months after discharge, was applied EUROQUOL- 5D
questionnaire for assessing the HRQOL through telephone interview.
Significant variables in the univariate analysis were entered into a
multivariate logistic regression model to calculate the Odds Ratio
(OR) with confidence interval 95 %.
Results: Questionnaire response 178 patients (61.2 % males, age 70.7 ±
9.8). They were divided into two groups: group 1: problems in some di-
mension of HRQOL of EUROQOL 5D and group 2: without problems. In
the Univariate analysis,group 2 patients (with problems) presented the
following characteristics: were older (p < 0.01); were mostly males (p <
0.01); lower preoperative hemoglobin (p < 0.05), received more RBC (p <
0.01) as well as a higher Hospitality stay (p < 0.01). Patients receiving
more RBC have a further deterioration in HRQOL (OR 1.23, 95 % CI 1.07
to 1.41, p = 0.004) .In multivariate analysis, transfusion of more RBC
causes more deterioration in HRQOL after adjusting for age and gender
OR (1.18, 95 % CI 1.04 to 1.34), p = 0.012); by preoperative and postopera-
tive hemoglobin (OR 1.19, 95 % CI 1.04 to 1.37, p = 0.013) but not by stay
(OR 1.11, 95 % CI 0.95 to 1.28), p = 0.184) considering stay a mediator
in the causal chain.
Conclusions
Transfusion of packed red blood cells reduces HRQOL after cardiac
surgery.
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Introduction: Given that surgical procedures have become minimally
invasive, we thought that postoperative energy expenditure would
be decreased. In fact, the resting energy expenditure (REE) measured
by an indirect calorimeter after minimally invasive esophagectomy in
the intensive care unit (ICU) was significantly lower than the basal
energy expenditure (BEE) estimated using the Harris-Benedict equa-
tion (HBE) [1]. However, postoperative REE after cardiovascular sur-
gery remains unclear.
Objectives: We hypothesized that the postoperative REE would be
lower than the BEE in patients in the ICU who had undergone cardio-
vascular surgery and conducted a prospective observational study to
investigate it.
Methods: The ethics committee from our hospital approved this pro-
spective study. This study included patients who underwent cardio-
vascular surgery in our hospital from September 2013 to March 2015.
After surgery, the REE was measured using an Engström device (GE
Healthcare Japan, Tokyo, Japan), which consists of a ventilator and
an indirect calorimeter, and was measured from the time from ICU
admission to extubation or at 9 AM on postoperative day 1. The pa-
tients received pressure-controlled ventilation (tidal volume: 6–
10 mL/kg) in the ICU under dexmedetomidine and propofol sedation.
The ventilation setting and the doses of these sedative agents were
adjusted by each physician in accordance with the Richmond
Agitation-Sedation Scale (RASS). Patients received an infusion of a
10 % glucose solution at a rate of 192 kcal/day after admission into
the ICU. We maintained the blood glucose level between 110 to
180 mg/dL using an artificial pancreas (STG-55, Nikkiso, Tokyo,
Japan). The following data were obtained: age, body weight, height,
RASS, and REE for each hour during ventilation. The REE and the BEE
estimated using the HBE were compared using the paired t-test.
Results: Forty-seven patients (23 female and 24 male) were enrolled in
this study. The mean age, body weight, and height were 73 ± 10 years
(mean ± standard deviation), 55 ± 10 kg, and 155 ± 10 cm, respectively.
Seventy three percent of patients received a cardiopulmonary bypass
(CBP). The average temperature and RASS during ventilation were 38.2
± 3.3 °C and −3 ± 1, respectively. The average REE during ventilation
was 1314 ± 148 kcal/day (23.9 ± 6.8 kcal/kg/day). The average BEE was
1147 ± 148 kcal/day. The average REE during ventilation was signifi-
cantly higher than the BEE (114 ± 35 % of the BEE, p = 0.02). In addition,
the REE was not significantly different between patients who received
a CBP and patients who did not receive a CBP.
Conclusions: The REE after cardiovascular surgery was significantly
higher than the BEE regardless of whether a CBP was performed. In
postoperative patients, it is important to note the difference in surgi-
cal procedures when estimating the optimal target calorie level for
nutrition therapy.
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Introduction: Connective tissue diseases represent a rare, heteroge-
neous group of diseases that commonly impair the function of many
organs.
Objectives: Aim of this study was to determine whether a history of
connective tissue disease has any impact on postoperative morbidity
and mortality in patients who undergo cardiac surgery under the use
of cardiopulmonary bypass.
Methods: We retrospectively reviewed our electronic database of
1618 consecutive cardiac surgery patients from May 2012 to March
2016. We analyzed the postoperative outcome indices of cardiac sur-
gical patients with a history of connective tissue disease.
Results: A total of 15 (5 females) patients were identified (group A):
12 rheumatoid arthritis, 2 ankylosing spondylitis, 1 psoriatic arthritis.
Oral steroids were used in 6 and methotrexate in 3 patients. The fol-
lowing operations were performed (1 emergency): 8 valve surgery, 5
coronary artery bypass and 2 operations on thoracic aorta. Compar-
ing with the rest of the cohort (group B), the study group patients:
were older (69,6 ± 7 vs 65,2 ± 10), their average pre-op mean ejection
fraction was 57,3 ± 10 % vs 55,6 ± 11 % and their pre-op eGFR(MDRD)
was 76,2 ± 3 vs 73,7 ± 23 mL/min/1.73 m2. Pulmonary hypertension-
defined as pre-op doppler systolic pulmonary pressure > 30 mmHg-
was found in 5/15 patients (36,6 % vs 22,49 %, p = 0,34). Median dur-
ation of mechanical ventilation was 11 hours for group A vs 7 hours
for group B. Transfusion with > 3 red blood units was required in 5/
15 (36,6 % vs 23,4 %, p = 0,36). Post-op low cardiac output syndrome
developed in 2/15 (13,3 % vs 5,49 %, p = 0,43). Acute kidney injury
defined by RIFLE criteria complicated 2/15 patients (13,3 % vs
15,6 %, p = 0,78). Post-op atrial fibrillation developed in 7/15 (46,6 %
vs 33,6 %, p = 0,31). One patient required non invasive ventilation for
post-op respiratory failure. Median ICU days were 2 in both groups.
No patient of the study group developed sternal wound infection or
had prolonged (>24 hours) mechanical ventilation while hospital
mortality was 0 %.
Conclusions: According to the results of this single-center retrospect-
ive study, cardiac surgery procedures could be performed safely in
patients with a history of connective tissue disease.
References: Lee J. Outcome of patients with connective tissue disease
requiring intensive care for respiratory failure. Rheumatol Int.
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Introduction: Red Cell Distribution width (RDW) is associated with
mortality and bloodstream infection risk in the critically ill. In survi-
vors of critical care with chronic liver disease (CLD) it is not know if
RDW can predict subsequent risk of all-cause mortality following hos-
pital discharge.
Objectives: We hypothesized that an increase in RDW at hospital dis-
charge in CLD patients who received critical care would be associ-
ated with increased mortality following hospital discharge.
Methods: We performed a two center observational study of patients
treated in medical and surgical intensive care units in Boston, Massa-
chusetts. We studied 4,442 patients, age ≥ 18 years, who had chronic
liver disease, received critical care between 1998 and 2012 and sur-
vived hospitalization. The exposure of interest was RDW within
24 hours of hospital discharge and categorized a priori as ≤13.3 %,
13.3-14.0 %, 14.0-14.7 %, 14.7-15.8 %, 15.8-17.0 % and >17.0 %. The
primary outcome was all cause mortality in the 90 days following
hospital discharge determined using the US Social Security Adminis-
tration Death Master File. Adjusted odds ratios were estimated by
multivariable logistic regression models with inclusion of covariate
terms for age, race, gender, Deyo-Charlson Index, patient type (med-
ical versus surgical), sepsis and number of organs with acute failure.
Results: The cohort patients were 62.6 % male, 21.4 % nonwhite and
35.7 % surgical. 14.9 % of the cohort had sepsis and the mean age
was 59 years. Mean(SD) MELD score was 15.0(8.0). 90-day post dis-
charge mortality was 10.3 %. RDW at hospital discharge was a robust
predictor of all cause post discharge mortality and remained so fol-
lowing multivariable adjustment. Patients with a discharge RDW
14.7-15.8 %, 15.8-17.0 % or >17.0 % have an adjusted OR of 90-day
post discharge mortality of 2.31 (95%CI, 1.16-4.62; P = 0.017), 3.24
(95%CI, 1.65-6.38; P = 0.001) or 6.06 (95%CI, 3.13-11.71; P < 0.001)
relative to patients with a discharge RDW ≤13.3 %. Estimates were
similar with additional adjustment for MELD score. Discharge RDW
has moderate discrimination for 90-day post discharge mortality
(AUC = 0.76; 95 % CI 0.74-0.78). Additionally, patients with a dis-
charge RDW 15.8-17.0 % or >17.0 % have an adjusted OR of 30-day
readmission of 1.60 (95%CI, 1.13-2.26) or 1.41 (95%CI, 1.01-1.98) rela-
tive to a discharge RDW ≤13.3 %. Finally, patients with a discharge
RDW 15.8-17.0 % or >17.0 % have an adjusted OR of care facility
placement of 1.50 (95%CI, 1.11-2.02) or 1.45 (95%CI, 1.08-1.94) rela-
tive a discharge RDW ≤13.3 %.
Conclusions: In CLD patients treated with critical care who survive
hospitalization, an elevated RDW at discharge is a robust predictor of
subsequent mortality, hospital readmission and placement in a care
facility. Increased RDW at discharge likely reflects the presence of
ongoing inflammation or oxidative stress which may explain the
observed impact on CLD patient outcomes following hospital
discharge.
A768
Early increase in protein intake reduces mortality in underweight
critically ill patients
M.V. Viana1,2, T.A. Tonietto1,2, L.A. Gross3, V.L. Costa3, A.L.J. Tavares3, B.O.
Lisboa3, R.B. Moraes1, S.R. Vieira4, L.V. Viana5, M.J. Azevedo6
1Hospital de Clínicas de Porto Alegre, Intensive Care Unit, Porto Alegre,
Brazil; 2Hospital Nossa Senhora Conceição, Intensive Care Unit, Porto
Alegre, Brazil; 3Universidade Federal do Rio Grande do Sul, Faculdade de
Medicina, Porto Alegre, Brazil; 4Universidade Federal do Rio Grande do
Sul, Faculdade de Medicina - Department of Intensive Care, Porto
Alegre, Brazil; 5Universidade Federal do Rio Grande do Sul, Faculdade de
Medicina - Department of Medical Nutrition, Porto Alegre, Brazil;
6Universidade Federal do Rio Grande do Sul, Faculdade de Medicina -
Department of Endocrinology, Porto Alegre, Brazil
Correspondence: M.V. Viana - Hospital Nossa Senhora Conceição,
Intensive Care Unit, Porto Alegre, Brazil
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A768
Introduction: Critically ill patients with body mass index (BMI) lower
than 20 kg/m2 have worse outcomes than normal or overweight pa-
tients possibly because underweight is a marker of malnutrition. It
has been suggested that in malnourished critically ill patients an
early increased intake of calories and protein might improve their
prognosis.
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Objectives: To evaluate the impact of nutritional support, especially
calories and protein, on specific outcomes - need of tracheostomy,
ICU readmission, and intra-hospital mortality - in underweight critic-
ally ill patients.
Methods: Prospective, two-center, observational study, was designed
to asses the effect of nutritional intake in underweight critically ill pa-
tients. All patients consecutively admitted (November 2015 to March
2016) to general intensive care units (ICU) with IMC < 20 kg/m2 were
included. Exclusion criteria were: palliative care, exclusively oral nutri-
tion, pregnancy, life expectancy < 24 h, and ICU readmission. Patients
had their nutritional intake evaluated after ICU admission between
days 2 and 3 (1st evaluation). Another evaluation was performed be-
tween days 5 and 7 (2nd evaluation) if patient had not been dis-
charged from ICU, was not on exclusively oral nutrition, or on
palliative care. Patients were divided into groups according calorie in-
take (group A:< 20 kcal/kg/day; group B:≥20 kcal/kg/dia) and protein
intake (group C:< 1 g protein/g/day; group D:≥ 1 g protein/kg/day).
Patients were followed in the hospital until their death or discharge.
Results: The hospital mortality rate of 83 included patients was
55.4 % after 17 (10–32) days of follow-up. There was an increment in
calories (19.6 ± 9.7 to ± 27.6 ± 11.2; p < 0.001) and protein (0.9 ± 0.6 to
1.33 ± 0.7; p < 0.001) intakes between 1st and 2nd evaluation. The cal-
oric intake (Kcal/day) both in the 1st (19.2 ± 9.2 vs. 16.3 ± 10; p =
0.189) and 2nd evaluation (27.8 ± 10 vs. 27.5 ± 11.9; p = 0.916) did not
differ between survivors and no survivors; there was a trend for a
higher protein intake (g/Kg/day) in survivors in the 1st evaluation
(0.96 ± 0.56 vs. 0.69 ± 0.62; p = 0.051). Mortality did not differ accord-
ing caloric intake in the 1st (Table 79) and 2nd evaluation. Patients
who received >1 g of protein/day (Group D) in the 1st evaluation
(Table 79) had lower mortality than those who received less protein
(Group C), but not in 2nd evaluation. Frequency of tracheostomies
was higher in patients who received more calories (group B) and pro-
tein(Group D) only in the 1st evaluation. Multivariate logistic models
confirmed (OR, 95%CI) that protein intake was negatively associated
with mortality [protein intake 0.43(0.18-0.99); SAPS3 1.07(1.02-1.11)]
and with need of tracheotomy [protein intake 3.06(1.03-9.07); SAPS3
0.94(0.90-9.99)] even after adjustment for illness severity. ICU re-
admission did not differ among groups.
Conclusion: In underweight critically ill patients an early high protein
intake at ICU admission has a protective role for mortality.
Grant acknowledgement
FIPE - HCPA
A769
Quality indicators of nutritional therapy measured by dieticians
may be associate with the outcome of the critical care patient
G.D. Ceniccola1,2, R.S.F. Pequeno1, T.P. Holanda2, V.S. Mendonça1, W.M.C.
Araújo2, L.S.F. Carvalho3
1Hospital de Base do Distrito Federal, Residência em Nutrição Clínica,
Brasília, Brazil; 2Universidade de Brasília, Departamento de Nutrição,
Brasília, Brazil; 3Universidade Estadual de Campinas, Universidade de
Ciências Médicas, Campinas, Brazil
Correspondence: G.D. Ceniccola - Universidade de Brasília,
Departamento de Nutrição, Brasília, Brazil
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A769
Introduction: Nutritional risk and malnutrition must be screened at
admission in intensive care units (ICU) because these patients usually
benefit from early nutritional therapy1. Nutritional parameters should
be monitored by quality indicators (QI), but their goals and associ-
ation with patient outcome are still unknown.
Objectives: To estimate the impact of malnutrition, nutritional risk
and high caloric deficit on mortality at a 60 days follow-up in a gen-
eral ICU population.
Methods: Consecutive adult patients who remained in the ICU for
greater then 48 hours were included and prospectively followed.
Data were abstracted from electronic health records (EHR) by trained
ICU dietitians on their sex, age, APACHE II and baseline nutrition as-
sessment at admission2. Daily nutrition information was collected on
the type (i.e. EN, PN, oral, none) and amount of nutrition received
(total calories) from ICU admission for a maximum of the first 7 days
(EN only) unless death or discharge occurred sooner. Heavy caloric
deficit occurred when < 25 % of the caloric needs was achieved in
the first ICU week. Patients were followed while in hospital and their
outcomes determined at 60 days after ICU admission. Online forms
were elaborated to enter abstracted data with a secure web-based
tool (GoogleDocs, © 2012).
Results
A total of 236 EHR were verify from 2014 to 2015 in 4 this audit,
85.6 % were screened for Nutritional risk of that 91.1 % had nutri-
tional risk according to NRS 2002 tool2, 85.2 % were accessed with
ASPEN-ADA3 tool, diagnosing 23.4 % of malnutrition. 91.1 % of the
EHR had information on the nutrients received, heavy caloric deficit
was verif in 27.4 % of the EHR with this information. Binary logistic
regression evidenced risk of mortality at 60 days 8.01 times higher
(95%CI 1.86 - 34.7, Wald = 7.8, p = 0.005) in patients malnourished
and with heavy caloric deficit in the first ICU week at the same time
when compared with patients without these two risk factors (con-
trolled by sex, age and APACHE II). Either malnutrition or heavy cal-
oric deficit when present increases the mortality risk in 5.83 times
(95%CI 1,33 - 25.4, Wald = 5.5, p = 0.019). Nutritional risk was not re-
lated with mortality at 60 days.
Conclusion: The QI presented are potentially useful nutritional
markers and could implement ICU routine, the presence of a dietitian
in the multidisciplinary team can facilitate that task. The combination
of malnutrition and heavy caloric deficit were relevant nutritional QI
associated with ICU mortality regardless of sex, age and Apache II.
More studies are needed to establish goals for these QI and to de-
velop this field.
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Table 79 (abstract A768). Clinical characteristics and nutritional
support
Caloric intake Protein intake
Group A
(<20kcal/
kg) n=50
Group B
(≥20kcal/
kg) n=33
P Group C
(<1g
protein/kg)
n=48
Group D
(≥1g
protein/kg)
n=35
P
Age (ys) 55.7±17.6 54.8±18.6 0.839 54 ± 18.4 57.3±17.3 0.409
Male (%) 32(64) 18(54.5) 0.386 32 (66.7) 18 (51.4) 0.161
SAPS 3 70.6±13.2 68.2±9 0.471 71±14.9 66±14.3 0.121
Nutric ≥ 5 (%) 25(50) 16 (48.5) 0.893 25 (52.1) 16 (39) 0.567
Tracheostomy
(%)
5(10) 12(37.5) 0.030 5 (10.4) 12 (35.3) 0.006
ICU
readmission
(%)
6(12) 3(9.4) 0.711 6(12.5) 3(8.8) 0.729
Mortality (%) 31(62) 15(45.5) 0.138 31 (64.6) 15(42.9) 0.049
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Introduction: Enteral nutrition (EN) is currently the route of choice
for feeding critically ill patients (1); however, due to the unpredict-
able nature of critical illness, the delivery is frequently disrupted.
Common reasons for inadequate delivery are gastrointestinal in-
tolerance, fasting for diagnostic procedures, surgery and airway
management (2). Cumulative calorie deficits contribute to malnu-
trition (3) and poor outcome including increased infections,
length of ICU /hospital stay and mortality (4). There is no recog-
nised guidance on the length of time that should elapse between
stopping EN and commencing anaesthetic procedures. We devel-
oped and implemented our own fasting guidelines to address
the EN interruptions on our units. In our trust, only radiologists
or ICU consultants are allowed to confirm placement. We believe
that this is negatively influencing tube confirmation times and
contributing to EN under delivery.
Objectives: To compare specific interruptions to EN in 3 different
adult intensive care units (ICU), assessing impact on nutrition
delivery·
 To examine compliance with ICU fasting guidelines on
stopping and restarting enteral nutrition prior to operative and
non-operative procedures
Methods: An audit over 1 month in 3 adult different ICU's in a large
London trust, each with its own unique specialities.
Results: Data was collected on 59 patients. See Table 81 for
demographic details. The most frequent reasons for stopping
EN were removal and confirmation of nasogastric tubes, extuba-
tion and cancelations. Each was associated with an average def-
icit of 800kcals and 35 g protein per episode. The nutritional
deficits relating to each episode of fasting are detailed in Ta-
bles 82 and 83.
Conclusions: Although the case mix was different, each unit expe-
rienced frequent fasting impacting on enteral nutrition delivery.
The reasons were similar for all units. Each fasting period was as-
sociated with considerable calorie and protein deficit. Despite
having ICU specific fasting guidelines in place, violations were ob-
served for all procedures especially extubation and tracheostomy,
where the fast far exceeded 4 hours. Restarting EN was also ex-
tended waiting on NGT confirmation after the procedure. Pro-
longed fasting and delays in restarting EN suggests limited
appreciation of nutritional deficits and associated negative impact
of fasting by ICU staff.Further education to our ICU staff is recom-
mended on fasting guidance to increase awareness and compli-
ance. In addition, the current practice for NGT confirmation
should be reviewed with the view to allowing ICU trainees to
confirm position following appropriate training.
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Table 80 (abstract A769). Demographics
Characteristic Non survivors (mean,
95%CI)
Survivors (mean,
95%CI)
P - value (Mann-
Whitney test)
Age (n= 236) 59.31; 55.69−62.93 50.76; 47.99−53.54 0.001
Body Mass index
(n= 217)
26.51; 25.05−27.96 25.84; 25.12−26.56 0.865
Apache II (n= 232) 23.22; 21.40−25.03 17.03; 15.69−18.36 0.0001
Nutritional Risk
Screening 2002
(n= 202)
3.82; 3.55−4.08 3.49; 3.30−3.68 0.031
Length of ICU stay
(n= 234)
19.31 15.46–23.17 31.11; 25.92–36.30 0.01
Length of hospital stay
(n= 227)
25.91; 22.06–29.76 60.31; 53.69–66.94 0.0001
Fig. 112 (abstract A769). Malnutrition at admission
Fig. 113 (abstract A769). Caloric deficit in the first week of ICU
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Introduction: Diarrhoea is a common complication in patients receiv-
ing enteral nutrition in the intensive care unit (ICU). International or-
ganizations[1]'[2] recommend fibre-based formula to control
diarrhoea. Nevertheless, there are reported inconsistencies on the
benefits of fibre in reducing diarrhoea. [3] Furthermore, the
recommended amount of fibre for the ICU patient group remains
controversial.
Objective: To establish the optimum amount of dietary fibre for
regular bowel function in the ICU population.
Methods: A retrospective review of all patients on ETF for > 5 days
between January and December/2015. Inclusion criteria was ETF with
fibre-based formula and exclusion was non-fibre ETF. Feeding for-
mula contained mixed fibre with fructooligosaccharides. A quantita-
tive score based on stool volume and consistency was used for daily
assessment of diarrhoea; diarrhoea was defined as a score ≥15. [4]
Patients were split into two groups: Group D (GD) - diarrhoea and
Group N (GN) - normal bowel function. Parametric tests were used to
assess the difference between the mean faecal scores and fibre in-
take of fibre between the groups.
Results: Two hundred and fifty one patients fitted the inclusion
criteria. Patients were male (153/251) and age 54 ± 17 years. Data
are presented as mean and standard deviation (SD). Faecal scores
were 9.9 (1.6) and 17.4 (1.8) (P < 0.001) for GN (216/251) and GD
(35/251) respectively. Fibre intake was significantly higher on GD
at 21.64 g/day (7.2) compared to GN at 11.8 (6.6) (P < 0.002).
Flatulence and abdominal pain was only reported in the group D,
on patients with a fibre intake >25 g/day. Nutritional intake was
similar for both groups that received >75 % of caloric and pro-
tein prescription. Both groups were on prokinectics; GD was on
metoclopramide (36) and erythromycin (8) and GN on 39/6 for
both prokinectics.
Conclusion: Fibre intake has an impact on bowel function. A high
fibre intake is associated with diarrhoea and flatulence. The higher
rate of flatulence is likely to result from fermentation of the soluble
fibre in the colon. The optimum fibre intake for the ICU group is <
20 g/day.
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Introduction: Several clinical trials have shown beneficial effects of
parenteral lipid emulsions based on n-3 polyunsaturated fatty acids
(PUFAs) (derived from fish oil) in intensive care unit (ICU) patients re-
ceiving parenteral nutrition (PN). Many of these studies have been
criticized for the heterogeneity of the patient´s population. Recently,
controversy has arisen due to conflicting results on clinical outcomes.
Objectives: To assess the effects of a lipid emulsion based on n-3
PUFAs compared with a MCT (medium-chain triglycerides)/LCT (long-
Table 81 (abstract A770) Patient demographics
St Mary's
Hospital
Hammersmith
Hospital
Charing Cross
Hospital
No. of patients Total of 59 21/59 14/59 24/59
Age years- (median) 57 59 61
Gender -number *Female, +
Male
4 F*, 17M+ 2F, 12M 12F, 12M
Diagnosis: Number (%) Number (%) Number (%)
Trauma/ neurosurgery 11 (52) 0 3 (13)
Medical / Sepsis 6 (29) 9 (64) 13 (54)
Surgery (GI, pancreatic,
cardiac, vascular)
2 (10) 4 (29) 6 (25)
Renal or Liver failure 2 (10) 1 (7) 2 (8)
Table 82 (abstract A770) Nutrition deficits per episode of fasting
Procedure Total time off
feed Hours
Median (IQR)
Energy deficit per
episode Kcal
Median (IQR)
Protein deficit per
episode Grams
Median (IQR)
St Mary´s Hospital
NGT insertion &
confirmation
15 (11–17) 1164 (1078–1503) 62 (42–70)
Extubation 14 (12–31) 1008 (983–1980) 47 (46–72)
Tracheostomy
(Percutaneous &
surgical)
12 (10–20) 892 (832–1476) 54 (47–69)
Hammersmith Hospital
NGT insertion &
confirmation
9 (8–13) 800 (655–1400) 36 (25–67)
Extubation 12 (6–14) 825 (482–966) 30 (20–42)
Tracheostomy
(Percutaneous &
surgical)
11 (11–14) 1100 (958–1206) 46 (42–51)
Table 83 (abstract A770). Nutrition deficits per episode of fasting
Procedure Total time off
feed Hours
Median (IQR)
Energy deficit
per episode Kcal
Median (IQR)
Protein deficit per
episode Grams
Median (IQR)
Charing Cross Hospital
NGT insertion &
confirmation
12 (4–15) 591 (274–1091) 27 (13–45)
Extubation 10 (8–12) 647 (504–741) 30 (26–34)
Tracheostomy
(Percutaneous & surgical)
11 (9–12) 874 (705–934) 40 (32–43)
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chain triglycerides) lipid emulsion on liver dysfunction, infectious
complications and other clinical outcomes in a cohort of critically ill
patients with Apache II > 17 and length of ICU stay of at least 5 days.
Methods: Observational retrospective single-centre cohort study in a
general ICU from September 2014 to July 2015. Patients in the fish
oil cohort (n 14) received n-3 PUFAs-enriched PN and patients in the
standard PN cohort (n 10), a MCT/LCT lipid emulsion. Baseline charac-
teristics of patients, energy and fat intake, laboratory parameters (in-
cluding liver function tests), new infections, insulin requirements,
days on mechanical ventilation, length of ICU and hospital stay and
mortality were recorded. Significance level was defined at a p value
of less than 0.05.
Results: Both groups had similar baseline characteristics : age (63 ±
17 vs 63 ± 12), Apache II (18 ± 6 vs 18 ± 7), SAPS 3 (66 ± 12 vs 61 ±
15), prealbumin at admission (11 mg/dl ± 10 vs 9 ± 6). The variable
results are shown in Tables 84 and 85.
Conclusions: The use of a fish oil based emulsion in PN had no
effect on new infections, insulin requirements, hospital length of
stay and hospital mortality when compared with MCT/LCT based
emulsion in ICU patients with Apache II score > 17. Bilirubin con-
centrations and ICU length of stay were lower in the MCT/LCT
group. There is also a non-significant trend toward less ventilator-
days per patient in the MCT/LCT group. More strong evidence is
required before giving a recommendation on lipid emulsions in
critically ill patients requiring PN.
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Introduction: In metabolic ICU research it is often desirable to measure
local blood flow to quantify production/utilization of various substrates.
The gold standard is to do this through dilution techniques of e.g. cold
water or dye. These methods are however invasive and may cause pain
or risk of injury of the patient. It is therefore desirable to use noninva-
sive techniques, such as Strain Gauge Venous Occlusion Plethysmogra-
phy (SGVOP) and Doppler Ultra Sound (DUS). Both of these are used
today but they measure blood flow through different principles and
gives results in different units. These methods have previously been
compared in healthy subjects but never in ICU Patients.
Objectives: We wanted to investigate the correlation between
SGVOP and DUS and how they are able to detect changes in blood
flow in ICU patients.
Methods: ICU patients (n = 10) with an expected stay of >24 hours
were recruited after informed consent. All patients underwent simultan-
eous blood flow measurements of both legs at two separate time
points (5–26 hours) and medical data was collected from charts. SGVOP
was performed on the left side with the cuff placed on the medial thigh
and a strain gauge placed on the thickest part of the calf, which was
hanging free as the foot was supported by pillows. Blood flow was esti-
mated as a mean of five measurements. DUS was performed on the
right leg by measuring the diameter of the superficial femoral artery
(SFA) thrice and assess blood flow was at angle >600 as a mean of five
heart strokes. A mean of three such measurements was calculated.
Results: The mean values at the two time points were 36.3 ± 27.4
and 28.6 ± 21.0 ml x min−1 x 100 ml tissue−1 (with 10 % variability)
for SGVOP and for DUS 189 ± 126 and 128 ± 60 ml/min (7.7 % vari-
ability). The r value for comparison between the methods in all mea-
surements was 0.684 (p < 0.001) and for the change in blood flow
between the time points 0.423 (p = 0.223). However 3 patients had
higher doses of noradrenaline (>0.075 μg/kg/min) and changes in
noradrenaline between the time points. When these were excluded
from the analysis, the r value for the remaining 7 patients were 0.710
(p = 0.004) for all measurements and 0.913 (p = 0.004) to assess the
change between time points.
Conclusions: SGVOP measures blood flow in the lower leg and does
not correlate exactly with DUS of SFA. The methods however correl-
ate fairly good and approximates changes in blood flow very good in
stable hemodynamic conditions, similarly as in previous studies in
healthy subjects, but fails to do so in situations with higher doses
and changes in noradrenaline. This might be because noradrenaline
alters the portion of blood going to skin and muscle respectively.
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Introduction: The Diffuse infiltrative lung disease (PID) is a relatively
common complication of Scleroderma (ScS) and its evolution is
highly variable and difficult to predict.
Patients and methods: It is a retrospective study including 54 files of
patients with a systemic Scleroderma and followed up by our service,
for a period of 29 years from January 1985 until December 2013. The
diagnosis of CBS has been selected according to the criteria of the
ACR as defined in 1980.
Results: Lung damage was objectified in 35 patients (64, 81 %), 28
women and 7 men, middle-aged 39.96 years ± 14.96. The average
timeappearance of lung damage was 34, 20 ± 27, 31 months. Lung
damage was revealed by a Dyspnea on exertion in 20 cases
(37.03 %) associated with a dry cough in 18 (33.33 %). Lung damage
was asymptomatic in 10 cases (14.41 %).Chest x-ray performed in all
patients was normal in 25 cases (46.30 %). She showed reticular
opacities in 9 patients (16.67 %), reticulonodularin 15 cases (27.77 %)
and honeycomb images in 5 cases (9.26 %). The EFR practiced in 52
Table 84 (abstract A772). metabolic variables
MCT/LCT Fish oil p
Average daily caloric intake (Kcal/day)
SD: Standard Deviation
1445 (SD 306) 1479 (SD 281) 0,8
Average daily lipid intake (g/day) 54 (SD 11) 47 (SD 14) 0,08
Days on PN 13 (SD 10) 12 (SD 8) 0,57
Bilirubin on 7th day of PN (mg/dl) 0,55 (SD 0,07) 1,26 (SD 0,8) 0,04
Daily intravenous insulin requirements
(median, IQR) IQR: interquartile range
12 (0–26) 18 (8–38) 0,76
Table 85 (abstract A772). Clinical outcome
MCT/LCT Fish oil p
Days on mechanical ventilation (median) 7 (0,75−17) 15 (9–31) 0,05
ICU length of stay (days) (median, IQR) 11 (4–20) 19 (15–34) 0,03
Hospital length of stay (days) (median, IQR) 44 (23–88) 44 (30–68) 0,06
New infections in ICU (n,%) 4 (40%) 9 (64%) 0,76
Hospital mortality (n,%) 4 (40%) 4 (28%) 0,28
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patients revealed a restrictive syndrome in 28 cases. Thoracic CT con-
firmed the diagnosis of diffuse interstitial Pneumonitis. It showed: a
glass aspect frosted (n = 8), reticular intra-lobulaires images (n = 12),
images in honeycomb (n = 9) and pulmonary micronodules (n =
6).Fifteen patients had benefited from monthly cures of cyclophos-
phamide. The evolution was marked by the stabilization of lesions in
15 cas(42,85 %) improvement in 10 cases (28.57 %) and worsening of
lung damage in 10 (18.8 %) patients.
Conclusion: The lung damage is currently the leading cause of mor-
tality in Systemic Scleroderma.
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Introduction: Mortality of cirrhotic patients with extrahepatic compli-
cations is high due to associated comorbidities. For these reasons it
is important to individualize each case in severity and severity of the
cause of ICU admission.
Objectives: To analyze the ability of differents severity indexes (both
general and specific) in predicting hospital and annual mortality of
liver cirrhosis patients admitted to an Intensive Care Unit.
Methods: Retrospective observational study on a prospective data-
base of 10 years duration. All patients were admitted consecutively
with primary or secondary diagnosis of cirrhosis. The mortality pre-
diction is performed by constructing ROC curves calculating the area
under the curve (AUC) with confidence intervals at 95 % (95 % CI).
Results: 229 patients were analyzed (mean age 58.6 ± 13.1 years, and
78.6 % males) . The APACHE II index admission was 25 ± 10 SAPS II
49 ± 21 and 21 ±MELD index 9. The SOFA rate and maximum income
was 7 ± 4 and 11 ± 4, respectively. Hospital mortality and the year
was 47.6 % and 60.7 % respectively. ABC and 95 % CI for hospital
mortality and per year is presented in Table 86. ABC.
Conclusions: Cirrhotic patients admitted to ICU have a high mortality.
The severity indexes both general and the specific MELD cirrhosis well
predict hospital mortality. However, that best mortality predictor is the
maximum SOFA index, with high capacity to predict mortality per year.
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Introduction: Autoimmune diseases are significant challenge for
Intensive Care physicians. They are often complicated by
multiple-organ dysfunction and side effects of long-term im-
munosuppressive therapy. Moreover, treatment of infections is
particularly difficult concerning constant immunosuppression.
Primary systemic vasculitides (PSV) are subgroup of autoimmune
diseases associated with especially problematic clinical course
often complicated by diffuse alveolar hemorrhage leading to re-
spiratory failure.
Objectives: The aim of the study was to compare patients suffering
from systemic autoimmune diseases with those suffering from pri-
mary systemic vasculitides in terms of clinical condition severity on
admission, treatment requirements and in-hospital mortality in ICU
setting.
Methods: Medical records of 74 patients with systemic autoimmune
diseases (SAD) including primary systemic vasculitides admitted to
Intensive Care Unit of the Jagiellonian University Medical College,
Krakow, Poland between 2001 and 2014 were analyzed in terms of
demographic, clinical and laboratory data. Severity of patients' clin-
ical condition was assessed using SAPS II, SAPS III, APACHE II, APA-
CHE III and SOFA scales.
Results: Demographic and clinical data are presented in Fig. 114.
23 patients with PSV and 51 patients with SAD were enrolled in
the study. Patients with PSV had significantly higher scores in
SAPS II, APACHE II and SOFA scales and required mechanical ven-
tilation (87,0 % vs 64,7 %, p = 0,04), renal replacement therapy
(69,6 % vs 21,6 %, p < 0,001) and blood products transfusions
(78,3 % vs 49,0 %, p = 0,02) more often than patients with SAD.
Also mortality was significantly higher among PSV group (60,9 %
vs 35,3 %, p = 0,04).
Conclusions: Patients with PSV treated in the ICU are in more severe
condition, require more complex intensive therapy and have poorer
prognosis than patients with other SAD.
Table 86 (abstract A775). Desciption of SOFA abstractions
SOFA abstractions used
as endpoint
Description
Early-SOFA Between-group difference in mean SOFA score on
study days 2, 3, 4 or 5
Late-SOFA Between-group difference in mean SOFA score on
study days 7, 10 or 14
Delta-SOFA Delta SOFA as defined by RCT authors:
Between-group difference in SOFA maximum during
ICU stay minus admission SOFA,
or;
Between-group difference in SOFA on a fixed day
minus admission SOFA, with the last observation
carried forward in case of discharge or death
Fig. 114 (abstract A776). Demographic and clinical characteristic
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Introduction: Deep vein thrombosis (DVT) is a common clinical situ-
ation causing morbidity and an important mortality . Because it can
be a complicated pulmonary embolism can be life-threatening.
Objectives: Our goal is to study clinical features, Para clinical and
scalable DVT complicated pulmonary embolism (DVT/PE).
Materials. And methods: We conducted a retrospective and descrip-
tive study of the records of patients hospitalized for DVT/PE in the
service of internal medicine, CHU Charles NICOLLES over a period of
30 years (1985–2015). We compared the patients with a DVT/PE
(Group 1 G1) versus those who did not have pulmonary embolism
complicating PST (Group 2 G2).
Results: We collected 120 cases of DVT. The mean age of patients
was 41.76 ans [15–78]. The DVT/PE (Group1 G1) were observed in 28
patients either in 23.33 % of cases.. It was 14 women and 14 men.
DVT non complicated with pulmonary embolism (Group 2 G2) were
observed among 92 patients (76.66 %) . It was 36 women and 56
men. Elderly patients were significantly fewer in the group G1 (3 pa-
tients) versus 10 older subjects in the Group G2 (p = 0.01). Regarding
thrombotic risk factors, there was no significant difference between
the 2 groups. The frequency of recurrence weren't similar between
the 2 groups: 3 in the group G1 and 26 in the Group G2. There were
also significant etiological difference between the 2 groups. Indeed,
neoplasia was observed in 2 patients group G1 and 9 patients in
Group G2 (p = 0.02). Thrombophilia, Becket's disease,Lupus and hy-
perhomocystéinemia are kept respectively in 2,2,2 and 0 for patients
of Group G 1 versus 6,24,3 and 4 patients of the Group G2. The cause
of the DVT was idiopathic 17(60) patients of the group G1 and51(55)
patients of the Group G2 (p =0.6).
Conclusions: Pulmonary embolism is a common and serious compli-
cation that can jeopardize the vital prognosis of the patient where
the interests of well know the risk factors predisposing to this
complication.
Outcome analysis II
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Introduction: The Sequential Organ Failure Assessment score (SOFA)
is increasingly used as a surrogate endpoint in intensive care Ran-
domized Controlled Trials (RCTs). Serially measured SOFA is inde-
pendently associated with mortality in observational cohorts [1], but
the association between RCT treatment effects on SOFA vs. mortality
has not yet been quantified. It is currently unclear which SOFA ab-
straction is the most responsive and consistent surrogate endpoint for
mortality in RCTs.
Objectives: Using study-level data from published RCTs that re-
port both SOFA and mortality, our objective was to quantify the
relation between SOFA endpoints and mortality and to identify
which SOFA abstraction best reflects between-group mortality
differences.
Methods: RCTs in adult intensive care patients reporting both
SOFA and mortality endpoints were identified using a PubMed
and Embase query. Reported SOFA abstractions were classified
as early, late and delta according to the definition used to com-
pute the SOFA endpoint (Table 87). Treatment effects on SOFA
were calculated as the between-group SOFA standardized differ-
ence. Treatment effects on mortality were calculated as log odds
ratio (OR) of treatment vs. control group mortality. We used
random-effects meta-regression to: (i) quantify the linear
relationship between RCT treatment effects on mortality (logOR)
and SOFA; (ii) quantify residual heterogeneity (expressed as I2
and tau). The review protocol was prospectively registered
(CRD42016034014).
Results: Data from 87 studies were included in the analysis
(Fig. 115). Fifty-five studies used Early-SOFA, 32 studies used
Late-SOFA and 25 studies used Delta-SOFA as an endpoint. Stud-
ies reporting different SOFA abstractions had comparable charac-
teristics regarding sample size, year of publication and study
population.
Between-group differences in Early-SOFA and Late-SOFA were not
significantly associated with between-group differences in mortality
(slope = 0.40 (SE 0.21), p = 0.116 and Slope = 0.18 (SE 0.25), p = 0.457,
respectively), but difference in Delta-SOFA was (slope = 0.70 (SE 0.22),
p = 0.005) (Fig. 116). The heterogeneity of the association was lowest
for Delta-SOFA (I2 = 0 % vs. 14 % and 13 %, p < 0.01 against both
using F-test on tau2).
Conclusions: Time-fixed Early- and Late-SOFA were the most fre-
quently reported outcome measures among the reviewed RCTs.
However, based on study level data aggregated in this systematic re-
view, Delta-SOFA appears to be the most responsive and consistent
surrogate endpoint for mortality.
References
[1] Ferreira et al. Serial evaluation of the SOFA score to predict outcome in
critically ill patients. JAMA 286, 1754–1758 (2001).
Intensive Care Medicine Experimental 2016, 4(Suppl 1):30 Page 397 of 607
A779
Clinical characteristics and outcome of those > =90 years receiving
intensive care in a regional hospital: a retrospective observational
study
H.P. Shum1, H.S. King1, K.C. Chan2, W.W. Yan1
1Pamela Youde Nethersole Eastern Hospital, Hong Kong, China; 2Tuen
Mun Hospital, Hong Kong, China
Correspondence: H.P. Shum - Pamela Youde Nethersole Eastern
Hospital, Hong Kong, China
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A779
Fig. 115 (abstract A778). Flowdiagram of the systematic search
Fig. 116 (abstract A778). Meta-regression analyses
Table 87 (abstract A778). Values of the different analyzed index
Hospital Mortality Year mortality
ABC CI-95 % ABC CI-95 %
APACHE II 0 836 0 782-0 882 0 769 0 709-0 822
SAPS II 0 853 0 801-0 896 0 796 0 738-0 846
MELD 0 871 0 820-0 911 0 799 0 741-0 841
initial SOFA 0 827 0 772-0 874 0 744 0 715-0 827
delta SOFA 0 727 0 664-0 774 0 723 0 660-0 779
maximum SOFA 0 912 0 868-0 945 0 856 0 803-0 898
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Introduction: As the prognosis of very elderly patients is generally
limited, admissions to intensive care among these patients are often
restricted. Therefore, only very few information is available on their
prognosis.
Objectives: To evaluate the clinical characteristics and outcome of
critically ill patients > =90 years old and compared with those be-
tween 70 and 79 years old.
Methods: Retrospective analysis of administrative data of patients admit-
ted between 1/1/2009 and 31/12/2013 to an ICU of a regional hospital.
Results: Over 5 years, 109 patients aged ≥90 years old were admitted
(1.4 % total ICU admission). Their median age was 92 and predomin-
antly female (62.4 %). The majority of patients (96.3 %) were emer-
gency admission with 36.7 % for postoperative care. Compared with
those aged 70–79, those aged > =90 years old had similar prevalence
of comorbidities (except metastatic carcinoma), comparable chance
to receive mechanical ventilation but less likely to have renal replace-
ment therapy (RRT) (16.2 % vs. 4.6 %). Despite having similar disease
severity as assessed by Acute Physiology and Chronic Health Evaluation
(APACHE) IV minus age score, they have higher ICU, hospital, 90-day,
180-day and 2-year mortality. After adjustment of disease severity, co-
morbidities and the use of RRT, their 2-year mortality differed by 1.9
times. Around 60 % of patients aged > =90 years old could be dis-
charged home but only 41.3 % survived 2 years after ICU admission.
Conclusions: Despite the fact that two-third of them could be dis-
charged home following treatment in ICU, only around 40 % survived
2 years from ICU admission. These findings provided useful informa-
tion for ICU triage purpose.
A780
Admission of critical octogenarian patients to intensive care (ICU).
Short and long term results
J. Gonzalez Londoño, C. Lorencio Cardenas, M. Morales Pedrosa, C.
Murcia Gubianas, C. Fuster Bertolin, N. Vila Batllori, J.M. Sirvent
1Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain
Correspondence: J. Gonzalez Londoño - Dr Josep Trueta University
Hospital, Intensive Care Unit, Girona, Spain
Intensive Care Medicine Experimental 2016, 4(Suppl 1):A780
Objectives: The ICU admission of patients over 80 years of age has
been questioned because of the high mortality and low life expect-
ancy of these patients. However, with the growing increase of the life
expectancy of the population together with the improvement of
diagnostic and therapeutic techniques, more and more, age is not a
limiting factor for ICU admission. Our goal is to analyze the short and
long term the morbidity and mortality of octogenarian patients ad-
mitted to the ICU, as well as functional status after ICU discharge.
Materials and methods: Retrospective observational study in which
all patients over 80 years old admitted to a polyvalent ICU of a ter-
tiary hospital during the years 2012–2014 were included. Demo-
graphic variables, severity indices (APACHE II), initial lactate, mortality
and length of stay were registered. Patients were followed during
one year after ICU discharge. 6 months and one year mortality as
well as the value of the Karnofsky scale after 1 year of discharge
were registered.
Results: During the study period, 178 octogenarian patients were in-
cluded [2012 = 52 (29.2 %); 2013 = 62 (34.8 %) and 2014 = 64 (36 %)].
56.7 % were male with a median age of 82.7 years of age (±2.4) and
an APACHE II of 21.8 (±7.1). The initial lactate was 25.1 mg/dL (±22).
Reasons for admission were non-respiratory sepsis (38.8 %), post-
operative cardiac surgery (16.9 %), cardiac arrest (5.6 %), polytrauma
(4.5 %), pneumonia (4.5 %), and cerebral hemorrhage (3.9 %). The
average intake was 6.7dies (±7.7) in the ICU and 17.7dies (±15) in the
hospital. ICU mortality was 30.3 % and hospital mortality was 41 %.
Mortality at 6 months of discharge from ICU was 48.3 % and at one
year of discharge 51.1 %. The Karnofsky scale after one year of ICU
discharge was 73.2 (±16.2).
The mortality for octogenarian patients was 10 % higher than the
global mortality of ICU admitted patients during the same period
(30.3 % vs. 21 %). Both the initial APACHE II and lactate were
significantly higher in patients eventually died (20.4 ± 6.3 vs 25.3 ±
7.8; p < 7.20 vs 12:05 ± 30.8 and 22.7 ± 24, p < 0.05). ICU mortality was
significantly higher in patients with pneumonia (75 %). However,
mortality was significantly lower in postoperative cardiac surgery
(6.7 %; p < 0.05).
Conclusions: The number of octogenarian patients admitted to
ICUs has been increasing in recent years. Mortality in patients
over 80 years of age admitted to our ICU is higher than the
overall mortality of our ICU. However, it varies significantly de-
pending on the diagnosis. The initial lactate and APACHE II are
also prognostic in this group of patients. The mortality of octoge-
narians patients admitted to our ICU reaches the 50 % after one
year of discharge, and those who survive cannot perform a nor-
mal daily activity.
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Background: Acute variceal haemorrhage (AVH) presenting to Inten-
sive Care Unit (ICU) is associated with significant mortality.[1]
Objectives: To compare outcomes and factors associated with hos-
pital mortality (HM) in patients admitted with AVH to a busy district
general hospital ICU.
Methods: A retrospective study of adult patients (N = 82) admitted to
ICU with a primary admission diagnosis of AVH from 1993–2016 was
performed by searching the electronic medical records database. We
applied statistical analysis (Pearson chi-square) to assess the differ-
ences in outcomes for patients receiving different interventions.
Results: The median age of our patient population was 56.3 years,
62 % were male, and there were 8 transfers to tertiary centres.
The percentage HM for patients admitted to ICU with a variceal
bleed was found to be 43 %, with mortality rising to 59 % if that
patient was intubated and ventilated, and 92 % if that patient re-
ceived inotropic support during their admission. Inotropic support
(OR, 11.9; 95 % CI, 1.5 to 97.3; chi-square 7.9 P = 0.0048) and an
APACHEII score above 40 (OR, 3.98; 95 % CI, 1.0-15.5; chi-square
4.4 P = 0.0459) were both significant independent predictors for
mortality. Intubation and ventilation alone was not a significant
mortality predictor.
Conclusions: A patient presenting to ICU with an AVH is predicted to
have a significantly worse outcome if they are commenced on ino-
tropic support, with mortality rising to 92 % from 43 %. Intubation
and ventilation alone was not a significant predictor of a worse out-
come. This result should prompt a consideration of outcomes when
starting inotropic support in a patient on ICU who presents with a
variceal bleed.
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Introduction: Loss of muscle mass in critically ill patients admitted to
Intensive Care Unit (ICU) is common1 and contributes to ICU ac-
quired weakness. Loss of rectus femoris muscle has been shown to
be related to length of stay in ICU2; however previous studies have
not investigated the relationship between mortality and muscle loss.
Objectives: To seek an association between muscle loss and 28-day
mortality in medical ICU (MICU) patients and compare rates of
muscle loss in patients dead or alive at 28-day.
Methods: This was an observational study in the MICU of a university
affiliated academic medical centre. Serial measurements of rectus
femoris thickness (RFT) by ultrasound were performed on admission,
day 3,7 and 10.Other parameters including demographics, body mass
index (BMI), Acute Physiology and Chronic Health Evaluation II (APA-
CHE II) and Charlson co-morbidly index were collected. Analysis was
performed with a generalised linear mixed model.
Results: We included 45 patients (65 % male, mean age 63 ± 11 years,
mean BMI 25.2 ± 4.8 kg/m2, mean APACHE II score 28 ± 8),median
(IQR) ICU and hospital stay of 6(3–10) and 14(5–55) days respectively
with a 24.4 % 28-day mortality.Both patient group lost significant
muscle thickness (mean loss of right RFT, day 3: −7.9 ± 7 %,day 10:
−11.3 ± 9 %, p < 0.001) from 0–10 days but no difference was ob-
served between the groups (p = 0.45).Loss of RFT was significantly as-
sociated with length of stay in the hospital (p = 0.048,R2 = 0.1).Each
1 % loss in the RFT was associated with 28 % increased relative risk
for mortality (p < 0.001,OR 1.28,95 % CI 1.14-1.45).
Conclusions: Critically ill patients uniformly lose muscle during their
hospital stay and muscle loss was significantly associated with 28-
day mortality.
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Introduction: Little is known about the epidemiology and outcome
of critical illness in low- and middle-income countries (1). In these
settings, intensive care medicine is challenged by delicate resource
restrictions which are likely to affect patient outcome (2).
Objective: To evaluate the epidemiology and outcome of critical ill-
ness in Mongolia, a lower-middle income country in Central Asia.
Methods: In this prospective observational study, demographic, clin-
ical and outcome data of all critically ill patients admitted to the in-
tensive care units (ICU) of five tertiary university teaching hospitals
Fig. 117 (abstract A782). Loss of Rectus Femoris Dead vs Alive
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and five secondary hospitals in the capital city of Ulaanbaatar as well
as nine secondary province hospitals were collected during a six
month period in 2014/15. The study protocol was approved by the
Ethics Committee of the Mongolian Medical University.
Results: During the observation period, 2,032 patients (53.6 % male)
with a median age of 49 years (interquartile range, 36–62 years) were
admitted to the study ICUs. The ten most frequent ICU admission
diagnoses were stroke (ischemic and hemorrhagic) (n = 354; 17.4 %),
decompensated liver cirrhosis (n = 187; 9.2 %), acute or acute-on-
chronic heart failure (n = 182; 9 %), infection (n = 169; 8.3 %), trauma
(n = 153; 7.5 %), traumatic brain injury (n = 145; 7.1 %), acute abdo-
men (n = 143; 7 %), pre-eclampsia/eclampsia (n = 117; 5.8 %), acute
or acute-on-chronic renal failure (n = 80; 3.9 %) and postoperative
care following elective and emergency surgery (n = 66; 3.2 %). 100 %,
31.7 % and 13 % of patients had access to mechanical ventilation,
renal replacement therapy and invasive hemodynamic monitoring,
respectively. ICU mortality was 23.5 % in the total population and
26.6 % when maternal cases were excluded. Multiple organ dysfunc-
tion syndrome (38.1 %), coma (36.6 %) and shock (15.6 %) were the
three most common causes of death. The five ICU admission diagno-
ses with the highest case fatality rate were lung tuberculosis
(51.9 %), traumatic brain injury (42.1 %), decompensated liver cirrho-
sis (33.7 %), stroke (31.9 %) and infection (30.8 %). The five ICU ad-
mission diagnoses causing most death cases were stroke (n = 113),
decompensated liver cirrhosis (n = 63), traumatic brain injury (n = 61),
infection (n = 52) and acute abdomen (n = 38).
Conclusions: Critical illness in Mongolia affects younger patients than
reported from high-income countries. ICU admission diagnoses are
similar with a particularly high incidence of stroke and decompen-
sated liver cirrhosis. Total ICU mortality is approximately 25 % with
most ICU deaths caused by stroke, decompensated liver cirrhosis and
traumatic brain injury.
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Introduction: Chloride alterations play a major physiologic role in the
development of acid–base disorders. Most of the studies related to
abnormalities in chloride concentration have been focused on the
hyperchloremic metabolic acidosis. Although hypochloremic meta-
bolic alkalosis has been suggested as a predictor of mortality, this
issue remains insufficiently studied.
Objective: To assess the prognostic value of hypochloremia in a large
cohort of critically ill patients.
Methods: We conducted a single-center retrospective observational
study that included all patients admitted at the ICU between 2007
and 2015. Chloride serum concentration adjusted to blood sodium
level, acid–base status, routine laboratory, and clinical variables were
measured at admission. The primary outcome was defined as the all-
cause hospital death according to quintiles of serum chloride levels.
We performed a multivariate logistic regression, in which quintiles of
chloride levels were analyzed as dummy variables.
Results: We included 4898 patients. APACHE II score was 13 ± 7. Hos-
pital mortality was 12 %. Fig. 118 shows the hospital mortality in the
different quintiles of chloride concentration.
In the multivariate analysis, the quintile of chloride concentration of
99 ± 3 mEq/L was independently associated with a worse outcome
(OR = 2.00, 95 % CI = 1.46-2.76, P = 0.001) after adjusting to APACHE II
score, vasopressor requirements, mechanical ventilation, and lactate
levels.
Conclusions: In this large series of critically ill patients, the presence
of hypochloremia at ICU admission was an independent predictor of
mortality. In contrast, hyperchloremia was not associated with in-
creased mortality.
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Introduction: Continuous renal replacement therapy (CRRT) is com-
monly employed in ICU for patients with acute kidney injury and is
associated with increased morbidity and mortality. However, renal
outcomes at in the longer term are not widely described in the litera-
ture and have never been described in Ireland.
Objectives: We analysed all patients admitted to our tertiary ICU
who were commenced on CRRT over a 2 year period. Our primary
aim was to calculate the mortality of this cohort and estimate the
likelihood of survivors requiring long-term dialysis. Our secondary
aim was to analyse the characteristics of those requiring long-term
dialysis.
Method: We conducted a retrospective cohort study of all patients
requiring CRRT admitted to our ICU between 2013 and 2015. From
the Clinical Information System, we analysed patient age, sex, diag-
nosis, illness severity scores, pre-CRRT creatinine levels, AKIN scores,
length of CRRT and ICU admission. Survivors with new onset renal
failure were followed up at 6 and 12 months to determine survival,
dialysis dependency and serum creatinine level. This study received
ethical committee waiver.
Results: Of 686 ICU admissions, 202 patients (29.4 %) received CRRT.
50 % of these patients died prior to hospital discharge. 85 patients
had new onset renal failure and survived to hospital discharge. The 5
patients dialysed for toxin removal were excluded from further ana-
lysis. 11 patients (13.8 %) required ongoing CRRT at hospital dis-
charge whereas 69 patients (86.2 %) did not. Of those requiring
ongoing CRRT, 1 patient had died at 6 months, 2 further patients
had died at 12 months, and 1 patient was lost to follow-up. Of the
remaining 7 patients, 4 (57 %) were dialysis dependent at 12 months.
Of the 69 patients who did not require RRT at hospital discharge, 12
had died at 6 months and 3 further patients had died at 12 month
follow-up. 4 patients were lost to follow-up and a further 5 patients
Fig. 118 (abstract A784).
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did not have blood results available. Of the remaining 45 patients,
100 % were not dialysis dependent at 12 months.
Conclusions: The mortality rate for patients admitted to ICU and
commenced on CRRT in our cohort was consistent with that in the
international literature. The likelihood of requiring long-term dialysis
for survivors was similarly consistent. This novel information is of
value in the management and prognostication of patients requiring
CRRT in an Irish ICU setting.
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Introduction: During acute illness, the risk of death depends mainly
on the severity of the disease, the previous health status of the pa-
tient, and how he (she) responds to injury or disease. In the last dec-
ade, several studies have evaluated the impact of sex on mortality of
patients with different acute problems and they have found that hor-
mones may be a factor that also influences the outcome of critically
ill patients.
Objective: To evaluate the capacity of serum estradiol levels to pre-
dict mortality in critically ill patients.
Patients and methods: A prospective study was performed in critic-
ally ill patients admitted to the intensive care unit (ICU). Serum estra-
diol level was measured at admission to the ICU, its discriminative
capacity to predict mortality was determined by analysis of the re-
ceiver operative characteristics (ROC) curve, and its association with
mortality by logistic regression analysis. A p value < 0.05 was consid-
ered statistically significant.
Results: We included 131 patients with a mean age of 48.9 years,
57.3 % men. The serum estradiol was higher in non-survivors com-
pared with survivors: 116 vs 67.2 pg/mL, respectively (p < 0.0001).
The area under the ROC curve of serum estradiol to predict mortality
was 0.74 (p < 0.0001). The serum estradiol >97.9 pg/mL had sensitiv-
ity 60 %, specificity 90 %, positive predictive value 64 %, negative
predictive value 88 %, positive likelihood 6, and negative likelihood
0.44 to identify mortality. In the multivariate analysis, it had OR of
6.47 (p = 0.002) for ICU mortality.
Conclusions: Serum estradiol is elevated in critically ill patients, espe-
cially in those who die, it has good discriminative ability for mortality
and is an independent risk factor for death in this group of patients.
Keywords: Critically ill patients, serum estradiol, mortality.
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Introduction: Secondhand smoke (SHS) exposure is harmful and a
major problem worldwide that is associated with ill health and mor-
tality (1,2).
Objectives: The purpose of this study was to investigate the associ-
ation between exposure to secondhand smoke (SHS) on outcomes in
intensive care unit (ICU) after scoliosis surgery.
Methods: This prospective observational study was conducted in 103 pa-
tients, 12–18 years, with idiopathic scoliosis for elective posterior spinal
fusion. All patients underwent standard total intravenous anesthesia and
epidural morphine with PCA. Quality of pain relief and sedation were
assessed using the Numeric Visual Analog Scale (NVAS), Richmond Agita-
tion Sedation Scale (RASS). The patients were divided into three groups:
Group S; consisted of smokers, Group SHS; consisted of exposure
smokers, and Group NS; consisted of individuals who did not have any
history of smoking and were not exposed to smoke. Information was re-
ported in questionnaires and took blood samples for analysis of serum
cotinine obtained at the time of study enrollment. Demographic and clin-
ical characteristics included morphine usage, blood transfusion, duration
of mechanical ventilator support and length of ICU stay were recorded.
Results: The patient characteristics did not differ between the
groups. There was a statistically significant difference among groups
in terms of serum cotinine levels. There were no significant differ-
ences in NVAS and RASS scores between the groups. The HR and
MAP were not differ between the three groups of patients at all the
evaluation time. Morphine consumption was significantly less in
Group SHS compared with that of Group S at all time points (P <
0.05). There were no significant differences regarding the number of
transfused blood units between the three groups of patients. Dur-
ation of MV support was significantly higher in group SHS than in
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group S (P < 0.05). The median length of ICU stay was significantly
longer in group SHS than in group S (P < 0.05). The occurrence of
pneumonia in this population was also similar between the three
groups of patients. there were no significant differences between the
groups with regard to postoperative side effects.
Conclusions: We found that SHS was associated with increased
length of ICU stay compared to nonsmokers among scoliosis surgery
patient. We concluded that it is important to avoid SHS before at ICU
admission when possible.
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Introduction: Acute kidney injury (AKI) occurs in 20 - 50 % in pa-
tients with severe sepsis, with more than half of these patients need-
ing continuous renal replacement therapy (CRRT)1. The mortality
among the patients needing CRRT generally exceeds 60 %2,3.
Objectives: To evaluate the outcome of patients in the medical in-
tensive care unit (MICU) with a diagnosis of severe sepsis with AKI
and who required CRRT.
Methods: We conducted a retrospective analysis of patients admitted
to Changi General Hospital MICU with a diagnosis of severe sepsis
with AKI who required CRRT from June 2013 to January 2015.
Results: A total of 213 patients were screened and 33 were excluded
because of incomplete data. One hundred and eighty patient records
were analyzed. Of these, 105 (58.3 %) were male. The mean APACHE
II score was 28.13 ± 9.64. The median length of MICU stay was 3 days
(interquartile range 1–7) and median hospital length of stay was
16 days (interquartile range 9–33). The median duration of dialysis
was 1 day (interquartile range 1–2). The MICU mortality was 38.9 %
and hospital mortality was 39.4 %.
Conclusions: Mortality rates in our study were lower than what is
previously stated in the literature. It may be worthwhile to conduct a
multicentre study which includes other institutions in Singapore.
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Introduction: Patients admitted to Adult Critical Care following Brain
Injury who survive their hospital episode but do not regain 'normal'
functionality (sufficient to return home) remain dependent upon
healthcare for substantial periods of time. This poster compares the
pathways experienced by two groups of patients with Brain Injuries
(Traumatic vs Hypoxic) with the intention of influencing future plan-
ning strategies.
Objectives
 To identify the number of admissions and length of stay (LOS)
in Critical Care/On the ward of patients with TBI/HBI;
 To identify the hospital discharge destination of survivors
following TBI/HBI, where discharge home was not possible;
 Review of currents pathways for on-going management of TBI/
HBI patients following cessation of acute care.
Methods: Retrospective analysis of data collected via Ward Watcher
software (Critical Care Audit Ltd) of all TBI/HBI admissions to the
Adult Critical Care Directorate of a large London teaching hospital
between 01/01/2011 up to the 20/03/2016.
Results: Between 01/01/2011 and 20/03/2016, 205 patients were ad-
mitted to Adult Critical Care with TBI, versus 41 patients with HBI.
The average LOS in Adult Critical Care units for patients suffering TBI
is 9.7 days versus 23.4 days following HBI. Following Critical Care dis-
charge, hospital (ward) stay is 29.9 days for TBI patients and 48.9 days
for HBI patients.
TBI patients Adult Critical Care Stay during this period was 1980 days
versus 938 days for patients with HBI. Following discharge from this
London teaching hospital, those patients unsuitable for discharge
home received on-going care in other 'centres' .
Centre discharged to
 TBI 19 % Rehabilitation Centres, 78 % Other Hospitals, 20 %
Nursing Home.
 HBI 19 % Rehabilitation Centres, 51 % Other Hospitals,
20%Other Hospitals,10 % Still awaiting discharge.
Analysis of care provision for these patients identified a clear
structure and pathway for patients with TBI, supported by a mul-
tiprofessional team with structured, frequent patient reviews. In
comparison, patients with HBI had no clear pathway or review
frequency, although were supported by several therapeutic
disciplines.
Conclusion: It is clear that patients experiencing severe Brain Injury
(regardless of type) do experience prolonged hospital stays and un-
certain recovery pathways. Although larger in number, patients with
HBI tend to occupy both Critical Care and Ward Beds for lengthier
periods than patients with TBI. This may lead to delays in accessing
appropriate ongoing care and/or inappropriate use of resources in
specialised hospital beds.
Further work is needed to unpick the layers of consistency in service
provision for both groups.
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Introduction: Mortality in critically ill patients is high either while in
the ICU but also after discharge from the Intensive Care Unit (ICU).
The mortality rate must be understood and integrated into the hos-
pital reality where the ICU is inserted.
Objectives: In the present study we aim to understand factors associ-
ated with ICU and hospital mortality and the trajectories and burden
of functional limitations of ICU survivors.
Methods: Mortality was characterized at the time of discharge from
ICU, in the first 48 hours of ICU and after ICU. Studied variables in-
cluded type of admission (scheduled surgery, urgent surgery, medical
and trauma), age, gender, SAPS II, main diagnosis, median length of
stay (LS) before ICU, in ICU and after ICU.
Student test was performed to compare continuous values and chi-
square for categorical variables. Man-Whitney U test was performed
to study continuous variables nonparametric. Statistical significance
was defined as p-values less than 0,05.
Results: A total of 446 patients were discharged from ICU in 2015.
118 (26.45 %) died in the ICU. 38 (8.5 %) patients died in the remain-
der time of their hospitalization. Hospital mortality was 34.9 %. Of
the patients who died in the ICU, 59 (50 %) died in the first 48 hours.
Of the patients who died from septic shock, 36 were medical and 35
urgent surgical.
Septic shock was the main cause of death in medical and, in particular,
in urgent surgical population. Medical patients had a early ICU mortality
(<48 h) that was higher than in surgical patients. Higher age and higher
severity of disease was also associated with higher mortality. Mortality
was significantly higher in those patients who had a longer lenght of
stay in hospital before ICU admission (Table 88).
Those who died after ICU had a median lenght of stay in hospital of
49 days; of these, a median of 8 days were spent in the ICU, a median of
13 days were spent in the ward before ICU admission and a median of
28 days were spent after ICU discharge until death occurs in the ward.
Conclusions: The perception of the conditions under which death
occurs can help to rethink the organization of the critical patient cir-
cuit in the hospital, in particular to prompt earlier ICU admissions
and to adress more aproppriately those patients who might or not
benefit from ICU admission.
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Introduction: QuickSOFA (qSOFA) was recently suggested to identify
patients with suspected infection at higher risk of worse outcomes.
However, qSOFA in non-infected patients has not been described. The
objective of this study was to evaluate if qSOFA might predict hospital
mortality in a Brazilian cohort of non-infected critically ill patients.
Methods: This is a retrospective cohort study conducted at a private
tertiary hospital (Hospital Sirio-Libanes) at São Paulo, Brazil. We ex-
tracted relevant information from the adult intensive care unit (ICU)
database (sistema Epimed™). A comparison was performed between
SAPS 3 score model and qSOFA model at ICU admission both as a di-
chotomous variable (≥2 criteria - “qSOFA positive” versus 0–1 criterion -
“qSOFA negative”) and as an ordinal variable from 0 to 3 (according to
the number of qSOFA criteria met) for predicting hospital mortality in
patients admitted to the ICU without infection. Models discriminations
were compared using area under the ROC curves.
Results: Between January 2012 to December 2014 we studied 1,150
patients (hospital mortality of 12 %). Patients who died were more
severely ill compared to patients those who survived (SAPS 3 of
56 [47–63] versus 36 [29–45] respectively; p < 0.001), were older,
more frequently came from the ward with longer hospital length
of stay before ICU admission, had more comorbidities, more fre-
quently required mechanical ventilation and vasoactive drugs as
well as dialysis, had higher lactate levels at admission (2.1 [1.3 -
3.5] versus 1.6 [1.1 - 2.5] respectively; p < 0.001), and more fre-
quently were “qSOFA positive” (30.4 % vs 9.1 % respectively, p <
0.001). However, area under ROC curve for SAPS 3 was higher
(0.84 [95 % CI 0.82 - 0.86]) than for qSOFA both as a dichotom-
ous variable (0.61 [95 % CI 0.58 - 0.64]) as an ordinal variable
(0.67 [95 % CI 0.65 - 0.70]; p < 0.001 for comparisons between
SAPS 3 and both qSOFA models).
Conclusion: The utility of qSOFA to recognize severity of illness
and predict mortality in our cohort of ICU patients is similar to
the previous description in suspected infection, but less accurate
than SAPS 3.
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Table 88 (abstract A791). Characteristics of patients who suffered
hospital mortality
Study variables Patients
discharged
from hospital
alive (n= 290)
Patients
discharged
from hospital
dead (n=156 )
p
Admission type: urgent
surgery;scheduled
surgery;Medical;Trauma
72;62;130;26 50;9;83;14 <0,001*
Age in years (median) 59,58 64,9 0,001**
SAPS II (median) 46,46 64,9 <0,001**
Diagnosis (top 5):Septic
shock;cardiogenic shock;
Hypovolemic
shock;Neurological
emergency;Respiratory
failure
93;13;11;20;24 79;5;6;21;9 0,127**;0,127**;
0,127**;0,127**;0,127**
length of hospital stay
(LS) in days (median)
32,2 22 -
LS before ICU 4 8 0,039***
LS in ICU 6,78 7,09 -
LS after ICU 21 7,0 -
(*chi-square ;**t-student test; *** Mann-Whitney U test)
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